Citrus Sinensis ID: 012267
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 467 | 2.2.26 [Sep-21-2011] | |||||||
| Q94AG2 | 625 | Somatic embryogenesis rec | yes | no | 1.0 | 0.747 | 0.927 | 0.0 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 1.0 | 0.743 | 0.940 | 0.0 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.972 | 0.738 | 0.816 | 0.0 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.970 | 0.730 | 0.772 | 0.0 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.925 | 0.718 | 0.709 | 1e-173 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.997 | 0.767 | 0.572 | 1e-143 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.970 | 0.713 | 0.563 | 1e-142 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.957 | 0.700 | 0.555 | 1e-141 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.970 | 0.738 | 0.563 | 1e-140 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.980 | 0.724 | 0.552 | 1e-138 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 805 bits (2080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/467 (92%), Positives = 451/467 (96%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNI++LQVLDLSNNRLSG VPDNGSFSLFTPISFANNLDLCGPVT PCPGSPPFSP
Sbjct: 159 MSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSP 218
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPFI PPP+S+P G TGAIAGGVAAGAALLFAAPAIAFAWWRRRKP + FFDVPAEE
Sbjct: 219 PPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEE 278
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLADG+LVAVKRLKEERTP
Sbjct: 279 DPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTP 338
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PL
Sbjct: 339 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPL 398
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 399 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 458
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 459 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 518
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQ NY E E+EQ+IQVALLCTQGSPM+RPKMSEVVRMLEG
Sbjct: 519 LDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLEG 578
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAE+WDEWQKVE+LR+E++L+P+PNSDWI+DST NLHAVELSGPR
Sbjct: 579 DGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 800 bits (2066), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/467 (94%), Positives = 454/467 (97%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNI +LQVLDLSNNRLSG VPDNGSFSLFTPISFANNLDLCGPVT RPCPGSPPFSP
Sbjct: 162 MSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSP 221
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPFIPPP + +PGG SATGAIAGGVAAGAALLFAAPA+AFAWWRRRKPQEFFFDVPAEE
Sbjct: 222 PPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEE 281
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADG+LVAVKRLKEERTP
Sbjct: 282 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTP 341
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL
Sbjct: 342 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 401
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
W R++IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA+LMDYKD
Sbjct: 402 AWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKD 461
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 462 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 521
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQ+NY EAEVEQLIQVALLCTQ SPM+RPKMSEVVRMLEG
Sbjct: 522 LDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 581
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAE+WDEWQKVEVLRQEVEL+ HP SDWI+DST+NLHA+ELSGPR
Sbjct: 582 DGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAMELSGPR 628
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/469 (81%), Positives = 404/469 (86%), Gaps = 15/469 (3%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPP 61
SLT + +LQVLDLSNN L+G +P NGSFSLFTPISFAN +P + P
Sbjct: 159 SLTAVLTLQVLDLSNNPLTGDIPVNGSFSLFTPISFAN------------TKLTPLPASP 206
Query: 62 PPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEED 121
PP I P P S G N TGAIAGGVAAGAALLFA PAIA AWWRR+KPQ+ FFDVPAEED
Sbjct: 207 PPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEED 266
Query: 122 PEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG 181
PEVHLGQLKRFSLRELQVA+D+FSNKNILGRGGFGKVYKGRLADG+LVAVKRLKEERT G
Sbjct: 267 PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG 326
Query: 182 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLD 241
GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP SQ PLD
Sbjct: 327 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 386
Query: 242 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301
WP R+RIALGSARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT
Sbjct: 387 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 446
Query: 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRAFDLARLANDDDVMLL
Sbjct: 447 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 506
Query: 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421
DWVKGLLKEKKLE LVD DLQ NY + EVEQLIQVALLCTQ SPM+RPKMSEVVRMLEGD
Sbjct: 507 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 566
Query: 422 GLAERWDEWQKVEVLRQEVELAPH--PNSDWIV-DSTENLHAVELSGPR 467
GLAERW+EWQK E+ RQ+ H S WI+ DST + SGPR
Sbjct: 567 GLAERWEEWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/470 (77%), Positives = 395/470 (84%), Gaps = 17/470 (3%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
M+LT++ LQVLD+SNNRLSG +P NGSFSLFTPISFANN +T P
Sbjct: 165 MTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANN-----SLTDLP--------E 210
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPP P P G T AIAGGVAAGAALLFA PAIAFAWW RRKPQ+ FFDVPAEE
Sbjct: 211 PPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEE 270
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRF+LREL VATD+FSNKN+LGRGGFGKVYKGRLADG+LVAVKRLKEERT
Sbjct: 271 DPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTK 330
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP L
Sbjct: 331 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPAL 390
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWP RK IALGSARGL+YLHDHCD KIIHRDVKAANILLDEEFEAVVGDFGLAKLM+Y D
Sbjct: 391 DWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYND 450
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQ+AFDLARLANDDD+ML
Sbjct: 451 SHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIML 510
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVK +LKEKKLE LVD +L+ YVE EVEQLIQ+ALLCTQ S M+RPKMSEVVRMLEG
Sbjct: 511 LDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEG 570
Query: 421 DGLAERWDEWQKVEVLRQEV--ELAPHPNSDWIVDSTENLHAVEL-SGPR 467
DGLAERW+EWQK E+ + + PH +DW++ + +L + SGPR
Sbjct: 571 DGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 620
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 608 bits (1568), Expect = e-173, Method: Compositional matrix adjust.
Identities = 328/462 (70%), Positives = 361/462 (78%), Gaps = 30/462 (6%)
Query: 9 LQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPP 68
L VLD+SNNRLSG +P NGSFS FT +SFANN P P
Sbjct: 167 LDVLDISNNRLSGDIPVNGSFSQFTSMSFANN----------------------KLRPRP 204
Query: 69 PISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQ 128
SP + + AI GVAAGAALLFA RRK Q F DVPAEEDPEV+LGQ
Sbjct: 205 ASPSPSPSGTSAAIVVGVAAGAALLFALAWWL-----RRKLQGHFLDVPAEEDPEVYLGQ 259
Query: 129 LKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQT 188
KRFSLREL VAT+ FS +N+LG+G FG +YKGRLAD +LVAVKRL EERT GGELQFQT
Sbjct: 260 FKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQT 319
Query: 189 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI 248
EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP LDWP RK I
Sbjct: 320 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHI 379
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
ALGSARGL+YLHDHCD KIIH DVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVR
Sbjct: 380 ALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVR 439
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368
GTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQ+AFDLARLANDDD+MLLDWVK +L
Sbjct: 440 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVL 499
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWD 428
KEKKLE LVD +L+ YVE EVEQLIQ+ALLCTQ S M+RPKMSEVVRMLEGDGLAERW+
Sbjct: 500 KEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWE 559
Query: 429 EWQKVEVLRQEV--ELAPHPNSDWIVDSTENLHAVEL-SGPR 467
EWQK E+ + + PH +DW++ + +L + SGPR
Sbjct: 560 EWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1310), Expect = e-143, Method: Compositional matrix adjust.
Identities = 273/477 (57%), Positives = 331/477 (69%), Gaps = 11/477 (2%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDN--GSFSLFTPISFANNLDLCGPVTGRPCPG----- 54
+L N+ +LQ L LS N L+G +PD+ G L + +NNL P + P
Sbjct: 131 TLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQSLFKIPKYNFTA 190
Query: 55 ---SPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRR-KPQ 110
S + P P + S + TG IAG V+ A +L F + + +
Sbjct: 191 NNLSCGGTFPQPCVTESSPSGDSSSRKTGIIAGVVSGIAVILLGFFFFFFCKDKHKGYKR 250
Query: 111 EFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVA 170
+ F DV E D + GQL+RF+ RELQ+ATD FS KN+LG+GGFGKVYKG L+DG+ VA
Sbjct: 251 DVFVDVAGEVDRRIAFGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVYKGLLSDGTKVA 310
Query: 171 VKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 230
VKRL + PGG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYP+M N SVA CL
Sbjct: 311 VKRLTDFERPGGDEAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSVAYCL 370
Query: 231 RERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290
RE P LDW RK+IALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct: 371 REIKPGDPVLDWFRRKQIALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 430
Query: 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 350
GLAKL+D + T+VTT VRGT+GHIAPE +STGKSSEKTDVFGYGIMLLEL+TGQRA D +
Sbjct: 431 GLAKLVDVRRTNVTTQVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLELVTGQRAIDFS 490
Query: 351 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 410
RL +DDV+LLD VK L +EK+LE +VD L +Y++ EVE +IQVALLCTQ +P +RP
Sbjct: 491 RLEEEDDVLLLDHVKKLEREKRLEDIVDKKLDEDYIKEEVEMMIQVALLCTQAAPEERPA 550
Query: 411 MSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
MSEVVRMLEG+GLAERW+EWQ +EV RQE DW DS N A+ELSG R
Sbjct: 551 MSEVVRMLEGEGLAERWEEWQNLEVTRQEEFQRLQRRFDWGEDSINNQDAIELSGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-142, Method: Compositional matrix adjust.
Identities = 269/477 (56%), Positives = 327/477 (68%), Gaps = 24/477 (5%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPP 61
SL N++ L LDLS N LSG VP SL + N +C T + C G+ P
Sbjct: 172 SLANMTQLTFLDLSYNNLSGPVPR----SLAKTFNVMGNSQICPTGTEKDCNGTQPKPMS 227
Query: 62 PPFIPPPPISSPGGNSATG-AIAGGVAAGAALLFAAPAIAFAWWRRR-KPQEFFFDVPAE 119
SS GG A+ GV+ L WWRRR Q FFD+ +
Sbjct: 228 ITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRRRHNKQVLFFDINEQ 287
Query: 120 EDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT 179
E+ LG L+RF+ +ELQ AT +FS+KN++G+GGFG VYKG L DGS++AVKRLK+
Sbjct: 288 NKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVKRLKDINN 347
Query: 180 PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP 239
GGE+QFQTE+EMIS+AVHRNLLRL GFC T +ERLLVYPYM+NGSVAS L+ +P
Sbjct: 348 GGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLKAKPV---- 403
Query: 240 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299
LDW TRKRIALG+ RGL YLH+ CDPKIIHRDVKAANILLD+ FEAVVGDFGLAKL+D++
Sbjct: 404 LDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHE 463
Query: 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
++HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITG RA + + AN
Sbjct: 464 ESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGA- 522
Query: 360 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+LDWVK L +EKKLE +VD DL++NY EVE+++QVALLCTQ P+ RPKMSEVVRMLE
Sbjct: 523 ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRMLE 582
Query: 420 GDGLAERWD-EWQKVEVLRQEVELAPHPN--------SDWIVDSTENLHAVELSGPR 467
GDGL E+W+ Q+ E R PN SD DS+ + A+ELSGPR
Sbjct: 583 GDGLVEKWEASSQRAETNRS----YSKPNEFSSSERYSDLTDDSSVLVQAMELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1292), Expect = e-141, Method: Compositional matrix adjust.
Identities = 271/488 (55%), Positives = 344/488 (70%), Gaps = 41/488 (8%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRP--CP-GSPP 57
+SL+N++ L LDLS N LSG VP F +F+ + G P CP G+ P
Sbjct: 171 LSLSNMTQLAFLDLSYNNLSGPVPR------FAAKTFS--------IVGNPLICPTGTEP 216
Query: 58 FSPPPPFIPPP--------PISSPGGNSATGAIAGGVAAGA-ALLFAAPAIAFAWWRRRK 108
IP P+ + G + AIA G + G +L+F A + F WWR+R
Sbjct: 217 DCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGL-FLWWRQRH 275
Query: 109 PQEFFFDVP-AEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGS 167
Q FFDV EV LG L+RF RELQ+AT++FS+KN+LG+GG+G VYKG L D +
Sbjct: 276 NQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDST 335
Query: 168 LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 227
+VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYPYM+NGSVA
Sbjct: 336 VVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVA 395
Query: 228 SCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV 287
S ++ +P LDW RKRIA+G+ARGL YLH+ CDPKIIHRDVKAANILLD+ EAVV
Sbjct: 396 SRMKAKP----VLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVV 451
Query: 288 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
GDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLEL+TGQRAF
Sbjct: 452 GDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAF 511
Query: 348 DLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL--QNNYVEAEVEQLIQVALLCTQGSP 405
+ + AN VM LDWVK + +EKKLE+LVD +L + +Y E E++++++VALLCTQ P
Sbjct: 512 EFGKAANQKGVM-LDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLP 570
Query: 406 MDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQ------EVELAPHPNSDWIVDSTENLH 459
RPKMSEVVRMLEGDGLAE+W+ Q+ + + + E+ + SD DS+ +
Sbjct: 571 GHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLLVQ 630
Query: 460 AVELSGPR 467
A+ELSGPR
Sbjct: 631 AMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1281), Expect = e-140, Method: Compositional matrix adjust.
Identities = 276/490 (56%), Positives = 330/490 (67%), Gaps = 37/490 (7%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDN------------------GSF--SLFTPISF---A 38
++ N+ LQ L LS N+L+G +P++ G SLF + +
Sbjct: 137 TIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTS 196
Query: 39 NNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPA 98
NNL+ CG GR P P + S TG IAG VA +LF
Sbjct: 197 NNLN-CG---GRQ---------PHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILL 243
Query: 99 IAFAWWRRR-KPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGK 157
F R + ++ F DV E D + GQLKRF+ RELQ+ATD+FS KN+LG+GGFGK
Sbjct: 244 FLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGK 303
Query: 158 VYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217
VYKG L D + VAVKRL + +PGG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLV
Sbjct: 304 VYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLV 363
Query: 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 277
YP+M N S+A LRE LDW TRKRIALG+ARG YLH+HC+PKIIHRDVKAAN+
Sbjct: 364 YPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANV 423
Query: 278 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 337
LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIML
Sbjct: 424 LLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 483
Query: 338 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVA 397
LEL+TGQRA D +RL +DDV+LLD VK L +EK+L +VD +L Y++ EVE +IQVA
Sbjct: 484 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVA 543
Query: 398 LLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTEN 457
LLCTQGSP DRP MSEVVRMLEG+GLAERW+EWQ VEV R+ DW DS N
Sbjct: 544 LLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHN 603
Query: 458 LHAVELSGPR 467
A+ELSG R
Sbjct: 604 QDAIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1263), Expect = e-138, Method: Compositional matrix adjust.
Identities = 263/476 (55%), Positives = 330/476 (69%), Gaps = 18/476 (3%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSP-PFSP 60
SL+ I L ++D+S N LSG +P + + N +CGP C P P +
Sbjct: 165 SLSKIEGLTLVDISYNNLSGSLPKVSARTF----KVIGNALICGPKAVSNCSAVPEPLTL 220
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
P P S N A+A + AA + F WWR R+ ++ FFDV +
Sbjct: 221 PQD---GPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQY 277
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEV LG LKR++ +EL+ AT+ F++KNILGRGG+G VYKG L DG+LVAVKRLK+
Sbjct: 278 DPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIA 337
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGE+QFQTEVE IS+A+HRNLLRLRGFC + ER+LVYPYM NGSVAS L++ + L
Sbjct: 338 GGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPAL 397
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DW RK+IA+G+ARGL YLH+ CDPKIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D
Sbjct: 398 DWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 457
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITGQ+A D R A+ VM
Sbjct: 458 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVM- 516
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVK L +E KL+ L+D DL + + E+E+++QVALLCTQ +P RPKMSEV++MLEG
Sbjct: 517 LDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEG 576
Query: 421 DGLAERWDEWQKVEVLRQEVELAP---------HPNSDWIVDSTENLHAVELSGPR 467
DGLAERW+ Q Q L P SD+I +S+ + A+ELSGPR
Sbjct: 577 DGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 467 | ||||||
| 50657183 | 621 | somatic embryogenesis receptor kinase 1 | 1.0 | 0.752 | 1.0 | 0.0 | |
| 227184173 | 621 | somatic embryogenesis receptor-like kina | 1.0 | 0.752 | 1.0 | 0.0 | |
| 152926154 | 624 | somatic embryogenesis receptor kinase [C | 1.0 | 0.748 | 0.987 | 0.0 | |
| 406868969 | 626 | protein kinase [Prunus persica] | 1.0 | 0.746 | 0.987 | 0.0 | |
| 152926161 | 624 | somatic embryogenesis receptor kinase [C | 1.0 | 0.748 | 0.985 | 0.0 | |
| 399146059 | 626 | somatic embryogenesis receptor-like kina | 1.0 | 0.746 | 0.980 | 0.0 | |
| 399146057 | 632 | somatic embryogenesis receptor-like kina | 1.0 | 0.738 | 0.974 | 0.0 | |
| 306489670 | 626 | somatic embryogenesis receptor-like kina | 1.0 | 0.746 | 0.978 | 0.0 | |
| 255588059 | 661 | BRASSINOSTEROID INSENSITIVE 1-associated | 1.0 | 0.706 | 0.976 | 0.0 | |
| 356576127 | 624 | PREDICTED: somatic embryogenesis recepto | 1.0 | 0.748 | 0.978 | 0.0 |
| >gi|50657183|dbj|BAD32780.1| somatic embryogenesis receptor kinase 1 [Citrus unshiu] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2486), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/467 (100%), Positives = 467/467 (100%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP
Sbjct: 155 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 214
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE
Sbjct: 215 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 274
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP
Sbjct: 275 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 334
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL
Sbjct: 335 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 394
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 395 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG
Sbjct: 515 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 575 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 621
|
Source: Citrus unshiu Species: Citrus unshiu Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|227184173|gb|ACP20180.1| somatic embryogenesis receptor-like kinase [Citrus sinensis] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2482), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/467 (100%), Positives = 467/467 (100%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP
Sbjct: 155 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 214
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE
Sbjct: 215 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 274
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP
Sbjct: 275 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 334
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL
Sbjct: 335 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 394
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 395 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 454
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 455 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 514
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG
Sbjct: 515 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 574
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 575 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 621
|
Source: Citrus sinensis Species: Citrus sinensis Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|152926154|gb|ABS32228.1| somatic embryogenesis receptor kinase [Carica papaya] gi|164522080|gb|ABY60779.1| somatic embryogenesis receptor kinase [Carica papaya] | Back alignment and taxonomy information |
|---|
Score = 948 bits (2450), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/467 (98%), Positives = 464/467 (99%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNN LSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP
Sbjct: 158 MSLTNISSLQVLDLSNNHLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 217
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPF+PPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE
Sbjct: 218 PPPFVPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 277
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADG+LVAVKRLKEERTP
Sbjct: 278 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTP 337
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PL
Sbjct: 338 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPL 397
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 398 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 457
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 458 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 517
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQ NYV+AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG
Sbjct: 518 LDWVKGLLKEKKLEMLVDPDLQKNYVDAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 577
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 578 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 624
|
Source: Carica papaya Species: Carica papaya Genus: Carica Family: Caricaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|406868969|gb|AFS64763.1| protein kinase [Prunus persica] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2449), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/467 (98%), Positives = 464/467 (99%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNN LSG VPDNGSFSLFTPISFANNL+LCGPVTGRPCPGSPPFSP
Sbjct: 160 MSLTNISSLQVLDLSNNHLSGEVPDNGSFSLFTPISFANNLNLCGPVTGRPCPGSPPFSP 219
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPF+PPPPIS+PGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE
Sbjct: 220 PPPFVPPPPISTPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 279
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP
Sbjct: 280 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 339
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PL
Sbjct: 340 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPL 399
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 400 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 459
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 460 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 519
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG
Sbjct: 520 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 579
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 580 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 626
|
Source: Prunus persica Species: Prunus persica Genus: Prunus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|152926161|gb|ABS32233.1| somatic embryogenesis receptor kinase [Carica papaya] gi|164522085|gb|ABY60783.1| somatic embryogenesis receptor kinase [Carica papaya] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2447), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/467 (98%), Positives = 464/467 (99%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNN LSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP
Sbjct: 158 MSLTNISSLQVLDLSNNHLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 217
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPF+PPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE
Sbjct: 218 PPPFVPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 277
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADG+LVAVKRLKEERTP
Sbjct: 278 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTP 337
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PL
Sbjct: 338 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPL 397
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 398 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 457
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 458 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 517
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQ NY++AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG
Sbjct: 518 LDWVKGLLKEKKLEMLVDPDLQRNYIDAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 577
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 578 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 624
|
Source: Carica papaya Species: Carica papaya Genus: Carica Family: Caricaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399146059|gb|AFP25206.1| somatic embryogenesis receptor-like kinase [Malus hupehensis] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2434), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/467 (98%), Positives = 464/467 (99%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNN LSGVVPDNGSFSLFTPISFANN++LCGPVTGRPCPGSPPFSP
Sbjct: 160 MSLTNISSLQVLDLSNNGLSGVVPDNGSFSLFTPISFANNMNLCGPVTGRPCPGSPPFSP 219
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPF+PPPPIS PGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE
Sbjct: 220 PPPFVPPPPISIPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 279
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP
Sbjct: 280 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 339
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP+Q PL
Sbjct: 340 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPNQPPL 399
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWP+RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 400 DWPSRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 459
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 460 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 519
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQ+NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG
Sbjct: 520 LDWVKGLLKEKKLEMLVDPDLQSNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 579
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 580 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 626
|
Source: Malus hupehensis Species: Malus hupehensis Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399146057|gb|AFP25205.1| somatic embryogenesis receptor-like kinase [Malus hupehensis] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2176), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/473 (97%), Positives = 466/473 (98%), Gaps = 6/473 (1%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN+DLCGPVTGRPCPGSPPFSP
Sbjct: 160 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNMDLCGPVTGRPCPGSPPFSP 219
Query: 61 PPPFIPPPPISSPG------GNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFF 114
PPPF+PPPPIS+PG GNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFF
Sbjct: 220 PPPFVPPPPISTPGIASLVGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFF 279
Query: 115 DVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL 174
DVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL
Sbjct: 280 DVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL 339
Query: 175 KEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 234
KEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP
Sbjct: 340 KEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 399
Query: 235 PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294
P+Q PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK
Sbjct: 400 PNQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 459
Query: 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 354
LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN
Sbjct: 460 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 519
Query: 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
DDDVMLLDWVKGLLKEKKLEMLVDPDLQ+NYVEAEVEQLIQVALLCTQGSPMDRPKMSEV
Sbjct: 520 DDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 579
Query: 415 VRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
VRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 580 VRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 632
|
Source: Malus hupehensis Species: Malus hupehensis Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|306489670|gb|ADM94278.1| somatic embryogenesis receptor-like kinase [Rosa canina] | Back alignment and taxonomy information |
|---|
Score = 839 bits (2168), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/467 (97%), Positives = 463/467 (99%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNN LSG VPDNGSFSLFTPISFANNL+LCGPVTGRPCPGSPPFSP
Sbjct: 160 MSLTNISSLQVLDLSNNHLSGEVPDNGSFSLFTPISFANNLNLCGPVTGRPCPGSPPFSP 219
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPF+PPPPIS+PGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE
Sbjct: 220 PPPFVPPPPISTPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 279
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP
Sbjct: 280 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 339
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PL
Sbjct: 340 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPL 399
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 400 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 459
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 460 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 519
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQ NYV+AEVEQLIQVALLCTQGSPM+RPKMSEVVRMLEG
Sbjct: 520 LDWVKGLLKEKKLEMLVDPDLQRNYVDAEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 579
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKV+VLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 580 DGLAERWDEWQKVKVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 626
|
Source: Rosa canina Species: Rosa canina Genus: Rosa Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255588059|ref|XP_002534492.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223525200|gb|EEF27892.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2157), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/467 (97%), Positives = 463/467 (99%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNISSLQVLDLSNN LSGVVPDNGSFSLFTPISFANNLDLCGPVTG PCPGSPPFSP
Sbjct: 143 MSLTNISSLQVLDLSNNHLSGVVPDNGSFSLFTPISFANNLDLCGPVTGHPCPGSPPFSP 202
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPF+PPPPIS+PGGNSATGAIAGGVAAGAALLFAAPA+AFAWWRRRKPQEFFFDVPAEE
Sbjct: 203 PPPFVPPPPISAPGGNSATGAIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEE 262
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADG+LVAVKRLKEERTP
Sbjct: 263 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTP 322
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ PL
Sbjct: 323 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPL 382
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 383 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 442
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 443 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 502
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQ+ YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG
Sbjct: 503 LDWVKGLLKEKKLEMLVDPDLQSKYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 562
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKVEVLRQE++LAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 563 DGLAERWDEWQKVEVLRQEIDLAPHPNSDWIVDSTENLHAVELSGPR 609
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576127|ref|XP_003556185.1| PREDICTED: somatic embryogenesis receptor kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/467 (97%), Positives = 462/467 (98%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
MSLTNI++LQVLDLSNN LSGVVPDNGSFSLFTPISFANNLDLCGPVTG PCPGSPPFSP
Sbjct: 158 MSLTNITALQVLDLSNNHLSGVVPDNGSFSLFTPISFANNLDLCGPVTGHPCPGSPPFSP 217
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
PPPF+PPPPIS+PGGN ATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE
Sbjct: 218 PPPFVPPPPISAPGGNGATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 277
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP
Sbjct: 278 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 337
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP Q PL
Sbjct: 338 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPHQEPL 397
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD
Sbjct: 398 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 457
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
Sbjct: 458 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 517
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
LDWVKGLLKEKKLEMLVDPDLQNNY+EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG
Sbjct: 518 LDWVKGLLKEKKLEMLVDPDLQNNYIEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 577
Query: 421 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 467
DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR
Sbjct: 578 DGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVELSGPR 624
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 467 | ||||||
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.781 | 0.581 | 0.917 | 1e-204 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.781 | 0.584 | 0.906 | 1.5e-203 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.781 | 0.588 | 0.796 | 1.3e-169 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.989 | 0.768 | 0.633 | 2.4e-153 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.764 | 0.582 | 0.662 | 5e-125 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.982 | 0.726 | 0.528 | 4.5e-124 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.980 | 0.717 | 0.526 | 1.1e-122 | |
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.773 | 0.587 | 0.591 | 2.3e-116 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.882 | 0.649 | 0.515 | 1.7e-109 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.685 | 0.493 | 0.610 | 1.9e-106 |
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1754 (622.5 bits), Expect = 1.0e-204, Sum P(2) = 1.0e-204
Identities = 335/365 (91%), Positives = 346/365 (94%)
Query: 103 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 162
WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR
Sbjct: 264 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323
Query: 163 LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222
LADG+LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383
Query: 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282
NGSVASCLRERPPSQLPL W R++IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443
Query: 283 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
FEAVVGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 503
Query: 343 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQ 402
GQRAFDLARLANDDDVMLLDWV VDPDLQ+NY EAEVEQLIQVALLCTQ
Sbjct: 504 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQ 563
Query: 403 GSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVE 462
SPM+RPKMSEVVRMLEGDGLAE+WDEWQKVEVLRQEVEL+ HP SDWI+DST+NLHA+E
Sbjct: 564 SSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAME 623
Query: 463 LSGPR 467
LSGPR
Sbjct: 624 LSGPR 628
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1746 (619.7 bits), Expect = 1.5e-203, Sum P(2) = 1.5e-203
Identities = 331/365 (90%), Positives = 345/365 (94%)
Query: 103 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 162
WWRRRKP + FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGR
Sbjct: 261 WWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGR 320
Query: 163 LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222
LADG+LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA
Sbjct: 321 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 380
Query: 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282
NGSVASCLRERPPSQ PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 381 NGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 440
Query: 283 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT
Sbjct: 441 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 500
Query: 343 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQ 402
GQRAFDLARLANDDDVMLLDWV VDPDLQ NY E E+EQ+IQVALLCTQ
Sbjct: 501 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQ 560
Query: 403 GSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEVELAPHPNSDWIVDSTENLHAVE 462
GSPM+RPKMSEVVRMLEGDGLAE+WDEWQKVE+LR+E++L+P+PNSDWI+DST NLHAVE
Sbjct: 561 GSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVE 620
Query: 463 LSGPR 467
LSGPR
Sbjct: 621 LSGPR 625
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1519 (539.8 bits), Expect = 1.3e-169, Sum P(2) = 1.3e-169
Identities = 293/368 (79%), Positives = 318/368 (86%)
Query: 103 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 162
WW RRKPQ+ FFDVPAEEDPEVHLGQLKRF+LREL VATD+FSNKN+LGRGGFGKVYKGR
Sbjct: 253 WWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGR 312
Query: 163 LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222
LADG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA
Sbjct: 313 LADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 372
Query: 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282
NGSVASCLRERP LDWP RK IALGSARGL+YLHDHCD KIIHRDVKAANILLDEE
Sbjct: 373 NGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEE 432
Query: 283 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
FEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 433 FEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 492
Query: 343 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQ 402
GQ+AFDLARLANDDD+MLLDWV VD +L+ YVE EVEQLIQ+ALLCTQ
Sbjct: 493 GQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQ 552
Query: 403 GSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLRQEV--ELAPHPNSDWIVDSTENLHA 460
S M+RPKMSEVVRMLEGDGLAERW+EWQK E+ + + PH +DW++ + +L
Sbjct: 553 SSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIE 612
Query: 461 VEL-SGPR 467
+ SGPR
Sbjct: 613 NDYPSGPR 620
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1450 (515.5 bits), Expect = 2.4e-153, Sum P(2) = 2.4e-153
Identities = 297/469 (63%), Positives = 332/469 (70%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCXXXXXXXXX 61
SL + L+ L L NN LSG +P + + + +NN L G + P
Sbjct: 137 SLGKLGKLRFLRLYNNSLSGEIPRSLTALPLDVLDISNNR-LSGDI---PVNGSFSQFTS 192
Query: 62 XXXXXXXXXXXXXGNSXXXXXXXXXXXXXXXXXXXXXXXXXWWRRRKPQEFFFDVPAEED 121
S WW RRK Q F DVPAEED
Sbjct: 193 MSFANNKLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALAWWLRRKLQGHFLDVPAEED 252
Query: 122 PEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG 181
PEV+LGQ KRFSLREL VAT+ FS +N+LG+G FG +YKGRLAD +LVAVKRL EERT G
Sbjct: 253 PEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKG 312
Query: 182 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLD 241
GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP LD
Sbjct: 313 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALD 372
Query: 242 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301
WP RK IALGSARGL+YLHDHCD KIIH DVKAANILLDEEFEAVVGDFGLAKLM+Y D+
Sbjct: 373 WPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDS 432
Query: 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQ+AFDLARLANDDD+MLL
Sbjct: 433 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLL 492
Query: 362 DWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421
DWV VD +L+ YVE EVEQLIQ+ALLCTQ S M+RPKMSEVVRMLEGD
Sbjct: 493 DWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGD 552
Query: 422 GLAERWDEWQKVEVLRQEV--ELAPHPNSDWIVDSTENLHAVEL-SGPR 467
GLAERW+EWQK E+ + + PH +DW++ + +L + SGPR
Sbjct: 553 GLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1187 (422.9 bits), Expect = 5.0e-125, Sum P(2) = 5.0e-125
Identities = 238/359 (66%), Positives = 275/359 (76%)
Query: 110 QEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLV 169
++ F DV E D + GQLKRF+ RELQ+ATD+FS KN+LG+GGFGKVYKG L D + V
Sbjct: 256 RDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKV 315
Query: 170 AVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 229
AVKRL + +PGG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYP+M N S+A
Sbjct: 316 AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHR 375
Query: 230 LRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289
LRE LDW TRKRIALG+ARG YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGD
Sbjct: 376 LREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 435
Query: 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349
FGLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D
Sbjct: 436 FGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDF 495
Query: 350 ARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP 409
+RL +DDV+LLD V VD +L Y++ EVE +IQVALLCTQGSP DRP
Sbjct: 496 SRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRP 555
Query: 410 KMSEVVRMLEGDGLAERWDEWQKVEVLRQ-EVELAPHPNSDWIVDSTENLHAVELSGPR 467
MSEVVRMLEG+GLAERW+EWQ VEV R+ E E DW DS N A+ELSG R
Sbjct: 556 VMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQR-RFDWGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1185 (422.2 bits), Expect = 4.5e-124, Sum P(2) = 4.5e-124
Identities = 251/475 (52%), Positives = 311/475 (65%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCXXXXXXXXX 61
SL+ I L ++D+S N LSG +P S F I N +CGP C
Sbjct: 165 SLSKIEGLTLVDISYNNLSGSLP-KVSARTFKVIG---NALICGPKAVSNCSAVPEPLTL 220
Query: 62 XXXXXXXXXXXXXGNSXXXXXXXXXXXXXXXXXXXXXXXXXWWRRRKPQEFFFDVPAEED 121
G+ WWR R+ ++ FFDV + D
Sbjct: 221 PQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFL--WWRYRRNKQIFFDVNEQYD 278
Query: 122 PEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG 181
PEV LG LKR++ +EL+ AT+ F++KNILGRGG+G VYKG L DG+LVAVKRLK+ G
Sbjct: 279 PEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAG 338
Query: 182 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLD 241
GE+QFQTEVE IS+A+HRNLLRLRGFC + ER+LVYPYM NGSVAS L++ + LD
Sbjct: 339 GEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALD 398
Query: 242 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301
W RK+IA+G+ARGL YLH+ CDPKIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+
Sbjct: 399 WSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 458
Query: 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITGQ+A D R A+ VML
Sbjct: 459 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVML- 517
Query: 362 DWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421
DWV +D DL + + E+E+++QVALLCTQ +P RPKMSEV++MLEGD
Sbjct: 518 DWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGD 577
Query: 422 GLAERWDEWQKVEVLRQEVELAP-----HPN----SDWIVDSTENLHAVELSGPR 467
GLAERW+ Q Q L P P SD+I +S+ + A+ELSGPR
Sbjct: 578 GLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-122, Sum P(2) = 1.1e-122
Identities = 251/477 (52%), Positives = 314/477 (65%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCXXXXXXXX 60
+SL+N++ L LDLS N LSG VP F+ T S N +C T C
Sbjct: 171 LSLSNMTQLAFLDLSYNNLSGPVP---RFAAKT-FSIVGNPLICPTGTEPDCNGTTLIPM 226
Query: 61 XXXXXXXXXXXXXXGN-SXXXXXXXXXXXXXXXXXXXXXXXXXWWRRRKPQEFFFDVP-A 118
G+ + WWR+R Q FFDV
Sbjct: 227 SMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDG 286
Query: 119 EEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER 178
EV LG L+RF RELQ+AT++FS+KN+LG+GG+G VYKG L D ++VAVKRLK+
Sbjct: 287 NHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGG 346
Query: 179 TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL 238
GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYPYM+NGSVAS ++ +P
Sbjct: 347 ALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPV--- 403
Query: 239 PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298
LDW RKRIA+G+ARGL YLH+ CDPKIIHRDVKAANILLD+ EAVVGDFGLAKL+D+
Sbjct: 404 -LDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDH 462
Query: 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 358
+D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLEL+TGQRAF+ + AN V
Sbjct: 463 QDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGV 522
Query: 359 MLLDWVXXXXXXXXXXXXVDPDL--QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
ML DWV VD +L + +Y E E++++++VALLCTQ P RPKMSEVVR
Sbjct: 523 ML-DWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVR 581
Query: 417 MLEGDGLAERWDEWQKVEVLRQ------EVELAPHPNSDWIVDSTENLHAVELSGPR 467
MLEGDGLAE+W+ Q+ + + + E+ + SD DS+ + A+ELSGPR
Sbjct: 582 MLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLLVQAMELSGPR 638
|
|
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 2.3e-116, Sum P(2) = 2.3e-116
Identities = 216/365 (59%), Positives = 270/365 (73%)
Query: 106 RRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD 165
RR + FFDV E+D ++ GQLKRFSLRE+Q+ATDSF+ N++G+GGFGKVY+G L D
Sbjct: 251 RRTKYDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPD 310
Query: 166 GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225
+ VAVKRL + +PGGE FQ E+++IS+AVH+NLLRL GFC T +ER+LVYPYM N S
Sbjct: 311 KTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLS 370
Query: 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285
VA LR+ + LDWPTRKR+A GSA GL YLH+HC+PKIIHRD+KAANILLD FE
Sbjct: 371 VAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEP 430
Query: 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 345
V+GDFGLAKL+D THVTT VRGT+GHIAPEYL TGKSSEKTDVFGYGI LLEL+TGQR
Sbjct: 431 VLGDFGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQR 490
Query: 346 AFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQGSP 405
A D +RL +++++LLD + VD +L Y EVE ++QVALLCTQGSP
Sbjct: 491 AIDFSRLEEEENILLLDHIKKLLREQRLRDIVDSNL-TTYDSKEVETIVQVALLCTQGSP 549
Query: 406 MDRPKMSEVVRMLEGDG-LAERWDEWQKVEVLR-QEVELAPHPNSDWIVDSTE-NLHAVE 462
DRP MSEVV+ML+G G LAE+W EW+++E +R +E L P + W + T + ++
Sbjct: 550 EDRPAMSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIR 609
Query: 463 LSGPR 467
LS R
Sbjct: 610 LSTAR 614
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1023 (365.2 bits), Expect = 1.7e-109, Sum P(2) = 1.7e-109
Identities = 220/427 (51%), Positives = 272/427 (63%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCXXXXXXXXX 61
SL+ I L LDLS N L G VP F T + A N +C C
Sbjct: 165 SLSQIPHLSFLDLSYNNLRGPVP---KFPART-FNVAGNPLICKNSLPEICSGSISASPL 220
Query: 62 XXXXXXXXXXXXXGNSXXXXXXXXXXXXXXXXXXXXXXXXXWWRRRKPQEFFFDVP-AEE 120
G W+R+++ + + +E
Sbjct: 221 SVSLRSSS-----GRRTNILAVALGVSLGFAVSVILSLGFIWYRKKQRRLTMLRISDKQE 275
Query: 121 DPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP 180
+ + LG L+ F+ REL VATD FS+K+ILG GGFG VY+G+ DG++VAVKRLK+
Sbjct: 276 EGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGT 335
Query: 181 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
G QF+TE+EMIS+AVHRNLLRL G+C + +ERLLVYPYM+NGSVAS L+ +P L
Sbjct: 336 SGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPA----L 391
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
DW TRK+IA+G+ARGL YLH+ CDPKIIHRDVKAANILLDE FEAVVGDFGLAKL++++D
Sbjct: 392 DWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHED 451
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITG RA + + + ML
Sbjct: 452 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAML 511
Query: 361 LDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
+WV VD +L Y EV +++QVALLCTQ P RPKMSEVV+MLEG
Sbjct: 512 -EWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEG 570
Query: 421 DGLAERW 427
DGLAERW
Sbjct: 571 DGLAERW 577
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 1.9e-106, Sum P(2) = 1.9e-106
Identities = 199/326 (61%), Positives = 247/326 (75%)
Query: 103 WWRRRKPQEFFFDVPAEEDPEVH-LGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKG 161
W+R+++ + ++ +++ + LG L+ F+ REL V TD FS+KNILG GGFG VY+G
Sbjct: 261 WYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRG 320
Query: 162 RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221
+L DG++VAVKRLK+ G+ QF+ E+EMIS+AVH+NLLRL G+C T ERLLVYPYM
Sbjct: 321 KLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYM 380
Query: 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 281
NGSVAS L+ +P LDW RKRIA+G+ARGL YLH+ CDPKIIHRDVKAANILLDE
Sbjct: 381 PNGSVASKLKSKPA----LDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDE 436
Query: 282 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELI 341
FEAVVGDFGLAKL+++ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELI
Sbjct: 437 CFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 496
Query: 342 TGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDPDLQNNYVEAEVEQLIQVALLCT 401
TG RA + + + ML +WV +D +L NY + EV +++QVALLCT
Sbjct: 497 TGLRALEFGKTVSQKGAML-EWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCT 555
Query: 402 QGSPMDRPKMSEVVRMLEGDGLAERW 427
Q P RPKMSEVV MLEGDGLAERW
Sbjct: 556 QYLPAHRPKMSEVVLMLEGDGLAERW 581
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q94AG2 | SERK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9271 | 1.0 | 0.7472 | yes | no |
| Q9XIC7 | SERK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9400 | 1.0 | 0.7436 | no | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 467 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| TIGR03921 | 350 | TIGR03921, T7SS_mycosin, type VII secretion-associ | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 9e-50
Identities = 70/194 (36%), Positives = 99/194 (51%), Gaps = 10/194 (5%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LG GGFG VY R G VA+K +K+E + + E+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
LV Y GS+ L+E L RI L GL YLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 269 HRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 326
HRD+K NILLD + + DFGL+KL+ + + T + GT ++APE L G SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 327 KTDVFGYGIMLLEL 340
K+D++ G++L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 85/280 (30%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 145 SNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+ LG G FG+VYKG+L VAVK LKE+ + +F E ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N+++L G C +V YM G + S LR+ P L AL ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYL 118
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
IHRD+ A N L+ E + DFGL++ + D + + I +APE L
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 320 STGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
GK + K+DV+ +G++L E+ T G++ + ++N++ +L+++K +L
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYP--GMSNEE---VLEYLK---NGYRLPQ--- 224
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
P E+ L+ L C P DRP SE+V +L
Sbjct: 225 PP----NCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 85/280 (30%), Positives = 132/280 (47%), Gaps = 29/280 (10%)
Query: 145 SNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+ LG G FG+VYKG L VAVK LKE+ + +F E ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N+++L G C ++V YM G + LR+ P +L AL ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS--LSDLLSFALQIARGMEYL 119
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
IHRD+ A N L+ E + DFGL++ + D + + I +APE L
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 320 STGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
GK + K+DV+ +G++L E+ T G+ + ++N + +L+++K K +L
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYP--GMSNAE---VLEYLK---KGYRLPK--- 225
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
P E+ +L+ L C P DRP SE+V +L
Sbjct: 226 PP----NCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 4e-48
Identities = 74/199 (37%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG G FG VYK + G +VAVK L K + + E+ ++ H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
LV Y G + L P L K+IAL RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHSN---G 118
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS 325
IIHRD+K NILLDE + DFGLAK + + +TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 326 EKTDVFGYGIMLLELITGQ 344
K DV+ G++L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 89/285 (31%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 148 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
LG G FG+VYKG+L VAVK LKE+ + F E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLP----LDWPTRKRIALGSARGLSY 258
L G C LV YM G + LR+ RP P L A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---A 315
L K +HRD+ A N L+ E+ + DFGL++ + D + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374
PE L G + K+DV+ +G++L E+ T G + L+N++ +L++++ K +L
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEE---VLEYLR---KGYRLP 227
Query: 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
P+ Y E+ +L+ C Q P DRP SE+V LE
Sbjct: 228 K---PE----YCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 7e-47
Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 25/275 (9%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
+ LG G FGKVY R G LVA+K +K+++ + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
RL + LV Y G + L++R L D + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDE--ARFYLRQILSALEYLHSK 116
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
I+HRD+K NILLDE+ + DFGLA+ +D +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 323 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382
+ D++ G++L EL+TG+ F +D + L +K +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP----GDDQLLELF--------KKIGKPKPPFPPP 219
Query: 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
+ E + LI+ LL P R E ++
Sbjct: 220 EWDISPEAKDLIR-KLLVKD--PEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 82/278 (29%), Positives = 128/278 (46%), Gaps = 35/278 (12%)
Query: 150 LGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 204
LG G FG+VYKG L VAVK LKE + +F E ++ H N++RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
G C +V YM G + LR+ L ++AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---APEYLST 321
+HRD+ A N L+ E + DFGL++ + D + G I APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKD 178
Query: 322 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
GK + K+DV+ +G++L E+ T G++ + ++N++ +L+ ++ +L P+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY--PGMSNEE---VLELLE---DGYRLPR---PE 227
Query: 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
E+ +L+ L C P DRP SE+V L
Sbjct: 228 ----NCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 148 NILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVHRNLLRLR 205
+LGRG FG VY D G L+AVK ++ EL + E+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 206 GFCMTPTER-LLVY-PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
G + L ++ Y++ GS++S L++ L P ++ GL+YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLAYLHSN- 120
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTG 322
I+HRD+K ANIL+D + + DFG AK + D + T +VRGT +APE +
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 323 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
+ D++ G ++E+ TG+ + + L N +
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPW--SELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
F +G+GGFG+VYK R G VA+K +K E E E++++ H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ G + E +V + + GS+ L+ L + +GL YLH +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN 117
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST 321
IIHRD+KAANILL + E + DFGL+ L D K + GT +APE ++
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING 171
Query: 322 GKSSEKTDVFGYGIMLLELITGQ 344
K D++ GI +EL G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (310), Expect = 2e-31
Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 24/285 (8%)
Query: 143 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL--QFQTEVE-MISMAVHR 199
S+ LG G FG+VY R D LVA+K L ++ + +F E++ + S+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N+++L F LV Y+ GS+ L ++ + PL I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 260 HDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHV-----TTAVRGTIGH 313
H IIHRD+K NILLD + + DFGLAKL+ + + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 314 IAPEYL---STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370
+APE L S +S +D++ GI L EL+TG F+ + ++ L ++
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415
L + E + + P +R S +
Sbjct: 235 LA------SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 80/287 (27%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 148 NILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
LG G FGKV R G VAVK L F+ E+E++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 203 RLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+ +G C P R L+ Y+ +GS+ L+ ++ + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLG 126
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEY 318
+ IHRD+ A NIL++ E + DFGLAK++ + G I APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFD------LARLANDDDVMLLDWVKGLLKEKK 372
L T K S +DV+ +G+ L EL T L + M++ + LLKE
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG- 242
Query: 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
E L P EV L++ LC + P DRP ++++ +++
Sbjct: 243 -ERLPRPP----SCPDEVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-29
Identities = 107/440 (24%), Positives = 197/440 (44%), Gaps = 78/440 (17%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPF--- 58
+L N+ SL +++S+N L G +P G+F + A N+DLCG G G PP
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG---GDTTSGLPPCKRV 622
Query: 59 --SPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEF---- 112
+P F I+ GA L+ A A F + R R E
Sbjct: 623 RKTPSWWFY----ITC--------------TLGAFLVLALVAFGFVFIRGRNNLELKRVE 664
Query: 113 ---------FFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR- 162
FFD K ++ ++ S +N++ RG G YKG+
Sbjct: 665 NEDGTWELQFFDSKV----------SKSITINDI---LSSLKEENVISRGKKGASYKGKS 711
Query: 163 LADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221
+ +G VK + + + P E+ +++ H N+++L G C + L++ Y+
Sbjct: 712 IKNGMQFVVKEINDVNSIPSSEIADMGKLQ------HPNIVKLIGLCRSEKGAYLIHEYI 765
Query: 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 281
+++ LR L W R++IA+G A+ L +LH C P ++ ++ I++D
Sbjct: 766 EGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818
Query: 282 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELI 341
+ E + L L+ ++ ++APE T +EK+D++G+G++L+EL+
Sbjct: 819 KDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 342 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV--EAEVEQLIQVALL 399
TG+ D + +++W + + L+M +DP ++ + + E+ +++ +AL
Sbjct: 873 TGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH 929
Query: 400 CTQGSPMDRPKMSEVVRMLE 419
CT P RP ++V++ LE
Sbjct: 930 CTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 207
+G+G FGKVY R +DG L +K + E + EV+++ H N+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLP------LDWPTRKRIALGSARGLSYLHD 261
+ +V Y G ++ ++++ P LDW + + L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKYLHS 121
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
KI+HRD+K NI L +GDFG++K++ T V GT +++PE L
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQ 176
Query: 322 GKS-SEKTDVFGYGIMLLELITGQRAFD 348
K + K+D++ G +L EL T + F+
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 50/288 (17%)
Query: 148 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
++G G FG+V +GRL VA+K LK + L F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRER----PPSQLPLDWPTRKRIALGSARGLSYL 259
L G +++ YM NGS+ LRE QL + G A G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-------VGMLRGIASGMKYL 122
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHI 314
+ +HRD+ A NIL++ V DFGL++ ++ + TT +R T
Sbjct: 123 SEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT---- 175
Query: 315 APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKK 372
APE ++ K + +DV+ +GI++ E+++ G+R + D++ + DV+ K + +
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI-----KAVEDGYR 226
Query: 373 LEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
L +D P L Q+ L C Q +RP S++V L+
Sbjct: 227 LPPPMDCPSA-----------LYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 23/226 (10%)
Query: 144 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL 201
+ +++GRG FG VYKG L G VA+K++ E+ L+ E++++ H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA---RGLSY 258
++ G T ++ Y NGS+ +++ P L +A+ +GL+Y
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAY 114
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
LH+ +IHRD+KAANIL ++ + DFG+A ++ + +V GT +APE
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEV 170
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRA-FDLA------RLANDDD 357
+ +S +D++ G ++EL+TG +DL R+ DD
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH 216
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 149 ILGRGGFGKVYKGR-LADGSL----VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
+LG G FG VYKG + +G VA+K L+EE +P + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRE---RPPSQLPLDWPTRKRIALGSARGLSYLH 260
L G C++ L+ M G + +R SQ L+W + A+G+SYL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 319
+ +++HRD+ A N+L+ + DFGLAKL+D + + I +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 320 STGKSSEKTDVFGYGIMLLELIT-GQRAFD 348
+ K+DV+ YG+ + EL+T G + ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 7/199 (3%)
Query: 144 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
F+ + LG G FG+V++G + VA+K LK + + FQ EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
L C ++ M GS+ + LR P L + +A A G++YL +
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
IHRD+ A NIL+ E+ V DFGLA+L+ +D ++++ + APE S G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 324 SSEKTDVFGYGIMLLELIT 342
S K+DV+ +GI+L E+ T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 67/200 (33%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+G+G FG V G G VAVK LK++ T F E +++ H NL++L G
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ--AFLAEASVMTTLRHPNLVQLLG 67
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+ +V YMA GS+ LR R + + L + AL G+ YL +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---N 122
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
+HRD+ A N+L+ E+ A V DFGLAK V+ T APE L K S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178
Query: 327 KTDVFGYGIMLLELITGQRA 346
K+DV+ +GI+L E+ + R
Sbjct: 179 KSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 92/285 (32%), Positives = 132/285 (46%), Gaps = 41/285 (14%)
Query: 148 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
++G+G FG VY G L D AVK L QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 204 LRGFCMTPTE--RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI---ALGSARGLSY 258
L G C+ P+E L+V PYM +G + + +R PT K + L A+G+ Y
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIRS------ETHNPTVKDLIGFGLQVAKGMEY 113
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIA 315
L K +HRD+ A N +LDE F V DFGLA+ + +Y H T + + +A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374
E L T K + K+DV+ +G++L EL+T G + DV D LL+ ++L
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--------PDVDSFDITVYLLQGRRL- 221
Query: 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
LQ Y + L +V L C P RP SE+V +E
Sbjct: 222 ------LQPEYCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 150 LGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
LG+G FG VY+G + VA+K + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL---PLDWPTRKRI---ALGSARGLS 257
L G T L+V MA G + S LR R P L PT ++ A A G++
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTTAVRGTIG 312
YL K +HRD+ A N ++ E+ +GDFG+ + + DY K VR
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372
+APE L G + K+DV+ +G++L E+ T LA +GL E+
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT------LAEQP----------YQGLSNEEV 230
Query: 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
L+ ++D + E ++L+++ +C Q +P RP E+V L+
Sbjct: 231 LKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
+G+G FG VYKG L + VAVK + P + +F E E++ H N+++L G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 269
+V + GS+ + LR + ++L + +++L +A G+ YL IH
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR-KKKNRLTVK--KLLQMSLDAAAGMEYLESKN---CIH 116
Query: 270 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT----IGHIAPEYLSTGKSS 325
RD+ A N L+ E + DFG+++ ++ + T G I APE L+ G+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 326 EKTDVFGYGIMLLELITG 343
++DV+ YGI+L E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 70/279 (25%), Positives = 113/279 (40%), Gaps = 34/279 (12%)
Query: 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+LG+G G VYK R G + A+K++ + Q E++ +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRER---PPSQLPLDWPTRKRIALGSARGLS 257
+++ G E +V YM GS+A L++ P L IA +GL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-------AYIARQILKGLD 113
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
YLH IIHRD+K +N+L++ + E + DFG++K+++ T V GT+ +++PE
Sbjct: 114 YLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE 170
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
+ S D++ G+ LLE G+ F L ++ +
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFEL-----------MQAIC 216
Query: 378 D---PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 413
D P L E I C Q P RP +E
Sbjct: 217 DGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-23
Identities = 83/276 (30%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 147 KNILGRGGFGKVYKGRLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
K+ LG G +G+VY+G SL VAVK LKE+ E F E ++ H NL++L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
G C ++ +M G++ LRE ++ +A + + YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA--VVLLYMATQISSAMEYLEKK--- 123
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKS 324
IHRD+ A N L+ E V DFGL++LM DT+ A + I APE L+ K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 325 SEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383
S K+DV+ +G++L E+ T G + L+ V LL EK M
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELL-EKGYRM-------- 224
Query: 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
E ++ ++ C Q +P DRP +E+ + E
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-23
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 46/285 (16%)
Query: 144 FSNKNILGRGGFGKVYKG-RLADGSLVAVK---------RLKEERTPGGELQFQTEVEMI 193
F N +G+G FG V+K R AD + A+K R +EE E ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI--------DEARVL 53
Query: 194 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLD--WPTRKRIALG 251
+ ++R + + +V Y NG + L+ + LP D W R +
Sbjct: 54 AKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQ 109
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 311
GL++LH KI+HRD+K+ N+ LD +GD G+AKL+ T V GT
Sbjct: 110 ILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTP 165
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371
+++PE +EK+DV+ G++L E TG+ FD AN+ ++L ++G
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKIIRG----- 216
Query: 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
V P + Y +QL Q+ C RP +++R
Sbjct: 217 -----VFPPVSQMY----SQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 5e-23
Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 33/290 (11%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMI 193
++ + + ++G G FG+V++G L VA+K LK T F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 194 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 253
H N++RL G +++ YM NG++ LR+ R G A
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIA 117
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTI 311
G+ YL D +HRD+ A NIL++ E V DFGL++++ D + T+ T+ + I
Sbjct: 118 AGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLK 369
APE ++ K + +DV+ +GI++ E+++ G+R + D++ + +VM K +
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----NHEVM-----KAIND 225
Query: 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+L +D + V QL+ L C Q RP+ ++V +L+
Sbjct: 226 GFRLPAPMD-------CPSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 7e-23
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG+G FGKV R G L A+K LK+++ TE ++S H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 207 FCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA-LGSARGLSYLHDHCD 264
+ E+L LV Y G + S L + + + R A + A L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEER-ARFYAAEIVLA--LEYLHSL-- 112
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 324
II+RD+K NILLD + + DFGLAK + T GT ++APE L
Sbjct: 113 -GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 325 SEKTDVFGYGIMLLELITGQRAFD 348
+ D + G++L E++TG+ F
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 8e-23
Identities = 67/197 (34%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LG G FG+V+ G + VAVK LK +P LQ E +++ H L++L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAVC 70
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+V YM+ GS+ L+ +L L P +A A G++YL I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR---NYI 125
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEYLSTGKSS 325
HRD+ A NIL+ E + DFGLA+L+ +D TA G I APE + G+ +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI--EDDEY-TAREGAKFPIKWTAPEAANYGRFT 182
Query: 326 EKTDVFGYGIMLLELIT 342
K+DV+ +GI+L E++T
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 9e-23
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNL 201
+ +G G +G+VYK R G LVA+K+++ E G + E++++ H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 202 LRLRGFCMTPTERL-----LVYPYMA---NGSVASCLRERPPSQLPLDWPTRKRIALGSA 253
+RL+ T + +V+ YM G L + P + K
Sbjct: 61 VRLKEIV---TSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTE--SQIKCYMKQLL 110
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
GL YLH + I+HRD+K +NIL++ + + DFGLA+ +++ T T+ +
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 314 IAPEYL--STGKSSEKTDVFGYGIMLLELITGQRAF 347
PE L +T + + D++ G +L EL G+ F
Sbjct: 168 RPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 9e-23
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 30/226 (13%)
Query: 139 VATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEM 192
V D+ K LG G FGKV+ G D LVAVK LKE + F+ E E+
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 193 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK------ 246
++ H N+++ G C ++V+ YM +G + LR P L P
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 247 ----RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302
+IA+ A G+ YL +HRD+ N L+ + +GDFG++ +D +
Sbjct: 122 SQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVY 173
Query: 303 VTT--AVRGT----IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
T V G I + PE + K + ++DV+ +G++L E+ T
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 149 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGG---ELQ------FQTEVEMISMAVH 198
++G+G +G+VY G ++AVK+++ T G Q ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N+++ GF T + Y+ GS+ SCLR + L + GL+Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFFTEQVLEGLAY 123
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPE 317
LH I+HRD+KA N+L+D + + DFG++K D D +++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 318 YLSTGKS--SEKTDVFGYGIMLLELITGQR 345
+ + S K D++ G ++LE+ G+R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+ F LG G +G VYK G +VA+K + + E+ ++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPY 59
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL---GSARGLS 257
+++ G T+ +V Y GSV+ ++ L T + IA + +GL
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTL---TEEEIAAILYQTLKGLE 113
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IG---H 313
YLH + K IHRD+KA NILL+EE +A + DFG++ + T A R T IG
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFW 165
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
+APE + + K D++ GI +E+ G
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 5e-22
Identities = 86/289 (29%), Positives = 128/289 (44%), Gaps = 38/289 (13%)
Query: 150 LGRGGFGKVYKGR---LAD--GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 204
LG+G FG V R L D G +VAVK+L+ T F+ E+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 205 RGFCMTPTER--LLVYPYMANGSVASCL---RERPPSQLPLDWPTRKRIALGSARGLSYL 259
+G C + R LV Y+ GS+ L RER LD A +G+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER------LDHRKLLLYASQICKGMEYL 124
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPE 317
+ +HRD+ NIL++ E +GDFGL K++ D + V I APE
Sbjct: 125 GSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 318 YLSTGKSSEKTDVFGYGIMLLELIT------GQRAFDLARLAND-DDVMLLDWVKGLLKE 370
L+ K S +DV+ +G++L EL T A + + ND M++ + LLK
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
L P AE+ ++ C P RP SE+ +E
Sbjct: 242 NG--RLPAPP----GCPAEIYAIM---KECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 80/276 (28%), Positives = 118/276 (42%), Gaps = 30/276 (10%)
Query: 150 LGRGGFGKVYKGR----LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
LG G FG V +G VAVK LK ++ F E ++ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
G +T ++V GS+ LR+ + T A+ A G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK--- 116
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT-IGHIAPEYLSTGK 323
+ IHRD+ A NILL + + +GDFGL + L +D +V APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 324 SSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382
S +DV+ +G+ L E+ T G+ + A L+ + +D K+ E L P
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPW--AGLSGSQILKKID--------KEGERLERP--- 223
Query: 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
EA + + V L C +P DRP + + L
Sbjct: 224 ----EACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 149 ILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRNL 201
LG G FG+V K S VAVK LK++ T +E+EM+ M H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPPSQ---LPLDWPTRKRI--------A 249
+ L G C +V Y A+G++ LR RPP + P + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVR 308
ARG+ +L K IHRD+ A N+L+ E+ + DFGLA+ + + D + TT R
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ +APE L + ++DV+ +G++L E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 34/276 (12%)
Query: 149 ILGRGGFGK--VYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLR 205
+LG+G FG+ +Y+ R D SLV K + R + E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
M L+ Y G++ + + + + SA +SY+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 325
I+HRD+K NI L + +GDFG++K++ + + T V GT +++PE K +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 326 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 385
K+D++ G +L EL+T +R FD N LV +Q NY
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLN---------------------LVVKIVQGNY 218
Query: 386 ---VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
V +LI + Q P RP EV+
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGF 207
LG G FG+V++G + + VAVK LK PG F E +++ H L++L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
C +V M GS+ L+ L L P +A A G++YL
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---NY 124
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 327
IHRD+ A N+L+ E V DFGLA+++ + I APE + S K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 328 TDVFGYGIMLLELIT 342
+DV+ +GI+L E++T
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ---FQTEVEMISMAVHRNLLRLRG 206
LG G FG+V+ G + VA+K LK+ G + F E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+T ++ YM NGS+ L+ +L + +A A G++++
Sbjct: 69 -VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIERK---N 122
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
IHRD++AANIL+ E + DFGLA+L++ + + I APE ++ G +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 327 KTDVFGYGIMLLELITGQR 345
K+DV+ +GI+L E++T R
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 149 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+LG+G FG+V+KG L D + VAVK KE+ +++F +E ++ H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 209 MTPTERLLVYPYM---ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
T+R +Y M G S LR++ L + AL +A G++YL
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESK--- 112
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 325
IHRD+ A N L+ E + DFG+++ D + + I APE L+ G+ S
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 326 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 385
++DV+ YGI+L E F L G+ ++ E V+ + +
Sbjct: 173 SESDVWSYGILLWE------TFSLGVCP----------YPGMTNQQAREQ-VEKGYRMSC 215
Query: 386 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
+ + + +V C P +RPK SE+ + L
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 148 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
++G G VY L + VA+KR+ E+ + + EV+ +S H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+ E LV PY++ GS+ ++ P LD + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLSTG 322
IHRD+KA NILL E+ + DFG++ + T VR GT +APE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 323 KS-SEKTDVFGYGIMLLELITG 343
K D++ +GI +EL TG
Sbjct: 182 HGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 150 LGRGGFGKVYKG--RLADGSL--VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
LG G FG V KG + G VAVK LK+E G+ +F E +++ H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
G C +LV G + L++R + K +A A G++YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV----SDLKELAHQVAMGMAYLESK--- 114
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGK 323
+HRD+ A N+LL +A + DFG+++ + + TTA R + APE ++ GK
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 324 SSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL- 381
S K+DV+ YG+ L E + G + + + + + +L+ E L P+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPY--GEMKGAEVIAMLE---------SGERLPRPEEC 223
Query: 382 -QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421
Q Y + L C + P DRP SE+ D
Sbjct: 224 PQEIY---------SIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 30/282 (10%)
Query: 149 ILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
LGRG FG+V+ + +LV VK L++ + + +F+ E++M H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 203 RLRGFCMTPTERLLVYPYMANGS-----VASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
RL G C ++ Y G A+ ++ PL + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
+L + + +HRD+ A N L+ + E V L+K + + + + +APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
+ S K+DV+ +G+++ E+ T Q L++++ V L+ KLE+ V
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE-------VLNRLQAGKLELPV 240
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
E +L ++ C +P DRP SE+V L
Sbjct: 241 P--------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKR--LKEERTPGGELQFQTEVEMISMAVH 198
+ F+ +G+G FG+VYK +VA+K L+E ++Q E++ +S
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ--QEIQFLSQCRS 58
Query: 199 RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
+ + G +L ++ Y GS L+ LD I GL
Sbjct: 59 PYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGK-----LDETYIAFILREVLLGLE 112
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGH 313
YLH+ IHRD+KAANILL EE + + DFG L M ++T V GT
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFW 164
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
+APE + EK D++ GI +EL G
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 150 LGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
LG G FGKVYKG L + VA+K LKE P + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALG 251
L G C +++ Y+A+G + L P + LD IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 310
A G+ YL H +HRD+ A N L+ E + DFGL++ + D + V +
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 340
+ + PE + GK + ++D++ +G++L E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
LG G FG V+ G+ VA+K ++E E F E +++ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 210 TPTERLLVYPYMANGSVASCLRERP---PSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+V YMANG + + LRER ++ LD + + YL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG--- 120
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
IHRD+ A N L+ E+ V DFGLA+ + + + + PE + S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 327 KTDVFGYGIMLLELITG 343
K+DV+ +G+++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 148 NILGRGGFGKVYKGRLADGSLVAVKR--LKEERTPGGELQF---QTEVEMISMAVHRNLL 202
+LG+G +G VY G G L+AVK+ L E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ G C+ + ++ GS++S L P P+ K+I G++YLH++
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNN 121
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-----TAVRGTIGHIAPE 317
C ++HRD+K N++L + DFG A+ + + H T ++ GT +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQ 344
++ K+D++ G + E+ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 72/219 (32%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKG----RLADGS--LVAVKRLKEERTPGGELQFQTEVE 191
+V DS + LG G FG+VY+G R D VAVK L E + E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 192 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RP----PSQLPLDWPTRK 246
++S H+N++RL G R ++ MA G + S LRE RP PS L +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK--DLL 119
Query: 247 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHV 303
A A+G YL ++ IHRD+ A N LL + A + DFG+A+ + Y+ ++
Sbjct: 120 FCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYY 175
Query: 304 TTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 340
R I + PE G + KTDV+ +G++L E+
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 3e-20
Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 149 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
I+G G FG V +G G VAVK +K + T F E +++ H+NL+RL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ +V M+ G++ + LR R + + + + +L A G+ YL K++
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESK---KLV 122
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 328
HRD+ A NIL+ E+ A V DFGLA++ + V+ T APE L K S K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 329 DVFGYGIMLLELITGQRA 346
DV+ YG++L E+ + RA
Sbjct: 179 DVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 150 LGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
+G+G FG+V++ R ++VAVK LKEE + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ------------------LPLDWPTR 245
L G C L++ YMA G + LR R P LPL +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYKDTH 302
IA A G++YL + K +HRD+ N L+ E + DFGL++ DY
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
A+ I + PE + + + ++DV+ YG++L E+ +
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 6e-20
Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 59/293 (20%)
Query: 149 ILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 204
++G G FG+V +GRL VA+K LK T F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
G +++ +M NG++ S LR+ + R G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM-- 125
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIG--HIAPEYLS 320
+HRD+ A NIL++ V DFGL++ + D D T+++ G I APE ++
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 321 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
K + +DV+ YGI++ E+++ G+R + W
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPY---------------W---------------- 213
Query: 380 DLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
D+ N V +EQ L Q+ L C Q RPK ++V L+
Sbjct: 214 DMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 6e-20
Identities = 72/278 (25%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-----FQTEVEMISMAVHRNLL 202
LG G F Y+ R + G+L+AVK++ R E + + E+ +++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
R+ G + L +MA GSV+ L + + + RGLSYLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV----IINYTEQLLRGLSYLHEN 122
Query: 263 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEY 318
+IIHRDVK AN+L+D + + + DFG A + K T + GTI +APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
L + DV+ G +++E+ T + ++ + +N + L+ + + +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIASATTAPSIPEHLS 237
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
P L++ V L C + P DRP E+++
Sbjct: 238 PGLRD------------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 8e-20
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
D LG G G V K G ++AVK ++ E + Q E++++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
++ G + + YM GS+ L+E Q + +IA+ +GL+YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEY 318
+ KIIHRDVK +NIL++ + + DFG++ + T V GT ++APE
Sbjct: 118 E--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPER 170
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQ 344
+ S K+D++ G+ L+EL TG+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 8e-20
Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 150 LGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+GRG FG+V+ GRL AD + VAVK +E P + +F E ++ H N++RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+V + G + LR P L ++ +A G+ YL I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGK 323
HRD+ A N L+ E+ + DFG+++ ++ A G + I APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 324 SSEKTDVFGYGIMLLE 339
S ++DV+ +GI+L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 17/220 (7%)
Query: 148 NILGRGGFGKVYKG-RLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLR 205
N +G G FGKVY L G L+AVK ++ + P + E++++ + H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
G + + + Y + G++ L LD + L GL+YLH H
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEYLSTG 322
I+HRD+K ANI LD +GDFG A + T + V+ G ++APE ++ G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 323 KSSEK---TDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
K D++ G ++LE+ TG+R + + L N+ +M
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 18/211 (8%)
Query: 149 ILGRGGFGKVYK-GRLADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
++GRG FG V+ R AD LV +K++ E+ T L Q E +++ + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARGLSYLHDH 262
+ ++V Y G++A +++R S L L + + +AL ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHVHTK 120
Query: 263 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
I+HRD+K NILLD+ V +GDFG++K++ K T V GT +I+PE
Sbjct: 121 ---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEG 175
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAFDLARL 352
++K+D++ G +L EL + +RAF+ A L
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 77/289 (26%), Positives = 135/289 (46%), Gaps = 42/289 (14%)
Query: 149 ILGRGGFGKVYKGRLA--DGSL--VAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLR 203
ILG G FG V +G+L+ DGS VAVK +K + E++ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 204 LRGFCMTPTER------LLVYPYMANGSVASCLRERPPSQLPLDWPTRK--RIALGSARG 255
L G C + +++ P+M +G + S L LP P + + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTI 311
+ YL + IHRD+ A N +L E+ V DFGL+K + Y+ + + +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPV 179
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 370
IA E L+ + K+DV+ +G+ + E+ T GQ + + N + + D+++ +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY--PGVENHE---IYDYLRHGNRL 234
Query: 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
K+ E +D +L + C + P DRP +++ +LE
Sbjct: 235 KQPEDCLD-------------ELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 150 LGRGGFGKVYKG-RLADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 204
LG G FG VY+G L DG AVK + + Q + E+ ++S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 205 RGFCMTPTERLLVY-PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
G + L ++ + GS+A L++ P+ ++I LG L YLHD
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR- 121
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STG 322
+HRD+K ANIL+D + DFG+AK + + +G+ +APE + G
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQG 177
Query: 323 KSSEKTDVFGYGIMLLELITGQ 344
D++ G +LE+ TG+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG-ELQ-FQTEVEMISM 195
++ +S LG G FG+V+ G + + VAVK LK PG +Q F E ++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKT 57
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 255
H L+RL ++ YMA GS+ L+ ++ L P + A G
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEG 115
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
++Y+ IHRD++AAN+L+ E + DFGLA++++ + + I A
Sbjct: 116 MAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA 172
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELIT 342
PE ++ G + K+DV+ +GI+L E++T
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 72/278 (25%), Positives = 129/278 (46%), Gaps = 39/278 (14%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVH---RNLLR 203
++GRG +G VY+G+ + G +VA+K + + TP ++ Q EV ++S N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
G + ++ Y GSV + ++ P ++ + R+ + L Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV- 120
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
+IHRD+KAANIL+ + DFG+A L++ + +T V GT +APE ++ GK
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177
Query: 324 SSE-KTDVFGYGIMLLELITGQRAF---DLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
+ K D++ GI + E+ TG + D R M+L + K K P
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-----IPKSKP------P 220
Query: 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
L++N + + + C P +R E+++
Sbjct: 221 RLEDNGYSKLLREFVA---ACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 31/278 (11%)
Query: 149 ILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 204
++G G FG+V GRL VA+K LK T F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
G ++V YM NGS+ + LR+ + R G A G+ YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDM-- 125
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLSTG 322
+HRD+ A NIL++ V DFGL++++ D + + T + I APE ++
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 323 KSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381
K + +DV+ YGI++ E+++ G+R + ++N D +K + + +L +D
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPY--WEMSNQ------DVIKAIEEGYRLPAPMD--- 233
Query: 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
A + QL+ L C Q +RPK ++V +L+
Sbjct: 234 ----CPAALHQLM---LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 8e-19
Identities = 65/210 (30%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 149 ILGRGGFGKVYKG-RLADGSLV----AVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
+LG G FG VYKG + +G V A+K L E P ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLH 260
L G C++PT + LV M +G + + E SQL L+W + A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL 319
+ +++HRD+ A N+L+ + DFGLA+L++ + + I +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 320 STGKSSEKTDVFGYGIMLLELIT-GQRAFD 348
K + ++DV+ YG+ + EL+T G + +D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 52/193 (26%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
+G G FG V+ G + VA+K ++E E F E +++ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 269
+ LV+ +M +G ++ LR + T + L G++YL +IH
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 270 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 329
RD+ A N L+ E V DFG+ + + +T + + +PE S K S K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 330 VFGYGIMLLELIT 342
V+ +G+++ E+ +
Sbjct: 184 VWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 150 LGRGGFGKVYKG---RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+G G FGKV G R + V VK L+ TP +L F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 207 FCMTPTERLLVYPYMANGSVASCLR-ERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
C+ LLV + G + + LR R +R+A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEY----- 318
IH D+ N L + +GD+GLA L Y + + T + +APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 319 --LSTGKSSEKTDVFGYGIMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLE 374
L ++K++++ G+ + EL T + + DL+ D+ V+ K +++E+ ++
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS----DEQVL-----KQVVREQDIK 229
Query: 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
L P L Y + E V C P RP EV +L
Sbjct: 230 -LPKPQLDLKYSDRWYE----VMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 140 ATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVK--RLKEERTPGGELQFQTEVEMI-SM 195
T F ++G G +GKVYK R G LVA+K + E+ E + + E ++
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59
Query: 196 AVHRNLLRLRG--FCMTPT----ERLLVYPYMANGSVASCLR--ERPPSQLPLDWPTRKR 247
+ H N+ G P + LV GSV ++ + +L +W
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW----- 114
Query: 248 IAL---GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 304
IA + RGL+YLH++ K+IHRD+K NILL + E + DFG++ +D
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 305 TAVRGTIGHIAPEYLSTGKSSEKT-----DVFGYGIMLLELITGQ 344
T + GT +APE ++ + + + DV+ GI +EL G+
Sbjct: 172 TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 148 NILGRGGFGKVYKGR----LADGS---LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
N LG G FG+VY+G L GS VAVK L++ T + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLR----ERPPSQLPLDWPTRKRIALGSARGL 256
+++L G C+ + ++ M G + S LR ER L L I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLDVAKGC 119
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTI 311
YL IHRD+ A N L+ E+ +GDFGLA+ + YK + G +
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLL 175
Query: 312 G--HIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF 347
+APE L GK + ++DV+ +G+++ E++T GQ+ +
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 207
+G G +G VYK R +A G LVA+K +K E PG + + Q E+ M+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 208 CMTPTERLLVYPYMANGSVAS--CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
+ + +V Y GS+ + P S+L + + R+ + +GL+YLH+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKGLAYLHET--- 120
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH---IAPEYL-- 319
IHRD+K ANILL E+ + + DFG++ + T T A R + IG +APE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TA-TIAKRKSFIGTPYWMAPEVAAV 175
Query: 320 -STGKSSEKTDVFGYGIMLLELITGQ 344
G K D++ GI +EL Q
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 149 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQ-----------FQTEVEMISMA 196
++G G FG VY G A G L+AVK+++ P E+ ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVE---LPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
H N+++ G + + Y+ GSVA+ L + L ++I +GL
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGL 119
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-----AVRGTI 311
+YLH+ IIHRD+K ANIL+D + + DFG++K ++ T +++G++
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
+APE + + K D++ G +++E++TG+ F
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 150 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRG 206
LG+GGFG+V ++ G + A K+L ++R GE E +++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLSYLHDHC 263
T + LV M G + + P R +A+ GL +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-----EARAIFYAAQIICGLEHLHQR- 114
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
+I++RD+K N+LLD+ + D GLA ++ K GT G++APE L
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 324 SSEKTDVFGYGIMLLELITGQRAF 347
D F G L E+I G+ F
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 148 NILGRGGFGKVYK-GRLADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHRNLLRLR 205
+G+G FG V K R +DG ++ K + T + Q +EV ++ H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 206 GFCMTPTERLLVYPYM---ANGSVAS----CLRERPPSQLPLDWPTRKRIALGSARGLSY 258
+ + + L Y M G +A C +ER + W RI L
Sbjct: 66 DRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYE 120
Query: 259 LH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316
H ++HRD+K ANI LD +GDFGLAK++ + + T V GT +++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
E L+ EK+D++ G ++ EL F
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 150 LGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
LG G FGKV+ D LVAVK LKE + FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL-----------PLDWPTRKRIALGS 252
G C L+V+ YM +G + LR P L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTI 311
A G+ YL +HRD+ N L+ + +GDFG+++ + D + V I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ PE + K + ++D++ +G++L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 149 ILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
+LG G FG VYKG DG VA+K L+E +P + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRE---RPPSQLPLDWPTRKRIALGSARGLSYLH 260
L G C+T T +L V M G + +RE R SQ L+W + A+G+SYL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 319
+ +++HRD+ A N+L+ + DFGLA+L+D +T + I +A E +
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 320 STGKSSEKTDVFGYGIMLLELIT-GQRAFD 348
+ + ++DV+ YG+ + EL+T G + +D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 78/291 (26%), Positives = 135/291 (46%), Gaps = 45/291 (15%)
Query: 150 LGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
LG+G FG VY+G D + VAVK + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLR------ERPPSQLPLDWPTRKRI---ALGSAR 254
L G L+V MA+G + S LR E P + P PT + + A A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 130
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIG 312
G++YL+ K +HRD+ A N ++ +F +GDFG+ + + Y+ + +G +
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVR 186
Query: 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372
+APE L G + +D++ +G++L E+ + LA +GL E+
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP-------YQGLSNEQV 230
Query: 373 LEMLVDPDL--QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421
L+ ++D Q + V L++ +C Q +P RP E+V +L+ D
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG--GELQFQTEVEMISM 195
++ +S LG G FG+V+ G + VAVK LK PG F E +++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK----PGTMSPESFLEEAQIMKK 57
Query: 196 AVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
H L++L + + E + +V YM+ GS+ L++ L L P +A A
Sbjct: 58 LRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAA 113
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 314
G++Y+ IHRD+++ANIL+ + + DFGLA+L++ + + I
Sbjct: 114 GMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 315 APEYLSTGKSSEKTDVFGYGIMLLELITGQR 345
APE G+ + K+DV+ +GI+L EL+T R
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 66/198 (33%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 149 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 209 MTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ L +V YMA GS+ LR R S L D + +L + YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYLEAN---NF 123
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 327
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 328 TDVFGYGIMLLELITGQR 345
+DV+ +GI+L E+ + R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVH 198
F +LG G FG VYKG + +G VA+K L+E +P + E +++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE---RPPSQLPLDWPTRKRIALGSARG 255
++ RL G C+T T +L + M G + +RE SQ L+W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGH 313
++YL + +++HRD+ A N+L+ + DFGLAKL+ D K+ H + I
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKW 177
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFD 348
+A E + + ++DV+ YG+ + EL+T G + +D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 26/267 (9%)
Query: 150 LGRGGFGKVYK-GRLADGSLVAVKRLKEERTPGGE-LQFQTEVEMISMAVHRNLLRLRGF 207
LG+G +G VYK RL+D A+K + E E+ +++ H N++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ + +V Y G ++ + +R + + RI + RGL LH+ KI
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 327
+HRD+K+ANILL +GD G++K++ K T + GT ++APE S K
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWKGRPYSYK 181
Query: 328 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVE 387
+D++ G +L E+ T F+ AR D L+ K P + Y
Sbjct: 182 SDIWSLGCLLYEMATFAPPFE-ARSMQD------------LRYKVQRGKYPP-IPPIY-- 225
Query: 388 AEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ L Q P RP ++
Sbjct: 226 --SQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 149 ILGRGGFGKVYKGR------LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
LG G FGKV K A + VAVK LKE + +E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRER------------PPSQLPLDWPTRKRIAL 250
+L G C LL+ Y GS+ S LRE + LD P + + +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 251 GS--------ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302
G +RG+ YL + K++HRD+ A N+L+ E + + DFGL++ + +D++
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 303 VTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
V + R + +A E L + ++DV+ +G++L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 150 LGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 204
LG G FGKV G +VAVK LK E ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 205 RGFCMTPTER--LLVYPYMANGSVASCLRERPP------SQLPLDWPTRKRIALGSARGL 256
+G C + L+ Y+ GS LR+ P +QL L A G+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGS----LRDYLPKHKLNLAQLLL-------FAQQICEGM 120
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIG 312
+YLH IHRD+ A N+LLD + +GDFGLAK + + H VR +
Sbjct: 121 AYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVF 175
Query: 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
A E L K S +DV+ +G+ L EL+T
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 35/284 (12%)
Query: 150 LGRGGFGKVYKGRL-ADGSL--VAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLR 205
LG G FG V +G+L D S+ VAVK +K E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 206 GFCMTPTER------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS--ARGLS 257
G C+ E +++ P+M +G + S L P PT+ + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAP 316
YL IHRD+ A N +L+E V DFGL+K + D + + + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
E L+ + K+DV+ +G+ + E+ T GQ + ++ + D+++ + K+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLRQGNRLKQ--- 235
Query: 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
PD ++ L + C +P DRP + LE
Sbjct: 236 --PPDC--------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 150 LGRGGFGKVY--------KGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRN 200
LG G FG+V K + VAVK LK++ T +E+EM+ M H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPPS--------QLPLDWPTRKRI--- 248
++ L G C ++ Y + G++ LR RPP +LP + T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 307
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + D + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
R + +APE L + ++DV+ +G++L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 73/239 (30%), Positives = 102/239 (42%), Gaps = 44/239 (18%)
Query: 110 QEFFFDVPAEEDPEVHLGQLKRFS-LRELQVATDSFSNKNILGRGGFGKVYKGR-LADGS 167
E F +DPE K F+ LRE+ G G FG VY R +
Sbjct: 5 AELFSK----DDPE------KLFTDLREI-------------GHGSFGAVYFARDVRTNE 41
Query: 168 LVAVKRLKEERTPGGELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 224
+VA+K++ E ++Q EV + H N + +G + LV Y G
Sbjct: 42 VVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99
Query: 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284
S + L + PL I G+ +GL+YLH H IHRD+KA NILL E
Sbjct: 100 SASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGT 153
Query: 285 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGIMLLEL 340
+ DFG A L+ ++ V GT +APE + G+ K DV+ GI +EL
Sbjct: 154 VKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVH 198
+ LG G +G VYK R G +VA+K+++ EE P L+ E+ ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR---EISLLKELKH 57
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N+++L T + LV+ Y + L +RP PL K I RGL+Y
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAY 113
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
H H +I+HRD+K NIL++ + + DFGLA+ T V T+ + APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI 169
Query: 319 L------STGKSSEKTDVFGYGIMLLELITGQ 344
L ST D++ G + E+ITG+
Sbjct: 170 LLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LG+G FG+V+ G + VA+K LK +P LQ E +++ H L++L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQL--YA 68
Query: 209 MTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ E + +V YM+ GS+ L+ L L P +A A G++Y+
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM---NY 123
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 327
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 328 TDVFGYGIMLLELITGQR 345
+DV+ +GI+L EL T R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 67/271 (24%), Positives = 100/271 (36%), Gaps = 47/271 (17%)
Query: 144 FSNKNILGRGGFGKVYKGRLADGSLV-AVK--------RLKEERTPGGELQFQTEVEMIS 194
F ++G+G FGKV + D + A+K R E + E+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN--- 58
Query: 195 MAVHRNLLRLR-GFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 252
H L+ L F E + LV + G LR ++ K
Sbjct: 59 ---HPFLVNLWYSFQ--DEENMYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEI 109
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 312
L YLH IIHRD+K NILLDE+ + DF +A +TT+ GT G
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPDTLTTSTSGTPG 164
Query: 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM------------- 359
++APE L S D + G+ E + G+R + D +
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224
Query: 360 ----LLDWVKGLLKEKKLEMLVDP--DLQNN 384
+D + LL+ + L D DL+N+
Sbjct: 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 210 TPTERLLVYPYMANGSVASCLRE---RP-PSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
+V YM+NG + + LRE R PSQL + G++YL
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-------LEMCKDVCEGMAYLESK--- 119
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV--RGTIGHIAPEYLSTGK 323
+ IHRD+ A N L+D++ V DFGL++ + D T++V + + PE L K
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 324 SSEKTDVFGYGIMLLELIT-GQRAFDL 349
S K+DV+ +G+++ E+ + G+ ++
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 149 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLR 203
+LG+G FG+VY D G +AVK++ + T + E++++ H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 204 LRGFCMTPTERLLVY-PYMANGSVASCLRERPPSQLPLDWPTRK--RIALGSARGLSYLH 260
G C+ E L ++ YM GSV L+ + TRK R L G+ YLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALT---ETVTRKYTRQIL---EGVEYLH 121
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEY 318
+ I+HRD+K ANIL D +GDFG +K + + T +V GT ++PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 319 LSTGKSSEKTDVFGYGIMLLELIT 342
+S K DV+ G ++E++T
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
+G G +G VYK R G +VA+K++K + G E++++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ LV+ +M + + +++R Q L K +GL++ H H I
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYLSTG 322
+HRD+K N+L++ E + DFGLA+ Y VT R APE L
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYR------APELLLGD 173
Query: 323 KS-SEKTDVFGYGIMLLELITGQRAF 347
K S D++ G + EL++ + F
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLRGF 207
LG+G FG+V+ G + VA+K LK PG + F E +++ H L+ L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 208 CMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+ E + +V +M GS+ L+E L L P +A A G++Y+
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIERM---N 122
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
IHRD++AANIL+ + + DFGLA+L++ + + I APE G+ +
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 327 KTDVFGYGIMLLELITGQR 345
K+DV+ +GI+L EL+T R
Sbjct: 183 KSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 29/272 (10%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLRGF 207
LG G FG+V+ + VAVK +K PG F E ++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKLHA- 68
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+T ++ +MA GS+ L+ S+ PL P + A G++++
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NY 123
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 327
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G + K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 328 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVE 387
+DV+ +GI+L+E++T R ++N + + L E+ M E
Sbjct: 184 SDVWSFGILLMEIVTYGRI-PYPGMSNPEVIRAL--------ERGYRM--------PRPE 226
Query: 388 AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
E+L + + C + P +RP + +L+
Sbjct: 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 148 NILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+ LG G G V K RL G + A+K + + P + Q E+E+ +++ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 207 FCMTPTERLL--VYPYMANGSVASC---LRERPP--SQLPLDWPTRKRIALGSARGLSYL 259
+ + + Y GS+ S +++R + L +IA +GLSYL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYL 121
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEY 318
H KIIHRD+K +NILL + + + DFG++ +L++ T GT ++APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPER 174
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
+ S +DV+ G+ LLE+ + F + ++ + ++ E+ +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPELKDE 231
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
P + E E + I+ C + P RP MLE
Sbjct: 232 PGNGIKWSE-EFKDFIKQ---CLEKDPTRRPTPW---DMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 141 TDSFSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+ + N +G G G+VYK A G VA+K+++ + EL E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIIN-EILIMKDCKHP 75
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N++ + E +V YM GS+ + + + ++ P + +GL YL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYL 132
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H +IHRD+K+ NILL ++ + DFG A + + + + V GT +APE +
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVI 188
Query: 320 STGKSSEKTDVFGYGIMLLELITGQ 344
K D++ GIM +E+ G+
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 25/227 (11%)
Query: 138 QVATDSFSNKNILGRGGFGKVY--------KGRLADGSLVAVKRLKEERTPGGELQFQTE 189
+V D LG G FG+V K + + VAVK LK + T +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 190 VEMISM-AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPP--------SQLP 239
+EM+ M H+N++ L G C ++ Y + G++ LR RPP +Q+P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 240 LDWPTRKRI---ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296
+ + K + A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 297 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ D + TT R + +APE L + ++DV+ +G++L E+ T
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 150 LGRGGFGKVY--------KGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRN 200
LG G FG+V K + + VAVK LK++ T +E+EM+ M H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP---------SQLPLDWPTRKRIALG 251
++ L G C ++ Y + G++ LR R P +++P + T K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 252 S---ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 307
+ ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
R + +APE L + ++DV+ +G+++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 150 LGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 204
LG FGK+YKG L LVA+K LK+ P +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPS-------------QLPLDWPTRKRIALG 251
G +++ Y+ G + L R P + LD IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 310
A G+ YL H +H+D+ A NIL+ E+ + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
I + PE + GK S +D++ +G++L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 144 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
F+ +G+G FG+V+KG +VA+K + E Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ G + T+ ++ Y+ GS LR P + + ++ + +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDYLHSE 120
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
K IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 323 KSSEKTDVFGYGIMLLELITGQ 344
K D++ GI +EL G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 26/224 (11%)
Query: 149 ILGRGGFGKVYKG-RLADGSL----VAVKRLKEERTPGGELQFQTEVE-MISMAV--HRN 200
+LG G FG V+KG + +G VA+K + ++R+ G FQ + M++M H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRS--GRQTFQEITDHMLAMGSLDHAY 70
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS---QLPLDWPTRKRIALGSARGLS 257
++RL G C + +L V GS+ +R+ S Q L+W + A+G+
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMY 123
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAP 316
YL +H ++HR++ A NILL + + DFG+A L+ D + + + I +A
Sbjct: 124 YLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVM 359
E + G+ + ++DV+ YG+ + E+++ G + R D++
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNLLRLRGF 207
+G G G V+K + G VA+K++ R GG Q E++ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ +LV YM ++ LR+ PL K +G++Y+H + I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 326
+HRD+K AN+L+ + + DFGLA+L ++ + + T + APE L K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 327 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
D++ G + EL+ G F ++D+ L
Sbjct: 181 GVDLWAVGCIFAELLNGSPLF-----PGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 60/192 (31%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 148 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--------- 197
+G G +G VYK R L G VA+K++ R P E E I ++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSE-------EGIPLSTLREIALLKQ 54
Query: 198 -----HRNLLRLRGFCMTP-TER----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
H N++RL C P T+R LV+ ++ + +A+ L + P LP + T K
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPE--TIKD 111
Query: 248 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 307
+ RG+ +LH H I+HRD+K NIL+ + + + DFGLA++ Y T+V
Sbjct: 112 LMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSV 166
Query: 308 RGTIGHIAPEYL 319
T+ + APE L
Sbjct: 167 VVTLWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 150 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLRGF 207
LG G FGKVYK + + G A K ++ E EL+ F E++++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ ++ + G++ S + E + L P + + L++LH H K+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 268 IHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
IHRD+KA NILL + + + DFG+ AK T GT +APE ++ +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKD 182
Query: 327 -----KTDVFGYGIMLLEL 340
K D++ GI L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 150 LGRGGFGKVY--------KGRLADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRN 200
LG G FG+V K R VAVK LK+ T +E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPP-----------SQLPLDWPTRKRI 248
++ L G C ++ Y A G++ LR RPP + L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 307
A ARG+ YL + IHRD+ A N+L+ E+ + DFGLA+ + D + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
R + +APE L + ++DV+ +GI++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
+G G +G V K R A G +VA+K+ KE E + EV+++ H N++ L+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
LV+ Y+ ++ L E P LP D + + ++Y H H I
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELL-EASPGGLPPD--AVRSYIWQLLQAIAYCHSH---NI 121
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL----STGK 323
IHRD+K NIL+ E + DFG A+ + + T T + APE L + GK
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 324 SSEKTDVFGYGIMLLELITGQRAF 347
DV+ G ++ EL+ G+ F
Sbjct: 182 P---VDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 39/217 (17%)
Query: 149 ILGRGGFGKV----YKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMI----------S 194
+LGRG FGKV YK G L A+K LK+ G++ + EVE + +
Sbjct: 6 VLGRGHFGKVLLAEYKK---TGELYAIKALKK-----GDIIARDEVESLMCEKRIFETAN 57
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
H L+ L T V Y A G + + D + R +A
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--------DVFSEPRAVFYAAC 109
Query: 255 ---GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGT 310
GL YLH++ KI++RD+K N+LLD E + DFGL K M + D T+ GT
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGT 164
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
+APE L+ + D +G G+++ E++ G+ F
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 149 ILGRGGFGKVYKGRL-ADGSLVAVKRL------KEERTPGGELQFQTEVEMIS-MAVHRN 200
I+G G F V + A+K L KE++ + E E+++ + H
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK----YVKIEKEVLTRLNGHPG 63
Query: 201 LLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
+++L + E L V Y NG + +R+ LD + A L YL
Sbjct: 64 IIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYL 118
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------------YKD 300
H IIHRD+K NILLD++ + DFG AK++D K+
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
+ GT +++PE L+ + + +D++ G ++ +++TG+ F
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 147 KNILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLL 202
++++G G FG+V K R+ L A+KR+KE + F E+E++ + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLR-----ERPPS-----QLPLDWPTRKRIALGS 252
L G C L Y +G++ LR E P+ +++ + +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 253 --ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 310
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + V+ T
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 181
Query: 311 IGHI-----APEYLSTGKSSEKTDVFGYGIMLLELIT 342
+G + A E L+ + +DV+ YG++L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 150 LGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 204
LG G FGKV R G VAVK LK E + E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 205 RGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+G C L+ ++ +GS+ L P ++ ++ + + A+ +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYLS 320
+ +HRD+ A N+L++ E + +GDFGL K ++ + T + + APE L
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 321 TGKSSEKTDVFGYGIMLLELIT 342
K +DV+ +G+ L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 144 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
F+ +G+G FG+VYKG +VA+K + E Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
R G + T+ ++ Y+ GS L+ P + + R+ + +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYLHSE 120
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
+ IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 323 KSSEKTDVFGYGIMLLELITGQ 344
K D++ GI +EL G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRG 206
++G G +G+VYKGR + G L A+K + + T E + + E+ M+ + HRN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 207 FCMTPT------ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+ + LV + GSV ++ + L +W I RGLS+LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH 128
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 184
Query: 321 TGKSSE-----KTDVFGYGIMLLELITG 343
++ + K+D++ GI +E+ G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRG 206
++G G +G+VYKGR + G L A+K + + T E + + E+ M+ + HRN+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 207 FCMTPT------ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+ + + LV + GSV ++ + L DW I RGL++LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH 138
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194
Query: 321 TGKSSEKT-----DVFGYGIMLLELITG 343
++ + T D++ GI +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQ---TEVEMISMAVHR 199
FS+ +G G FG VY R + + +VA+K++ E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N ++ RG + LV Y GS + L + PL + G+ +GL+YL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL 131
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY- 318
H H +IHRDVKA NILL E +GDFG A +M + V GT +APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 319 --LSTGKSSEKTDVFGYGIMLLEL 340
+ G+ K DV+ GI +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 73/293 (24%), Positives = 135/293 (46%), Gaps = 37/293 (12%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLADG-------SLVAVKRLKEERTPGGELQFQTEV 190
+VA + + LG+G FG VY+G +A G + VA+K + E + ++F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 191 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPPSQLPLDWPT 244
++ +++RL G L++ M G + S LR E P Q P
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 245 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 304
++A A G++YL+ + K +HRD+ A N ++ E+F +GDFG+ + + Y+ +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYR 176
Query: 305 TAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362
+G + ++PE L G + +DV+ +G++L E+ T LA
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP------ 221
Query: 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415
+G+ E+ L +++ L + + L ++ +C Q +P RP E++
Sbjct: 222 -YQGMSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 144 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
F+ +G+G FG+V+KG +VA+K + E Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ G + T+ ++ Y+ GS L P PLD I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLE---PG--PLDETQIATILREILKGLDYLHSE 120
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLST 321
K IHRD+KAAN+LL E E + DFG+A + DT + GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 322 GKSSEKTDVFGYGIMLLELITGQ 344
K D++ GI +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 149 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLR 205
I+GRGGFG+VY R AD G + A+K L ++R GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 206 GFCMT-----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLS 257
CMT P + + M G + L + + K + + GL
Sbjct: 60 -VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF-------SEKEMRFYATEIILGLE 111
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
++H+ +++RD+K ANILLDE + D GLA K H + GT G++APE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 318 YLSTGKSSEKT-DVFGYGIMLLELITGQRAF 347
L G + + + D F G ML +L+ G F
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 147 KNILGRGGFGKVYKGR------LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
K LG G FGKV+ D LVAVK LK+ T FQ E E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 68
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL-DWPTRK-----------RI 248
+++ G C ++V+ YM +G + LR P + L D R+ I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 307
A A G+ YL +HRD+ N L+ +GDFG+++ + D + V
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
I + PE + K + ++DV+ +G++L E+ T
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 150 LGRGGFGKVYKGRLADG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+G G FGKV G + G + V VK L+ + +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 207 FCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
C T LLV + G + LR R + D T +R+A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGK 323
IH D+ N LL + +GD+GL+ YK+ + T + + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHN-KYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 324 S-------SEKTDVFGYGIMLLEL 340
+++++V+ G+ + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 149 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLR 205
I+GRGGFG+VY R AD G + A+K L ++R GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 206 GFCM-----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI-ALGSARGLSYL 259
CM TP + + M G + L SQ + R A GL ++
Sbjct: 60 -VCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHM 113
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 320 STGKSSEKT-DVFGYGIMLLELITGQRAF 347
G + + + D F G ML +L+ G F
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNL 201
F N +G G +G VY+ R G +VA+K+++ + G + E+ ++ H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 202 LRLRGFCMTPTERL----LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
+ L+ + + L LV Y +AS L P P K + L RGL
Sbjct: 69 VELKE--VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT---PFSESQVKCLMLQLLRGLQ 122
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
YLH++ IIHRD+K +N+LL ++ + DFGLA+ +T V T+ + APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 318 YL-STGKSSEKTDVFGYGIMLLELITGQ 344
L + D++ G +L EL+ +
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 57/204 (27%), Positives = 109/204 (53%), Gaps = 27/204 (13%)
Query: 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANIL 278
+M GS+ ++ P +P++ +IA+ GL+YL++ H +I+HRD+K +NIL
Sbjct: 84 FMDCGSLDRIYKKGGP--IPVE--ILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNIL 136
Query: 279 LDEEFEAVVGDFGLA-KLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 336
++ + + DFG++ +L++ DT V GT +++PE + GK + K+DV+ GI
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 337 LLELITGQRAFDLARLAND--DDVM-LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQL 393
++EL G+ F + + +D DD M +LD ++ +++E P L ++ ++
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRLPSSDFPEDLRDF 245
Query: 394 IQVALLCTQGSPMDRPKMSEVVRM 417
+ LL P +RP ++ M
Sbjct: 246 VDACLLKD---PTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 147 KNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
K LG G FGKV+ D LVAVK LK+ + F E E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 68
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL---DWPTR------KRIALG 251
+++ G C+ ++V+ YM +G + LR P + + + P IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 310
A G+ YL +HRD+ N L+ E +GDFG+++ + D + V
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
I + PE + K + ++DV+ G++L E+ T
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQTEVEMISMAVHRNLLRLR 205
LG G + VYKGR G +VA+K + EE TP ++ E+ ++ H N++RL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRLH 64
Query: 206 GFCMTPTERLLVYPYMANGSVASCLR---ERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
T + +LV+ YM L+ + + LD T K +G+++ H++
Sbjct: 65 DVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
+++HRD+K N+L+++ E + DFGLA+ + V T+ + AP+ L
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGS 175
Query: 323 KS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
++ S D++ G ++ E+ITG+ F N++D +L
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLF---PGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
LG G FG V+ G+ VA+K + E E F E +++ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR----GLSYLHDHCDP 265
+V +M NG + + LR+R +L K + L + G+ YL +
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQ-GKL------SKDMLLSMCQDVCEGMEYLERN--- 119
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKS 324
IHRD+ A N L+ V DFG+ + + D + +++ + + PE + K
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 325 SEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383
S K+DV+ +G+++ E+ T G+ F + +N + V ++ + L P L +
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPF--EKKSNYEVVEMI---------SRGFRLYRPKLAS 227
Query: 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
V +V C P RP +E++R +
Sbjct: 228 MTV-------YEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 66/222 (29%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 149 ILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQ------FQTEVEMISMAVHRNL 201
+LG+G FGKV RL G L AVK LK++ LQ TE ++S+A +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPF 57
Query: 202 LRLRGFCMTPTERLLVYPYMANGS-----VASCLRERPPSQLPLDWPTRKRIALGSARGL 256
L C +RL NG + R D + A L
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--------FDEARARFYAAEITSAL 109
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316
+LHD II+RD+K N+LLD E + DFG+ K + T+ GT +IAP
Sbjct: 110 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAP 165
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 358
E L D + G++L E++ G F+ N+DD+
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 149 ILGRGGFGKVYKGRL-----ADGSL-VAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNL 201
LG G FGKV + +D + VAVK LK +E++++S + H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL-H 260
+ L G C L++ Y G + + LR + S L L+ + A+G+++L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE--DLLSFSYQVAKGMAFLAS 159
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYL 319
+C IHRD+ A N+LL + DFGLA+ +M+ + V R + +APE +
Sbjct: 160 KNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 320 STGKSSEKTDVFGYGIMLLELIT 342
+ ++DV+ YGI+L E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 20/200 (10%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
LG G FGKVYK + + ++A ++ + ++ + E+++++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 269
++ + A G+V + + E + PL P + + + L+YLH++ KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 270 RDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 325
RD+KA NIL + + + DFG++ + + +D+ + GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 326 E-----KTDVFGYGIMLLEL 340
+ K DV+ GI L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 149 ILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG- 206
+LG+G FGKV L L AVK LK++ + Q + ++ + +L L G
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKD------VILQDD-DVECTMTEKRVLALAGK 54
Query: 207 -------FCMTPT-ERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
T +RL V Y+ G L D P + A GL
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGD----LMFHIQRSGRFDEPRARFYAAEIVLGLQ 110
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAP 316
+LH+ II+RD+K N+LLD E + DFG+ K + T T+ GT +IAP
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAP 165
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 357
E LS D + G++L E++ GQ F+ +D+D
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFE----GDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 149 ILGRGGFGKVY--KGRLADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLR 205
+G G FGK+Y K + +D +K + + P E + + EV +++ H N++
Sbjct: 7 KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 206 GFCMTPTERLLVYPYMANGSVASCL-RER----PPSQLPLDWPTRKRIALGSARGLSYLH 260
+V Y G + + R+R Q+ L W + I+LG L ++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSWFVQ--ISLG----LKHIH 118
Query: 261 DHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
D KI+HRD+K+ NI L + A +GDFG+A+ ++ T V GT +++PE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
+ KTD++ G +L EL T + F+ N+ ++L +G + P
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE----GNNLHQLVLKICQGYFAP------ISP 224
Query: 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+ + + + + QL +V SP DRP ++ +++
Sbjct: 225 NFSRD-LRSLISQLFKV-------SPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 127 GQLKRFSLRELQVATDS---FSNKNILGRGGFGKVYKGRLADGS-LVAVKRLKEERTPGG 182
G LK + EL D F++ +G G FG VY R + +VA+K++
Sbjct: 7 GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 183 ELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP 239
E ++Q EV+ + H N + +G + LV Y GS + L + P
Sbjct: 67 E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH---KKP 121
Query: 240 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299
L I G+ +GL+YLH H +IHRD+KA NILL E + + DFG A +
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 300 DTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGIMLLEL 340
++ V GT +APE + G+ K DV+ GI +EL
Sbjct: 179 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 149 ILGRGGFGKVYKGRLAD-GSLVAVKRLK---EERTPGGELQ-FQTEVEMISMAVHRNLLR 203
+LG+G FG+VY AD G +AVK+++ E E+ + E++++ +H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 204 LRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
G P ER L +M GS+ L+ S L ++ G+SYLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS 124
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYL 319
+ I+HRD+K ANIL D +GDFG +K + T +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 320 STGKSSEKTDVFGYGIMLLELIT 342
S K D++ G ++E++T
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 25/181 (13%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGG----------ELQFQTEVEMISMAVH 198
LG G + VYK R G +VA+K++K E++ E++ H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N++ L + LV+ +M + ++++ P D K L + RGL Y
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPAD---IKSYMLMTLRGLEY 117
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
LH + I+HRD+K N+L+ + + DFGLA+ + +T V T + APE
Sbjct: 118 LHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173
Query: 319 L 319
L
Sbjct: 174 L 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 150 LGRGGFGKVYKGR--LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLR 203
+G G +GKV+K R G VA+KR++ EE P ++ + + H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 204 LRGFCMTP-----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
L C T+ LV+ ++ + + + L + P +P + T K + RGL +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE--TIKDMMFQLLRGLDF 125
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
LH H +++HRD+K NIL+ + + DFGLA++ ++ T+V T+ + APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEV 180
Query: 319 LSTGKSSEKTDVFGYGIMLLEL 340
L + D++ G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
DS+ LG G + VYKG+ +G LVA+K ++ + G E ++ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
++ L T LV+ Y+ + + + + P P K RGLSY+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHP---ENVKLFLFQLLRGLSYIH 120
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YL 319
I+HRD+K N+L+ + E + DFGLA+ +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLL 176
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAF 347
+ + S D++G G + +E+I G AF
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 149 ILGRGGFGKVYKGRLAD-GSLVAVKRL----KEERTPGGELQFQTEVEMISMAVHRNLLR 203
+LGRG FG+VY AD G +AVK++ + T + E++++ H +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 204 LRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
G P E+ L YM GS+ L+ + L +R +G+SYLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS 124
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPEYL 319
+ I+HRD+K ANIL D +GDFG +K + +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 320 STGKSSEKTDVFGYGIMLLELIT 342
S K DV+ ++E++T
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRL--KEERTPGGELQFQTEVEMISMAVHRNLLRL-- 204
LG G FG+VYK R + G +VA+K++ E+ G + E++++ H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLID 74
Query: 205 ------RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
+V PYM S L E P +L K L G++Y
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKL--TESQIKCYMLQLLEGINY 130
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297
LH++ I+HRD+KAANIL+D + + DFGLA+ D
Sbjct: 131 LHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 73/300 (24%), Positives = 131/300 (43%), Gaps = 45/300 (15%)
Query: 137 LQVATDSFSNKNILGRGGFGKVYKGRLADGSL-----VAVKRLKEERTPGGELQFQTEVE 191
+ ++ D + ++L G FG+++ G L D V VK +K+ + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 192 MISMAVHRNLLRLRGFCMTPTERLLV-YPYMANGSVASCLRE--RPPSQLPLDWPTRKRI 248
++ H+N+L + C+ E V YPYM G++ L++ + P T++ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 249 ALGS--ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYK---D 300
+ A G+SYLH +IH+D+ A N ++DEE + + D L++ MDY D
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVM 359
+ +A E L + S +DV+ +G++L EL+T GQ + ++
Sbjct: 178 NE-----NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY--------VEID 224
Query: 360 LLDWVKGLLKEKKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
+ L +L ++ PD +L V C P +RP S++V+ L
Sbjct: 225 PFEMAAYLKDGYRLAQPINCPD-----------ELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKR----LKEERTPGGELQFQTEVEMISMA 196
D++ +G G +GKVYK R G LVA+K+ + EE P L+ + ++M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 197 VHRNLLRLRGFCMTPTER-------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 249
++ ++RL + E LV+ Y+ + PL T K
Sbjct: 61 IY--IVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAK-----LMDYKDTHV 303
+G+++ H H ++HRD+K N+L+D++ + + D GL + + Y V
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 304 TTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 347
T R APE L S D++ G + E+ Q F
Sbjct: 174 TLWYR------APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 207
+G G +G VYK R L G L AVK +K E PG + Q E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPP-SQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
++ + + Y GS+ P S+L + + R+ + +GL+YLH
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK-- 127
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLSTG 322
+HRD+K ANILL + + + DFG+A + T A R GT +APE +
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 323 KS---SEKTDVFGYGIMLLELITGQRA-FDL 349
K+ ++ D++ GI +EL Q FDL
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLK------EERTPGGELQFQTEVEMISMAVHRNLL 202
LG G FG VY R G LVA+K++K EE E++ + + H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS-----LRKLNEHPNIV 61
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+L+ E V+ YM G++ +++R + I +GL+++H H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSE--SVIRSIIYQILQGLAHIHKH 118
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL--S 320
HRD+K N+L+ + DFGLA+ + + + T V T + APE L S
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRS 173
Query: 321 TGKSSEKTDVFGYGIMLLELITGQ 344
T SS D++ G ++ EL T +
Sbjct: 174 TSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 150 LGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEM-ISMAVH-RNLLRLRG 206
LG+GGFG+V ++ A G L A K+L ++R + VE I VH R ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 207 FCMTPTERLLVYPYMANGS----VASCLRERPPSQLPLDWPTRKRIALGSAR---GLSYL 259
T T+ LV M G + + E P P R +A+ GL +L
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP-------RACFYTAQIISGLEHL 113
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEY 318
H +II+RD+K N+LLD + + D GLA +L D + T GT G +APE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPEL 168
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAF 347
L + D F G+ L E+I + F
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 76/281 (27%), Positives = 113/281 (40%), Gaps = 51/281 (18%)
Query: 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQ---TEVEMISMAVHRNLLRLR 205
+G G FG VY + +VAVK++ E ++Q EV+ + H N + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
G + LV Y GS + L + PL I G+ +GL+YLH H
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTG 322
+IHRD+KA NILL E + + DFG A ++ V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 323 KSSEKTDVFGYGIMLLELITGQRAF-------DLARLANDDDVMLLDWVKGLLKEKKLEM 375
+ K DV+ GI +EL + L +A +D
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND------------------- 236
Query: 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
P LQ+N + C Q P +RP +E++R
Sbjct: 237 --SPTLQSNEWTDSFRGFVD---YCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+ +G +G+V+ + + G + A+K +K+ Q E ++ ++ ++ +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 209 MTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
++ LV Y+ G +AS L L D R IA L YLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDV-ARIYIA-EIVLALEYLHSN---G 113
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAK-------LMDYKDTHVTTAVRGTIGHIAPEYL 319
IIHRD+K NIL+D + DFGL+K + D + GT +IAPE +
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 320 STGKSSEKTDVFGYGIMLLELITG 343
S+ D + G +L E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 32/288 (11%)
Query: 136 ELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS 194
E + D + +LG+G +G VY R L+ +A+K + ER E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHS 60
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER--PPSQLPLDWPTRKRIALGS 252
HRN+++ G + + GS+++ LR + P L + T
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQI 117
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGT 310
GL YLHD+ +I+HRD+K N+L++ + VV DFG +K + + T GT
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP-CTETFTGT 172
Query: 311 IGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368
+ ++APE + G D++ G ++E+ TG+ F L M + G+
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGEPQAAM---FKVGMF 227
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
K + P++ + + AE + I L C + P R ++++
Sbjct: 228 K-------IHPEIPES-LSAEAKNFI---LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 144 FSNKNILGRGGFGKVYKGRLA--DGSL--VAVKRLKEERTPGGEL-QFQTEVEMISMAVH 198
F+ +LG+G FG V + +L DGS VAVK LK + ++ +F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 199 RNLLRLRGFCM--TPTERL----LVYPYMANGSVASCLRERPPSQLPLDWP--TRKRIAL 250
N+++L G + RL ++ P+M +G + + L + P P T R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRG 309
A G+ YL IHRD+ A N +L+E V DFGL+K + D + A +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 310 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF 347
+ +A E L+ + +DV+ +G+ + E++T GQ +
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 149 ILGRGGFGKVY----KGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL 204
+LG G +GKV+ G G L A+K LK+ +Q E + + L +
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEH-TRTERQVLEAV 61
Query: 205 RG--FCM-------TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS-AR 254
R F + T T+ L+ Y+ G + + L +R + R+ +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAEIVL 116
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 314
L +LH II+RD+K NILLD E V+ DFGL+K ++ + GTI ++
Sbjct: 117 ALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 315 APEYLSTGKS--SEKTDVFGYGIMLLELITGQRAF 347
APE + G + D + G++ EL+TG F
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 134 LRELQVATDSFSNKNILGRGGFGKVYK-GRLADGSLVAVKRLKEERTPGGELQFQTEVEM 192
L L TD++ +G+G +GKVYK DGSL AVK L E++ + + +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72
Query: 193 ISMAVHRNLLRLRGFC-----MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
S+ H N+++ G + + LV GSV ++ LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 248 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 307
I G+ GL +LH++ +IIHRDVK NILL E + DFG++ + T+V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 308 RGTIGHIAPEYLSTGKSSE-----KTDVFGYGIMLLELITG 343
GT +APE ++ + + + DV+ GI +EL G
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVH 198
T+ + + +G G FG V R G VA+K++ K TP + E++++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N++ L ++P E + + + L RP L+ + RGL Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP-----LEKQFIQYFLYQILRGLKY 123
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
+H ++HRD+K +NIL++E + + DFGLA++ +D +T V T + APE
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV-STRYYRAPEI 176
Query: 319 LST-GKSSEKTDVFGYGIMLLELITGQRAF 347
+ T K + D++ G + E++ G+ F
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 204
+G G +G VYK R G VA+K ++ E+ P ++ ++ + H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 205 RGFCMT-----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
C T T+ LV+ ++ + + + L + PP LP + T K + RGL +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLDFL 124
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H +C I+HRD+K NIL+ + + DFGLA++ + T V T+ + APE L
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVL 179
Query: 320 STGKSSEKTDVFGYGIMLLEL 340
+ D++ G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-----MDYKDTHVTTAVR 308
GL YLH +IIHRDVK NI +++ + +GD G A+ +
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-------GLA 217
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELI 341
GT+ APE L+ K + K D++ GI+L E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 64/280 (22%), Positives = 124/280 (44%), Gaps = 26/280 (9%)
Query: 143 SFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK--EERTPGGELQFQTEVEMISMAVHR 199
+F + +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLR--ERPPSQLPLDWPTRKRIALGSARGLS 257
N+++ + E +V G ++ ++ ++ +P + + L SA L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
++H +++HRD+K AN+ + +GD GL + K T + V GT +++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
+ + K+D++ G +L E+ Q F D + L KK+E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLC------KKIEQCD 224
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
P L +++ E+ QL+ +C P RP ++ V +
Sbjct: 225 YPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 149 ILGRGGFGKVYKGRLADGS-LVAVKRLKEERTPGGELQFQTEVEMISMAV------HRNL 201
+LG+G FGKV L + A+K LK++ + E M+ V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWEHPFL 58
Query: 202 LRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR----- 254
L FC T+ L V Y+ G + ++ R AR
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSS------------GRFDEARARFYAAE 104
Query: 255 ---GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 311
GL +LH II+RD+K N+LLD++ + DFG+ K + +T GT
Sbjct: 105 IICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTP 160
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
+IAPE L K +E D + +G++L E++ GQ F
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 149 ILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVE--MISMA-VHRNLLRL 204
+LG+G FGKV+ L A+K LK++ + T VE ++S+A H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 205 RGFCMTPTERLL--VYPYMANGS----VASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
+C T+ L V Y+ G + SC + D P A GL +
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--------FDLPRATFYAAEIICGLQF 111
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
LH I++RD+K NILLD + + DFG+ K D T GT +IAPE
Sbjct: 112 LHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEI 167
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAF 347
L K + D + +G++L E++ GQ F
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 63/277 (22%), Positives = 116/277 (41%), Gaps = 22/277 (7%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK--EERTPGGELQFQTEVEMISMAV 197
+F + +G+G F VYK L DG +VA+K+++ E E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H N+++ + E +V G ++ ++ + + T + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
++H +I+HRD+K AN+ + +GD GL + K T + V GT +++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
+ + K+D++ G +L E+ Q F D + L KK+E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLC------KKIEKCD 224
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
P L ++ E+ L+ C P RP +S V
Sbjct: 225 YPPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 67/279 (24%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLR- 205
++G+G +G+V R DG +K+L E + + E +++S H N++ R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 206 ----GFCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARGLS 257
+ +V + G + L+E+ LP ++W + +AL
Sbjct: 67 SWEGEDGLL----YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------Q 116
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
YLH+ I+HRD+K N+ L VGD G+A++++ + +T + GT +++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
S + K+DV+ G + E+ T + AF+ A D + ++ ++G L
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFN----AKDMNSLVYRIIEGKL--------- 219
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
P + +Y E+ +LI +L + P RP + ++R
Sbjct: 220 -PPMPKDY-SPELGELIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 143 SFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAV 197
+F +G G +G VYK R G +VA+K+++ E P ++ E+ ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELN 57
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H N+++L T + LV+ ++ + + + P S +PL P K +GL+
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLA 114
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIG 312
+ H H +++HRD+K N+L++ E + DFGLA+ + Y VT R
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR---- 167
Query: 313 HIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAF 347
APE L K S D++ G + E++T + F
Sbjct: 168 --APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 25/270 (9%)
Query: 147 KNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
+ ILG G G VYK L ++AVK + + T + Q +E+E++ ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
G + +M GS+ R+ P RIA+ +GL+YL
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DVYRKIPE-------HVLGRIAVAVVKGLTYLWSL--- 114
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 325
KI+HRDVK +N+L++ + + DFG++ + ++ T V GT ++APE +S +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYG 171
Query: 326 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 385
+DV+ GI +EL G+ + N +M L + L+ +VD D
Sbjct: 172 IHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPL---------QLLQCIVDEDPPVLP 221
Query: 386 VEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415
V E+ + C + P +RP ++
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LG G + V+KGR +LVA+K ++ E G EV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 209 MTPTERLLVYPYMANG---SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
T LV+ Y+ + + +C L + K RGLSY H
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNC------GNL-MSMHNVKIFMFQLLRGLSYCHKR--- 122
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKS 324
KI+HRD+K N+L++E+ E + DFGLA+ + V T+ + P+ L + +
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 325 SEKTDVFGYGIMLLELITGQRAF 347
S D++G G +L E+ TG+ F
Sbjct: 182 STPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 143 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHR 199
+F +LG+GGFG+V ++ A G + A K+L+++R GE E +++ R
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GL 256
++ L T LV M G + + + R +A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCGL 115
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316
LH +I++RD+K NILLD+ + D GLA + + GT+G++AP
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAP 170
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
E + + + D + G +L E+I GQ F
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 149 ILGRGGFGKVY-KGRLADGSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRL 204
++G+G FGKV R +DGS AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 205 RGFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
T + V Y+ G + L RER + P + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-----PRARFYAAEVASAIGYLHSL- 115
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 322
II+RD+K NILLD + V+ DFGL K ++ ++T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 323 KSSEKTDVFGYGIMLLELITGQRAF 347
D + G +L E++ G F
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 147 KNILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLL 202
++++G G FG+V + + L A+K LKE + F E+E++ + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLR-----ERPP-------SQLPLDWPTRKRIAL 250
L G C + Y G++ LR E P + L + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRG 309
A G+ YL + + IHRD+ A N+L+ E + + DFGL++ ++ +V T R
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 310 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ +A E L+ + K+DV+ +G++L E+++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 168 LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 227
LVAVK L+ + + F EV+++S N+ RL G C ++ YM NG +
Sbjct: 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 228 SCLRERPP-------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 280
L++ + L + T +A A G+ YL +HRD+ N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164
Query: 281 EEFEAVVGDFGLAKLM---DYKDTHVTTAVRGT----IGHIAPEYLSTGKSSEKTDVFGY 333
+ + + DFG+++ + DY V+G I +A E + GK + K+DV+ +
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 334 GIMLLELIT 342
G+ L E++T
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 33/283 (11%)
Query: 150 LGRGGFGKVYKGRLADGSLVA---VKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+G G FGKV + + VA VK LK + + +F + + + H N+L+ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
C+ LLV+ Y G + S L + + +R+A A G++++H H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT------AVRGTIGHIAPEY-- 318
+H D+ N L + VGD+G+ YK+ ++ T +R + E+
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 319 -LSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR--LANDDDVMLLDWVKGLLKEKKLEM 375
L T + ++ ++V+ G+ L EL F+ A ++ D +L+ V +K+++++
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL------FENAAQPYSHLSDREVLNHV---IKDQQVK- 228
Query: 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
L P L+ Y E E L Q L SP R EV R+L
Sbjct: 229 LFKPQLELPYSERWYEVL-QFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 150 LGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG+GGFG+V ++ + G + A K+L ++R GE E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLSYLHDHC 263
+ T LV M G + + L ++ R+ SA+ G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-----RVIHYSAQITCGILHLHSM- 114
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
I++RD+K N+LLD++ + D GLA ++ KD T GT G++APE L
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 324 SSEKTDVFGYGIMLLELITGQRAF 347
S D F G + E++ G+ F
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
LG G FGKVYK + + +A ++ E ++ + E+E+++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 269
+ ++ + G+V + + E L P + I L YLH KIIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 270 RDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYL--STGK 323
RD+KA N+LL + + + DFG++ K + +D+ + GT +APE + T K
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMK 188
Query: 324 SSE---KTDVFGYGIMLLEL 340
+ K D++ GI L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-12
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 148 NILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLLR 203
+++G G FG+V K R+ L A+KR+KE + F E+E++ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLR-----ERPP-------SQLPLDWPTRKRIALG 251
L G C L Y +G++ LR E P + L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 310
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ ++ +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ +A E L+ + +DV+ YG++L E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 150 LGRGGFGKVYKGR--LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
LG G + VYKGR L D +LVA+K ++ E G EV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
T LV+ Y+ + + L + S ++ K RGL+Y H K+
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 326
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 327 KTDVFGYGIMLLELITGQRAF 347
+ D++G G + E+ TG+ F
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 9e-12
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 150 LGRGGFGKVYKGRLAD-GSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
+G G +G V+K R + G +VA+K+ E E P + E+ M+ H NL+ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ LV+ Y + +V + L E+ P +P K+I + + +++ H H
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNEL-EKNPRGVPEH--LIKKIIWQTLQAVNFCHKH---NC 121
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 326
IHRDVK NIL+ ++ + + DFG A+++ T V T + APE L +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGP 180
Query: 327 KTDVFGYGIMLLELITGQ 344
DV+ G + EL+TGQ
Sbjct: 181 PVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 57/188 (30%), Positives = 82/188 (43%), Gaps = 31/188 (16%)
Query: 169 VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL-------RGFCMT-PTERLLVYPY 220
V VK + +TPG E++++ HR ++ L CM P + ++ Y
Sbjct: 122 VIVKAVTGGKTPG------REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTY 175
Query: 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 280
+ +R LPL+ I L+YLH IIHRDVK NI LD
Sbjct: 176 V----------DRS-GPLPLE--QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLD 219
Query: 281 EEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLE 339
E AV+GDFG A KL + DT GT+ +PE L+ KTD++ G++L E
Sbjct: 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
Query: 340 LITGQRAF 347
+
Sbjct: 280 MSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 147 KNILGRGGFGKVYKGRLADG----------------SLVAVKRLKEERTPGGELQFQTEV 190
K LG G FG+V+ A+G LVAVK L+ + T F E+
Sbjct: 10 KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 191 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-PSQLPL--DWPTRKR 247
+++S + N++RL G C++ ++ YM NG + L +R S + P+
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 248 -----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302
+A+ A G+ YL +HRD+ N L+ + + DFG+++ + Y +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL-YSGDY 184
Query: 303 VTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
R I +A E + GK + +DV+ +G+ L E+ T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 50/199 (25%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G+G G V+ +A G VA+K++ ++ P EL E+ ++ + N++
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ E +V Y+A GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVI 137
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 328
HRD+K+ N+LL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 329 DVFGYGIMLLELITGQRAF 347
D++ GIM +E++ G+ +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 143 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHR 199
+F + +LG+GGFG+V ++ A G + A K+L+++R GE E +++ R
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GL 256
++ L T LV M G + + +R +A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVFYAAEITCGL 115
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316
LH +I++RD+K NILLD+ + D GLA ++ + GT+G++AP
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAP 170
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
E + + + D +G G ++ E+I G+ F
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+++ + LG G + VYKGR G LVA+K ++ E G E ++ H N
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN 64
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDW------PTRKRIALGS-A 253
++ L T LV+ Y+ + Q +D R+ L
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYL----------DTDLKQY-MDDCGGGLSMHNVRLFLFQLL 113
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVR 308
RGL+Y H +++HRD+K N+L+ E E + DFGLA+ Y + VT R
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 309 GTIGHIAPEYL--STGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND 355
P+ L ST S+ D++G G + E+ TG+ F + D
Sbjct: 171 ------PPDVLLGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 150 LGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G+G G VY +A G VA+K++ ++ P EL E+ ++ + N++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ E +V Y+A GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 328
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 329 DVFGYGIMLLELITGQRAF 347
D++ GIM +E++ G+ +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHR 199
D + N + G +G VY+ R G +VA+K+LK E+ G + E+ ++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 200 NLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
N++ ++ + + +V Y+ + + S + L K + L G++
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQ---SEVKCLMLQLLSGVA 120
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIG 312
+LHD+ I+HRD+K +N+LL+ + DFGLA+ L Y VT R
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR---- 173
Query: 313 HIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
APE L + S D++ G + EL+T + F
Sbjct: 174 --APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 52/223 (23%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 147 KNILGRGGFGKVYKG---RLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
+G G FG VY+G + + VAVK K +P +F E ++ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 203 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+L G ++ + P G + S L+ S LD + + + L+YL
Sbjct: 71 KLIGVITENPVWIVMELAPL---GELRSYLQVNKYS---LDLASLILYSYQLSTALAYLE 124
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
+ +HRD+ A N+L+ +GDFGL++ ++ + + + + I +APE ++
Sbjct: 125 SK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 321 TGKSSEKTDVFGYGIMLLE-LITGQRAFDLARLANDDDVMLLD 362
+ + +DV+ +G+ + E L+ G + F + N+D + ++
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPF--QGVKNNDVIGRIE 222
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 10/208 (4%)
Query: 143 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHR 199
+F +LG+GGFG+V ++ A G + A KRL+++R GE E +++ +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++ L T LV M G + + +R +A L L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-----EEERALFYAAEILCGL 115
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
D ++RD+K NILLD+ + D GLA + + GT+G++APE L
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVL 173
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAF 347
+ + + D +G G ++ E+I GQ F
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 51/290 (17%)
Query: 150 LGRGGFGKVYKGRLADG--SLVAVKRL----------KEERTPGGELQFQTEVEMISMAV 197
LG G FG VYK R + +L+A+K + K ER +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66
Query: 198 -HRNLLRLRGFCMTPTERLLVYPYMANGS----VASCLRER----PPSQLPLDWPTRKRI 248
H N++R +RL + + G+ + L+E+ ++ W ++
Sbjct: 67 RHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---WNIFVQM 122
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
L L YLH + +I+HRD+ NI+L E+ + + DFGLAK ++ +T+ V
Sbjct: 123 VLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV- 174
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368
GTI + PE + EK DV+ +G +L ++ T Q F ML L
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------ML------SL 221
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
K +E + +P L +V +I C RP + +V M+
Sbjct: 222 ATKIVEAVYEP-LPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 152 RGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 210
+G FG VY + + G A+K LK+ +MI+ N+ R M
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKS-------------DMIAKNQVTNVKAERAIMMI 52
Query: 211 PTE-----RL-----------LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
E +L LV Y+ G AS ++ LP DW ++ IA
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDW-AKQYIA-EVVL 108
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 314
G+ LH IIHRD+K N+L+D+ + DFGL++ V GT ++
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYL 160
Query: 315 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
APE + + +D + G ++ E + G F
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 44/247 (17%)
Query: 147 KNILGRGGFGKVY--------------------KGRLADGSLVAVKRLKEERTPGGELQF 186
K LG G FG+V+ KGR LVAVK L+ + F
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66
Query: 187 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER------------- 233
EV+++S N++RL G C+ ++ YM NG + L
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 234 -PPSQLP-LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291
P LP + + + +AL A G+ YL +HRD+ N L+ E + DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 292 LAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349
+++ + Y + R I +A E + GK + +DV+ +G+ L E++ +
Sbjct: 184 MSRNL-YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 350 ARLANDD 356
L ++
Sbjct: 243 GELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 150 LGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G+G G VY +A G VA+K++ ++ P EL E+ ++ H N++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ E +V Y+A GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 137
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 328
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 329 DVFGYGIMLLELITGQ 344
D++ GIM +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRL 204
++G+G FGKV + ADG AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 205 RGFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
T + V Y+ G + L RER + P + A A L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE-----PRARFYAAEIASALGYLHSL- 115
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 322
II+RD+K NILLD + V+ DFGL K +++ T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171
Query: 323 KSSEKTDVFGYGIMLLELITGQRAF 347
D + G +L E++ G F
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 149 ILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN---LLRL 204
+LG+G FGKV R L A+K LK++ + T VE +A+ L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 205 RGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
C +RL V Y+ G + +++ + P I++G L +LH
Sbjct: 67 HS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLHRR- 120
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
II+RD+K N++LD E + DFG+ K D T GT +IAPE ++
Sbjct: 121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 324 SSEKTDVFGYGIMLLELITGQRAFD 348
+ D + YG++L E++ GQ FD
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 143 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHR 199
+F + +LG+GGFG+V ++ A G + A K+L+++R GE E ++ R
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++ L T LV M G + + +R +A L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-----DEQRAIFYAAELCCGL 115
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---TIGHIAP 316
D +I++RD+K NILLD+ + D GLA + +T VRG T+G++AP
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAP 170
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
E ++ K + D +G G ++ E+I GQ F
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 150 LGRGGFGKVYKGR--LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
LG G + V+KGR L + +LVA+K ++ E G EV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 208 CMTPTERLLVYPYMAN---------GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
T LV+ Y+ G++ S K RGL+Y
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-------------HNVKIFLYQILRGLAY 119
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE- 317
H K++HRD+K N+L++E E + DFGLA+ + V T+ + P+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 175
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
L + + S + D++G G + E+ +G+ F
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 149 ILGRGGFGKVYKGRLAD-GSLVAVKRLK-EERTPGGELQ---FQTEVEMISMAVHRNLLR 203
+LG+G FG+VY D G +A K+++ + +P + + E++++ H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 204 LRGFCMTPTERLLV--YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
G E+ L YM GSV L+ + L ++ G+SYLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS 124
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYL 319
+ I+HRD+K ANIL D +GDFG +K + T +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 320 STGKSSEKTDVFGYGIMLLELIT 342
S K DV+ G ++E++T
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 149 ILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRG 206
+LG+G FGKV L G AVK LK++ + T VE +A+ N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 207 FCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLSYLHD 261
+C T+ L V ++ G + ++++ L R +A GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-------YRATFYAAEIVCGLQFLHS 114
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
II+RD+K N++LD + + DFG+ K + D +T GT +IAPE L
Sbjct: 115 K---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQG 170
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAF 347
K + D + +G++L E++ GQ F
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 28/223 (12%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVK--RLKEERTPGGELQFQTEVEMISMAVH 198
D F +G G +G+VYK R D G LVA+K RL E+ G + E++++ H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNH 65
Query: 199 RNLLRLRGFCMTPTERL----------LVYPYMAN---GSVASCLRERPPSQLPLDWPTR 245
RN++ L+ + L LV+ YM + G + S L +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------- 118
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
K GL+Y H +HRD+K +NILL+ + + + DFGLA+L + +++ T
Sbjct: 119 KSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 306 AVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
T+ + PE L + DV+ G +L EL T + F
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 12/231 (5%)
Query: 149 ILGRGGFGKVYKGRLADGSLV-AVKRLKEERTPGGEL--QFQTEVEMISMAV-HRNLLRL 204
++GRG + KV RL + A+K +K+E E QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
T + V Y+ G + ++ + +LP + + A L+YLH+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLA--LNYLHER-- 115
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 324
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 325 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
D + G+++ E++ G+ FD+ +++ D D++ ++ EK++ +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 150 LGRGGFGKVYKG--RLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG G FG V KG ++ + VA+K LK E + E E++ + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
C E L++ MA+G + ++ + + + G+ YL
Sbjct: 63 VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLEGK---N 115
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTGKS 324
+HRD+ A N+LL + A + DFGL+K + D++ +A + + APE ++ K
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 325 SEKTDVFGYGIMLLELIT-GQRAF 347
S ++DV+ YGI + E + GQ+ +
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 149 ILGRGGFGKVYKGRLADGSLV-AVKRLKEERTPGGELQ------FQTEVEMISMAVHRNL 201
+LG+G FGKV L V A+K LK++ LQ TE ++++A
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI----LQDDDVDCTMTEKRILALAAKHPF 57
Query: 202 LRLRGFCMTPTERLL-VYPYMANGSVA-SCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
L C +RL V Y+ G + R R D P + A L +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFL 112
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H H +I+RD+K NILLD E + DFG+ K TT GT +IAPE L
Sbjct: 113 HRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEIL 168
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 358
+ D + G+++ E++ GQ F+ N+DD+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 140 ATDSFSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH 198
A S+ N LG G + VYKG +G LVA+K + + G E ++ H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N++ L T V+ YM + +A + + P P + + RGL+Y
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN---VRLFMFQLLRGLAY 118
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
+H I+HRD+K N+L+ E + DFGLA+ ++ V T+ + P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 319 L--STGKSSEKTDVFGYGIMLLELITGQRAF 347
L +T SS D++G G + +E++ GQ AF
Sbjct: 175 LLGATDYSSA-LDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 64/274 (23%), Positives = 125/274 (45%), Gaps = 36/274 (13%)
Query: 150 LGRGGFGK--VYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLRG 206
+G G FGK + K + DG +K + + E + + EV ++S H N+++ +
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARGLSYLHDH 262
+V Y G + + + P LDW + I L L ++HD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--ICLA----LKHVHDR 120
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
KI+HRD+K+ NI L ++ +GDFG+A++++ T + GT +++PE
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 323 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382
+ K+D++ G +L E+ T + AF+ + N ++L ++G P +
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----LVLKIIRGSY----------PPVS 222
Query: 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
++Y ++ L+ + +P DRP ++ ++
Sbjct: 223 SHY-SYDLRNLVSQLF---KRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 45/252 (17%)
Query: 127 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL-----KEERTP 180
GQ L +L+ + +G G G+VYK R G ++AVK++ KEE
Sbjct: 7 GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK- 58
Query: 181 GGELQFQTEVEMISMAVHR--NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL 238
+ +++++ + H +++ G+ +T ++ + M+ + L +R Q
Sbjct: 59 ----RILMDLDVVLKS-HDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKR--IQG 109
Query: 239 PLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLM 296
P+ ++ + + L YL + H +IHRDVK +NILLD + DFG++ +L+
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166
Query: 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK----TDVFGYGIMLLELITGQRAFD---- 348
D K +A G ++APE + + K DV+ GI L+EL TGQ +
Sbjct: 167 DSK-AKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
Query: 349 ----LARLANDD 356
L ++ ++
Sbjct: 224 EFEVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 70/299 (23%), Positives = 103/299 (34%), Gaps = 50/299 (16%)
Query: 149 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 207
+ K + +LVAVK++ + +L+ Q E+ H N+L
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66
Query: 208 CMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL---GSARGLSYLH-DH 262
L +V P MA GS L+ P LP IA L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIHSKG 121
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI------AP 316
IHR VKA++ILL + + V+ + M + +P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 317 EYLSTGKS--SEKTDVFGYGIMLLELITGQRAF-DLARLANDDDVMLLDWVKGL---LKE 370
E L +EK+D++ GI EL G F D+ MLL+ V+G L +
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM-----PATQMLLEKVRGTVPCLLD 232
Query: 371 KKLEMLVDPDLQNNYVEAEV----------------EQLIQVALLCTQGSPMDRPKMSE 413
K L + + + E E Q LC Q P RP S+
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 53/154 (34%), Positives = 73/154 (47%), Gaps = 23/154 (14%)
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGK 323
+IHRD+K+ANILL +GDFG +K+ Y T V GT ++APE
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKM--YAATVSDDVGRTFCGTPYYVAPEIWRRKP 221
Query: 324 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383
S+K D+F G++L EL+T +R FD N ++VM K L DP +
Sbjct: 222 YSKKADMFSLGVLLYELLTLKRPFD---GENMEEVM----------HKTLAGRYDPLPPS 268
Query: 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
E Q I ALL P RP S+++ M
Sbjct: 269 ISPEM---QEIVTALLS--SDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 144 FSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL--KEERTPGGELQFQTEVEMISMAVHRN 200
+ N ++G G +G V K + + G +VA+K+ E+ ++ + E+ M+ H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
L+ L LV+ ++ + +V L + P LD ++ RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTHVTTAVRGTIGHIA 315
H IIHRD+K NIL+ + + DFG A+ + Y D T R A
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR------A 168
Query: 316 PEYL-STGKSSEKTDVFGYGIMLLELITGQRAF 347
PE L K D++ G ++ E++TG+ F
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G+G G VY +A G VA++++ ++ P EL E+ ++ + N++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ E +V Y+A GS+ + E + + R+ + + L +LH + ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 328
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 329 DVFGYGIMLLELITGQRAF 347
D++ GIM +E+I G+ +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 142 DSFSNKNILGRGGFGKVY------------KGRLADGS-----LVAVKRLKEERTPGGEL 184
+ K LG G FG+V+ K D S LVAVK L+E+
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 185 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL-RERPPSQLP---- 239
F E++++S N++RL C+T ++ YM NG + L R P
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 240 --LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297
+ + T +A A G+ YL +HRD+ N L+ + + + DFG+++ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL- 180
Query: 298 YKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
Y + R I ++ E + GK + +DV+ +G+ L E++T
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 136 ELQVATDSFSNKNILGRGGFGKVYKGRL---ADG---SLVAVKRLKEERTPGGELQFQTE 189
E+ ++T F + LG FGKVYKG L A G VA+K LK++ +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 190 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS------------Q 237
M S H N++ L G +++ Y ++ + L R P +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 238 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM- 296
L+ I A G+ +L H ++H+D+ N+L+ ++ + D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 297 --DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
DY + + I ++PE + GK S +D++ YG++L E+ +
Sbjct: 176 AADYYKLMGNSLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 84/347 (24%), Positives = 138/347 (39%), Gaps = 91/347 (26%)
Query: 149 ILGRGGFGKVYKG------RLADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNL 201
+LG G FGKV + + + + VAVK LKE T +E++ +I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 202 LRLRGFCMTPTERLL-VYPYMANGSVASCL----------RERPPSQLPLDWPT------ 244
+ L G C P L+ + + G++++ L RE+ P Q
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 245 RKRIALGS------------------------------------------ARGLSYLHDH 262
+RI G ARG+ +L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLS 320
K IHRD+ A NILL E + DFGLA+ + YKD + R + +APE +
Sbjct: 194 ---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARLPLKWMAPESIF 249
Query: 321 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
+ ++DV+ +G++L E+ + G + ++ + L D + + P
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR----------MRAP 299
Query: 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAER 426
+ E+ +++ L C QG P +RP S +V +L GD L E
Sbjct: 300 E----NATPEIYRIM---LACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 166 GSLVAVKRL---KEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222
G VAVK++ K++R EL F EV ++ H N++ + + E +V ++
Sbjct: 44 GRQVAVKKMDLRKQQRR---ELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99
Query: 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282
G++ + + ++ + L + LS+LH +IHRD+K+ +ILL +
Sbjct: 100 GGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSD 151
Query: 283 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ DFG + K+ ++ GT +APE +S + D++ GIM++E++
Sbjct: 152 GRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD 210
Query: 343 GQRAF 347
G+ +
Sbjct: 211 GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 143 SFSNKNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVH 198
S + ILG G FG++ +G L S VA+ L+ + F E + H
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N++RL G ++V YM+NG++ S LR + QL + G A G+ Y
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAG--QLMGMLPGLASGMKY 122
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAP 316
L + +H+ + A +L++ + + F +L + K + T + G + AP
Sbjct: 123 LSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLE 374
E + S +DV+ +GI++ E+++ G+R + D++ DV+ K + E
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS----GQDVI-----KAV--EDGFR 226
Query: 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ + N L Q+ L C Q +RP+ S++
Sbjct: 227 LPAPRNCPN--------LLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 150 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRG- 206
+GRG FG V K G+++AVKR++ + + +++++ + +++ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 207 --------FCM----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
CM ++ Y Y L+ P ++ +IA+ + +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEV-------LKSVIPEEI------LGKIAVATVK 118
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 313
L+YL + + KIIHRDVK +NILLD + DFG++ +L+ D+ T G +
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPY 173
Query: 314 IAPEYLSTGKSSE---KTDVFGYGIMLLELITG 343
+APE + ++DV+ GI L E+ TG
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 166 GSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLL-VYPYMA 222
G VA+K L+ + +F+ E + + H N++ L P L V+ Y+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL--- 279
+ LRE + L R+ L L+ H+ I+HRD+K NI++
Sbjct: 63 GRT----LREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 280 DEEFEAVVGDFGLAKLM-DYKDTHVTTAVR-----GTIGHIAPEYLSTGKSSEKTDVFGY 333
A V DFG+ L+ +D V T R GT + APE L + +D++ +
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 334 GIMLLELITGQRAFDLARLA-------NDDDVMLLDWVKGL 367
G++ LE +TGQR A +A + DV L W+ G
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH 216
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 25/201 (12%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHRNLLRLRGF 207
+G G +G VYK R + G L A+K +K E PG + Q E+ M+ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPP-SQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+ + + + GS+ P S+ + + +R+ + +GL YLH
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK-- 127
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST- 321
+HRD+K ANILL + + DFG++ + T A R GT +APE +
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 322 --GKSSEKTDVFGYGIMLLEL 340
G ++ D++ GI +EL
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 149 ILGRGGFGKVYKGRLADG----SLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRN--- 200
+LG G +GKV+ R G L A+K L++ + T E + R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---GLS 257
L+ L T + L+ Y++ G + + L +R D + + S L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALE 119
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
+LH I++RD+K NILLD E V+ DFGL+K ++ T + GTI ++APE
Sbjct: 120 HLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 318 YL-STGKSSEKTDVFGYGIMLLELITGQRAFDL 349
+ G + D + GI++ EL+TG F L
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 59/234 (25%), Positives = 89/234 (38%), Gaps = 48/234 (20%)
Query: 148 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGG-------------------ELQFQ 187
LG G +GKV K G +VA+K++K EL+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 188 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
E++ H N++ L + LV MA S L++ ++ L K
Sbjct: 75 NEIK------HENIMGLVDVYVEGDFINLVMDIMA-----SDLKKVVDRKIRLTESQVKC 123
Query: 248 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LMDYKDT 301
I L GL+ LH +HRD+ ANI ++ + + DFGLA+ D
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 302 HVTTAVRG-------TIGHIAPEYL-STGKSSEKTDVFGYGIMLLELITGQRAF 347
T R T+ + APE L K D++ G + EL+TG+ F
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMA 196
++ D F + LG G G V+K L+ ++L E P Q E++++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALGSAR 254
++ G + E + +M GS+ L++ R P Q+ ++++ +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI------LGKVSIAVIK 114
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 313
GL+YL + KI+HRDVK +NIL++ E + DFG++ +L+D + + GT +
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 168
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344
++PE L S ++D++ G+ L+E+ G+
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 60/231 (25%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EVEMI 193
+ +G G +G V G VA+K++ F E++++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53
Query: 194 SMAVHRNLLRLRGFCMTPTERL------LVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
H N++ L + P +V M + ++ S PL T
Sbjct: 54 RHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQPL---TDDH 104
Query: 248 I------ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301
I L RGL YLH +IHRD+K +NIL++ + + DFGLA+ +D +
Sbjct: 105 IQYFLYQIL---RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 302 H--------VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITG 343
VT R APE LS+ + ++ D++ G + EL+T
Sbjct: 159 EKGFLTEYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQ--FQTEVEMISMAVHRNLLRL-R 205
LG GGFG+V ++ A+K +K+ Q +E E++ H +++L R
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 206 GFCMTPTERLLVY---PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
F ++ +Y Y G + + LR+R ++ R IA YLH+
Sbjct: 61 TF----KDKKYIYMLMEYCLGGELWTILRDR--GLFD-EYTARFYIA-CVVLAFEYLHNR 112
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST 321
II+RD+K N+LLD + DFG AK L + T T GT ++APE +
Sbjct: 113 ---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILN 166
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
D + GI+L EL+TG+ F +D+D M
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFG----EDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 151 GRGGFGKVYKGRLADGS---LVAVKRLKEERTPGGELQFQT--EVEMISMAVHRNLLRLR 205
GRG +G+VYK + +G A+K+ K ++ + E+ ++ H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 206 GFCMTPTERL--LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
+ ++ L++ Y + R ++ + K + G+ YLH +
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 264 DPKIIHRDVKAANILL--DEEFEAVV--GDFGLAKL 295
++HRD+K ANIL+ + VV GD GLA+L
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMA 196
++ D F + LG G G V K + L+ ++L E P Q E++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALGSAR 254
++ G + E + +M GS+ L+E R P ++ ++++ R
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI------LGKVSIAVLR 114
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 313
GL+YL + +I+HRDVK +NIL++ E + DFG++ +L+D + + GT +
Sbjct: 115 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 168
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344
++PE L S ++D++ G+ L+EL G+
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 27/211 (12%)
Query: 150 LGRGGFGKVYKGRLAD-GSLVAVKRL--------KEERTPGGELQFQTEVEMISMAVHRN 200
+G+G FG+VY+ R D + A+K L KE GE + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI---LVRTLLDESPF 57
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALGS-ARGLS 257
++ L+ T ++ LV YM+ G + L++ R R + + L
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-------RAKFYIAELVLALE 110
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
+LH + I++RD+K NILLD + DFGL+K + D T GT ++APE
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPE 166
Query: 318 YLSTGKSSEK-TDVFGYGIMLLELITGQRAF 347
L K K D + G+++ E+ G F
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 63/292 (21%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LGRG +G V K R + G+++AVKR++ V S R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR------------ATVN--SQEQKRLLMDL-DIS 53
Query: 209 MTPTERLLVYPYMAN--------GSVASCL-----------RERPPSQLPLDWPTRKRIA 249
M R + PY G V C+ ++ L + +IA
Sbjct: 54 M----RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIA 109
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 309
+ + L YLH +IHRDVK +N+L++ + + DFG++ + D+ T G
Sbjct: 110 VSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAG 165
Query: 310 TIGHIAPEYLSTGKSSE----KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365
++APE ++ + + K+DV+ GI ++EL TG+ +D W
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-------------SWKT 212
Query: 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
+ K++ P L E + + C + + +RP E+++
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 149 ILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG- 206
+LG+G FGKV R L A+K LK+ ++ Q + +M V + +L L G
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKK------DVVIQDDDVECTM-VEKRVLALSGK 59
Query: 207 --------FCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
C +RL V Y+ G + +++ + P IA+ GL
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI----GLF 115
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
+LH II+RD+K N++LD E + DFG+ K + D T GT +IAPE
Sbjct: 116 FLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPE 171
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
++ + D + +G++L E++ GQ F+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLR 205
+LG+G FGKV R A G A+K LK+E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 206 GFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKRI---ALGSARGLSYLH 260
+ +RL V Y G + L RER S+ R R + SA L YLH
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE------DRARFYGAEIVSA--LGYLH 112
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
CD +++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 113 S-CD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 321 TGKSSEKTDVFGYGIMLLELITGQRAF 347
D +G G+++ E++ G+ F
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLR 205
+LG+G FGKV R A G A+K LK+E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 206 GFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGS-ARGLSYLHDHC 263
T V Y+ G + L RER S+ R R L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE------DRTRFYGAEIVSALDYLHSG- 114
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
KI++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 324 SSEKTDVFGYGIMLLELITGQRAF 347
D +G G+++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 148 NILGRGGFGKVYKGR-LADGSLVAVKR-LKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
+G+G FG+V+K R +VA+K+ L E G + E++++ + H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 206 GFCMTPTERLLVYPYMANGSVAS-------C------LRERPPSQLPLDWPTRKRIALGS 252
C T N S C L + L K++
Sbjct: 78 EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEIKKVMKML 128
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294
GL Y+H + KI+HRD+KAANIL+ ++ + DFGLA+
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 69/296 (23%), Positives = 113/296 (38%), Gaps = 68/296 (22%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEV------------------- 190
LG+G F K++KG ++ E GEL +TEV
Sbjct: 3 LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49
Query: 191 -EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 249
M+S H++L+ G C+ E ++V Y+ GS+ + L++ + + + W + +A
Sbjct: 50 ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISW--KLEVA 106
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 309
A L +L D + H +V A N+LL E + G+ KL D ++ V
Sbjct: 107 KQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVLP 160
Query: 310 T------IGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362
I + PE + ++ S D + +G L E+ +G D + LD
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG----------GDKPLSALD 210
Query: 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
K L + L P E+ LI C P RP ++R L
Sbjct: 211 SQKKLQFYEDRHQLPAPKW------TELANLINQ---CMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 14/231 (6%)
Query: 149 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLR 205
++GRG + KV RL + + A+K +K+E E QTE + A L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 206 GFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
C T RL LV Y+ G + ++ + +LP + + A L++LH+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEE--HARFYAAEICIALNFLHER-- 115
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 324
II+RD+K N+LLD + + D+G+ K T+ GT +IAPE L +
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 325 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
D + G+++ E++ G+ FD+ + ++ D+ D++ ++ EK + +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDI--ITDNPDMNTEDYLFQVILEKPIRI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 61/234 (26%), Positives = 111/234 (47%), Gaps = 18/234 (7%)
Query: 149 ILGRGGFGKVYKGRLADGSLV-AVKRLKEERTPGGEL--QFQTEVEMISMAV-HRNLLRL 204
++GRG + KV L + A+K +K+E E QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 205 RGFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPT--RKRIALGSARGLSYLHD 261
T + V +++ G + + R+R +LP + I+L L++LH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLA----LNFLHE 114
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
D + G+++ E++ G+ FD+ ++++ D D++ ++ EK++ +
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 143 SFSNKNILGRGGFGKVYKGRLADG----SLVAVKRLKE----ERTPGGELQFQTEVEMIS 194
+F +LG G +GKV+ R G L A+K LK+ ++ E +TE +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTE-HTRTERQVLE 59
Query: 195 MAVHRN-LLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPPSQLPLDWPTRKRIALG 251
L+ L T T+ L+ Y+ G + + L RER Q +I G
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EVQIYSG 112
Query: 252 S-ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 310
L +LH II+RD+K NILLD V+ DFGL+K + + GT
Sbjct: 113 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 311 IGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAF 347
I ++AP+ + G + D + G+++ EL+TG F
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 19/223 (8%)
Query: 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL--KEERTPGGELQFQTEVE 191
+R+LQ+ + + ++GRG FG+V R V +L K E + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 192 MISMAVHRNLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 249
I MA + ++ FC ++ L V YM G + + + +P W K
Sbjct: 95 DI-MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWA--KFYT 148
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVR 308
L +H +IHRDVK N+LLD+ + DFG MD TAV
Sbjct: 149 AEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204
Query: 309 GTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAF 347
GT +I+PE L + G + D + G+ L E++ G F
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 149 ILGRGGFGK--VYKGRLADGSLVAVKRLKEERTPGGELQFQT---EVEMISMAVHRNLLR 203
++G G FG+ + + +D +KE R P + E +++ H N++
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYA----MKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERP----PSQLPLDWPTRKRIALGSARGLSYL 259
+ +V Y G + ++ + P L W + + LG + ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLG----VQHI 116
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H+ +++HRD+K+ NI L + + +GDFG A+L+ + T V GT ++ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAF 347
+ K+D++ G +L EL T + F
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 27/228 (11%)
Query: 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLV-AVKRL-KEERTPGGELQFQTEV 190
+ +L++ + F ++GRG FG+V R V A+K L K E + F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 191 EMISMAVHRN---LLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTR 245
I MA H N +++L ++ L V YM G + + + +P W R
Sbjct: 94 RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKW-AR 145
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THV 303
A L +H IHRDVK N+LLD+ + DFG MD +
Sbjct: 146 FYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD-ANGMVRC 200
Query: 304 TTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAF 347
TAV GT +I+PE L + G + D + G+ L E++ G F
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ--FQTEVEMISMAVHRNLLRLR 205
++G+GG G+VY VA+K+++E+ + L+ F E ++ + +H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 206 GFCMTPTERLLVY---PYMANGSVASCLRE-RPPSQLPLDW------PTRKRIALGSARG 255
C ++ VY PY+ ++ S L+ L + I
Sbjct: 69 SIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------------Y 298
+ Y+H ++HRD+K NILL E V+ D+G A Y
Sbjct: 126 IEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ + GT ++APE L +SE TD++ G++L +++T
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 144 FSNKNILGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
F+ +LG+G FGKV R L A+K LK++ + Q + +M V + +L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD------VIIQDDDVECTM-VEKRVL 54
Query: 203 RLRG---------FCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 252
L G C +RL V Y+ G + +++ + P IA+G
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG- 113
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 312
L +LH II+RD+K N++LD E + DFG+ K + T GT
Sbjct: 114 ---LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTPD 166
Query: 313 HIAPE---YLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
+IAPE Y GKS D + +G++L E++ GQ FD
Sbjct: 167 YIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 148 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
N +G G G VYK G L A+K + Q E+E++ H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
E ++ +M GS+ + L R+ ++ G++YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEG---THIADEQFLADVARQILS-----GIAYLHRR---H 188
Query: 267 IIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
I+HRD+K +N+L++ + DFG LA+ MD ++ V GTI +++PE ++T
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTD 243
Query: 323 KSSEK-----TDVFGYGIMLLELITGQRAFDLAR 351
+ D++ G+ +LE G+ F + R
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 52/239 (21%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVE-------MI 193
D F LG G FG+V R G A+K L + ++ +VE ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA-----KIVKLKQVEHVLNEKRIL 55
Query: 194 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 253
H L+ L G + LV Y+ G + S LR+ R A
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS------------GRFPEPVA 103
Query: 254 R--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
R L YLH D I++RD+K N+LLD + + DFG AK + + T
Sbjct: 104 RFYAAQVVLALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156
Query: 306 AVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
+ GT ++APE + + GK+ D + GI++ E++ G F DD+ + +
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPPFF------DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 149 ILGRGGFGKVY-KGRLADGSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRL 204
++G+G FGKV R DG AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 205 RGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ TE+L V ++ G + L RER + P + A A L YLH
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-----PRARFYAAEIASALGYLHS- 114
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLST 321
I++RD+K NILLD + V+ DFGL K + DT TT GT ++APE +
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRK 170
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAF 347
D + G +L E++ G F
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 150 LGRGGFGKVYKGRLAD-GSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 204
+G G +G V+K + + +VA+KR++ +E P L+ E+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRL 64
Query: 205 RGFCMTPTERLLVYPYMANG---SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
+ + LV+ Y SC + +D K +GL++ H
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD-------IDPEIVKSFMFQLLKGLAFCHS 117
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294
H ++HRD+K N+L+++ E + DFGLA+
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
R + YLH++ +IIHRD+KA NI ++ + +GDFG A + + GTI
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344
APE L+ D++ GI+L E+ T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVH 198
F K+++GRG FG+V R A G + A+K +K+ E F+ E +++S++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 199 RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLD----WPTRKRIALGSA 253
+ +L+ + + L LV Y G + S L R Q D + +A+ S
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
+ Y +HRD+K N+L+D + DFG A + + GT +
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 314 IAPEYLSTGKSSEKT------DVFGYGIMLLELITGQRAF 347
IAPE L+T K D + G++ E+I G+ F
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 48/218 (22%)
Query: 150 LGRGGFGKVYKGR---------LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+G G FG+V+ R L ++ V RLK+E+ E ++ H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRVLKEVSHPF 62
Query: 201 LLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---- 254
++RL F +R L + Y+ G + S LR R + +
Sbjct: 63 IIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYAS 108
Query: 255 ----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRG 309
L YLH +I++RD+K NILLD+E + DFG AK L D T + G
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCG 160
Query: 310 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
T ++APE + + ++ D + GI++ E++ G F
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLR 205
++G+G FGKV R A+ AVK L+++ E +E ++ V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 206 GFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
F ++L V Y+ G + L RER + P + A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-----PRARFYAAEIASALGYLHSL- 115
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
I++RD+K NILLD + V+ DFGL K + + T+ GT ++APE L
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 324 SSEKTDVFGYGIMLLELITGQRAF 347
D + G +L E++ G F
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 59/273 (21%), Positives = 118/273 (43%), Gaps = 26/273 (9%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLK--EERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+GRG F +VY+ L D VA+K+++ E E++++ H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 207 FCMTPTERLLVYPYMANGSVASCLR--ERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
+ E +V G ++ ++ ++ +P + + L SA + ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMHSR-- 125
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 324
+++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 183
Query: 325 SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 384
+ K+D++ G +L E+ Q F D + L +K+E P L
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF------YGDKMNLFSLC------QKIEQCDYPPLPTE 231
Query: 385 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
+ ++ +L+ +C P RP + V ++
Sbjct: 232 HYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 149 ILGRGGFGKVY---KGRLAD-GSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLR 203
+LG+G FGKV+ K D G L A+K LK+ ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
L T + L+ ++ G + + R ++ K A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFT----RLSKEVMFTEEDVKFYLAELALALDHLHSL- 117
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDTHVTTAVRGTIGHIAPEYLST 321
II+RD+K NILLDEE + DFGL+K + K + + GT+ ++APE ++
Sbjct: 118 --GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR 172
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAF 347
++ D + +G+++ E++TG F
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 7/122 (5%)
Query: 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL-HDHCDPKIIHRDVKAANILLDE 281
S + + S PLD R + A+G+ +L +C IHRDV A N+LL +
Sbjct: 193 QSSDSKDEEDTEDSW-PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTD 247
Query: 282 EFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 340
A + DFGLA+ +M+ + V R + +APE + + ++DV+ YGI+L E+
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
Query: 341 IT 342
+
Sbjct: 308 FS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 10/179 (5%)
Query: 166 GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225
G VAVK++ + EL F EV ++ H N++ + + E +V ++ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285
+ + + ++ + L R LSYLH+ +IHRD+K+ +ILL +
Sbjct: 106 LTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344
+ DFG + K+ ++ GT +APE +S + D++ GIM++E+I G+
Sbjct: 158 KLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----HVTTAVRG 309
RGL Y+H +IHRD+K +N+L++E+ E +GDFG+A+ + T +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-A 173
Query: 310 TIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELI 341
T + APE LS + + D++ G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 38/127 (29%), Positives = 70/127 (55%), Gaps = 15/127 (11%)
Query: 220 YMANGSVASCLRE--RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 277
+M GS+ L++ R P + +I++ RGL+YL + KI+HRDVK +NI
Sbjct: 80 HMDGGSLDQVLKKAGRIPENI------LGKISIAVLRGLTYLRE--KHKIMHRDVKPSNI 131
Query: 278 LLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 336
L++ E + DFG++ +L+D + + GT +++PE L + ++D++ G+
Sbjct: 132 LVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 337 LLELITG 343
L+E+ G
Sbjct: 188 LVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 150 LGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G G G V + + G LVAVK++ + EL F EV ++ H N++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ E +V ++ G++ + + ++ + L + LS LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 328
HRD+K+ +ILL + + DFG + K+ ++ GT +APE +S +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 329 DVFGYGIMLLELITGQ 344
D++ GIM++E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 46/219 (21%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 204
+G G +G VYK R G +VA+K+++ +E P ++ E+ ++ H N++RL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIVRL 63
Query: 205 RGFCMTPTERLLVY--------PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
+ + LV+ YM + P LD P K +G+
Sbjct: 64 LDVVHSENKLYLVFEFLDLDLKKYM----------DSSPLT-GLDPPLIKSYLYQLLQGI 112
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRG 309
+Y H H +++HRD+K N+L+D E + DFGLA+ + Y TH VT R
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYR- 166
Query: 310 TIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 347
APE L + S D++ G + E++ + F
Sbjct: 167 -----APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G G G V R G VAVK + + EL F EV ++ H+N++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ E ++ ++ G++ + SQ L+ + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 328
HRD+K+ +ILL + + DFG + KD ++ GT +APE +S +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 329 DVFGYGIMLLELITGQ 344
D++ GIM++E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGEL------QFQTEVEMISMAVHRNLL 202
LG+G FG VY + D VA +RLK + P GEL Q E +++S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ + ++ Y + L E + L + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
+I+HRD+KA NI L +GDFG+++L+ + T GT +++PE L
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 323 KSSEKTDVFGYGIMLLELITGQRAF 347
K+D++ G +L E+ AF
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAF 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 204
+G G +G VYKGR G +VA+K+++ EE P ++ E+ ++ H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIVCL 64
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARGLSYLH 260
+ M + L++ ++ S ++ LP +D K +G+ + H
Sbjct: 65 QDVLMQESRLYLIFEFL------SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL- 319
+++HRD+K N+L+D + + DFGLA+ V T T+ + APE L
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEVLL 174
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAF 347
+ + S D++ G + E+ T + F
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKA 274
LL+ Y + G + +++R LP + L +H ++HRD+K+
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKS 197
Query: 275 ANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 331
ANI L +GDFG +K Y D+ V ++ GT ++APE + S+K D++
Sbjct: 198 ANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 332 GYGIMLLELITGQRAF 347
G++L EL+T R F
Sbjct: 256 SLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 46/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 172 KRLKEERTPGGE---LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV--------YPY 220
+RL +R G +Q + E+ + H N+L++ + ++ Y +
Sbjct: 193 ERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSF 252
Query: 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 280
M + + ++RP L TR I + Y+HD K+IHRD+K NI L+
Sbjct: 253 MYDEAFD--WKDRP-----LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 281 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 340
+ + V+GDFG A + + GT+ +PE L+ E TD++ G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 341 IT 342
++
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLR 205
+LG+G FGKV + A G A+K LK+E + TE ++ + H L L+
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 206 GFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGS-ARGLSYLHDHC 263
T V Y G + L RER S+ R R L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE------DRARFYGAEIVSALDYLH--S 113
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
+ +++RD+K N++LD++ + DFGL K KD GT ++APE L
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 324 SSEKTDVFGYGIMLLELITGQRAF 347
D +G G+++ E++ G+ F
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQT---EVEMISMAVHRNLLRLRG 206
LG+G +G VYK + +KE R E +F E++++ AV ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMA--MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+ YM GS+ ++ + +RI +GL +L + +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG-IPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEYLSTGK 323
IIHRDVK N+L++ + + DFG++ + V + + IG ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 324 SSE------KTDVFGYGIMLLELITG 343
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 210 TPTER--LLVYPYMANG--SVASCLRERPPSQLPLDWPTR--KRIALGSARGLSYLHDHC 263
+ ++R L++ Y + + R ++ P+ P K + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 264 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 317
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 318 YLSTGKSSEKT-DVFGYGIMLLELITGQRAF 347
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQT---------EVE 191
D + N + +G G +G+V G VA+K+L P FQ+ E+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR---P-----FQSAIHAKRTYRELR 66
Query: 192 MISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWPT 244
++ H N++ L TP L LV M + + ++ + S
Sbjct: 67 LLKHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSD-----DH 119
Query: 245 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HV 303
+ + RGL Y+H IIHRD+K +NI ++E+ E + DFGLA+ D + T +V
Sbjct: 120 IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV 176
Query: 304 TTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
T + APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 177 ATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 33/236 (13%)
Query: 150 LGRG--GFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLR 205
+GRG VY R G+LV V+ E L+ Q EV + H N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
T + ++ P+MA GS S L+ P + I G+ RGL+YLH +
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM--SEALIGNILFGALRGLNYLHQN--- 120
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------YKDTHVTTAVRGTIGHI 314
IHR++KA++IL+ + +V GL+ L Y +T+V + +
Sbjct: 121 GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWL 175
Query: 315 APEYLSTGKS--SEKTDVFGYGIMLLELITGQRAF-DLARLANDDDVMLLDWVKGL 367
+PE L + K+D++ GI EL TG+ F D+ R MLL +KG
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-----MLLQKLKGP 226
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 18/167 (10%)
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
M + N ++L T +L+ Y+ +G + L+ + L K+I
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVE 120
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGH 313
L+ LH H IIH D+K N+L D + + + D+GL K++ + GT+ +
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDY 172
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
+PE + D + G++ EL+TG+ F D+D L
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-----EDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 150 LGRGGFGKVYKGRLADGSLV-AVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRG 206
+G+G FGKV + R D + A+K +++ T E +A ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR-GLSYLHDHCDP 265
+P + LV ++ G + L+ L +R R L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL-----SRARFYTAELLCALENLHKF--- 112
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 325
+I+RD+K NILLD + + DFGL KL + KD T GT ++APE L +
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 326 EKTDVFGYGIMLLELITG 343
+ D + G++L E++TG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 144 FSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
F LG G FG+V + G A+K LK+ E+ +V+ ++ +++L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR-----EILKMKQVQHVAQ--EKSIL 72
Query: 203 R----------LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 252
+ F + ++ G + + LR+ + P D K
Sbjct: 73 MELSHPFIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRK--AGRFPND--VAKFYHAEL 127
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 312
YLH D II+RD+K N+LLD + V DFG AK K T + GT
Sbjct: 128 VLAFEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPE 180
Query: 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
++APE + + + D + G++L E I G F
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 46/147 (31%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 152 RGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGFC 208
RG FGKVY GR + L AVK +K+ + Q + E ++A+ ++ ++ L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ LV Y+ G V S L D + A L YLH H II
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRH---GII 126
Query: 269 HRDVKAANILLDEEFEAVVGDFGLAKL 295
HRD+K N+L+ E + DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 150 LGRGGFGKVYKG---RLADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHRNLLRLR 205
LG G FG V KG VAVK LK + P + + E ++ + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 206 GFCMTPTERLLVYPYMAN-GSVASCLRERPPSQLPLDWPTRKRI---ALGSARGLSYLHD 261
G C E ++ +A G + L++ T K I + G+ YL +
Sbjct: 63 GIC--EAESWMLVMELAELGPLNKFLQKNKHV-------TEKNITELVHQVSMGMKYLEE 113
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYL 319
+HRD+ A N+LL + A + DFGL+K + + + G + APE +
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 320 STGKSSEKTDVFGYGIMLLELIT-GQRAF 347
+ K S K+DV+ +G+++ E + GQ+ +
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 150 LGRGGFGKVYKGRL-ADGSLVAVKRLKEERT------PGGE--LQFQTEVEMISMAVHRN 200
LG+G F +YKG L L V +E L F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
L++L G C+ E ++V Y+ G + L R + + L W + +A A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVR-GTIGHIAPE 317
D K++H +V NIL+ G KL D T ++ R I IAPE
Sbjct: 119 DK---KLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPE 174
Query: 318 YLSTGKSS--EKTDVFGYGIMLLEL 340
+ G++S D + +G LLE+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 25/203 (12%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLK------EERTPGGELQFQTEVEMISMAVHRNLL 202
+G G F +V K + G A+K +K E+ E+Q + ++ H N+L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ-----ALRRLSPHPNIL 61
Query: 203 RLRGFCM-TPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
RL T RL LV+ M + ++ ++ R + PL K + L ++H
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YL 319
+ I HRD+K NIL+ ++ + DFG + + K + T T + APE L
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLL 171
Query: 320 STGKSSEKTDVFGYGIMLLELIT 342
+ G K D++ G + E+++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 25/176 (14%)
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 310
ARG+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 238
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 369
+ +APE + + ++DV+ +G++L E+ + G + ++ + L + +
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---- 294
Query: 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 425
+ P+ Y E+ ++ L C +P DRP SE+V +L GD L E
Sbjct: 295 ------MRAPE----YATPEIYSIM---LDCWHNNPEDRPTFSELVEIL-GDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 135 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSL--VAVKRLKEERTPGGEL--QFQTEV 190
R+ ++ + F+ LG G FG+V + VA+KR ++ + + +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 191 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR--ERPPSQLPLDWPTRKRI 248
++++ H + L G + LV ++ G + LR +R P+ + + + +
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
+ L+ I++RD+K N+LLD++ + DFG AK++D + T +
Sbjct: 143 IFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLC 189
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
GT +IAPE L + D + GI + E++ G F
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 141 TDSFSNKNILGRGGFGKVYK-GRLADGSLVAVKRLKEERTPGGELQFQTEVE---MISMA 196
+D++ +G+G +GKV+K +GS AVK L P ++ + E E + +++
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALS 72
Query: 197 VHRNLLRLRGF-----CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 251
H N+++ G + LV GSV ++ ++ P I
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 311
+ GL +LH + K IHRDVK NILL E + DFG++ + T+V GT
Sbjct: 133 ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTP 188
Query: 312 GHIAPEYLSTGKS-----SEKTDVFGYGIMLLELITG 343
+APE ++ + + DV+ GI +EL G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 210 TPTER--LLVYPYMANG--SVASCLRERPPSQLPLDWP--TRKRIALGSARGLSYLHDHC 263
+ +R L++ Y + + R ++ P+ P K + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 264 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 317
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 318 YLSTGKSSEKT-DVFGYGIMLLELITGQRAF 347
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLR 205
+LG+G FGKV R A G A+K L++E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 206 GFCMTPTERLLVYPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGS-ARGLSYLHDHC 263
T V Y G + L RER ++ R R L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSALEYLHSR- 114
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
+++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 324 SSEKTDVFGYGIMLLELITGQRAF 347
D +G G+++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 147 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEE---RTPGGELQFQTEVEMISMAVHR 199
+LG+GG+GKV++ R G+ + A+K LK+ R + E ++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR----- 254
++ L T + L+ Y++ G + L R+ I +
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-------------REGIFMEDTACFYLS 107
Query: 255 ----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 310
L +LH II+RD+K NILLD + + DFGL K ++ T VT GT
Sbjct: 108 EISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGT 163
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
I ++APE L + D + G ++ +++TG F
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL--KEERTPGGELQ-FQTEVEMISMAVH 198
+ F ++GRG FG+V +L + V ++ K E E F+ E +++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCL---RERPPSQLPLDWPTRKRIALGSARG 255
+ + L LV Y G + + L +R P + + IA+ S
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGTIGHI 314
L Y +HRD+K NIL+D + DFG KLM+ + AV GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 315 APEYLST-----GKSSEKTDVFGYGIMLLELITGQRAF 347
+PE L GK + D + G+ + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 40/139 (28%), Positives = 73/139 (52%), Gaps = 13/139 (9%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 312
RGL Y+H ++HRD+K AN+ ++ E+ +GDFGLA+++D +H G +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 313 --HIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM--LLDWVKGL 367
+ +P LS ++ D++ G + E++TG+ F A++ + M +L+ V +
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA---GAHELEQMQLILESVPVV 238
Query: 368 LKEKKLEML-VDPDLQNNY 385
+E + E+L V P N
Sbjct: 239 REEDRNELLNVIPSFVRND 257
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ + D +T V T +
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 314 IAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
RGL Y+H ++HRD+K +N+LL+ + + DFGLA+ K +T V T +
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 314 IAPEYLSTGKSSEKT---DVFGYGIMLLELITGQRAF 347
APE L SE T DV+ G + EL+ + F
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 58/275 (21%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 158 VYKGRLADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215
+YKG + V ++ K+ L + E++ + N+L++ GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 216 ----LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 271
L+ Y G LRE + L + T+ +A+ +GL L+ + +++
Sbjct: 95 PRLSLILEYCTRGY----LREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148
Query: 272 VKAANILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAV---RGTIGHIAPEYLSTGKSS 325
+ + + L+ E ++ + GL K++ +K+ V V + I EY
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKN--VNFMVYFSYKMLNDIFSEYT------ 200
Query: 326 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD-PDLQNN 384
K D++ G++L E+ TG+ F+ N + D + + K L++ +D P
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFE-----NLTTKEIYDLI--INKNNSLKLPLDCPLEIKC 253
Query: 385 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
VEA CT + RP + E++ L
Sbjct: 254 IVEA-----------CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTI 311
+GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR--- 182
Query: 312 GHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 347
APE L+ ++ D++ G ++ E++TG+ F
Sbjct: 183 ---APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
RGL YLH I+HRD+K N+L++ + DFGLA++ + ++ T T +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 314 IAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 347
APE L + + D++ G + EL+ + F
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 67/245 (27%), Positives = 98/245 (40%), Gaps = 52/245 (21%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGEL-QFQTEVEMISMAVH 198
F +LG+G G+V+ RL G L A+K L K+E ++ + TE E+++ H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR---- 254
L L T T LV Y G + L+ +P L + AR
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE----------VARFYAA 110
Query: 255 ----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR-- 308
L YLH I++RD+K NILL E ++ DF L+K D + V+ A+R
Sbjct: 111 EVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 309 --------------------------GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
GT +IAPE +S D + GI+L E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
Query: 343 GQRAF 347
G F
Sbjct: 228 GTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL--KEERTPGGELQFQTEVE 191
+R+L++ + + ++GRG FG+V R V +L K E + F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 192 MISMAVHRNLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERP-PSQLPLDWPTRKRI 248
I MA + ++ F +R L V YM G + + + P + + +
Sbjct: 95 DI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--TTA 306
AL + + + IHRDVK N+LLD+ + DFG M+ K+ V TA
Sbjct: 154 ALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTA 203
Query: 307 VRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAF 347
V GT +I+PE L + G + D + G+ L E++ G F
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 310
A+G+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 244
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 369
+ +APE + + ++DV+ +G++L E+ + G + ++ D++ +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEF--------CRR 294
Query: 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
K+ + PD Y E + Q L C G P RP SE+V L
Sbjct: 295 LKEGTRMRAPD----YTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLLRL 204
+G G +G VYK R +A+K+++ +E P ++ E+ ++ H N++RL
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQHGNIVRL 66
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
+ + LV+ Y+ + + + P + K RG++Y H H
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 265 PKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE L +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSR 179
Query: 324 S-SEKTDVFGYGIMLLELITGQRAF 347
S D++ G + E++ + F
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK----LMDYKDTHVTTAVRG 309
+ L Y+H +IHRD+K +NILL+ + + DFGLA+ L + + V T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 310 TIGHIAPEYL--STGKSSEKTDVFGYGIMLLELITGQRAF 347
T + APE L ST + ++ D++ G +L E++ G+ F
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 48/231 (20%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAV--- 197
D F ++GRG FG+V AV ++K ER ++ + EM+ A
Sbjct: 1 DDFEIIKVIGRGAFGEV-----------AVVKMKHTERIYA--MKILNKWEMLKRAETAC 47
Query: 198 ---HRNLLRLRGFCMTPTER----------LLVYPYMANGSVASCL---RERPPSQLPLD 241
RN+L + G C T LV Y G + + L +R P +
Sbjct: 48 FREERNVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF 106
Query: 242 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301
+ +A+ S L Y +HRD+K N+LLD + DFG M+ T
Sbjct: 107 YIAEMVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157
Query: 302 HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAF 347
++ GT +I+PE L GK + D + G+ + E++ G+ F
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLK--EERTPGGELQFQTEVEMISMAVH 198
+ F ++G G +G V K R + +VA+K+ K EE E + E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N++ L+ + LV+ Y+ ++ L E P P + + + +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP---EKVRSYIYQLIKAIHW 115
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPE 317
H + I+HRD+K N+L+ + DFG A+ L + + + T V T + +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPE 171
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
L + D++ G +L EL GQ F
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ D + T T +
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 314 IAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
APE L+ ++ D++ G ++ EL+ G+ F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 253 ARGLSYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 310
A+G+S+L +C IHRD+ A NILL + DFGLA+ + +V R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 369
+ +APE + + ++DV+ YGI+L E+ + G + G+
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-----------------PGMPV 322
Query: 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ K ++ + E ++ + C P+ RP ++V+++E
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGT 310
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D + H +T V T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-AT 172
Query: 311 IGHIAPEYLSTGKSSEKT-DVFGYGIMLLELITGQRAF 347
+ APE + K K D++ G +L E+++ + F
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 150 LGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEV---------EMISMAVHR 199
+G G +G V G VA+K+L FQ+E+ ++ H
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--------FQSEIFAKRAYRELTLLKHMQHE 74
Query: 200 NLLRLRG-FCMTPTER-----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 253
N++ L F + LV PYM + P S+ + + + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQML----- 127
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTI 311
GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--- 181
Query: 312 GHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 347
APE L+ ++ D++ G ++ E++TG+ F
Sbjct: 182 ---APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGELQ-FQTEVEMISMAVH 198
D F ++GRG FG+V ++ + G + A+K L K E E F+ E +++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 199 RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLR---ERPPSQLPLDWPTRKRIALGSAR 254
R + L + L LV Y G + + L +R P + + +A+ S
Sbjct: 61 RWITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 314
L Y +HRD+K N+LLD+ + DFG + T + GT +I
Sbjct: 120 QLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170
Query: 315 APEYL-----STGKSSEKTDVFGYGIMLLELITGQRAF 347
+PE L G+ + D + G+ + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 49/153 (32%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 207 FCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
FC T+R L V Y+ G A+ L+ LP+D R A + L YLH++
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDM-ARMYFA-ETVLALEYLHNY-- 120
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDY----------KDTH--VTTAVRGT 310
I+HRD+K N+L+ + DFGL+K LM KDT + V GT
Sbjct: 121 -GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
+IAPE + + D + GI+L E + G
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 17/164 (10%)
Query: 184 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWP 243
L F ++S H +L + G C+ +E ++V ++ +G + CLR + ++P+ W
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-KEKGRVPVAWK 119
Query: 244 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303
L SA LSYL D ++H +V A NILL + + G + + D V
Sbjct: 120 ITVAQQLASA--LSYLEDK---NLVHGNVCAKNILLARLG---LAE-GTSPFIKLSDPGV 170
Query: 304 TTAVRG------TIGHIAPEYLSTGKS-SEKTDVFGYGIMLLEL 340
+ I IAPE + G S S D + +G LLE+
Sbjct: 171 SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 36/133 (27%), Positives = 49/133 (36%), Gaps = 47/133 (35%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPD-------------NGSF-SLFTPIS----------- 36
SL +I+SL+VLDLS N +G +P+ NG+ S P +
Sbjct: 461 SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520
Query: 37 -FANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFA 95
F +N LCG R C P +S A IA GV+ L
Sbjct: 521 NFTDNAGLCGIPGLRAC--------------GPHLSV----GAKIGIAFGVSVAFLFLVI 562
Query: 96 APAIAFAWWRRRK 108
WW+RR+
Sbjct: 563 CAMC---WWKRRQ 572
|
Length = 623 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 51/239 (21%)
Query: 150 LGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQ--------TEVEMISMAVHRN 200
+G+GG+G+V+ + D G +VA+KR+K+ L F+ TE ++++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK------SLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR------ 254
L++L L Y+ G + L ++ AR
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN------------NLGVLSEDHARFYMAEM 110
Query: 255 --GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 310
+ LH+ IHRD+K N L+D + DFGL+K + VT A V G+
Sbjct: 111 FEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYANSVVGS 161
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM--LLDWVKGL 367
++APE L D + G ML E + G F + ++ L W + L
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS---GSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGT 310
R L Y+H + HRD+K NIL + + + + DFGLA++ + DT T T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 311 IGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAF 347
+ APE + K + D++ G + E++TG+ F
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 59/247 (23%), Positives = 92/247 (37%), Gaps = 58/247 (23%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVH 198
D F ++GRG FG+V+ R G + A+K L++ + E ++++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 199 RNLLRLRGFC-MTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRI-----ALG 251
+++L + E L LV YM G + + L + P + R I AL
Sbjct: 61 PWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEET-ARFYIAELVLALD 115
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR--- 308
S L + IHRD+K NIL+D + + DFGL K
Sbjct: 116 SVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCK--KMNKAKDREYYLNDS 164
Query: 309 ---------------------------GTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLEL 340
GT +IAPE L G + D + G++L E+
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEM 223
Query: 341 ITGQRAF 347
+ G F
Sbjct: 224 LYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAVRG 309
GL Y+H ++HRD+K N+L++ + E + DFGLA+ +T V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 310 TIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
T + APE LS ++ DV+ G +L EL+ + F
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-- 310
ARG+ +L +HRD+ A N+LL + + DFGLA+ + + +V+ +G+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 311 --IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ +APE + + +DV+ YGI+L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 150 LGRGGFGKVYK------GRLADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLL 202
LGRG FGKV + + A VAVK LKE T TE++ +I + H N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 203 RLRGFCMTPTERLLV-YPYMANGSVASCLR 231
L G C P L+V Y G++++ LR
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLR 104
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 314
G+ +LH IIHRD+K +NI++ + + DFGLA+ + T T +
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 315 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
APE + E D++ G ++ EL+ G F
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 4/102 (3%)
Query: 239 PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD- 297
PL +A + Y+H IIHRD+K N+L++ + +GDFG A
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312
Query: 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLE 339
T + GT+ APE L+ + D++ G+++ E
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 27/209 (12%)
Query: 150 LGRGGFGKVYKGRLAD---------GSLVAVKRLKEERTPGGE---LQFQTEVEMISMAV 197
LGRG ++Y G L +K + + P L F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H++++ L G C+ E ++V ++ G + + + L P + ++A A LS
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALS 119
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGT----IG 312
YL D ++H +V NILL E + G+ G KL D +T R I
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAR--EGIDGECGPFIKLSD-PGIPITVLSRQECVERIP 173
Query: 313 HIAPEYLSTGKS-SEKTDVFGYGIMLLEL 340
IAPE + K+ S D + +G L E+
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|234398 TIGR03921, T7SS_mycosin, type VII secretion-associated serine protease mycosin | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 18/64 (28%), Positives = 24/64 (37%)
Query: 45 GPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWW 104
P GRP +P + P PPP G+AA A ++ A A
Sbjct: 287 PPEDGRPLRPAPAPARPVAAPAPPPPPDDTPRGRVALWGAGLAALAVVVGLAAAAVRRRG 346
Query: 105 RRRK 108
RRR+
Sbjct: 347 RRRR 350
|
Members of this family are subtilisin-related serine proteases, found strictly in the Actinobacteria and associated with type VII secretion operons. The designation mycosin is used for members from Mycobacterium [Protein fate, Protein and peptide secretion and trafficking, Protein fate, Protein modification and repair]. Length = 350 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 19/100 (19%)
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LM-DYKDTHVTTAV 307
G+ +LH IIHRD+K +NI++ + + DFGLA+ +M Y VT
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 183
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
R APE + E D++ G ++ E+I G F
Sbjct: 184 R------APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 54/232 (23%)
Query: 143 SFSNKNILGRGGFGKVYKGRLADGS-LVAVKRLKEERTPGGELQFQTEVEMISMAV-HRN 200
S+ NI+G G FG VY+ D S VA+K++ ++ Q++ +I + H N
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHIN 120
Query: 201 LLRLRGF----CMTPTERLL------------VYPYMANGSVASCLRERPPSQLPLDWPT 244
++ L+ + C E+ + V+ YM + + R LPL
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA-------RNNHALPL--FL 171
Query: 245 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHV 303
K + R L+Y+H I HRD+K N+L+D + + DFG AK +
Sbjct: 172 VKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL------- 221
Query: 304 TTAVRGTIGHI------APEYLSTGKSSEKT--DVFGYGIMLLELITGQRAF 347
A + ++ +I APE L G ++ T D++ G ++ E+I G F
Sbjct: 222 -LAGQRSVSYICSRFYRAPE-LMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 467 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.33 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.25 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.03 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 97.96 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.74 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.69 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.39 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.37 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.31 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.25 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.2 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.18 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.01 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.8 | |
| PLN02236 | 344 | choline kinase | 96.58 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.54 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.54 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.54 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.53 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 96.5 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.01 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.0 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.93 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.73 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.63 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.51 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.23 | |
| PF13504 | 17 | LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO | 94.98 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.96 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-60 Score=459.07 Aligned_cols=289 Identities=53% Similarity=0.900 Sum_probs=255.4
Q ss_pred cccccCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeee
Q 012267 128 QLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207 (467)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 207 (467)
..+.|+++++..+|++|+..++||+|+||.||+|.+.+|..||||++....... ..+|..|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999999999999887655433 5569999999999999999999999
Q ss_pred eeCCC-ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 208 CMTPT-ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 208 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
|.+.+ +.+||||||++|+|.++|+..... +++|..|++||.++|+||+|||..+.|+|+||||||+|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999986543 699999999999999999999999999999999999999999999999
Q ss_pred EeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 287 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
|+|||+++..............||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+... ......+.+|+..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHHH
Confidence 99999997654312211111179999999999999999999999999999999999999887533 2234458999999
Q ss_pred HhhhcccccccCcccc-CcccH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 367 LLKEKKLEMLVDPDLQ-NNYVE-AEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.+....+.+++||++. ..+.. .++..+..++.+|++.+|.+||+|.||+++|+.+
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999999999999987 55554 6889999999999999999999999999999653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=439.50 Aligned_cols=379 Identities=26% Similarity=0.490 Sum_probs=264.5
Q ss_pred ccCCCCCCeEEcccCcccccCCCCCCCCccCcccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccee
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSPPPPFIPPPPISSPGGNSATGAI 82 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N~~Lcg~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 82 (467)
+.++++|+.|||++|+|+|.||..+.+..+...++.||+.+||...... ..++ .. . ......++
T Consensus 567 l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~---~~~c----------~~--~-~~~~~~~~ 630 (968)
T PLN00113 567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG---LPPC----------KR--V-RKTPSWWF 630 (968)
T ss_pred HhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC---CCCC----------cc--c-cccceeee
Confidence 4566677777777777777777776677777778888888887532110 0000 00 0 01111222
Q ss_pred eeeehhhHHHHHHHHHhhhhhhccCCCCccc-cCCCCCC-Ccc-cccCcccccCHHHHHHHhcCCCCCCeeeecCceEEE
Q 012267 83 AGGVAAGAALLFAAPAIAFAWWRRRKPQEFF-FDVPAEE-DPE-VHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVY 159 (467)
Q Consensus 83 ~~~v~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~ 159 (467)
++++++++++++++++++++++|+++..+.. ....... ... ........++++++ ...|...++||+|+||.||
T Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy 707 (968)
T PLN00113 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASY 707 (968)
T ss_pred ehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEE
Confidence 2222233333333333333333333221110 0000000 000 00011122334433 3457788899999999999
Q ss_pred EEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCC
Q 012267 160 KGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL 238 (467)
Q Consensus 160 ~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~ 238 (467)
+|+. .+|..||||+++..... ...|++.+++++||||++++|+|.+.+..++||||+++|+|.++++.
T Consensus 708 ~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------ 776 (968)
T PLN00113 708 KGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------ 776 (968)
T ss_pred EEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------
Confidence 9997 47899999998643221 23468889999999999999999999999999999999999999963
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeeccccccccccccc
Q 012267 239 PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318 (467)
Q Consensus 239 ~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~ 318 (467)
++|..+..|+.|+++||+|||..+.++|+||||||+||+++.++.+++. ||........ ....++..|+|||+
T Consensus 777 -l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~ 849 (968)
T PLN00113 777 -LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPET 849 (968)
T ss_pred -CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCccc
Confidence 7999999999999999999997767799999999999999999988875 6655432211 12257899999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCc--ccHHHHHHHHHH
Q 012267 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN--YVEAEVEQLIQV 396 (467)
Q Consensus 319 ~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~--~~~~~~~~l~~l 396 (467)
+.+..++.++|||||||++|||+||+.||+.. ......+.+|++..........++|+.+... ...++..++.++
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 926 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAE---FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL 926 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCcc---cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHH
Confidence 99999999999999999999999999999532 2334557788876665555666777766432 345667789999
Q ss_pred HHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 397 ALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 397 ~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+.+||+.+|++||+|.||++.|++.
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHHHHHh
Confidence 9999999999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=388.50 Aligned_cols=253 Identities=33% Similarity=0.511 Sum_probs=205.8
Q ss_pred CCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-ceEEEeeccCC
Q 012267 146 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMAN 223 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 223 (467)
..+.||+|+||+||+|.+.+...||||++...... .....|.+|+.+|.+++|||||+++|+|.++. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34559999999999999975445999999754322 22568999999999999999999999999987 79999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-cccCCCCCCcEEECCCC-cEEEeecCCccccCCCCC
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK-IIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~ 301 (467)
|+|.++++.. ....+++..++.++.+||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999885 233599999999999999999999999 7 99999999999999997 99999999998754322
Q ss_pred eeeeccccccccccccccc--CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 302 HVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~--~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||..... .+.........
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~-------- 262 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGG-------- 262 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcC--------
Confidence 2233367999999999999 56899999999999999999999999964221 11111111111
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
........+...+..++.+||+.||..||++.+++..|+.+
T Consensus 263 -~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 263 -LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred -CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 11111222457788999999999999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=370.01 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=211.9
Q ss_pred CCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-ceEEEeeccCC
Q 012267 146 NKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMAN 223 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 223 (467)
..+.||+|..|+|||+.++ +++.+|+|++.....+...+++.+|+++++..+||+||++||.|.... ...++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 3567999999999999986 789999999977767777789999999999999999999999999988 59999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
|||++++...+. +++...-+|+.+|++||.|||+ . +||||||||+|||++..|++||+|||.++.+...
T Consensus 163 GSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 163 GSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999987532 8999999999999999999996 5 8999999999999999999999999999877543
Q ss_pred eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
....+.||..|||||-+.+..|+.++||||||+.++|+.+|+.||... ........+.+...+.+.. |++.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~pp------P~lP 303 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPP------PRLP 303 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCC------CCCC
Confidence 455678999999999999999999999999999999999999999643 2223344444444443321 2222
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. .+..++..++..||++||.+||+++|+++
T Consensus 304 ~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 304 EG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22 35577899999999999999999999854
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=386.10 Aligned_cols=259 Identities=30% Similarity=0.476 Sum_probs=215.0
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
+...+.+...+.||+|.||.||.|.+.....||+|.++.... ...+|.+|+++|++++|+|||+++|+|......+||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 333344445677999999999999998777999999987532 345799999999999999999999999998899999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
||||+.|+|.++|+.... ..+...+.+.++.|||+||+||+++ ++|||||..+||||+++..+||+||||++...
T Consensus 280 tE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 999999999999998332 2388899999999999999999999 99999999999999999999999999999654
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
...........-...|.|||.+..+.++.|||||||||+||||+| |+.|+.. ....+.+..+.+..++.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------msn~ev~~~le~GyRlp-- 424 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------MSNEEVLELLERGYRLP-- 424 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------CCHHHHHHHHhccCcCC--
Confidence 444434444445678999999999999999999999999999999 8888753 22334444443333332
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.+..+...+.++|..||+.+|++|||++.+...|++.
T Consensus 425 --------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 425 --------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred --------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 2344668899999999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=357.88 Aligned_cols=199 Identities=28% Similarity=0.460 Sum_probs=181.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.+|...+.||+|+||+||+|+++ ++..||||.+.+.. .+...+.+..|+.+|+.++|||||.+++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56888888999999999999976 68999999997765 44455668899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC------CcEEEeecCCc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLA 293 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgl~ 293 (467)
||.||+|.++|+.++. +++.....++.|||.||++||++ +||||||||+||||+.. -.+||+|||++
T Consensus 90 yC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998753 89999999999999999999999 99999999999999765 45899999999
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
+.+. ........+|++-|||||+++.++|+.|+|+||+|+|||+|++|+.||+.
T Consensus 163 R~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9875 44455678899999999999999999999999999999999999999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=373.50 Aligned_cols=248 Identities=28% Similarity=0.481 Sum_probs=209.6
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.+|...++||+|+|++||.++. .+|+.||+|++.+... ....+.+.+|+++.+.++|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999997 7899999999976432 334557899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
|+|.+++|.++++.+. ++++.++..++.||+.||.|||++ +|+|||||..|+|++++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998543 499999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .....+.+||+.|+|||++.....+..+||||+|||||.||+|++||+... ++.....-...+-.-
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------VKETYNKIKLNEYSM 237 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------HHHHHHHHHhcCccc
Confidence 3 345566899999999999999999999999999999999999999996421 111111111111111
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
| ........+++..+|+++|.+|||+++|+.
T Consensus 238 P-------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 P-------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred c-------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 123356778899999999999999999964
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=359.13 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=207.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcc------hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG------GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
..+.|...+.||+|+||.|-+|.. ++|+.||||++++..... .....++|+++|++++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345677788999999999999985 489999999997654332 1223579999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC---CcEEEee
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGD 289 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~D 289 (467)
..||||||++||+|.+.+..+.. +.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999987654 66677788999999999999999 99999999999999766 6799999
Q ss_pred cCCccccCCCCCeeeecccccccccccccccCCCC---CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
||+|+... ....+...+||+.|.|||++.+... ..+.|+||+|||||-+++|.+||.... ....+.+.+.
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~----~~~sl~eQI~- 395 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY----TDPSLKEQIL- 395 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc----CCccHHHHHh-
Confidence 99999865 5667888999999999999976543 458899999999999999999996421 2221222111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
.+++ .+- ........++..+++.+||..||++|||+.|+ |+..++.
T Consensus 396 ---~G~y--~f~----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea---L~hpW~~ 441 (475)
T KOG0615|consen 396 ---KGRY--AFG----PLQWDRISEEALDLINWMLVVDPENRPSADEA---LNHPWFK 441 (475)
T ss_pred ---cCcc--ccc----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH---hcChhhh
Confidence 0110 011 11234556788999999999999999999988 4555443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=387.70 Aligned_cols=262 Identities=28% Similarity=0.468 Sum_probs=218.4
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
..+.+....+.||+|.||+||+|+.. +...||||.++.....+...+|++|++++..++|||||+++|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34455666788999999999999853 356899999998877778889999999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPS----------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~ 282 (467)
..+||+|||..|+|.++|...... ..+++..+.+.||.|||.||.||-++ .+|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 999999999999999999764321 23488999999999999999999999 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCCeeee-cccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccH
Q 012267 283 FEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVML 360 (467)
Q Consensus 283 ~~~kl~Dfgl~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~ 360 (467)
..|||+||||++.....+.+... ...-..+|||||.+..++||.+||||||||+|||++| |+.|+.... ..
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-----n~-- 712 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-----NQ-- 712 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----hH--
Confidence 99999999999976655544433 2223579999999999999999999999999999998 999986421 11
Q ss_pred HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 361 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+ |-..++. .++ -..++.+..++++||..||+.+|++||+++||-.+|+.-
T Consensus 713 -E-VIe~i~~--------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 713 -E-VIECIRA--------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -H-HHHHHHc--------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 1 1122222 222 233556778999999999999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=344.61 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=211.1
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeee-eeeCCCc-eEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRG-FCMTPTE-RLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 217 (467)
.+|.+.++||+|+||+||++.+ .+|..||.|.++-.... ....+...|+.+|+.++|||||++++ .+.+.++ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3466678899999999999985 58999999999855433 33456889999999999999999999 4555555 7899
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||..|+|..+++........++++.+|+++.|++.||..+|++... -|+||||||.||+|+.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999987666666799999999999999999999994221 3999999999999999999999999999988
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... .......+||+.||+||.+...+|+.||||||+||++|||+.-++||... ++.+..+.. .....
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI-~qgd~--- 245 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKI-EQGDY--- 245 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHH-HcCCC---
Confidence 643 34455678999999999999999999999999999999999999999642 233333222 21111
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
|.+ ....+...+.+++..|+..||+.||+.-.+++.+..
T Consensus 246 --~~~---p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 --PPL---PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CCC---cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111 124566889999999999999999996555555544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=338.53 Aligned_cols=244 Identities=28% Similarity=0.352 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch--HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|++.++||+|+||+||.++.. +++.+|+|++++...... .+....|..+|..++||.||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999865 689999999987654332 45688999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
+||+.||.|..+|++... +++..+.-++..|+.||.|||++ +||||||||+|||||++|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999987653 88888888999999999999999 99999999999999999999999999998643
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
..+..+..++||+.|||||++.+..++..+|+||+|+++|||++|.+||... +..++......... ..
T Consensus 177 -~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k~---~~ 244 (357)
T KOG0598|consen 177 -KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGKL---PL 244 (357)
T ss_pred -cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCcC---CC
Confidence 3445566789999999999999999999999999999999999999999642 23344444443320 01
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 410 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 410 (467)
-|. -......+++...++.||++|-.
T Consensus 245 ~p~-------~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 245 PPG-------YLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCc-------cCCHHHHHHHHHHhccCHHHhcC
Confidence 111 11245677778888999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.58 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=218.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
....+.++||.|.||.||+|+++ ....||||.++....+..+.+|+.|..+|.+++||||+++.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34556789999999999999875 24689999999988888888999999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
.|||++|+|+.+|+.+... +.+.+...++.+||.||+||-+. ++|||||..+||||+.+...|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999987643 88999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCeeeecccc--cccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 298 YKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 298 ~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.......+...| ..+|.|||.+...++|.+|||||||+||||.++ |.+||-.. .-.+.++...+..++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--------SNQdVIkaIe~gyRL- 853 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------SNQDVIKAIEQGYRL- 853 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--------chHHHHHHHHhccCC-
Confidence 544333333333 468999999999999999999999999999877 99998421 112223333222222
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
..+.++...|.+||+.||++|-.+||++.||+..|++.-..
T Consensus 854 ---------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 854 ---------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ---------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 23556778899999999999999999999999999885443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=324.24 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+.|+...++|+|+||+||+++.+ +|+.||||++..... +.-.+-.++|+++|+.++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999976 699999999965443 3334457899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
||+. ++.+-|.....+ ++...+.+++.|+++|+.|+|++ +++||||||+||||+.++.+||+|||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9988 555555554332 78889999999999999999999 999999999999999999999999999998864
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHH-----------
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL----------- 367 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 367 (467)
.+...+.++.|.+|+|||.+.+ .+|...+|||++||++.||++|.+.|...+ +.+..-.+...
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-----DiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-----DIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-----hHHHHHHHHHHHcccCHHHHHH
Confidence 4555666778999999999987 689999999999999999999999885322 11111111111
Q ss_pred -hhhcccccccCcccc-----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 368 -LKEKKLEMLVDPDLQ-----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 368 -~~~~~~~~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
........+.-|... ....+....-+++++..|++.||.+|++-+|++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111222222222211 1112233456889999999999999999998863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=353.83 Aligned_cols=267 Identities=29% Similarity=0.479 Sum_probs=213.2
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT 210 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 210 (467)
.+..+|++..+.+.+...||+|.||+||+|++-+ .||||+++.... +...+.|..|+..+++-+|.||+-++|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 4457777777888888999999999999999863 499999987653 3344579999999999999999999999998
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
+.. .+|+-+|+|-+|+.+|+.... .++....+.|+.|||+||.|||.+ +|||||||+.|||+.+++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 887 999999999999999997653 388899999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCC-CCeeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 291 GLAKLMDYK-DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 291 gl~~~~~~~-~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
|++..-..- .........|...|||||++. ..+|+..+||||||+|+|||+||..||.. ...++.+...-++
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi----~~~dqIifmVGrG 608 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI----QNRDQIIFMVGRG 608 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC----CChhheEEEeccc
Confidence 998643221 122223344788999999986 35789999999999999999999999962 1111111111000
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
. .-|++ ......+.+++.+|+..||..++++||.+.+|+.+|+..
T Consensus 609 ~---------l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 609 Y---------LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred c---------cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 0 00111 112334567899999999999999999999999988874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=333.93 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=211.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
..+.|++.++||.|..++||+|++. .++.||||++..+........+++|+..++.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3467889999999999999999864 789999999988776666678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
.||.+||+.++++.....+ +++..+..|..++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999998865544 88999999999999999999999 999999999999999999999999998765543
Q ss_pred CCCe---eeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 299 KDTH---VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 299 ~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
.... ....+.||++|||||++.. ..|+.|+||||||++..||.+|..||..... ....+..+......
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTLQNDPPT 251 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHhcCCCCC
Confidence 3221 1145679999999999543 4689999999999999999999999964211 11111111111100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. -..+..+........+.+++..|++.||++|||+.++++
T Consensus 252 ~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 011112223344567899999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.15 Aligned_cols=263 Identities=27% Similarity=0.462 Sum_probs=205.1
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
.+..++|.+.++||+|+||.||+|.. .++..||||+++..........+..|+.++..+ +||||++++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999974 235689999997654444455789999999999 89999999999876
Q ss_pred CC-ceEEEeeccCCCChhhhhhcCCCC-----------------------------------------------------
Q 012267 211 PT-ERLLVYPYMANGSVASCLRERPPS----------------------------------------------------- 236 (467)
Q Consensus 211 ~~-~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 236 (467)
.+ ..++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578999999999999998753210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe-eeeccccc
Q 012267 237 -----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 310 (467)
Q Consensus 237 -----~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~ 310 (467)
..++++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13478889999999999999999999 9999999999999999999999999999865322221 12223456
Q ss_pred ccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHH
Q 012267 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAE 389 (467)
Q Consensus 311 ~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 389 (467)
..|+|||++.+..++.++|||||||++|||++ |..||..... .. .+... ...... ... ....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~---~~~~~-~~~~~~-----~~~----~~~~ 302 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NE---EFCQR-LKDGTR-----MRA----PENA 302 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cH---HHHHH-HhcCCC-----CCC----CCCC
Confidence 78999999998899999999999999999997 9999964211 11 11111 111110 001 1122
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 390 VEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 390 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...+.+++.+||+.||.+|||+.||++.|++
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.37 Aligned_cols=260 Identities=30% Similarity=0.478 Sum_probs=214.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC--CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA--DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
..+.+..+.||+|.||.||.|... +|. .||||.++.....+...+|++|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455667788999999999999865 343 49999998887777788999999999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 215 LLVYPYMANGSVASCLRERPPS---QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
++++|||++|+|..+|++.... ...++....+.++.+||+|+.||+++ ++|||||..+|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999875221 34588999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecc-cccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhh
Q 012267 292 LAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
||+.+...+....... .-...|||||.+..+.++.|+|||||||+|||++| |..||.... -.+......+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--------n~~v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--------NFEVLLDVLE 919 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--------hHHHHHHHHh
Confidence 9995544443333322 22468999999999999999999999999999999 888884321 1122222333
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.+++. .+..+...++++|..||+.+|++||++..|++.+..+
T Consensus 920 ggRL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 920 GGRLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred CCccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 33221 2445568899999999999999999999999988764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=349.11 Aligned_cols=242 Identities=27% Similarity=0.449 Sum_probs=201.5
Q ss_pred CCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 144 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
.+..+-||+|+.|.||+|++. ++.||||+++.- -..+++.|++++|+||+.+.|+|....-.|||||||..
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 344677999999999999996 678999987532 23678899999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|.|.++|+.... +.-.....+..+||.||.|||.+ .|||||||+-||||..+..+||+|||-++.+... ..
T Consensus 197 GqL~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 197 GQLYEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred ccHHHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 999999987543 77778899999999999999999 9999999999999999999999999999876543 23
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
...++||..|||||++.+.+.++|+|||||||||||||||.-||..... .. .+..+-...+.-
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds--------sA---------IIwGVGsNsL~L 330 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS--------SA---------IIWGVGSNSLHL 330 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch--------he---------eEEeccCCcccc
Confidence 3457899999999999999999999999999999999999999953210 00 011111112222
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..+..+.+.+.-|+.+||+..|.+||++++++.-|+-
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 2344566778889999999999999999999999863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=332.56 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=202.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC--ceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 218 (467)
.++...+.||+|+||+||++... +|...|||.+....... ...+.+|+.+|++++|||||+++|...... ..++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45667789999999999999975 58999999987653333 456899999999999999999999865554 588999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecCCccccC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD 297 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~ 297 (467)
||+++|+|.+++...+. .+++..+..+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999998653 389999999999999999999999 9999999999999999 7999999999998765
Q ss_pred C--CCCeeeecccccccccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 298 Y--KDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 298 ~--~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
. ..........||+.|||||++..+. ...++|||||||++.||+||+.||... .....++-......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~--- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGRED--- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccC---
Confidence 3 2223344567999999999998643 345999999999999999999999642 11112222222111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 418 (467)
.-|.+ +........+++..|++.+|.+|||+.++++.-
T Consensus 240 --~~P~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 --SLPEI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred --CCCCC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11222 222346678889999999999999999997654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=340.87 Aligned_cols=267 Identities=23% Similarity=0.311 Sum_probs=206.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCC-ceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT-ERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv 217 (467)
.++|...++||.|.||.||+|+- .+|..||||+++.....-.+.--++|++.|++++ ||||+++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 46788889999999999999985 4799999999987654433334578999999999 999999999999887 99999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
||||+. +|+++++.+ ..++++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+...
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999976 999999986 34599999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCeeeeccccccccccccccc-CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC--------CccHHHHHHHHh
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD--------DVMLLDWVKGLL 368 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~ 368 (467)
.. ...+.++.|.+|+|||++. ...|+.+.|+|++|||++|+.+-++.|-+....++- ......|.....
T Consensus 162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 43 3355677899999999875 567899999999999999999999988542211000 000011111100
Q ss_pred hhcccccccCccccC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 369 KEKKLEMLVDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
-...+ .+.-|...+ ........+.++++.+|+++||.+|||+.|.++.
T Consensus 240 La~~m-nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAM-NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHh-ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000 011111111 1122356778999999999999999999998653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=338.18 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=205.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 216 (467)
.+.|+.+++||+|.||.||+|+. .+|..||+|+++.+.. +....-..+|+.+|++++||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35677788999999999999985 5899999999987653 33344678999999999999999999998876 68999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|+|||++ +|.-++..... .++..++..++.|++.||.|+|+. +|+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999988 88888876433 389999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc----
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK---- 371 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 371 (467)
........+..+-|.+|+|||++.+ ..|+.+.|+||.||||.||++|++.|.... +.....-+-.+....
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t-----EveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT-----EVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc-----HHHHHHHHHHHhCCCChhc
Confidence 7666665666677999999999887 468999999999999999999999986422 111111111111110
Q ss_pred c----cc--cccCcccc-----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 K----LE--MLVDPDLQ-----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~----~~--~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ +. ..+.|... ...........++|+..+|..||.+|.|+.++++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 00 00111100 0001122345678888899999999999998853
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=335.03 Aligned_cols=266 Identities=23% Similarity=0.387 Sum_probs=205.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-----------------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLAD-----------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 203 (467)
.++|...++||+|+||.||+|.+.+ +..||+|.+...........+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997532 34799999976554445567999999999999999999
Q ss_pred eeeeeeCCCceEEEeeccCCCChhhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcc
Q 012267 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPP---------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268 (467)
Q Consensus 204 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~iv 268 (467)
+++++.+.+..++||||+++|+|.+++..... ....++|..++.++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999865321 112478899999999999999999999 999
Q ss_pred cCCCCCCcEEECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc--CCC
Q 012267 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQR 345 (467)
Q Consensus 269 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt--g~~ 345 (467)
||||||+|||+++++.+||+|||+++.+...... ......++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865432221 1222345788999999988889999999999999999987 556
Q ss_pred CcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 346 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 346 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
||.... .......+............. .....+...+.+++.+||+.+|.+|||+.+|.+.|++
T Consensus 241 p~~~~~-----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELT-----DEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCC-----HHHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 664311 111222222222211110000 0011223678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=337.75 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch--HHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 216 (467)
..+|...+.||.|+|++|++|+.. +++.||||++.+...... .+-...|-++|.+| .||.|++++-.|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 467888999999999999999854 799999999865433222 22466788888888 79999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|+||+++|+|.++|+..+. +++.....++.+|+.||+|||++ |||||||||+|||||+|+++||+|||.|+.+
T Consensus 152 vLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999998754 88889999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCe----------e--eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 297 DYKDTH----------V--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 297 ~~~~~~----------~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
...... . ...++||..|.+||++.....+..+|+|+||||||+|+.|++||.... +...+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyliF---- 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYLIF---- 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHHHH----
Confidence 532211 1 144789999999999999999999999999999999999999996422 11111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+..+. +.. .+.......+.+|+.+.|..||.+|+|.+||-+
T Consensus 297 qkI~~---l~y--------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 QKIQA---LDY--------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHH---hcc--------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111 111 112222366778888889999999999977754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.87 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=206.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
...|..-.+||+|+.|.||.|.. .+++.||||++.....+ ..+-+.+|+.+|+..+|+|||++++.|...+++|+|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34677778999999999999974 47889999999765433 23457899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
||++|+|.+.+.... +++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 999999999987653 88999999999999999999999 9999999999999999999999999999887644
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
.. ......||+.|||||+.....|.+|.||||||++++||+-|.+||-.. .....-|.-. .. --|
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE------~PlrAlyLIa--~n------g~P 487 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE------NPLRALYLIA--TN------GTP 487 (550)
T ss_pred cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC------ChHHHHHHHh--hc------CCC
Confidence 43 445567999999999999999999999999999999999999999421 1111111110 01 111
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+ .........+.+++.+||+.|+.+||++.|+|+
T Consensus 488 ~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KL--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred Cc--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11 123334467889999999999999999999964
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.89 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=208.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc----chHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCc
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP----GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 213 (467)
..+.|...+.||+|+||+|+.|... +|..||+|++...... .....+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568889999999999999999864 7899999977654211 22345678999999999 9999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEeecCC
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGL 292 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl 292 (467)
.++||||+.+|+|.+++..... +.+.....++.|++.|++|+|++ +|+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998432 78899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCC-C-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-S-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
+.... .........+||+.|+|||++.+.. | ..++||||+||+||.|++|+.||+... ..........
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~~- 237 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIRK- 237 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHhc-
Confidence 99764 3344566678999999999999877 7 489999999999999999999997411 1111111111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCc
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 425 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 425 (467)
....-|... . ...+..++.+|+..+|.+|+++.+|+ +..++..
T Consensus 238 ---~~~~~p~~~---~---S~~~~~Li~~mL~~~P~~R~t~~~i~---~h~w~~~ 280 (370)
T KOG0583|consen 238 ---GEFKIPSYL---L---SPEARSLIEKMLVPDPSTRITLLEIL---EHPWFQK 280 (370)
T ss_pred ---CCccCCCCc---C---CHHHHHHHHHHcCCCcccCCCHHHHh---hChhhcc
Confidence 111111111 0 46788999999999999999999996 4444444
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=346.28 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=205.9
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
....++|+..+.||+|+||.||+|+. .++..||||+++..........+.+|+.++..+ +||||++++++|..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456788899999999999999963 245689999997554444455788999999999 89999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCC-------------------------------------------------------
Q 012267 211 PTERLLVYPYMANGSVASCLRERPP------------------------------------------------------- 235 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 235 (467)
.+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999875321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 236 ----------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 236 ----------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
....++|..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 112478999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 300 DTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 300 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ......+++. .... ..
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~----~~~~~~~~~~----~~~~--~~ 337 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP----VDSKFYKMIK----EGYR--ML 337 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC----chHHHHHHHH----hCcc--CC
Confidence 2211 122334567999999999999999999999999999998 888885321 1111122211 1100 00
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.+. ....++.+++.+||+.||++||++.+|++.|++
T Consensus 338 ~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 SPE-------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCC-------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111 112568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=329.32 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=204.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.++|++.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+..+.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999753 3668999999866544445578999999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||.... ..+......+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--------~~~~~~~~~~~~~--- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--------GQDVIKAVEDGFR--- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHHCCCC---
Confidence 2221111122235678999999998999999999999999999775 999995321 1111221111100
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. ........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 227 ---~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ---LP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ---CC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 00 112234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=328.57 Aligned_cols=260 Identities=16% Similarity=0.267 Sum_probs=203.1
Q ss_pred cccccCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcch--HHHHHHHHHHHHhcCCCeeeeee
Q 012267 128 QLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG--ELQFQTEVEMISMAVHRNLLRLR 205 (467)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~ 205 (467)
+.+.++.++++. .....||+|++|.||+|.+ +|+.||||+++....... .+.+.+|+.++.+++||||++++
T Consensus 11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 344555555522 2236799999999999998 588999999976433221 34678999999999999999999
Q ss_pred eeeeC----CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC
Q 012267 206 GFCMT----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 281 (467)
Q Consensus 206 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~ 281 (467)
|++.+ ....++||||+++|+|.+++.... .++|.....++.+++.||.|||+.. +++||||||+||++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECC
Confidence 99876 346789999999999999998643 3889999999999999999999742 7889999999999999
Q ss_pred CCcEEEeecCCccccCCCCCeeeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCcc
Q 012267 282 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359 (467)
Q Consensus 282 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~ 359 (467)
++.+||+|||+++.+.... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------- 226 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------- 226 (283)
T ss_pred CCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------
Confidence 9999999999998654221 12347889999999976 678999999999999999999999996321
Q ss_pred HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 360 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..++......... . +.+ .......+.+++.+||+.||.+|||+++|++.|+.
T Consensus 227 ~~~~~~~i~~~~~-~----~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 227 TKEIYDLIINKNN-S----LKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHHHHHhcCC-C----CCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1122222211110 0 111 11234568899999999999999999999999976
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.58 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcch-HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|...++||+|.||.||+|+. .+|+.||||+++.....++ .....+|++.|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999985 4899999999987654433 3468899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
||+. +|...++... ..++-..+..++.++++|++|+|++ .|+||||||.|+|++++|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 9999998753 3588889999999999999999999 9999999999999999999999999999988755
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc--
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML-- 376 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 376 (467)
....... +-|..|+|||.+.+ ..|+...|+||.|||+.||+-|.+-|...+ +.+....+-..+.....+.+
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-----DidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-----DIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-----hHHHHHHHHHHcCCCCcccCcc
Confidence 4433333 56889999999877 468999999999999999999887664311 11111111122111111111
Q ss_pred ----cC-------cc-ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 377 ----VD-------PD-LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 377 ----~d-------~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
-| |. .....-.......++++..++..||.+|.|++|.+++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 10 0111223344667999999999999999999998643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=341.56 Aligned_cols=264 Identities=29% Similarity=0.441 Sum_probs=210.3
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEEC--CC--CE-EEEEEecc--CCCcchHHHHHHHHHHHHhcCCCeeeeee
Q 012267 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLA--DG--SL-VAVKRLKE--ERTPGGELQFQTEVEMISMAVHRNLLRLR 205 (467)
Q Consensus 133 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~g--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 205 (467)
.-..|+..-++....++||+|+||.||+|++. ++ .. ||||..+. ........+|+.|.++++.++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 34456666677777899999999999999865 22 23 89999875 23455566899999999999999999999
Q ss_pred eeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcE
Q 012267 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 206 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 285 (467)
|++......++|||+|.||+|.++|+.... .++..++..++.+.|.||+|||++ +++||||..+|+|++.++.+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence 999999999999999999999999998754 389999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCeeee-cccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHH
Q 012267 286 VVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 363 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 363 (467)
||+|||+++... ...... ...-...|+|||.+....++.++|||||||++||+++ |..||.... ......+
T Consensus 302 KISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-----~~~v~~k 374 (474)
T KOG0194|consen 302 KISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-----NYEVKAK 374 (474)
T ss_pred EeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-----HHHHHHH
Confidence 999999987543 111111 1123578999999999999999999999999999999 888985421 1112222
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 364 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+ ...+. . -.........+..++.+||..+|++||+|.++.+.|+..
T Consensus 375 I---~~~~~-r--------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 375 I---VKNGY-R--------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred H---HhcCc-c--------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 2 11111 0 011112336677888899999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=333.26 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=210.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|-..+.||+|+||.||||+-+ +.+.||+|.+.+... ....+.+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45667788999999999999865 688999999865443 3344568999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+.| +|..+|..... +++..+..|+.+++.||.|||++ +|+|||+||.|||++.++.+|++|||+++.+..
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9977 99999987543 89999999999999999999999 999999999999999999999999999998764
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
.....+.+.||+-|||||+..+.+|+..+|.||+|||+||+.+|++||... .+.+.++....+...
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~v~------ 218 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDPVK------ 218 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCCCC------
Confidence 455666778999999999999999999999999999999999999999532 344555555443211
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+......+..++...+.+||..|.+..+++.
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12234466778888889999999999988864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=330.42 Aligned_cols=250 Identities=27% Similarity=0.369 Sum_probs=210.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
...|+..+.||+|+||.||+|.+. +++.||+|++..+......+++++|+.++..++++||.++||.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 346777889999999999999864 7899999999988877777789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
||.+|++.+.++.... +++..+.-|+.++..||.|||.+ +.+|||||+.|||+..+|.+|++|||.+..+...
T Consensus 92 y~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999987543 46677778899999999999999 9999999999999999999999999999887644
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
... ...+.||+.|||||++....|+.|+||||||++.+||++|.+|+....... - -..+..-..|
T Consensus 165 ~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------v---lflIpk~~PP 229 (467)
T KOG0201|consen 165 VKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------V---LFLIPKSAPP 229 (467)
T ss_pred hhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------E---EEeccCCCCC
Confidence 333 366789999999999998899999999999999999999999985311100 0 0011112233
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+ .+...+.+++..|+++||+.||++.++++
T Consensus 230 ~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4433 34466888999999999999999999975
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=342.25 Aligned_cols=263 Identities=26% Similarity=0.441 Sum_probs=205.1
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
....++|...+.||+|+||.||+|... ++..||||+++..........+..|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344567888999999999999998742 34579999997655444455688999999999 89999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCC-------------------------------------------------------
Q 012267 211 PTERLLVYPYMANGSVASCLRERPP------------------------------------------------------- 235 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 235 (467)
....++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864311
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe-e
Q 012267 236 -----------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-V 303 (467)
Q Consensus 236 -----------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~ 303 (467)
...++++..+++++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 112478899999999999999999999 9999999999999999999999999999765432221 1
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
.....++..|+|||++....++.++|||||||++|||++ |+.||.... ....... ..... . ....+.
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~----~~~~~~~----~~~~~-~-~~~~~~-- 338 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL----VNSKFYK----MVKRG-Y-QMSRPD-- 338 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc----ccHHHHH----HHHcc-c-CccCCC--
Confidence 122235568999999988899999999999999999997 999995321 1111111 11110 0 000111
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.....+.+++.+||+.+|.+||++.+|+++|++
T Consensus 339 -----~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 -----FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred -----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=321.80 Aligned_cols=264 Identities=28% Similarity=0.392 Sum_probs=198.0
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHH--hcCCCeeeeeeeeeeCCC----ceEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMIS--MAVHRNLLRLRGFCMTPT----ERLL 216 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~----~~~l 216 (467)
.....+++|+|.||.||||.+. ++.||||+++. ...+.|..|-++.+ .++|+||+++++.-.... +.+|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445578999999999999985 58999999954 34557888877766 468999999999866544 7899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc------CCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD------HCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~------~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
|++|.+.|+|.++|..+. ++|....+|+..+++||+|||+ +++|+|+|||||++||||.+|++..|+||
T Consensus 286 Vt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999874 8999999999999999999996 35789999999999999999999999999
Q ss_pred CCccccCCCC-CeeeecccccccccccccccCCC-C-----CcchhHHHHHHHHHHHHcCCCCccc--------ccc-cC
Q 012267 291 GLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGK-S-----SEKTDVFGYGIMLLELITGQRAFDL--------ARL-AN 354 (467)
Q Consensus 291 gl~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~-~-----~~~sDv~s~Gvil~elltg~~p~~~--------~~~-~~ 354 (467)
|+|..+.... .......+||.+|||||++.+.. + -.+.||||+|.|||||++...-++. +.. .-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998775332 22333467999999999987532 2 2478999999999999996554421 100 00
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccC-cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQN-NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+....+.+...-.+++ +.+ |.+.. ......+..+.+.+..||..||+.|.|+.=|.+++.+.
T Consensus 441 G~hPt~e~mq~~VV~k-K~R----P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRK-KQR----PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred cCCCCHHHHHHHHHhh-ccC----CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 1111121111111111 111 11111 11124567789999999999999999999999988774
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=333.93 Aligned_cols=269 Identities=23% Similarity=0.369 Sum_probs=218.0
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
+.+.+...+.++||+|.||.|.++....+.+||||.++.......+.+|.+|+++|.+++||||+.++|+|..++..++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34566677889999999999999999888999999999888888888999999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
+|||++|+|.+++..+.... +.-....+|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+.
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999998874322 34456677999999999999998 99999999999999999999999999999766
Q ss_pred CCCCeeee-cccccccccccccccCCCCCcchhHHHHHHHHHHHHc--CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 298 YKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 298 ~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
..+.+... ...-..+|||||.+..+++|.+||||+||+++||+++ ...||.... +....+-...+++.....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCcc
Confidence 55444333 3345679999999999999999999999999999876 667875321 111111111222211111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
..-..+..+...+++++++||..+.++||+++++...|++..
T Consensus 764 ------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 ------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111223445678999999999999999999999999998643
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=322.49 Aligned_cols=249 Identities=30% Similarity=0.525 Sum_probs=195.2
Q ss_pred CCeeeecCceEEEEEEEC-----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 147 KNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.+.||.|.||.||+|.+. .+..|+||.++..........+.+|++.+.+++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999876 357899999976555555678999999999999999999999999888899999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++|+|.++|.... ...+++..++.|+.||++||+|||+. +++|+||+++||++++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999862 22489999999999999999999999 999999999999999999999999999987632222
Q ss_pred -eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 302 -HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 302 -~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
...........|+|||.+.+..++.++||||||+++|||++ |+.||... ...++........... .
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~~~~--~-- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQRLP--I-- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTEETT--S--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccccce--e--
Confidence 12222346778999999998889999999999999999999 67887431 2223333332222211 0
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 418 (467)
.......+.+++..||+.+|++||++.+|++.|
T Consensus 227 ------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111236688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=316.92 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=203.3
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
++|+..+.||+|+||.||++.+.++..+|+|.+.... .....+..|++++.+++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4577788999999999999998888899999986432 23457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++|+|.++++.... .+++..++.++.+++.||.|||++ +++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999976432 388999999999999999999999 999999999999999999999999999876543222
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.+........ ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~---~~~~~ 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFR---LYRPK 224 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCC---CCCCC
Confidence 22222335668999999988889999999999999999999 899985321 1122222222111 11121
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
. ....+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ~-------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 L-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred C-------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 1256889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=328.35 Aligned_cols=200 Identities=26% Similarity=0.378 Sum_probs=176.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||.||+++.. +|..||+|.+...........+.+|++++..++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467889999999999999999976 6889999999765444445578999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 3888999999999999999999852 6999999999999999999999999998755322
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
......|+..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22334689999999999998999999999999999999999999953
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=304.85 Aligned_cols=197 Identities=27% Similarity=0.403 Sum_probs=178.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.....-. ..+...+|..+|+.+.||.++++++.|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777889999999999999976 78999999997654322 2335778999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||++||.|..++++... ++.+...-++.+|+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999998653 88899999999999999999999 999999999999999999999999999997642
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
.+.+.+||+.|+|||.++...+..++|.|||||++|||+.|.+||..
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 26678999999999999999999999999999999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=334.49 Aligned_cols=264 Identities=28% Similarity=0.406 Sum_probs=219.7
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
.++|+....+....++||-|.||.||.|.|+ -...||||.++.+.. ...+|++|..+|+.++|||+|+++|+|....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4777888888888999999999999999986 356799999987544 3558999999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
.+|||+|||.+|+|.++|++..... ++-...+.++.||+.||.||..+ ++|||||..+|+|+.++..+||+|||+
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999999875433 66677889999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++++............-...|.|||.+....++.|+|||+|||+|||+.| |..||.. ..+.+. -.+++.
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG--------idlSqV-Y~LLEk- 481 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQV-YGLLEK- 481 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC--------ccHHHH-HHHHhc-
Confidence 99986544433333334678999999999999999999999999999988 8888843 222222 222222
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
...-.....|...++++|+.||+++|.+||++.|+-+.++...
T Consensus 482 --------gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 482 --------GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --------cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1111224456688999999999999999999999999887643
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=321.00 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=206.4
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
...++|+..+.||+|++|.||+|...++..||+|.++... ....++.+|+.++++++|+||+++++++...+..++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3456788899999999999999998778889999987543 23457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999997653 23489999999999999999999999 999999999999999999999999999987652
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
...........+..|+|||++.+..++.++||||||+++|||+| |+.||.... .. ............
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~---~~~~~~~~~~~~---- 223 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----NA---EVLQQVDQGYRM---- 223 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----HH---HHHHHHHcCCCC----
Confidence 22111112223457999999998899999999999999999999 999985311 11 111111111000
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.........+.+++.+|++.+|.+||++.++++.|++
T Consensus 224 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 ------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011223678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=321.78 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=205.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
..++|+..++||+|++|.||+|...++..||+|.+.... .....+..|+.++..++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 346788889999999999999998888899999986532 234578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999976432 2378899999999999999999998 9999999999999999999999999999875432
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.........++..|+|||++....++.++|||||||++|+|+| |+.||.... .. ........... .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~---~~~~~~~~~~~-----~ 223 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----NS---DVMSALQRGYR-----M 223 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----HH---HHHHHHHcCCC-----C
Confidence 2222223335678999999988889999999999999999998 999985311 11 11111111100 0
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+. . ......+.+++.+|++.+|++||+++++++.|++
T Consensus 224 ~~-~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PR-M----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC-C----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 0 1123568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.26 Aligned_cols=252 Identities=26% Similarity=0.351 Sum_probs=198.5
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.|+..+.||+|+||+||+|... +|+.||||.+...... .....+.+|+.++..++|+|++++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3667789999999999999864 7899999998654322 223457889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988865322 2488999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ....... ........
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~-~~~~~~~~------- 221 (285)
T cd05631 156 --ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE----RVKREEV-DRRVKEDQ------- 221 (285)
T ss_pred --CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc----chhHHHH-HHHhhccc-------
Confidence 222344689999999999999999999999999999999999999964221 1001111 11111000
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 416 (467)
..........+.+++.+||+.||.+||+ +.++++
T Consensus 222 ---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122356888999999999999997 666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=323.73 Aligned_cols=258 Identities=27% Similarity=0.486 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECC------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|+..+.||+|+||.||+|.... ...||+|.++..........+.+|+..+..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999998642 25799999976554444557899999999999999999999999988999
Q ss_pred EEeeccCCCChhhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC
Q 012267 216 LVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 283 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~ 283 (467)
++|||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999764221 13488899999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHH
Q 012267 284 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 284 ~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 361 (467)
.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--------NQ 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 999999999976532221 12223346788999999988889999999999999999998 999985321 11
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 362 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+.... +...... .........+.+++.+||+.+|.+||++++|++.|+.
T Consensus 234 ~~~~~-i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEM-IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH-HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 1111111 1122344778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.65 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=200.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..+.||+|+||+||+|+.. +++.||||+++.... ......+.+|++++..++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999976 688999999975432 2234467899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|++++.+..+.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776554332 2388899999999999999999999 9999999999999999999999999999876433
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCC-------CCccHHHHHHHHhhhcc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 372 (467)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+.....+.........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 33233345689999999999988899999999999999999999999964211000 00000001111111111
Q ss_pred cccccCccccC------cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQN------NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
......+.... .........+.+++.+|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111100 001113356899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=318.53 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.++|+..+.||+|+||+||+|.+.. ...||||.++..........+..|+.++..++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568889999999999999998742 458999998766555555678999999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999976432 489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... . .+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----~---~~~~~~~~~~~~~- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----N---QDVIKAVEDGYRL- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----H---HHHHHHHHcCCCC-
Confidence 522222 2222334678999999998899999999999999999998 999984311 1 1111111111000
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+. .......+.+++.+||+.+|++||++.+|++.|++
T Consensus 228 ----~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 ----PP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ----CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 11223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=322.80 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=204.9
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
+.+++|+..+.||+|+||.||+|.+. ++..||||.+..........++.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 256799999865433334557889999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 213 ERLLVYPYMANGSVASCLRERPPS------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
..++||||+++|+|.+++...... ...+++..+..++.|+++||.|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998753221 23468889999999999999999998 999999999999999999999
Q ss_pred EeecCCccccCCCCCeee-ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHH
Q 012267 287 VGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 364 (467)
|+|||+++.......... ....++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~~ 231 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQVL 231 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 999999875543222111 11234678999999998889999999999999999999 788885321 11222
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...... .... . .......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 232 ~~~~~~-~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEG-GLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcC-CcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 1100 0 11123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=337.67 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=206.5
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 210 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 210 (467)
....++|.+.++||+|+||.||+|+.. .+..||||+++..........+..|++++.++. ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 445678899999999999999999853 234799999976554444567899999999996 9999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCC-------------------------------------------------------
Q 012267 211 PTERLLVYPYMANGSVASCLRERPP------------------------------------------------------- 235 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 235 (467)
....++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998865311
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEE
Q 012267 236 -------------------------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 278 (467)
Q Consensus 236 -------------------------------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nil 278 (467)
....+++..++.++.|+++||+|||+. +|+|+||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012478889999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCC
Q 012267 279 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDD 356 (467)
Q Consensus 279 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~ 356 (467)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---- 345 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---- 345 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence 999999999999999865432221 1222346778999999988889999999999999999997 9999853210
Q ss_pred CccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 357 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.... ........ .+. ........+.+++.+||+.+|++||++.+|.++|+.
T Consensus 346 ~~~~----~~~~~~~~-----~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 346 DSTF----YNKIKSGY-----RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred hHHH----HHHHhcCC-----CCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 0011 11111110 000 111234678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=321.66 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=198.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...++||.|+||+||+|... ++..||+|+++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888899999999999999875 68999999997654444445678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++ +|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 99998875432 378899999999999999999999 99999999999999999999999999987643222
Q ss_pred CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh----------
Q 012267 301 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 369 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 369 (467)
. ......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...... ...........
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-----EELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhcc
Confidence 1 1223457899999998865 56899999999999999999999999542110 00000100000
Q ss_pred --hcccccccCccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 --EKKLEMLVDPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 --~~~~~~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.........+...... .........+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000111111110000 0112245789999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=298.70 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=211.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEE-ECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----Cc
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 213 (467)
..++|++.+.||+|||+.||+++ ..++..||+|++.... .++.+..++|++..++++|||++++++++... .+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45789999999999999999998 4578999999997765 44556788999999999999999999988644 34
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.|++++|...|+|.+.+......+..+++.+.+.|+.+|++||.+||+. .|++.||||||.|||+.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999998776666799999999999999999999997 345999999999999999999999999998
Q ss_pred cccCCCCCee--------eeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHH
Q 012267 294 KLMDYKDTHV--------TTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 294 ~~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 362 (467)
.......... ......|..|+|||.+. +...++++|||||||+||+|+.|..||+.... .+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~G------- 248 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QG------- 248 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cC-------
Confidence 7654221111 11123688999999885 45668999999999999999999999975321 11
Q ss_pred HHHHHhhhcccc-cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 363 WVKGLLKEKKLE-MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 363 ~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+.+. .+..+.+.-.......+.+.+++.+|++.||.+||++.+++..++.
T Consensus 249 --------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 249 --------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred --------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1111 1122222222223366889999999999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=316.74 Aligned_cols=247 Identities=21% Similarity=0.375 Sum_probs=209.4
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchH--HHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.+|++.+.||+|.||+|-+|.. ..|+.||||.++++...... ..+.+|+++|+.++||||+.++.+|.+.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677778999999999999974 68999999999877654433 35889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||..+|.|++++.+... +++.+...++.||..|+.|+|.+ +++|||||.+|||+|+|+++||+|||++.++.
T Consensus 133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 99999999999998754 99999999999999999999999 99999999999999999999999999998753
Q ss_pred CCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
+....+.++|++-|.+||++++.+| .+..|-|||||+||.|+.|..||+.. +....+++.... .+ .
T Consensus 205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs~G-aY---r 271 (668)
T KOG0611|consen 205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQISRG-AY---R 271 (668)
T ss_pred -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhhcc-cc---c
Confidence 4556677899999999999999888 68999999999999999999999752 233334333221 11 1
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.|. ......-+|++||..+|++|-|+.+|..-
T Consensus 272 EP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 EPE--------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCC--------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 121 12345678899999999999999998654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.80 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.+|+..+.||+|+||+||+|++. +|. .||+|.++..........+..|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56888999999999999999864 333 48999997554444556788999999999999999999998764 5689
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|+||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999986532 378899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCeee-ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||+... ..++.. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~~~-~~~~~~-- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISS-ILEKGE-- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH-HHhCCC--
Confidence 53332221 22234678999999999899999999999999999998 999985321 111111 111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 423 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 423 (467)
....+ ..+...+.+++..||+.+|.+||++.+++..|.....
T Consensus 229 ~~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 RLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 00001 1122568899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=319.51 Aligned_cols=256 Identities=29% Similarity=0.396 Sum_probs=204.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
..+|...+.||+|++|.||+|... .++.||+|.+... ......+..|++++..++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345777889999999999999865 5889999998643 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999976432 2489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..++........ .
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~~------~ 223 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKGY------R 223 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCC------C
Confidence 2222222234568999999998899999999999999999998 999985321 112212111110 0
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+.. .......+.+++.+||+.+|++||++.+++++|+..
T Consensus 224 ~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MER----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111 112236688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=332.09 Aligned_cols=263 Identities=30% Similarity=0.449 Sum_probs=204.5
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
++..++|++.++||+|+||.||+|... +++.||+|+++..........+..|+.++.++ +|+||++++++|..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 445678999999999999999999642 35789999997654444445678899999999 89999999998875
Q ss_pred C-CceEEEeeccCCCChhhhhhcCCCC-----------------------------------------------------
Q 012267 211 P-TERLLVYPYMANGSVASCLRERPPS----------------------------------------------------- 236 (467)
Q Consensus 211 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 236 (467)
. ...+++|||+++++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5678999999999999998643210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee-eecccccc
Q 012267 237 ----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTI 311 (467)
Q Consensus 237 ----~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~g~~ 311 (467)
..+++|..+..++.||+.||+|||+. +|+||||||+|||+++++.++|+|||+++.+....... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12589999999999999999999999 99999999999999999999999999998754322221 22234567
Q ss_pred cccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHH
Q 012267 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEV 390 (467)
Q Consensus 312 ~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 390 (467)
.|+|||++.+..++.++|||||||++|||++ |..||..... ...+ ......... . .. .....
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~----~~~~----~~~~~~~~~-~-~~-------~~~~~ 302 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----DEEF----CRRLKEGTR-M-RA-------PEYAT 302 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc----cHHH----HHHHhccCC-C-CC-------CccCC
Confidence 8999999999999999999999999999998 9999853211 1111 111111100 0 00 11223
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 391 EQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 391 ~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..+.+++.+||+.+|++||++.||++.|++
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=321.28 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=205.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECC------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|...+.||+|+||.||+|...+ +..||||.++..........+.+|++++..++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467778899999999999998643 47899999976554445568999999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcE
Q 012267 216 LVYPYMANGSVASCLRERPP----------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 285 (467)
+||||+++++|.+++..... ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 99999999999999976432 223478999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHH
Q 012267 286 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 363 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 363 (467)
+|+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.... . .+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-----~---~~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-----N---EEV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HHH
Confidence 99999998754322211 1122335678999999999999999999999999999998 999985321 1 111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 364 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+.... ...... ........+.+++.+||+.+|.+||++.||++.|++
T Consensus 234 ~~~~~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECIT-QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHH-cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111 111100 011223668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=314.31 Aligned_cols=262 Identities=20% Similarity=0.320 Sum_probs=209.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.+.||+|+||.||+|+.. +++.||||.++... .......+..|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999865 78999999886432 2233446889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.........+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999875433334588899999999999999999999 999999999999999999999999999886543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... .....+....... ..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~------~~ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKIEQC------DY 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHHhcC------CC
Confidence 221 1223457889999999988889999999999999999999999985321 1122222221110 11
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
+.. ........+.+++.+||+.+|++||++.+|++.|++..
T Consensus 226 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111 11233466889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.23 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=202.7
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCc
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 213 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 213 (467)
...-++|...++||+|+||+|+++..+ +++.+|||.+++...- +..++.+.|.+++.... ||.+++++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999976 6889999999877543 33456788888887775 9999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.|+||||+.||++..+.+.. .+++..+.-++..|+.||+|||++ +|||||||.+|||||.+|.+||+||||+
T Consensus 444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 99999999999965555433 289999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
+..- ..+..+.+++||+.|||||++.+..|+.++|.|||||+||||+.|..||.... ++ +.....+.+
T Consensus 516 Ke~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd----Ee----e~FdsI~~d--- 583 (694)
T KOG0694|consen 516 KEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD----EE----EVFDSIVND--- 583 (694)
T ss_pred cccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC----HH----HHHHHHhcC---
Confidence 8632 23446778999999999999999999999999999999999999999996421 11 111111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
+.. ++.....+.+.++.+.+.++|++|..+
T Consensus 584 -~~~-------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVR-------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCC-------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 233344778899999999999999877
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=322.64 Aligned_cols=244 Identities=23% Similarity=0.266 Sum_probs=197.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999975 689999999864321 123346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997643 388899999999999999999999 999999999999999999999999999986532
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.... ........... ..
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~-~~----- 215 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAG-KL----- 215 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-Cc-----
Confidence 2 123458999999999998889999999999999999999999995321 11122221111 00
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVV 415 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl 415 (467)
.+ .......+.+++.+||+.||.+||+ +.+++
T Consensus 216 -~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 216 -EF----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred -CC----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 01 1111246789999999999999995 66664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.48 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=201.2
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+|++.+.||+|+||.||+|+.. +++.||||+++.... ......+..|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888899999999999999976 589999999975422 1233468889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999997643 388899999999999999999999 999999999999999999999999999975432
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... ....+
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~--~~~~~ 220 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWKE--TLQRP 220 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhccc--cccCC
Confidence 22345689999999999998999999999999999999999999964211 111111111000 00011
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
... .........+.+++.+|+..+|.+||++.++++.
T Consensus 221 ~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 110 0011234568889999999999999999998653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=331.23 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=206.1
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCC-C-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER-T-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~-~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.-|++.+-||+|+.|.|-+|++ .+|+.+|||++.... . ......+.+|+-+|+.+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3467788899999999999985 589999999997652 2 222346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|-|++++..++. +++.+..+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|.+-
T Consensus 92 Eyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-- 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-- 162 (786)
T ss_pred EecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc--
Confidence 99999999999988654 88999999999999999999999 9999999999999999999999999999863
Q ss_pred CCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
..+....+.+|++.|.|||++.+.+| ..++||||.|||||.||||+.||+.. ++...+....+ +..+.
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~-G~f~M-- 231 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQR-GVFEM-- 231 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHc-CcccC--
Confidence 34556677899999999999999988 68999999999999999999999632 22232222211 11110
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.....+..+|+.+|+..||++|.|++||++
T Consensus 232 --------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 232 --------PSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred --------CCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 1222355778889999999999999999954
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=326.22 Aligned_cols=201 Identities=25% Similarity=0.379 Sum_probs=175.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
..++|+..++||+|+||.||++... ++..+|+|.+...........+.+|++++..++|+||++++++|...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999976 688999999876544444557899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.+++.||.|||+.. +++|+||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997643 3788899999999999999999742 699999999999999999999999999875432
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 12234588999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=314.07 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=196.9
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
+.||+|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 78999999986554444456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeee-e
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-T 305 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~ 305 (467)
.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99997542 2388999999999999999999999 999999999999999999999999999875432111111 1
Q ss_pred cccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCc
Q 012267 306 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 384 (467)
Q Consensus 306 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 384 (467)
....+..|+|||.+.+..++.++||||||+++|||++ |..||..... .. ........ . .. .
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~~~-~----~~----~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIEQG-V----RL----P 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHHcC-C----CC----C
Confidence 1123457999999998889999999999999999998 8888853210 01 11111110 0 00 1
Q ss_pred ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 385 YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 385 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........+.+++.+|++.+|++|||+.+|+++|+.
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 111223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.93 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
++|+..+.||+|+||+||+|...++..+|+|.+..... ....+.+|+.++.+++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 45777889999999999999987777899999875432 3456899999999999999999999999888899999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
.+|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999976432 389999999999999999999999 999999999999999999999999999876543222
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+........... ..+
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~---~~~- 223 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRL---YRP- 223 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcCCCC---CCC-
Confidence 22222335678999999988889999999999999999999 9999853210 1111111111110 001
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 224 ------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112367899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=321.49 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=197.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999976 6899999999755433334467889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+. ++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 688888765432 378889999999999999999999 9999999999999999999999999998754322
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc---cc-
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---LE- 374 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~- 374 (467)
. .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....+.+........ ..
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD----IQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhCCCChhhccc
Confidence 2 12233457899999998865 4578899999999999999999999964210 0001111111000000 00
Q ss_pred ----cccCcc-cc---CcccH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 ----MLVDPD-LQ---NNYVE------AEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ----~~~d~~-~~---~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...++. .. ..... .....+.+++..|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00 00000 01245778999999999999999998853
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=324.63 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=199.1
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
||+|+||.||+|+.. +++.||+|+++... .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 68899999986432 222334678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeec
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 306 (467)
.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccc
Confidence 99997643 388999999999999999999999 9999999999999999999999999998754322 222334
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
..||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+......... ..+ .
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~-------~~~----~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEP-------LRF----P 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC-------CCC----C
Confidence 568999999999999899999999999999999999999995321 122222222110 001 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCc
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 425 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 425 (467)
......+.+++.+||+.||.+||++..+.+.|+...+..
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 112356788999999999999997766666676665544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=326.15 Aligned_cols=242 Identities=23% Similarity=0.283 Sum_probs=194.3
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
++||+|+||.||+++.. +|+.||||+++.... ......+..|+.++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 789999999975422 222346788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeee
Q 012267 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 304 (467)
Q Consensus 225 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 304 (467)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 9999987643 388999999999999999999999 9999999999999999999999999998753221 2223
Q ss_pred ecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCc
Q 012267 305 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 384 (467)
Q Consensus 305 ~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 384 (467)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... +..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~~-------~~~~--- 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------EIRF--- 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcC-------CCCC---
Confidence 34568999999999999899999999999999999999999995311 11111111111 0111
Q ss_pred ccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 385 YVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 385 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
.......+.+++.+||+.||++|| ++.++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 112235688899999999999999 7888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=295.28 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=206.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
-++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.... ....++.+|+++-+.++||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 367888999999999999999865 7889999998654322 2244789999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
+||..+|+|...|...... .++......++.|+|.||.|+|.. +|+||||||+|+|++..+..||+|||.+..-+
T Consensus 101 lEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999965432 378888899999999999999999 99999999999999999999999999987643
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.......+||..|.+||+..+...+...|+|++|++.||++.|.+||+... ..+..+.. ...+..
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI----~k~~~~ 240 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRI----RKVDLK 240 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHH----HHcccc
Confidence 334556789999999999999999999999999999999999999996421 11111111 112223
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+|. .......+++.+|+..+|.+|.+..||+.
T Consensus 241 ~p~-------~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 FPS-------TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CCc-------ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 332 22356788999999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=328.51 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=192.1
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+|+..++||+|+||+||+|+.. +|+.||||++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4555678999999999999865 689999999965544444557899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 999986532 145677889999999999999999 99999999999999999999999999998654221
Q ss_pred eeeecccccccccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 302 HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.......|+..|+|||++.. ...+.++|||||||++|||++|+.||.... ...............
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~----- 292 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-----QGDWASLMCAICMSQ----- 292 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhccC-----
Confidence 12233468999999998743 234568999999999999999999996311 111111111111000
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.. .......+.+++.+||+.||++||++.|+++
T Consensus 293 -~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 -PPEA----PATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0101 1122356889999999999999999999865
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=320.71 Aligned_cols=267 Identities=25% Similarity=0.365 Sum_probs=200.8
Q ss_pred CCCCCeeeecCceEEEEEEE-----CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEE
Q 012267 144 FSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 216 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 216 (467)
|...+.||+|+||+||++.. .++..||+|.++..........+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 357899999997654444456788999999999999999999988653 45789
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999764 289999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCe--eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... ......++..|+|||.+....++.++||||||+++|||+||+.|+...... ......+...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccchhhhh
Confidence 432211 111223566799999998888999999999999999999999998532110 000000000000000011
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
...+..............+.+++..||+.+|++|||+++|+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111111122346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=315.25 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=203.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
..++|+..+.||+|++|.||+|...++..||+|.++.... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3457888899999999999999988888899999875433 2456899999999999999999999875 456899999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... ..+++..++.++.+++.||+|||+. +++|+||||+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999976432 2388999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... . .+..........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~---~~~~~~~~~~~~------ 221 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----N---REVLEQVERGYR------ 221 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----H---HHHHHHHHcCCC------
Confidence 2222222335668999999988889999999999999999999 889985311 1 111111111100
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+ .........+.+++.+|++.+|++|||+.++.+.|++
T Consensus 222 ~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 M----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0111223568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=314.56 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.+|+..+.||+|+||.||+|.+.++..+|+|.+..... ....+..|++++..++|+||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 35777889999999999999987777899999864322 2346888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999976432 489999999999999999999999 999999999999999999999999999876542221
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... . +........ ....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~---~~~~~~~~~------~~~~ 221 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----S---EVVESVSAG------YRLY 221 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----H---HHHHHHHcC------CcCC
Confidence 11112223457999999998889999999999999999999 8999853211 1 111111111 0000
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
. .......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 222 ~----~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 R----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0 1113467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=312.07 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=198.8
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChh
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 227 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 227 (467)
++||+|+||.||+|...++..||+|.++..........+.+|++++..++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876554444557889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeecc
Q 012267 228 SCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 307 (467)
Q Consensus 228 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 307 (467)
+++..... .+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++..............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99875432 378999999999999999999999 999999999999999999999999999875432211111222
Q ss_pred cccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 308 ~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
.++..|+|||++.+..++.++||||||+++|++++ |..||.... .............. ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--------~~~~~~~~~~~~~~----------~~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--------NQQAREQVEKGYRM----------SCP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHHcCCCC----------CCC
Confidence 34567999999988889999999999999999998 999985321 11111111111000 001
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
......+.+++.+|++.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 122367899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.49 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=207.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+..+|+..++||.|+||.||+|...++..+|+|.+..... .....+..|+.++..++|+||+++++++......++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4466888899999999999999988899999999875432 234468899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... ..+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999987532 3489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .......++..|+|||.+....++.++||||||+++|+|++ |+.||.... .. +..........
T Consensus 158 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~~---~~~~~~~~~~~------ 222 (261)
T cd05148 158 V-YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----NH---EVYDQITAGYR------ 222 (261)
T ss_pred c-ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----HH---HHHHHHHhCCc------
Confidence 1 11223345678999999988889999999999999999998 899995321 11 11111111100
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..........+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00112223668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=326.41 Aligned_cols=239 Identities=22% Similarity=0.280 Sum_probs=194.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||.||+|+.. +|+.||||.++.... ......+..|+.++..++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 689999999865321 123346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999998643 278888999999999999999999 999999999999999999999999999986542
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... ... .-
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~-~~~---~~ 234 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILA-GRL---KF 234 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhc-CCc---CC
Confidence 21 23468999999999999889999999999999999999999995311 1111111111 110 00
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 410 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 410 (467)
|. . ....+.+++..||+.||.+||+
T Consensus 235 p~---~----~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 235 PN---W----FDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred CC---C----CCHHHHHHHHHHhhcCHHHcCC
Confidence 11 1 1245788999999999999997
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=315.17 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=202.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.++|++.++||+|+||.||+|.+.++..||+|.++.... ....+..|++++..++|+||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 457889999999999999999987777899999975332 2456889999999999999999999874 4567999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++..... ..+++..+..++.++++||+|||+. +++|+||||+||++++++.++|+|||.+..+....
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999976422 2378999999999999999999999 99999999999999999999999999998664333
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
........++..|+|||+..+..++.++||||||+++|||+| |+.||.... . .+.......... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~---~~~~~~~~~~~~------~ 222 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----N---REVLDQVERGYR------M 222 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----h---HHHHHHHhcCCC------C
Confidence 222223345678999999988889999999999999999999 888885321 0 011111111000 0
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.........+.+++.+|++.+|++||++.+++++|++
T Consensus 223 ----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0112334678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.25 Aligned_cols=261 Identities=21% Similarity=0.235 Sum_probs=196.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
..+|+..+.||+|+||.||++... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 467999999999999999999864 789999996532 246789999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
++. ++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 995 68988886643 388999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC---CccHHHHHHHHhh---h---
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD---DVMLLDWVKGLLK---E--- 370 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~---~--- 370 (467)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||-........ ...+...+...-. +
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 222333456999999999999889999999999999999999999887432111100 0011111100000 0
Q ss_pred ---ccccc---------ccCccccC--cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 ---KKLEM---------LVDPDLQN--NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ---~~~~~---------~~d~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+.. ...+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00000000 001123456889999999999999999999863
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=327.42 Aligned_cols=268 Identities=24% Similarity=0.389 Sum_probs=219.4
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEECC---C--CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee
Q 012267 135 RELQVATDSFSNKNILGRGGFGKVYKGRLAD---G--SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209 (467)
Q Consensus 135 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 209 (467)
...+...+..+..++||.|.||.||+|.+.+ | -.||||.-+.+..+...+.|+.|..+++.++||||++++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3445555666677899999999999998642 2 3599999998888888889999999999999999999999987
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
+ ...|+|||.++.|.|..+|+.+... ++......++.||+.||+|||+. ++|||||..+|||+.....+|++|
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence 5 4579999999999999999986543 88889999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHh
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
||+++.+............-...|||||.++...++.+||||.|||.+||+++ |..||..... .
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---s------------ 599 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---S------------ 599 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc---c------------
Confidence 99999987665554444445678999999999999999999999999999876 9999964210 0
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCccc
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 427 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 427 (467)
..-..+...-+-..++.+...++.++.+||+.+|.+||++.++...|.++...+..
T Consensus 600 ---DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 600 ---DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred ---ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 10011111111122445667899999999999999999999999999886664444
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=317.81 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCceEEEEEEE-----CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++|+..+.||+|+||+||+|.. .++..||+|.++..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999974 24678999999765444444578899999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC
Q 012267 217 VYPYMANGSVASCLRERPP-------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 283 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~ 283 (467)
||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999864321 123478899999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHH
Q 012267 284 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 284 ~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 361 (467)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~~--- 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----NQ--- 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HH---
Confidence 999999999976533221 12222335678999999988889999999999999999998 998985311 11
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 362 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..... ....... .. .......+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 234 ~~~~~-~~~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEM-VRKRQLL-----PC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH-HHcCCcC-----CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 1111100 00 11123568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=318.79 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=199.3
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
...++|....+||+|+||.||+|+-+ +|..+|+|++++... ....+..+.|-.+|....+++||+++-.|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35678999999999999999999855 799999999986542 223446888999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
|||||++||++..+|..... |++.....++.+++-|+..||+. |+|||||||+|+|||..|++||+||||+.-
T Consensus 218 LiMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999987653 88888999999999999999999 999999999999999999999999999853
Q ss_pred cCC--------------------CC---C-----e------------------eeecccccccccccccccCCCCCcchh
Q 012267 296 MDY--------------------KD---T-----H------------------VTTAVRGTIGHIAPEYLSTGKSSEKTD 329 (467)
Q Consensus 296 ~~~--------------------~~---~-----~------------------~~~~~~g~~~y~aPE~~~~~~~~~~sD 329 (467)
+.. .. . . .....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 00 0 0 011235999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCC
Q 012267 330 VFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP 409 (467)
Q Consensus 330 v~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 409 (467)
+||+|||+||||.|.+||...... .....+..|...+.. |. ......+..++|.+|+. ||.+|-
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~f---------P~-----~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLKF---------PE-----EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhccC---------CC-----cCcccHHHHHHHHHHhc-CHHHhc
Confidence 999999999999999999642211 111222333222111 11 11122567788888888 999998
Q ss_pred CHHHH
Q 012267 410 KMSEV 414 (467)
Q Consensus 410 s~~ev 414 (467)
...-+
T Consensus 435 G~~G~ 439 (550)
T KOG0605|consen 435 GSKGA 439 (550)
T ss_pred CcccH
Confidence 73333
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=321.04 Aligned_cols=263 Identities=30% Similarity=0.457 Sum_probs=207.0
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
....++|+..+.||+|+||.||++... +...+|+|.+...........+.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 445567888899999999999999864 23689999987654444445688999999999 79999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEE
Q 012267 211 PTERLLVYPYMANGSVASCLRERP------------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 278 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nil 278 (467)
....+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999997532 1233589999999999999999999998 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCC
Q 012267 279 LDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDD 356 (467)
Q Consensus 279 l~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~ 356 (467)
+++++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 239 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----- 239 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----
Confidence 9999999999999998654322211 122234578999999988889999999999999999998 999885311
Q ss_pred CccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 357 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..+... ....... ..........+.+++.+||+.+|.+|||+.++++.|++.
T Consensus 240 ---~~~~~~-~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 ---VEELFK-LLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHH-HHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111 1111110 001112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=324.55 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=194.1
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||.||+++.. ++..||||+++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 688999999975432 22234577899999888 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCc
Confidence 99999887543 389999999999999999999999 999999999999999999999999999874321 1222
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||..|+|||++.+..++.++|||||||++|||+||+.||+.............++........... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CCC
Confidence 33456899999999999989999999999999999999999999743322222222233333332222111 111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
.....+.+++.+|++.||.+||++
T Consensus 227 ----~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 227 ----SLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCC
Confidence 123567889999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=308.91 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=210.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|++|.||+|... +|+.||+|.++... .......+.+|++++.+++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 78999999986422 2223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.........+++..++.++.++++||.|||+. +++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876444444589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ....++...... .. ..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~----~~ 226 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEK-CD----YP 226 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhc-CC----CC
Confidence 3221 223457889999999988889999999999999999999999985321 122222221111 00 00
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+ . ........+.+++.+||..+|++||++.+|+++|++.
T Consensus 227 ~-~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 P-L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C-C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 1 0113345788999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=313.21 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=204.8
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+..++|...++||+|+||.||+|...+++.||+|.+..... ....+..|+.++++++|+|++++++++. .+..+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 34567888999999999999999988899999999875432 3457889999999999999999999864 56789999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999876432 3488999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
..........++..|+|||++....++.++||||||+++|||++ |+.||.... . .+.+.........
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~---~~~~~~~~~~~~~---- 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----N---PEVIQNLERGYRM---- 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----h---HHHHHHHHcCCCC----
Confidence 22222223345678999999988889999999999999999999 999995321 1 1111111111000
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. .......+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 --~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 --PR----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01 11123568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=331.50 Aligned_cols=264 Identities=22% Similarity=0.347 Sum_probs=206.1
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeee
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCM 209 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 209 (467)
++...++|.+.+.||+|+||.||+|++. .+..||||+++..........+..|++++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3455567888899999999999999853 346899999976544444457889999999997 999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCC------------------------------------------------------
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPP------------------------------------------------------ 235 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 235 (467)
.....++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCC
Q 012267 236 ----------------------------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 275 (467)
Q Consensus 236 ----------------------------------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~ 275 (467)
....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112478888999999999999999998 9999999999
Q ss_pred cEEECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCccccccc
Q 012267 276 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 353 (467)
Q Consensus 276 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~ 353 (467)
|||+++++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 999999999999999999764322211 1122346788999999988889999999999999999998 8889853210
Q ss_pred CCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 354 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.+.......... ....| ......+.+++..||+.+|.+||++++|++.|++
T Consensus 348 -------~~~~~~~~~~~~--~~~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 -------NEQFYNAIKRGY--RMAKP-------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred -------hHHHHHHHHcCC--CCCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011111111110 00011 1123678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.57 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=213.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc-eEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 218 (467)
++|...+++|+|+||.++..+++ ++..|++|.+....... .+....+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999999876 67899999998665333 34468899999999999999999999998888 99999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
+|++||+|.+.+.... ...+++..+..++.|++.|+.|||++ .|+|||||+.|||++.+..+||+|||+++.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998865 33489999999999999999999998 999999999999999999999999999999875
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. .....+.||+.|+.||.+.+.+|..|+|||||||++|||++-+++|.... ....+....+. ..+
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~~-----~~~ 224 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINRG-----LYS 224 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhhc-----cCC
Confidence 44 34455679999999999999999999999999999999999999996432 22223222221 122
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
| .+..+..++..++..|+..+|..||++.+++.+
T Consensus 225 P-----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 P-----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C-----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2 234456778999999999999999999999876
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=323.98 Aligned_cols=246 Identities=25% Similarity=0.337 Sum_probs=192.7
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||+||+|+.. +++.||+|+++.... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 688999999975432 22234577888888766 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~ 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence 99999887543 388999999999999999999999 9999999999999999999999999998753221 222
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...............++.......... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC------C--
Confidence 23456899999999999999999999999999999999999999643222222222233333322221111 1
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
.......+.+++.+||+.||++||+.
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11123567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.52 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=202.9
Q ss_pred CCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+|...+.||+|+||.||+|... ....+++|.+...........+..|+.++..++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3677889999999999999753 2357999988765444445578899999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 217 VYPYMANGSVASCLRERPP--------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
++||+.+|+|.+++..... ...++++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864311 123588999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccC
Q 012267 277 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 354 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~ 354 (467)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999997653322211 122235678999999988889999999999999999998 999985321
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
...+.+++ .... .... .......+.+++..|++.+|.+||++.++++.|++.
T Consensus 235 --~~~~~~~~----~~~~-----~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 235 --PERLFNLL----KTGY-----RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHHHHHHH----hCCC-----CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11111211 1110 0001 112235688999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.24 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=193.1
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
++||+|+||.||+++.. +|..||+|+++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 789999999975421 223345778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeee
Q 012267 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 304 (467)
Q Consensus 225 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 304 (467)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence 9999887643 388999999999999999999999 9999999999999999999999999998753221 1222
Q ss_pred ecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCc
Q 012267 305 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 384 (467)
Q Consensus 305 ~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 384 (467)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~~~-------~~~p-- 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE-------IRFP-- 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC-------CCCC--
Confidence 34568999999999998899999999999999999999999995321 111111111110 0111
Q ss_pred ccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 385 YVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 385 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
......+.+++.+||+.||.+|| ++.++++
T Consensus 216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11235678899999999999998 7777753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.97 Aligned_cols=251 Identities=26% Similarity=0.331 Sum_probs=195.9
Q ss_pred CCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCC---cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCce
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERT---PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 214 (467)
+|++.+.||+|+||+||+++.. ++..||+|++..... ......+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999752 578999999864321 12234577899999999 599999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999997643 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
..............||..|+|||++.+. .++.++|||||||++|||+||+.||..... .............
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~---- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE----RNTQSEVSRRILK---- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC----CCCHHHHHHHHhc----
Confidence 6543333333445689999999998765 478899999999999999999999963211 1111122221111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVV 415 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl 415 (467)
.++.+.. .....+.+++.+||+.||++|| ++++++
T Consensus 226 ---~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 265 (332)
T cd05614 226 ---CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265 (332)
T ss_pred ---CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHH
Confidence 1111111 1225578899999999999999 555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=321.48 Aligned_cols=242 Identities=25% Similarity=0.299 Sum_probs=194.4
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
++||+|+||.||++... +|+.||+|++..... ......+..|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 689999999975422 223346788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeee
Q 012267 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 304 (467)
Q Consensus 225 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 304 (467)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 9999887643 388999999999999999999999 9999999999999999999999999998753221 2222
Q ss_pred ecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCc
Q 012267 305 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN 384 (467)
Q Consensus 305 ~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 384 (467)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+........ +..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~~~-------~~~~p~- 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------DIKFPR- 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhccC-------CccCCC-
Confidence 34568999999999998899999999999999999999999995321 11111111111 011111
Q ss_pred ccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 385 YVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 385 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
.....+.+++.+||+.||.+|| ++.++++
T Consensus 217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 ---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred ---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 1235678899999999999997 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=312.86 Aligned_cols=248 Identities=25% Similarity=0.316 Sum_probs=193.9
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
||+|+||+||++... +|+.||+|.+....... ....+..|++++..++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 78899999986533221 224577899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeec
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 306 (467)
.+++.........+++..++.++.|++.||.|||+. +|+||||||+||++++++.++|+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865433344589999999999999999999999 999999999999999999999999999976543222 2234
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ... ...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~---------~~~--~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRILN---------DSV--TYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc----chhHHHHHHhhcc---------cCC--CCc
Confidence 5689999999999999999999999999999999999999963211 1111111111110 000 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
......+.+++..||+.+|++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 22346688999999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.43 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=201.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.++|...+.||+|++|.||+|...++..+|+|.+..... ....+.+|+.+++.++|+|++++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 356888899999999999999987777899998865332 3456889999999999999999999875 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997643 23478999999999999999999999 99999999999999999999999999997654332
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
........++..|+|||...+..++.++||||||+++|||+| |+.||.... ......+ ...... +
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~---~~~~~~------~ 222 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----NREVLEQ---VERGYR------M 222 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH---HHcCCC------C
Confidence 222222335678999999988889999999999999999999 899985311 1111111 111100 0
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. ........+.+++.+||+.+|.+||++++|+++|++
T Consensus 223 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 P----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred C----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 111233668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.09 Aligned_cols=257 Identities=24% Similarity=0.327 Sum_probs=204.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-----
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 212 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 212 (467)
..++|.+.++||+|+||+||+|+.. +|+.||||++..... ......+..|+..+..++|+|++++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999854 789999999975433 233446888999999999999999988765432
Q ss_pred ---ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 213 ---ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 213 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
..++||||+++|+|.+++........++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 35799999999999999987554455689999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCC-CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh
Q 012267 290 FGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 290 fgl~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+++....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~~~~ 258 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMHKTL 258 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHh
Confidence 99998654321 222334568999999999999999999999999999999999999995321 222222222
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
... .++ + .......+.+++..||+.+|.+||++.++++.
T Consensus 259 ~~~-----~~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR-----YDP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC-----CCC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 111 1 11223568899999999999999999998763
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=313.24 Aligned_cols=263 Identities=26% Similarity=0.422 Sum_probs=205.9
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 211 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 211 (467)
++..++|++.++||+|+||.||+|... .+..||+|.++..........+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456678999999999999999999753 24589999987554434445688899999999999999999999999
Q ss_pred CceEEEeeccCCCChhhhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcE
Q 012267 212 TERLLVYPYMANGSVASCLRERPP------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 285 (467)
+..++||||+++|+|.+++..... .....++..+..++.|++.||.|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 123467888999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHH
Q 012267 286 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 363 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 363 (467)
+|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..++
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence 999999987543222111 111234678999999988889999999999999999998 788885311 1122
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 364 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.......... .. .......+.+++.+|++.+|++|||+.++++.|++.
T Consensus 231 ~~~~~~~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFVMDGGYL------DQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHcCCCC------CC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 2221111110 00 111235789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=315.51 Aligned_cols=265 Identities=23% Similarity=0.392 Sum_probs=202.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC---------------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLAD---------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 205 (467)
.++|++.+.||+|+||.||++.... ...||+|.++..........+.+|++++.+++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987532 2358999997655444556789999999999999999999
Q ss_pred eeeeCCCceEEEeeccCCCChhhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcE
Q 012267 206 GFCMTPTERLLVYPYMANGSVASCLRERPP--------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 277 (467)
Q Consensus 206 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Ni 277 (467)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 112478999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc--CCCCcccccccC
Q 012267 278 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQRAFDLARLAN 354 (467)
Q Consensus 278 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt--g~~p~~~~~~~~ 354 (467)
++++++.+||+|||++......... ......++..|+|||.+....++.++|||||||++|+|++ |..||....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--- 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--- 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---
Confidence 9999999999999998765322211 1122234678999999988889999999999999999998 566774311
Q ss_pred CCCccHHHHHHHHhhhc-ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 355 DDDVMLLDWVKGLLKEK-KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
............... .......+ ......+.+++.+||+.+|++||++.+|++.|++
T Consensus 238 --~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 --DEQVIENTGEFFRNQGRQIYLSQT-------PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --hHHHHHHHHHhhhhccccccCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111110 00000011 1123579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=314.81 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=197.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-------------chHHHHHHHHHHHHhcCCCeeeeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-------------GGELQFQTEVEMISMAVHRNLLRLRG 206 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~ 206 (467)
-+.|++.+.||+|.||.|-+|+.. +++.||||++.+.... ...+...+|+.+|++++|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 467999999999999999999965 7999999999643211 11236789999999999999999999
Q ss_pred eeeCC--CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 207 FCMTP--TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 207 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
+..++ +..|||+|||..|.+...=-. ...+++.+.++++.++..||.|||.+ +|+||||||+|+||+++|+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 98765 578999999998887543222 12289999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCC----CeeeecccccccccccccccCCC----CCcchhHHHHHHHHHHHHcCCCCcccccccCCC
Q 012267 285 AVVGDFGLAKLMDYKD----THVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGIMLLELITGQRAFDLARLANDD 356 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~ 356 (467)
+||+|||.+....... ........||+.|+|||...++. .+.+.||||+||+||-|+.|+.||-...
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----- 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence 9999999998663211 11222357999999999987632 3678999999999999999999995311
Q ss_pred CccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 012267 357 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418 (467)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 418 (467)
..+..... +...+.-....+..+.+.+++.++|.+||+.|.+..+|....
T Consensus 324 ---~~~l~~KI---------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ---ELELFDKI---------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ---HHHHHHHH---------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11222221 111221111224457788999999999999999999986543
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.77 Aligned_cols=260 Identities=28% Similarity=0.390 Sum_probs=203.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
..++|.+.+.||+|++|.||+|.+.+ +..||+|.+...........+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678888999999999999998753 568999988755444445578999999999999999999999999889
Q ss_pred eEEEeeccCCCChhhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC---cEEE
Q 012267 214 RLLVYPYMANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 287 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl 287 (467)
.++||||+++++|.+++..... ....++|..++.++.||+.||+|||+. +++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 123489999999999999999999999 999999999999998764 5999
Q ss_pred eecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHH
Q 012267 288 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 288 ~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999998653222111 111223568999999998899999999999999999997 9999853211 11121
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........ .........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 233 ~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 233 FVTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11111110 0011223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=337.52 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=209.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCC-CEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeee-eeeC------C
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADG-SLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRG-FCMT------P 211 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~~------~ 211 (467)
.-+++++++|.+|||+.||+|....+ ..||+|++-.. .+.....+.+|+++|++|+ |+|||.+++ .... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 34566778999999999999997655 99999998665 5556667899999999997 999999999 3321 1
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
-+.+|.||||.+|+|-|++..+.... |++.++++|+.++++|+++||.. +|+|||||||.+||||+.++..||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 35689999999999999998765444 89999999999999999999995 7789999999999999999999999999
Q ss_pred CccccCCCCCee--------eecccccccccccccc---cCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccH
Q 012267 292 LAKLMDYKDTHV--------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360 (467)
Q Consensus 292 l~~~~~~~~~~~--------~~~~~g~~~y~aPE~~---~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~ 360 (467)
.+.--....... .....-|+.|+|||++ .+...++|+|||+|||+||-|+....||+...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------- 262 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------- 262 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence 886322111000 0112368999999986 46788999999999999999999999997421
Q ss_pred HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCccc
Q 012267 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 427 (467)
Q Consensus 361 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 427 (467)
...+++....-...+.+...+.+||..||+.||.+||++-||+..+.++.-.+++
T Consensus 263 ------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 263 ------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 1122333322222356778999999999999999999999999999876544444
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.29 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=207.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC-----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-CCc
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTE 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 213 (467)
..++|...++||+|+||.||+|.... +..|++|++...........+..|+.++.+++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678889999999999999998765 688999998765444455678899999999999999999998776 567
Q ss_pred eEEEeeccCCCChhhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 214 RLLVYPYMANGSVASCLRERPPS----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
.++++||+++|+|.+++...... ...+++..++.++.+++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998764322 14589999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHH
Q 012267 290 FGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 367 (467)
Q Consensus 290 fgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 367 (467)
||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.... . .++....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~---~~~~~~~ 232 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----P---FEMAAYL 232 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----H---HHHHHHH
Confidence 99998654332221 122345678999999988889999999999999999999 999995321 1 1222211
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 368 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 368 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
....... . .......+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 233 ~~~~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 233 KDGYRLA------Q----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HcCCCCC------C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111110 0 111235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=318.62 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=193.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC--CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhc---CCCeeeeeeeeee-----C
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLKEERTPG-GELQFQTEVEMISMA---VHRNLLRLRGFCM-----T 210 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~--~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~ 210 (467)
++|+..+.||+|+||.||+|+.. +|..||+|+++...... ....+.+|+.++..+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46889999987543322 233556677776655 6999999999985 2
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
....++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 356799999996 599999876432 2388999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh-
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK- 369 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 369 (467)
|+++..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-----~~~~~~i~~~~~~ 227 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIGL 227 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHHhCC
Confidence 999865432 223345589999999999888899999999999999999999999964211 111111111100
Q ss_pred ---hccc------ccccCcccc---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 ---EKKL------EMLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ---~~~~------~~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.... .....+... ..........+.+++.+|++.+|++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 000000000 0000112355779999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.81 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=204.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CC---CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.++..........+..|++++..++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356788899999999999999875 33 37999998765444445678899999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999997643 2389999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCeeee--cccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 297 DYKDTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 297 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
......... ....+..|+|||++....++.++|||||||++|||++ |+.||.... ..++.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~~~i~~~~~- 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVMKAINDGFR- 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhcCCC-
Confidence 432221111 1123457999999988889999999999999999997 999985321 1122222211110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.+. .......+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 229 ----~~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ----LPA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011 112336688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=315.80 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=205.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
..++|...+.||+|+||.||+|... .+..||+|.+...........+.+|+.++..++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3467888899999999999999864 2368999998655444445578899999999999999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEE
Q 012267 214 RLLVYPYMANGSVASCLRERPPS------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV 287 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 287 (467)
.++||||+++|+|.+++...... ...++|..++.++.|++.||.|||+. +++|+||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999999754321 22478999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHH
Q 012267 288 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 288 ~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||+| |+.||.... .....++.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~~- 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVLKFV- 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHHHHH-
Confidence 99999876543221 11223346788999999988889999999999999999998 999985311 11111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. .... +.. .......+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 --~-~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 --I-DGGH-----LDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --h-cCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 1110 001 11124678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=314.38 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=198.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++|+..+.||+|+||+||+|.+. +|. .+++|.+...........+..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46777889999999999999864 444 4788887543333333467788888999999999999998754 45788
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999976432 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
..... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||.... .....+++ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~----~~~~-- 228 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----PHEVPDLL----EKGE-- 228 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH----HCCC--
Confidence 43222 12233446778999999988889999999999999999998 999985321 11111221 1111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
....+.. +...+.+++.+||..+|.+|||+.|+++.|+.
T Consensus 229 ~~~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 229 RLAQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred cCCCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1111111 22457888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.17 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
.++|+..++||+|+||+||+|++. +|. .||+|+++..........+..|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 456888899999999999999853 444 48999997655555566788999999999999999999998754 578
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+++||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999976432 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 296 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 296 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
+....... .....++..|+|||...+..++.++|||||||++|||++ |..||+... ...+..++. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLE----KGER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH----CCCc
Confidence 64332221 112234678999999988889999999999999999998 899985321 111222211 1100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
. + . .......+.+++.+||+.||++||++.++++.|+.....
T Consensus 230 ~----~-~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 L----P-Q----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred C----C-C----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0 0 0 112235688999999999999999999999999775443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=322.98 Aligned_cols=261 Identities=20% Similarity=0.338 Sum_probs=193.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----CceE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERL 215 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 215 (467)
+|+..++||+|+||.||+|... +|..||||+++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777889999999999999865 789999999864322 22334688999999999999999999988643 2479
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68999887543 389999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC--eeeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh-
Q 012267 296 MDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE- 370 (467)
Q Consensus 296 ~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 370 (467)
...... .......|+..|+|||++.+ ..++.++|||||||++|||+||+.||..... .....++......
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~ 227 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTP 227 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCC
Confidence 432211 12234568999999999865 6789999999999999999999999954211 0011111110000
Q ss_pred ----------cccccc---cCccccCc---ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 ----------KKLEML---VDPDLQNN---YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ----------~~~~~~---~d~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... +.+..... ........+.+++.+||+.+|++|||+.|+++
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00000000 00011245789999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=314.35 Aligned_cols=266 Identities=24% Similarity=0.399 Sum_probs=206.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC-----------------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLAD-----------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 203 (467)
.++|+..+.||+|+||.||+|.... +..||+|.+...........+..|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999987542 24689999976655555667899999999999999999
Q ss_pred eeeeeeCCCceEEEeeccCCCChhhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPP-------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 204 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
+++++...+..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976541 122489999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc--CCCCccccccc
Q 012267 277 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQRAFDLARLA 353 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt--g~~p~~~~~~~ 353 (467)
|++++++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 99999999999999998765432221 2223345778999999988889999999999999999998 667774311
Q ss_pred CCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 354 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...................... ........+.+++.+|++.+|.+|||+.+|++.|++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111122111111111110000 111223678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.33 Aligned_cols=265 Identities=25% Similarity=0.309 Sum_probs=200.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch-HHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 217 (467)
+.|+..+.|++|+||.||+|+.+ +++.||+|+++.+....+ ...-++|+.+|.+.+|||||.+..+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34666788999999999999975 789999999987653322 2246799999999999999999998764 3578999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
||||+. +|..++.... .++...++..+..|+++|++|||.+ -|+|||||++|+|+++.|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999988 9999998865 3488899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.. ....+..+-|..|+|||.+.+. .|++..|+||+|||+.||+++++.|...... ..+.... ..+ +...+.
T Consensus 229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~----dQl~~If-~ll--GtPte~ 300 (419)
T KOG0663|consen 229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI----DQLDKIF-KLL--GTPSEA 300 (419)
T ss_pred CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH----HHHHHHH-HHh--CCCccc
Confidence 43 3334555679999999998774 6899999999999999999999988542211 1111111 111 000000
Q ss_pred cCcc-------------------ccCcccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 377 VDPD-------------------LQNNYVEA-EVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 377 ~d~~-------------------~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
+-|. +...+... ..+.-++++...+..||.+|-|+.|. |+...+.
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~---L~h~~F~ 365 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG---LKHEYFR 365 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh---hcccccc
Confidence 0010 01111100 22556778888899999999999987 5554443
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.41 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=199.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
..++|+..+.||+|+||.||+++.. ++..||+|++..... ......+..|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999875 688999999964321 1223357789999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++.... ++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999987542 67788889999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCeeeecccccccccccccccCC----CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~ 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMDHKN 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCC
Confidence 43322223345689999999998653 47899999999999999999999996421 1111112211100
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~ 416 (467)
....|. .......+.+++..|++.+|.+ ||++.++++
T Consensus 265 --~~~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 265 --SLTFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred --cCCCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 010111 1112356788999999999988 999998854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=310.58 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=206.3
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
...++|.+.++||+|++|.||+|...++..||||.+..... ...++..|+.++++++|+|++++++++......++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 44578899999999999999999988888999999875432 3457899999999999999999999999888999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++..... ..+++..+..++.+++.|++|||++ +++|+||||+||++++++.++|+|||++..+..
T Consensus 81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999987532 2489999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
..........++..|+|||.+.+..++.++||||||+++|+|+| |+.||.... . ............ . .
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~---~~~~~~~~~~~~--~-~ 224 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----N---REVLEQVERGYR--M-P 224 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHHcCCC--C-C
Confidence 22111122234568999999998889999999999999999998 999985311 1 111111111100 0 0
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.+ ......+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RP-------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 1113568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=324.19 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=199.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||+||+++.. +|+.||+|+++.... ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999865 789999999975432 223446888999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999987522 389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCeeeeccccccccccccccc------CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.... .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--------SAKTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 3333334456899999999986 4567899999999999999999999995321 1112222221111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
... .|. .......+.+++..|++ +|.+||++.+++
T Consensus 227 ~~~--~~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 227 FLK--FPE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred ccC--CCC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 100 010 01123557788888997 999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.19 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=205.4
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 211 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 211 (467)
...++|...+.||+|+||.||+|... .+..||||.++..........+..|+++++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34467888999999999999999742 34589999987654444455789999999999 799999999999999
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
+..++||||+++|+|.++++.... ..+++.++..++.+++.||+|||++ +++|+||||+||+++.++.++++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999976432 2389999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhh
Q 012267 292 LAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 292 l~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ........ ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~----~~~~~~~~----~~ 258 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP----VDSKFYKL----IK 258 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC----chHHHHHH----HH
Confidence 99865433221 1222345678999999998889999999999999999998 999985321 11111111 11
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
... . +.. .......+.+++.+|++.+|++||++.||++.|++
T Consensus 259 ~~~-~----~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 259 EGY-R----MAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred cCC-c----CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 110 0 000 01112568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.69 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=202.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+|...+.||+|+||.||+|... .+..||+|+++..........+..|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556678999999999999863 2478999999765443334568899999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 217 VYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
++||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999999863211 123478889999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHH
Q 012267 285 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 362 (467)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||... ...+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------CHHH
Confidence 99999999886542221 12223345678999999988889999999999999999998 88888531 1122
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 363 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+........ .. .........+.+++..||+.+|.+||++++|++.|+.
T Consensus 235 ~~~~i~~~~-~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQ-VL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCC-cC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222222111 10 0112234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.44 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=196.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECC--CCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLAD--GSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~--g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++|...+.||+|+||.||+|.... +..||+|++.... .......+..|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568888999999999999998643 3689999986432 122334678899999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999997653 388999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .......... .. .+
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~---~~~~~~i~~~-~~--~~ 247 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----P---LLIYQKILEG-II--YF 247 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----H---HHHHHHHhcC-CC--CC
Confidence 22 223468999999999998889999999999999999999999995321 0 1111111111 10 01
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVV 415 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl 415 (467)
| ......+.+++.+|++.+|++|+ ++++++
T Consensus 248 -p-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 248 -P-------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred -C-------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence 1 11124577899999999999995 787774
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=311.50 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=207.7
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|++|.||+|.. .++..+|||.+..... ......+..|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999996 4789999998864322 223346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.........+++..++.++.++++||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875433344589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.... .....+...... ...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~------~~~ 225 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQ------CDY 225 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc------chHHHHhhhhhc------CCC
Confidence 222 2223457889999999988889999999999999999999999985311 111122221111 111
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+... .......+.+++.+||+.+|.+||||.+|++.+++
T Consensus 226 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 PPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111 12234578899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=308.03 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=195.2
Q ss_pred eeeecCceEEEEEEEC---CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 149 ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
.||+|+||.||+|.+. .+..||+|++...........+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355799999976544444557899999999999999999999875 457899999999999
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeee
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 305 (467)
|.+++..... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++............
T Consensus 81 L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999875322 389999999999999999999999 9999999999999999999999999999865433222111
Q ss_pred --cccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 306 --AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 306 --~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
...++..|+|||.+.+..++.++|||||||++|||++ |..||.... . .++......... +..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~---~~~~~~~~~~~~------~~~- 219 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-----G---PEVMSFIEQGKR------LDC- 219 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-----H---HHHHHHHHCCCC------CCC-
Confidence 1223568999999988889999999999999999996 999995321 1 111111111110 001
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
......++.+++.+||..+|++||++.+|.+.|+..
T Consensus 220 ---~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 ---PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112236788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=315.66 Aligned_cols=257 Identities=23% Similarity=0.389 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC--EEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS--LVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 217 (467)
++|+..++||+|+||.||+|... ++. .+++|.++..........+..|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999875 333 47899887544444455788999999999 799999999999999999999
Q ss_pred eeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcE
Q 012267 218 YPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 285 (467)
+||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999976421 112488999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHH
Q 012267 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 364 (467)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||+| |..||.... ..++.
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--------~~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--------CAELY 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999998642211 11111123457999999988889999999999999999998 999995321 11122
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
....... .+.. .......+.+++.+||+.+|.+||++.++++.|++.
T Consensus 229 ~~~~~~~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 229 EKLPQGY------RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHhcCC------CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2111110 0001 111235688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=317.81 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=192.8
Q ss_pred CeeeecCceEEEEEEE----CCCCEEEEEEeccCCC---cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 148 NILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+.||+|+||.||+++. .+++.||||+++.... ......+..|++++..++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3578999999865321 12234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++.... .+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 153 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE- 153 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence 99999999997643 277888899999999999999999 9999999999999999999999999998753322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
........|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .. .+.+
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~-~~--~~~~- 221 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKG-KL--NLPP- 221 (323)
T ss_pred CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC-CC--CCCC-
Confidence 222334568999999999998889999999999999999999999995321 11122222111 00 0111
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 222 -------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 -------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1225678999999999999999 7777754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=313.53 Aligned_cols=266 Identities=23% Similarity=0.388 Sum_probs=203.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-----------------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-----------------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 203 (467)
.++|+..+.||+|+||.||++... ++..||+|+++..........+..|++++..++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357889999999999999998532 234699999976544445567899999999999999999
Q ss_pred eeeeeeCCCceEEEeeccCCCChhhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPS-------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 204 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
+++++...+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999999764321 12478889999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc--CCCCccccccc
Q 012267 277 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT--GQRAFDLARLA 353 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt--g~~p~~~~~~~ 353 (467)
|++++++.++|+|||+++.+....... .....++..|+|||......++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 999999999999999987653322111 122234678999999888889999999999999999998 6778753211
Q ss_pred CCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 354 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
................ ....+. ...+...+.+++.+||+.+|.+||++.+|++.|++
T Consensus 240 ----~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 ----EQVIENTGEFFRDQGR-QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ----HHHHHHHHHHHhhccc-cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111100 001110 11223678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=314.61 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
.+|.+.+.||+|+||+||++... ++..+|+|.+.... ......+..|++++.+++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56888899999999999999752 34569999886532 333457889999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 216 LVYPYMANGSVASCLRERPP---------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999975431 223489999999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHH
Q 012267 287 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 364 (467)
|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|+| |+.||..... .+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVI 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence 9999999765322211 1122335678999999998889999999999999999998 9999853211 1111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..... .... .... .....+.+++.+||+.+|.+|||+.+|++.|++.
T Consensus 233 ~~i~~-~~~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 233 ECITQ-GRVL-----QRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHHc-CCcC-----CCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11111 1110 0111 1225689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=324.74 Aligned_cols=252 Identities=20% Similarity=0.278 Sum_probs=192.8
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.|+..+.||+|+||+||+|+.. +++.||||+++.... ......+..|++++..++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 688999999965432 2233468899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997643 378889999999999999999999 9999999999999999999999999997643110
Q ss_pred CC----------------------------------------------eeeecccccccccccccccCCCCCcchhHHHH
Q 012267 300 DT----------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 333 (467)
Q Consensus 300 ~~----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~ 333 (467)
.. .......||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123468999999999998889999999999
Q ss_pred HHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHH--ccCCCCCCCCCH
Q 012267 334 GIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALL--CTQGSPMDRPKM 411 (467)
Q Consensus 334 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~ 411 (467)
||++|||+||+.||..... ............ ...-+.. .. ....+.+++.+ |+..++..||++
T Consensus 235 G~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~--~~~~~~~-~~----~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP--------TETQLKVINWEN--TLHIPPQ-VK----LSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH--------HHHHHHHHcccc--ccCCCCC-CC----CCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999964211 011111111000 0000100 01 12345555554 667777789999
Q ss_pred HHHHH
Q 012267 412 SEVVR 416 (467)
Q Consensus 412 ~evl~ 416 (467)
.++++
T Consensus 300 ~~~l~ 304 (381)
T cd05626 300 DDIKA 304 (381)
T ss_pred HHHhc
Confidence 99965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.14 Aligned_cols=252 Identities=25% Similarity=0.310 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||+||+|+.. +|+.||||+++.... ......+..|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999975 789999999975322 123446889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999998752 388999999999999999999998 999999999999999999999999999986543
Q ss_pred CC----------------------------CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccc
Q 012267 299 KD----------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 350 (467)
Q Consensus 299 ~~----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~ 350 (467)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 11223345899999999999999999999999999999999999999642
Q ss_pred cccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 012267 351 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVVR 416 (467)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~ 416 (467)
. ........... ......|.. ......+.+++..|+. +|.+||+ +.++++
T Consensus 234 ~--------~~~~~~~i~~~--~~~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 234 T--------LQETYNKIINW--KESLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred C--------HHHHHHHHhcc--CCcccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 1 11111111110 000111110 0123567888899997 9999999 999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=333.51 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=201.9
Q ss_pred CCCCCCeeeecCceEEEEEEEC-C-CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-D-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.|...+.||+|++|.||+|... + +..||+|.+.... ......+..|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3788899999999999999754 4 6788998775432 23334678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++........++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998876443445689999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 301 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 301 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~-----~~~ 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGK-----YDP 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-----CCC
Confidence 1 22344568999999999999899999999999999999999999995321 112222221111 011
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .......+.+++..||+.+|++||++.+++.
T Consensus 291 -~----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -F----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -C----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 1112356889999999999999999999864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=324.16 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=198.4
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 136 ELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 136 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
.+....++|+..++||+|+||.||+++.. +++.||+|.+..... ......+.+|+.++..++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999975 688999999864221 222345788999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999999754 278888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCC----CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
+...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .........
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~ 260 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIM 260 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 987643332233455699999999998654 37889999999999999999999996321 111112221
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVR 416 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~ 416 (467)
.... ....|. .......+.+++..|+..++.+ ||++.|+++
T Consensus 261 ~~~~--~~~~p~-----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 261 DHKN--SLNFPE-----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred hCCc--ccCCCC-----cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 1110 000010 1112345677788888755543 889988755
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=310.16 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-C---CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-D---GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++|.+.+.||+|+||.||+|... + +..+|+|.++..........+..|+.++..++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999863 2 3479999987654444456789999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999976532 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCeeeec--ccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 298 YKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 298 ~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
......... ..++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~- 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAIEEGYRL- 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHHhCCCcC-
Confidence 333222221 123567999999998889999999999999999887 9999853211 1111111111000
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+. .......+.+++.+|++.+|.+||+|.++++.|++
T Consensus 229 ----~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ----PA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ----CC-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 10 11223567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=317.73 Aligned_cols=240 Identities=26% Similarity=0.337 Sum_probs=188.8
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHH---HhcCCCeeeeeeeeeeCCCceEEE
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
|++.+.||+|+||.||+|... +|+.||||+++.... ......+..|.+++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999865 689999999975321 12223456665554 567899999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888653 389999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~------ 217 (324)
T cd05589 153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVNDE------ 217 (324)
T ss_pred CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC------
Confidence 21 222334568999999999999899999999999999999999999996321 112222221111
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
+.. .......+.+++.+||+.||.+||++
T Consensus 218 -~~~----p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 218 -VRY----PRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred -CCC----CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 001 11123567889999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=313.91 Aligned_cols=261 Identities=27% Similarity=0.432 Sum_probs=205.8
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC--------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
...++|.+.+.||+|+||.||+|+.. ++..||+|.+...........+..|+.++..+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888899999999999999741 24579999987544344455788999999999 8999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcE
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 277 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Ni 277 (467)
.....++||||+++|+|.+++...... ...+++..+..++.|+++||+|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 999999999999999999999764221 13478899999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCC
Q 012267 278 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAND 355 (467)
Q Consensus 278 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~ 355 (467)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----- 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----
Confidence 99999999999999998664322221 222335678999999988889999999999999999998 78887431
Q ss_pred CCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 356 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...++........... ........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 244 ---~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 244 ---PVEELFKLLKEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ---CHHHHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 1222222221111100 011233668889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=311.68 Aligned_cols=264 Identities=25% Similarity=0.330 Sum_probs=203.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+|+..++||+|+||+||++... +++.||||.+...... .....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999865 6899999998653322 223457789999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999886542 22489999999999999999999999 9999999999999999999999999998865322
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+........
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~------- 221 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKEDQ------- 221 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc-----hhhHHHHHHHHhhhcc-------
Confidence 2 1223458899999999988889999999999999999999999996421 1111111111111100
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhcCCCC-ccchhhh
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVRMLEGDGLA-ERWDEWQ 431 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~L~~~~~~-~~~~~~~ 431 (467)
..........+.+++..||+.||.+|| ++.++ ++...+. ..|..++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l---~~~~~~~~~~~~~~~ 273 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV---KAHPFFRTANFKRLE 273 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH---hcCcCccCCCHHHHh
Confidence 011122345688999999999999999 77776 4444443 2344443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=317.31 Aligned_cols=238 Identities=28% Similarity=0.393 Sum_probs=190.2
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||+||+|+.. +++.||||+++... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999987532 122334567788888766 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence 99999987643 388999999999999999999999 9999999999999999999999999998754322 222
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~----~~~~~--- 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE----VVYPT--- 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCC----CCCCC---
Confidence 334568999999999998889999999999999999999999996321 112222221111 11111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMS 412 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 412 (467)
.....+.+++.+|++.||.+||++.
T Consensus 218 ----~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 218 ----WLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ----CCCHHHHHHHHHHcccCHHHCCCCC
Confidence 1235678899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.08 Aligned_cols=260 Identities=29% Similarity=0.421 Sum_probs=203.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC--------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCC
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 211 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 211 (467)
.++|.+.+.||+|+||.||++... .+..+|+|.++..........+..|++++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467888999999999999999752 23579999997654444445688899999999 799999999999999
Q ss_pred CceEEEeeccCCCChhhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE
Q 012267 212 TERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 279 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill 279 (467)
+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 9999999999999999999764321 12488999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCC
Q 012267 280 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDD 357 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 357 (467)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 99999999999998755322111 1111224568999999988889999999999999999998 888885311
Q ss_pred ccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 358 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..+..... ...... .........+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 248 --~~~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 248 --VEELFKLL-KEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred --HHHHHHHH-HcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11222211 111100 01112235788899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=312.50 Aligned_cols=260 Identities=27% Similarity=0.462 Sum_probs=205.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
..++|+..+.||+|+||.||+|... ++..||+|.+...........+..|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999863 4678999999765544445678899999999999999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCC
Q 012267 214 RLLVYPYMANGSVASCLRERPP------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 275 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~ 275 (467)
.++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999975321 123478899999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCccccccc
Q 012267 276 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 353 (467)
Q Consensus 276 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~ 353 (467)
||++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~--- 236 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--- 236 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999999999999998754322211 1112234567999999988889999999999999999997 88888421
Q ss_pred CCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 354 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...++...... ..... . .......+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 237 -----~~~~~~~~~~~-~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 -----AHEEVIYYVRD-GNVLS-----C----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----CHHHHHHHHhc-CCCCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11222222211 11100 0 11223668899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=307.26 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=194.7
Q ss_pred eeeecCceEEEEEEEC---CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 149 ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
.||+|+||.||+|.+. ++..+|+|+++..... .....+..|+.++..+.|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 5789999998754332 23457889999999999999999999875 45678999999999
Q ss_pred ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeee
Q 012267 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 304 (467)
Q Consensus 225 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 304 (467)
+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999997543 388999999999999999999999 999999999999999999999999999987654332211
Q ss_pred --ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 305 --TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 305 --~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
....++..|+|||.+....++.++|||||||++|||++ |+.||.... . .++.... ..... +..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~---~~~~~~i-~~~~~-----~~~ 219 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----G---NEVTQMI-ESGER-----MEC 219 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHH-HCCCC-----CCC
Confidence 11224578999999988888999999999999999998 999996321 1 1222221 11110 011
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.......+.+++.+||+.+|++||++.+|++.|++
T Consensus 220 ----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 ----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11123568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=306.62 Aligned_cols=250 Identities=30% Similarity=0.457 Sum_probs=203.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.++|...+.||.|++|.||+|... |+.||+|.++.... ....+..|+.++..++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457888899999999999999875 78999999975533 455788999999999999999999999998999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999986542 2489999999999999999999999 99999999999999999999999999998653221
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. ....+..|+|||++.+..++.++||||||+++|||++ |..||.... ..+.......... +
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~------~ 218 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPHVEKGYR------M 218 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHhcCCC------C
Confidence 1 2234568999999988889999999999999999997 999985321 1111111111100 0
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. .......+.+++.+||..+|++||++.+++++|+.
T Consensus 219 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EA----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CC----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00 11223678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=315.47 Aligned_cols=239 Identities=25% Similarity=0.346 Sum_probs=188.0
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHh-cCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||.||+|+.. +++.||||+++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999975421 2223345566666664 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999987643 388889999999999999999999 99999999999999999999999999997543222 22
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~-------~~~~-- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFDSILND-------RPHF-- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-------CCCC--
Confidence 334568999999999998899999999999999999999999996321 11111111111 0111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSE 413 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 413 (467)
.......+.+++..||+.+|.+||++.+
T Consensus 216 --~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 216 --PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 1112255778999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=313.69 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=203.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
.+|...+.||+|+||.||+|+.. ++..+++|.+.... ......+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777889999999999999742 34569999886433 233456889999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC
Q 012267 216 LVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 283 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~ 283 (467)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999976432 112489999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHH
Q 012267 284 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 284 ~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 361 (467)
.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|||+| |+.||..... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~ 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------T 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 9999999999765432211 1222346788999999998899999999999999999999 9999853211 1
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 362 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+..... ....... . .......+.+++.+||+.+|.+||++++|+++|+++
T Consensus 233 ~~~~~~-~~~~~~~-----~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 EVIECI-TQGRVLE-----R----PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHH-hCCCCCC-----C----CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 1111110 0 111235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=317.49 Aligned_cols=241 Identities=26% Similarity=0.363 Sum_probs=191.5
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||.||+|+.. +++.||||+++.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 578999999875422 22334567788888765 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99999987643 388999999999999999999999 99999999999999999999999999987533222 22
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ............ ...|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~----~~~p~--- 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDD----VLYPV--- 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC----CCCCC---
Confidence 334568999999999998899999999999999999999999996321 112222222111 11111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCC-------CHHHHH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRP-------KMSEVV 415 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~evl 415 (467)
.....+.+++..|++.+|++|| ++.+++
T Consensus 218 ----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 218 ----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 1125678899999999999999 666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=316.43 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=199.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC--EEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS--LVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 217 (467)
++|+..+.||+|+||.||+|.+. ++. .+|+|.++..........+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999865 454 46888776544444455788999999999 899999999999999999999
Q ss_pred eeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcE
Q 012267 218 YPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 285 (467)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999975431 122488999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHH
Q 012267 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 364 (467)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||.... ..+..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY 233 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--------hHHHH
Confidence 99999998632211 11111223567999999988889999999999999999998 999985321 11111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
......... .. .......+.+++.+||+.+|++||++.++++.|++
T Consensus 234 ~~~~~~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 234 EKLPQGYRL------EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHHhcCCcC------CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110000 00 11123467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=308.49 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=196.7
Q ss_pred CCCCCeeeecCceEEEEEEECC-CC--EEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------Cc
Q 012267 144 FSNKNILGRGGFGKVYKGRLAD-GS--LVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TE 213 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~~-g~--~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 213 (467)
|.+.++||+|+||.||+|...+ +. .||+|.++.... ......+..|++++..++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456889999999999998753 33 699999875432 23345688999999999999999999987532 24
Q ss_pred eEEEeeccCCCChhhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 214 RLLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
.+++|||+++|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999875322 1223489999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCeee-ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhh
Q 012267 292 LAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 292 l~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
+++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSEIYDYLRQ 229 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHc
Confidence 9987543222111 12235678999999998889999999999999999999 888885311 1111111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..... . .......+.+++.+||+.+|++|||+.+|++.|++
T Consensus 230 ~~~~~---~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 230 GNRLK---Q-------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCC---C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11100 0 11223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.89 Aligned_cols=201 Identities=21% Similarity=0.332 Sum_probs=173.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|+||+||++... +++.||||+++.... ......+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 689999999965321 122345788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCC
Q 012267 299 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344 (467)
Q Consensus 299 ~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~ 344 (467)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999989999999999999999999999
Q ss_pred CCccc
Q 012267 345 RAFDL 349 (467)
Q Consensus 345 ~p~~~ 349 (467)
.||..
T Consensus 234 ~Pf~~ 238 (363)
T cd05628 234 PPFCS 238 (363)
T ss_pred CCCCC
Confidence 99953
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=324.15 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=195.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ......+..|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999975 689999999975321 222345788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCe-------------------------------------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHH
Q 012267 299 KDTH-------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELI 341 (467)
Q Consensus 299 ~~~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ell 341 (467)
.... ......||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011235899999999999889999999999999999999
Q ss_pred cCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 012267 342 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK---MSEVVR 416 (467)
Q Consensus 342 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~ 416 (467)
+|..||.... ..+......... .....+. .......+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~--------~~~~~~~i~~~~--~~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDN--------PQETYRKIINWK--ETLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCC--------HHHHHHHHHcCC--CccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999995321 111111111110 0000010 00112456778888886 9999998 777744
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=305.62 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=202.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|++|.||+|... ++..|++|.+.... .......+..|+++++.++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999875 68999999986532 233455788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... ...+++..++.++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998642 23488999999999999999999998 99999999999999999999999999988654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ........... .. +.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~-----~~ 220 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRG-VF-----PP 220 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-CC-----CC
Confidence 2 2233457889999999998889999999999999999999999996321 11111111111 10 11
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ .......+.+++.+||+.+|++||++.++++
T Consensus 221 ~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 V----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred C----ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1 1123367899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=307.60 Aligned_cols=257 Identities=24% Similarity=0.429 Sum_probs=204.5
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++..++|...+.||+|+||.||++...++..+|+|.++... .....+.+|+++++.++|+|++++.+++.. ...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 34457888899999999999999998778889999886432 234568899999999999999999999887 778999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++..... ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 999999999999976432 2478899999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
...........++..|+|||++....++.++|||||||++|+++| |+.||.... ......+.. ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~----~~~~--- 221 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALE----RGYR--- 221 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHh----CCCC---
Confidence 322222222335678999999988889999999999999999999 999985321 111111111 1100
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.+ ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 -~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -MP-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CC-----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 011223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.59 Aligned_cols=242 Identities=23% Similarity=0.282 Sum_probs=192.9
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
+.||+|+||.||++... +|..||+|+++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 789999999975422 222345778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 225 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GAT 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccc
Confidence 9999887643 38999999999999999999997 6 8999999999999999999999999998753222 222
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||..|+|||++.+..++.++|||||||++|||+||+.||.... ........... . ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~~-~------~~~p~ 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-E------IRFPR 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhcC-C------CCCCC
Confidence 234568999999999998899999999999999999999999995321 11111111110 0 01111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
.....+.+++.+||+.||++|+ ++.++++
T Consensus 218 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 218 ----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1225678899999999999996 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=305.11 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=194.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-----ceEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERLL 216 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 216 (467)
.|...+++|+|+||.||+|.+. +++.||||+...+... -..|+++|++++|||||++.-+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4566789999999999999965 5789999998654332 237899999999999999999886432 2358
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEeecCCccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 295 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~ 295 (467)
|||||+. +|.+.++........++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999988 99999986433344477788899999999999999998 99999999999999977 8999999999998
Q ss_pred cCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc---
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--- 371 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 371 (467)
+...... ..+.-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+ ....+...++ .+.-.
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s----~~dQL~eIik-~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS----SVDQLVEIIK-VLGTPTRE 248 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC----HHHHHHHHHH-HhCCCCHH
Confidence 7654443 23345789999999877 468999999999999999999999995422 1111222222 21111
Q ss_pred cc-------ccccCccccCc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KL-------EMLVDPDLQNN-----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~-------~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+ .+.-.|.+... .......+.++++.++++.+|.+|.++.|++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11 01112222211 12233467889999999999999999988864
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=305.83 Aligned_cols=248 Identities=29% Similarity=0.474 Sum_probs=197.2
Q ss_pred CeeeecCceEEEEEEEC--C--CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA--D--GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||.||+|... + +..||+|.+...........+..|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 26899999976654444567899999999999999999999876 4567999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..++.++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999998654 389999999999999999999999 99999999999999999999999999998664333222
Q ss_pred eec--ccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 304 TTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 304 ~~~--~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
... ..++..|+|||.+.+..++.++||||||+++|+|++ |+.||... .......++. ..... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-----~~~~~~~~~~---~~~~~---~~-- 219 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-----KGAEVIAMLE---SGERL---PR-- 219 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHHH---cCCcC---CC--
Confidence 111 123467999999988889999999999999999998 99999532 1111222221 11110 00
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.......+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 220 -----~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 -----PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 111235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=306.49 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=198.1
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+|+..++||+|+||.||+|... ++..||+|.+...........+..|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999864 788999999876544444557889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999996542 267888999999999999999999 9999999999999999999999999999765322
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ ......+........ .+.+
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~------~~~~ 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG-SLMPLQLLQCIVDED------PPVL 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc-ccchHHHHHHHhccC------CCCC
Confidence 12234688999999999988899999999999999999999999964221111 111111111111110 1111
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
. .......+.+++.+|++.+|.+||+++++++.
T Consensus 221 ~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 P---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1 11122467899999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.34 Aligned_cols=264 Identities=25% Similarity=0.386 Sum_probs=204.1
Q ss_pred cCCCCCCeeeecCceEEEEEEE-----CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--Cce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 214 (467)
..|+..+.||+|+||.||++.. .++..||+|.++..........+.+|+.+++.++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567788999999999999974 257889999997654444456789999999999999999999998775 567
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 899999999999999875422 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCe--eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccccc-------CCCCccHHHHHH
Q 012267 295 LMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA-------NDDDVMLLDWVK 365 (467)
Q Consensus 295 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~-------~~~~~~~~~~~~ 365 (467)
........ ......++..|+|||++.+..++.++||||||+++|||+|++.|....... .........++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66433221 122344677899999998888999999999999999999988765321100 001111111211
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.. ...... .........+.+++.+|++.+|.+||++.++++.|+++
T Consensus 238 ~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VL-EEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 111000 00112346799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.82 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc----hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++|...+.||+|++|.||+|... ++..||+|.+....... ....+.+|++++.+++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 68999999986543221 22357889999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|+||+++++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987643 378889999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCeee--ecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... . ... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~--~~~-~~~~~~~~~-- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-----A--MAA-IFKIATQPT-- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-----h--HHH-HHHHhccCC--
Confidence 32211111 23457789999999999889999999999999999999999995311 1 111 111111000
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.+.+ .......+.+++.+||..+|.+|||+.++++.
T Consensus 225 ---~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ---NPQL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111 11223568889999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=307.96 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=195.4
Q ss_pred CeeeecCceEEEEEEEC-CCC--EEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGS--LVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||.||+|... ++. .+++|.++..........+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875 343 57888887544444455788999999999 799999999999999999999999999
Q ss_pred CChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 224 GSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 224 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999976431 122478999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||.... ..+........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKLPQG 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHHHHHHhCC
Confidence 986322111 1111223567999999988889999999999999999997 999995321 11111111111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.... . .......+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 228 ~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRLE------K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCC------C----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1100 0 111235688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.25 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=194.8
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
||+|+||.||+++.. +|+.||+|.+...... .....+..|++++.+++||||+++.+++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 6899999998643221 2233456799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeec
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 306 (467)
.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...... .....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeec
Confidence 998865432 2388999999999999999999999 9999999999999999999999999998765422 22233
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.... ................ .. .. .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~-----~~--~~---~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK----EKVAKEELKRRTLEDE-----VK--FE---H 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc----chhhHHHHHHHhhccc-----cc--cc---c
Confidence 458899999999988889999999999999999999999995321 1111112211111110 00 00 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
......+.+++..||+.||++||+++|+++.+.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 122356889999999999999999988765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=307.44 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=200.0
Q ss_pred CCCCCeeeecCceEEEEEEEC-C---CCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc-----
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-D---GSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 213 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~---g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 213 (467)
|.+.+.||+|+||.||+|... + +..||+|+++..... .....+..|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 466789999999999999864 2 368999999764332 233468899999999999999999998876544
Q ss_pred -eEEEeeccCCCChhhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 214 -RLLVYPYMANGSVASCLRERPP--SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 214 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
.++++||+++|+|..++..... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999999865321 223589999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHh
Q 012267 291 GLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 291 gl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
|+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.... . .++.....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~---~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----N---HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHH
Confidence 9998654332211 111234678999999988889999999999999999999 888885311 1 11222111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.... +.. .......+.+++.+||+.||.+||++.+|++.|++.
T Consensus 230 ~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR------LKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC------CCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 001 112346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.23 Aligned_cols=241 Identities=27% Similarity=0.367 Sum_probs=192.0
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
+.||+|+||+||+|+.. ++..||||+++.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 578999999975421 22234567888888877 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVT 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCc
Confidence 99999987653 389999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.... ............ ...+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~~~~----~~~~---- 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSILEDE----VRYP---- 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCC----CCCC----
Confidence 233458999999999999999999999999999999999999995321 111111111110 0011
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCH-----HHHH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKM-----SEVV 415 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl 415 (467)
......+.+++.+||+.||.+||++ .+++
T Consensus 217 ---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll 250 (318)
T cd05570 217 ---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIK 250 (318)
T ss_pred ---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHh
Confidence 1123568899999999999999999 7664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=321.15 Aligned_cols=263 Identities=28% Similarity=0.436 Sum_probs=201.7
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 211 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 211 (467)
...++|...+.||+|+||.||+|.. .+++.||||+++..........+..|+.++.++ +|+||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456899999999999999999973 357889999997654444445688999999999 689999999988654
Q ss_pred -CceEEEeeccCCCChhhhhhcCCCC------------------------------------------------------
Q 012267 212 -TERLLVYPYMANGSVASCLRERPPS------------------------------------------------------ 236 (467)
Q Consensus 212 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 236 (467)
...++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999999999998753210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe-eeec
Q 012267 237 ---------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTA 306 (467)
Q Consensus 237 ---------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~ 306 (467)
...+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12368888999999999999999999 9999999999999999999999999998765322111 1122
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 385 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 385 (467)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||..... . ...... ....... ..+.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~---~~~~~~-~~~~~~~--~~~~----- 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----D---EEFCRR-LKEGTRM--RAPD----- 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----c---HHHHHH-HhccCCC--CCCC-----
Confidence 335678999999988889999999999999999997 9999853210 0 011111 1111100 0011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 386 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 386 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.....+.+++..||+.+|++||++.+|++.|+..
T Consensus 306 --~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 306 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1124688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=291.72 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=202.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc----c---hHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCC
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP----G---GELQFQTEVEMISMA-VHRNLLRLRGFCMTPT 212 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~----~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 212 (467)
+.|...++||.|..++|-++..+ +|..+|+|++...... . -.+.-.+|+.+|+++ .||+|+.+.+++..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 56777889999999999998764 7889999998533221 1 122456799999988 5999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++|+|.|+.|.|.|+|.... .++++...+|+.|+.+|+.|||.. +||||||||+|||+|++.++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999998754 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccC------CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
++.+. .+...+..+||++|+|||.+.- ..|+...|.|+.|||||.|+.|.+||-.... -.+-.
T Consensus 170 a~~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---------mlMLR 238 (411)
T KOG0599|consen 170 ACQLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---------MLMLR 238 (411)
T ss_pred eeccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---------HHHHH
Confidence 99764 4556778899999999998742 3578899999999999999999999943110 00011
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..-++.. .+......+......+++.+|++.||++|.|++|+++
T Consensus 239 ~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111111 1122224455677889999999999999999999864
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=321.50 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=200.6
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMT 210 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 210 (467)
+.++....++|+..+.||+|+||.||+++.. +++.||+|++..... ......+.+|+.++..++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4555666789999999999999999999976 688999999864221 1223357789999999999999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
....++||||+++|+|.+++.... ++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999987542 77888899999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCC----CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
|++...............||+.|+|||++... .++.++|||||||++|||++|+.||.... .......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 99987643333233445699999999998653 37899999999999999999999996421 1111122
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVRM 417 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 417 (467)
...........+ .......+.+++..|+..++.+ ||++.++++.
T Consensus 259 i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 259 IMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 211111000000 1122355778888899844433 6788877653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=318.83 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=196.0
Q ss_pred CeeeecCceEEEEEEE----CCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccC
Q 012267 148 NILGRGGFGKVYKGRL----ADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 222 (467)
+.||+|+||.||+++. .+|+.||+|+++..... .....+..|++++.+++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 35889999999754322 223456789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
+|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 999999987543 389999999999999999999999 99999999999999999999999999987643221 2
Q ss_pred eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+........ .. .+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~-~~------~~- 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKA-KL------GM- 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcC-CC------CC-
Confidence 2334568999999999998888999999999999999999999996321 11111111111 00 01
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHhcCC
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSE--VVRMLEGDG 422 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e--vl~~L~~~~ 422 (467)
.......+.+++.+||+.||++||++.+ +.+.++...
T Consensus 218 ---p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 218 ---PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 1112256788999999999999999766 444454443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=320.56 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=196.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-----ceE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 215 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 215 (467)
+|+..+.||+|+||.||++... +|+.||||++..... ......+.+|++++..++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 789999999865322 223456889999999999999999999998776 789
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+|+||+. ++|.+++.... .+++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 58888876532 389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCC--------CCccHHHHHHH
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLAND--------DDVMLLDWVKG 366 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~ 366 (467)
.............++..|+|||++.+. .++.++|||||||++|||++|+.||........ .......+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 543333333334578899999998764 478999999999999999999999964221100 00000000000
Q ss_pred H--hhhcccccccCc-ccc--CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 L--LKEKKLEMLVDP-DLQ--NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~--~~~~~~~~~~d~-~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ...........+ ... ..........+.+++.+|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0 000000000000 000 0001112356889999999999999999999865
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.40 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=192.1
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCC-eeeeeeeeeeCCCceEEEe
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 218 (467)
+|+..+.||+|+||.||+|+.. +++.||||+++... .......+..|.+++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999875 57899999997532 122344677889999988765 5888999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987643 278999999999999999999999 999999999999999999999999999874322
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. .......||..|+|||++.+..++.++|||||||++|||+||+.||.... ..+........ .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~-~------ 217 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIMEH-N------ 217 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-C------
Confidence 22 22334568999999999999899999999999999999999999996321 11111111111 0
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
..+ .......+.+++.+||+.+|.+|++.
T Consensus 218 ~~~----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSY----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011 11123567889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=312.97 Aligned_cols=240 Identities=25% Similarity=0.359 Sum_probs=189.4
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHh-cCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
+.||+|+||+||+|+.. +++.||||+++.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 578999999975421 2223356667777775 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 99999997642 378899999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~-------~~~~~- 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRMD-------NPCYP- 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-------CCCCC-
Confidence 234568999999999998899999999999999999999999996321 11111111110 01111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHH-HH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMS-EV 414 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev 414 (467)
......+.+++.+||+.+|++||++. ++
T Consensus 217 ---~~~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 217 ---RWLTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred ---ccCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 11225578899999999999999997 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=315.53 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=203.5
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC--------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
...++|.+.+.||+|+||.||++... ....||+|.++..........+..|++++..+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34467888899999999999999742 24579999987554444455788999999999 6999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcE
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 277 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Ni 277 (467)
.....++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 88899999999999999999976421 123489999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCC
Q 012267 278 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAND 355 (467)
Q Consensus 278 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~ 355 (467)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---- 241 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---- 241 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC----
Confidence 99999999999999998654222111 111223467999999988889999999999999999999 888885311
Q ss_pred CCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 356 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..+........... .. .......+.+++.+||+.+|++||++.++++.|++
T Consensus 242 ----~~~~~~~~~~~~~~------~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 242 ----VEELFKLLREGHRM------DK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred ----HHHHHHHHHcCCCC------CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111111111100 00 11223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=308.04 Aligned_cols=264 Identities=27% Similarity=0.412 Sum_probs=199.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 214 (467)
.+|+..+.||+|+||.||++... ++..||+|.++... ......+..|++++..++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999742 57899999986542 3334578899999999999999999998754 3467
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 899999999999999975422 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeee--ecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccccc------C-CCCccHHHHHH
Q 012267 295 LMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA------N-DDDVMLLDWVK 365 (467)
Q Consensus 295 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~------~-~~~~~~~~~~~ 365 (467)
.......... ....++..|+|||++.+..++.++|||||||++|||++|..++...... . ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 7643322111 1122345699999998888999999999999999999988775321100 0 00000000011
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
....... ...........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111100 0000112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=308.36 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=201.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CC---CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+|...+.||+|+||.||+|... ++ ..||||.+...........|..|+.+++.++||||+++.+++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999865 33 3699999876544445567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++..... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999976432 388999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCee--eeccc--ccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 299 KDTHV--TTAVR--GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 299 ~~~~~--~~~~~--g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
..... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||.... ......++. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i~---~~~~~ 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAIE---QDYRL 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHHH---cCCcC
Confidence 22211 11111 2357999999998899999999999999999886 999985321 111222221 11000
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+ ...+....+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 231 -----~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 -----P-----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred -----C-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 011223568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=302.68 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=198.6
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChh
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 227 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 227 (467)
++||+|++|.||++...+++.||+|.+...........+..|+++++.++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999876554445567899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeee-ec
Q 012267 228 SCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TA 306 (467)
Q Consensus 228 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~ 306 (467)
+++..... .+++..+..++.+++.||+|||++ +++||||+|+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99976432 378899999999999999999999 999999999999999999999999999875432111111 11
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 385 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 385 (467)
...+..|+|||.+.+..++.++||||||+++|||+| |..||.... . ....... .... .. ..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-----~---~~~~~~~-~~~~--~~-------~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS-----N---QQTRERI-ESGY--RM-------PA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC-----H---HHHHHHH-hcCC--CC-------CC
Confidence 223567999999988889999999999999999999 888885321 0 1111111 1000 00 01
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 386 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 386 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.......+.+++.+|++.+|.+||++.||++.|++
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.25 Aligned_cols=252 Identities=25% Similarity=0.445 Sum_probs=201.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.+|+..+.||+|+||.||+|.+.++..+|+|.+..... ....+..|+++++.++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 45777889999999999999987788999999865432 2446889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|.+++..... .+++..++.++.+++.|++|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999976432 378999999999999999999999 999999999999999999999999999875532221
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ........... .....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~---~~~~~~~ 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINAG---FRLYKPR 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhCC---CCCCCCC
Confidence 11122234578999999988889999999999999999998 999985321 11222221111 0111122
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
. ....+.+++.+||+.+|++||++.+|++.|.
T Consensus 225 ~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 L-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred C-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 1367899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=312.76 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=189.3
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHh-cCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||.||+|+.. +|..||+|.++.... ......+..|..++.. .+||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 688999999975421 2223356677777765 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 99999987643 378899999999999999999999 9999999999999999999999999998743211 122
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .+.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--------~~~~~~~~~~~-------~~~~~~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--------EDELFESIRVD-------TPHYPR 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-------CCCCCC
Confidence 334568999999999999999999999999999999999999995321 11111111110 111111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHH-HH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMS-EV 414 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev 414 (467)
.....+.+++.+||+.||++||++. ++
T Consensus 218 ----~~~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 218 ----WITKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred ----CCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 1225678899999999999999984 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=301.88 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=193.0
Q ss_pred CeeeecCceEEEEEEECC---CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 148 NILGRGGFGKVYKGRLAD---GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45799999876554444557889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 225 SVASCLRERPP-SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 225 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
+|.+++..... .....++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 223467788889999999999999999 99999999999999999999999999987543222211
Q ss_pred -eecccccccccccccccCC-------CCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 304 -TTAVRGTIGHIAPEYLSTG-------KSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 304 -~~~~~g~~~y~aPE~~~~~-------~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.....++..|+|||++... .++.++||||||+++|||++ |+.||.... ...... .... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~~~~~~---~~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS-----DEQVLT---YTVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC-----hHHHHH---HHhh-cccC
Confidence 1223467889999988542 35789999999999999996 999995321 111111 1111 1111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
...++.+... ....+.+++..|+ .+|++|||+++|++.|+
T Consensus 229 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222222211 2245777888998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.07 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=197.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...+.||+|+||+||+|+.. ++..||+|.++..........+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999875 68899999997654444445678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88888865432 378889999999999999999999 99999999999999999999999999987643222
Q ss_pred CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh----------
Q 012267 301 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 369 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 369 (467)
. ......++..|+|||.+.+ ..++.++|||||||++|+|+||+.||...... ...........
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhh
Confidence 2 1223357889999998865 46789999999999999999999999542210 00000000000
Q ss_pred --hcccccccCccccC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 --EKKLEMLVDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 --~~~~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......-.+.... .........+.+++.+|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000010000 000112345789999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=328.57 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=190.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-------
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------- 211 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 211 (467)
...+|...++||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467999999999999999999875 68899999885432 1345799999999999999999876432
Q ss_pred -CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEee
Q 012267 212 -TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGD 289 (467)
Q Consensus 212 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~D 289 (467)
...++||||+++ +|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 235689999975 78777765333344589999999999999999999999 999999999999999665 799999
Q ss_pred cCCccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||...... ..+........
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~~ 288 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRIIQVLG 288 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhC
Confidence 99998654322 2223457999999998865 46899999999999999999999999642110 01111111000
Q ss_pred h--h-------cccccccCcccc-----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 369 K--E-------KKLEMLVDPDLQ-----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 369 ~--~-------~~~~~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
. . .....+.-+... .........++.+++.+||+.||.+|||+.|++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 0 000000001110 001111235688999999999999999999986
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.13 Aligned_cols=252 Identities=18% Similarity=0.249 Sum_probs=192.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||+||++... +|+.||||++.... .......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999865 78999999986432 1222346788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997643 378889999999999999999999 999999999999999999999999999863211
Q ss_pred CCCe----------------------------------------------eeecccccccccccccccCCCCCcchhHHH
Q 012267 299 KDTH----------------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 332 (467)
Q Consensus 299 ~~~~----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s 332 (467)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245899999999999889999999999
Q ss_pred HHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCC---C
Q 012267 333 YGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR---P 409 (467)
Q Consensus 333 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---P 409 (467)
|||++|||+||+.||..... .+......... ..+.-|. .......+.+++.+|+. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~--~~~~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS--------HETYRKIINWR--ETLYFPD-----DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH--------HHHHHHHHccC--CccCCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999953211 11111111100 0010111 00122457788888887 66665 5
Q ss_pred CHHHHHH
Q 012267 410 KMSEVVR 416 (467)
Q Consensus 410 s~~evl~ 416 (467)
++.++++
T Consensus 298 ~~~~~l~ 304 (377)
T cd05629 298 GAHEIKS 304 (377)
T ss_pred CHHHHhc
Confidence 8888754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=312.73 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=192.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEe
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+|...+.||+|+||.||+|+.. ++..||||+++.... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999876 578999999975432 12233466777777766 5899999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999987643 288899999999999999999999 999999999999999999999999999875332
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. ........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ........... ..
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~~-~~----- 218 (323)
T cd05616 154 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEH-NV----- 218 (323)
T ss_pred C-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CC-----
Confidence 2 222334568999999999999999999999999999999999999996321 11111111111 00
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
.+ .......+.+++.+|++.+|.+|++.
T Consensus 219 -~~----p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AY----PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CC----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01 11123567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=302.12 Aligned_cols=251 Identities=18% Similarity=0.286 Sum_probs=202.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+|+..+.||.|+||.||++... ++..||+|.++........+.+..|+.+++.++|+||+++++.+...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 688999999875544445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++|+|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+||++++++.++++|||++.......
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 99999998875422 2378889999999999999999999 99999999999999999999999999987654322
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||.... .......... ..... +
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~-----~ 220 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVCQ-GSYKP-----L 220 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHhc-CCCCC-----C
Confidence 22233458889999999988889999999999999999999999995321 1111111111 11110 1
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.......+.+++.+||+.+|++||++.+|+..
T Consensus 221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.60 Aligned_cols=199 Identities=26% Similarity=0.368 Sum_probs=173.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||+|+||.||++... ++..+|+|.++.........++..|++++.+++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999865 68889999987554444445688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... .+++..+..++.|+++||.|||+.+ +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997642 3888999999999999999999732 8999999999999999999999999998754321
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 12334678999999999888899999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=301.03 Aligned_cols=266 Identities=24% Similarity=0.293 Sum_probs=200.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCe-eeeeeeeeeCCC------
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPT------ 212 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------ 212 (467)
..|...++||+|+||+||+|+.. +|+.||+|+++.... +.......+|+.++++++|+| |+++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555677999999999999864 789999999987654 223335679999999999999 999999998877
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++||||+.. +|..++.........++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78899999966 99999987653323366688999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh-
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE- 370 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 370 (467)
|+........ .....+|..|.|||++.+. .|+...||||+|||+.||++++.-|..... ...+.. +-..+..
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~-If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFR-IFRLLGTP 240 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHH-HHHHcCCC
Confidence 9966533222 3344579999999999886 689999999999999999999998854221 111111 1111110
Q ss_pred ---cccccccCcccc----Ccc-c-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 371 ---KKLEMLVDPDLQ----NNY-V-------EAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 371 ---~~~~~~~d~~~~----~~~-~-------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.+.....-|+.. ... . ........+++.+|++.+|.+|.|++..++.
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111001110 000 0 0111367889999999999999999999775
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.80 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=201.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
.+|...++||+|+||.||++... ++..+|+|.+... .......+..|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46777899999999999999642 3568999988643 3334457899999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 216 LVYPYMANGSVASCLRERPPS-----------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
++|||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999999764321 12488999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHH
Q 012267 285 AVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 362 (467)
+||+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~ 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TE 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HH
Confidence 9999999987553222111 122234678999999998899999999999999999998 9999853110 11
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 363 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........... ..+ ......+.+++.+||+.+|.+||++.+|++.|++
T Consensus 233 ~~~~~~~~~~~---~~~-------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECITQGREL---ERP-------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcCccC---CCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111000 001 1123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=313.67 Aligned_cols=245 Identities=25% Similarity=0.325 Sum_probs=192.0
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||+||+|... +++.||+|+++..... .....+..|..++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6789999999754322 2234577889888887 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 99999887543 389999999999999999999999 9999999999999999999999999998753221 222
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......++........... .|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~---~p~--- 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITD--NPDMNTEDYLFQVILEKPIR---IPR--- 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCC--CcccccHHHHHHHHHhCCCC---CCC---
Confidence 3345689999999999999999999999999999999999999964221 11111222222222211110 111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMS 412 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 412 (467)
.....+.+++.+||+.||.+||++.
T Consensus 225 ----~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 ----FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1125578899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=300.92 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=199.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHH--HhcCCCeeeeeeeeeeCC----Cce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMI--SMAVHRNLLRLRGFCMTP----TER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~~~~~~~~~----~~~ 214 (467)
.+...+.+.||+|.||.||+|.++ |+.||||++... .+..+.+|.++. ..++|+||+.+++.-..+ .++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 455677889999999999999997 788999999543 234555666655 567999999998875433 367
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-----HCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-----~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
+||++|.+.|||+|+|.... ++-...++++..+|.||++||. +.+|.|.|||||+.||||..++...|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 99999999999999998743 8889999999999999999995 5688999999999999999999999999
Q ss_pred cCCccccCCCCCe---eeecccccccccccccccCCC----C--CcchhHHHHHHHHHHHHcC----------CCCcccc
Q 012267 290 FGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK----S--SEKTDVFGYGIMLLELITG----------QRAFDLA 350 (467)
Q Consensus 290 fgl~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~----~--~~~sDv~s~Gvil~elltg----------~~p~~~~ 350 (467)
+|||......... .....+||.+|||||++...- + -..+||||||.|+||+.-. +.||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999765433222 233456999999999985421 1 2468999999999999752 3466432
Q ss_pred cccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 351 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
...+. + .+-++..+-..+++..++.+ ....+.+..+.++|..||..+|.-|-|+--|-+.|.+.
T Consensus 440 Vp~DP---s-~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 440 VPSDP---S-FEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred CCCCC---C-HHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 21111 1 12222233233333333332 23567888999999999999999999998888888764
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=304.71 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
..|+..+.||.|+||.||+|... ++..||+|.+...........+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677788999999999999875 68899999987654444456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++... ++++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999998753 278889999999999999999999 99999999999999999999999999997654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......++..|+|||++.+..++.++|||||||++|||+||+.||...... ...... . ..
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~-~---------~~ 216 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFLI-P---------KN 216 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhhh-h---------cC
Confidence 1 222345788999999998888999999999999999999999998532110 111000 0 00
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
............+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0111223445678899999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=325.58 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=208.2
Q ss_pred CCCCeeeecCceEEEEEEEC-CC----CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 145 SNKNILGRGGFGKVYKGRLA-DG----SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~-~g----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
...++||+|+||+||+|.+- .| .+||||++......+...+++.|+-.|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34589999999999999863 33 4799999988777777889999999999999999999999998776 889999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
||+.|+|.++++.+.. .+..+..+.|..|||+||.|||.+ ++|||||..+||||.....+||.|||+++.+...
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999998644 378889999999999999999999 9999999999999999999999999999988755
Q ss_pred CCeeeec-ccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 300 DTHVTTA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 300 ~~~~~~~-~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
....... ..-.+.|||-|.+....++.++|||||||++||++| |..|++.... +-+..+++.+.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---------~eI~dlle~ge----- 917 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---------EEIPDLLEKGE----- 917 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---------HHhhHHHhccc-----
Confidence 4433322 223568999999999999999999999999999998 8999864321 11222222211
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+-..++-+..++..++.+||..|+..||+++++...+.+.
T Consensus 918 ----RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 918 ----RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ----cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 1122344567899999999999999999999999888653
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=303.87 Aligned_cols=249 Identities=31% Similarity=0.432 Sum_probs=199.0
Q ss_pred CeeeecCceEEEEEEECC--C--CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLAD--G--SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|++|.||+|.+.+ + ..||||.+...........+..|+.++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 36999999766544445578999999999999999999999988 888999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
++|.+++..... ..++|..++.++.|+++||+|||++ +++|+||+|+||+++.++.+||+|||++..+.......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987542 3489999999999999999999999 99999999999999999999999999998764322211
Q ss_pred --eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 304 --TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 304 --~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.......... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~--~~~~-- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--------GSQILKKIDKEGE--RLER-- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcCC--cCCC--
Confidence 112346789999999998889999999999999999999 999985321 1112222111100 0000
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
.......+.+++.+|++.+|++||++.+|++.|.
T Consensus 223 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 -----PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1122356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=314.44 Aligned_cols=239 Identities=26% Similarity=0.334 Sum_probs=188.2
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHH-HHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||+||+|+.. +|+.||||++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 789999999864321 112234455554 46789999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 99999987643 388899999999999999999999 9999999999999999999999999998753221 222
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... . .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~--~~~~---- 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-L--RLKP---- 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-C--CCCC----
Confidence 334568999999999999899999999999999999999999995321 112222222110 0 0111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSE 413 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 413 (467)
.....+.+++.+|++.+|.+||++.+
T Consensus 218 ----~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 218 ----NISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred ----CCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 11356888999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.30 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|+..+.||+|+||.||+|+.. +...|++|.+...........+..|++++.+++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999864 246799998865443323457899999999999999999999999989999
Q ss_pred EEeeccCCCChhhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 216 LVYPYMANGSVASCLRERPPSQ-----LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
+||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654221 2589999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.... . ...+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-----~---~~~~~~~~- 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-----D---EEVLNRLQ- 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----h---HHHHHHHH-
Confidence 9987543222222233345678999999988888999999999999999999 788885311 1 11111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........ .......+.+++.+||+.+|.+||++.++++.|.+
T Consensus 233 ~~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111000 11123578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=302.68 Aligned_cols=251 Identities=33% Similarity=0.514 Sum_probs=203.1
Q ss_pred CeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||.||+|.... +..|++|.++..........+..|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998753 7899999997665444456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 224 GSVASCLRERPPS-----QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 224 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
++|.+++...... ...+++..++.++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875321 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 299 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 299 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... .......++..|+|||.+....++.++||||||+++|||++ |..||.... ..+.......... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~---~ 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGYR---L 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCC---C
Confidence 321 12233446889999999988889999999999999999999 699996421 1111221111100 0
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
.. .......+.+++.+||+.+|++|||+.++++.|+
T Consensus 227 ~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC-------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01 1122467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=303.66 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=198.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+..|+.++..++|+||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 357888999999999999999964 788999999865422 233467889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.... ++++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999999987543 388999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCeeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.. ......++..|+|||.+. ...++.++|||||||++|||++|+.||....... ..... .....
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----------~~~~~-~~~~~ 226 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----------ALFLM-SKSNF 226 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----------hheee-ecCCC
Confidence 11 122345788999999874 3457889999999999999999999985321100 00000 00000
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 418 (467)
..+.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 227 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111110 112336788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=300.99 Aligned_cols=250 Identities=32% Similarity=0.465 Sum_probs=192.2
Q ss_pred CeeeecCceEEEEEEEC----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-CCceEEEeeccC
Q 012267 148 NILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPYMA 222 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~ 222 (467)
+.||+|+||.||+|.+. ++..||+|.+...........+..|+.+++.++|||++++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998644333345578899999999999999999998764 556789999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
+|+|.+++..... ..++..+..++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999976432 267788899999999999999998 9999999999999999999999999998755322111
Q ss_pred ---eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcC-CCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 303 ---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 303 ---~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
......++..|+|||.+.+..++.++||||||+++|||++| ..||... . ..+...........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~---~~~~~~~~~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----D---SFDITVYLLQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----C---HHHHHHHHhcCCCC-----
Confidence 11123356789999999888899999999999999999995 5555321 1 11222222111100
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.. .......+.+++..||+.+|++||++.+|++.|++.
T Consensus 222 -~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -LQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 011235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=308.62 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.+|+..+.||+|++|.||+|... ++..||+|.+...... ....+..|+.+++.++|+|++++++++......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 57888899999999999999864 6889999998754433 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++... .+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998653 278899999999999999999999 99999999999999999999999999987643222
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+.. ...... +.
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~-~~~~~~------~~ 235 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYL-IATNGT------PE 235 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHH-HhcCCC------CC
Confidence 1 12234578899999999888889999999999999999999999953211 111111 111000 00
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ .........+.+++.+||..+|++||++.+|++
T Consensus 236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred C--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 011123356888999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.74 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=201.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..++||+|+||.||+|... +|+.||||+++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999875 689999999975432 223456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 219 PYMANGSVASCLRERPP-------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
||+++|+|.+++..... .....++..++.++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999874211 112367788899999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-----------------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccC
Q 012267 292 LAKLMDYKDT-----------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 354 (467)
Q Consensus 292 l~~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~ 354 (467)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 9986521110 011224589999999999999999999999999999999999999964110
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-KMSEVVRMLEG 420 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~ 420 (467)
... .+ . ....++... .........+.+++.+|++.||++|| +++++++.|+.
T Consensus 237 ---~ki-~~--~-------~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 237 ---RKI-SY--R-------DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred ---hhh-hh--h-------hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 00 0 000111000 00112235678899999999999995 67777777765
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=304.59 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=202.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.++|...+.||+|+||.||+|...+ ...||||...........+.+..|+.+++.++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3567788999999999999998643 246999998765544455678999999999999999999999875 55789
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++..... .+++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999976432 389999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
............++..|+|||.+....++.++||||||+++|||++ |..||.... ......+ .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~---~~~~~~~-- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----NNDVIGR---IENGERL-- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHH---HHcCCcC--
Confidence 4332222222334568999999988889999999999999999986 999995321 1111111 1111111
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
. . .......+.+++.+|+..+|.+|||+.++++.|++..
T Consensus 228 -~---~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -P---M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -C---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 1 1122356888999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=312.25 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=206.4
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC--------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeee
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFC 208 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 208 (467)
+....+|++.+.||+|+||.||+|... .+..||+|.++..........+..|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 444467888999999999999999742 12369999887554444456788999999999 799999999999
Q ss_pred eCCCceEEEeeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 209 MTPTERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 209 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
...+..+++|||+++|+|.+++..... ....++|..++.++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 999999999999999999999976421 123488999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccC
Q 012267 277 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 354 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~ 354 (467)
|++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---- 240 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---- 240 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC----
Confidence 999999999999999997654322111 111223567999999998889999999999999999998 88888431
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
...++.......... . . .......+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 241 ----~~~~~~~~~~~~~~~-~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 241 ----PVEELFKLLKEGHRM-D-----K----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----CHHHHHHHHHcCCCC-C-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 122222222111110 0 0 1122356889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.47 Aligned_cols=200 Identities=25% Similarity=0.341 Sum_probs=170.9
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+|+..++||+|+||+||+|+.. +++.||+|++..... ......+..|++++..++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999865 688999999865321 2223468889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997643 378888999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------CeeeecccccccccccccccCCCCCcchhHHHH
Q 012267 300 D----------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 333 (467)
Q Consensus 300 ~----------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~ 333 (467)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 001122468999999999999899999999999
Q ss_pred HHHHHHHHcCCCCccc
Q 012267 334 GIMLLELITGQRAFDL 349 (467)
Q Consensus 334 Gvil~elltg~~p~~~ 349 (467)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (382)
T cd05625 235 GVILYEMLVGQPPFLA 250 (382)
T ss_pred hHHHHHHHhCCCCCCC
Confidence 9999999999999963
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.74 Aligned_cols=264 Identities=26% Similarity=0.399 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 214 (467)
+.|+..+.||+|+||.||+|.+. ++..||||.++..........+..|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677789999999999999853 3679999999765443345579999999999999999999999877 5578
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999986542 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCee--eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC-------CccHHHHHH
Q 012267 295 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD-------DVMLLDWVK 365 (467)
Q Consensus 295 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 365 (467)
......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+......... ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765222211 11223456799999998888999999999999999999999998542211000 001111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
. ..... ...........+.+++.+||+.+|++||++.||+++|+.+
T Consensus 238 ~-~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 L-LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred H-HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 11100 0001112236788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=306.54 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=196.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCC------
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP------ 211 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------ 211 (467)
+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 5567888899999999999999865 68899999986542 3345688899999988 699999999998753
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 45789999999999999998643 22488999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||..... ...+..
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~~- 227 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL- 227 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHHH-
Confidence 9876532221 223345889999999986 33578899999999999999999999953211 111110
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... .+... .......+.+++.+||+.+|.+|||+.++++
T Consensus 228 -~~~~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 -IPRNP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HhcCC-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 11111 1112356889999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.43 Aligned_cols=252 Identities=29% Similarity=0.471 Sum_probs=197.3
Q ss_pred CeeeecCceEEEEEEECC-------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 148 NILGRGGFGKVYKGRLAD-------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+.||+|+||.||+|+..+ +..+|||.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999986554344456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-----cEEEeecCC
Q 012267 221 MANGSVASCLRERPPS---QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-----EAVVGDFGL 292 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgl 292 (467)
+++++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999754221 23478999999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 293 AKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 293 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
+......... ......++..|+|||++.+..++.++|||||||++|||+| |+.||.... .. +........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~~---~~~~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----NQ---EVLQHVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----HH---HHHHHHhcC
Confidence 8755322211 1122235678999999998899999999999999999998 999985321 11 111111111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
... .........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 230 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Ccc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 0111234678899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.76 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=191.7
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHH-HHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||.||+|+.. +|+.||+|++..... ......+..|.. ++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 688999999864322 122234555554 57889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 99998887542 378888999999999999999999 9999999999999999999999999998753222 122
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~------~~-- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHK-PL------QL-- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcC-CC------CC--
Confidence 334568999999999998889999999999999999999999995321 11222222111 00 01
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHhcCCC
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMS-EVVRMLEGDGL 423 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~~L~~~~~ 423 (467)
.......+.+++.+|++.+|.+||+.. ++.+.++...+
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 216 --PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred --CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 111235688999999999999999864 44444544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.68 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=191.2
Q ss_pred eeeecCceEEEEEEECCC---CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 149 ILGRGGFGKVYKGRLADG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
.||+|+||.||+|...++ ..+++|.++..........+.+|+..+..++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 35667776654444445679999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC-Ceee
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 304 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 304 (467)
|.+++..........++..+..++.||+.||+|||+. +++||||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986543333467778889999999999999998 99999999999999999999999999986432111 1112
Q ss_pred ecccccccccccccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 305 TAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 305 ~~~~g~~~y~aPE~~~~-------~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
....++..|+|||++.. ..++.++||||||+++|||++ |..||.... ..+........ .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~-~~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKD-QQVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhh-ccccc
Confidence 23457889999998743 245789999999999999997 566774211 11222222222 12223
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
.++.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33433322 2255777888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=321.69 Aligned_cols=192 Identities=23% Similarity=0.303 Sum_probs=165.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
..|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++......++|||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46888899999999999999976 578999996422 2356899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+. ++|.+++..... .++|..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 689888865422 489999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCc
Q 012267 301 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347 (467)
Q Consensus 301 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~ 347 (467)
. .......||..|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 1 1223456899999999999999999999999999999999988765
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.86 Aligned_cols=200 Identities=24% Similarity=0.339 Sum_probs=171.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+|+..+.||+|+||.||+|+.. +++.||||++..... ......+..|++++..++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888899999999999999865 689999999864321 1223457889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997643 378888899999999999999999 9999999999999999999999999997532100
Q ss_pred C------------------------------------------CeeeecccccccccccccccCCCCCcchhHHHHHHHH
Q 012267 300 D------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 337 (467)
Q Consensus 300 ~------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil 337 (467)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234689999999999998999999999999999
Q ss_pred HHHHcCCCCccc
Q 012267 338 LELITGQRAFDL 349 (467)
Q Consensus 338 ~elltg~~p~~~ 349 (467)
|||++|+.||..
T Consensus 235 yell~G~~Pf~~ 246 (376)
T cd05598 235 YEMLVGQPPFLA 246 (376)
T ss_pred eehhhCCCCCCC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=302.82 Aligned_cols=248 Identities=29% Similarity=0.408 Sum_probs=198.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee-CCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~ 220 (467)
++|...+.||+|+||.||++... |..||+|.++... ....+..|+.++++++|+|++++++++. ..+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 56888899999999999999875 7889999986432 2446889999999999999999999764 45678999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++..... ..+++..++.++.+++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999976432 2378999999999999999999999 99999999999999999999999999987543221
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
....++..|+|||++.+..++.++||||||+++|||++ |+.||... ...++........ .+
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~~~------~~ 218 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRVEKGY------KM 218 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcCC------CC
Confidence 12234568999999988889999999999999999997 99998531 1122222211110 01
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. .......+.+++.+|++.+|++|||+.++++.|++
T Consensus 219 ~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DA----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11 11223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=304.74 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=202.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||.|++|.||+|... +++.||+|.+...........+..|+++++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999865 68899999997654444455788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++... ++++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999999764 489999999999999999999999 99999999999999999999999999998765332
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......++..|+|||++.+..++.++||||||+++|+|+||+.||..... ........ .. ..+.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~-~~-----~~~~ 217 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLIP-KN-----NPPS 217 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHHhh-hc-----CCCC
Confidence 1 22234578899999999988899999999999999999999999963210 01111111 11 1111
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+... .....+.+++.+||..+|++||+++++++
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 02356888999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.14 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=199.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.|+..+.||+|+||.||+|... ++..||+|.+...........+..|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3455677999999999999865 678999999875544444557889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|.+++... .+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++..+.....
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999998643 378999999999999999999999 999999999999999999999999999876543221
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
......++..|+|||++.+..++.++||||||+++|||+||+.|+..... . .+... .... ..+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~---~~~~~-~~~~-----~~~~~ 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-----M---RVLFL-IPKN-----SPPTL 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-----h---hHHhh-hhcC-----CCCCC
Confidence 12223578899999999988899999999999999999999999853210 0 00100 0000 11111
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.......+.+++.+||+.+|.+||++.+|++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11234568899999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=311.47 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=210.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 215 (467)
....|++.+.||.|.||.||+++.+ +|+.+|+|.+.+..... ....+.+|+.+|.++. |||||.+.+.|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999976 59999999997655433 3467899999999998 999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC----CcEEEeecC
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFG 291 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg 291 (467)
+|||++.||.|.+.+... .+++.....++.|++.+++|||+. +|+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999876 189999999999999999999998 99999999999999543 479999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++..... .......+||+.|+|||++....++..+||||+||++|.|++|..||.... ...... .... .
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~----~~~~~~----~i~~-~ 253 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET----EFEIFL----AILR-G 253 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC----hhHHHH----HHHc-C
Confidence 9998754 556667889999999999999999999999999999999999999996422 111111 1111 1
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+..+.............+++..|+..||.+|+|+.++++
T Consensus 254 ------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 ------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 112223334445677889999999999999999999977
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=309.65 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=198.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...+.||+|+||.||+|+.. ++..||+|.++..........+..|+.++..++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999875 68899999997654444445678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
++ ++|.+++..... .+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 589988876432 378899999999999999999999 99999999999999999999999999987543222
Q ss_pred CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh-----------
Q 012267 301 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL----------- 368 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 368 (467)
. ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... ...........
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhh
Confidence 1 1222346889999998865 4578899999999999999999999964211 00111111100
Q ss_pred -hhcccccccCccccCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 369 -KEKKLEMLVDPDLQNN----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 369 -~~~~~~~~~d~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..........+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000111000 01112345788999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.66 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=199.2
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-----chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
+|...+.||+|+||.||+|...+|+.+|||.+...... .....+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778899999999999999888999999998654221 1224588899999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++.... ++++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997643 378899999999999999999999 99999999999999999999999999987643
Q ss_pred CCC-----CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 298 YKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 298 ~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
... ........++..|+|||++.+..++.++||||||+++|+|++|+.||..... ...... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~-~~~~~- 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFY-IGAHR- 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHHH-hhhcc-
Confidence 211 1122334588999999999988899999999999999999999999953210 111100 00000
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+.+.. .....+.+++.+||+.+|.+||++.++++
T Consensus 225 ---~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 ---GLMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111111 22356789999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=304.02 Aligned_cols=261 Identities=25% Similarity=0.315 Sum_probs=202.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 219 (467)
+|+..+.||.|++|.||++... +++.+|+|.+...........+.+|++++++++|+||++++++|... ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777889999999999999975 68899999987654444456789999999999999999999998653 46799999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999998765333334588899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...............+... ... ....+.
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~ 231 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPN-PELKDE 231 (287)
T ss_pred c---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCc-hhhccC
Confidence 1 123446889999999998899999999999999999999999997532211111222222211 110 000000
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ........+.+++.+||+.+|.+|||+.||++
T Consensus 232 -~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 -PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 01123467889999999999999999998855
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=314.56 Aligned_cols=198 Identities=24% Similarity=0.292 Sum_probs=167.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-----
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 212 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 212 (467)
..++|+..+.||+|+||.||++... +|..||||++..... ......+.+|+.++..++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999865 689999999965432 223446789999999999999999999986443
Q ss_pred -ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 213 -ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 213 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999975 67666643 278888999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
+++.... ........||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 169 ~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 169 LARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred Ccccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9975432 1222334688999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.52 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=189.8
Q ss_pred eeeecCceEEEEEEECC---CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 149 ILGRGGFGKVYKGRLAD---GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
.||+|+||+||+|...+ ...+++|.+...........+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 457888887655444445578899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee-
Q 012267 226 VASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV- 303 (467)
Q Consensus 226 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 303 (467)
|.+++...... ....++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765422 22356788899999999999999999 99999999999999999999999999986533221111
Q ss_pred eecccccccccccccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 304 TTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~-------~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.... . .+......... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~---~~~~~~~~~~~-~~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-----D---EQVLKQVVREQ-DIK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-----H---HHHHHHHhhcc-Ccc
Confidence 122335678999998642 356889999999999999999 788885311 1 01111111111 111
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
..++.+. ......+.+++..|| .||++|||+++|++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1122221 122355667788888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=320.57 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=203.0
Q ss_pred CCCCeeeecCceEEEEEEEC--CC--CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 145 SNKNILGRGGFGKVYKGRLA--DG--SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
...++||+|.||.|++|.|. +| ..||||.++.........+|++|+.+|.+++|+|++++||+..+ ....||||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 33478999999999999875 34 36999999876655456689999999999999999999999877 678899999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
++.|+|.+.|++. ....+-......++.|||.||+||.++ ++|||||..+|+||-....+||+||||.+.+...+
T Consensus 192 aplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999982 233477788999999999999999999 99999999999999999999999999999887554
Q ss_pred Ceeeec--ccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 301 THVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 301 ~~~~~~--~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
...... ..-.+.|.|||.+....++.+||||+|||+||||+| |..||-.- .-.+.++. +
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--------~g~qIL~~----------i 328 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--------RGIQILKN----------I 328 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--------CHHHHHHh----------c
Confidence 443221 223568999999999999999999999999999998 77787431 11122221 2
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 418 (467)
|..-.-.....+.++++++++.||..+|.+|||+..|.+.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22222223556779999999999999999999999997443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=304.80 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=202.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.+|...+.||+|+||+||+|... +|. .||+|.+...........+.+|+.++.+++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56777899999999999999864 333 6899988766554455678899999999999999999999987 78899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999986532 389999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCeee-ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
........ ....++..|+|||.+....++.++||||||+++||+++ |+.||+... ..++........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~--- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGE--- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCC---
Confidence 53322211 11223568999999988889999999999999999999 999996421 112222111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
....+. .....+.+++.+||..+|.+||++.++++.|++.
T Consensus 229 ~~~~~~-------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 RLPQPP-------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCCCCC-------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001111 1224688899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=313.08 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=192.5
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHH-HHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||+||+|+.. +|+.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 789999999865321 122234555554 46779999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 99999887543 388999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~---~~~~~---- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKP---LVLRP---- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCC---ccCCC----
Confidence 234568999999999999999999999999999999999999995321 111222221110 01111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH-HhcCCC
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM-LEGDGL 423 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~-L~~~~~ 423 (467)
.....+.+++.+|++.+|.+||++++.++. ++...+
T Consensus 218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 218 ----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred ----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 122557789999999999999999754444 344333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=299.40 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||+|++|.||+|... ++..|++|.++.... ..++.+|++++++++|+|++++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 57888899999999999999976 478999999865422 55799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999987543 2489999999999999999999999 99999999999999999999999999988654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||....... .. .... . ...+.
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~-~~~~-~-----~~~~~ 218 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AI-FMIP-N-----KPPPT 218 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hh-hhhc-c-----CCCCC
Confidence 1 2223447889999999988889999999999999999999999996421100 00 0000 0 00011
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ .........+.+++.+||+.+|++|||+.||++
T Consensus 219 ~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 L--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1 011123356889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=302.79 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCceEEEEEEECC--CCEEEEEEeccCC---------CcchHHHHHHHHHHHHh-cCCCeeeeeeeeeeC
Q 012267 143 SFSNKNILGRGGFGKVYKGRLAD--GSLVAVKRLKEER---------TPGGELQFQTEVEMISM-AVHRNLLRLRGFCMT 210 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~--g~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 210 (467)
+|+..+.||+|+||.||+|.... +..+|+|.+.... .......+..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 7889999885321 11223356778887764 799999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988653333345899999999999999999999631 7999999999999999999999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...........
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~~ 228 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVEA 228 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhhc
Confidence 9998654332 2334558889999999998889999999999999999999999985321 11111111111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
... +.. .......+.+++.+||+.||++||++.||..++++
T Consensus 229 -~~~----~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 -VYE----PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -cCC----cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111 100 01123568899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=312.82 Aligned_cols=245 Identities=25% Similarity=0.306 Sum_probs=189.9
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHH-HHHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEV-EMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
+.||+|+||+||+|+.. +++.||+|++..... ......+..|. .++..++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 678899999865321 11222344444 356788999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+.+..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence 99999997643 277788889999999999999999 9999999999999999999999999998753222 222
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .. ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~--~~~~---- 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNK-PL--QLKP---- 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhC-Cc--CCCC----
Confidence 334568999999999999999999999999999999999999995321 11222222111 00 0111
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
.....+.+++.+|++.+|.+||++.+.+..+.
T Consensus 218 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 218 ----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred ----CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 12356788999999999999999876554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=310.17 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++|+..+.||+|+||.||+|.+. +|. .||+|.+...........+.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56777889999999999999864 444 57999887654444445788999999999999999999998754 4679
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
++||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+|+||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999876432 378999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... .....+++. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~---~~~~~- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLE---KGERL- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH---CCCCC-
Confidence 432221 1122335678999999988889999999999999999997 899985321 111222211 11100
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..+ ..+...+.+++..||..+|++||++.++++.|+..
T Consensus 231 --~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 --PQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001 11235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=310.03 Aligned_cols=202 Identities=23% Similarity=0.341 Sum_probs=171.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|+||+||+++.. +++.||+|++.... .......+..|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999999999999975 68999999986421 1122345788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999976322 388899999999999999999999 999999999999999999999999999876543
Q ss_pred CCCeeeecccccccccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 33222233458999999999863 4578899999999999999999999953
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=337.31 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=199.0
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCc
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTE 213 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~ 213 (467)
+...++|.+.+.||+|+||+||+|... ++..||+|.+...... .....+..|+.++..++||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999975 6788999998754322 234568899999999999999999998854 356
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCcccCCCCCCcEEECCC-------
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD----PKIIHRDVKAANILLDEE------- 282 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~----~~ivH~dlk~~Nill~~~------- 282 (467)
.+|||||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+|+||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997643333458999999999999999999998521 259999999999999642
Q ss_pred ----------CcEEEeecCCccccCCCCCeeeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCcccc
Q 012267 283 ----------FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLA 350 (467)
Q Consensus 283 ----------~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~~ 350 (467)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998654221 2234468999999999854 45789999999999999999999999531
Q ss_pred cccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 351 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
. ....++...... +.+. .......+.+++..||+.+|.+||++.|++
T Consensus 247 ~-------~~~qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 247 N-------NFSQLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred C-------cHHHHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 1 122222221111 1110 011235688999999999999999999998
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=306.03 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=204.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||+|+||+||++... +|..||+|++...........+..|++++..++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777789999999999999865 68899999987654444556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... ++++..+..++.+++.||.|||+.. +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999987643 3899999999999999999999732 79999999999999999999999999986542211
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCC---CCccHHHHHHHHhhhccccccc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND---DDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.....|+..|+|||++.+..++.++|||||||++|+|+||+.||........ ....+.++........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 1234588999999999888899999999999999999999999964321110 1111222222222111
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 418 (467)
.+.+. .......+.+++.+|++.||.+|||+.||++..
T Consensus 230 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111 112345688999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=308.71 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=191.7
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEe
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 218 (467)
+|+..+.||+|+||+||+|... +|+.||+|+++.... ......+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677789999999999999865 689999999875321 222345778888888775 577888999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999987643 389999999999999999999999 999999999999999999999999999875332
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. ........||..|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~-~~----- 218 (323)
T cd05615 154 D-GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--------EDELFQSIMEH-NV----- 218 (323)
T ss_pred C-CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CC-----
Confidence 2 222334568999999999998889999999999999999999999996421 11112221111 10
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
.. .......+.+++.+|++.+|.+|++.
T Consensus 219 -~~----p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SY----PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CC----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01 11123567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=303.43 Aligned_cols=253 Identities=29% Similarity=0.439 Sum_probs=198.5
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHH-HHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
|+..+.||+|+||+||+++.. +++.||+|++.......... ....|+.++.+++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 455688999999999999976 56689999997654333322 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|.+++.... .+++..++.++.|+++||.|||+. +++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998322 389999999999999999999999 99999999999999999999999999987542 223
Q ss_pred eeeeccccccccccccccc-CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 302 HVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......++..|+|||++. +..++.++||||+|+++|+|++|..||... ................... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~~~~~----~- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----NSDDQLEIIEKILKRPLPS----S- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----SHHHHHHHHHHHHHTHHHH----H-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----cchhhhhhhhhcccccccc----c-
Confidence 3444566899999999998 788999999999999999999999999642 0011111111111100000 0
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ........+.+++..||+.+|++||++.++++
T Consensus 223 ~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 SQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00001267999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=303.89 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=196.1
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|++|.||+|+.. ++..||+|.++..... .....+..|+.++..++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999975 6899999998654322 2234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
++ ++|.+++..... ...+++..++.++.|+++||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 689888876432 23489999999999999999999999 99999999999999999999999999987654322
Q ss_pred CeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh----------
Q 012267 301 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 369 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 369 (467)
.......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||...... ............
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhcch
Confidence 112223468899999988654 5789999999999999999999999632110 000000000000
Q ss_pred -hccccccc----CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 -EKKLEMLV----DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 -~~~~~~~~----d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
........ ...+ .........++.+++.+||+.||.+|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0000 0001112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.92 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=202.1
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
+.++.+..+.++|+..+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++..+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 344556667889999999999999999999865 68899999886432 2234678899999998 6999999999874
Q ss_pred -----CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 210 -----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 210 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
..+..++||||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 34568999999999999998875433334588999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCeeeecccccccccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCcc
Q 012267 285 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~ 359 (467)
++|+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~------- 234 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP------- 234 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-------
Confidence 99999999876542221 2223458899999998753 4478899999999999999999999853211
Q ss_pred HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 360 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
...+. .... .......++. .....+.+++.+||+.+|++|||+.||++.
T Consensus 235 ~~~~~-~~~~-~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 235 MRALF-KIPR-NPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hHHHh-hccc-cCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00110 0000 0000111111 122468899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=293.97 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=197.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccC-CCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-----CCc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEE-RTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~ 213 (467)
...|...+.||+|+||.|+.+... +|+.||||++... ......+...+|+++|+.++|+||+.+++++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666788999999999999865 7999999998633 233344567899999999999999999998865 356
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.|+|+|+| .-+|...++.+.. ++......++.|+++||.|+|+- +|+||||||+|+|++.+..+||+|||+|
T Consensus 101 vYiV~elM-etDL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 79999999 4599999987643 78888899999999999999999 9999999999999999999999999999
Q ss_pred cccCCC-CCeeeeccccccccccccccc-CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh--
Q 012267 294 KLMDYK-DTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-- 369 (467)
Q Consensus 294 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 369 (467)
+..... .....+.+..|..|.|||++. ...|+.+.||||.|||+.||++|++.|.+.... +..+.+...+.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-----~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-----HQLQLILELLGTP 247 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-----HHHHHHHHhcCCC
Confidence 987532 223345566799999999874 567999999999999999999999999542211 11111111110
Q ss_pred -hccccccc----------CccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 -EKKLEMLV----------DPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 -~~~~~~~~----------d~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+..+..+- -|...... .+......++++.+||..||.+|+|++|.++
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000 00000000 0112245678899999999999999998854
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.36 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=196.7
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.|+..++||+|+||.||++... +++.||||.+....... ....+..|+.++.+++|+|++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999875 68899999986543222 23357789999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999999865432 2388999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .. ...-........ . .
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~----~~-~~~~~~~~~~~~--~----~ 222 (285)
T cd05630 156 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KI-KREEVERLVKEV--Q----E 222 (285)
T ss_pred c--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc----cc-hHHHHHhhhhhh--h----h
Confidence 2 12234689999999999988899999999999999999999999964211 00 001111111100 0 0
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVV 415 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl 415 (467)
.. .......+.+++..||+.||++||| +.|++
T Consensus 223 ~~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~ 259 (285)
T cd05630 223 EY----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK 259 (285)
T ss_pred hc----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH
Confidence 01 1112355789999999999999999 66764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=300.68 Aligned_cols=247 Identities=25% Similarity=0.329 Sum_probs=193.9
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
|+..++||+|+||+||+|... +++.||+|.+...... .....+..|++++..++|+|++++.+.+...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566688999999999999875 6889999998654322 2233577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998875432 2489999999999999999999999 99999999999999999999999999987643221
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ......+.... ... ...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~~~~-~~~--~~~---- 223 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVDRRV-LET--EEV---- 223 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhh-hcc--ccc----
Confidence 12334589999999999888899999999999999999999999963211 00011111111 110 000
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 412 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 412 (467)
........+.+++..|++.+|++||++.
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 224 ----YSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ----cCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 1112235678899999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=304.94 Aligned_cols=262 Identities=25% Similarity=0.306 Sum_probs=191.8
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhc---CCCeeeeeeeeeeC-----CC
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT-----PT 212 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 212 (467)
+|+..+.||+|+||+||+|+.. +|+.||+|.++...... ....+..|++++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999875 68999999987543222 223455677766655 79999999998864 24
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999975 89888876432 2389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh---
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 369 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 369 (467)
+....... ......++..|+|||++.+..++.++|||||||++|+|++|++||..... ...+.........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFDLIGLPPE 228 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHHHHhCCCCh
Confidence 98654221 22234578999999999888899999999999999999999999953211 1111111110000
Q ss_pred hcccc------cccCccc---cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 EKKLE------MLVDPDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ~~~~~------~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... ....+.. ...........+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0000000 00011123356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=315.65 Aligned_cols=260 Identities=19% Similarity=0.288 Sum_probs=197.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|+||+||++... +++.||+|+++... .......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999875 68999999996432 1222346788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997643 388899999999999999999999 999999999999999999999999999875421
Q ss_pred CCC----------------------------------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCC
Q 012267 299 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344 (467)
Q Consensus 299 ~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~ 344 (467)
... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0012346899999999999999999999999999999999999
Q ss_pred CCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 345 RAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 345 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
.||.... ............. ...+.+.. .....+.+++.+|+ .+|.+|++...+-+.++...+.
T Consensus 234 ~Pf~~~~--------~~~~~~~i~~~~~-~~~~p~~~------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 297 (360)
T cd05627 234 PPFCSET--------PQETYRKVMNWKE-TLVFPPEV------PISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE 297 (360)
T ss_pred CCCCCCC--------HHHHHHHHHcCCC-ceecCCCC------CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence 9995321 1111111111000 00011110 11244666666665 4999999755555556665543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=310.32 Aligned_cols=193 Identities=25% Similarity=0.389 Sum_probs=165.0
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
....+|+..+.||+|+||.||+|+.. ++..||+|..... ....|+.++.+++|+||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34567999999999999999999975 5788999975432 234689999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+. ++|.+++.... .++++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 68988886542 2489999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~ 347 (467)
.. .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 1223356899999999999989999999999999999999865554
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.30 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.+|+..+.||+|++|.||+|.. .+++.||+|.+..... .....+..|+.+++.++|+|++++++++...+..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 6788899999999999999986 4789999999865433 2345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++... .+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998653 278899999999999999999999 99999999999999999999999999987654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .. . ....... .+.
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~---~~-~----~~~~~~~------~~~ 234 (297)
T cd06656 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RA-L----YLIATNG------TPE 234 (297)
T ss_pred c-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc---hh-e----eeeccCC------CCC
Confidence 1 122345788999999999888999999999999999999999999542110 00 0 0000000 000
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .........+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 L--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011122355788999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=301.05 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=199.0
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.+|+..+.||.|++|.||+|.. .+|+.|++|.+..... .....+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4688889999999999999986 4789999999865433 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++... .+++..+..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999998653 288999999999999999999999 99999999999999999999999999987654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... . ......... .......
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~-~~~~~~~~~-~~~~~~~-- 237 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------L-RALYLIATN-GTPELQN-- 237 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------H-HHHHHHHhc-CCcccCC--
Confidence 2 12234578899999999988899999999999999999999999964211 0 111111110 0000001
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
.......+.+++.+||..+|.+||++.+|+
T Consensus 238 -----~~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 238 -----PEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred -----cccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 112234677899999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.48 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=198.4
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++.+++.+.....||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3455666777789999999999999865 67889999986543 233457889999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecCCcc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAK 294 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~ 294 (467)
+|+||+++++|.+++...... ...++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999999864221 1127888899999999999999999 9999999999999976 6799999999987
Q ss_pred ccCCCCCeeeecccccccccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
....... ......++..|+|||++.... ++.++||||||+++|+|++|+.||..... .....+......
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--- 228 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAMFKVGMFK--- 228 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhHhhhhhhc---
Confidence 6532221 122335788999999986543 78899999999999999999999853110 001111110000
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+.+ .......+.+++.+||+.+|.+|||+.++++
T Consensus 229 ----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ----IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01111 1223356888999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=294.89 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=203.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..++||.|+||.||.++.. ++..+++|.+.... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999999854 68899999986543 233445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999998653 23488999999999999999999998 99999999999999999999999999998654333
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......++..|+|||.+.+..++.++||||||+++|||++|..||.... ..+.+...... ... +
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~-~~~----~- 220 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQG-NYT----P- 220 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcC-CCC----C-
Confidence 2 2233458899999999988888999999999999999999999995321 11222222111 111 0
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
........+.+++.+||+.+|.+||++.++++.
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 011223568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=307.40 Aligned_cols=199 Identities=23% Similarity=0.303 Sum_probs=164.7
Q ss_pred CCCeeeec--CceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 146 NKNILGRG--GFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 146 ~~~~lg~G--~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+.++||+| +|++||++... +|+.||+|++....... ....+..|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 78999999865 78999999997654332 2345778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++|+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999754322 388999999999999999999999 999999999999999999999999986543321111
Q ss_pred e------eeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 302 H------VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 302 ~------~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112236678999999875 4588999999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.95 Aligned_cols=263 Identities=26% Similarity=0.336 Sum_probs=202.2
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
+.+.++..++++|...+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++.++ +|+|++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 344555667889999999999999999999874 68899999986432 2234677889999888 7999999999987
Q ss_pred CC-----CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 210 TP-----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 210 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
.. ...++||||+++++|.++++........+++..++.++.|++.||+|||+. +++|+||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 53 357999999999999999875433334589999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCeeeecccccccccccccccCC-----CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCcc
Q 012267 285 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~ 359 (467)
+||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||..... ...
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~----~~~ 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP----VKT 241 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH----HHH
Confidence 99999999876542221 12234578899999987543 368899999999999999999999953210 000
Q ss_pred HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 360 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ ..... .....+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 242 ~----~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 L----FKIPR-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H----HHHhc-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11111 11111111 1123356889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=298.64 Aligned_cols=257 Identities=23% Similarity=0.262 Sum_probs=201.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch--HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+.|+..+.||+|.-|+||+++.. ++..+|+|++.+...... ....+.|-++|+.++||.+..+|+.+..+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45566778999999999999987 468999999976543322 235778999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
|||+||+|..+++.+..+. +++..+.-++..|+-||+|||.. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~--fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKR--FSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCCCc--cchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999876543 88889999999999999999999 999999999999999999999999998654311
Q ss_pred C----------------------------------C---------------------CeeeecccccccccccccccCCC
Q 012267 299 K----------------------------------D---------------------THVTTAVRGTIGHIAPEYLSTGK 323 (467)
Q Consensus 299 ~----------------------------------~---------------------~~~~~~~~g~~~y~aPE~~~~~~ 323 (467)
. . ...+..++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 01122346899999999999999
Q ss_pred CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCC
Q 012267 324 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQG 403 (467)
Q Consensus 324 ~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~ 403 (467)
.+.++|+|+|||+||||+.|+.||... .....+...+. ..+.-.........+.+||...|.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~----~~~~Tl~NIv~-------------~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGS----NNKETLRNIVG-------------QPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCC----CchhhHHHHhc-------------CCCcCCCCCcchhHHHHHHHHHhcc
Confidence 999999999999999999999999642 22222222221 1111111224456788999999999
Q ss_pred CCCCCCCHHHHHHHHhc
Q 012267 404 SPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 404 ~p~~RPs~~evl~~L~~ 420 (467)
||.+|....-=...+++
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 99999983333333343
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=299.52 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=197.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.+.|++.+.||+|+||.||+|+.. ++..|++|.+... .......+..|+.+++.++|+|++++++.+......++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 367888899999999999999975 5889999998654 23344568889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|..++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999988765322 389999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
. .......++..|+|||++. ...++.++|||||||++|||++|+.||.... ............
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~--- 231 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSE--- 231 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--------HHHHHHHHhcCC---
Confidence 1 1122344788999999884 3456889999999999999999999985321 011111111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+... ........+.+++.+||+.+|++||++.++++
T Consensus 232 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 ---PPTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01110 01122356888999999999999999998854
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.42 Aligned_cols=265 Identities=21% Similarity=0.231 Sum_probs=195.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 211 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 211 (467)
..++|...+.||+|+||.||++... .++.||||++...... .....+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999864 6889999999754322 2334677899999999999999999988643
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
...++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999965 67776653 278889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCC----------CCcc--
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND----------DDVM-- 359 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~----------~~~~-- 359 (467)
+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||........ ....
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99864322 222345689999999999988999999999999999999999999964221000 0000
Q ss_pred --HHHHHHHHhhh-cccccccCcccc--------CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 360 --LLDWVKGLLKE-KKLEMLVDPDLQ--------NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 360 --~~~~~~~~~~~-~~~~~~~d~~~~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+...+...... ........+... ..........+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00000000000 000000001000 0001112356789999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.45 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=195.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHH-HHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..+.||+|+||.||++... +|..||+|+++..........+..|+.. ++..+|+|++++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999975 6999999999765443344456666665 566789999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|++ |+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6898888764333456899999999999999999999853 7999999999999999999999999998765321
Q ss_pred CCeeeecccccccccccccccC----CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.... . .. +........
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~--~~-~~~~~~~~~----- 223 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK----T--PF-QQLKQVVEE----- 223 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc----c--CH-HHHHHHHhc-----
Confidence 11222457889999998864 456889999999999999999999995311 0 01 111111111
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+.+. .......+.+++.+||+.+|.+||++.+|++
T Consensus 224 -~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111 1112356889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.30 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=195.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC---CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
..+|.+.+.||+|+||.||++... .+..||+|.+.... ...+|+++++.++|+||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 457999999999999999999753 35789999885432 346899999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
||++. ++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 6888888433 2389999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc---
Q 012267 298 YKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL--- 373 (467)
Q Consensus 298 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 373 (467)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+...++.. .....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~-~~~~~~~~ 314 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCM-QVHPLEFP 314 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHh-ccCccccC
Confidence 3322 12234568999999999999999999999999999999999999995432111 011111111100 00000
Q ss_pred --------------ccccCcccc-Ccc--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 374 --------------EMLVDPDLQ-NNY--VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 374 --------------~~~~d~~~~-~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.....+... ... .......+.+++.+|+..+|++|||+.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000 00112457788999999999999999999653
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=295.85 Aligned_cols=249 Identities=24% Similarity=0.428 Sum_probs=197.6
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch--------HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG--------ELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
+|.....||+|++|.||+|... ++..||+|.+........ .+.+..|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677789999999999999864 688999998865432211 2357889999999999999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997643 378889999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCC-----eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh
Q 012267 294 KLMDYKDT-----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 294 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
+....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... . . .-+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~--~-~~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-----Q--L-QAIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-----H--H-HHHHHHh
Confidence 86642111 11122347889999999988889999999999999999999999996321 0 0 1011100
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ...+.+. ......+.+++.+||+.+|.+||++.+|++
T Consensus 226 ~------~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E------NASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c------cCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 1111111 122366888999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.80 Aligned_cols=202 Identities=23% Similarity=0.325 Sum_probs=171.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..++||+|+||.||+++.. +++.||+|++.... .......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999976 57889999986422 1122334788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976322 388899999999999999999999 999999999999999999999999999876543
Q ss_pred CCCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 3332333456899999999986 34678999999999999999999999953
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.85 Aligned_cols=252 Identities=32% Similarity=0.507 Sum_probs=201.6
Q ss_pred CCCCCeeeecCceEEEEEEECC-----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 144 FSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
|++.+.||.|+||.||++...+ +..||+|.++..........+..|+..+..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998753 38899999976654445668999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999764321 179999999999999999999999 999999999999999999999999999986653
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
..........++..|+|||.+.+..++.++||||+|+++++|++ |+.||... ............... .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~~---~ 224 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVLEYLKKGYRL---P 224 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcCCCC---C
Confidence 32222212336789999999988889999999999999999998 78888531 111122211111110 0
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 418 (467)
. .......+.+++.+|+..+|++|||+.++++.|
T Consensus 225 ~-------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 K-------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C-------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 111346688899999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=310.22 Aligned_cols=202 Identities=23% Similarity=0.327 Sum_probs=172.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||.||+++.. +++.||+|.+.... .......+..|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 68899999986422 1122335788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976422 378889999999999999999999 999999999999999999999999999986644
Q ss_pred CCCeeeecccccccccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
..........|++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 33333334568999999999865 4678899999999999999999999953
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=298.79 Aligned_cols=239 Identities=25% Similarity=0.368 Sum_probs=184.4
Q ss_pred eeeecCceEEEEEEECC-------------------------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeee
Q 012267 149 ILGRGGFGKVYKGRLAD-------------------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 203 (467)
.||+|+||.||+|.... ...|++|++..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999997421 13589998864322 22346788899999999999999
Q ss_pred eeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC
Q 012267 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 283 (467)
Q Consensus 204 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~ 283 (467)
++++|......++||||+++|+|..++..... .+++..+..++.|+++||+|||+. +|+||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 99999999999999999999999999875322 378899999999999999999999 999999999999997643
Q ss_pred -------cEEEeecCCccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHH-HcCCCCcccccccC
Q 012267 284 -------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLEL-ITGQRAFDLARLAN 354 (467)
Q Consensus 284 -------~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el-ltg~~p~~~~~~~~ 354 (467)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 3799999987643221 12246788999998865 5679999999999999998 579999853211
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
.....+.. .. ..+.. .....+.+++.+||+.+|++||++.+|++.|.
T Consensus 228 ---~~~~~~~~----~~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ---SEKERFYE----KK-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHHHH----hc-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111111 00 00000 11245889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=295.67 Aligned_cols=238 Identities=25% Similarity=0.387 Sum_probs=188.6
Q ss_pred CeeeecCceEEEEEEECC-C----------CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 148 NILGRGGFGKVYKGRLAD-G----------SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 468999999999999764 3 25788877644322 5578899999999999999999999988 77899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-------cEEEee
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-------EAVVGD 289 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-------~~kl~D 289 (467)
||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999987542 488999999999999999999998 999999999999999887 799999
Q ss_pred cCCccccCCCCCeeeecccccccccccccccCC--CCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHH
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||.... . ..+...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-----~---~~~~~~ 218 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-----S---SEKERF 218 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-----c---hhHHHH
Confidence 999886543 1223466789999998776 78999999999999999999 577775321 0 011111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
..... ....+ ....+.+++.+||..+|.+|||+.+|++.|+
T Consensus 219 ~~~~~---~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQH---RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCC---CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11000 00000 0167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=296.27 Aligned_cols=254 Identities=26% Similarity=0.344 Sum_probs=201.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||.|++|.||+|... ++..+++|.+...... ....+..|+++++.++||||+++++++......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 357888899999999999999875 6789999999754332 45578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.... ..+++..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999987642 2388999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCeeeecccccccccccccccCC---CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
. .......++..|+|||.+.+. .++.++||||||+++|||+||+.||..... .... .... ... .
T Consensus 155 ~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~----~~~~----~~~~-~~~---~ 221 (262)
T cd06613 155 I-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----MRAL----FLIS-KSN---F 221 (262)
T ss_pred h-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHH----HHHH-hcc---C
Confidence 1 122334578899999998776 789999999999999999999999953210 0000 0000 000 0
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+.+ .........+.+++.+||+.+|.+|||+.+|+.
T Consensus 222 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01111 112234467889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.84 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=203.6
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+|+..+.||+|++|.||++... +++.||+|++...........+.+|++++++++||||+++++++...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999976 689999999976655555567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
++++|.+++.... .++++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999998653 348889999999999999999999 7 99999999999999999999999999987553221
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.+........ +.
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~------~~ 223 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNEPP------PR 223 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcCCC------CC
Confidence 11 15578899999999988999999999999999999999999954211 11122222222221110 11
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+. .......+.+++.+||..+|++|||+.+++.
T Consensus 224 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11 1113456889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=296.12 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=199.2
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-CCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 219 (467)
+|+..+.||+|++|.||++... +++.||+|.+..... ......+..|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999865 578999999865433 2234468889999999999999999998764 445789999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.... ..++++.+++.++.+++.|++|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997642 22489999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. .......+++.|+|||++.+..++.++||||||+++++|++|+.||.... ...+...... ... +
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~-~~~-----~ 220 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIE-GKL-----P 220 (257)
T ss_pred C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh-cCC-----C
Confidence 2 22233457889999999998889999999999999999999999985321 1122222111 111 1
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+ .......+.+++.+|++.+|.+||++.++++
T Consensus 221 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PM----PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CC----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11 1223366889999999999999999999965
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=297.40 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=200.9
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCceEEEe
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVY 218 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 218 (467)
+|+..+.||.|+||.||++... +|..||+|.++.... ......+..|+++++.++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999864 688999999875433 2334468889999999999999999998764 34578999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||+++++|.+++........++++..++.++.+++.||.|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765433445899999999999999999999221 229999999999999999999999999999876
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...+.... .....
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~--- 227 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKI-KEGKF--- 227 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHH-hcCCC---
Confidence 53322 1233458899999999998889999999999999999999999996421 11111111 11111
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.+ .......+.+++.+|++.+|.+||++.+|++
T Consensus 228 --~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 --RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred --CCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111 1223467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.73 Aligned_cols=247 Identities=29% Similarity=0.465 Sum_probs=197.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
++|+..+.||+|+||.||++.. +++.||+|.++... ....+..|+.++.+++|+|++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4578889999999999999975 57889999986532 234688999999999999999999998654 579999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 99999999976532 2378999999999999999999998 9999999999999999999999999998754321
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..++......... .++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~----~~~- 218 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVKECVEKGYR----MEP- 218 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHHHHHhCCCC----CCC-
Confidence 111223567999999988889999999999999999998 999985321 1122111111100 010
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.......+.+++.+||+.+|.+||++.+|++.|++
T Consensus 219 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11223668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=300.67 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=198.7
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+|+..+.||+|+||.||++... +|..||+|.++..........+.+|++++.+++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999976 789999999876544444457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|..++..... ...+++..+..++.+++.||.|||+.+ +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 82 DAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred CCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999998876421 224899999999999999999999632 8999999999999999999999999998754322
Q ss_pred eeeecccccccccccccccCCC------CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~------~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||.... ......-....... .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~-~--- 226 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-----YANIFAQLSAIVDG-D--- 226 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-----hhhHHHHHHHHhhc-C---
Confidence 122334788999999985543 4889999999999999999999995321 11111111111100 0
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 227 --~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 --PPTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --CCCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0111 1224466889999999999999999998865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=301.35 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=200.6
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
.++.++..+.+.|+..+.||.|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 355666667789999999999999999999974 68899999985432 2334678889999888 6999999999985
Q ss_pred C------CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC
Q 012267 210 T------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 283 (467)
Q Consensus 210 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~ 283 (467)
. ....+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 3 4567999999999999999976432 2378888999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCc
Q 012267 284 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 358 (467)
Q Consensus 284 ~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~ 358 (467)
.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||......
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----- 232 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----- 232 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-----
Confidence 999999999875532211 122345788999999875 345788999999999999999999999532110
Q ss_pred cHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 359 MLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ..... ....+... .......+.+++.+||+.+|.+||++.|+++
T Consensus 233 --~~-~~~~~------~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 --RA-LFLIP------RNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hh-hhhHh------hCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 00000 00011111 1123357899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.82 Aligned_cols=246 Identities=26% Similarity=0.431 Sum_probs=197.3
Q ss_pred CCCCeeeecCceEEEEEEEC-CCCEEEEEEecc---CCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc--eEEEe
Q 012267 145 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKE---ERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--RLLVY 218 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~---~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~ 218 (467)
+...+||+|+|-+||+|.+. +|..||--.++. ...+.....|..|+.+|+.|+|+||++++.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999875 687888555442 2334444679999999999999999999999987665 67899
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEeecCCccccC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMD 297 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~ 297 (467)
|.+..|+|..|+++... ++.+.+..|+.||++||.|||++ .|+|+|||||.+||||+.+ |.|||+|.|||..+.
T Consensus 123 EL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999998764 78889999999999999999996 7899999999999999765 899999999999865
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
... .....|||.|||||++. ..|++..||||||+.++||+|+..||.. ......+.+-|..-.+...+..+-
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHHHHHHcCCCHHHhhccC
Confidence 332 22367999999999986 7899999999999999999999999942 112222333333333333344444
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
|| ++.++|..|+.. .++|||+.|+|.
T Consensus 270 dP------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 DP------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 44 477899999999 999999999964
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=298.37 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=199.9
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
-|+..+.||+|+||.||+|... ++..||+|.+...........+.+|++.+.+++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999864 688999999865444444557889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|.+++... .+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998653 378999999999999999999999 999999999999999999999999999876543221
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
......++..|+|||.+.+..++.++|||||||++|+|++|..||.... ...+....... . .+.+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~-~-----~~~~ 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFLIPKN-N-----PPTL 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHHHhcC-C-----CCCC
Confidence 1223457889999999988888999999999999999999999985311 11111111110 0 0111
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223568889999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=295.36 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||.|++|+||+|... ++..+|+|++...........+.+|++.++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888899999999999999864 68899999997655444556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 12489999999999999999999999 99999999999999999999999999987665332
Q ss_pred Ce---eeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 301 TH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 301 ~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.. ......|+..|+|||++... .++.++|||||||++|+|++|+.||..... .....+. ....
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~----~~~~----- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP----MKVLMLT----LQND----- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh----hhhHHHH----hcCC-----
Confidence 22 12334578899999998776 789999999999999999999999963211 0111111 1110
Q ss_pred cCccccCcc-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNY-VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+.... .......+.+++..||+.+|++||++.+|++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111100 1233466889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=310.52 Aligned_cols=197 Identities=23% Similarity=0.290 Sum_probs=167.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------C
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 212 (467)
.++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999865 688999999975432 22344678899999999999999999987543 3
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 56999999965 77777753 278889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
++..... .......++..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 9865322 222334689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.05 Aligned_cols=240 Identities=25% Similarity=0.373 Sum_probs=186.3
Q ss_pred CeeeecCceEEEEEEECC-------------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 148 NILGRGGFGKVYKGRLAD-------------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
+.||+|+||.||+|...+ ...|++|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999998532 2358999876532 22344688899999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc-------EEE
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-------AVV 287 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------~kl 287 (467)
++||||+++|+|..++.... .++++..++.++.||++||+|||+. +|+||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999999887542 2388999999999999999999999 9999999999999987664 899
Q ss_pred eecCCccccCCCCCeeeeccccccccccccccc-CCCCCcchhHHHHHHHHHHHH-cCCCCcccccccCCCCccHHHHHH
Q 012267 288 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELI-TGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 288 ~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+..... .+. .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~-~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK-E 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH-H
Confidence 999998754321 1234678899999886 466899999999999999997 58888753211 010 0
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
..... .. ... ......+.+++.+||+.||.+||++.+|++.|+
T Consensus 220 ~~~~~-~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEG-QC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhc-Cc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11110 00 000 111356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=298.62 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=198.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|++.+.||.|++|.||+|... ++..||+|.+... .......+..|++++++++|+||+++++++......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 356888889999999999999875 6889999998654 23334568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... ++++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 9999999999876432 389999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.. ......++..|+|||.+. ...++.++||||||+++|||++|+.||.... ............
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~--- 224 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLLKILKSE--- 224 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHHHHhcCC---
Confidence 21 222345788999999874 3456789999999999999999999995321 011111111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+. ........+.+++..||+.+|.+||++.+|++
T Consensus 225 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 225 ---PPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ---CCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 01110 01122356788999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=298.26 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=196.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46677788999999999999864 688999999865432 2334578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999987643 388999999999999999999999 99999999999999999999999999987654221
Q ss_pred Ceeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 301 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.......|+..|+|||++. ...++.++|||||||++|+|++|+.||..... ... +...... . ..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~----~~~----~~~~~~~-~---~~ 227 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP----MRA----LFLMTKS-N---FQ 227 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc----hhh----HHhhhcc-C---CC
Confidence 1223345889999999874 45678999999999999999999999843110 000 0000000 0 00
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.... .......+.+++.+|++.+|++||++.+|++
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111110 0012245788999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=294.38 Aligned_cols=250 Identities=21% Similarity=0.353 Sum_probs=201.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|+||.||++... +|+.||+|.+.... ......++..|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999865 68899999986543 223345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+.+++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999876432 2378899999999999999999998 99999999999999999999999999997654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......|+..|+|||++.+..++.++|||||||++++|++|+.||.... ..+.+........ +.
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~------~~ 220 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGSY------PP 220 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCCC------CC
Confidence 1 1223347889999999988889999999999999999999999985321 1122222221110 00
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .......+.+++.+||+.+|.+||++.+|++
T Consensus 221 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 V----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred C----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 1122356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=296.04 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=192.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc----chHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP----GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 214 (467)
.+|...+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999864 6899999998643221 123357889999999999999999998875 3567
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997643 278899999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCC--CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 295 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 295 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
.+.... ........++..|+|||++.+..++.++|||||||++|||++|+.||.... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--------~~~~~~~~~~~-- 224 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIATQ-- 224 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--------hHHHHHHHhcC--
Confidence 653211 111223457889999999998889999999999999999999999995311 01111111110
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+.+. ......+.+++ .||..+|++||+++||++
T Consensus 225 ---~~~~~~~----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 ---PTNPQLP----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCCCCCc----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0112111 11223344554 688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=299.54 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=198.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..+.||+|++|.||+|+.. +|+.||+|++..... ......+..|+++++.++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999976 689999999865432 2233467899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|..++.... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888765432 389999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh---------
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 369 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 369 (467)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ...+..+......
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD----VDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChHHhhhc
Confidence 21 2223447789999999865 4578999999999999999999999953211 0011111110000
Q ss_pred --hcccccccCccccCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 --EKKLEMLVDPDLQNNY-----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 --~~~~~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.........+...... .......+.+++.+||+.+|++||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000111110000 0112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.54 Aligned_cols=201 Identities=22% Similarity=0.323 Sum_probs=163.8
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC------CCeeeeeeee
Q 012267 135 RELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV------HRNLLRLRGF 207 (467)
Q Consensus 135 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~ 207 (467)
+++...+++|.+.++||+|+||+||+|... +++.||||+++... .....+..|+.++..++ |.++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344556788999999999999999999865 68899999996422 12234556666666654 4568999998
Q ss_pred eeCC-CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCC--
Q 012267 208 CMTP-TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEF-- 283 (467)
Q Consensus 208 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~-- 283 (467)
+... .+.++|||++ +++|.+++.... .+++..+..|+.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence 8764 5678999988 778999887643 38999999999999999999997 5 899999999999998765
Q ss_pred --------------cEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 284 --------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 284 --------------~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999876422 122345689999999999999999999999999999999999999964
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=300.17 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=203.7
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+|...+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++|+||+++++.+...+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6788899999999999999875 578999999865432 2223467889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 82 YVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999997643 388999999999999999999999 9999999999999999999999999998642111
Q ss_pred C--------------CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 300 D--------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 300 ~--------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
. ........++..|+|||.+....++.++||||||+++|||++|+.||.... ..++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~~ 226 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFG 226 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 0 001112346789999999988889999999999999999999999995311 112222
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 423 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 423 (467)
...... ...+... ......+.+++.+||+.+|++||++.++.+.|+...+
T Consensus 227 ~~~~~~----~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 227 QVISDD----IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHHhcc----cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 221111 1111111 1223567899999999999999999888888988655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.47 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=195.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||+|++|.||+|... +++.||||.+...........+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999976 68999999987544333334577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+.+ +|.+++..... .+++.....++.|+++||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 99998876432 488999999999999999999999 99999999999999999999999999987543221
Q ss_pred CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh---ccc---
Q 012267 301 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKL--- 373 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 373 (467)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||..... .............. ...
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD----VEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHhcCCCChhhhhhh
Confidence 11 122236788999998865 4578999999999999999999999953210 00000000000000 000
Q ss_pred ------cc----ccC-ccccCcc-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 ------EM----LVD-PDLQNNY-VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ------~~----~~d-~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ... ..+.... .......+.+++.+|++.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 000 0000000 0011256788999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.12 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=198.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..++||+|+||.||+|... +++.||+|++....... ..+.+..|++++..++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35778899999999999999976 58999999986543322 34568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.++..... .+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988776432 289999999999999999999999 9999999999999999999999999998865433
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH----------HHh
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK----------GLL 368 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~ 368 (467)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ........ ...
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI----DQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHHHHhCCCchhhHHHh
Confidence 2 22233457889999999875 44688999999999999999999998532110 00000000 000
Q ss_pred hh-cccccccCccccCc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 369 KE-KKLEMLVDPDLQNN-----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 369 ~~-~~~~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ........+..... ........+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 00000011111000 01123466889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=304.56 Aligned_cols=196 Identities=24% Similarity=0.375 Sum_probs=160.1
Q ss_pred CCeeeecCceEEEEEEEC---CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCceEEEeecc
Q 012267 147 KNILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYM 221 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~ 221 (467)
.++||+|+||+||+|+.. ++..||+|.+..... ...+.+|+.++++++||||+++++++.. ....+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 367999999999999864 467899999865322 3357789999999999999999998854 45678999998
Q ss_pred CCCChhhhhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE----CCCCcEEEeecCC
Q 012267 222 ANGSVASCLRERPP-----SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGL 292 (467)
Q Consensus 222 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl 292 (467)
. ++|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 6 488888754321 123488899999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCC--eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 293 AKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 293 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 987543221 12234568999999999876 4579999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=307.99 Aligned_cols=260 Identities=22% Similarity=0.270 Sum_probs=192.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 211 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 211 (467)
..++|...+.||+|+||+||+|... ++..||||++...... .....+.+|+++++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 6889999998654322 2234577899999999999999999987543
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 77998887643 288999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh-
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK- 369 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 369 (467)
+++..... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+......
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~ 235 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----DQLKRIMEVVGTP 235 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCC
Confidence 99865422 223458999999999876 56899999999999999999999999532110 001111100000
Q ss_pred ---------hcccccccC--ccccCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 ---------EKKLEMLVD--PDLQNN----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ---------~~~~~~~~d--~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
......... +..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000 00011234678999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=296.34 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=194.0
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccC
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 222 (467)
|+..+.||+|+||.||+|... ++..+++|.+.... ......+..|+++++.++|+|++++++++...+..++||||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 556678999999999999976 57788999885432 3334568889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
+++|..++.... .++++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 999999886532 2489999999999999999999999 99999999999999999999999999987543221 1
Q ss_pred eeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 303 VTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
......++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.+......... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~~ 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPP-TLA 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhcCCC-CCC
Confidence 223345889999999874 3456789999999999999999999985321 11111111111100 001
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
.+ ......+.+++.+||+.+|.+||++.+++
T Consensus 230 ~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 230 QP-------SRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred Cc-------cccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11 11235688999999999999999999885
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=297.61 Aligned_cols=266 Identities=24% Similarity=0.293 Sum_probs=195.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++++|...+.||+|+||.||+|... +|..||+|++...........+.+|+.++..++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567888999999999999999864 688999999976544444446788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+. ++|.+++..... .+.+..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 678777654322 377888999999999999999999 999999999999999999999999999875432
Q ss_pred CCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH-----------H
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK-----------G 366 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~ 366 (467)
... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||+..... ...+.+... .
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHHHHcCCCChhhhhh
Confidence 211 12223468899999998754 5788999999999999999999999642110 000000000 0
Q ss_pred HhhhcccccccCccccCcc------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNY------VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
............+...... .......+.+++.+|++.||.+|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000000 0011356778999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=295.89 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=196.7
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc---------hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG---------GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
+|...+.||.|++|.||+|... +|+.||+|.++...... ..+.+..|+.++..++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667789999999999999864 68999999885421111 1235778999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++||||+++++|.+++.... ++++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997652 388899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-eeeecccccccccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh
Q 012267 293 AKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 293 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
+........ .......++..|+|||.+.... ++.++||||||+++|++++|..||.... ....+. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------~~~~~~-~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-------AIAAMF-KLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-------hHHHHH-Hhhc
Confidence 976432211 1123345788999999987654 7899999999999999999999985211 111111 1111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .....+++. ........+.+++..||+.+|.+||++.+|++
T Consensus 227 ~-~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 K-RSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred c-ccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0 111111111 11223467888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=304.71 Aligned_cols=255 Identities=26% Similarity=0.301 Sum_probs=198.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|++|+||+|... ++..||+|.+....... ....+..|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999876 58999999997654332 3446889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+.+++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999875432 3489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCe----------------------------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccc
Q 012267 299 KDTH----------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 350 (467)
Q Consensus 299 ~~~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~ 350 (467)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 111235788999999999888999999999999999999999999632
Q ss_pred cccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 012267 351 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418 (467)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 418 (467)
.. . ..+. .... ..............+.+++.+||+.+|++||++...++.+
T Consensus 236 ~~----~---~~~~-~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 236 NR----D---ETFS-NILK---------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred ch----H---HHHH-HHhc---------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 11 0 1111 1111 0000000111346789999999999999999943333333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=290.03 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=198.9
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC----cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT----PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
+|+..+.||+|++|.||+|... ++..|++|.+..... ......+..|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 789999999865332 22345688999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
+||+++++|.+++.... ++++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997643 378999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCeeeecccccccccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ...............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~-- 221 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELP-- 221 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCC--
Confidence 322 223445788999999987766 8999999999999999999999995421 111111111101110
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+ .......+.+++.+||+.+|.+||++.++++
T Consensus 222 ---~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ---PI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---Cc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01 1112356788999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=296.49 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=199.0
Q ss_pred CCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC---CCeeeeeeeeeeCCCceEEEe
Q 012267 143 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 218 (467)
.|+..+.||+|+||.||+|.. .++..||+|.++.........++.+|+.+++.++ |+|++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999996 4789999999876544445567889999999886 999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++... ++++...+.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998653 388999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..+.... ....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~~------~~~~ 218 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMMLI------PKSK 218 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhcc------ccCC
Confidence 332 2233458889999998865 4568999999999999999999999964211 1111100 0001
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+... .....+.+++.+||+.+|++||++.+++.
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111111 13356889999999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=298.15 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=199.5
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|++|.||+|... +++.||+|.++.... ......+..|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6788899999999999999976 688999999875432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
++++.+..+..... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99877766554422 388999999999999999999999 99999999999999999999999999988765443
Q ss_pred CeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh-----------
Q 012267 301 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL----------- 368 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 368 (467)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ...........
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhhc
Confidence 3233345578899999999887 789999999999999999999999853211 00000000000
Q ss_pred -hhcccc-----cccCccc-cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 369 -KEKKLE-----MLVDPDL-QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 369 -~~~~~~-----~~~d~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... ...++.. ...........+.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 0000000 00011122467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=296.89 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=199.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCC-----
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT----- 212 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----- 212 (467)
++++|+..+.||+|++|.||+|... +++.+++|++..... ....+..|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999975 678999999865432 345788999999998 6999999999997644
Q ss_pred -ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 213 -ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 213 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
..++||||+++++|.+++.........+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999999876432334589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
++....... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||.... ..... ..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~----~~ 229 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH----PMRAL----FK 229 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc----hHHHH----HH
Confidence 987654222 12233457889999998753 346789999999999999999999995311 00011 11
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.... ..+.+ .........+.+++.+||..||++|||+.+|++
T Consensus 230 ~~~~------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRN------PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcc------CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1110 01111 111224467889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=301.75 Aligned_cols=195 Identities=24% Similarity=0.387 Sum_probs=159.1
Q ss_pred CeeeecCceEEEEEEEC---CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCceEEEeeccC
Q 012267 148 NILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMA 222 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 222 (467)
.+||+|+||+||+|+.. ++..||+|.+..... ...+.+|+++++.++||||+++++++.. ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999865 357899999865322 3357789999999999999999998854 456789999986
Q ss_pred CCChhhhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE----CCCCcEEEeecCCc
Q 012267 223 NGSVASCLRERP-----PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 293 (467)
Q Consensus 223 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 293 (467)
+ +|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7888775321 1223588999999999999999999999 99999999999999 56678999999999
Q ss_pred cccCCCCC--eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 294 KLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 294 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
+....... .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 86543221 12233457899999999876 4579999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=284.47 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=201.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++.|++.++||+|.|+.||++.. .+|+.+|+|+++... .....+.+.+|+.+-..++||||+++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677778999999999999975 479999999986543 2234567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC---CcEEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~ 295 (467)
|+|.|++|..-|-.+. ..++..+-..+.||+++|.|.|.+ +|||||+||.|+++-.. --+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999987665432 267777888999999999999999 99999999999999433 3589999999998
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
+. +........||++|||||++...+|+..+|||+.|||||-|+.|.+||.... .....++.... ..
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~I~~g---~y 229 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQIKAG---AY 229 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHHHhcc---cc
Confidence 76 5666777889999999999999999999999999999999999999995311 11111111110 01
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
-+++ ...+....+..+++.+|+..||.+|.|+.|.+
T Consensus 230 d~~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 230 DYPS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCCC----cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1112 12233346678899999999999999998763
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=297.34 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=200.2
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|++|.||+|... +|..||+|++..... ......+.+|+.++++++|+|++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999975 689999999976543 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+ +++|.+++.... .++++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987643 3489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc--------
Q 012267 301 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-------- 371 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 371 (467)
........++..|+|||.+.+. .++.++||||+|+++|||+||++||.... ......++.......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-----DIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-----HHHHHHHHHHHcCCCChHHHhhc
Confidence 2223334578899999998654 46899999999999999999988774311 111111111111000
Q ss_pred ----ccccccCccccC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 ----KLEMLVDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ----~~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+..+.... ....+....+.+++.+|++.+|.+||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 001122377889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=299.57 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=194.2
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|++|.||+|+.. +|..||+|+++..... .....+..|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999975 6899999998754322 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
++ ++|.+++.... ..+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 58888876532 2389999999999999999999999 99999999999999999999999999988654322
Q ss_pred CeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc------cc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK------KL 373 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 373 (467)
. ......++..|+|||.+.+. .++.++|||||||++|+|+||..|+.... ......+......... ..
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC----CHHHHHHHHHHHhCCCChHHhHHh
Confidence 1 12223468899999988764 46899999999999999999999863211 0000000000000000 00
Q ss_pred ccccC----ccccC-----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 EMLVD----PDLQN-----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ~~~~d----~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+ +.... .........+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 00000 001123456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=290.41 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=204.8
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+|+..+.||+|++|.||+|... ++..|+||++...........+..|+..+.+++|+|++++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5788899999999999999976 589999999976554344567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
++++|.+++... .++++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999865 238999999999999999999999 8 99999999999999999999999999988664332
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.. .....++..|+|||.+.+..++.++||||||+++|+|+||+.||..... ....+......... .+.
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~------~~~ 222 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGP------PPS 222 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCC------CCC
Confidence 22 1234478899999999988899999999999999999999999964221 11122222221110 111
Q ss_pred ccCcccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEA-EVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ ... ....+.+++..|++.+|++||++.++++
T Consensus 223 ~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 223 L----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred C----CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1 111 3467899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=289.89 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=199.7
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|...+.||+|++|.||+|... ++..|++|.++..... .....+..|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999865 7899999998765432 2455789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997643 278889999999999999999999 99999999999999999999999999988765333
Q ss_pred Ceee---ecccccccccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 301 THVT---TAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 301 ~~~~---~~~~g~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.... ....++..|+|||++.+.. .+.++||||||+++|+|++|+.||.... .. .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~----~~---~~~~~~~~~----- 221 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD----NE---FQIMFHVGA----- 221 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc----ch---HHHHHHHhc-----
Confidence 2211 1345788999999998766 7899999999999999999999995321 01 011111000
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 222 -~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 -GHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111111 1112356778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=292.24 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=197.6
Q ss_pred CCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC------
Q 012267 144 FSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 212 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 212 (467)
|...+.||+|+||.||+|.+. ++..||||+++.... .....++..|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999853 368899999975432 233456889999999999999999999886532
Q ss_pred ceEEEeeccCCCChhhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 213 ERLLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
..++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999998875422 1223478899999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHh
Q 012267 291 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 291 gl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
|+++........ ......++..|++||.+....++.++||||||+++|||++ |+.||.... ...+..+. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~~---~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYL---I 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHHH---H
Confidence 998865432211 1122335678999999988889999999999999999999 888885311 11111111 1
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
...... . .......+.+++.+||+.+|++||++.++++.|+++
T Consensus 230 ~~~~~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111110 0 112236799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=313.25 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=199.4
Q ss_pred eeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChh
Q 012267 149 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 227 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 227 (467)
+||+|.||+||-|++. +...+|||-+..... ....-+.+|+.+.+.++|.|||+++|.|.+++.+-+.||.++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999965 566899999965432 23335889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC-CCCcEEEeecCCccccCCCCCeee
Q 012267 228 SCLRERPPSQLPL--DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVT 304 (467)
Q Consensus 228 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~ 304 (467)
++|+..-+ |+ .+.++--+.+||++||.|||.+ .|||||||-+||||+ -.|.+||+|||-++.+.. -...+
T Consensus 661 sLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~T 733 (1226)
T KOG4279|consen 661 SLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCT 733 (1226)
T ss_pred HHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccc
Confidence 99987432 34 6777888899999999999999 999999999999995 568999999999987653 23345
Q ss_pred ecccccccccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 305 TAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 305 ~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
..+.||..|||||++..+ .|..++|||||||++.||.||++||...... ....++-+.. +..
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----------qAAMFkVGmy------KvH 797 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----------QAAMFKVGMY------KVH 797 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----------hHhhhhhcce------ecC
Confidence 667799999999999764 4789999999999999999999999532111 0111111111 122
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
...+.+...+...++++|+.++|.+||++++++ ++..+.
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL---~DpFlq 836 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLL---QDPFLQ 836 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhc---cCcccc
Confidence 334566677888999999999999999999984 454444
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.11 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=193.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC----cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--Cce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT----PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 214 (467)
.+|+..++||+|+||.||+|... +|..||||.+..... ......+..|+.++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999865 689999998864321 11234678899999999999999999988764 457
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
+++|||+++++|.+++.... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987643 278888999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCC--CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 295 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 295 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~-~~~~~~-- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAI-FKIATQ-- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHH-HHHhcC--
Confidence 543211 111223457889999999988889999999999999999999999995311 01111 111100
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+. ........+.+++.+|+. +|++||++++|++
T Consensus 225 ---~~~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 ---PTNPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00111 122334567778888884 9999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.40 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=208.7
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.-|.+.+.||+|.|+.|-+|++ -+|..||||++.+..... ....+.+|++.|+.++|||||++|++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577778999999999999984 489999999997654333 34468899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecCCccccCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~ 298 (467)
.-.+|+|+++|.++..+ +.+....+++.||..|+.|+|+. .+|||||||+||.+.+ -|-+||.|||++-.+
T Consensus 98 LGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf-- 169 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF-- 169 (864)
T ss_pred ecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC--
Confidence 99999999999887544 88899999999999999999999 8999999999998754 578999999998754
Q ss_pred CCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
..+......+|+..|-|||++.+..| .++.||||||||||-|++|+.||+.... .+.+..++
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-----------------SETLTmIm 232 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-----------------SETLTMIM 232 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-----------------hhhhhhhh
Confidence 34556677889999999999999887 5789999999999999999999974321 12333444
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
|-.. ..+.....++.++|..||..||++|.+.++|+.
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4432 335566788999999999999999999998864
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=307.92 Aligned_cols=237 Identities=23% Similarity=0.270 Sum_probs=182.4
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhc---CCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMA---VHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
||+|+||+||+|+.. +|+.||||++...... .....+..|..++.+. .||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 6899999998643221 1222345566666555 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.++|+|||++...... ...
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKT 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCC
Confidence 99999987643 388999999999999999999999 9999999999999999999999999998753322 222
Q ss_pred eecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 304 TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
.....||..|+|||++.+. .++.++|||||||++|+|+||+.||.... ..+........ .. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~-~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAFG-KV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHcC-CC------CCC
Confidence 3345689999999998754 47899999999999999999999995321 11111111111 00 011
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMS 412 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 412 (467)
.. .....+.+++.+||+.+|.+||++.
T Consensus 218 ~~---~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 KN---VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred Cc---cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 00 1225577899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.30 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=186.3
Q ss_pred CeeeecCceEEEEEEECC--------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 148 NILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+.||+|+||.||+|.... ...||+|.+.... ......+..|+.++..++|||++++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999998642 2348888875432 2233468889999999999999999999999899999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc--------EEEeecC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE--------AVVGDFG 291 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg 291 (467)
|+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999986533 388999999999999999999999 9999999999999987765 6899999
Q ss_pred CccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCC-CCcccccccCCCCccHHHHHHHHhh
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQ-RAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
++..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.... . ..... ...
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-----~---~~~~~-~~~ 219 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-----S---QKKLQ-FYE 219 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-----H---HHHHH-HHH
Confidence 8865432 122457889999999976 45789999999999999999995 5553211 0 01110 111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
. . ..+. .....++.+++.+||+.+|++|||++++++.|+
T Consensus 220 ~-~------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D-R------HQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c-c------ccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 0011 111256889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=290.06 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=199.2
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|++|.||++... ++..+|||.+..... ......+..|+++++.++|+|++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777889999999999999864 688999999865432 23345788999999999999999999999989999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEeecCCccccCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~ 299 (467)
+++++|.+++.... ...+++..+..++.++++||+|||++ +++|+||+|+||+++++ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997643 23488999999999999999999999 99999999999999865 46899999999865432
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+....... ...
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~~~~~~-~~~---- 220 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLKIMSGT-FAP---- 220 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHHHHhcC-CCC----
Confidence 2 1223457889999999998888999999999999999999999985421 111121111110 000
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ .......+.+++.+||+.+|.+|||+.|+++
T Consensus 221 -~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 -I----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -C----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1112356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.37 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=194.2
Q ss_pred CCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 147 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
...||+|+||.||+|... ++..||+|.+..... .....+.+|+.++..++|||++++++++...+..++||||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 356999999999999865 689999999865432 234568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeee
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 305 (467)
|.+++... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... ....
T Consensus 105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 99987542 278999999999999999999999 99999999999999999999999999987543222 1223
Q ss_pred cccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcc
Q 012267 306 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 385 (467)
Q Consensus 306 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 385 (467)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .. ..+..... .. .+... .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~---~~~~~~~~-~~-----~~~~~--~ 239 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-----PV---QAMKRLRD-SP-----PPKLK--N 239 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH---HHHHHHhc-cC-----CCCcc--c
Confidence 3458899999999988889999999999999999999999995321 11 11111111 00 00000 0
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 386 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 386 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......+.+++.+||+.+|.+||++.+|++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1112255788999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.36 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=195.3
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccC
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 222 (467)
|.....||+|+||.||++... ++..||||.+.... ......+..|+..+..++|+||+++++.+...+..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333466999999999999864 68899999986533 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
+++|.+++... .+++..+..++.||+.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 99999988543 278899999999999999999999 999999999999999999999999999875432221
Q ss_pred eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.... . ...+... . ....+.+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~---~~~~~~~-~-----~~~~~~~~ 239 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----P---LQAMRRI-R-----DNLPPRVK 239 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHH-H-----hcCCCccc
Confidence 1223457889999999988889999999999999999999999985311 0 0111111 0 01111111
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
. .......+.+++..|+..+|.+|||++++++.
T Consensus 240 ~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 D--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 11123457788999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=307.00 Aligned_cols=196 Identities=26% Similarity=0.364 Sum_probs=169.0
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-C-----CeeeeeeeeeeCCCce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-H-----RNLLRLRGFCMTPTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~ 214 (467)
.+|.+.++||+|+||.|.+|.. .+++.||||+++... .-..+-..|+.+|..++ | -|+|+++++|...++.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 3788899999999999999985 479999999997643 23345678999999887 3 4799999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC--cEEEeecCC
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGL 292 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgl 292 (467)
|||+|.+.. +|.++|+.+.-.+ ++...+..|+.||+.||.+||+. +|||+||||+||||.+-. .+||+|||.
T Consensus 264 ciVfELL~~-NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhhhh-hHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999855 9999999875443 88899999999999999999999 999999999999997654 699999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
++..... .. .+..+..|+|||++.+.+|+.+.|+||||||+.||++|.+.|..
T Consensus 338 Sc~~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 338 SCFESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccccCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 9875322 11 44467789999999999999999999999999999999887743
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=293.74 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=195.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||.|++|.||+|+.. +|..||||+++..... .....+..|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 6899999998754322 2234688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+. ++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 689998876432 2489999999999999999999999 99999999999999999999999999987654222
Q ss_pred CeeeecccccccccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc--------
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-------- 371 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 371 (467)
. ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.... ......+.....-...
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCChhhhhhhh
Confidence 1 112234678899999887644 5889999999999999999999995321 1111111111100000
Q ss_pred -------ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 -------KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.........+. .........+.+++.+|++.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000112245778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=296.81 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=194.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+.|...+.||+|+||+||+|... +|+.||+|.+..... ......+.+|+++++.++|||++++.++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999875 689999999864322 223346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+. |+|.+++..... ++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 578777764322 389999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCeeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
. ....++..|+|||++. ...++.++||||||+++|||+||+.||..... ...........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~~~---- 230 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQND---- 230 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhcCC----
Confidence 2 1235788999999874 45678999999999999999999999853210 01111111000
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+. .......+.+++.+||+.+|++||++.+|+.
T Consensus 231 --~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 231 --SPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred --CCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 01111 1224467899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.94 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=199.1
Q ss_pred CCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCc-----chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+|+..+.||+|++|.||+|.. .+++.||+|.+...... .....+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 47899999998643321 123468899999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeecCCccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 295 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~ 295 (467)
||||+++++|.+++.... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997643 388999999999999999999999 999999999999998776 599999999876
Q ss_pred cCCCCC---eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 296 MDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 296 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
...... .......++..|+|||.+.+..++.++||||+|+++|+|++|..||..... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASA-- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhcc--
Confidence 543211 112234578899999999888889999999999999999999999953211 1111111111000
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
... ..........+.+++.+|+..+|.+||++.++++
T Consensus 227 ---~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ---TTA----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCC----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001 1112233467889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=297.14 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=193.6
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|...+.||+|+||.||++... +++.||+|.+...........+..|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999865 689999999876544444557889999999996 99999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 221 MANGSVASCLRER-PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 221 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
+.. +|.++.... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 665543211 011234899999999999999999999742 8999999999999999999999999998765322
Q ss_pred CCeeeecccccccccccccccCC---CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+-+......
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~------ 226 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKG------ 226 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCC------
Confidence 21 1223478899999998766 68999999999999999999999995321 111111111110
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+.+...........+.+++.+||+.+|++|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111211111234467899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=293.90 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=198.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+|+..+.||.|++|.||+|+.. +|..||||.++..........+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 689999999976554444556788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 89888876542 23489999999999999999999999 999999999999999999999999999976543211
Q ss_pred eeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH-----------Hhh
Q 012267 302 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG-----------LLK 369 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 369 (467)
......++..|++||.+.+. .++.++||||||+++|+|++|+.||...... ......... ...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhHHHHhc
Confidence 11223467899999988654 5688999999999999999999999642210 000000000 000
Q ss_pred hcccccccCcccc----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 EKKLEMLVDPDLQ----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ~~~~~~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
........ +... ..........+.+++..|++.+|.+||++.++++
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTF-PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred Cchhcccc-cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0000 0001122356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=296.20 Aligned_cols=262 Identities=22% Similarity=0.274 Sum_probs=196.7
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc----chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
+|...+.||+|++|.||+|... +|+.||||.++..... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 6899999999755432 1233567899999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+ +|+|.+++.... ..+++..++.++.||++||+|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999997643 2489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh-------
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK------- 369 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 369 (467)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||..... ...+.........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHHHHcCCCchhhhh
Confidence 3221 1222345778999998854 4578999999999999999999877753211 0001111000000
Q ss_pred -hcccccccCccccC-----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 -EKKLEMLVDPDLQN-----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 -~~~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.............. .........+.+++.+||+.+|++|||+.||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000000 001123467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=294.81 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=199.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...+.||+|+||.||++... ++..||+|.+..... .....+..|+.+++.++|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 57888899999999999999864 688999999864332 2345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++... .+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999998753 278899999999999999999999 99999999999999999999999999887554322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
. ......++..|+|||.+....++.++||||||+++|++++|+.||....... .+....... -+.
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--------~~~~~~~~~------~~~ 234 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG------TPE 234 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--------heeehhcCC------CCC
Confidence 2 2223457889999999988888999999999999999999999996421110 000000000 000
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
. .........+.+++.+||+.+|.+||++.+++..
T Consensus 235 ~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111223567889999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=293.60 Aligned_cols=244 Identities=25% Similarity=0.317 Sum_probs=196.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|++|.||++... +++.||+|.++.... ......+..|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999875 689999999864322 223446889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 388999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... . ......... ..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~~-~~------ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----P---IQIYEKILE-GK------ 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHhc-CC------
Confidence 2 233458899999999988888999999999999999999999995321 0 111111111 00
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVV 415 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl 415 (467)
..+.. .....+.+++.+||+.+|.+|| ++++++
T Consensus 215 ~~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 VRFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 01111 1135678899999999999999 566653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=290.63 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=197.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.|...+.||+|++|.||++... +++.+++|++.... ......+.+|+.+++.++|+|++++++++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 3445578999999999999864 78899999986432 223446889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|.+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999998762 278899999999999999999999 999999999999999999999999998875432221
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ........... . .+..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~~-~-----~~~~ 235 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRDN-L-----PPKL 235 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHhc-C-----CCCC
Confidence 2233458899999999988889999999999999999999999985311 11222221111 0 1111
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. .......+.+++.+||+.+|++||++.++++
T Consensus 236 ~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cc--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 10 1112356899999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=291.11 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=202.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++.|+..+.||+|++|.||+|... ++..|++|++..... ....+..|++.+..++|+|++++++++......++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566888889999999999999976 688999999975433 4557889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998754 2489999999999999999999998 999999999999999999999999999875542
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .......... ......+
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~~~ 238 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLITTK-GIPPLKN 238 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc-CCCCCcc
Confidence 221 12223477899999999888899999999999999999999999853111 0111111111 1111001
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......+.+++.+|++.+|.+||++.+|++
T Consensus 239 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 -------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113356889999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=289.28 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=200.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|+||.||+|... +|..||+|.+...... .....+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999975 6889999998654322 2344678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeecCCccccCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 299 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 299 (467)
+++++|.+++..... ..+++..+..++.++++||+|||+. +++|+||||+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999976432 2479999999999999999999999 999999999999999886 4699999998765432
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. .......|+..|+|||++.+..++.++||||||+++|||++|..||.... ..+++....... ..+
T Consensus 156 ~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-----~~~ 221 (257)
T cd08225 156 M-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQGY-----FAP 221 (257)
T ss_pred c-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhccc-----CCC
Confidence 2 22223457889999999988889999999999999999999999985321 222332222111 111
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .......+.+++.+|++.+|++|||+.+|++
T Consensus 222 -~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 -I----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -C----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 1112356889999999999999999999965
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=289.81 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=202.5
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..++||+|++|.||++... ++..+|+|.+..... ......+..|+++++.++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999865 788999999875432 23344678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.........+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999877433334589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ........ .....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~------- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDLRYKV-QRGKY------- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-hcCCC-------
Confidence 2223447889999999998889999999999999999999999996421 11111111 11111
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..........+.+++.+|++.+|.+||++.++++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 --PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1112234467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=293.52 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=196.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 217 (467)
++|+..+.||.|++|.||+|... +++.+|+|.++...... ....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999976 68899999997543322 233567899999999999999999998877 889999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+.+ +|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 99998876432 489999999999999999999999 99999999999999999999999999988665
Q ss_pred CCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCC--------CccHHHHHH--H
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDD--------DVMLLDWVK--G 366 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~--~ 366 (467)
.... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......... ......|.. .
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 3321 12223468899999988754 4689999999999999999999999642110000 000000000 0
Q ss_pred Hh--hhcccccccCccccCcccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LL--KEKKLEMLVDPDLQNNYVEA-EVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~--~~~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ............+....... ....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00000000001111111111 2466789999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=297.51 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=199.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 217 (467)
....|++.+.||+||.+.||++...+.+.||+|++.... .......|..|++.|.+++ |.+|+.+++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 345688899999999999999998888889998876443 3334457999999999995 99999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||= .-+|..+|+..... ...| .+..+..|++.++.++|.+ +|||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9965 55999999886543 2345 7788899999999999999 9999999999999865 589999999999876
Q ss_pred CCCCe-eeecccccccccccccccCC-----------CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 298 YKDTH-VTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 298 ~~~~~-~~~~~~g~~~y~aPE~~~~~-----------~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
..... .....+||+.||+||.+... +.+.+|||||+|||||+|+.|+.||.... ..|.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------n~~a- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------NQIA- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------HHHH-
Confidence 55444 34456799999999988533 24679999999999999999999995311 1121
Q ss_pred HHhhhcccccccCccccCccc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 366 GLLKEKKLEMLVDPDLQNNYV-EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+..+.||...-.+. ...-.+++++|..||+.||++||++.++|+
T Consensus 581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 234455553211111 111133999999999999999999999965
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.44 Aligned_cols=245 Identities=29% Similarity=0.425 Sum_probs=197.9
Q ss_pred CCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.|...+.||.|+||.||-|++ .+.+.||||++.-..... ...++.+|+..|..++|||++.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 455567899999999999985 478899999997543222 23479999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
||- |+-.|++.-+. .++.+.++..|..+.+.||+|||+. +.||||||..|||+++.|.|||+|||.+.....
T Consensus 107 YCl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 995 48888876543 3488889999999999999999999 999999999999999999999999999987653
Q ss_pred CCeeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
...+.||+.|||||++. .+.|+-|+||||+|++-.||.-.++|+-... -+..+. .+...
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----------AMSALY---HIAQN 240 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALY---HIAQN 240 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----------HHHHHH---HHHhc
Confidence 33567999999999875 4789999999999999999999999963211 011111 11111
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
-.|.+. ..+....+.+++..|+++-|.+|||..+++.
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 223333 3455677888889999999999999988854
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=291.44 Aligned_cols=258 Identities=21% Similarity=0.259 Sum_probs=193.0
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCC--CceEEEee
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLVYP 219 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 219 (467)
|+..+.||+|+||.||+|... ++..||+|+++.............|+..+.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999865 689999999876543333334567888888885 99999999999887 88999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|++ |+|.+.+.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 58888887543 2489999999999999999999999 9999999999999999 99999999999865432
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh----------
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---------- 368 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 368 (467)
.. .....++..|+|||.+.. ..++.++|||||||++|||++|+.||..... .....+.....
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcCCCCHHHHHh
Confidence 21 122347889999997644 5578999999999999999999999954211 11111111111
Q ss_pred -hhcccccccCccccCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 369 -KEKKLEMLVDPDLQNN----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 369 -~~~~~~~~~d~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..........+..... ........+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000011111111000 01123577999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=291.87 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=196.3
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEEEee
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYP 219 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 219 (467)
|+..+.||.|++|.||+|+.. +|..+|+|++.... .......+..|++++..++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999976 58899999997653 222344688899999999999999999999887 78999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8988887642 2489999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc---cccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK---KLEM 375 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 375 (467)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||..... ......+....... ....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-----LEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchhhccc
Confidence 3222233446788999997764 4578999999999999999999999964221 00111111100000 0000
Q ss_pred --------------ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 --------------LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 --------------~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.....+.......+...+.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000112467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=292.32 Aligned_cols=266 Identities=22% Similarity=0.262 Sum_probs=193.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCc-----
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE----- 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 213 (467)
++|+..+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999975 68999999986543222 2346788999999995 6999999999877655
Q ss_pred eEEEeeccCCCChhhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecC
Q 012267 214 RLLVYPYMANGSVASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 291 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 291 (467)
.++||||+++ +|.+++...... ...+++..++.++.||++||.|||+. +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898888754332 34589999999999999999999999 9999999999999998 8899999999
Q ss_pred CccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...+..........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence 98755322111 122246788999998865 4578999999999999999999999953210 00011111000000
Q ss_pred c--cccccc-------Ccccc----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 K--KLEMLV-------DPDLQ----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ~--~~~~~~-------d~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ...... -+... ..........+.+++.+||+.+|.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000 00000 0001123466889999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.58 Aligned_cols=265 Identities=27% Similarity=0.415 Sum_probs=213.4
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEEC----C----CCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeee
Q 012267 136 ELQVATDSFSNKNILGRGGFGKVYKGRLA----D----GSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRG 206 (467)
Q Consensus 136 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 206 (467)
.++...++..+.+.||+|.||.|++|... . ...||||.++..........+..|+++++.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 46666677777789999999999999743 1 4579999998877776777899999999988 5999999999
Q ss_pred eeeCCCceEEEeeccCCCChhhhhhcCC---CCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCC
Q 012267 207 FCMTPTERLLVYPYMANGSVASCLRERP---PSQ---------LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKA 274 (467)
Q Consensus 207 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~---------~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~ 274 (467)
.|......++|+||+..|+|.++++... .-. ..++....+.++.|||.||+||++. ++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 000 2388899999999999999999999 999999999
Q ss_pred CcEEECCCCcEEEeecCCccccCCCCCeeeecccc--cccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCccccc
Q 012267 275 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLAR 351 (467)
Q Consensus 275 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~ 351 (467)
+|||+.++..+||+|||+++..............+ ...|||||.+....|+.|||||||||+||||+| |..||...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~- 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI- 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-
Confidence 99999999999999999999654444443332223 346999999999999999999999999999998 77887431
Q ss_pred ccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 352 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. ..+.++ .++++. +-..+..+..++.++|+.||+.+|++||++.++++.|+.
T Consensus 526 ---~~---~~~l~~-~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 526 ---PP---TEELLE-FLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred ---Cc---HHHHHH-HHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 00 112211 222211 011133345789999999999999999999999999988
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.07 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=195.7
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
|+..+.||.|++|.||+|... +|..||+|++....... ....+..|+++++.++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999865 79999999987543222 2346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
+ ++|.+++..... ..+++..++.++.|+++||+|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 699999876542 2489999999999999999999998 999999999999999999999999999976542221
Q ss_pred eeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc---------
Q 012267 302 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--------- 371 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 371 (467)
. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ...+.+.........
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhhhhhh
Confidence 1 1222457899999987654 568999999999999999999999953211 011111111100000
Q ss_pred --c----cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 --K----LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 --~----~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ......+.. ..........+.+++.+|++.+|.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000 0001122356889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=280.82 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=201.2
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
+|+..+.||+|++|.||++... ++..+++|++..... .....+.+|+++++.++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 3677789999999999999976 688999999976543 34457899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++++|.+++.... ..+++..+..++.++++||+|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987753 2489999999999999999999998 999999999999999999999999999876543321
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......... ........+
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~~~-- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--------PMKALFKIAT-NGPPGLRNP-- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHh-cCCCCcCcc--
Confidence 233457889999999988889999999999999999999999985321 0111111111 111111111
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
......+.+++.+||+.+|++|||+.++++
T Consensus 221 -----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 -----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -----cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111356889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=300.58 Aligned_cols=263 Identities=20% Similarity=0.324 Sum_probs=195.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----Cce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 214 (467)
+++|+..++||+|+||.||+|... +|+.||||.++..........+..|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999864 78999999986543333445678899999999999999999987644 357
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++|+||+.+ +|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999965 888877653 389999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCe--eeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 295 LMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 295 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCC
Confidence 65422211 1123457889999998654 5689999999999999999999999953211 01111111111100
Q ss_pred ---ccccccCcc-------cc--Cc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 372 ---KLEMLVDPD-------LQ--NN-----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 372 ---~~~~~~d~~-------~~--~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
....+.+.. .. .. ........+.+++.+||+.+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00 00 001123568899999999999999999988654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=287.93 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=199.8
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
+|+..+.||.|+||.||+|... ++..||+|.+..... ......+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777889999999999999976 689999999975432 1334578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+.+++|.+++... .++++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999765 2388999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+....... .....
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~~~~~-- 221 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--ADVLY-- 221 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--ccccC--
Confidence 2 223345788999999998888999999999999999999999999642211 11222221111 00111
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM--SEVV 415 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~evl 415 (467)
.......+.+++.+||+.+|.+||++ +|++
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 ------PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11223678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=287.20 Aligned_cols=243 Identities=24% Similarity=0.315 Sum_probs=194.1
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
||.|++|.||+++.. ++..||+|++...... .....+..|+.+++.++|+||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 5889999998754322 3345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeec
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 306 (467)
.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997643 278899999999999999999998 99999999999999999999999999998764332 2223
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ...+.......... . ....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-----~----~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNG-----K----LEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCC-----C----CCCC
Confidence 4578899999999888899999999999999999999999964211 11222222211000 0 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 416 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 416 (467)
......+.+++.+||+.+|.+||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 112467899999999999999999 566544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.11 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=194.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|+..+.||+|++|.||+|... ++..||||.++..........+..|+.++.+.. |+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356788899999999999999986 489999999976544444556777887776665 999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+. ++|.+++..... ++++..+..++.+++.||+|||+.. +|+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 477777765322 4899999999999999999999732 899999999999999999999999999876542
Q ss_pred CCCeeeecccccccccccccccCCC----CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ..+..........
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~-- 236 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQEEP-- 236 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHHHhcCCC--
Confidence 221 12234678999999987553 78899999999999999999999953110 0111111111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
+.... .......+.+++.+||+.+|.+||++.++++.
T Consensus 237 ----~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 ----PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 00123568899999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.59 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=197.3
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC----
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT---- 212 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 212 (467)
...++|++.+.||+|+||.||+|... +|+.||+|+++.... ......+..|+++++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999976 688999999975432 223346778999999999999999999987654
Q ss_pred ------ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 213 ------ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 213 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 7777776542 2489999999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 287 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-----~~~~~~~~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-----ELAQLELIS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHH
Confidence 99999998664333222222335778999998764 456899999999999999999999996321 111111111
Q ss_pred HHhhhccc---ccc--------cCcccc-----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 366 GLLKEKKL---EML--------VDPDLQ-----NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 366 ~~~~~~~~---~~~--------~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
........ ..+ .++... ..........+.+++..||+.+|.+||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110000 000 000000 0000012356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=285.66 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=204.6
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|...+.||.|++|.||++... ++..|++|++...... .....+..|+++++.++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999975 6899999999754332 3445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.........+++..+..++.++++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543334589999999999999999999999 99999999999999999999999999998654332
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......|++.|+|||.+....++.++||||+|+++++|++|+.||.... ..+........ ... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~-----~ 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKG-QYP-----P 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcC-CCC-----C
Confidence 22333457889999999988889999999999999999999999985421 11222222111 111 1
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ .......+.+++.+||..+|++||++.++++
T Consensus 223 ~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 I----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 1122366889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.85 Aligned_cols=260 Identities=25% Similarity=0.324 Sum_probs=203.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCC---cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCce
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERT---PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 214 (467)
+|+..+.||+|++|.||+++.. ++..||||.++.... ......+..|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999999742 578899999864321 12234578899999999 599999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999987542 388999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCeeeecccccccccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||.... .......+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG----EQNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc----ccchHHHHHHHHHcc--
Confidence 65433322233345788999999987655 7889999999999999999999995321 111112222222111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
.+... ......+.+++.+||+.+|++|||+.++.+.|+...+.
T Consensus 228 -----~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~ 270 (288)
T cd05583 228 -----KPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270 (288)
T ss_pred -----CCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence 01111 11225578899999999999999999999999886553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=285.51 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=204.1
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccC
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 222 (467)
|.+..+||+|+||.||+|.++ +|..+|||.+..+ ....++.+|+.++.+.+.+++|++||.+.....+|+|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 455678999999999999875 7999999998754 335578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
.|+..+.++.+. .++++.++..++...++||+|||.. .-+|||||..|||++.+|.+||+|||.+..+... -.
T Consensus 112 AGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA 184 (502)
T KOG0574|consen 112 AGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA 184 (502)
T ss_pred CCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence 999999998753 3599999999999999999999998 8899999999999999999999999999876432 22
Q ss_pred eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
....+.||+.|||||++..-.|..++||||+|++..||.-|++||...-.. +..+ .+. ..|.-.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------RAIF---MIP--T~PPPT 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------RAIF---MIP--TKPPPT 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------ceeE---ecc--CCCCCC
Confidence 334466999999999999999999999999999999999999999532110 0000 000 011111
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
-..+.....++-+++..|+-+.|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12245667889999999999999999999887653
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=289.01 Aligned_cols=243 Identities=28% Similarity=0.340 Sum_probs=185.3
Q ss_pred eeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHH---HhcCCCeeeeeeeeeeCCCceEEEeeccC
Q 012267 149 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 222 (467)
+||+|+||.||++... +++.||+|.+....... ....+..|..++ ...+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 68999999986543221 122334444333 34479999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
+|+|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999987643 389999999999999999999999 99999999999999999999999999987543221
Q ss_pred eeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 303 VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .... ...... .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~-~~~~~~------~~~~~~ 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHE-IDRMTL------TVNVEL 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHHH-HHHHhh------cCCcCC
Confidence 123458999999998864 56789999999999999999999999642111 1111 111100 011111
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVRM 417 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 417 (467)
.......+.+++.+|++.||.+|| +++++++.
T Consensus 219 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 122335688899999999999999 58888553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=292.55 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=193.9
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
|...+.||+|+||.||+|+.. ++..||+|.+...... .....+..|+++++.++|+|++++++++.+.+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999865 6889999998643222 2234688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+. |+|.+++.... .++++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 58888776432 2489999999999999999999999 9999999999999999999999999998754321
Q ss_pred Ceeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 301 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
....++..|+|||++. ...++.++|||||||++|||++|+.||.... .............
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~----- 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES----- 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhccC-----
Confidence 2235788999999873 4568899999999999999999999985311 0111111111110
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
+.. ........+.+++.+||+.+|.+||++.+|++.+-
T Consensus 242 -~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 -PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 000 01123356889999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=269.60 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=202.0
Q ss_pred CCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 147 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
...||+|..|.|++++.+ +|...|||.+.........+.++..+.++.+.+ .|.||+.+|||..+...++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 345999999999999976 689999999988777777777888888877665 89999999999999999999998843
Q ss_pred ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeee
Q 012267 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 304 (467)
Q Consensus 225 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 304 (467)
.+..+++... .++++..+-++...+.+||.||..++ +|+|||+||+|||+|+.|.+|++|||++..+-. +...
T Consensus 176 C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--SkAh 248 (391)
T KOG0983|consen 176 CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKAH 248 (391)
T ss_pred HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--cccc
Confidence 5666665532 24888888899999999999999887 999999999999999999999999999976642 3334
Q ss_pred ecccccccccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 305 TAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 305 ~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
...+|-+.|||||-+.. ..|..++||||||+.|+||.||+.||..-. .+ .+.+...++++. |.+
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----td---Fe~ltkvln~eP------P~L 315 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TD---FEVLTKVLNEEP------PLL 315 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----cc---HHHHHHHHhcCC------CCC
Confidence 44568899999998853 467899999999999999999999996411 11 122222232211 222
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH---hcCCCCccchhhhHh
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML---EGDGLAERWDEWQKV 433 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L---~~~~~~~~~~~~~~~ 433 (467)
... ......+.+++..||.+|+.+||...++++.= .-+.+..+..+|..|
T Consensus 316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~d 368 (391)
T KOG0983|consen 316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKD 368 (391)
T ss_pred Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHH
Confidence 221 11456788999999999999999999986521 112234455566433
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=298.41 Aligned_cols=265 Identities=20% Similarity=0.236 Sum_probs=195.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 211 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 211 (467)
..++|+..+.||+|+||.||+|... +|+.||+|.+..... ......+..|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3477999999999999999999865 789999999864322 22334677899999999999999999988643
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35699999996 4888887642 78889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCC-------CCccHHHHH
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLDWV 364 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~-------~~~~~~~~~ 364 (467)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .+....++.
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998654321 12334578899999999998999999999999999999999999953211000 000000000
Q ss_pred HH-------Hhhhcc------cccccCcc----ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 365 KG-------LLKEKK------LEMLVDPD----LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 365 ~~-------~~~~~~------~~~~~d~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ...... ........ ............+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000000 00000000 000001123456789999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=294.06 Aligned_cols=270 Identities=22% Similarity=0.295 Sum_probs=195.5
Q ss_pred CCCCCCeeeecCceEEEEEEEC---CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA---DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERL 215 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 215 (467)
.|...+.||+|++|.||+|... ++..||+|.+.... .......+..|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999975 47899999997632 122234577899999999999999999999987 7899
Q ss_pred EEeeccCCCChhhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC----CCcEEEeec
Q 012267 216 LVYPYMANGSVASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE----EFEAVVGDF 290 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 290 (467)
+||||+++ +|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777776543322 23588999999999999999999999 9999999999999999 899999999
Q ss_pred CCccccCCCCC--eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCC-----ccHHH
Q 012267 291 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD-----VMLLD 362 (467)
Q Consensus 291 gl~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~-----~~~~~ 362 (467)
|++........ .......++..|+|||++.+ ..++.++||||||+++++|++|+.||.......... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 11223457889999998766 457899999999999999999999996432211000 00111
Q ss_pred HHHHHhh-----------hcccccc----cCccccCcccH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 363 WVKGLLK-----------EKKLEML----VDPDLQNNYVE-------AEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 363 ~~~~~~~-----------~~~~~~~----~d~~~~~~~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
++..+.. ....... ........... .....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1110000 0000000 00000000000 22356889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=292.72 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=190.7
Q ss_pred Ceeeec--CceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRG--GFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G--~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
..||+| +||+||++... +|+.||+|++...... ...+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999874 7999999998754332 2345688899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
++|.+++...... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999998875322 388899999999999999999998 99999999999999999999999998654322111100
Q ss_pred ------eecccccccccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH---------
Q 012267 304 ------TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG--------- 366 (467)
Q Consensus 304 ------~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 366 (467)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...... .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCCCCCCcccc
Confidence 0111245679999998763 4789999999999999999999999642100 000000000
Q ss_pred -------H----------------hhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 -------L----------------LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 -------~----------------~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ........+.+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0000000111111111222345577899999999999999999999953
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=281.51 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=202.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEEEe
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 218 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 218 (467)
+|...+.||+|++|.||+|... ++..|++|++..... ......+.+|++.+++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999976 789999999865432 23345788999999999999999999999988 8899999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... .+++..++.++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999998654 489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.... ......++..|+|||.+.+...+.++||||||+++++|++|+.||.... ..............
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~----- 221 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGE----- 221 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCC-----
Confidence 3221 1233457889999999988889999999999999999999999996422 11111111111000
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...........+.+++.+|++.+|.+||++.++++
T Consensus 222 ----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 ----PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111222467889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=282.61 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=189.8
Q ss_pred HHHHHhcCCCCCCee--eecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHh-cCCCeeeeeeeeeeCC
Q 012267 136 ELQVATDSFSNKNIL--GRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRNLLRLRGFCMTP 211 (467)
Q Consensus 136 ~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~ 211 (467)
+.....++|.+.+.+ |+|+||.||++... ++..+|+|.+....... .|+..... .+|+|++++++.+...
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 333344566766666 99999999999864 68899999986532211 12222222 2699999999999999
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeec
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDF 290 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Df 290 (467)
+..++||||+++++|.+++.... ++++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999999997653 489999999999999999999999 999999999999999998 9999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
|++....... ...++..|+|||++.+..++.++||||||+++|||++|+.||.... ........+......
T Consensus 155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~- 225 (267)
T PHA03390 155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEELDLESLLKRQQK- 225 (267)
T ss_pred ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---cchhhHHHHHHhhcc-
Confidence 9987654221 2357889999999998889999999999999999999999996321 111122222222100
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC-HHHHH
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVV 415 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl 415 (467)
.. .........+.+++.+||+.+|.+||+ +++++
T Consensus 226 ----~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 226 ----KL-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred ----cC-------CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 00 001123356889999999999999996 68875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=312.11 Aligned_cols=204 Identities=22% Similarity=0.326 Sum_probs=160.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC--CCCEEEEEEec--------------c--CCCcchHHHHHHHHHHHHhcCCCee
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLK--------------E--ERTPGGELQFQTEVEMISMAVHRNL 201 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~--~g~~vavK~~~--------------~--~~~~~~~~~~~~e~~~l~~l~h~ni 201 (467)
..++|++.+.||+|+||+||++..+ ++..+++|.+. . .........+.+|+.++.+++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998754 22222222110 0 0111223457899999999999999
Q ss_pred eeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC
Q 012267 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 280 (467)
Q Consensus 202 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~ 280 (467)
+++++++...+..++|++++. ++|.+++...... ...........++.||+.||.|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 5777777543211 11234566778999999999999999 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCc
Q 012267 281 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347 (467)
Q Consensus 281 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~ 347 (467)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999876543333334456899999999999999999999999999999999987643
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=286.00 Aligned_cols=265 Identities=25% Similarity=0.351 Sum_probs=197.0
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEeecc
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
|.+.+.||+|++|+||+|... +++.|+||++.............+|+..+.+++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 578999999876544333334567899999999 999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
+|+|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887654 22489999999999999999999999 999999999999999999999999999986543221
Q ss_pred eeeeccccccccccccccc-CCCCCcchhHHHHHHHHHHHHcCCCCcccccccC--------CCCccHHHHHHHHhhhcc
Q 012267 302 HVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN--------DDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 372 (467)
.....++..|+|||++. ...++.++||||||++++||++|+.||....... ........|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 12344788999999875 4457899999999999999999999985321100 000001112221111111
Q ss_pred cccccCcccc---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+..... ..........+.+++.+||+.+|.+|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1111100000 0000111366889999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=284.68 Aligned_cols=242 Identities=26% Similarity=0.313 Sum_probs=189.1
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
||+|+||+||++... +|+.||+|.+..... ......+..|++++..++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 689999999865322 22233567899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeec
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 306 (467)
.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..... ......
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccc
Confidence 999976542 2489999999999999999999999 999999999999999999999999999876542 112223
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
..++..|+|||++.+..++.++||||||+++|+|++|+.||...... ........... .. .. ...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~-----~~--~~----~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEELKRRTL-----EM--AV----EYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHHHhccc-----cc--cc----cCC
Confidence 45788999999998888999999999999999999999999642211 11111111100 00 00 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRPKMSE 413 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RPs~~e 413 (467)
......+.+++.+||+.+|.+||+.++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 122356889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=287.42 Aligned_cols=256 Identities=16% Similarity=0.213 Sum_probs=183.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHH----------HHHHHHHHHHhcCCCeeeeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGEL----------QFQTEVEMISMAVHRNLLRLRG 206 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~----------~~~~e~~~l~~l~h~niv~~~~ 206 (467)
.++|.+.++||+|+||+||+|...+ +..+|+|...........+ ....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4678999999999999999998754 3466777543222111110 1122334455678999999998
Q ss_pred eeeCCC----ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC
Q 012267 207 FCMTPT----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282 (467)
Q Consensus 207 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~ 282 (467)
.+.... ..+++++++.. ++.+.+.... ..++..+..++.|+++||+|||+. +|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 765443 34678887643 6766665432 256788899999999999999999 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCC------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC
Q 012267 283 FEAVVGDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 356 (467)
Q Consensus 283 ~~~kl~Dfgl~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~ 356 (467)
+.++|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~---~ 239 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH---N 239 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc---c
Confidence 9999999999986542211 111224589999999999999999999999999999999999999964211 1
Q ss_pred CccH----HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 357 DVML----LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 357 ~~~~----~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
.... .++...... +.+. .......+.+++..|++.+|++||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAAKCDFIKRLHE---------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHhHHHHHHHhhh---------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1101 111111111 1110 0112366889999999999999999999998874
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=287.91 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=199.4
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
||.|+||.||+++.. +|+.|++|.+...... .....+..|++++.+++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 5899999998654321 2344688899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC-----
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----- 301 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 301 (467)
.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99998643 389999999999999999999999 999999999999999999999999999875432211
Q ss_pred --eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 302 --HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 302 --~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
.......++..|+|||.......+.++||||||+++|+|++|+.||.... .......... .... -+
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~---~~ 221 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN-GKIE---WP 221 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-CCcC---CC
Confidence 12233457889999999988888999999999999999999999995321 1111111111 0000 00
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
. .......+.+++.+||+.+|++|||+..+.+.|+...+.
T Consensus 222 ~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 222 E-----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred c-----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 0 000236688999999999999999998888888776553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=282.50 Aligned_cols=248 Identities=20% Similarity=0.242 Sum_probs=191.1
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHH-HHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
+.||+|++|.||+|... +|+.||||+++..... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 6889999998653221 112234445444 3455899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
++|.+++.... ++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997643 378889999999999999999999 999999999999999999999999999875432
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ........... ... ..+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~--~~~~~-- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--------PDAVFDNILSR-RIN--WPEEV-- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhc-ccC--CCCcc--
Confidence 223457889999999988888999999999999999999999995321 11111111111 000 00011
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
.......+.+++.+||+.+|++||++.++.+.|....
T Consensus 217 --~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~ 253 (260)
T cd05611 217 --KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253 (260)
T ss_pred --cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChH
Confidence 1123366889999999999999999888877776643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=285.88 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=197.7
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
|+..+.||.|++|.||+|... +|+.+++|+++..... .....+..|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999875 7899999998754433 23456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++ +|.+++.... .++++..+..++.++++||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 8888887643 2489999999999999999999999 99999999999999999999999999987664332
Q ss_pred eeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh--hcccccccC
Q 012267 302 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--EKKLEMLVD 378 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d 378 (467)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...... ..+......... ........+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI----DQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCchHhcccchh
Confidence 112223477889999998776 7899999999999999999999998532110 000000000000 000000000
Q ss_pred ---------ccc----cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 ---------PDL----QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ---------~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.. ...........+.+++..||+.+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00111234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=284.13 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=194.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC----CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--Cce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 214 (467)
.+|...+.||+|+||.||+|... ++..||+|.+.... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999864 68999999875321 122334688999999999999999999998764 457
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++++||+++++|.+++.... .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987643 278889999999999999999999 99999999999999999999999999997
Q ss_pred ccCCC--CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 295 LMDYK--DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 295 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
..... .........++..|+|||++.+..++.++|||||||++|+|++|+.||.... .... +...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~-~~~~~~~-~ 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAA-IFKIATQ-P 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHH-HHHHHcC-C
Confidence 65321 1111223457889999999988888999999999999999999999995311 0111 1111110 0
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+. ........+.+++.+|++ +|..||+..+++.
T Consensus 226 ----~~~~----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ----TKPM----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCC----CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111 122233668889999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=287.81 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=193.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..+.||+|++|+||+|... +|+.||+|.+...... .....+..|+++++.++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 6899999998654322 223467889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecCCccccCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~ 298 (467)
|++ ++|.+++..... ..+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 588888765432 2367888899999999999999999 9999999999999985 56799999999976532
Q ss_pred CCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. .......++..|+|||++.+ ..++.++||||||+++|+|+||+.||...... ........ .... ......
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~~-~~~~-~~~~~~ 228 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIFR-ILGT-PNEETW 228 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHH-HhCC-CChhhc
Confidence 21 11122346789999998865 45789999999999999999999999532110 00000000 0000 000000
Q ss_pred ------------CccccC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 ------------DPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 ------------d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.... .........+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 001112355788999999999999999999975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=297.53 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=204.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
...|.+...||+|.|++|.+|++. ++..||||.+.+..... ....+.+|+++|..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888899999999999999865 79999999997654433 3345889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+.+|.+++++..+.. ........++.|+..|++|+|++ .|||||||.+||||+.+..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence 99999999999998764 45578888999999999999999 99999999999999999999999999998875
Q ss_pred CCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
........+|++.|.|||++.+..+ .+.+|+||+|++||.|+.|..||+...... .-
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------------------Lr 264 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------------------LR 264 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------------------cc
Confidence 4556677889999999999998776 789999999999999999999997532211 11
Q ss_pred CccccCcc--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNY--VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
++.+.+.+ ..-...++-+++++++-.+|.+|++++++..
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11111111 1111245677888899999999999998843
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=301.89 Aligned_cols=200 Identities=29% Similarity=0.434 Sum_probs=174.2
Q ss_pred CCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------CceEE
Q 012267 144 FSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERLL 216 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 216 (467)
+...+.||+|+||.||+|+. .+|+.||||.++........+....|++++++++|+|||+++++-... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457899999999999995 489999999998776666677889999999999999999999986543 35689
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC--CCC--cEEEeecCC
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEF--EAVVGDFGL 292 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgl 292 (467)
|||||.+|||...|.... +...+++.+.+.+..+++.||.|||++ +|+||||||.||++- .+| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998754 344599999999999999999999999 999999999999983 334 479999999
Q ss_pred ccccCCCCCeeeeccccccccccccccc-CCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
|+.++. ......++||..|++||++. ...|+..+|.|||||++|+.+||..||..
T Consensus 171 Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 997753 34667788999999999998 48889999999999999999999999964
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=289.21 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=194.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 216 (467)
.++|+..+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.++.+++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367888999999999999999975 68999999987543222 223466899999999999999999998754 46799
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+.+ +|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999965 8888887542 2489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc---
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK--- 372 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 372 (467)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... ......-+........
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-----EIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCChhh
Confidence 432211 122235778999999865 457899999999999999999999995321 1111111111100000
Q ss_pred ---------cccccCccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 ---------LEMLVDPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ---------~~~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
......+...... .......+.+++.+|++.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000 0112456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=285.95 Aligned_cols=243 Identities=22% Similarity=0.344 Sum_probs=192.9
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
.+||+|+||.||++... +|..||||.+.... ......+..|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 56999999999999874 78999999985432 23445688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeec
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 306 (467)
.+++... .+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9987543 278899999999999999999999 999999999999999999999999999875543221 1233
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||.... . .+.+..... ...+.+.. .
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-----~---~~~~~~~~~------~~~~~~~~--~ 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----P---LKAMKMIRD------NLPPKLKN--L 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHh------hCCcccCC--c
Confidence 457889999999988888999999999999999999999985311 0 111111110 01111100 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112245778899999999999999999866
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=284.84 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=193.9
Q ss_pred CCCCCCeeeecCceEEEEEEE----CCCCEEEEEEeccCCC---cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCce
Q 012267 143 SFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 214 (467)
+|+..+.||+|+||.||+++. .+|..||+|+++.... ......+..|+.++..+ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 3688999999865321 22234678899999999 599999999999988899
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++++|.+++.... ++++..+..++.|+++||.|||+. +++||||+|+|||+++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997643 378889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
..............|+..|+|||.+... .++.++||||||+++|+|++|+.||.... .......+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSE- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC----ccccHHHHHHHhhccC-
Confidence 6543322222334578899999998653 46789999999999999999999995311 1112222222221111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEV 414 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev 414 (467)
+.. .......+.+++.+||+.+|++|| ++.++
T Consensus 229 ------~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l 265 (290)
T cd05613 229 ------PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEI 265 (290)
T ss_pred ------CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 111 111235678899999999999997 55555
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=280.50 Aligned_cols=248 Identities=26% Similarity=0.464 Sum_probs=200.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+|+..+.||+|++|.||++... ++..|++|.+...... .....+.+|++++.+++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 6789999999765432 2344688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999987652 389999999999999999999999 99999999999999999999999999998765333
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... ....... .... . .+.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~~-~~~~-~-----~~~ 218 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALFR-IVQD-D-----HPP 218 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHH-Hhcc-C-----CCC
Confidence 21 233457889999999988788999999999999999999999985321 1111111 1100 0 011
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ .......+.+++.+||..+|++||++.+++.
T Consensus 219 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 L----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1112356889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=288.22 Aligned_cols=258 Identities=25% Similarity=0.321 Sum_probs=187.0
Q ss_pred eeeecCceEEEEEEECCCCEEEEEEeccC-CCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChh
Q 012267 149 ILGRGGFGKVYKGRLADGSLVAVKRLKEE-RTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 227 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 227 (467)
.+|.|+++.||++.. +++.||||+++.. ........+..|+++++.++|+||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344445555555544 6899999999765 23334457899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC------
Q 012267 228 SCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------ 301 (467)
Q Consensus 228 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~------ 301 (467)
+++...... .+++..+..++.|+++||+|||++ +|+|+||||+||+++.++.+||+|||.+........
T Consensus 88 ~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 88 DLLKTHFPE--GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999865322 378889999999999999999999 999999999999999999999999998865432111
Q ss_pred eeeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh----hh-----
Q 012267 302 HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL----KE----- 370 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~----- 370 (467)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||...... ....+-..... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCchhh
Confidence 11122346778999999865 35789999999999999999999999632110 00000000000 00
Q ss_pred --ccccc----ccCccc----cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 --KKLEM----LVDPDL----QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 --~~~~~----~~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... ..++.. ...........+.+++.+||+.+|++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 001100 00112233467889999999999999999998854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=288.15 Aligned_cols=263 Identities=23% Similarity=0.324 Sum_probs=192.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-------
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------- 212 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 212 (467)
++|+..+.||+|+||.||+|... ++..||||.+...... .....+.+|++++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999875 6899999998654322 22335678999999999999999999987654
Q ss_pred -ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 213 -ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 213 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999965 8888876542 2389999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCe---eeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHH
Q 012267 292 LAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 367 (467)
Q Consensus 292 l~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 367 (467)
++......... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||..... ......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~~~ 239 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLISQL 239 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHH
Confidence 99865432211 11223467889999988664 468899999999999999999999853211 1111111111
Q ss_pred hh---hccccc---------ccCccccCcccH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 368 LK---EKKLEM---------LVDPDLQNNYVE------AEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 368 ~~---~~~~~~---------~~d~~~~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ...... ...+.-...... .....+.+++.+||+.+|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 10 000000 000000000000 01245678999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=281.49 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=195.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC----CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
+|.+.+.||+|+||.||+++.. .+..+++|.++... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999865 34556666654321 222334577889999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++.........+++..++.++.|+++||.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876433344589999999999999999999999 9999999999999976 569999999987654
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.... ........... .
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~------~ 221 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEG------P 221 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcC------C
Confidence 322 22233457889999999988888999999999999999999999985311 11222211111 0
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 2233467889999999999999999999965
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=284.79 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=193.3
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhc---CCCeeeeeeeeeeCCCc-----
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMA---VHRNLLRLRGFCMTPTE----- 213 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 213 (467)
|+..+.||+|+||.||+|+.. ++..||+|+++...... ....+..|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556788999999999999986 58999999997543322 233466777776655 69999999999987776
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.+++|||+.+ +|.+++..... ..+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 89998876432 2489999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
........ .....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+..+..........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHHHcCCCChH
Confidence 76543221 1223468899999999988899999999999999999999999863211 11111111111000000
Q ss_pred c---------cccCcccc---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 E---------MLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ~---------~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ........ ..........+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000000 0111233466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=294.34 Aligned_cols=262 Identities=20% Similarity=0.322 Sum_probs=195.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeC----CCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 215 (467)
++|+..+.||+|++|.||+|... +|..||+|++...... .....+..|+.++.+++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888999999999999999865 6899999998754322 234467789999999999999999998763 34679
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 68999886543 289999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCC---eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh--
Q 012267 296 MDYKDT---HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-- 369 (467)
Q Consensus 296 ~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 369 (467)
...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g~~ 231 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLGSP 231 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhCCC
Confidence 543221 11223467889999998765 45789999999999999999999999542110 00011000000
Q ss_pred ---------hcccccccC--ccccC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 ---------EKKLEMLVD--PDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ---------~~~~~~~~d--~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
........+ +.... .........+.+++.+||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000 00000 001123467899999999999999999998865
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=292.12 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=195.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCC--CceE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP--TERL 215 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~ 215 (467)
.++|+..+.||+|+||.||+|... +|..+|+|++.... .......+..|+.++.++ +|+||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999875 68899999885432 222334577899999999 999999999998653 4679
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||++ ++|.+++... .++|..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 5999988764 378999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC----eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCC-----------CCcc
Q 012267 296 MDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-----------DDVM 359 (467)
Q Consensus 296 ~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~-----------~~~~ 359 (467)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543221 12233457889999998754 4578899999999999999999999953211000 0000
Q ss_pred HHHHHHHHhhhcccccccCcccc--CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 360 LLDWVKGLLKEKKLEMLVDPDLQ--NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
+..+. .......+......... ..........+.+++.+||+.+|.+|||+.++++.
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIK-SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHH-hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 00000000000000000 00011134678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.90 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=198.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.|.++..||.|+||.||+|..+ ++-..|-|++... .....++++-|+++|+.+.||+||++++.|...+.++++.|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3444566999999999999876 4556677877543 3344557999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
.||.+..++-.-.. ++...++..++.|++.||.|||++ +|+|||||..|||++-+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STR 184 (1187)
T ss_pred CCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHH
Confidence 99999998876432 489999999999999999999999 99999999999999999999999999875422 222
Q ss_pred eeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 302 HVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.....+.||++|||||+.. ..+|..++||||||++|.||..+.+|..... -...+....+.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaKS------ 250 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKS------ 250 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhhc------
Confidence 3345577999999999864 5688999999999999999999999975321 11111111111
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
-.|.+. .+......+.+++..||.+||..||++.++++
T Consensus 251 ePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 112222 13455677889999999999999999998854
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=289.79 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=195.5
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-CCce
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTER 214 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 214 (467)
...+++|+..+.||.|+||.||+|... ++..||||++..... ......+..|++++..++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346778999999999999999999865 789999998864322 2234567889999999999999999999875 5678
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++|+||+ +++|.+++... ++++.....++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 56898888643 278888889999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCC-------CCccHHHHHHH
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLDWVKG 366 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~ 366 (467)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||........ .+....+|...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 122346788999998765 5689999999999999999999999953211000 00000111111
Q ss_pred HhhhcccccccCccccCccc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNYV-----EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
............-....... ......+.+++.+|++.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111000000000000000 112367889999999999999999998843
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=294.92 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=195.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----Cc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 213 (467)
.++|...+.||+|+||+||+|+.. ++..||||.+.... .......+..|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888899999999999999864 68999999986532 222334677899999999999999999988644 34
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 68988887543 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh---
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 369 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 369 (467)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ............
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPS 229 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 8654322 22233457889999998764 4688999999999999999999999954211 000000000000
Q ss_pred --------hccc-------ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 370 --------EKKL-------EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 370 --------~~~~-------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.... ....++... .........+.+++.+||+.+|++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000 000000000 0011234668899999999999999999999755
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=287.42 Aligned_cols=246 Identities=30% Similarity=0.431 Sum_probs=192.1
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.|...+.||+|++|.||+|+.. ++..+|+|.+.... .......+..|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666678999999999999975 67899999986432 22233467889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+. |+|.+++.... .++++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 68888776432 2378999999999999999999999 9999999999999999999999999998765422
Q ss_pred CCeeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||.... -...........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~----- 230 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE----- 230 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHhhcC-----
Confidence 2235788999999874 3567889999999999999999999985311 001111111110
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.+... .......+.+++.+||+.+|.+||++.+|++.
T Consensus 231 -~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 231 -SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -CCCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 01111 11233568889999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=279.86 Aligned_cols=242 Identities=28% Similarity=0.349 Sum_probs=185.2
Q ss_pred eeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHH---HHHhcCCCeeeeeeeeeeCCCceEEEeeccC
Q 012267 149 ILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 222 (467)
+||+|+||.||+|... +++.||+|.+...... .....+..|.. .+....||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 6889999998654322 11222334433 3445679999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
+|+|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999887542 389999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 303 VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||....... .... ..... ...+.+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~~-~~~~~------~~~~~~ 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEI-DRMTL------TMAVEL 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHHH-HHHhh------ccCCCC
Confidence 1234588999999998754 68899999999999999999999996431111 0010 00000 011111
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
.. .....+.+++.+|+..+|.+|| ++.++++
T Consensus 219 ~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 1236788999999999999999 8988863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=287.48 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=191.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC------
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 212 (467)
.++|+..+.||.|++|.||+|... +++.||||++....... ....+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468888999999999999999965 68999999986543322 2335678999999999999999999875433
Q ss_pred --ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 213 --ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 213 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
..++|+||+.+ +|...+.... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 45899999965 7777776532 2489999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCe----------eeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCcc
Q 012267 291 GLAKLMDYKDTH----------VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359 (467)
Q Consensus 291 gl~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~ 359 (467)
|++......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~ 234 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----D 234 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----H
Confidence 999765422111 1122346788999998765 45789999999999999999999999532111 0
Q ss_pred HHHHHHHHhhh---------ccccccc----CccccCc---ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 360 LLDWVKGLLKE---------KKLEMLV----DPDLQNN---YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 360 ~~~~~~~~~~~---------~~~~~~~----d~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...-+...... ..+.... ....... ........+.+++.+|++.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 0000000 0000000 00112256889999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.42 Aligned_cols=244 Identities=29% Similarity=0.425 Sum_probs=191.0
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
|...+.||+|+||+||+|+.. +|..|++|.+...... .....+..|++++..++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999864 6889999998654322 2234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+. |+|.+++.... .++++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 58888776532 2489999999999999999999999 999999999999999999999999999864321
Q ss_pred Ceeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 301 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||.... . ...+....... .
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----~---~~~~~~~~~~~-~---- 237 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----A---MSALYHIAQND-S---- 237 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----h---HHHHHHHHhcC-C----
Confidence 12345788999999984 4567889999999999999999999985321 1 11111111110 0
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+... .......+.+++.+||+.+|.+||++.++++
T Consensus 238 -~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 -PTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1112245888999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=286.51 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=200.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
..+.|+.-++||+|+||.||-+..+ +|..+|.|.+.+..... .+.-.+.|-.+|.+++.+.||.+--.|.+.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467888899999999999999865 79999999886544322 23346788999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|+..|.||+|.-+|.+.+. ..+++..+.-++.+|+-||.+||+. +||+|||||+|||+|+.|+++|+|.|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999999988654 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.. .......+||.+|||||++++..|+...|.||+||+||||+.|+.||...... +...+ +.....
T Consensus 338 ~~--g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk~eE-vdrr~~------- 403 (591)
T KOG0986|consen 338 PE--GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VKREE-VDRRTL------- 403 (591)
T ss_pred CC--CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hhHHH-HHHHHh-------
Confidence 53 33344457999999999999999999999999999999999999999653211 00000 111100
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 412 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 412 (467)
-|+ ..++....++..++....|++||.+|..-+
T Consensus 404 ~~~---~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 EDP---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cch---hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 011 122334445666666777899999997654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=288.29 Aligned_cols=267 Identities=21% Similarity=0.232 Sum_probs=196.8
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCM 209 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 209 (467)
....++...+++|...+.||+|+||.||+|.. .+|..||+|++..... ......+.+|+.++.+++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566677889999999999999999999985 4789999999875422 222346778999999999999999999875
Q ss_pred CC------CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC
Q 012267 210 TP------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 283 (467)
Q Consensus 210 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~ 283 (467)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 43 3467888876 77998887653 288999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHH
Q 012267 284 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 284 ~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 362 (467)
.+||+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..
T Consensus 158 ~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~ 229 (345)
T cd07877 158 ELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKL 229 (345)
T ss_pred CEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 999999999875432 1223457889999998866 5678999999999999999999999953211 000111
Q ss_pred HHHHHhh--hcccc---------------cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 363 WVKGLLK--EKKLE---------------MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 363 ~~~~~~~--~~~~~---------------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+..... ..... ........ .........+.+++.+|++.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000 00000 00000000 000012345789999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=281.22 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=199.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 217 (467)
++|...+.||+|++|.||+|... +|..||+|++..... ......+..|.+++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999875 789999999865322 223446888999999998 99999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999998653 389999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC-------------------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCc
Q 012267 298 YKDT-------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 358 (467)
Q Consensus 298 ~~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~ 358 (467)
.... .......++..|+|||......++.++||||||++++++++|+.||.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~- 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----E- 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----H-
Confidence 3221 12223347889999999988889999999999999999999999996422 0
Q ss_pred cHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCH----HHHH
Q 012267 359 MLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM----SEVV 415 (467)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~evl 415 (467)
......... ... .........+.+++.+||+.+|.+||++ ++++
T Consensus 228 --~~~~~~~~~---~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 228 --YLTFQKILK---LEY--------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred --HHHHHHHHh---cCC--------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 011111111 000 0111123668899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=287.27 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=197.8
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-----ceE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 215 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 215 (467)
+|...+.||.|++|.||+|+.. ++..||||++..... ......+..|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 589999999875432 333457889999999999999999999988765 789
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||++ ++|.+++.... ++++..++.++.+++.||+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 48998887643 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--eeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc-
Q 012267 296 MDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK- 371 (467)
Q Consensus 296 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 371 (467)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .....+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCCC
Confidence 653321 112334578899999999887 7899999999999999999999999542210 0000000000000
Q ss_pred ----------ccccccC---ccc---cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 ----------KLEMLVD---PDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ----------~~~~~~d---~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.....+. ... ...........+.+++.+||+.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000000 000 00001113456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.94 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=189.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------C
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 212 (467)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++..++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888899999999999999864 689999999865332 22234678999999999999999999998654 2
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++|+||+.. +|..++.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 77766531 288899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH------
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK------ 365 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------ 365 (467)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+.....
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~ 235 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL----DQLTQILKVTGVPG 235 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCC
Confidence 8754321 123346788999999866 46889999999999999999999999642110 00000000
Q ss_pred ----HHhhhcccccccC--ccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 366 ----GLLKEKKLEMLVD--PDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 366 ----~~~~~~~~~~~~d--~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
............. +...... .......+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000000 0000000 0012345789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.90 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=189.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee----------
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM---------- 209 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---------- 209 (467)
..+|+..++||+|+||.||+++.+ ||+.||||+|...........+.+|+..+++++|||||+++..+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 356888899999999999999977 899999999987654444556889999999999999999874210
Q ss_pred ----------------------------------------------C----------------------C----------
Q 012267 210 ----------------------------------------------T----------------------P---------- 211 (467)
Q Consensus 210 ----------------------------------------------~----------------------~---------- 211 (467)
. +
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 0
Q ss_pred -------------------------------CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 012267 212 -------------------------------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260 (467)
Q Consensus 212 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh 260 (467)
..+|+-||||+.-+|.++++.+.-.. .-...++++.+|++||+|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence 12368889999888888877654221 34678899999999999999
Q ss_pred cCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC-----------------CCCCeeeecccccccccccccccCC-
Q 012267 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------------YKDTHVTTAVRGTIGHIAPEYLSTG- 322 (467)
Q Consensus 261 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-----------------~~~~~~~~~~~g~~~y~aPE~~~~~- 322 (467)
++ +||||||||.||++|++..|||+|||++.... .......+...||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998621 0011123445699999999999764
Q ss_pred --CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHc
Q 012267 323 --KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLC 400 (467)
Q Consensus 323 --~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c 400 (467)
.|+.|+|+||+|||++||+. ||.... .-...+ ..++...+..- ..+..+....-.+++.++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------ERa~iL-~~LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------ERASIL-TNLRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchH-------HHHHHH-HhcccCCCCCC------cccccccchHHHHHHHHH
Confidence 49999999999999999986 564211 000111 11111111111 112233344556889999
Q ss_pred cCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 401 TQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 401 l~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
+++||.+|||+.|+ |+...+.
T Consensus 855 l~hdP~kRPtA~eL---L~s~llp 875 (1351)
T KOG1035|consen 855 LSHDPSKRPTATEL---LNSELLP 875 (1351)
T ss_pred hcCCCccCCCHHHH---hhccCCC
Confidence 99999999999988 4444444
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=287.85 Aligned_cols=262 Identities=24% Similarity=0.312 Sum_probs=192.5
Q ss_pred cCCC-CCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-------------hHHHHHHHHHHHHhcCCCeeeeeee
Q 012267 142 DSFS-NKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-------------GELQFQTEVEMISMAVHRNLLRLRG 206 (467)
Q Consensus 142 ~~~~-~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~~~~ 206 (467)
++|. ..+.||.|+||+||+|... +++.||||.++...... ....+.+|++++..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3577999999999999865 68999999986543221 0124678999999999999999999
Q ss_pred eeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 207 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
++...+..++||||+. |+|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 69999986532 388899999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCC-------------CeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccc
Q 012267 287 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARL 352 (467)
Q Consensus 287 l~Dfgl~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~ 352 (467)
|+|||++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~- 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN- 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999987654111 1111223367889999998764 46899999999999999999999995321
Q ss_pred cCCCCccHHHHHHHHhhhccc----ccc-------cCccccC---cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 353 ANDDDVMLLDWVKGLLKEKKL----EML-------VDPDLQN---NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~----~~~-------~d~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......+......... ... ..+.... .........+.+++.+|++.+|++||++.+++.
T Consensus 239 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 ----EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ----HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111111110000 000 0000000 001112356889999999999999999999964
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=279.60 Aligned_cols=260 Identities=27% Similarity=0.358 Sum_probs=196.5
Q ss_pred CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
|+..+.||+|++|.||+|+.. +++.||+|.+..... ......+..|+.++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999976 589999999976532 222346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
+ ++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999998753 2389999999999999999999999 999999999999999999999999999886543222
Q ss_pred eeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc---------
Q 012267 302 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--------- 371 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 371 (467)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..............
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-----IDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHHHhCCCcHHHHHhhc
Confidence 12223356789999998766 789999999999999999999999854211 00111111100000
Q ss_pred cc--ccccCccccC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KL--EMLVDPDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~--~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ....-+.... .........+.+++.+||+.+|++||++.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0000000000 001112467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.43 Aligned_cols=252 Identities=28% Similarity=0.380 Sum_probs=197.3
Q ss_pred hcCCCCCCeeeecCceEEEEEE-ECCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+-++....+||.|.||.||-|. ..+|+..|+|-++..... .......+|+.++..++|||+|+++|+-..++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4466677899999999999998 457999999998754322 22335789999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
|||++|+|.+++..... .++.....+..|++.|++|||++ +||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999986543 56666777889999999999999 999999999999999999999999999987654
Q ss_pred CCCe---eeecccccccccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 299 KDTH---VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 299 ~~~~---~~~~~~g~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
.... ......||+.|||||++.+.. ..-+.||||+|||++||+||++||.... .+|.-.+-
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---------ne~aIMy~---- 1453 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---------NEWAIMYH---- 1453 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---------chhHHHhH----
Confidence 4211 223456999999999997643 4568999999999999999999995311 12222110
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....--|. .+.....+-.+++.+|++.||++|-++.|+++
T Consensus 1454 V~~gh~Pq----~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1454 VAAGHKPQ----IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhccCCCC----CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 00011121 22234456678899999999999988776643
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=285.97 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=192.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-----
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 212 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 212 (467)
..++|+..+.||+|+||.||+|... +|..||||++..... ......+..|+++++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999854 789999999864332 222346789999999999999999999987543
Q ss_pred -ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 213 -ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 213 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 77999888642 388999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCC-------CCccHHHH
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLDW 363 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~-------~~~~~~~~ 363 (467)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .......|
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 98765322 123356889999998875 4578999999999999999999999963211000 00000011
Q ss_pred HHHHhhhcc------cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 364 VKGLLKEKK------LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 364 ~~~~~~~~~------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
......... +.......+ ..........+.+++.+|++.||.+|||+.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 111100000 000000000 000112234578999999999999999999987
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=271.65 Aligned_cols=201 Identities=28% Similarity=0.369 Sum_probs=177.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|...++||+|.||+|-+++-+ +|+.+|+|++++..... ....-..|-++|...+||.+..+.-.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888899999999999999855 79999999998765432 233467889999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||..||.|.-+|..... +++....-+-..|+.||.|||++ +||+||||.+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsrer~----FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV----FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred EEEccCceEeeehhhhhc----ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-
Confidence 999999999988876432 77777777888999999999999 9999999999999999999999999999852
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
...+..+..++||+.|+|||++....|..+.|.|.+||++|||++|+.||..
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 3455667789999999999999999999999999999999999999999963
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.97 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=188.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC---------
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--------- 211 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 211 (467)
.+|...+.||.|+||.||+|... +|..||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 67888999999999999999865 689999999865443 3345688999999999999999999876543
Q ss_pred -----CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC-CCCcE
Q 012267 212 -----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFEA 285 (467)
Q Consensus 212 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~ 285 (467)
...++||||++ ++|.+++... .+++..++.++.||++||.|||+. +++||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35689999997 5898888643 288999999999999999999999 999999999999997 45678
Q ss_pred EEeecCCccccCCCCCe--eeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHH
Q 012267 286 VVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 362 (467)
+++|||++..+...... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...... .....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~----~~~~~ 230 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL----EQMQL 230 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 99999999765322111 1122346889999997654 56788999999999999999999999532110 00000
Q ss_pred HHHH-----------Hhhh--cccc-cccCcccc-CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 363 WVKG-----------LLKE--KKLE-MLVDPDLQ-NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 363 ~~~~-----------~~~~--~~~~-~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
.... .... .... ....+... ..........+.+++.+|++.+|.+|||+.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 0000 0000 0000 00000000 000011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=286.76 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=193.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc----
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE---- 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 213 (467)
..++|+..+.||+|++|.||+|+.. ++..||||++..... ......+..|+.+++.++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999975 688999999865322 2233457789999999999999999998766554
Q ss_pred --eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 214 --RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 214 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 66999988752 389999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .+.+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--------~~~~~~i~~~ 231 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--------IDQLKRIMNL 231 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHh
Confidence 99865322 223457889999998865 4678999999999999999999999953211 0111111000
Q ss_pred --------------cccccccCc--ccc-Ccc---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 --------------KKLEMLVDP--DLQ-NNY---VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 --------------~~~~~~~d~--~~~-~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
......+.. ... ... .......+.+++.+|++.+|++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 000 000 0112467889999999999999999999854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=269.14 Aligned_cols=237 Identities=28% Similarity=0.329 Sum_probs=191.7
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
||.|++|.||++... +++.+|+|.+....... ....+..|+++++.++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 58999999987653322 344688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeec
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 306 (467)
.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99997653 389999999999999999999998 99999999999999999999999999987654322 12334
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 307 ~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
..++..|+|||...+...+.++|+||||+++|+|++|+.||.... . .......... . ..+ .
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~---~~~~~~~~~~-~------~~~----~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-----R---KEIYEKILKD-P------LRF----P 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHhcC-C------CCC----C
Confidence 457889999999988888999999999999999999999995321 1 1111121110 0 001 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRPKMSE 413 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RPs~~e 413 (467)
......+.+++.+||..+|++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111366789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=272.40 Aligned_cols=266 Identities=24% Similarity=0.339 Sum_probs=213.3
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEECC------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeee
Q 012267 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206 (467)
Q Consensus 133 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 206 (467)
...++.+...+++...++.+|.||.||.|.+.+ .+.|-||.++....+-....++.|.-.+..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 356677778889999999999999999996543 45678888877766666667888988899999999999999
Q ss_pred eeeC-CCceEEEeeccCCCChhhhhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC
Q 012267 207 FCMT-PTERLLVYPYMANGSVASCLRERP----PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 281 (467)
Q Consensus 207 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~ 281 (467)
++.+ ....+++|.++.-|+|..+|.... .....++-.+...++.|++.||+|||++ ++||.||..+|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 9875 456799999999999999998322 2234577888899999999999999999 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCcc
Q 012267 282 EFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVM 359 (467)
Q Consensus 282 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~ 359 (467)
..++||+|-.+++.+...+.+ ..........||+||.+....|+.++|||||||+||||+| |+.|+-.....
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------ 505 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------ 505 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH------
Confidence 999999999999876544433 2223335678999999999999999999999999999998 88898432111
Q ss_pred HHHHHHHHhhh-cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 360 LLDWVKGLLKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 360 ~~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+ +...+++ .++ ..+..+..+++.+|.-||...|++||+++|+++-|.+
T Consensus 506 --E-m~~ylkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 --E-MEHYLKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred --H-HHHHHhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 1122221 222 2244566889999999999999999999999999876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.90 Aligned_cols=264 Identities=20% Similarity=0.243 Sum_probs=188.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC-C--CCEEEEEEeccCCCc-chHHHHHHHHHHHHhc-CCCeeeeeeeeeeC----CCc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-D--GSLVAVKRLKEERTP-GGELQFQTEVEMISMA-VHRNLLRLRGFCMT----PTE 213 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~--g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~ 213 (467)
+|+..+.||+|+||.||+++.. + +..||+|++...... .....+..|++++.++ .|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677789999999999999965 4 779999998643222 2244678899999998 59999999987543 245
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++++||+. ++|.+++.... .+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688899886 68999886543 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCC-------CCccHHH
Q 012267 294 KLMDYKDT---HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLD 362 (467)
Q Consensus 294 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~-------~~~~~~~ 362 (467)
+....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .+....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86542211 11223458899999998765 4689999999999999999999999964221000 0000000
Q ss_pred HHHHHhhhcc------cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 363 WVKGLLKEKK------LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 363 ~~~~~~~~~~------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
+......... ....-...+ ..........+.+++.+|++.+|.+|||+.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1110000000 000000000 000011235688999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=267.43 Aligned_cols=263 Identities=23% Similarity=0.331 Sum_probs=198.1
Q ss_pred cccCHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHh-cCCCeeeeeeee
Q 012267 130 KRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRNLLRLRGF 207 (467)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~ 207 (467)
..|+-++++. ...||.|.||+|+|-.++ .|+..|||+++.........+++.|.+...+ -+.||||+++|.
T Consensus 59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3455554444 345999999999999865 7999999999987776667788889887554 479999999999
Q ss_pred eeCCCceEEEeeccCCCChhhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 208 CMTPTERLLVYPYMANGSVASCLRER-PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 208 ~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
+...+..|+-||.|.- ||..+.+.- ......+++...-.|....+.||.||-... .|+|||+||+|||+|..|.+|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEe
Confidence 9999999999999954 666543321 011223777778888888899999999875 899999999999999999999
Q ss_pred EeecCCccccCCCCCeeeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 287 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
|+|||++..+. ++...+.-+|-..|||||-+.. ..|..+|||||||++|||+.||+.|+.... +..+.+
T Consensus 209 LCDFGIcGqLv--~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql 279 (361)
T KOG1006|consen 209 LCDFGICGQLV--DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQL 279 (361)
T ss_pred eecccchHhHH--HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHH
Confidence 99999997653 2233344468889999998864 348899999999999999999999995311 122222
Q ss_pred HHHhhhcccccccCccccC-cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 365 KGLLKEKKLEMLVDPDLQN-NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
...+.... |.+.. ....+....+..++..|+-+|-..||...++.++
T Consensus 280 ~~Vv~gdp------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 CQVVIGDP------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHcCCC------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22222211 12211 1123456778899999999999999999988653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.93 Aligned_cols=146 Identities=32% Similarity=0.428 Sum_probs=130.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|.+.++||+|+||+||+|... +++.||||+++.... ......+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999976 689999999975432 222346888999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
||+.+++|.+++.... .+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 278889999999999999999998 99999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=261.61 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=194.1
Q ss_pred hcCCCCC-CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC----CCc
Q 012267 141 TDSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT----PTE 213 (467)
Q Consensus 141 ~~~~~~~-~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~ 213 (467)
+++|++. ++||-|-.|.|-.+..+ +|+.+|+|++... + ..++|++...+. .|||||.++++|.+ ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--P----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--H----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3445433 67999999999999865 7999999998532 1 346788876655 59999999999864 345
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC---CcEEEeec
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDF 290 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Df 290 (467)
+++|||.|+||.|++.+++++. ..++++++..|+.||+.|+.|||+. +|.||||||+|+|...+ -.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 6799999999999999998753 4589999999999999999999999 99999999999999654 46899999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
|+|+.... .......+-|+.|.|||++...+|....|+||+||++|-|++|.+||.... +..+..=++.....
T Consensus 209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h-----g~aispgMk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKRRIRT 281 (400)
T ss_pred ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC-----CccCChhHHhHhhc
Confidence 99986432 233444567999999999999999999999999999999999999995311 11111111211111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.. .+.........+...++++..|..+|++|.|+.+++.
T Consensus 282 gqy------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 GQY------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCc------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 110 0112223455677888999999999999999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=261.76 Aligned_cols=205 Identities=27% Similarity=0.381 Sum_probs=169.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC---C--CCEEEEEEeccCCCcch-HHHHHHHHHHHHhcCCCeeeeeeeeeeC-CCce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA---D--GSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNLLRLRGFCMT-PTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~---~--g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 214 (467)
..|+....||+|.||.||+|.-. + ...+|+|.++......+ .....+|+.+++.++|+|++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46888899999999999999643 2 23799999976543222 3467899999999999999999999887 7788
Q ss_pred EEEeeccCCCChhhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC----CcEEEee
Q 012267 215 LLVYPYMANGSVASCLRERPPS-QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGD 289 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~D 289 (467)
++++||.+. +|.+.|+-+... ...++-..+..|+.||+.|+.|||++ =|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 899988754322 24588889999999999999999999 79999999999999877 8999999
Q ss_pred cCCccccCCCCC--eeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccc
Q 012267 290 FGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLA 350 (467)
Q Consensus 290 fgl~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~ 350 (467)
+|+++.+...-. .....++-|..|+|||.+.+. .||.+.|||+.|||+.||+|-.+.|...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999998754321 123345568999999998875 5899999999999999999998888653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=266.42 Aligned_cols=219 Identities=21% Similarity=0.185 Sum_probs=174.5
Q ss_pred cCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhh
Q 012267 153 GGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 231 (467)
Q Consensus 153 G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 231 (467)
|.+|.||++... +++.||+|+++... .+..|...+....|||++++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 889999999865 78999999986542 23344455555679999999999999999999999999999999987
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeecccccc
Q 012267 232 ERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 311 (467)
Q Consensus 232 ~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~ 311 (467)
... .+++..+..++.|+++||.|||+. +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 643 389999999999999999999999 9999999999999999999999999987654321 12234567
Q ss_pred cccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHH
Q 012267 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVE 391 (467)
Q Consensus 312 ~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 391 (467)
.|+|||.+.+..++.++||||+|+++|||++|+.|+........ . .... .+ ......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~--~~~~---~~----~~~~~~ 203 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------T--HTTL---NI----PEWVSE 203 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------c--cccc---CC----cccCCH
Confidence 89999999888889999999999999999999988753211000 0 0000 01 111235
Q ss_pred HHHHHHHHccCCCCCCCCCH
Q 012267 392 QLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 392 ~l~~l~~~cl~~~p~~RPs~ 411 (467)
.+.+++.+|++.||++||++
T Consensus 204 ~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHccCCHHHhcCC
Confidence 67889999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=304.85 Aligned_cols=210 Identities=25% Similarity=0.360 Sum_probs=186.1
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeee
Q 012267 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCM 209 (467)
Q Consensus 133 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 209 (467)
...++....++|.+.++||+|+||.|..++++ +++.||+|++++... ......|..|-.+|..-+.+.|+.+.-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35667778899999999999999999999976 689999999976321 223457899999999999999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
+..++|+|||||+||+|-.++.+.. ++++..+.-++..|+.||.-||+. |+|||||||+|||||..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999998865 378888888899999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCeeeeccccccccccccccc----C-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS----T-GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
||.+..+.....-.....+|||.|++||++. + +.|...+|.||+||++|||+.|..||..
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 9999888766666666778999999999985 2 5789999999999999999999999964
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=257.45 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=196.7
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEE-ECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCC
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 211 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 211 (467)
+.++-..++ ++||+|+++.|--++ ..+|..||||++.+. ....+....+|++++...+ |+||+.++++|.++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 455544554 689999999999987 568999999999665 3334557889999999885 99999999999999
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc---EEEe
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVG 288 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~ 288 (467)
..+|||||-|.||+|..+|+++.. +++.+..++..+|+.||.|||.+ +|.||||||+|||..+... +||+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence 999999999999999999987653 89999999999999999999999 9999999999999976543 7999
Q ss_pred ecCCccccCCCC------Ceeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC-
Q 012267 289 DFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD- 356 (467)
Q Consensus 289 Dfgl~~~~~~~~------~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~- 356 (467)
||.+..-..... .......+|+..|||||+.. ...|..+.|.||||||||-|++|.+||......+..
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 999875432111 11223356889999999763 346789999999999999999999999764332211
Q ss_pred -CccHHHHHHHHhhhcccccccCcc--ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 357 -DVMLLDWVKGLLKEKKLEMLVDPD--LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 357 -~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... .....-...+.+.. +.............+++...+..++.+|.++.++++
T Consensus 302 drGe~Cr----~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCR----VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccH----HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000000 00000011111111 111112334455666777777899999999988865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=271.27 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=192.2
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCC--cch----HHHHHHHHHHHHhcCCCeeeeeeeeee-CCCc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT--PGG----ELQFQTEVEMISMAVHRNLLRLRGFCM-TPTE 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~ 213 (467)
++|-..++||+|+|+.||+|.+ ...+.||||+-..... .+. .+...+|.++.+.+.||.||++|+|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4566678899999999999984 4678999998643322 111 124678999999999999999999997 4567
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEEeec
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 290 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 290 (467)
+|-|+|||+|.+|.-+|+.+.. ++++++..|+.||+.||.||... +|+|+|-||||.|||+-+ .|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 8899999999999999987653 89999999999999999999986 779999999999999954 478999999
Q ss_pred CCccccCCCCC------eeeecccccccccccccccC----CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccH
Q 012267 291 GLAKLMDYKDT------HVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360 (467)
Q Consensus 291 gl~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~----~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~ 360 (467)
|+++.++.... ..+....||.+|++||.+-- .+.+.|+||||.|||+|..+.|+.||... ...+.+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn----qsQQdI 693 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN----QSQQDI 693 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc----hhHHHH
Confidence 99999864432 24455679999999998753 34688999999999999999999999531 111111
Q ss_pred HHHHHHHhhhccc---ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 012267 361 LDWVKGLLKEKKL---EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414 (467)
Q Consensus 361 ~~~~~~~~~~~~~---~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 414 (467)
+.+..+ .++-.|. .+-...+...+|++||+..-++|....++
T Consensus 694 -------LqeNTIlkAtEVqFP~-----KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 694 -------LQENTILKATEVQFPP-----KPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred -------HhhhchhcceeccCCC-----CCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 111111 1111111 11112456678899999999998766554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=270.11 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=193.1
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch--HHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCce
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 214 (467)
+...+|....+||+|+||+|.+|.-+ +.+.+|||+++++...+. .+.-+.|-++|... +-|.++.+...|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 33457888999999999999999865 578999999987654332 22345677777766 467899999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
|+||||+.||+|--+++.-+. +.+..+.-+|..||-||-|||++ +|++||||.+|||+|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999999987654 66677888899999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.- .-+...+..++||+.|+|||++...+|+.++|.|||||+||||+.|++||+... ++ +.....
T Consensus 499 En-i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD----E~----elF~aI------- 562 (683)
T KOG0696|consen 499 EN-IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----ED----ELFQAI------- 562 (683)
T ss_pred cc-ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC----HH----HHHHHH-------
Confidence 52 234455677899999999999999999999999999999999999999997521 11 111111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 410 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 410 (467)
.+... .++.....+...+...-+.+.|.+|..
T Consensus 563 --~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 --MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --HHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 11111 122233355666666677888888853
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=286.74 Aligned_cols=267 Identities=25% Similarity=0.363 Sum_probs=211.6
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee--
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM-- 209 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-- 209 (467)
++.+...++-|++.++||.|.+|.||+++. ++|+.+|+|++..... ..+++..|.++++.. .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344445567889999999999999999985 4799999999866443 344677888888876 6999999999986
Q ss_pred ---CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 210 ---TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 210 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
.++++|||||||.+||..|++++.. ...+.|..+..|+..++.|+.+||.+ .++|||||-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 4578999999999999999998865 34499999999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCCCeeeecccccccccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHH
Q 012267 287 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~ 361 (467)
+.|||++..+... ........||+.|||||++.. ..|+.++|+||||++..||.-|.+|+-..-.
T Consensus 164 LvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------- 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------- 233 (953)
T ss_pred Eeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------
Confidence 9999999877532 233444569999999999853 3467899999999999999999999843211
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCccc
Q 012267 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 427 (467)
Q Consensus 362 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 427 (467)
++.++. ....|...-..+....+++.++|..|+.+|-.+||++.+++ +...+.+..
T Consensus 234 --mraLF~-----IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll---~hpFi~e~~ 289 (953)
T KOG0587|consen 234 --MRALFL-----IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL---KHPFITEQP 289 (953)
T ss_pred --hhhhcc-----CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc---cCCcccccc
Confidence 111111 11122222233567778999999999999999999998774 444444443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=242.22 Aligned_cols=213 Identities=23% Similarity=0.353 Sum_probs=175.3
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
+..+.+++..++......||+|++|.|-+-++. +|...|+|+++.....+..+..+.|+.+..+. .+|.+|.++|...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 333445666666666778999999999988864 89999999998776666666788888876654 6999999999988
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
.....++.||.|.- ||..+-..--..+..+++..+-+|+..+..||.|||++. .++|||+||+|||++.+|++|++|
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 88999999999965 887776553334445888999999999999999999986 899999999999999999999999
Q ss_pred cCCccccCCCCCeeeecccccccccccccccC----CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
||.+-.+..+ -..+.-.|-..|||||.+.. ..|+.||||||||+.+.||.+++.||+.
T Consensus 193 FGIsG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 193 FGISGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred cccceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 9999876432 22222457889999998753 3689999999999999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=255.32 Aligned_cols=239 Identities=30% Similarity=0.391 Sum_probs=192.2
Q ss_pred CceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhc
Q 012267 154 GFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 232 (467)
Q Consensus 154 ~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 232 (467)
+||.||+|... +|+.+|+|++...........+..|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 58999999997654433256899999999999999999999999999999999999999999999976
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeeccccccc
Q 012267 233 RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 312 (467)
Q Consensus 233 ~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~ 312 (467)
... +++..++.++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 532 78899999999999999999999 99999999999999999999999999998765332 2334457889
Q ss_pred ccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHH
Q 012267 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ 392 (467)
Q Consensus 313 y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 392 (467)
|++||.+....++.++||||||+++++|++|..||... ... .......... .... . .........
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~----~~~---~~~~~~~~~~-~~~~----~---~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD----DQL---LELFKKIGKP-KPPF----P---PPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CcH---HHHHHHHhcc-CCCC----c---cccccCCHH
Confidence 99999998888899999999999999999999998531 111 1111111111 0000 0 000003367
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 012267 393 LIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 393 l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.+++.+|+..+|.+||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=279.34 Aligned_cols=238 Identities=22% Similarity=0.327 Sum_probs=190.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++.|.....+|.|+|+.|-.+... +++..+||++..... +-.+|+.++.+. +|+|++++.+.+.+..+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567888888999999999999864 688899999976521 234566565554 6999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE-CCCCcEEEeecCCccccC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgl~~~~~ 297 (467)
|.+.++-+.+.+..... .. ..+..|+.+|+.|+.|||.+ ++|||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988888876542 22 67778999999999999999 99999999999999 688999999999998765
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. ....+-|..|.|||++....+++++|+||||++||+|++|+.||..... + .+.... +.
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~----~---~ei~~~---------i~ 527 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA----G---IEIHTR---------IQ 527 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc----h---HHHHHh---------hc
Confidence 33 2223457899999999999999999999999999999999999965321 1 111111 11
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
.+ .+.........+++.+||+.||.+||+|.++.
T Consensus 528 ~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 528 MP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred CC----ccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 11 11123345678899999999999999999984
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.23 Aligned_cols=263 Identities=20% Similarity=0.224 Sum_probs=170.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-C----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeee------e
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-D----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF------C 208 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~ 208 (467)
..++|...+.||+|+||.||+|++. + +..||||++..... .+.+..+ .+....+.+++.+... +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4578999999999999999999975 4 68999998854221 1111111 1122222222222211 2
Q ss_pred eCCCceEEEeeccCCCChhhhhhcCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCC
Q 012267 209 MTPTERLLVYPYMANGSVASCLRERPPS----------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 272 (467)
Q Consensus 209 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dl 272 (467)
......++||||+.+++|.+++...... ........+..++.|++.||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4566789999999999999998754210 00112334567999999999999999 9999999
Q ss_pred CCCcEEECC-CCcEEEeecCCccccCCCCCeeeecccccccccccccccCC----------------------CCCcchh
Q 012267 273 KAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----------------------KSSEKTD 329 (467)
Q Consensus 273 k~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~sD 329 (467)
||+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986543333334456689999999965322 2345679
Q ss_pred HHHHHHHHHHHHcCCCCcccccc-----cCCCCccHHHHHHHHhhhcccccccCccccCcc--cHHHHHHHHHHHHHccC
Q 012267 330 VFGYGIMLLELITGQRAFDLARL-----ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY--VEAEVEQLIQVALLCTQ 402 (467)
Q Consensus 330 v~s~Gvil~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~--~~~~~~~l~~l~~~cl~ 402 (467)
||||||+||||+++..+++.... ....+.....|....... ..+.+...+ .........+++.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999998776542100 000111222332211100 000000000 00011235589999999
Q ss_pred CCCCCCCCHHHHHH
Q 012267 403 GSPMDRPKMSEVVR 416 (467)
Q Consensus 403 ~~p~~RPs~~evl~ 416 (467)
.||++|||+.++++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999975
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=235.42 Aligned_cols=197 Identities=25% Similarity=0.421 Sum_probs=167.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch-HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.|...++||+|.||+||+|+.. +++.||+|+++.+...+. .....+|+-+++.++|.|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999854 689999999987654433 34678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
|.. +|..+.....+. ++......++.|+++||.|.|++ ++.|||+||.|.||+.+|+.|++|||+++.++..-
T Consensus 83 cdq-dlkkyfdslng~---~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 888888765443 88889999999999999999999 99999999999999999999999999999876544
Q ss_pred CeeeecccccccccccccccCCC-CCcchhHHHHHHHHHHHHc-CCCCc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELIT-GQRAF 347 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~ellt-g~~p~ 347 (467)
...+.. .-|..|.+|.++.+.+ |+...|+||.|||+.|+.. |++.|
T Consensus 156 rcysae-vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 156 RCYSAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred Eeeece-eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 333333 3589999999998754 7899999999999999987 44445
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=272.90 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=192.0
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
++||+|.||+||-|+++ +|+.||||++.+.+.+ ..+.++++|+.+|..+.||.||.+.-.|+..+..++|||-+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 78999999999999875 8999999999765543 344579999999999999999999999999999999999994 56
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC---CcEEEeecCCccccCCCCCe
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~~ 302 (467)
..+.|-..... .+++....-++.||+.||.|||.+ +|+|+||||+|||+.+. -.+||+|||+|++.+. ..
T Consensus 649 MLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ks 721 (888)
T KOG4236|consen 649 MLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KS 721 (888)
T ss_pred HHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--hh
Confidence 66666543332 278888888899999999999999 99999999999999644 4799999999998763 34
Q ss_pred eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
..+.+.||+.|+|||++....|...-|+||.|||+|--++|..||.... ++.+-+.. ...+-|
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-------dIndQIQN-------AaFMyP--- 784 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-------DINDQIQN-------AAFMYP--- 784 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-------chhHHhhc-------cccccC---
Confidence 4566789999999999999999999999999999999999999996321 12111111 111111
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 414 (467)
.....+.....+++|...++..-.+|-|...-
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 12234444566777777778888888887654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=260.52 Aligned_cols=259 Identities=23% Similarity=0.283 Sum_probs=197.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC--CC----eeeeeeeeeeCCCc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--HR----NLLRLRGFCMTPTE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~~~~~~~~~~~ 213 (467)
+.+|.+...+|+|.||.|-.+... .+..||||+++.- ..-.+..+-|++++.++. .| -+|.+.++|.-.++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 688999999999999999999754 5789999999753 223445677899999884 22 27888899999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC------------
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE------------ 281 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~------------ 281 (467)
.|+|+|.+ |-|+.++|..+.. .+++...+..|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999988 6699999998644 3578889999999999999999999 9999999999999831
Q ss_pred --------CCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccccc
Q 012267 282 --------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA 353 (467)
Q Consensus 282 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~ 353 (467)
+..++|+|||.|..-.... ..++.|..|.|||++.+-.++..+||||+||||.|+.||...|....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-- 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-- 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC--
Confidence 3358999999998644332 34557889999999999999999999999999999999999996432
Q ss_pred CCCCccHHHHHHHHhhh-----------------ccc-----------ccccCccc----cCcccHHHHHHHHHHHHHcc
Q 012267 354 NDDDVMLLDWVKGLLKE-----------------KKL-----------EMLVDPDL----QNNYVEAEVEQLIQVALLCT 401 (467)
Q Consensus 354 ~~~~~~~~~~~~~~~~~-----------------~~~-----------~~~~d~~~----~~~~~~~~~~~l~~l~~~cl 401 (467)
+......++..+.. +.+ ..+.++-. .-...+.+...|++++..||
T Consensus 314 ---n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 314 ---NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred ---cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 11111222222110 100 11111100 01123455677999999999
Q ss_pred CCCCCCCCCHHHHHH
Q 012267 402 QGSPMDRPKMSEVVR 416 (467)
Q Consensus 402 ~~~p~~RPs~~evl~ 416 (467)
..||.+|+|+.|+++
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=277.01 Aligned_cols=264 Identities=21% Similarity=0.234 Sum_probs=179.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEE-----------------CCCCEEEEEEeccCCCcc-------------hHHHHHHH
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRL-----------------ADGSLVAVKRLKEERTPG-------------GELQFQTE 189 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~g~~vavK~~~~~~~~~-------------~~~~~~~e 189 (467)
..++|++.++||+|+||+||+|.. ..++.||||+++...... .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999986532211 11123346
Q ss_pred HHHHHhcCCCee-----eeeeeeeeC--------CCceEEEeeccCCCChhhhhhcCCC--------------------C
Q 012267 190 VEMISMAVHRNL-----LRLRGFCMT--------PTERLLVYPYMANGSVASCLRERPP--------------------S 236 (467)
Q Consensus 190 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 236 (467)
+.++.+++|.++ ++++++|.. ....++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677787753 3567999999999999999875321 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeeccccccccccc
Q 012267 237 QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316 (467)
Q Consensus 237 ~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aP 316 (467)
...++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11357788999999999999999999 999999999999999999999999999975432221111122347899999
Q ss_pred ccccCCCC----------------------CcchhHHHHHHHHHHHHcCCC-CcccccccCC----CCccHHHHHHHHhh
Q 012267 317 EYLSTGKS----------------------SEKTDVFGYGIMLLELITGQR-AFDLARLAND----DDVMLLDWVKGLLK 369 (467)
Q Consensus 317 E~~~~~~~----------------------~~~sDv~s~Gvil~elltg~~-p~~~~~~~~~----~~~~~~~~~~~~~~ 369 (467)
|.+..... ..+.||||+||++++|++|.. ||........ ....+..|... .
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence 98753221 235799999999999999875 6643211110 01112222111 0
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSP---MDRPKMSEVVR 416 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~evl~ 416 (467)
... .+-. ..........+++.+++..+| .+|+|++|+++
T Consensus 458 ~~~----~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQK----YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccC----CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000 0100 111223556778888888765 78999999853
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=250.99 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=191.7
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--------C
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTP--------T 212 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~ 212 (467)
.|....+||+|.||.||+|+.. +|+.||+|++-.+.... -.....+|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999865 67889998765433222 233567999999999999999999998632 3
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
.+++||++|+. +|.-+|.+... .++..++.+++.++..||.|+|.+ .|+|||+|+.||||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 47999999987 88888877533 288899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCe---eeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh
Q 012267 293 AKLMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 293 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
++.+...... ..+..+-|..|++||.+.+ ..++++.|||..|||+.||+||.+-++.. .++.....+..+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn-----teqqql~~Is~Lc 245 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN-----TEQQQLHLISQLC 245 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC-----hHHHHHHHHHHHh
Confidence 9876533221 2233345899999998876 56899999999999999999999887531 1122222222222
Q ss_pred hhccc-----------cccc--CccccCcc--cHHHH------HHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 369 KEKKL-----------EMLV--DPDLQNNY--VEAEV------EQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 369 ~~~~~-----------~~~~--d~~~~~~~--~~~~~------~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... -..+ .|-..+.+ ..+.+ ...++++..++..||.+|+.+.+++.
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11100 0000 01000000 11111 25677888899999999999998853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=279.62 Aligned_cols=256 Identities=26% Similarity=0.315 Sum_probs=190.1
Q ss_pred CCCCCCeeeecCce-EEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeec
Q 012267 143 SFSNKNILGRGGFG-KVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 143 ~~~~~~~lg~G~~g-~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
-|...+++|.|+.| .||+|... |+.||||++-.. ...-..+|+..|... .|||||++++.-.++...|+..|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 35556789999987 57999984 889999998432 233467899988876 599999999998899999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---C--CcEEEeecCCccc
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---E--FEAVVGDFGLAKL 295 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgl~~~ 295 (467)
|.. +|.+++...........-...+.+..|+++||++||+. +||||||||.||||+. + .+++|+|||+++.
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 955 99999987411111011134567888999999999998 9999999999999976 3 5799999999998
Q ss_pred cCCCCCee--eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcC-CCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 296 MDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 296 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
+....... .....||-+|+|||++....-+.++||||+|||+|+.++| ++||...-.. + ...+....
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---~-------~NIl~~~~ 730 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---Q-------ANILTGNY 730 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---h-------hhhhcCcc
Confidence 87554433 3345699999999999988888899999999999999986 9999642110 0 00011100
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCccch
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWD 428 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 428 (467)
.-..+.+ ..++ ...++|.+|++++|..||++.+| |....++..-.
T Consensus 731 ~L~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~V---L~HPlFW~~ek 775 (903)
T KOG1027|consen 731 TLVHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDV---LNHPLFWDSEK 775 (903)
T ss_pred ceeeecc------CchH--HHHHHHHHhcCCCcccCCCHHHH---hCCCccCChHH
Confidence 0000000 1111 67789999999999999999998 66666654433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=249.46 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=200.1
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch--HHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCce
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 214 (467)
...++|....+||+|+|++|..+++. +.+.+|+|+++++..... ..-.+.|-.+.... +||.+|.+..+|+....+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34568999999999999999999865 688999999986543222 22345666666544 799999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++|.||++||+|--+++.+.. +++..+.-+...|.-||.|||+. +|++||||.+|||+|..|++|++|||+++
T Consensus 327 ffvieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999888876543 88888888889999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.- ..+...+..++||+.|+|||++.+..|....|.|++||+++||+.|+.||+...+.+. +.+..+++-...-+..+.
T Consensus 400 e~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~-d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 400 EG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP-DMNTEDYLFQVILEKQIR 477 (593)
T ss_pred cC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc-ccchhHHHHHHHhhhccc
Confidence 63 3455667788999999999999999999999999999999999999999987654333 334444444443332221
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 410 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 410 (467)
-|+ ........++..-+++||++|..
T Consensus 478 ---ipr-------slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 ---IPR-------SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---ccc-------eeehhhHHHHHHhhcCCcHHhcC
Confidence 111 11233445666778899998853
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-33 Score=262.46 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=194.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCCC-EEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLADGS-LVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~g~-~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++.....||-|+||.|-++...... .+|+|.+++...-. ..+....|-.+|...+.|.||++|..|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4445567999999999999875433 48999987654322 34457889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
-|-||.|+..|+.++. ++.....-++..+.+|+.|||++ +||+|||||+|.++|.+|.+||.|||+|+.+.
T Consensus 501 aClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-- 571 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-- 571 (732)
T ss_pred hhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc--
Confidence 9999999999998764 77778888899999999999999 99999999999999999999999999999875
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
.+..+-.++||+.|.|||++.+.....++|.||||+++|||++|++||..... ......+ ++ .+..+--|
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-----mktYn~I---Lk--Gid~i~~P 641 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-----MKTYNLI---LK--GIDKIEFP 641 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHH---Hh--hhhhhhcc
Confidence 34556778999999999999999999999999999999999999999964221 1111111 11 11111112
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 410 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 410 (467)
........+++++.+..+|.+|..
T Consensus 642 -------r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 -------RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -------cccchhHHHHHHHHHhcCcHhhhc
Confidence 122245667788888899999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=258.53 Aligned_cols=203 Identities=24% Similarity=0.341 Sum_probs=170.6
Q ss_pred hcCCCCCCeeeecCceEEEEEE-ECCCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
..-|..++-||-|+||.|.++. .++...||.|.+++...- ........|-.+|.....+.||+||-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457778889999999999997 446778999999764321 2233577899999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||++||++-.+|...+. +.+....-++..+..|+.+.|.. |+|||||||+|||||.+|++||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999987654 67777777888999999999999 99999999999999999999999999986431
Q ss_pred CC--------CC---------------------------------eeeecccccccccccccccCCCCCcchhHHHHHHH
Q 012267 298 YK--------DT---------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 336 (467)
Q Consensus 298 ~~--------~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvi 336 (467)
.. .. ......+||..|+|||++....++..+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 10 00 00112459999999999999999999999999999
Q ss_pred HHHHHcCCCCcccc
Q 012267 337 LLELITGQRAFDLA 350 (467)
Q Consensus 337 l~elltg~~p~~~~ 350 (467)
||||+.|+.||...
T Consensus 861 l~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLAD 874 (1034)
T ss_pred HHHHhhCCCCccCC
Confidence 99999999999653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=229.35 Aligned_cols=211 Identities=35% Similarity=0.521 Sum_probs=182.7
Q ss_pred eeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChhh
Q 012267 150 LGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 228 (467)
Q Consensus 150 lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 228 (467)
||+|.+|.||++... +++.+++|++...........+.+|++.+..++|++++++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999976 4899999999765443234578999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecCCccccCCCCCeeeecc
Q 012267 229 CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAV 307 (467)
Q Consensus 229 ~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~ 307 (467)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 988652 2388999999999999999999999 9999999999999999 89999999999986543321 12224
Q ss_pred cccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCccc
Q 012267 308 RGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386 (467)
Q Consensus 308 ~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 386 (467)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 467899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 387 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=242.29 Aligned_cols=133 Identities=22% Similarity=0.327 Sum_probs=112.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-----C---Ceeeeeeeeee--
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----H---RNLLRLRGFCM-- 209 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~-- 209 (467)
..+|-..++||-|.|++||++.+. +.+.||+|+.+.... -.+..+.|+++|..++ | .+||+++++|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 467888999999999999999864 678999999875432 2334678999998874 2 36999999996
Q ss_pred --CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC
Q 012267 210 --TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 280 (467)
Q Consensus 210 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~ 280 (467)
++.+.|||+|++ |.+|..+|.....++ ++...+.+|+.||+.||.|||..| +|+|.||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 456899999999 669999998765544 778899999999999999999999 999999999999994
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=234.11 Aligned_cols=267 Identities=23% Similarity=0.263 Sum_probs=190.2
Q ss_pred CCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----CceEEE
Q 012267 145 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLV 217 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 217 (467)
+..+.||-|+||.||..++. +|+.||.|++..-. .-...+.+.+|+++|..++|.|++..+++..-. .+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999865 89999999985432 122345688999999999999999999886543 356788
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
+|.|.. +|...|... .+++-..++-+..||++||.|||+- +|.||||||.|.|++.|..+||+|||+++...
T Consensus 136 TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 998854 787777653 3477778888999999999999999 99999999999999999999999999999766
Q ss_pred CCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCC-------CCccHHHHHHHHhh
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLAND-------DDVMLLDWVKGLLK 369 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~ 369 (467)
..+...++...-|..|.|||++.+. .|+.+.||||.|||+.||+..+-.|........ .+....+-++...+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 5555555555568899999999874 689999999999999999988888754221100 00011111111111
Q ss_pred hcc---cccc-cCccccC--cc--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 370 EKK---LEML-VDPDLQN--NY--VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 370 ~~~---~~~~-~d~~~~~--~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
..+ ++.. -.|.+.. .. ....--.-+.+.+.++..||.+|.+..+.+.-+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111 1110 0111110 00 0111123445667788999999999988877654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=227.78 Aligned_cols=199 Identities=33% Similarity=0.502 Sum_probs=171.1
Q ss_pred CCCCCeeeecCceEEEEEEECC-CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccC
Q 012267 144 FSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 222 (467)
|...+.||.|++|+||++.... +..+++|.+...........+..|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999864 889999999765433245578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
+++|.+++...... +++..+..++.+++.++.|||+. +++|+||+++||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999999865321 78899999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeecccccccccccccc-cCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 012267 303 VTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~-~~~~~~~~sDv~s~Gvil~elltg~~p~~ 348 (467)
......++..|++||.+ ....++.++|||+||+++++|++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22334577889999998 66777889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=248.27 Aligned_cols=197 Identities=24% Similarity=0.357 Sum_probs=168.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch-----H--HHHHHHHHHHHhcC---CCeeeeeeeeeeC
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG-----E--LQFQTEVEMISMAV---HRNLLRLRGFCMT 210 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~-----~--~~~~~e~~~l~~l~---h~niv~~~~~~~~ 210 (467)
.+|+..+.+|.|+||.|+.|.++ +...|+||.+.+.+.-.. + -..-.|+.+|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888899999999999999976 566899999876542111 1 12456999999997 9999999999999
Q ss_pred CCceEEEeecc-CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 211 PTERLLVYPYM-ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 211 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
++..||+||-. ++-+|.++|..+.. +++.+...|+.||+.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999975 46699999987654 89999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcc
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~ 348 (467)
||.+.+.. ......++||..|.|||++.+.+| ....|||++|++||.++....||.
T Consensus 714 fgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987643 223445679999999999999887 667899999999999999888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=224.21 Aligned_cols=257 Identities=19% Similarity=0.281 Sum_probs=191.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeee-eeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGF-CMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~ 218 (467)
+.|.+.+.||+|.||.+-+++++ +.+.+++|-+..... ..++|.+|...--.+ .|.||+.-|+. |+..+..++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 56888899999999999999986 678899999876543 345788888654444 59999988875 55667778999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC--CCCcEEEeecCCcccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLM 296 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~ 296 (467)
||++.|+|.+-+...+ +-+....+++.|++.|+.|||++ ++||||||.+||||- +..++||+|||+.+..
T Consensus 102 E~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999887643 67788899999999999999999 999999999999993 3458999999998743
Q ss_pred CCCCCeeeecccccccccccccccCC-----CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
+ .......-+..|-+||..... ...+.+|||.||++++.++||+.||+.....+.......+|..+...
T Consensus 174 g----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 174 G----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred C----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 2 122223346679999976432 34678999999999999999999998655555555555555443322
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 423 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 423 (467)
.-|+.-. .....+.++..+-+.+++++|=...++-++-...+.
T Consensus 248 -----~~P~~F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 248 -----ALPKKFN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred -----cCchhhc----ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 1111111 122456667777889999999777777666655433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=225.06 Aligned_cols=194 Identities=26% Similarity=0.319 Sum_probs=161.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------Cc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TE 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 213 (467)
.+|...+.+|.|.. .|..+.+. .++.||+|.+..... ....+...+|...+..+.|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788899888 66666543 688999998754422 22334677899999999999999999998633 45
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.|+|||+|. .+|...++.. ++-..+..|..|++.|++|||+. +|+||||||+||++..+..+||.|||++
T Consensus 96 ~y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 699999995 4999988843 66678899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~ 348 (467)
+.-.. ....+.+..|..|.|||++.+..+.+.+||||.||++.||++|+--|.
T Consensus 166 r~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 166 RTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred cccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 85332 235566678889999999998889999999999999999999998885
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=213.23 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=190.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCC--ceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--ERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~l 216 (467)
.++|++.+++|+|.++.||.|.. .+.++++||+++.- ..+.+.+|+.+|..++ ||||++++++..++. ...|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 46788889999999999999984 57889999999643 3457889999999997 999999999998764 4579
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeecCCccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 295 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~ 295 (467)
|+||+.+.+...+... ++-..+...+.+++.||.|+|+. ||+|||+||.||+||... .++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999999877666543 66677888999999999999999 999999999999999664 699999999988
Q ss_pred cCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh----
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---- 370 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 370 (467)
......... ...+..|--||.+-. ..|..+-|+|||||++..|+..+.||-.. .+....+...++-+-.+
T Consensus 183 YHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG---~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 183 YHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG---HDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred cCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC---CCCHHHHHHHHHHhChHHHHH
Confidence 754433322 235667889998864 56788999999999999999999998421 12222222222211110
Q ss_pred --cccccccCccccC---ccc------------HH-HHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 371 --KKLEMLVDPDLQN---NYV------------EA-EVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 371 --~~~~~~~d~~~~~---~~~------------~~-~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
....-.+||.+.+ ... .. ...+.++++...+..|-.+|||++|.+
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 0111123443321 100 01 125577888888899999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=249.85 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=198.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|.....+|+|.+|.|||++.. +++..|||+++..... .....++|+-+++..+|+||+.++|.+...+..++.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 467888899999999999999965 7999999999865432 23457789999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
||.+|+|.+.-+... ++++.++..+.....+|++|||+. +=+|||||-.||++++.|.+|++|||.+-.+..
T Consensus 93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-
Confidence 999999999877643 488889999999999999999999 889999999999999999999999999865532
Q ss_pred CCeeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcc-cccccCCCCccHHHHHHHHhhhccccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFD-LARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
.......+.||+.|||||+.. .+.|..++|||+.|+...|+---++|.- .+. .-+..+.. ..
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----------mr~l~LmT----kS 230 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----------MRALFLMT----KS 230 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----------HHHHHHhh----cc
Confidence 222344567999999999863 5678999999999999999987776642 111 00111111 11
Q ss_pred ccCc-cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDP-DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+| .+.+ .......+.++++.|+.++|++||+++.+++
T Consensus 231 ~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1222 2211 1233466888999999999999999987765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=233.60 Aligned_cols=206 Identities=22% Similarity=0.225 Sum_probs=170.0
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC------CCeeeeeee
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV------HRNLLRLRG 206 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~ 206 (467)
+.-.+....+|......|+|-|++|..|... -|..||||+|.... ...+.=+.|+++|++|+ --|.++++.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3334556678888888999999999999865 57899999997642 22334468999999996 347899999
Q ss_pred eeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcE
Q 012267 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEA 285 (467)
Q Consensus 207 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~ 285 (467)
.|...+++|||||-+ ..+|.++|+..+.. ..|....+..++.|+.-||..|-.. +|+|.||||.||||++. ..+
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 999999999999987 45999999986543 3478889999999999999999997 99999999999999876 468
Q ss_pred EEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
||||||.|....... .+.+.-+-.|.|||++.+.+|+...|+||.||.||||.||+-.|..
T Consensus 577 KLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 577 KLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred eeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 999999998654332 2222235579999999999999999999999999999999998853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=262.64 Aligned_cols=195 Identities=14% Similarity=0.122 Sum_probs=137.4
Q ss_pred hcCC-Ceeeeeeeeee-------CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 012267 195 MAVH-RNLLRLRGFCM-------TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266 (467)
Q Consensus 195 ~l~h-~niv~~~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ 266 (467)
.++| .||++++++|. .....++++||+ +++|.++|.... .++++..++.++.||++||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 57888888772 234567888987 569999997532 2489999999999999999999999 9
Q ss_pred cccCCCCCCcEEECCC-------------------CcEEEeecCCccccCCCCC---------------eeeeccccccc
Q 012267 267 IIHRDVKAANILLDEE-------------------FEAVVGDFGLAKLMDYKDT---------------HVTTAVRGTIG 312 (467)
Q Consensus 267 ivH~dlk~~Nill~~~-------------------~~~kl~Dfgl~~~~~~~~~---------------~~~~~~~g~~~ 312 (467)
|+||||||+||||+.. +.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4455666666553211000 00111347888
Q ss_pred ccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHH
Q 012267 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ 392 (467)
Q Consensus 313 y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 392 (467)
|+|||++.+..++.++|||||||+||||++|..|+.... ........ ....+.. ......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~-----~~~~~~~-----~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRH-----RVLPPQI-----LLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHH-----hhcChhh-----hhcCHH
Confidence 999999999999999999999999999999988874210 01111100 0111111 111234
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 012267 393 LIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 393 l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...++.+||+++|.+||+|.||++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 567888999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=220.12 Aligned_cols=197 Identities=26% Similarity=0.433 Sum_probs=164.5
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCc
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 213 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 213 (467)
.....|...++||.|.|++||++.+. ..+.||+|.+.....+. .+..|+++|..+. +.||+++.+++...+.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 44567888999999999999999854 46789999987654433 5789999999885 9999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEeecCC
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGL 292 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl 292 (467)
..+|+||++.....++... ++...+..++..+..||+++|.+ |||||||||+|+|.+.. +.-.|.|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 9999999999999998876 67788999999999999999999 99999999999999754 5688999999
Q ss_pred ccccCC-C--------------------------------CC----------eeeecccccccccccccccCC-CCCcch
Q 012267 293 AKLMDY-K--------------------------------DT----------HVTTAVRGTIGHIAPEYLSTG-KSSEKT 328 (467)
Q Consensus 293 ~~~~~~-~--------------------------------~~----------~~~~~~~g~~~y~aPE~~~~~-~~~~~s 328 (467)
+..... . .+ ......+||++|.|||++... .-+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 872100 0 00 011123599999999998764 458899
Q ss_pred hHHHHHHHHHHHHcCCCCcc
Q 012267 329 DVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 329 Dv~s~Gvil~elltg~~p~~ 348 (467)
||||.|||++.+++++.||-
T Consensus 260 Diws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ceeeccceeehhhccccccc
Confidence 99999999999999999994
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=205.60 Aligned_cols=166 Identities=22% Similarity=0.273 Sum_probs=124.9
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... .++++..++.++.|++.||+|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999998642 2499999999999999999999998 5 999999999999999 99988654322
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
..|++.|+|||++.+..++.++|||||||++|||+||+.||.... .....+..+....... ++.. .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~---~~~~~~~~~~~~~~~~-------~~~~-~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER---ELSAILEILLNGMPAD-------DPRD-R 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc---hhcHHHHHHHHHhccC-------Cccc-c
Confidence 257899999999999999999999999999999999999995321 1111111221111110 0000 0
Q ss_pred cccHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 384 NYVEAEVE--QLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 384 ~~~~~~~~--~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........ .+.+++.+||+.+|.+||++.|+++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 01112222 58999999999999999999999988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-26 Score=202.37 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=184.5
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
..+|.+...|..|+|++. |..+++|+++... +.....+|..|...|+.+.||||+.++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345888999999999997 4456778876432 33334579999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeee
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 305 (467)
|+.++++.. ...++-.+..+++.++|+|++|||+. .|-|.---|.+..|++|++.+++|+- +-.++.... .
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe-----~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE-----V 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec-----c
Confidence 999999853 33467778999999999999999996 34455556899999999999988742 111111000 1
Q ss_pred cccccccccccccccCCCC---CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 306 AVRGTIGHIAPEYLSTGKS---SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 306 ~~~g~~~y~aPE~~~~~~~---~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
...-.+.||+||.++..+- -.++|+|||.+++|||.|...||........ + ++ ..-+.+..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-g------mk--ialeglrv------- 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-G------MK--IALEGLRV------- 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-h------hh--hhhccccc-------
Confidence 1112578999999987654 3579999999999999999999964321110 0 00 00111122
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..++.....+.+++.-|...||.+||.+..|+-.|++.
T Consensus 409 -~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 -HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 22233346688899999999999999999999999863
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=211.01 Aligned_cols=166 Identities=23% Similarity=0.241 Sum_probs=129.1
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC--CCCEEEEEEeccCC----CcchHHHHHHHHHHHHhcCCCeeee-eeeeeeCC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLR-LRGFCMTP 211 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~ 211 (467)
...+.|...+.||+|+||+||+|.+. +++.||||++.... .......+.+|++++..++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34578999999999999999999864 57788999875331 1223456899999999999999985 4432
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCC-CCCcEEECCCCcEEEeec
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDF 290 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Df 290 (467)
+..++||||+++++|... .. .. ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999632 11 11 145788999999999999 9999999 999999999999999999
Q ss_pred CCccccCCCCCee-------eecccccccccccccccCC
Q 012267 291 GLAKLMDYKDTHV-------TTAVRGTIGHIAPEYLSTG 322 (467)
Q Consensus 291 gl~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~ 322 (467)
|+++.+....... .....+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9998765332111 1345578899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=201.26 Aligned_cols=258 Identities=20% Similarity=0.242 Sum_probs=189.1
Q ss_pred CCCCCCeeeecCceEEEEEEECCC--CEEEEEEeccCCCcchHHHHHHHHHHHHhcCC----Ceeeeeeeee-eCCCceE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLADG--SLVAVKRLKEERTPGGELQFQTEVEMISMAVH----RNLLRLRGFC-MTPTERL 215 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~ 215 (467)
+|.+.+.||+|+||.||++..... ..+|+|........... .+..|..++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 789999999999999999997643 47899987654333222 56778888877763 5788888888 4777889
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-----CcEEEeec
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDF 290 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Df 290 (467)
+||+.+ |.+|.++..... ...++..+.+.|+.|++.+|.+||+. +++||||||.|+++... ..+.|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999977 779999887655 23489999999999999999999999 99999999999999765 46899999
Q ss_pred CCcc--ccCCCCCe------e-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHH
Q 012267 291 GLAK--LMDYKDTH------V-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 291 gl~~--~~~~~~~~------~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~ 361 (467)
|+++ ........ . .....||..|.++....+...+.+.|+||++.++.|++.|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~- 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----K- 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----H-
Confidence 9998 32212211 1 2235599999999999999999999999999999999999999954321111 1
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 362 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.-+...... ..... ...... ..+.++...+-..+...+|....+...|++.
T Consensus 247 ~~~~~~~~~----~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFEKDPRK----LLTDR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHhhh----hcccc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111111111 11110 111122 3344454555568999999999999887653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-22 Score=192.18 Aligned_cols=262 Identities=28% Similarity=0.363 Sum_probs=196.8
Q ss_pred CCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCC-eeeeeeeeeeCCCceEEEeec
Q 012267 144 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 220 (467)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|+.++..+.|+ +++++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999986 789999997665544 356799999999999988 799999999777778999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeecCCccccCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 299 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 299 (467)
+.++++.+++...... ..+.......++.+++.++.|+|.. +++|||+||+||+++..+ .++++|||+++.+...
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654321 2478889999999999999999999 899999999999999998 7999999999865433
Q ss_pred CCe-----eeecccccccccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 300 DTH-----VTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 300 ~~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||...... ..... ........
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~-~~~~~~~~ 230 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQ-TLKIILEL 230 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHH-HHHHHHhc
Confidence 322 2355679999999999987 57889999999999999999999997532210 00111 11111111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
... .................+.+++..|+..+|..|.++.+....
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 100 000000000001223567788888999999999999887654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-24 Score=217.07 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=184.2
Q ss_pred CCCCeeeecCceEEEEEEEC-CCCEEEEEEecc----CCCcch-HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 145 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKE----ERTPGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~----~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
....++|.|++|.|+..... .....+.|..+. ...... ...+..|+-+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977777643 344445554331 111111 112556777778889999999888887776666669
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
|||++ +|..++..... +...++..++.|+..|++|||+. +|.|||+|++|++++.++.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~~~~----~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK----LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcccc----cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999987522 67778899999999999999999 999999999999999999999999999987654
Q ss_pred CCC---eeeecccccccccccccccCCCCCc-chhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 299 KDT---HVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 299 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~-~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
... .......|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||..+....... ..........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccccc
Confidence 433 4556678999999999999988854 6899999999999999999997644322211 0000000000
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ..-..............++.++++.+|.+|-|+++|++
T Consensus 546 ~---~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 I---FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c---ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 00001112334456678999999999999999999853
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-22 Score=179.93 Aligned_cols=200 Identities=19% Similarity=0.260 Sum_probs=167.2
Q ss_pred cCCCCCCeeeecCceEEEEEE-ECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 219 (467)
-.|...++||+|+||.++.|+ +-+++.||||.=.... ..-++..|.+..+.+. .+.|-.++-|-..+.+-.||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 368888999999999999998 5589999999754322 2236778888888775 6788888888888888899999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-----CcEEEeecCCcc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDFGLAK 294 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgl~~ 294 (467)
.+ |-||.|++.-.+.. ++.+++..||.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+
T Consensus 105 LL-GPSLEDLFD~CgR~---FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRR---FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHhcCc---ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 88 77999988765443 89999999999999999999999 99999999999999644 358999999999
Q ss_pred ccCCCCCe------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccc
Q 012267 295 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR 351 (467)
Q Consensus 295 ~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~ 351 (467)
........ ......||.+||+-....+..-+.+.|.=|+|-++.+.|-|..||....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 76543322 2334569999999999999999999999999999999999999997643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=175.28 Aligned_cols=258 Identities=18% Similarity=0.212 Sum_probs=189.5
Q ss_pred hcCCCCCCeeeecCceEEEEEE-ECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC-CeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 218 (467)
...|...++||+|+||.+|.|. ..+|+.||||.-+.... .-++..|..+...+++ ..|-.++.|..+...-.+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4568889999999999999998 45899999998654322 2257788888888875 45667778888888999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC---CcEEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~ 295 (467)
|.+ |.||.+++.-.... ++.++++-++.|++.-++|+|.. +++||||||+|.|..-+ ..+.++|||+++.
T Consensus 91 dLL-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 988 77999998765433 88899999999999999999999 99999999999999644 4688999999986
Q ss_pred cCCCCCe------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh
Q 012267 296 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 296 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
....... ......||.+|.+-....+..-+.+.|+=|+|.+|..+.-|..||+....... .+-.+...
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyEkI~- 237 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYEKIS- 237 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHHHHH-
Confidence 5432221 22345699999998887777788999999999999999999999975332111 00011111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
+..+.- ...........++.-.+.-|-..--++-|....+-+.+.
T Consensus 238 EkK~s~-----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 238 EKKMST-----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HhhcCC-----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 111100 001112223355666667787878888888877666654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=198.00 Aligned_cols=216 Identities=24% Similarity=0.388 Sum_probs=164.0
Q ss_pred HhcCCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc-ccCCC
Q 012267 194 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI-IHRDV 272 (467)
Q Consensus 194 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~i-vH~dl 272 (467)
+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.... ..++|.....++.+|+.||+|||.. +| .|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 46789999999999999999999999999999999998843 3499999999999999999999998 55 99999
Q ss_pred CCCcEEECCCCcEEEeecCCccccCCC-CCeeeecccccccccccccccCC-------CCCcchhHHHHHHHHHHHHcCC
Q 012267 273 KAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTG-------KSSEKTDVFGYGIMLLELITGQ 344 (467)
Q Consensus 273 k~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~sDv~s~Gvil~elltg~ 344 (467)
+++|+++|....+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998776321 11111112234579999998763 1467899999999999999999
Q ss_pred CCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 012267 345 RAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 423 (467)
Q Consensus 345 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 423 (467)
.||+........ ..+...++. .-...+-|.+.... +....+..++..||..+|.+||++++|-..++...-
T Consensus 156 ~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999754332221 122222222 11122223322111 333468999999999999999999999999887544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=176.31 Aligned_cols=140 Identities=16% Similarity=0.189 Sum_probs=107.4
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcc-h------------------------HHHHHHHHHHHHhcCCCee
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-G------------------------ELQFQTEVEMISMAVHRNL 201 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~-~------------------------~~~~~~e~~~l~~l~h~ni 201 (467)
...||+|++|.||+|...+|+.||||+++...... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999998889999999997543211 0 0122348899999987776
Q ss_pred eeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCcccCCCCCCcEEEC
Q 012267 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL-HDHCDPKIIHRDVKAANILLD 280 (467)
Q Consensus 202 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-h~~~~~~ivH~dlk~~Nill~ 280 (467)
.....+.. ...++||||++++++....... .++++.....++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 43333222 2348999999988776543222 1378899999999999999999 687 999999999999998
Q ss_pred CCCcEEEeecCCcccc
Q 012267 281 EEFEAVVGDFGLAKLM 296 (467)
Q Consensus 281 ~~~~~kl~Dfgl~~~~ 296 (467)
++.++|+|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-23 Score=209.52 Aligned_cols=263 Identities=23% Similarity=0.254 Sum_probs=193.6
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHH---HHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ---FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++...+.||++.|=+|.+|+++.|. |+||++-+....-.... ...|++ ...++|||.+++.-......-.|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556678999999999999998776 99999865443323333 344444 566789999999888777777789999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc--C
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--D 297 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~--~ 297 (467)
|..+ +|+|.+..+.- +...+.+-|+.|++.||.-+|.. +|+|||||.+||||+.-.-+.|+||...+-. .
T Consensus 102 yvkh-nLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9866 99999876542 67778888999999999999999 9999999999999999999999999876533 2
Q ss_pred CCCC----eeeecccccccccccccccC----------CC-CCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHH
Q 012267 298 YKDT----HVTTAVRGTIGHIAPEYLST----------GK-SSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 298 ~~~~----~~~~~~~g~~~y~aPE~~~~----------~~-~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 361 (467)
.+.. ........-.+|+|||-+.. .. .+++.||||+||++.||++ |++||+.....
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~-------- 245 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL-------- 245 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH--------
Confidence 1111 12222234468999997643 12 5789999999999999987 78888643211
Q ss_pred HHHHH--HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCccchhhhHhHH
Q 012267 362 DWVKG--LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEV 435 (467)
Q Consensus 362 ~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 435 (467)
.+-.. ...+.-++.+-| ..+.++++.|++.||++|-++++.++.-.+..+.+.+-.+.++-.
T Consensus 246 aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~ 309 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYL 309 (1431)
T ss_pred hHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHH
Confidence 11000 000011111112 247789999999999999999999999999998888877766655
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-22 Score=177.69 Aligned_cols=174 Identities=10% Similarity=0.091 Sum_probs=133.6
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchH--HH------HHHHHHHHHhcCCCeeeeeeeeeeC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGE--LQ------FQTEVEMISMAVHRNLLRLRGFCMT 210 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~l~h~niv~~~~~~~~ 210 (467)
....+|+..+++|.|+||.||+... ++..+|||.++........ .. +.+|+..+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 5778999999754432221 12 5789999999999999999888653
Q ss_pred C--------CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC
Q 012267 211 P--------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282 (467)
Q Consensus 211 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~ 282 (467)
. ...++||||++|.+|.++.. ++. ....+++.+|..+|+. +++|||++|+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999988732 222 2456899999999999 99999999999999998
Q ss_pred CcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc
Q 012267 283 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342 (467)
Q Consensus 283 ~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt 342 (467)
+ ++|+|||........... ..+.....+..++|+||||+++..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 999999988654211100 012334455678999999999876653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=169.69 Aligned_cols=140 Identities=18% Similarity=0.216 Sum_probs=109.9
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcch-------------------------HHHHHHHHHHHHhcCCCee
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG-------------------------ELQFQTEVEMISMAVHRNL 201 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~-------------------------~~~~~~e~~~l~~l~h~ni 201 (467)
...||+|++|.||+|...+|+.||||+++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999987899999999976421100 1123578899999999887
Q ss_pred eeeeeeeeCCCceEEEeeccCCCChhhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEE
Q 012267 202 LRLRGFCMTPTERLLVYPYMANGSVASC-LRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILL 279 (467)
Q Consensus 202 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill 279 (467)
.....+... ..++||||++++++... +... .++......++.+++.++.+||+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 544443332 34899999998865443 3321 26778899999999999999999 8 99999999999999
Q ss_pred CCCCcEEEeecCCccccC
Q 012267 280 DEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~~~~ 297 (467)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=162.32 Aligned_cols=184 Identities=18% Similarity=0.083 Sum_probs=136.6
Q ss_pred CCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcc---hHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEeecc
Q 012267 146 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG---GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
....|++|+||+||.+.. .+.+++.+.+....... ....+.+|+++|.++. |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346899999999997766 67888888876543311 1224789999999995 5778888886 4569999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCC-CCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
.|.+|...+.. ....++.+++++|.++|++ +|+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998654321 1134678999999999999 9999999 7999999999999999999998654322
Q ss_pred Ce----e--------eecccccccccccccccCC-CCC-cchhHHHHHHHHHHHHcCCCCcc
Q 012267 301 TH----V--------TTAVRGTIGHIAPEYLSTG-KSS-EKTDVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 301 ~~----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~sDv~s~Gvil~elltg~~p~~ 348 (467)
.. . ......++.|++|+...-- ..+ ...+.++-|.-+|.++|+..++-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0 0011246677777644321 223 56788999999999999998863
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=170.05 Aligned_cols=197 Identities=24% Similarity=0.314 Sum_probs=136.2
Q ss_pred CCCeeeeeeeeeeC---------------------------CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHH
Q 012267 197 VHRNLLRLRGFCMT---------------------------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 249 (467)
Q Consensus 197 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 249 (467)
+|||||++.++|.+ +...|+||.-.+. +|.+++..+. .+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999987742 2345889987755 8999987654 4556777888
Q ss_pred HHHHHHHHHHHcCCCCCcccCCCCCCcEEE--CCCC--cEEEeecCCccccCCCC-----Ceeeeccccccccccccccc
Q 012267 250 LGSARGLSYLHDHCDPKIIHRDVKAANILL--DEEF--EAVVGDFGLAKLMDYKD-----THVTTAVRGTIGHIAPEYLS 320 (467)
Q Consensus 250 ~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfgl~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~ 320 (467)
.|+++|+.|||.+ +|.|||+|++|||+ |+|+ ...|+|||++..-.... ..-.-...|....||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999998 4444 47899999875422110 01111234777899999986
Q ss_pred CCCC------CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHH
Q 012267 321 TGKS------SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLI 394 (467)
Q Consensus 321 ~~~~------~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 394 (467)
..+- -.|+|.|+.|.+.||+++...||.... ..+ +.....++..-|.+.. .....+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG------em~-------L~~r~Yqe~qLPalp~----~vpp~~r 487 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG------EML-------LDTRTYQESQLPALPS----RVPPVAR 487 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc------hhe-------echhhhhhhhCCCCcc----cCChHHH
Confidence 5432 358999999999999999999995311 000 1111111212222221 1223466
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 395 QVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 395 ~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
+++...++.||.+|++..-....|+
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHHH
Confidence 7788889999999999865555553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=170.79 Aligned_cols=232 Identities=23% Similarity=0.310 Sum_probs=145.5
Q ss_pred CCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCC----------Ceeeeeeeeee---
Q 012267 146 NKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVH----------RNLLRLRGFCM--- 209 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~--- 209 (467)
..+.||.|+++.||.+++. +|+.+|||++...... ...+++.+|.-....+.+ -.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3578999999999999976 6899999998644422 234456666544444322 12222222211
Q ss_pred ------CC---C-----ceEEEeeccCCCChhhhhhc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCC
Q 012267 210 ------TP---T-----ERLLVYPYMANGSVASCLRE---RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 272 (467)
Q Consensus 210 ------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dl 272 (467)
.. . ..+++|+-+ .++|.+++.. .......+....++.+..|+++.+++||+. +++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11 1 236778777 5588887542 222222345566778889999999999999 9999999
Q ss_pred CCCcEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccC--------CCCCcchhHHHHHHHHHHHHcCC
Q 012267 273 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGIMLLELITGQ 344 (467)
Q Consensus 273 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDv~s~Gvil~elltg~ 344 (467)
+|+|++++.+|.++|+||+.....+ ........+..|.+||.... -.++.+.|.|++|+++|.|++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999998776432 12221234578999997643 24688999999999999999999
Q ss_pred CCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCC
Q 012267 345 RAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR 408 (467)
Q Consensus 345 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 408 (467)
.||+.......... .+ .. +.+..+.+..++..+|+++|.+|
T Consensus 248 lPf~~~~~~~~~~~---------------------~f-~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---------------------DF-SR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG---------------------GG-TT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc---------------------cc-hh-cCCcCHHHHHHHHHHccCCcccC
Confidence 99975432221111 11 11 12555778889999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-21 Score=188.07 Aligned_cols=236 Identities=25% Similarity=0.284 Sum_probs=179.5
Q ss_pred eeeecCceEEEEEE----ECCCCEEEEEEeccCCCcchHH-HHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEeeccC
Q 012267 149 ILGRGGFGKVYKGR----LADGSLVAVKRLKEERTPGGEL-QFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 149 ~lg~G~~g~V~~~~----~~~g~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 222 (467)
++|+|.||.|++++ ...|..+|.|.+++........ ....|..++...+ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999874 2357889999987654332221 3456777788886 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
+|.|...+..... +...........++-++.++|+. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988876543 56666677778899999999999 9999999999999999999999999999865322211
Q ss_pred eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
+||..|||||++. .....+|.||||++++||+||..||.. +.+...++.. .
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~----~------ 204 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAE----L------ 204 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhc----c------
Confidence 7999999999998 457789999999999999999999953 2222222211 1
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHhcC
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKM--SEVVRMLEGD 421 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~evl~~L~~~ 421 (467)
..+.......-+++..++..+|.+|--. ..+.+..+..
T Consensus 205 -~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~ 244 (612)
T KOG0603|consen 205 -EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE 244 (612)
T ss_pred -CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc
Confidence 1122333445566667778899998765 4555555543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=188.61 Aligned_cols=201 Identities=22% Similarity=0.256 Sum_probs=160.4
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC---CCeeeeeeeeeeCC
Q 012267 135 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTP 211 (467)
Q Consensus 135 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 211 (467)
.+.++....|.+.+.||+|+||+||+|...+|+.||+|+=+.....+ |.--.+++.+|+ -+.|..+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 44556677888899999999999999998889999999876544322 222233444444 23444555555567
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC-------CCCc
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-------EEFE 284 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~-------~~~~ 284 (467)
+.-+||+||.+.|+|.+++.... .++|...+.++.|++.-+..||.. +|||+||||+|.||. ++.-
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 77899999999999999998433 389999999999999999999999 999999999999994 2345
Q ss_pred EEEeecCCccccC-CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 012267 285 AVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRA 346 (467)
Q Consensus 285 ~kl~Dfgl~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p 346 (467)
++|+|||.+.-+. ..+.......++|-.+-.+|+..+++++...|.|.|+.+++-||.|+..
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 8999999986543 2344456667789999999999999999999999999999999998753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-19 Score=157.37 Aligned_cols=135 Identities=20% Similarity=0.218 Sum_probs=104.4
Q ss_pred CCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-----CCCeeeeeeeeeeCCC---c-e
Q 012267 145 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-----VHRNLLRLRGFCMTPT---E-R 214 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~ 214 (467)
...+.||+|+||.||. ++ ++.. +||++..... .....+.+|+.++..+ .||||++++|++.++. . .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4457899999999996 43 4444 6998865432 2345789999999999 5799999999998764 3 3
Q ss_pred EEEeec--cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCcccCCCCCCcEEECC----CCcEEE
Q 012267 215 LLVYPY--MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL-SYLHDHCDPKIIHRDVKAANILLDE----EFEAVV 287 (467)
Q Consensus 215 ~lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl-~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl 287 (467)
.+|+|| +.+|+|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 378999 55899999997632 4444 35577888777 999999 9999999999999974 347999
Q ss_pred eecCCc
Q 012267 288 GDFGLA 293 (467)
Q Consensus 288 ~Dfgl~ 293 (467)
+||+-+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=159.54 Aligned_cols=142 Identities=13% Similarity=0.101 Sum_probs=110.2
Q ss_pred CCCCCCeeeecCceEEEEEE--ECCCCEEEEEEeccCCCcc-----------------------hHHHHHHHHHHHHhcC
Q 012267 143 SFSNKNILGRGGFGKVYKGR--LADGSLVAVKRLKEERTPG-----------------------GELQFQTEVEMISMAV 197 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~--~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~ 197 (467)
.|.+.+.||+|++|.||+|. ..+|+.||||+++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 4689999999987542110 0123568999999887
Q ss_pred CCe--eeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-cccCCCCC
Q 012267 198 HRN--LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK-IIHRDVKA 274 (467)
Q Consensus 198 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~-ivH~dlk~ 274 (467)
+.. +.+++++ ...++||||+++++|........ .+.......++.|++.++++||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 532 3344433 23589999999988877653321 245566788999999999999999 8 99999999
Q ss_pred CcEEECCCCcEEEeecCCcccc
Q 012267 275 ANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 275 ~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=154.16 Aligned_cols=135 Identities=20% Similarity=0.308 Sum_probs=113.7
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcc-------hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+.||+|++|.||+|.. .|..|++|+........ ....+..|++++..+.|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 57789999875432211 123477899999999999988877777777888999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
++|++|.+++... .+ .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998653 22 7889999999999999999 999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=152.57 Aligned_cols=144 Identities=21% Similarity=0.151 Sum_probs=110.9
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc---------------------chHHHHHHHHHHHHh
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP---------------------GGELQFQTEVEMISM 195 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~ 195 (467)
+......|...+.||+|+||.||++...+|+.||||+++..... .....+..|...+..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33334447778999999999999999888999999987643210 011135678888888
Q ss_pred cCCCe--eeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCC
Q 012267 196 AVHRN--LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVK 273 (467)
Q Consensus 196 l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk 273 (467)
+.|++ +...++ ....++||||+++++|.+.... .....++.+++.++.++|+. +++|+||+
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 87774 444443 2455899999999998765431 23457888999999999998 99999999
Q ss_pred CCcEEECCCCcEEEeecCCccccC
Q 012267 274 AANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 274 ~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.6e-18 Score=151.09 Aligned_cols=131 Identities=19% Similarity=0.298 Sum_probs=106.9
Q ss_pred eeeecCceEEEEEEECCCCEEEEEEeccCCCcc-------hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 149 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.||+|++|.||+|.+ +|..|++|......... ....+..|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57889999865432111 1235678999999999887666555666677789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999876431 0 7889999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=171.82 Aligned_cols=138 Identities=18% Similarity=0.301 Sum_probs=111.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEE-eccCCC-c-----chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKR-LKEERT-P-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~-~~~~~~-~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
...|...+.||+|+||+||+|.+.+.. +++|+ +..... . .....+..|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345566789999999999999876443 44443 222111 1 112357899999999999999988888877778
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999998875 3467899999999999999 99999999999999 6778999999998
Q ss_pred cc
Q 012267 294 KL 295 (467)
Q Consensus 294 ~~ 295 (467)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-19 Score=170.51 Aligned_cols=123 Identities=26% Similarity=0.397 Sum_probs=106.1
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++.|++|...+|.+||...... ...+|...+.++.|++.|+.| + +.+|+|+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 468999999999999999755432 236788999999999999999 5 899999999999999999999999999
Q ss_pred ccccCCCC-----CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc
Q 012267 293 AKLMDYKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342 (467)
Q Consensus 293 ~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt 342 (467)
........ ....+...||..||+||.+.+..|+.|+||||||+||+|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87654333 223344569999999999999999999999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.8e-17 Score=167.34 Aligned_cols=227 Identities=21% Similarity=0.272 Sum_probs=146.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
..+|..++.|..|++|.||..+++ +.+.+|+| +++... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc--cccccCCccee-----------------
Confidence 357888999999999999999876 45678874 332211 1110 22222223222
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+-...++..+. ++. +++.+++|||+. +|+|||+||+|.+|+.-|++|++|||+.+.....
T Consensus 136 ----gDc~tllk~~g~----lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP----LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhcccCCC----Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 455555554332 221 227789999999 9999999999999999999999999998753211
Q ss_pred --------------CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 300 --------------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 300 --------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
.......++||+.|+|||++....|..-+|+|++|+|+||.+-|+.||...... +.+.
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--------elfg 268 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELFG 268 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--------HHHh
Confidence 011223467999999999999999999999999999999999999999643211 1122
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc-CCCCccch
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG-DGLAERWD 428 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~-~~~~~~~~ 428 (467)
.++.+.....--|.. ...+..+++.+.++.+|..|--...-+++-+. ..+.-+|.
T Consensus 269 ~visd~i~wpE~dea--------~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 269 QVISDDIEWPEEDEA--------LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhhhccccccCcC--------CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 222211100000221 12446667777788899999644444443332 23334444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=140.67 Aligned_cols=136 Identities=19% Similarity=0.206 Sum_probs=96.4
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchH-HH----------------------HHHHHHHHHhcCCCe--e
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGE-LQ----------------------FQTEVEMISMAVHRN--L 201 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~-~~----------------------~~~e~~~l~~l~h~n--i 201 (467)
.+.||+|+||+||+|...+|+.||||+++........ .. ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998653221111 01 124555555554332 3
Q ss_pred eeeeeeeeCCCceEEEeeccCCCChhhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEE
Q 012267 202 LRLRGFCMTPTERLLVYPYMANGSVASC-LRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILL 279 (467)
Q Consensus 202 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill 279 (467)
.+.++. ...++||||++++++... +.... .. .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 246899999999654321 21110 11 4577889999999999999 7 99999999999999
Q ss_pred CCCCcEEEeecCCcccc
Q 012267 280 DEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~~~ 296 (467)
+ ++.++++|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 889999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.6e-16 Score=131.32 Aligned_cols=135 Identities=17% Similarity=0.136 Sum_probs=113.4
Q ss_pred CCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC--CeeeeeeeeeeCCCceEEEeeccCC
Q 012267 146 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.++++++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 34679999999999999854 7899999865433 4468899999999976 5888999988888889999999998
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+.+..+ +......++.++++++++||.....+++|+|++|.||++++.+.+++.|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777544 4456778899999999999996445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.5e-15 Score=136.88 Aligned_cols=135 Identities=18% Similarity=0.202 Sum_probs=104.3
Q ss_pred Ceee-ecCceEEEEEEECCCCEEEEEEeccCCC------------cchHHHHHHHHHHHHhcCCCee--eeeeeeeeCCC
Q 012267 148 NILG-RGGFGKVYKGRLADGSLVAVKRLKEERT------------PGGELQFQTEVEMISMAVHRNL--LRLRGFCMTPT 212 (467)
Q Consensus 148 ~~lg-~G~~g~V~~~~~~~g~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~ 212 (467)
.+|| .|+.|+||.+... +..++||++..... ......+.+|++++.++.|+++ ...+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999999885 67899998853210 1122357889999999998774 66666644322
Q ss_pred ----ceEEEeeccCC-CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEE
Q 012267 213 ----ERLLVYPYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV 287 (467)
Q Consensus 213 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 287 (467)
..++||||+++ .+|.+++... +++.. .+.+++.+|.+||+. +|+|+||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 23599999997 6999888653 14432 356899999999999 9999999999999999899999
Q ss_pred eecCCccc
Q 012267 288 GDFGLAKL 295 (467)
Q Consensus 288 ~Dfgl~~~ 295 (467)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.5e-17 Score=165.49 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=185.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC--CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~--~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 217 (467)
..|...+-||+|+|+.|-..... ....+|+|.+.... ..........|..+-..+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666677999999999888653 34567777765443 2222334556777777776 99999999999999999999
Q ss_pred eeccCCCChhhhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCcccCCCCCCcEEECCCC-cEEEeecCCcc
Q 012267 218 YPYMANGSVASCL-RERPPSQLPLDWPTRKRIALGSARGLSYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 294 (467)
Q Consensus 218 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~ 294 (467)
++|..++++.+-+ +.... ..+......++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||++.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999988 43321 1344456678899999999999 77 999999999999999999 99999999998
Q ss_pred ccCC--CCCeeeecccc-cccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 295 LMDY--KDTHVTTAVRG-TIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 295 ~~~~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
.... .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|.....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~-- 248 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKG-- 248 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeeccccc--
Confidence 7665 23334445568 9999999999874 45788999999999999999999997644322 11222221110
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 414 (467)
. ..............++...++..+|..|.+.+++
T Consensus 249 -~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 249 -R--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred -c--------cccCccccCChhhhhcccccccCCchhccccccc
Confidence 0 0001111222446677778888899999998776
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.4e-15 Score=133.23 Aligned_cols=156 Identities=22% Similarity=0.347 Sum_probs=120.2
Q ss_pred HHHHHHhcCCCeeeeeeeeeeCC-----CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 012267 189 EVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263 (467)
Q Consensus 189 e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~ 263 (467)
-..-|-.+.|.|||++..|+.+. ....++.|||..|++..+|++.......+......+++.||..||.|||+ |
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 34455667799999999987654 34679999999999999999876666667888889999999999999999 6
Q ss_pred CCCcccCCCCCCcEEECCCCcEEEeecCCccccC---CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHH
Q 012267 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 340 (467)
Q Consensus 264 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~---~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el 340 (467)
.|.|+|+++..+.|++..++-+|++--.-...-. ...........+.++|.+||+-.....+-.+|||+||+-.+||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 8999999999999999999988885322111000 0001111122367899999988777778899999999999999
Q ss_pred HcCCC
Q 012267 341 ITGQR 345 (467)
Q Consensus 341 ltg~~ 345 (467)
..|.-
T Consensus 276 ailEi 280 (458)
T KOG1266|consen 276 AILEI 280 (458)
T ss_pred HHhee
Confidence 87653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.7e-14 Score=139.48 Aligned_cols=141 Identities=23% Similarity=0.266 Sum_probs=99.4
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcch---------------------------------------HHHHHH
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG---------------------------------------ELQFQT 188 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 188 (467)
+.||.|++|.||+|++.+|+.||||+.+......- +.+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864321100 012344
Q ss_pred HHHHHHhc----CCCeeeeeeeeee-CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHcC
Q 012267 189 EVEMISMA----VHRNLLRLRGFCM-TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR-GLSYLHDH 262 (467)
Q Consensus 189 e~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gl~~Lh~~ 262 (467)
|...+.++ +|.+-+.+-.++. .....++||||++|++|.++....... . .+..++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHhC
Confidence 55544444 2333333333332 244579999999999999876542111 2 23456666665 46788888
Q ss_pred CCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 263 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
+++|+|++|.||+++++++++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5e-12 Score=125.71 Aligned_cols=236 Identities=18% Similarity=0.167 Sum_probs=156.0
Q ss_pred ECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCH
Q 012267 163 LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDW 242 (467)
Q Consensus 163 ~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 242 (467)
..++.+|.|...+.... .......+-++.++.++||||++++..+......|+|+|-+. -|..++.+. ..
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GK 103 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HH
Confidence 34688899888865543 333456777889999999999999999999999999999874 466777663 33
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCC
Q 012267 243 PTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322 (467)
Q Consensus 243 ~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 322 (467)
......+.||+.||.|||..| +++|++|.-+.|+|+..|+.||++|.++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 456667889999999999776 899999999999999999999999988764332111 01111122346666654332
Q ss_pred CCCcchhHHHHHHHHHHHHcCCCCcccc-cccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHcc
Q 012267 323 KSSEKTDVFGYGIMLLELITGQRAFDLA-RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCT 401 (467)
Q Consensus 323 ~~~~~sDv~s~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl 401 (467)
. -..|.|-||++++|++.|..+-... .....-...........+.. ... .. ...++.+..|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~--------~~~------~r-~n~~~~~~~~~ 243 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGA--------TEL------KR-PNKLRFILECR 243 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhcc--------ccc------cc-cchhhHHHHHH
Confidence 2 3469999999999999993322110 00000000000100000000 000 00 11556677777
Q ss_pred CCCCCCCCCHHHHHHHHhcCCCCccch
Q 012267 402 QGSPMDRPKMSEVVRMLEGDGLAERWD 428 (467)
Q Consensus 402 ~~~p~~RPs~~evl~~L~~~~~~~~~~ 428 (467)
..-+--|=.+-+++.+|++..+.+.-.
T Consensus 244 ~~~gff~n~fvd~~~fLeel~lks~~e 270 (690)
T KOG1243|consen 244 LLGGFFRNDFVDTLLFLEELRLKSVEE 270 (690)
T ss_pred hccccccchHHHHHHHHHhcccCcHHH
Confidence 777888888888888888877765443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-13 Score=137.12 Aligned_cols=145 Identities=21% Similarity=0.238 Sum_probs=93.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-CCEEEEEEeccCCCc---------------------------------chH----
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTP---------------------------------GGE---- 183 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~-g~~vavK~~~~~~~~---------------------------------~~~---- 183 (467)
..|+. +.||+|++|.||+|++.+ |+.||||+++..... +-.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999987 999999999743210 001
Q ss_pred --HHHHHHHHHHHhcC----CCeeeeeeeeeeC-CCceEEEeeccCCCChhhhh--hcCCCCCCCCCHHHHHHHHHHHHH
Q 012267 184 --LQFQTEVEMISMAV----HRNLLRLRGFCMT-PTERLLVYPYMANGSVASCL--RERPPSQLPLDWPTRKRIALGSAR 254 (467)
Q Consensus 184 --~~~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~ 254 (467)
.++..|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.+.++- ...+.....+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 12344444443332 3344444444433 35678999999999998752 222111001111122222222
Q ss_pred HHHHHHcCCCCCcccCCCCCCcEEECCCC----cEEEeecCCccccC
Q 012267 255 GLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFGLAKLMD 297 (467)
Q Consensus 255 gl~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~~~~~ 297 (467)
++.. +++|+|++|.||+++.++ ++++.|||++..++
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3345 999999999999999988 99999999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.8e-13 Score=131.61 Aligned_cols=248 Identities=21% Similarity=0.198 Sum_probs=175.6
Q ss_pred cCCCCCCeeee--cCceEEEEEEE--C-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCce
Q 012267 142 DSFSNKNILGR--GGFGKVYKGRL--A-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~--G~~g~V~~~~~--~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 214 (467)
..|...+-+|. |.+|.||.+.+ . ++..+|+|+-+.... +.....-.+|+...++++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34555677999 99999999987 3 688999998443222 122223345666666664 99999988888899999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEee
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR----GLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGD 289 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~D 289 (467)
++-+|++. .+|..+.+..... ++....+.+..+..+ ||.++|+. +++|-|+||.||+...+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~---~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNF---LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhccccc---CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999885 6888887764332 455666777777777 99999999 99999999999999999 8899999
Q ss_pred cCCccccCCCCCe----eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 290 FGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 290 fgl~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
||+...+....-. ......|...|++||..++ -++..+|+|++|.++.+..++..+....... .|.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~- 336 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWS- 336 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--------Ccc-
Confidence 9999877543311 1222357889999998754 5688999999999999999988776432100 111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
.+.... +...+......++...+..+++.+|..|++.+.+.
T Consensus 337 ------~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 337 ------QLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ------cccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 011111 11111222224444578889999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.2e-12 Score=112.40 Aligned_cols=130 Identities=20% Similarity=0.193 Sum_probs=95.1
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeee-eeeeeeeCCCceEEEeeccCCCCh
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
+.|+.|.++.||+++.. +..|++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 56889999999999875 77899998754321 123467888888888655544 344432 3345899999999887
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
.+. . . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 1 11345678999999999982 12359999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.4e-11 Score=103.96 Aligned_cols=136 Identities=13% Similarity=0.123 Sum_probs=95.9
Q ss_pred CeeeecCceEEEEEEECC-------CCEEEEEEeccCCC---------------------cchHHHH----HHHHHHHHh
Q 012267 148 NILGRGGFGKVYKGRLAD-------GSLVAVKRLKEERT---------------------PGGELQF----QTEVEMISM 195 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~-------g~~vavK~~~~~~~---------------------~~~~~~~----~~e~~~l~~ 195 (467)
..||.|.-+.||.|...+ +..+|||+.+.... ......+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 47999998753110 1112223 378888888
Q ss_pred cCC--CeeeeeeeeeeCCCceEEEeeccCCCChhh-hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCcccCC
Q 012267 196 AVH--RNLLRLRGFCMTPTERLLVYPYMANGSVAS-CLRERPPSQLPLDWPTRKRIALGSARGLSYL-HDHCDPKIIHRD 271 (467)
Q Consensus 196 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-h~~~~~~ivH~d 271 (467)
+.. -++-.++++ ...++||||+.++.+.. .+++. .++......+..+++.+|..| |.. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 753 334444443 56789999997654422 22221 144455677888999999999 777 999999
Q ss_pred CCCCcEEECCCCcEEEeecCCcccc
Q 012267 272 VKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 272 lk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|++.||++++ +.+.|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.2e-11 Score=107.57 Aligned_cols=143 Identities=19% Similarity=0.223 Sum_probs=108.9
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCC--eeeeeeeeeeCC---CceEEEeeccC
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR--NLLRLRGFCMTP---TERLLVYPYMA 222 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~ 222 (467)
+.|+.|..+.||+++..+|..+++|.............+..|.+++..+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999998777889999976543322334678999999988753 356667766553 25689999999
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--------------------------------------- 263 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~--------------------------------------- 263 (467)
+.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988776542 12667777888888888888888521
Q ss_pred --------------CCCcccCCCCCCcEEECC--CCcEEEeecCCccc
Q 012267 264 --------------DPKIIHRDVKAANILLDE--EFEAVVGDFGLAKL 295 (467)
Q Consensus 264 --------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~ 295 (467)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-11 Score=120.36 Aligned_cols=249 Identities=20% Similarity=0.197 Sum_probs=170.0
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEE--CCCCEEEEEEeccCCCcchHHH-HHHHHHHHHhc-CCCeeeeeeeeeeCCCc
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRL--ADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMA-VHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~g~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 213 (467)
.....+|.....||.|.|+.|++... .++..|++|.+.........+. -..|+.+...+ .|.++++....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 33456788888999999999999864 3688999998865543322222 23455554444 58888887777777777
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEeecCC
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGL 292 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl 292 (467)
.++--||++++++...+.-. .-++...++.+..+++.++.++|+. .++|+|+||+||++..+ +.-+++|||+
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 78999999999887766321 1266678889999999999999998 99999999999999886 7789999999
Q ss_pred ccccCCCCCeeeeccccccccc--ccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHI--APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
...+..... ...+..++. +++......+..+.|+||||.-+.+.++|..--.. . .+|..
T Consensus 414 ~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~---~~~~~----- 474 (524)
T KOG0601|consen 414 WTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------G---VQSLT----- 474 (524)
T ss_pred ccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcc-------c---cccee-----
Confidence 864322111 111233444 55555566778999999999999999998654321 0 01110
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
+..-.-+... .....+..+...+..+++..||.+.++....+
T Consensus 475 --i~~~~~p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 475 --IRSGDTPNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --eecccccCCC-----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0000011111 11144555666677899999999887765543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.4e-10 Score=95.99 Aligned_cols=132 Identities=21% Similarity=0.326 Sum_probs=99.6
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEE-eccCCC-cch-----HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKR-LKEERT-PGG-----ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~-~~~~~~-~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
..+++|+-+.+|.+.+. |..+++|. +++... +.- ......|..++.+++--.|--.+=+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 44466664 332211 111 12356789999888655555555566788888999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
++|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888764 245667777888899999 999999999999998775 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.1e-09 Score=104.16 Aligned_cols=171 Identities=21% Similarity=0.297 Sum_probs=129.4
Q ss_pred CceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC----CCceEEEeeccCC-CChh
Q 012267 154 GFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPYMAN-GSVA 227 (467)
Q Consensus 154 ~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~ 227 (467)
.-.+.|++.. .+|..|++|+++..+..... ....-+++++++.|.|+|++.+++.. +..+++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3467899975 48999999999543322211 22345788999999999999998873 3467899999885 5777
Q ss_pred hhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 228 SCLRERPP-----------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 228 ~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
++...... .....++..+|.++.|+..||.++|+. |+..+-|.+++||++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 76544322 123467889999999999999999999 9999999999999999999999999887665
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRA 346 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p 346 (467)
..+.. |.+.. -.+-|.=.||.+++.|.||..-
T Consensus 444 ~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 43321 11111 2467889999999999999653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.5e-10 Score=93.42 Aligned_cols=144 Identities=17% Similarity=0.277 Sum_probs=105.4
Q ss_pred CCCeeeecCceEEEEEEECCCCEEEEEE-eccCC-Cc-----chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 146 NKNILGRGGFGKVYKGRLADGSLVAVKR-LKEER-TP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~g~~vavK~-~~~~~-~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
...++-+|+-+.|+++.+. |+...||. +.+.. .+ -......+|++.+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999985 67766664 32221 11 12335678999998886555555555677777889999
Q ss_pred eccCC-CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC---cEEEeecCCcc
Q 012267 219 PYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAK 294 (467)
Q Consensus 219 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~ 294 (467)
||+++ .++.+++....... ..-.....++..|-+.+.-||.+ +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 47888887654322 22223367888899999999999 999999999999997655 35899999986
Q ss_pred c
Q 012267 295 L 295 (467)
Q Consensus 295 ~ 295 (467)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.9e-09 Score=95.64 Aligned_cols=142 Identities=15% Similarity=0.094 Sum_probs=98.7
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcc----------hHHHHHHHHHHHHhcCCCe--eeeeeeeeeC-----
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG----------GELQFQTEVEMISMAVHRN--LLRLRGFCMT----- 210 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~----- 210 (467)
+++-.-....|++..+ +|+.|.||+........ ....+.+|...+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555445555777766 57889999774332111 0113678888887774322 2333444432
Q ss_pred CCceEEEeeccCCC-ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-------C
Q 012267 211 PTERLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-------E 282 (467)
Q Consensus 211 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-------~ 282 (467)
....++|+|++++. +|.+++..... .+.+......++.+++..+.-||.. +|+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 89998864321 1245567778999999999999999 9999999999999975 4
Q ss_pred CcEEEeecCCccc
Q 012267 283 FEAVVGDFGLAKL 295 (467)
Q Consensus 283 ~~~kl~Dfgl~~~ 295 (467)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.7e-09 Score=93.41 Aligned_cols=126 Identities=22% Similarity=0.242 Sum_probs=80.7
Q ss_pred EEEEEEECCCCEEEEEEeccCCC--------------------c-c----hHHHHHHHHHHHHhcCCC--eeeeeeeeee
Q 012267 157 KVYKGRLADGSLVAVKRLKEERT--------------------P-G----GELQFQTEVEMISMAVHR--NLLRLRGFCM 209 (467)
Q Consensus 157 ~V~~~~~~~g~~vavK~~~~~~~--------------------~-~----~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 209 (467)
.||.|...+|..+|||..+.... . . ......+|.+.|.++..- ++-+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999998899999998753210 0 0 112357899999998755 34445544
Q ss_pred CCCceEEEeeccC--CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 210 TPTERLLVYPYMA--NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY-LHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 210 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~-Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
...++||||++ |..+..+.... ++......++.+++..+.. +|.. +|+|+||.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24589999998 54444433221 1122445677777776666 4677 99999999999999988 899
Q ss_pred EeecCCcccc
Q 012267 287 VGDFGLAKLM 296 (467)
Q Consensus 287 l~Dfgl~~~~ 296 (467)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.9e-10 Score=117.22 Aligned_cols=204 Identities=20% Similarity=0.228 Sum_probs=142.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
..+.+.+.+-+.+|.++.++.+.-. .|...++|....... .........+-.++-..++|-++...--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456666777888999999887643 344445554432111 0011122222233333445666665555556677899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
+++|..+++|...++.-.. .+.......+..+.++++|||.. .+.|+|++|.|.+...++..+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999987542 33333444556778899999998 7999999999999999999999999843221
Q ss_pred CC------C------------------C------CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 012267 297 DY------K------------------D------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRA 346 (467)
Q Consensus 297 ~~------~------------------~------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p 346 (467)
.. . . ........+|+.|.+||...+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 0 0011234589999999999999999999999999999999999999
Q ss_pred cccc
Q 012267 347 FDLA 350 (467)
Q Consensus 347 ~~~~ 350 (467)
|+..
T Consensus 1035 ~na~ 1038 (1205)
T KOG0606|consen 1035 FNAE 1038 (1205)
T ss_pred CCCc
Confidence 9753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-08 Score=92.04 Aligned_cols=135 Identities=21% Similarity=0.168 Sum_probs=94.7
Q ss_pred CCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCC---------------------cchHHHHHHHHHHHHhcCCC--e
Q 012267 144 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT---------------------PGGELQFQTEVEMISMAVHR--N 200 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~--n 200 (467)
..+...||-|.-+.||.|....|.++|||.-+...+ .-.....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999999999999996532111 11223467788888888543 4
Q ss_pred eeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC
Q 012267 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 280 (467)
Q Consensus 201 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~ 280 (467)
+-+.+++ +...+||||++|--|...-- +-.....|+..|++-+.-+-.. |+||+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 4444443 56789999998866554321 1122334444555555555455 999999999999999
Q ss_pred CCCcEEEeecCCcc
Q 012267 281 EEFEAVVGDFGLAK 294 (467)
Q Consensus 281 ~~~~~kl~Dfgl~~ 294 (467)
++|.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999996554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.2e-08 Score=92.36 Aligned_cols=264 Identities=16% Similarity=0.173 Sum_probs=154.0
Q ss_pred CCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeee----ee--CCCc-eEEE
Q 012267 146 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGF----CM--TPTE-RLLV 217 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~----~~--~~~~-~~lv 217 (467)
....||+|+-+.+|-.--- +. .+-|+....-.. ... +.+..|... .||-+-.-+.+ .. +... .-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa-~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPA-AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCch-HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3567999999999964321 11 244666543221 111 122333333 35543221111 11 1222 4567
Q ss_pred eeccCCCC-hhhhhhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 218 YPYMANGS-VASCLRE--RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 218 ~e~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
|..+.+-. ...++.. +..+-....|...++.+..+|.+.+.||.. |.+-+|+.++|+|+++++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77665532 2222221 112223478999999999999999999999 99999999999999999999998865443
Q ss_pred ccCCCCCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcC-CCCcccccccCCCCccHH-HHHHHH
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLL-DWVKGL 367 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg-~~p~~~~~~~~~~~~~~~-~~~~~~ 367 (467)
.- ..+.......|...|.+||... +..-+..+|.|.+||++++++.| ++||.............. +.....
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 2333444556889999999765 23447789999999999999886 999976443332222221 111111
Q ss_pred hhh-cccccccCccccCcccHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHhc
Q 012267 368 LKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQG--SPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 368 ~~~-~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~evl~~L~~ 420 (467)
+.. ..-..-..|.-...........+..+..+|+.. ++.-|||++-.+..|..
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 110 000000001000111122223455556677765 47799999999988865
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.5e-09 Score=108.85 Aligned_cols=150 Identities=17% Similarity=0.324 Sum_probs=99.5
Q ss_pred HHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe--------eeecccccccccccccccCC
Q 012267 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTTAVRGTIGHIAPEYLSTG 322 (467)
Q Consensus 251 ~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~ 322 (467)
+++.||.|+|... ++||++|.|++|.++.++..||+.|+++......... ..--......|.|||++...
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999874 8999999999999999999999999987643321111 00111234579999999988
Q ss_pred CCCcchhHHHHHHHHHHHH-cCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHcc
Q 012267 323 KSSEKTDVFGYGIMLLELI-TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCT 401 (467)
Q Consensus 323 ~~~~~sDv~s~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl 401 (467)
..+.++|+||+||++|.+. .|+.-+.... ........... +..-...+......++.+-+.+.+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-----~~~~~~~~~~~----------~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANG-----GLLSYSFSRNL----------LNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccC-----Ccchhhhhhcc----------cccccccccccCcHHHHHHHHHHh
Confidence 8899999999999999998 4555443211 11111111110 100001112233456667777788
Q ss_pred CCCCCCCCCHHHHHHH
Q 012267 402 QGSPMDRPKMSEVVRM 417 (467)
Q Consensus 402 ~~~p~~RPs~~evl~~ 417 (467)
..++.-||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999988776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.5e-07 Score=83.13 Aligned_cols=104 Identities=18% Similarity=0.198 Sum_probs=78.9
Q ss_pred HHHHHHHHHHhcCC--CeeeeeeeeeeCC----CceEEEeeccCCC-ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 012267 185 QFQTEVEMISMAVH--RNLLRLRGFCMTP----TERLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257 (467)
Q Consensus 185 ~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~ 257 (467)
...+|...+..+.. -...+.+++.... ...++|+|++++. +|.+++..... .+......++.++++.++
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence 46677777666642 2234445554432 2348999999874 79999886432 444567889999999999
Q ss_pred HHHcCCCCCcccCCCCCCcEEECCCC---cEEEeecCCccc
Q 012267 258 YLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKL 295 (467)
Q Consensus 258 ~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~ 295 (467)
-||.. +|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.6e-07 Score=94.50 Aligned_cols=141 Identities=21% Similarity=0.241 Sum_probs=90.9
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcch---------------------------------------HHHHHH
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG---------------------------------------ELQFQT 188 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 188 (467)
+-|+.++-|.||+|++.+|+.||||+.+..-.+.- +.++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999999999999999864211100 011233
Q ss_pred HHHHHHhc----CCCeeeeeeeeeeC-CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHHcC
Q 012267 189 EVEMISMA----VHRNLLRLRGFCMT-PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG-LSYLHDH 262 (467)
Q Consensus 189 e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g-l~~Lh~~ 262 (467)
|..-+.++ ++..-+.+=.+|.+ .....|+|||++|-.+.+...-.... ++. ..++..++++ +.-+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~---k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDR---KELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCH---HHHHHHHHHHHHHHHHhc
Confidence 44433333 22222223333332 46679999999998888874322211 442 3333333332 2222234
Q ss_pred CCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 263 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
++.|.|..|.||+++.++++.+.|||+...++
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-06 Score=76.77 Aligned_cols=139 Identities=22% Similarity=0.174 Sum_probs=101.2
Q ss_pred eeecCceEEEEEEECCCCEEEEEEeccCC-----CcchHHHHHHHHHHHHhcCCCe--eeeeeeeee---CC--CceEEE
Q 012267 150 LGRGGFGKVYKGRLADGSLVAVKRLKEER-----TPGGELQFQTEVEMISMAVHRN--LLRLRGFCM---TP--TERLLV 217 (467)
Q Consensus 150 lg~G~~g~V~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~---~~--~~~~lv 217 (467)
-|.||.+-|+.-... |..+-+|+-.... .+.....|.+|...|.++..-+ +.++. ++. .+ -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 466888889998775 4578899864211 1445667999999998885322 33333 322 11 235799
Q ss_pred eeccCC-CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc--EEEeecCCcc
Q 012267 218 YPYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 294 (467)
Q Consensus 218 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~ 294 (467)
+|-+++ -+|.+++.+.... +.+...+..++.++++.++-||+. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 5888888664322 356677789999999999999999 9999999999999986666 9999998665
Q ss_pred c
Q 012267 295 L 295 (467)
Q Consensus 295 ~ 295 (467)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.9e-06 Score=77.19 Aligned_cols=139 Identities=12% Similarity=0.121 Sum_probs=83.8
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe--eeeeeeeeeCCCceEEEeeccCCCC
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 24467788875432 2335688999888875433 3556777767777789999998863
Q ss_pred -hhhh---------------------hhcCCCCCCCCCHHHHHH-HHH----------HHH-HHHHHHHcC-CCCCcccC
Q 012267 226 -VASC---------------------LRERPPSQLPLDWPTRKR-IAL----------GSA-RGLSYLHDH-CDPKIIHR 270 (467)
Q Consensus 226 -L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~ia-~gl~~Lh~~-~~~~ivH~ 270 (467)
+... +|....... ....... +.. .+. ....+|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~--~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS--TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC--cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 2111 111111111 1111100 000 011 112223221 13357899
Q ss_pred CCCCCcEEECCCCcEEEeecCCccc
Q 012267 271 DVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 271 dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
|+.|.||++++++ +.|+||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.1e-06 Score=74.41 Aligned_cols=154 Identities=19% Similarity=0.223 Sum_probs=97.1
Q ss_pred cCHHHHHHHhcCCCCCCe---eeecCceEEEEEEECCCCEEEEEEeccCCCcch------------------HH-----H
Q 012267 132 FSLRELQVATDSFSNKNI---LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGG------------------EL-----Q 185 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~------------------~~-----~ 185 (467)
.+++.+....++..+... |++|.-+.||+|...++..+|||+.+....... .. -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 445555555555555555 456777789999988899999999864321111 00 0
Q ss_pred HHHHHHHHHhcC--CCeeeeeeeeeeCCCceEEEeeccCCC-ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 012267 186 FQTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262 (467)
Q Consensus 186 ~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~ 262 (467)
..+|+.-|.++. +-.+-+.+++ ..-.|||||+... .-.-.|..- ++.......+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHh
Confidence 234555555543 2222222332 2347999998653 222222221 133335666777888888888773
Q ss_pred CCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 263 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
+ ++||+||+.-|||+. ++.+.|+|||-+....
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 3 999999999999999 7899999999886543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.8e-06 Score=72.43 Aligned_cols=138 Identities=14% Similarity=0.129 Sum_probs=90.2
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHH---------HHHHHHHHhcCC---Ceeeeeee
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQF---------QTEVEMISMAVH---RNLLRLRG 206 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~---------~~e~~~l~~l~h---~niv~~~~ 206 (467)
....+|...+++-......|.+-.. +|..+.+|..+..... .+..| .+++..+.+++. -..+.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3456788878888777777776666 5788999988654322 11111 233333333322 22222222
Q ss_pred ee-----eCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC
Q 012267 207 FC-----MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 281 (467)
Q Consensus 207 ~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~ 281 (467)
.. .-....+++|||++|-.|.++.. ++. .++..+.+++.-||.. |++|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 22 22344579999999988766532 221 2455677889999999 9999999999999986
Q ss_pred CCcEEEeecCCcc
Q 012267 282 EFEAVVGDFGLAK 294 (467)
Q Consensus 282 ~~~~kl~Dfgl~~ 294 (467)
++ +++.||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 65 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.4e-05 Score=86.75 Aligned_cols=149 Identities=12% Similarity=0.212 Sum_probs=91.8
Q ss_pred CCeeeecCceEEEEEEECCC---CEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCee--eeeeeeeeCC---CceEEE
Q 012267 147 KNILGRGGFGKVYKGRLADG---SLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNL--LRLRGFCMTP---TERLLV 217 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 217 (467)
.+.++.|.+..+|+....++ ..+++|+............+.+|.+++..+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35688999999999887654 3677887654333233446889999999885 6654 7778887664 457899
Q ss_pred eeccCCCChhhh-----------------------hhcCCCC-------CCCCCH--HHHHHHH---------------H
Q 012267 218 YPYMANGSVASC-----------------------LRERPPS-------QLPLDW--PTRKRIA---------------L 250 (467)
Q Consensus 218 ~e~~~~gsL~~~-----------------------l~~~~~~-------~~~l~~--~~~~~i~---------------~ 250 (467)
|||++|..+.+. ||..... ..+..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999987643211 1111100 001111 1111110 1
Q ss_pred HHHHHHHHHHcCC--------CCCcccCCCCCCcEEECCC-Cc-EEEeecCCccc
Q 012267 251 GSARGLSYLHDHC--------DPKIIHRDVKAANILLDEE-FE-AVVGDFGLAKL 295 (467)
Q Consensus 251 ~ia~gl~~Lh~~~--------~~~ivH~dlk~~Nill~~~-~~-~kl~Dfgl~~~ 295 (467)
.+.+.+.+|..+. .+.++|+|+++.||+++.+ .. +-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2334456664432 1359999999999999853 33 57999998765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.7e-07 Score=91.94 Aligned_cols=182 Identities=19% Similarity=0.167 Sum_probs=130.8
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe-eeeeeeeeeCCCceEEEeeccCCC-C
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVYPYMANG-S 225 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-s 225 (467)
+-+++|++++++|.+....+...++.+... ....-++++|-+++||| .+..++-+......+++++++.++ +
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 447889999999998544444445655332 35667899999999999 777777777777889999999877 2
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeee
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 305 (467)
....... ....+...+...+...-++++++||+. .=+|+| ||+..+ +..+.+||+....+.... ...
T Consensus 322 ~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 322 SALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred ccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 2221111 111133334445555667899999997 568998 777665 578999999987665433 334
Q ss_pred cccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 012267 306 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 306 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~ 348 (467)
...+++.++|||+...+.+..+.|+|+.|+-..++.-|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999988778877777653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.5e-06 Score=82.38 Aligned_cols=140 Identities=21% Similarity=0.240 Sum_probs=89.3
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcc------------------------------------hHHHHHHHHH
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG------------------------------------GELQFQTEVE 191 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~------------------------------------~~~~~~~e~~ 191 (467)
+-||.-+.|.||+|++++|+.||||+-+..-... .+.+|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999875421111 0112334443
Q ss_pred HHH----hcCCCe---eeeeeeeeeC-CCceEEEeeccCCCChhhhh--hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 012267 192 MIS----MAVHRN---LLRLRGFCMT-PTERLLVYPYMANGSVASCL--RERPPSQLPLDWPTRKRIALGSARGLSYLHD 261 (467)
Q Consensus 192 ~l~----~l~h~n---iv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~ 261 (467)
-.. .+.|-+ -|.+=.++++ .....|+||||+|..+.|.- .+.+ ++-. .|+..+.++ |++.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~---~i~~~l~~~--~~~q 316 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-----ISPH---DILNKLVEA--YLEQ 316 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-----CCHH---HHHHHHHHH--HHHH
Confidence 222 233444 1222233333 35679999999998777653 3332 4433 344444432 3333
Q ss_pred CCCCCcccCCCCCCcEEECC----CCcEEEeecCCccccC
Q 012267 262 HCDPKIIHRDVKAANILLDE----EFEAVVGDFGLAKLMD 297 (467)
Q Consensus 262 ~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgl~~~~~ 297 (467)
....|++|+|=.|.||++.. ++++.+.|||+.....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 33338999999999999984 6789999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.2e-05 Score=72.61 Aligned_cols=140 Identities=16% Similarity=0.116 Sum_probs=82.7
Q ss_pred eeecCc-eEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEeeccCCCChh
Q 012267 150 LGRGGF-GKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVA 227 (467)
Q Consensus 150 lg~G~~-g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 227 (467)
|-.|.. ..||+.... +..+.||+..... ...+..|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 334444 789999765 4678888875432 224667888877764 333446677766666789999999988776
Q ss_pred hhh-------------------hcCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHc----C
Q 012267 228 SCL-------------------RERPPSQLPLDW--PTRKRIAL--------------------GSARGLSYLHD----H 262 (467)
Q Consensus 228 ~~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------~ia~gl~~Lh~----~ 262 (467)
+.. +.......+... ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 111111111110 01110000 01111222211 1
Q ss_pred CCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 263 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23468999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.9e-05 Score=72.29 Aligned_cols=143 Identities=20% Similarity=0.219 Sum_probs=82.4
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCC--eeeeeeeeeeC---CCceEEEeeccC
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR--NLLRLRGFCMT---PTERLLVYPYMA 222 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~ 222 (467)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.++.. ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568999999999999876 68999987543 3345677888888777422 24455554322 234689999999
Q ss_pred CCChhh----------------hh---hcCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHc
Q 012267 223 NGSVAS----------------CL---RERPPSQLPLDWPT---------RKRI------------ALGSAR-GLSYLHD 261 (467)
Q Consensus 223 ~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gl~~Lh~ 261 (467)
+..+.. .+ +.......+..+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 11 11111111111111 0000 111222 2333332
Q ss_pred ----CCCCCcccCCCCCCcEEEC-CCCcEEEeecCCcc
Q 012267 262 ----HCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAK 294 (467)
Q Consensus 262 ----~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~ 294 (467)
.....++|+|+.+.||+++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234799999999999999 66667899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=9.1e-06 Score=71.51 Aligned_cols=105 Identities=21% Similarity=0.219 Sum_probs=81.8
Q ss_pred HHHHHHHHhcCC-CeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 012267 187 QTEVEMISMAVH-RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265 (467)
Q Consensus 187 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~ 265 (467)
..|.-++..+.+ +++.+++|+| ..++|.||...+++...-.. -..-..-+|..|.+||.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 457778888876 5999999998 34789999988766532100 00111268999999999999999999986444
Q ss_pred CcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 266 ~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
.+.-.|++++|+-+++++++|+.|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6778999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.9e-05 Score=65.27 Aligned_cols=133 Identities=22% Similarity=0.304 Sum_probs=92.6
Q ss_pred CCCeeeecCceEEEEEEECCCCEEEEEEeccCC---------------CcchHHHHHHHHHHHHhcC------CCeeeee
Q 012267 146 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEER---------------TPGGELQFQTEVEMISMAV------HRNLLRL 204 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~niv~~ 204 (467)
....||+|+.-.||. +++.....||++.... ......+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999984 4455567889886654 1122345667776665555 8889999
Q ss_pred eeeeeCCCceEEEeeccCC------CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEE
Q 012267 205 RGFCMTPTERLLVYPYMAN------GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 278 (467)
Q Consensus 205 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nil 278 (467)
+|+..++...-+|+|.+.+ -+|.+++.... ++. ... ..+-+-..||-.+ .|+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELR---QALDEFKRYLLDH---HIVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHH---HHHHHHHHHHHHc---CCeecCCCcccEE
Confidence 9999999999999998643 36777775542 443 333 3333455677787 8999999999999
Q ss_pred ECCCC----cEEEee-cCC
Q 012267 279 LDEEF----EAVVGD-FGL 292 (467)
Q Consensus 279 l~~~~----~~kl~D-fgl 292 (467)
+.... .+.|.| ||-
T Consensus 151 ~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEecCCCceEEEEEeCCCC
Confidence 95432 466666 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.1e-05 Score=65.65 Aligned_cols=127 Identities=17% Similarity=0.226 Sum_probs=86.4
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeee-eeeeeeCCCceEEEeeccCCCC
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR-LRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~gs 225 (467)
.+.|++|.+|.||+|.+. |..+|+|+-+.+. ....+..|.++|..+.-.++.+ ++.| +.-++.|||+.|-.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~ 98 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcc
Confidence 467999999999999996 5588999765433 3557889999999887655543 3333 22345599999888
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCC-CCcEEECCCCcEEEeecCCccc
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVK-AANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
|.++-... + .+....+++.---|... +|-|+.|. |...+|..+..+.|+||.-|..
T Consensus 99 L~~~~~~~-------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG-------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc-------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87664431 1 22334555554445555 89999987 4444444444899999998863
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.5e-05 Score=65.50 Aligned_cols=136 Identities=25% Similarity=0.367 Sum_probs=93.8
Q ss_pred CcccccCHHHHHHHhcCCCCCCeeeecCc-eEEEEEEECCCCEEEEEEecc---CC-------Ccc----------hHHH
Q 012267 127 GQLKRFSLRELQVATDSFSNKNILGRGGF-GKVYKGRLADGSLVAVKRLKE---ER-------TPG----------GELQ 185 (467)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~-g~V~~~~~~~g~~vavK~~~~---~~-------~~~----------~~~~ 185 (467)
..+.+|+. .+.+++..+.||.|.. |.||+++.. |..+|+|.++. .. ... ....
T Consensus 27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 34556665 2378899999999999 999999984 77999999421 00 000 0114
Q ss_pred HHHHHHHHHhcC---CCee--eeeeeeeeCC------------------CceEEEeeccCCCChhhhhhcCCCCCCCCCH
Q 012267 186 FQTEVEMISMAV---HRNL--LRLRGFCMTP------------------TERLLVYPYMANGSVASCLRERPPSQLPLDW 242 (467)
Q Consensus 186 ~~~e~~~l~~l~---h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 242 (467)
|..|.+...+++ +.++ |+.+||..-. ....||.||.+... .+.
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~- 166 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ- 166 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc-
Confidence 778888887775 4456 8999987311 12356777765532 122
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 243 PTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 243 ~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.+-+.++.+-|..+|.. +|+-+|+++.|.. .-+|+|||.+
T Consensus 167 ---~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 ---IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 22345666778889998 9999999999986 4689999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.1e-05 Score=84.63 Aligned_cols=45 Identities=36% Similarity=0.581 Sum_probs=19.9
Q ss_pred ccCCCCCCeEEcccCcccccCCCCC--CCCccCcccccccccCCCCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDNG--SFSLFTPISFANNLDLCGPV 47 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~~--~~~~~~~~~~~~N~~Lcg~~ 47 (467)
|++|++|+.|||++|+|+|.+|... .+......++.+|..+|+.+
T Consensus 486 l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 486 LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred HhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 3444444444444444444444320 01112234556666666543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00032 Score=66.76 Aligned_cols=78 Identities=14% Similarity=0.072 Sum_probs=55.2
Q ss_pred CCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC---CeeeeeeeeeeC---CCceEEEe
Q 012267 145 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH---RNLLRLRGFCMT---PTERLLVY 218 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~ 218 (467)
...+.||.|..+.||.....++ .+.+|..+... ....+..|.+.++.+.. -.+.+++++|.. .+..++||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3346799999999999987655 46777753311 12367889988887743 356677777654 35689999
Q ss_pred eccCCCCh
Q 012267 219 PYMANGSV 226 (467)
Q Consensus 219 e~~~~gsL 226 (467)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00027 Score=64.87 Aligned_cols=31 Identities=29% Similarity=0.459 Sum_probs=26.2
Q ss_pred CCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 265 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+.++|+|+.+.||+++++...-|.||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4589999999999998776567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00026 Score=64.98 Aligned_cols=142 Identities=17% Similarity=0.213 Sum_probs=80.1
Q ss_pred CeeeecCceEEEEEEECC--CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCee-eeeeeeeeCCCceEEEeeccCCC
Q 012267 148 NILGRGGFGKVYKGRLAD--GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 224 (467)
+.|..|-...+|+....+ +..|++|+....... ......|+.++..+....+ .++++.+. ..++|||++|.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 457778888999998764 678999976543211 1233467877777753333 33443332 24799999987
Q ss_pred Chhhh-----------------hhcCCCCC-------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 012267 225 SVASC-----------------LRERPPSQ-------LPL-DWPTRKRIAL----------------------GSARGLS 257 (467)
Q Consensus 225 sL~~~-----------------l~~~~~~~-------~~l-~~~~~~~i~~----------------------~ia~gl~ 257 (467)
++... +|...... ... .|..+..+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65321 11111110 011 1222111111 1111112
Q ss_pred HH----HcC-CCCCcccCCCCCCcEEECC-CCcEEEeecCCccc
Q 012267 258 YL----HDH-CDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 295 (467)
Q Consensus 258 ~L----h~~-~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~ 295 (467)
.| ... ....++|+|+.+.|||+++ ++.+.++||..+..
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 22 111 2236899999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00016 Score=77.52 Aligned_cols=196 Identities=19% Similarity=0.200 Sum_probs=133.2
Q ss_pred HHHHHHHHHhcCCCeeeeeeeeeeCCCce----EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 012267 186 FQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261 (467)
Q Consensus 186 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~ 261 (467)
...|.+.+.+..|+|++.++.|-...... .+..+++...++...+..-.. ++....+.+..++.+|+.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~----i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS----IPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc----cCHHHHHHHHHHHhhhHHHHHH
Confidence 34567778889999999999887654322 244578888888888776432 6777888888999999999999
Q ss_pred CCCCCcccCCCCCC---cEEECCCCcEEEe--ecCCccccCCCCCeeeecccccccccccccccCCCCC--cchhHHHHH
Q 012267 262 HCDPKIIHRDVKAA---NILLDEEFEAVVG--DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS--EKTDVFGYG 334 (467)
Q Consensus 262 ~~~~~ivH~dlk~~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~--~~sDv~s~G 334 (467)
. ...|.-+..+ +.-.+..+.+.++ ||+..+.+........ ..-+..|.+||......+. ...|+|++|
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHH
Confidence 8 5666555555 4455666667776 8888876654332222 2235568888887665554 447999999
Q ss_pred HHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 012267 335 IMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414 (467)
Q Consensus 335 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 414 (467)
..+..+..|..+-..... +.. .++.. .. ....+....|+..++++|+++.++
T Consensus 380 ll~~~~~~~~~i~~~~~~-----------~~~---------~l~~~-----~~---~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV-----------PVS---------LLDVL-----ST---SELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHhhhhhcCcccccccc-----------hhh---------hhccc-----cc---hhhhhhhhhhcchhhhhccchhhh
Confidence 999999988765422100 000 00000 00 145667778999999999999998
Q ss_pred HHHH
Q 012267 415 VRML 418 (467)
Q Consensus 415 l~~L 418 (467)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 7654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00028 Score=65.72 Aligned_cols=139 Identities=16% Similarity=0.110 Sum_probs=77.2
Q ss_pred eeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeee-eeeeeeeCCCceEEEeeccCCCChhh
Q 012267 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPYMANGSVAS 228 (467)
Q Consensus 150 lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~ 228 (467)
+..|-.+.+|+... ++..+++|+.......- ......|.+++..+....++ +++..+ ..++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 45677889998874 56678888764322111 01356788888777543332 233332 1378999999866542
Q ss_pred h-----------------hhcCCCCCCCCCHHHHH-HHHHHH---------HHHHHHHHcC-----CCCCcccCCCCCCc
Q 012267 229 C-----------------LRERPPSQLPLDWPTRK-RIALGS---------ARGLSYLHDH-----CDPKIIHRDVKAAN 276 (467)
Q Consensus 229 ~-----------------l~~~~~~~~~l~~~~~~-~i~~~i---------a~gl~~Lh~~-----~~~~ivH~dlk~~N 276 (467)
. +|.......+++..... ....++ ...+..+-.. ..+.++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 12221111222322111 111111 1112222211 12368999999999
Q ss_pred EEECCCCcEEEeecCCccc
Q 012267 277 ILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~ 295 (467)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0011 Score=65.11 Aligned_cols=76 Identities=14% Similarity=0.160 Sum_probs=52.1
Q ss_pred CeeeecCceEEEEEEECCC-CEEEEEEeccC------CCcchHHHHHHHHHHHHhcC---CCeeeeeeeeeeCCCceEEE
Q 012267 148 NILGRGGFGKVYKGRLADG-SLVAVKRLKEE------RTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g-~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 217 (467)
+.||.|.+..||++...+| +.|+||.-... ..+-....+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998776 48999985311 11223345667777777652 2345566666 44667899
Q ss_pred eeccCCCC
Q 012267 218 YPYMANGS 225 (467)
Q Consensus 218 ~e~~~~gs 225 (467)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0016 Score=62.77 Aligned_cols=142 Identities=13% Similarity=0.091 Sum_probs=75.0
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-----CCeeeeee-e--eeeCCCceEEEee
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----HRNLLRLR-G--FCMTPTERLLVYP 219 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e 219 (467)
+.++.|....+|+....+| .+++|+.. ... ......|+..+..+. .|.+++-. | +....+..+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 4566777789999887655 68889875 211 122333444444432 33333211 1 1122445789999
Q ss_pred ccCCCChhh-----------h---hhcCCC-------CCCCCCH-HHHHHH------------H-HHHHHHHHHHHcC--
Q 012267 220 YMANGSVAS-----------C---LRERPP-------SQLPLDW-PTRKRI------------A-LGSARGLSYLHDH-- 262 (467)
Q Consensus 220 ~~~~gsL~~-----------~---l~~~~~-------~~~~l~~-~~~~~i------------~-~~ia~gl~~Lh~~-- 262 (467)
|++|..+.. . +|.... ....+.| .....- . ..+...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998864321 1 111110 0011212 111111 1 1111222333211
Q ss_pred --CCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 263 --CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 263 --~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
...+++|+|+.+.||+++++...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23489999999999999977656899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00055 Score=65.23 Aligned_cols=143 Identities=14% Similarity=0.064 Sum_probs=83.6
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe--eeeeeee------eeCCCceEEEe
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGF------CMTPTERLLVY 218 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~ 218 (467)
.+.+..|....+|+....+ ..+++|+... .....+..|++++..+.+.. +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3457778778999987654 4688898754 12334566777776664322 3343332 12234568999
Q ss_pred eccCCCChhh----h----------hhcCC----C---CCCCCCHHHHH----------HHHHHHHHHHHHHHc----CC
Q 012267 219 PYMANGSVAS----C----------LRERP----P---SQLPLDWPTRK----------RIALGSARGLSYLHD----HC 263 (467)
Q Consensus 219 e~~~~gsL~~----~----------l~~~~----~---~~~~l~~~~~~----------~i~~~ia~gl~~Lh~----~~ 263 (467)
+|++|..+.. . +|... . ......|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 0 11110 0 00112332221 011123344555553 12
Q ss_pred CCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 264 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
..+++|+|+.|.||+++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2479999999999999998777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.39 E-value=6.8e-05 Score=82.14 Aligned_cols=158 Identities=13% Similarity=0.024 Sum_probs=115.0
Q ss_pred HHHHHHhcCCCeeeeeeeeee--CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--C
Q 012267 189 EVEMISMAVHRNLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--D 264 (467)
Q Consensus 189 e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~--~ 264 (467)
|..-++...|+++.....=.. +..+.+.+++|+.+|.+.+.|-+...+..+++.........+......-.|+.. .
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 334445567888876554333 345668999999999999999876555555554444444444345555555432 2
Q ss_pred CCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCC
Q 012267 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344 (467)
Q Consensus 265 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~ 344 (467)
.-.+|+++|+-|.+|..+..+|++++|+.+... ......+...+++.|+.|+..+...++.++|+|..|+-+|+..-|.
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 246899999999999999999999999998432 2233334455788899999998888999999999999999999888
Q ss_pred CCc
Q 012267 345 RAF 347 (467)
Q Consensus 345 ~p~ 347 (467)
.+|
T Consensus 1438 ~~f 1440 (2724)
T KOG1826|consen 1438 AYF 1440 (2724)
T ss_pred HHH
Confidence 776
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0011 Score=63.23 Aligned_cols=141 Identities=21% Similarity=0.228 Sum_probs=80.8
Q ss_pred CeeeecCceEEEEEEECC-------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeee-eeeeeeeCCCceEEEee
Q 012267 148 NILGRGGFGKVYKGRLAD-------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYP 219 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e 219 (467)
+.+..|-...+|+....+ +..+++|+...... .......|.+++..+....+. ++++++.. .+|+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 345667777999988654 57899998754321 122456777777776533332 34444432 35899
Q ss_pred ccCCCChhhh-----------------hhcCCCC-------CCCCCHHHHHHH--------------------------H
Q 012267 220 YMANGSVASC-----------------LRERPPS-------QLPLDWPTRKRI--------------------------A 249 (467)
Q Consensus 220 ~~~~gsL~~~-----------------l~~~~~~-------~~~l~~~~~~~i--------------------------~ 249 (467)
|++|..+... +|..... ..+.-|.....+ .
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9988766431 1111111 001111111111 1
Q ss_pred HHHHHHHHHHHc------CCCCCcccCCCCCCcEEECCC----CcEEEeecCCcc
Q 012267 250 LGSARGLSYLHD------HCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAK 294 (467)
Q Consensus 250 ~~ia~gl~~Lh~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~ 294 (467)
..+..-+.+|.. .....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 122222334432 234578999999999999985 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.01 Score=56.82 Aligned_cols=144 Identities=14% Similarity=0.103 Sum_probs=80.7
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe--eeeeeeee------eCCCceEEEe
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGFC------MTPTERLLVY 218 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~------~~~~~~~lv~ 218 (467)
.+.++.|....+|+....+| .+++|+...... ......|.+++..+.... +.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 45577777789999876555 577887754321 223455666666553222 33333321 1234568999
Q ss_pred eccCCCChhh--------------hhhcCCCC---C-----CCCCHHHHHH------------HHHHHHHHHHHHHc---
Q 012267 219 PYMANGSVAS--------------CLRERPPS---Q-----LPLDWPTRKR------------IALGSARGLSYLHD--- 261 (467)
Q Consensus 219 e~~~~gsL~~--------------~l~~~~~~---~-----~~l~~~~~~~------------i~~~ia~gl~~Lh~--- 261 (467)
+|++|..+.. .+|..... . ..-.|..... ....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998854321 01211110 0 0011221110 01123345555543
Q ss_pred -CCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 262 -HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 262 -~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
....+++|+|+.+.||++++++...|.||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223589999999999999988877899998774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00037 Score=64.93 Aligned_cols=135 Identities=19% Similarity=0.154 Sum_probs=90.4
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCC---------------------cchHHHHHHHHHHHHhcCC-Ce
Q 012267 143 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT---------------------PGGELQFQTEVEMISMAVH-RN 200 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h-~n 200 (467)
-++..+.||-|.-+.+|.+...+|++.++|.-+...+ .-++....+|...|+.+.. ..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3566788999999999999999999999986432111 0112234567777777642 11
Q ss_pred -eeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE
Q 012267 201 -LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 279 (467)
Q Consensus 201 -iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill 279 (467)
+-+.+ +.+..++|||++.+..|...-+-. +..++.. .+..-+--|-.+ |+||+|+.-=||++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~---~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVE-------DPPTLYD---DLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeecC-------ChHHHHH---HHHHHHHHHHHc---CceecccchheeEE
Confidence 22222 335678999999888776654321 2223322 233334455566 99999999999999
Q ss_pred CCCCcEEEeecCCcc
Q 012267 280 DEEFEAVVGDFGLAK 294 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~ 294 (467)
++++.++++||--..
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999997543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0053 Score=58.23 Aligned_cols=133 Identities=20% Similarity=0.232 Sum_probs=79.5
Q ss_pred cCceEEEEEEECCCCEEEEEEecc-CCCcchHHHHHHHHHHHHhcCC--CeeeeeeeeeeCCC--ceEEEeeccCCCChh
Q 012267 153 GGFGKVYKGRLADGSLVAVKRLKE-ERTPGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPT--ERLLVYPYMANGSVA 227 (467)
Q Consensus 153 G~~g~V~~~~~~~g~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~gsL~ 227 (467)
|..-.+|..... ++.++++ ... ...........+|+++++.+.- .-+-..+++|.+.. ..+.||+|++|..+.
T Consensus 36 G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~ 113 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW 113 (321)
T ss_pred CcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence 333344444433 7778888 331 2223334456778888877642 22344567776655 679999999885443
Q ss_pred hhhhcCCCCCCCCCHHHHHHHH-HHHHHHHHHHH----------------------------------------------
Q 012267 228 SCLRERPPSQLPLDWPTRKRIA-LGSARGLSYLH---------------------------------------------- 260 (467)
Q Consensus 228 ~~l~~~~~~~~~l~~~~~~~i~-~~ia~gl~~Lh---------------------------------------------- 260 (467)
+.+.... .. .+++ ..+++.|+-||
T Consensus 114 ~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 114 SALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred CcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 3322111 00 0111 13334444444
Q ss_pred ----cC-----CCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 261 ----DH-----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 261 ----~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
.+ ..+.++|+|+.+.|++++.+..+=|.||+++.+-
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 32 1347899999999999999988999999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0027 Score=59.81 Aligned_cols=140 Identities=21% Similarity=0.284 Sum_probs=70.6
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC---CCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
.+.++.|....+|+.. .++..+.||.-... ....|..|.+-|+.+. --.+.+++++....+..+||+||++.
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 4568889999999987 56788999987522 1235778888777773 44566788887777777999999987
Q ss_pred CCh--------hh---hhhc-CCCC-----------------CCCCCHHHH-----HHHHHHHH-----------HHHHH
Q 012267 224 GSV--------AS---CLRE-RPPS-----------------QLPLDWPTR-----KRIALGSA-----------RGLSY 258 (467)
Q Consensus 224 gsL--------~~---~l~~-~~~~-----------------~~~l~~~~~-----~~i~~~ia-----------~gl~~ 258 (467)
+.. -. .||. .... .-.-+|... +.-..+.+ +-+.-
T Consensus 97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~ 176 (288)
T PF03881_consen 97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER 176 (288)
T ss_dssp ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence 611 01 1222 1100 001234321 11111111 11122
Q ss_pred HHc-----CCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 259 LHD-----HCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 259 Lh~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
+.+ ...|.++|+||.+.|++.+.++.+.|.|-.
T Consensus 177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 221 125789999999999999999989998865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.008 Score=57.25 Aligned_cols=140 Identities=17% Similarity=0.220 Sum_probs=92.2
Q ss_pred CCCeeeecCceEEEEEEECCCCEEEEEEeccCCC--------cch-------------HH----HHHHHHHHHHhcCCCe
Q 012267 146 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT--------PGG-------------EL----QFQTEVEMISMAVHRN 200 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~--------~~~-------------~~----~~~~e~~~l~~l~h~n 200 (467)
+...|..|.-+-||.+.-.+|..+|||+++.... -.+ ++ -...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3456888999999999999999999999863210 000 00 1245666666665333
Q ss_pred eeeeeeeeeCCCceEEEeeccCCCCh-hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE
Q 012267 201 LLRLRGFCMTPTERLLVYPYMANGSV-ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 279 (467)
Q Consensus 201 iv~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill 279 (467)
|--.--+. -....|||+|+....- .-.|+. .+++...+..+-.+++.-|.-|-+.| ++||.||+--|+|+
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 21100000 0234799999863221 112222 23666677788889999999999888 89999999999998
Q ss_pred CCCCcEEEeecCCccc
Q 012267 280 DEEFEAVVGDFGLAKL 295 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~~ 295 (467)
.+ |.+.|+|.+-+..
T Consensus 299 hd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVE 313 (520)
T ss_pred EC-CEEEEEEcccccc
Confidence 65 5799999987653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.015 Score=54.59 Aligned_cols=31 Identities=29% Similarity=0.482 Sum_probs=25.9
Q ss_pred CCcccCCCCCCcEEECCCCc-EEEeecCCccc
Q 012267 265 PKIIHRDVKAANILLDEEFE-AVVGDFGLAKL 295 (467)
Q Consensus 265 ~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~ 295 (467)
+.++|+|+.+.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.015 Score=56.51 Aligned_cols=141 Identities=16% Similarity=0.158 Sum_probs=78.4
Q ss_pred eeeecCceEEEEEEECC-----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeee-eeeeeeeCCCceEEEeeccC
Q 012267 149 ILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPYMA 222 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~ 222 (467)
.+-.|-...+|+....+ +..|++|+..... . .......|..++..+...++. ++++.+..+ .|++|++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 34457777899887532 3678899875432 1 112345778777777544433 344554332 5799997
Q ss_pred CCChhhh-----------------hhcCCCC--CCCCCHHHHHHHHHH-----------------HHHHHHHHH----c-
Q 012267 223 NGSVASC-----------------LRERPPS--QLPLDWPTRKRIALG-----------------SARGLSYLH----D- 261 (467)
Q Consensus 223 ~gsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~~-----------------ia~gl~~Lh----~- 261 (467)
+.+|... +|..... ..+..|..+.++..+ +...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 1221111 111223333333211 111222222 1
Q ss_pred CCCCCcccCCCCCCcEEECC-CCcEEEeecCCccc
Q 012267 262 HCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 295 (467)
Q Consensus 262 ~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~ 295 (467)
.....++|+|+++.||++++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22336899999999999986 46899999988753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.043 Score=53.00 Aligned_cols=73 Identities=16% Similarity=0.123 Sum_probs=46.4
Q ss_pred eeeecCceEEEEEEECCC-CEEEEEEec----c--CCCcchHHHHHHHHHHHHhcC--CCe-eeeeeeeeeCCCceEEEe
Q 012267 149 ILGRGGFGKVYKGRLADG-SLVAVKRLK----E--ERTPGGELQFQTEVEMISMAV--HRN-LLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~g-~~vavK~~~----~--~~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 218 (467)
.||.|....||++...+| +.|+||.-. . ...+-......-|.+.|.... -|. +.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 579999742 1 122333334456666665543 343 3334443 566678999
Q ss_pred eccCC
Q 012267 219 PYMAN 223 (467)
Q Consensus 219 e~~~~ 223 (467)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.055 Score=53.21 Aligned_cols=74 Identities=15% Similarity=0.073 Sum_probs=47.8
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCC------CcchHHHHHHHHHHHHhcC---CCeeeeeeeeeeCCCceEEE
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEER------TPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 217 (467)
.+.||.|....||+.... +..++||+-.... .+-....-..|.+.|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 356899999999998874 4568999864111 1112223334566665443 246777788776 556889
Q ss_pred eeccCC
Q 012267 218 YPYMAN 223 (467)
Q Consensus 218 ~e~~~~ 223 (467)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0033 Score=62.22 Aligned_cols=51 Identities=16% Similarity=0.186 Sum_probs=40.2
Q ss_pred HHHHHHHHHHHHhcCCCeeeeeeeeeeCC-CceEEEeeccCCCChhhhhhcCC
Q 012267 183 ELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVYPYMANGSVASCLRERP 234 (467)
Q Consensus 183 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~ 234 (467)
..++.....+++.+.|+|+...+.+.... ....+|+|++ +-||.+.+..+.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 34677788899999999999999987654 3457899998 559999887654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.037 Score=53.04 Aligned_cols=29 Identities=34% Similarity=0.408 Sum_probs=25.3
Q ss_pred CCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 265 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 568999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0011 Score=35.77 Aligned_cols=18 Identities=44% Similarity=0.768 Sum_probs=16.5
Q ss_pred CCCeEEcccCcccccCCCC
Q 012267 8 SLQVLDLSNNRLSGVVPDN 26 (467)
Q Consensus 8 ~L~~ldls~N~lsG~iP~~ 26 (467)
+|++||||+|+|+ .||.+
T Consensus 1 ~L~~Ldls~n~l~-~ip~~ 18 (22)
T PF00560_consen 1 NLEYLDLSGNNLT-SIPSS 18 (22)
T ss_dssp TESEEEETSSEES-EEGTT
T ss_pred CccEEECCCCcCE-eCChh
Confidence 5899999999999 99975
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.057 Score=52.82 Aligned_cols=74 Identities=12% Similarity=0.148 Sum_probs=48.2
Q ss_pred CeeeecCceEEEEEEECC-CCEEEEEEec----c-CCCcchHHHHHHHHHHHHhcC--CCe-eeeeeeeeeCCCceEEEe
Q 012267 148 NILGRGGFGKVYKGRLAD-GSLVAVKRLK----E-ERTPGGELQFQTEVEMISMAV--HRN-LLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~-g~~vavK~~~----~-~~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 218 (467)
+.||-|....||++...+ +..|+||.-. . ...+-......-|.+.|.... -|. +.+++.+ ++....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 568999999999999753 5679999742 1 122333445566777776553 343 4445443 566678999
Q ss_pred eccCC
Q 012267 219 PYMAN 223 (467)
Q Consensus 219 e~~~~ 223 (467)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.13 Score=57.43 Aligned_cols=143 Identities=16% Similarity=0.177 Sum_probs=77.6
Q ss_pred eeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-------CCCeeeeeee-----eeeC-CC--c
Q 012267 149 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-------VHRNLLRLRG-----FCMT-PT--E 213 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~~-----~~~~-~~--~ 213 (467)
.|+ |..-.+|+....+|..+++|+.+.... ......|.+.+..+ .-|.+++-.+ .... .+ .
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEP---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccc---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 453 345778988887888999999875432 22233344444333 2344444321 1111 12 4
Q ss_pred eEEEeeccCCCChhhhh-----------------hc------CCCCCCCCCHHH-----------------HHHHHHHHH
Q 012267 214 RLLVYPYMANGSVASCL-----------------RE------RPPSQLPLDWPT-----------------RKRIALGSA 253 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l-----------------~~------~~~~~~~l~~~~-----------------~~~i~~~ia 253 (467)
.+.+++|++|..+.+.. +. .......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999997776511 10 001111233321 112222222
Q ss_pred HHHH----HHHcCCCCCcccCCCCCCcEEECCCC--cEE-EeecCCccc
Q 012267 254 RGLS----YLHDHCDPKIIHRDVKAANILLDEEF--EAV-VGDFGLAKL 295 (467)
Q Consensus 254 ~gl~----~Lh~~~~~~ivH~dlk~~Nill~~~~--~~k-l~Dfgl~~~ 295 (467)
+... .........+||+|+.+.|||++.+. ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 11122334799999999999999875 555 999998753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.17 Score=48.60 Aligned_cols=140 Identities=18% Similarity=0.241 Sum_probs=79.6
Q ss_pred eeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC---Ce---eeeeeee----eeCCCceEEEee
Q 012267 150 LGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH---RN---LLRLRGF----CMTPTERLLVYP 219 (467)
Q Consensus 150 lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~n---iv~~~~~----~~~~~~~~lv~e 219 (467)
|.+ .-..+|+....+|.. ++|+.+.. .. ..++..|+..+..+.- +- +..+-|- ...+...+.+++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~--~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WT--RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CC--HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 456789998877766 88888665 22 3345566666655531 11 2222221 112236788999
Q ss_pred ccCCCChhh-h--------------hhc----C----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHcCC
Q 012267 220 YMANGSVAS-C--------------LRE----R----PPSQLPLDWPT-------------RKRIALGSARGLSYLHDHC 263 (467)
Q Consensus 220 ~~~~gsL~~-~--------------l~~----~----~~~~~~l~~~~-------------~~~i~~~ia~gl~~Lh~~~ 263 (467)
|++|..+.. . |+. . ........|.. ......++...+..+.+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887772 1 111 0 00011233431 0112233444444444321
Q ss_pred ----CCC---cccCCCCCCcEEECCCCc-EEEeecCCcc
Q 012267 264 ----DPK---IIHRDVKAANILLDEEFE-AVVGDFGLAK 294 (467)
Q Consensus 264 ----~~~---ivH~dlk~~Nill~~~~~-~kl~Dfgl~~ 294 (467)
... +||+|+.|.||+++.+.. +.+.||+.+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 112 899999999999999885 8899999875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.064 Score=51.91 Aligned_cols=141 Identities=14% Similarity=0.172 Sum_probs=76.6
Q ss_pred eeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeee-eeeeeeeCCCceEEEeeccCC
Q 012267 149 ILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~ 223 (467)
.|..|=...+|+....+ +..|++|+...... .......|..++..+..-++. ++++++..+ +|.+|+++
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 45456677889887543 23788898754321 112345778787777654443 345554222 58899877
Q ss_pred CChhh-----------------hhhcCCCC--CCCCCHHHHHHHHHHH----------------------HHHHHHHHc-
Q 012267 224 GSVAS-----------------CLRERPPS--QLPLDWPTRKRIALGS----------------------ARGLSYLHD- 261 (467)
Q Consensus 224 gsL~~-----------------~l~~~~~~--~~~l~~~~~~~i~~~i----------------------a~gl~~Lh~- 261 (467)
-+|.. .+|..... ..+--|..+.++..++ .+-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 01221111 1111233332222211 111222211
Q ss_pred ---C-CCCCcccCCCCCCcEEECC-CCcEEEeecCCccc
Q 012267 262 ---H-CDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 295 (467)
Q Consensus 262 ---~-~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~ 295 (467)
. ...-+.|.|+.+.|||+++ ++.++++||..+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1124789999999999975 57899999998753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.25 Score=47.70 Aligned_cols=71 Identities=18% Similarity=0.171 Sum_probs=42.5
Q ss_pred cCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCC--eeeee---ee--eeeCCCceEEEeeccCCCC
Q 012267 153 GGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR--NLLRL---RG--FCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 153 G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~---~~--~~~~~~~~~lv~e~~~~gs 225 (467)
+.-..||+....+|..+++|+.+.... ...++..|.+.+..+... .++.. -| +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 445689999887888899998764332 234566677766555311 12221 12 1122345678999998764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.086 Score=46.86 Aligned_cols=153 Identities=13% Similarity=0.102 Sum_probs=87.4
Q ss_pred cCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhc
Q 012267 153 GGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 232 (467)
Q Consensus 153 G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 232 (467)
++.++.-.++.+-| ...+|+++.-...-...-|..+.++++++. .|+++..- +....-++.|+|-.-
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------
Confidence 34455555544333 345566543322222345677888888773 35555521 223345888888431
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeeccccccc
Q 012267 233 RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 312 (467)
Q Consensus 233 ~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~ 312 (467)
..... .++..=+++|.-.|+. .++.+|+|-.|+||+-|..|.+||.|-+.... .+.-
T Consensus 140 --------~i~~~-N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~ 196 (308)
T PF07387_consen 140 --------KINFS-NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVN 196 (308)
T ss_pred --------ccchh-HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heee
Confidence 11111 1222223567778864 34899999999999999999999999875321 0111
Q ss_pred ccccccccCCCCCcchhHHHHHHHHHHHHcCC
Q 012267 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344 (467)
Q Consensus 313 y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~ 344 (467)
|.--| ....|.++.+-+|=.-+++++...
T Consensus 197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 197 MVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred EEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 22211 123466777777777777776543
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.14 Score=49.11 Aligned_cols=31 Identities=19% Similarity=0.300 Sum_probs=27.8
Q ss_pred CCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 265 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
.+++|+|+.+.||++++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4799999999999999999999999987763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.24 Score=44.44 Aligned_cols=137 Identities=17% Similarity=0.235 Sum_probs=79.0
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC---CCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
+.+.-|.--..|.... +..++.||+-.. ....-|..|+.-|..+. --++-+++.+-.+.++.|+|+||++-|
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 3344444444444443 456788886422 12235777877666553 455667778778889999999999986
Q ss_pred Chhh-----------hhhcCC--------------CCCCCC----CHHH-----HHHHHHH--------------HHHHH
Q 012267 225 SVAS-----------CLRERP--------------PSQLPL----DWPT-----RKRIALG--------------SARGL 256 (467)
Q Consensus 225 sL~~-----------~l~~~~--------------~~~~~l----~~~~-----~~~i~~~--------------ia~gl 256 (467)
.+.. .|+... ....+= +|.+ |+....+ ++..+
T Consensus 97 ~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v 176 (286)
T COG3001 97 PLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKI 176 (286)
T ss_pred CCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHH
Confidence 6651 122111 001111 2221 2222222 22334
Q ss_pred HHHHcCC--CCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 257 SYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 257 ~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
.-+-..+ +|..+|+||...|+.+..+| +.+.|-
T Consensus 177 ~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDP 211 (286)
T COG3001 177 QELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFDP 211 (286)
T ss_pred HHHHhcCCCCcceeecccccccccccCCC-Ceeecc
Confidence 4443333 47899999999999999998 766653
|
|
| >PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.015 Score=29.08 Aligned_cols=14 Identities=64% Similarity=0.940 Sum_probs=9.9
Q ss_pred CCCCeEEcccCccc
Q 012267 7 SSLQVLDLSNNRLS 20 (467)
Q Consensus 7 ~~L~~ldls~N~ls 20 (467)
++|+.|||++|+|+
T Consensus 1 ~~L~~L~l~~n~L~ 14 (17)
T PF13504_consen 1 PNLRTLDLSNNRLT 14 (17)
T ss_dssp TT-SEEEETSS--S
T ss_pred CccCEEECCCCCCC
Confidence 57999999999986
|
... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.077 Score=50.74 Aligned_cols=53 Identities=25% Similarity=0.258 Sum_probs=47.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 240 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 240 l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
..|.+...|+.+.+.-+.-+..+. .+-|||+.-.||||+ +|.+.|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 568899999999888888888776 789999999999999 99999999999994
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 467 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-174 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-169 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-35 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-04 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 467 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-156 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-140 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-81 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-64 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-62 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-60 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-60 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 8e-59 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-56 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-56 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-55 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-55 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-55 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 8e-54 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-52 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-52 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-41 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-39 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-38 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-38 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-38 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 7e-38 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-38 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 9e-38 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-37 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-37 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-37 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-37 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-37 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-37 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-36 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-36 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-35 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-35 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-35 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-35 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-35 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-35 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-35 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-35 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-35 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 7e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-34 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-34 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-34 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-34 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-34 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 7e-34 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-34 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-34 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-34 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-33 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-33 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-33 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-33 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-33 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-33 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-33 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-33 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-33 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-33 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-33 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 9e-33 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-32 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-32 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-32 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-32 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-32 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-32 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-32 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-32 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-32 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-31 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-31 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-31 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-30 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-30 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-30 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-30 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-30 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-29 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-29 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-29 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-29 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-29 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-28 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-28 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-28 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 8e-28 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-27 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-27 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-26 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 6e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-26 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 7e-26 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-25 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-24 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-24 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-24 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-24 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-23 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-22 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-22 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-22 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 9e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-21 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-20 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-20 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-20 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-07 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 6e-20 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-20 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-19 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-19 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-19 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-04 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-19 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-19 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 6e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-18 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-18 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-18 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-18 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 7e-18 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-18 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-18 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-18 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-18 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-17 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-17 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-17 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-17 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-17 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-17 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-17 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-17 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-17 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-17 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-17 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-17 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-17 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-17 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-17 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-17 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-17 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-16 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-16 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-16 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-16 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-15 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-15 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-15 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-15 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-15 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-05 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-05 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-04 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-04 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-04 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-04 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-15 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-15 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-14 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-14 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-14 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-14 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-14 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-14 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-14 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-14 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-14 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-13 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-13 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 8e-13 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-04 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-04 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 7e-04 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-12 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-12 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 7e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-11 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-11 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-10 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-10 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 9e-10 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-09 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-07 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-07 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 8e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 5e-06 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 6e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 8e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-04 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-04 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-04 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 633 bits (1634), Expect = 0.0
Identities = 304/326 (93%), Positives = 314/326 (96%)
Query: 113 FFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVK 172
FFDVPAEEDPEVHLGQLKRFSLRELQVA+D+FSNKNILGRGGFGKVYKGRLADG+LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 173 RLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 232
RLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 233 RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292
RP SQ PLDWP R+RIALGSARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL 352
AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRAFDLARL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 353 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 412
ANDDDVMLLDWVKGLLKEKKLE LVD DLQ NY + EVEQLIQVALLCTQ SPM+RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 413 EVVRMLEGDGLAERWDEWQKVEVLRQ 438
EVVRMLEGDGLAERW+EWQK E+ RQ
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 445 bits (1146), Expect = e-156
Identities = 109/314 (34%), Positives = 171/314 (54%), Gaps = 22/314 (7%)
Query: 119 EEDPEVHLGQLKRFSLRELQVATDSFSNK------NILGRGGFGKVYKGRLADGSLVAVK 172
+ EV + FS EL+ T++F + N +G GGFG VYKG + + + VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 173 RLKEERTPG---GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 229
+L + QF E+++++ H NL+ L GF + LVY YM NGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 230 LRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289
L PL W R +IA G+A G+++LH++ IHRD+K+ANILLDE F A + D
Sbjct: 121 LSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 290 FGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
FGLA+ + + T +T+ + GT ++APE L G+ + K+D++ +G++LLE+ITG A D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 349 LARLANDDDVMLLDWVKGLLKEKK-LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD 407
R + +LLD + + E+K +E +D + N+ VE + VA C
Sbjct: 236 EHR----EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNK 290
Query: 408 RPKMSEVVRMLEGD 421
RP + +V ++L+
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-140
Identities = 114/306 (37%), Positives = 171/306 (55%), Gaps = 7/306 (2%)
Query: 117 PAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKE 176
A + + R L +L+ AT++F +K ++G G FGKVYKG L DG+ VA+KR
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 177 ERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS 236
E + G +F+TE+E +S H +L+ L GFC E +L+Y YM NG++ L
Sbjct: 74 ESSQG-IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 237 QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296
+ + W R I +G+ARGL YLH IIHRDVK+ NILLDE F + DFG++K
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 297 DYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAND 355
D TH++T V+GT+G+I PEY G+ +EK+DV+ +G++L E++ + A +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PR 247
Query: 356 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415
+ V L +W +LE +VDP+L + + + A+ C S DRP M +V+
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 416 RMLEGD 421
LE
Sbjct: 308 WKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 3e-81
Identities = 72/312 (23%), Positives = 117/312 (37%), Gaps = 35/312 (11%)
Query: 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE 191
L + + RG FG V+K +L VAVK + Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD--KQSWQNEYEVY 70
Query: 192 MISMAVHRNLLRLRGFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
+ H N+L+ G + L+ + GS++ L+ + W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCH 125
Query: 248 IALGSARGLSYLHDH-------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YK 299
IA ARGL+YLH+ P I HRD+K+ N+LL A + DFGLA + K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 300 DTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGIMLLELITGQRAFDLARLAN 354
T GT ++APE L + + D++ G++L EL + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD---GPV 242
Query: 355 DDDVMLLDWVKGL------LKEKKLEMLVDPDLQNNYVEAEV-EQLIQVALLCTQGSPMD 407
D+ ++ + G ++E + P L++ + + L + C
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 408 RPKMSEVVRMLE 419
R V +
Sbjct: 303 RLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-64
Identities = 72/322 (22%), Positives = 118/322 (36%), Gaps = 44/322 (13%)
Query: 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE 191
+ E + D+ ++GRG +G VYKG L D VAVK F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKN 57
Query: 192 MISMAV--HRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPPSQLPLDWPT 244
+ + + H N+ R E LLV Y NGS+ L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVS 112
Query: 245 RKRIALGSARGLSYLH------DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298
R+A RGL+YLH DH P I HRD+ + N+L+ + V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 299 -------KDTHVTTAVRGTIGHIAPEYL-------STGKSSEKTDVFGYGIMLLELITGQ 344
++ + + GTI ++APE L + ++ D++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 345 RAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD-----PDLQNNYVEAEV--EQLIQVA 397
+ + V + +++LV P + E + L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 398 LLCTQGSPMDRPKMSEVVRMLE 419
C R +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-62
Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 22/274 (8%)
Query: 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLR 205
K +G G FG V++ GS VAVK L E+ + F EV ++ H N++
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
G P +V Y++ GS+ L + ++ LD R +A A+G++YLH + +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 325
I+HR++K+ N+L+D+++ V DFGL++L + + GT +APE L S+
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 326 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY 385
EK+DV+ +G++L EL T Q+ + ++ V + + K ++ N
Sbjct: 218 EKSDVYSFGVILWELATLQQPW--------GNLNPAQVVAAVGFKCKR-----LEIPRN- 263
Query: 386 VEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ +V +I+ C P RP + ++ +L
Sbjct: 264 LNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-60
Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 36/283 (12%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+ ++GRG FG V K + VA+K+++ E F E+ +S H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNI 63
Query: 202 LRLRGFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
++L G C+ P E Y GS+ + L P L ++G++
Sbjct: 64 VKLYGACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVA 116
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316
YLH +IHRD+K N+LL + + DFG A + T +G+ +AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAP 172
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376
E SEK DVF +GI+L E+IT ++ FD + + + + +
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPL- 225
Query: 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ +E L+ C P RP M E+V+++
Sbjct: 226 --IK----NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 8e-60
Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 47/291 (16%)
Query: 147 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL------QFQTEVEMISMAVHR 199
+ +G+GGFG V+KGR + D S+VA+K L + G +FQ EV ++S H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 200 NLLRLRGFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 255
N+++L G P E ++ G + L ++ P+ W + R+ L A G
Sbjct: 84 NIVKLYGLMHNPPRMVME------FVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALG 134
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGT 310
+ Y+ + +P I+HRD+++ NI L E V DFGL++ H + + G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGN 189
Query: 311 IGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368
+APE + +EK D + + ++L ++TG+ FD + + ++ +
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGKIKFINMIR 243
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+E P + + + +I+ LC G P RP S +V+ L
Sbjct: 244 EEGLR-----PTIPED-CPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-59
Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 37/284 (13%)
Query: 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL---QFQTEVEMISMAVHRNLLR 203
+ I+G GGFGKVY+ G VAVK + + + E ++ +M H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
LRG C+ LV + G + L + + A+ ARG++YLHD
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEA 125
Query: 264 DPKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
IIHRD+K++NIL+ ++ E + DFGLA+ T +A G +A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAWMA 182
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
PE + S+ +DV+ YG++L EL+TG+ F + L G+ KL +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--------RGIDGLAVAYGVA-MNKLAL 233
Query: 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ +L++ C P RP + ++ L
Sbjct: 234 PIPST-----CPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-56
Identities = 72/287 (25%), Positives = 109/287 (37%), Gaps = 37/287 (12%)
Query: 147 KNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
+LG+G FG+ K G ++ +K L + F EV+++ H N+L+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 206 GFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
G + Y+ G++ ++ W R A A G++YLH
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM--- 127
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------YKDTHVTTAVRGTIG 312
IIHRD+ + N L+ E VV DFGLA+LM D V G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372
+APE ++ EK DVF +GI+L E+I A D D + GL
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------DPDYLPRTMDFGLNVRGF 239
Query: 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
L+ P+ + + C P RP ++ LE
Sbjct: 240 LDRYCPPNCP--------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLR 205
L G+++KGR G+ + VK LK + + F E + + H N+L +
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 206 GFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
G C +P + +M GS+ + L E +D + AL ARG+++LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
+P I + + ++++DE+ A + + + +APE L
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKP 184
Query: 324 S---SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
D++ + ++L EL+T + F D+ ++ + E P
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPF--------ADLSNMEIGMKVALEGLR-----PT 231
Query: 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ + V +L++ +C P RPK +V +LE
Sbjct: 232 IPPG-ISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 77/302 (25%), Positives = 129/302 (42%), Gaps = 37/302 (12%)
Query: 128 QLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQF 186
R + + ++ + +G G FG VYKG+ VAVK L TP F
Sbjct: 10 HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAF 67
Query: 187 QTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPPSQLPLD 241
+ EV ++ H N+L G+ P T+ + S+ L +
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ------WCEGSSLYHHLHASETK---FE 118
Query: 242 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KD 300
IA +ARG+ YLH IIHRD+K+ NI L E+ +GDFGLA
Sbjct: 119 MKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 301 THVTTAVRGTIGHIAPE---YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 357
+H + G+I +APE + S ++DV+ +GI+L EL+TGQ + + + N D
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQ 233
Query: 358 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
++ + G + +++N +++L+ C + +RP ++
Sbjct: 234 II---EMVG----RGSLSPDLSKVRSN-CPKRMKRLMA---ECLKKKRDERPSFPRILAE 282
Query: 418 LE 419
+E
Sbjct: 283 IE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-55
Identities = 70/305 (22%), Positives = 124/305 (40%), Gaps = 44/305 (14%)
Query: 131 RFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTE 189
L+E + + ++G+G FG+VY GR G VA++ + ER +L+ F+ E
Sbjct: 22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKRE 79
Query: 190 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 249
V H N++ G CM+P ++ ++ S +R+ LD ++IA
Sbjct: 80 VMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIA 136
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTT 305
+G+ YLH I+H+D+K+ N+ D + V+ DFGL + +
Sbjct: 137 QEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLR 192
Query: 306 AVRGTIGHIAPEYLSTGKS---------SEKTDVFGYGIMLLELITGQRAFDLARLANDD 356
G + H+APE + S+ +DVF G + EL + F
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK------TQ 246
Query: 357 DVMLLDWV--KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ W G+ P+L + E+ ++ C +RP +++
Sbjct: 247 PAEAIIWQMGTGMK----------PNLSQIGMGKEISDILL---FCWAFEQEERPTFTKL 293
Query: 415 VRMLE 419
+ MLE
Sbjct: 294 MDMLE 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 64/298 (21%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--HRNLLRLR 205
+G+G +G+V++G G VAVK E + E E+ + + H N+L
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 206 GFCMT----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH- 260
MT T+ L+ Y GS+ L+ LD + RI L A GL++LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 261 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 313
P I HRD+K+ NIL+ + + + D GLA + + GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 314 IAPE------YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA---RLANDDDVML---L 361
+APE + S ++ D++ +G++L E+ + + + D V
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ ++ ++ + + ++ + +L++ C +P R + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 5e-52
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 39/298 (13%)
Query: 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--HRNLLRLR 205
+G+G +G+V+ G+ G VAVK E + E E+ + H N+L
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 206 GFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH- 260
+ T+ L+ Y NGS+ L+ LD + ++A S GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHT 152
Query: 261 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 313
P I HRD+K+ NIL+ + + D GLA V GT +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 314 IAPE------YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA---RLANDDDV---MLL 361
+ PE + +S D++ +G++L E+ + + +L D V
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ ++ ++ KKL ++ ++ +L+ C +P R V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 66/298 (22%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--HRNLLRLR 205
+G+G FG+V++G+ G VAVK E + E E+ + H N+L
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 206 GFCM----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH- 260
T T+ LV Y +GS+ L + ++AL +A GL++LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157
Query: 261 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGTIGH 313
P I HRD+K+ NIL+ + + D GLA D + GT +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 314 IAPEYL------STGKSSEKTDVFGYGIMLLELITGQRAFDLA---RLANDDDV---MLL 361
+APE L +S ++ D++ G++ E+ + +L D V +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ ++ ++ E+KL + Q+ + ++++ C + R + + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 8e-41
Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 63/299 (21%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+ +GRG FG+V+ GRL + VAVK +E P + +F E ++ H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
++RL G C +V + G + LR L T ++ +A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLE 230
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA------VRGTIGHI 314
IHRD+ A N L+ E+ + DFG+++ + + V+ T
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWT---- 282
Query: 315 APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373
APE L+ G+ S ++DV+ +GI+L E + G +
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPY-------------------------- 316
Query: 374 EMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
P+L N VE+ + ++ C P RP S + + L+
Sbjct: 317 -----PNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 83/294 (28%), Positives = 120/294 (40%), Gaps = 59/294 (20%)
Query: 148 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 204 LRGFCMTPTE-RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
L G C+ L+V PYM +G + + +R + L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLASK 147
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEYL 319
K +HRD+ A N +LDE+F V DFGLA+ M +Y H T + + +A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 320 STGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
T K + K+DV+ +G++L EL+T G +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPY------------------------------- 233
Query: 379 PDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
PD+ + + Q L +V L C RP SE+V +
Sbjct: 234 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 36/291 (12%)
Query: 147 KNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
LG G FGKV R G VAVK LK E + E+E++ H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 202 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++ +G C L+ ++ +GS+ L + ++ + + A+ +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAP 316
+ +HRD+ A N+L++ E + +GDFGL K + D T + AP
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAP 198
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
E L K +DV+ +G+ L EL+T L M+ + + +
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIGPTHGQMTVTRLVNT 255
Query: 376 LVDPDLQNNYV-------EAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
L+ EV QL+ C + P +R ++ E
Sbjct: 256 -----LKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 70/304 (23%), Positives = 120/304 (39%), Gaps = 69/304 (22%)
Query: 147 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL 201
ILG G FG V +G L VAVK +K + + E++ F +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 202 LRLRGFC-----MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK--RIALGSAR 254
+RL G C + +++ P+M G + + L P P + + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 314
G+ YL + +HRD+ A N +L ++ V DFGL+K + D + +G I +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211
Query: 315 -----APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368
A E L+ + K+DV+ +G+ + E+ T G +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY--------------------- 250
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVV 415
P +QN+ + + L ++ C + P+DRP S +
Sbjct: 251 ----------PGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300
Query: 416 RMLE 419
LE
Sbjct: 301 LQLE 304
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-38
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVHRNLLRLRG 206
+GRG F VYKG VA L++ + E +F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 207 FCMTPTE---RLLVYP-YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ + +++ M +G++ + L+ + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 263 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
P IIHRD+K NI + +V +GD GLA L AV GT +APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 322 GKSSEKTDVFGYGIMLLELITGQ 344
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-38
Identities = 82/295 (27%), Positives = 121/295 (41%), Gaps = 61/295 (20%)
Query: 148 NILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 204 LRGFCMTPTE--RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
L G C +E L+V PYM +G + + +R + L A+G+ +L
Sbjct: 155 LLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 210
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 318
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +A E
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 319 LSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
L T K + K+DV+ +G++L EL+T G +
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPY------------------------------ 297
Query: 378 DPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
PD+ + + Q L +V L C RP SE+V +
Sbjct: 298 -PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-38
Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 33/238 (13%)
Query: 120 EDP-EVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSL-----VAVKR 173
E P + L LK F +LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKE----------TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 174 LKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 233
L+E +P + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 234 PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293
+ + + A+G++YL D +++HRD+ A N+L+ + DFGLA
Sbjct: 111 KDN---IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 294 KLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQR 345
KL+ ++ ++ A E + + ++DV+ YG+ + EL+T G +
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-38
Identities = 81/424 (19%), Positives = 135/424 (31%), Gaps = 75/424 (17%)
Query: 25 DNGSFSLFTPISFAN--------NLDLCGPVT--GRPCPGSPPFSPPPPFIPPPPISSPG 74
G + + F L G + CP S + P P
Sbjct: 217 KAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPST 276
Query: 75 GNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSL 134
I + G I R P + DPE +LK L
Sbjct: 277 LTHPQRRIDTLNSDG--YTPEPARITSPDKPRPMPMDTSVFESPFSDPE----ELKDKKL 330
Query: 135 RELQVATDSFSNKNILGRGGFGKVYKGRLADGS---LVAVKRLKEERTPGGELQFQTEVE 191
+ + LG G FG V +G VA+K LK+ + E +
Sbjct: 331 FLKR--DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 192 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 251
++ + ++RL G C +LV G + L + + +
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 444
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT- 310
+ G+ YL + +HR++ A N+LL A + DFGL+K + D++ T G
Sbjct: 445 VSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 311 -IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368
+ APE ++ K S ++DV+ YG+ + E ++ GQ+ +
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--------------------- 540
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVV 415
++ V A +EQ L + C DRP V
Sbjct: 541 ----------KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590
Query: 416 RMLE 419
+ +
Sbjct: 591 QRMR 594
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 46/296 (15%)
Query: 147 KNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
LG+G FG V R G +VAVK+L+ T F+ E+E++ H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 73
Query: 202 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++ +G C + R L+ Y+ GS+ L++ +D + +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL 130
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAP 316
+ IHRD+ NIL++ E +GDFGL K++ D I AP
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAP 186
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376
E L+ K S +DV+ +G++L EL T + +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEK---------------SKSPPAEFMRMIGND 231
Query: 377 VDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ ++ ++ + + C + RP ++ ++
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 72/296 (24%), Positives = 110/296 (37%), Gaps = 61/296 (20%)
Query: 147 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
++G+G FG VY G D + A+K L F E ++ H N+L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 203 RLRGFCMTPTE--RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
L G P E ++ PYM +G + +R + L ARG+ YL
Sbjct: 86 ALIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYLA 141
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPE 317
+ K +HRD+ A N +LDE F V DFGLA+ + +Y R + A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 318 YLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376
L T + + K+DV+ +G++L EL+T G +
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPY----------------------------- 229
Query: 377 VDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ + + Q L QV C + P RP +V +E
Sbjct: 230 --RHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 35/290 (12%)
Query: 147 KNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+ LG+G FG V R G+LVAVK+L+ P + FQ E++++ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFI 86
Query: 202 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++ RG P + LV Y+ +G + L+ LD + +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 143
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPE 317
+ +HRD+ A NIL++ E + DFGLAKL+ + V + I APE
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 318 YLSTGKSSEKTDVFGYGIMLLELIT-GQR-----AFDLARLANDDDVMLLDWVKGLLKE- 370
LS S ++DV+ +G++L EL T + A L + + DV L + LL+E
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 371 KKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
++L P EV +L+ LC SP DRP S + L+
Sbjct: 261 QRLPAPPACPA--------EVHELM---KLCWAPSPQDRPSFSALGPQLD 299
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 63/296 (21%), Positives = 111/296 (37%), Gaps = 46/296 (15%)
Query: 147 KNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
LG+G FG V R G +VAVK+L+ T F+ E+E++ H N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 104
Query: 202 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++ +G C + R L+ Y+ GS+ L++ +D + +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL 161
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAP 316
+ IHRD+ NIL++ E +GDFGL K++ D I AP
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAP 217
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376
E L+ K S +DV+ +G++L EL T +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------------- 264
Query: 377 VDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ ++ ++ + + C + RP ++ ++
Sbjct: 265 --GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 70/291 (24%), Positives = 113/291 (38%), Gaps = 38/291 (13%)
Query: 147 KNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
LG G FGKV G +VAVK LK + P ++ E++++ H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 202 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++ +G C LV Y+ GS+ L + A G++YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYL 150
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAP 316
H IHRD+ A N+LLD + +GDFGLAK + + + AP
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAP 206
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDV-----MLLDWVKGLLKE 370
E L K +DV+ +G+ L EL+T + + M + + LL+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266
Query: 371 -KKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
++L P EV L+ C + RP ++ +L+
Sbjct: 267 GERLPRPDKCPA--------EVYHLM---KNCWETEASFRPTFENLIPILK 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 62/305 (20%), Positives = 110/305 (36%), Gaps = 70/305 (22%)
Query: 147 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL 201
+LG+G FG V + +L VAVK LK + +++ F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 202 LRLRGFC------MTPTERLLVYPYMANGSVASCLRERPPSQLP--LDWPTRKRIALGSA 253
+L G +++ P+M +G + + L + P L T R + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VR 308
G+ YL IHRD+ A N +L E+ V DFGL++ + D + V+
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 367
A E L+ + +DV+ +G+ + E++T GQ +
Sbjct: 205 WL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-------------------- 240
Query: 368 LKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEV 414
++N + + + + C P RP + +
Sbjct: 241 -----------AGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL 289
Query: 415 VRMLE 419
LE
Sbjct: 290 RMELE 294
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 53/292 (18%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+S + LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 241
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
++L + +V YM+ GS+ L+ L L P +A A G++Y+
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVER 298
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 322 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
G+ + K+DV+ +GI+L EL T G+ + P
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPY-------------------------------PG 384
Query: 381 LQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ N V +VE+ L + C + P +RP + LE
Sbjct: 385 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-36
Identities = 62/292 (21%), Positives = 106/292 (36%), Gaps = 57/292 (19%)
Query: 147 KNILGRGGFGKVYKGRLADGS---LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 203
LG G FG V +G VA+K LK+ + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
L G C +LV G + L + + + + G+ YL +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 129
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLST 321
+HRD+ A N+LL A + DFGL+K + D++ T G + APE ++
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 322 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
K S ++DV+ YG+ + E ++ GQ+ +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPY-------------------------------KK 216
Query: 381 LQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
++ V A +EQ L + C DRP V + +
Sbjct: 217 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 61/307 (19%), Positives = 114/307 (37%), Gaps = 64/307 (20%)
Query: 135 RELQVATDSFSNKNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEV 190
R+ ++ + +G G FG V++G VA+K K + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 191 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 250
+ H ++++L G ++ G + S L+ R S LD + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAY 498
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTA 306
+ L+YL + +HRD+ A N+L+ +GDFGL++ M+ YK +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVK 365
++ APE ++ + + +DV+ +G+ + E++ G + F
Sbjct: 556 IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPF------------------ 593
Query: 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMS 412
++NN V +E L + C P RP+ +
Sbjct: 594 -------------QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 640
Query: 413 EVVRMLE 419
E+ L
Sbjct: 641 ELKAQLS 647
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 62/293 (21%), Positives = 119/293 (40%), Gaps = 54/293 (18%)
Query: 144 FSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
F ++G GGFG+V+K + DG +KR+K + + EV+ ++ H N++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIV 67
Query: 203 RLRGFCMTPTERLLVYP----------------YMANGSVASCLRERPPSQLPLDWPTRK 246
G + G++ + +R +L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV--LAL 125
Query: 247 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306
+ +G+ Y+H K+I+RD+K +NI L + + +GDFGL + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182
Query: 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR-AFDLARLANDDDVMLLDWVK 365
GT+ +++PE +S+ ++ D++ G++L EL+ AF+ ++ D
Sbjct: 183 --GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD---------- 230
Query: 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRML 418
L++ + + D + L+Q P DRP SE++R L
Sbjct: 231 --LRDGIISDIFDKKEKT---------LLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 53/296 (17%)
Query: 147 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
LG+G FG VY+G VA+K + E + ++F E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRER------PPSQLPLDWPTRKRIALGSAR 254
++RL G L++ M G + S LR P P ++A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 314
G++YL+ + K +HRD+ A N ++ E+F +GDFG+ + + D + +G G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLL 202
Query: 315 -----APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LANDDDVMLLDWV 364
+PE L G + +DV+ +G++L E+ T LA L+N+ V
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQ-------V 249
Query: 365 KGLLKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ E L+ PD + +L+ +C Q +P RP E++ ++
Sbjct: 250 LRFVMEGGLLDK---PD----NCPDMLFELM---RMCWQYNPKMRPSFLEIISSIK 295
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 61/306 (19%), Positives = 115/306 (37%), Gaps = 56/306 (18%)
Query: 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQ 187
S R+ ++ + +G G FG V++G VA+K K + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 188 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
E + H ++++L G ++ G + S L+ R S LD +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS---LDLASLIL 120
Query: 248 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 307
A + L+YL + +HRD+ A N+L+ +GDFGL++ M+ + +
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 366
+ I +APE ++ + + +DV+ +G+ + E++ G + F
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF------------------- 218
Query: 367 LLKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSE 413
++NN V +E L + C P RP+ +E
Sbjct: 219 ------------QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 266
Query: 414 VVRMLE 419
+ L
Sbjct: 267 LKAQLS 272
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMA 196
F +LG G FG VYKG VA+K L+E +P + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
+ ++ RL G C+T T L+ M G + +RE + + + A+G+
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 130
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTI 311
+YL D +++HRD+ A N+L+ + DFGLAKL+ ++ ++
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQR 345
A E + + ++DV+ YG+ + EL+T G +
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 75/294 (25%), Positives = 120/294 (40%), Gaps = 57/294 (19%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+S + LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 324
Query: 202 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++L +E +V YM+ GS+ L+ L L P +A A G++Y+
Sbjct: 325 VQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV 379
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 380 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 320 STGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
G+ + K+DV+ +GI+L EL T G+ +
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPY------------------------------- 465
Query: 379 PDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
P + N V +VE+ L + C + P +RP + LE
Sbjct: 466 PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 66/301 (21%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSL----VAVKRLKEERTPGGELQFQTEVEMISMAV 197
+ ILG G FG+VY+G + VAVK K++ T + +F +E ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 198 HRNLLRLRGFCMT-PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
H ++++L G PT ++ G + L S L T +L + +
Sbjct: 72 HPHIVKLIGIIEEEPT--WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAM 126
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----VRGTIG 312
+YL +HRD+ NIL+ +GDFGL++ ++ +D + + ++
Sbjct: 127 AYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-- 181
Query: 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 371
+PE ++ + + +DV+ + + + E+++ G++ F
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF------------------------ 215
Query: 372 KLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRML 418
L+N V +E+ L + C P DRP+ +E+V L
Sbjct: 216 -------FWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268
Query: 419 E 419
Sbjct: 269 S 269
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 77/321 (23%), Positives = 129/321 (40%), Gaps = 45/321 (14%)
Query: 118 AEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGS------LVAV 171
+P +V + + LG G FG+VY+G+++ VAV
Sbjct: 6 HHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 65
Query: 172 KRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 231
K L E + EL F E +IS H+N++R G + R ++ MA G + S LR
Sbjct: 66 KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 232 ERPPSQLPLDWPTRKR---IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV- 287
E P +A A G YL ++ IHRD+ A N LL V
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182
Query: 288 --GDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGIMLLEL 340
GDFG+A+ + + +G + PE G + KTD + +G++L E+
Sbjct: 183 KIGDFGMARDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 341 IT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD-PDLQNNYVEAEVEQLIQVAL 398
+ G + +N + +L++V +++ + P V +++
Sbjct: 239 FSLGYMPY--PSKSNQE---VLEFVT---SGGRMDPPKNCPG--------PVYRIM---T 279
Query: 399 LCTQGSPMDRPKMSEVVRMLE 419
C Q P DRP + ++ +E
Sbjct: 280 QCWQHQPEDRPNFAIILERIE 300
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 63/297 (21%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+ +G G FG V+ G + VA+K ++E E F E E++ H L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 65
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
++L G C+ LV +M +G ++ LR + T + L G++YL +
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEE 122
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAP 316
+IHRD+ A N L+ E V DFG+ + + D + ++ V+ +P
Sbjct: 123 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SP 174
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
E S + S K+DV+ +G+++ E+ + G+ +
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY---------------------------- 206
Query: 376 LVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ N+ V ++ + Q+ C + P DRP S ++R L
Sbjct: 207 ---ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 25/230 (10%)
Query: 127 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSL-----VAVKRLKEERTPG 181
G +K R + +LG G FG V+KG V +K ++++
Sbjct: 1 GAMKVL-ARIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ 57
Query: 182 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLD 241
+ I H +++RL G C + LV Y+ GS+ +R+ + L
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA---LG 113
Query: 242 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301
+ A+G+ YL +H ++HR++ A N+LL + V DFG+A L+ D
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 302 HVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQR 345
+ + ++ A E + GK + ++DV+ YG+ + EL+T G
Sbjct: 171 QLLYSEAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 58/279 (20%), Positives = 119/279 (42%), Gaps = 22/279 (7%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK-EERTPGGELQF-QTEVEMISMAVH 198
+F + +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N+++ + E +V G ++ ++ + + T + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
+H +++HRD+K AN+ + +GD GL + K T + V GT +++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
+ + K+D++ G +L E+ Q F + ++ L +K +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLY-------SLCKKIEQCDYP 256
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
P ++Y E+ QL+ +C P RP ++ V +
Sbjct: 257 PLPSDHY-SEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 69/307 (22%), Positives = 133/307 (43%), Gaps = 37/307 (12%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHR 199
+ + +G G FGK + DG +K + R E + + EV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP----LDWPTRKRIALGSARG 255
N+++ R +V Y G + + + LDW + I L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ--ICLA---- 137
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
L ++HD KI+HRD+K+ NI L ++ +GDFG+A++++ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
PE + K+D++ G +L EL T + AF+ + L +LK
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE------AGSMKNL-----VLKIISGSF 242
Query: 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEV 435
P + +Y ++ L+ + +P DRP ++ + LE +A+R +++ ++
Sbjct: 243 ---PPVSLHY-SYDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQL 292
Query: 436 LRQEVEL 442
+ +E L
Sbjct: 293 IAEEFCL 299
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 67/297 (22%), Positives = 115/297 (38%), Gaps = 63/297 (21%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+ + LG G FG V G+ VAVK +KE E +F E + + H L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKL 65
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
++ G C +V Y++NG + + LR L+ + G+++L
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLES 122
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAP 316
H + IHRD+ A N L+D + V DFG+ + + D +V++ V+ + AP
Sbjct: 123 H---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS----AP 174
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
E K S K+DV+ +GI++ E+ + G+ +
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY---------------------------- 206
Query: 376 LVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
N+ V +V Q + Q+ C P RP +++ +E
Sbjct: 207 ---DLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 60/323 (18%), Positives = 114/323 (35%), Gaps = 68/323 (21%)
Query: 116 VPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLK 175
+ ++ P ++ + LG G FG V G+ VA+K +K
Sbjct: 3 LGSKNAP-----STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK 57
Query: 176 EERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP 235
E E +F E +++ H L++L G C ++ YMANG + + LRE
Sbjct: 58 EGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH 115
Query: 236 SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295
+ + YL + +HRD+ A N L++++ V DFGL++
Sbjct: 116 R---FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 296 MDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDL 349
+ D + ++ VR + PE L K S K+D++ +G+++ E+ + G+ +
Sbjct: 170 V-LDDEYTSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-- 222
Query: 350 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ-------------LIQV 396
N+ + Q + +
Sbjct: 223 -----------------------------ERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253
Query: 397 ALLCTQGSPMDRPKMSEVVRMLE 419
C +RP ++ +
Sbjct: 254 MYSCWHEKADERPTFKILLSNIL 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 147 KNILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLL 202
++++G G FG+V K R+ L A+KR+KE + F E+E + + H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK------------RIAL 250
L G C L Y +G++ LR+ + + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 310
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199
Query: 311 IGHI-----APEYLSTGKSSEKTDVFGYGIMLLELIT 342
+G + A E L+ + +DV+ YG++L E+++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 27/280 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+ K+ LG G +G+VY+G VAVK LKE+ +F E ++ H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 277
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
L++L G C ++ +M G++ LRE ++ +A + + YL
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLE 335
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
IHR++ A N L+ E V DFGL++LM + I APE L+
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 321 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
K S K+DV+ +G++L E+ T G + + LL+ K E+ P
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLE--KDYRMER-------P 441
Query: 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ E++ ++ C Q +P DRP +E+ + E
Sbjct: 442 EGC-------PEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 75/293 (25%), Positives = 111/293 (37%), Gaps = 59/293 (20%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 248
Query: 202 LRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
++L G + L +V YMA GS+ LR R S L + +L + YL
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLE 306
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
+ +HRD+ A N+L+ E+ A V DFGL K V+ T APE L
Sbjct: 307 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALR 359
Query: 321 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
K S K+DV+ +GI+L E+ + G+ + P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPY-------------------------------P 388
Query: 380 DLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ V VE+ + V C RP ++ LE
Sbjct: 389 RIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-34
Identities = 79/332 (23%), Positives = 131/332 (39%), Gaps = 69/332 (20%)
Query: 111 EFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGS--- 167
+F+ + E+P + R RE++ + I+G G G+V GRL
Sbjct: 24 QFYAEPHTYEEPG----RAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRD 77
Query: 168 -LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226
VA+K LK T F +E ++ H N++RL G ++V YM NGS+
Sbjct: 78 VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286
+ LR + G G+ YL D +HRD+ A N+L+D
Sbjct: 138 DTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCK 191
Query: 287 VGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGIMLLELI 341
V DFGL++++ D G G I APE ++ S +DV+ +G+++ E++
Sbjct: 192 VSDFGLSRVL-EDDPDAAYTTTG--GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
Query: 342 T-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ-------- 392
G+R + ++ N V + VE+
Sbjct: 249 AYGERPY-------------------------------WNMTNRDVISSVEEGYRLPAPM 277
Query: 393 -----LIQVALLCTQGSPMDRPKMSEVVRMLE 419
L Q+ L C RP+ S++V +L+
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 71/306 (23%), Positives = 118/306 (38%), Gaps = 46/306 (15%)
Query: 135 RELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL----KEERTPGGELQFQTE 189
+ + + LG GGF V L DG A+KR+ +++R + Q E
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-----EAQRE 76
Query: 190 VEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPPSQLPLDWPTR 245
+M + H N+LRL +C+ L+ P+ G++ + + L
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
+ LG RGL +H HRD+K NILL +E + V+ D G
Sbjct: 137 LWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 306 AVR--------GTIGHIAPEYLSTGKS----SEKTDVFGYGIMLLELITGQRAFDLARLA 353
A+ TI + APE L + +S E+TDV+ G +L ++ G+ +D+
Sbjct: 194 ALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 354 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 413
D + L P Q+ + + QL+ + P RP +
Sbjct: 253 GD-----------SVALAVQNQLSIP--QSPRHSSALWQLLNSMM---TVDPHQRPHIPL 296
Query: 414 VVRMLE 419
++ LE
Sbjct: 297 LLSQLE 302
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 75/293 (25%), Positives = 112/293 (38%), Gaps = 59/293 (20%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNL 76
Query: 202 LRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
++L G + L +V YMA GS+ LR R S L + +L + YL
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLE 134
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
+ +HRD+ A N+L+ E+ A V DFGL K V+ T APE L
Sbjct: 135 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALR 187
Query: 321 TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
K S K+DV+ +GI+L E+ + G+ + P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPY-------------------------------P 216
Query: 380 DLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ V VE+ + +V C RP ++ LE
Sbjct: 217 RIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 62/305 (20%)
Query: 147 KNILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAV 197
LG G FG+V VAVK LK++ T +E+E M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK----------- 246
H+N++ L G C ++ Y + G++ LR R P + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 247 -RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 306 A-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LAND 355
V+ APE L + ++DV+ +G+++ E+ T L + +
Sbjct: 263 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE 312
Query: 356 DDVMLLDWVK-GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ L +K G +K P E+ ++ C P RP ++
Sbjct: 313 E---LFKLLKEGHRMDK-------PA----NCTNELYMMM---RDCWHAVPSQRPTFKQL 355
Query: 415 VRMLE 419
V L+
Sbjct: 356 VEDLD 360
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 57/298 (19%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAV 197
+ S ++G G FG+V GRL S VA+K LK T F E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H N++RL G ++V YM NGS+ S LR+ + G A G+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMK 161
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIA 315
YL D +HRD+ A NIL++ V DFGL +++ D + + T + I +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374
PE ++ K + +DV+ YGI+L E+++ G+R +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY--------------------------- 251
Query: 375 MLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
++ N V V++ L Q+ L C Q +RPK ++V +L+
Sbjct: 252 ----WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 45/292 (15%)
Query: 147 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
LG G FG+VY+G+++ VAVK L E + EL F E +IS H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR---IALGSARGLS 257
++R G + R ++ MA G + S LRE P +A A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVV---GDFGLAKLMDYKDTHVTTAVRGTIGHI 314
YL ++ IHRD+ A N LL V GDFG+A+ + + +G +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAML 248
Query: 315 -----APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368
PE G + KTD + +G++L E+ + G + +N + +L++V
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQE---VLEFVT--- 300
Query: 369 KEKKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+++ + P V +++ C Q P DRP + ++ +E
Sbjct: 301 SGGRMDPPKNCPG--------PVYRIM---TQCWQHQPEDRPNFAIILERIE 341
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 62/305 (20%)
Query: 147 KNILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAV 197
LG G FG+V VAVK LK++ T +E+E M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK----------- 246
H+N++ L G C ++ Y + G++ LR R P + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 247 -RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 306 A-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LAND 355
V+ APE L + ++DV+ +G+++ E+ T L + +
Sbjct: 217 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE 266
Query: 356 DDVMLLDWVK-GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ L +K G +K P E+ ++ C P RP ++
Sbjct: 267 E---LFKLLKEGHRMDK-------PA----NCTNELYMMM---RDCWHAVPSQRPTFKQL 309
Query: 415 VRMLE 419
V L+
Sbjct: 310 VEDLD 314
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 53/292 (18%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+S + LG G FG+V+ + VAVK +K F E ++ H L
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKL 245
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
++L T ++ +MA GS+ L+ S+ PL P + A G++++
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ 302
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
IHRD++AANIL+ + DFGLA++++ + + I APE ++
Sbjct: 303 R---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 322 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
G + K+DV+ +GI+L+E++T G+ + P
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPY-------------------------------PG 388
Query: 381 LQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ N V +E+ L + + C + P +RP + +L+
Sbjct: 389 MSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 59/291 (20%)
Query: 149 ILGRGGFGKVYKGRLADGSL---VAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRL 204
LG G FG V KG + VAVK LK E P + + E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
G C + +LV G + L++ + + + G+ YL +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQN--RHVKD--KNIIELVHQVSMGMKYLEES-- 136
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTG 322
+HRD+ A N+LL + A + DFGL+K + + + G + APE ++
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 323 KSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381
K S K+DV+ +G+++ E + GQ+ + +
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPY-------------------------------RGM 224
Query: 382 QNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ + V A +E+ + + LC +RP + V L
Sbjct: 225 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 67/299 (22%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
++ LG G FG+V+ G + VAVK LK+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRL 70
Query: 202 LRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
+RL T+ ++ YM NGS+ L+ +L + +A A G++++
Sbjct: 71 VRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTI--NKLLDMAAQIAEGMAFI 125
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHI 314
+ IHRD++AANIL+ + + DFGLA+L+ + + ++ T
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT---- 177
Query: 315 APEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373
APE ++ G + K+DV+ +GI+L E++T G+ +
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-------------------------- 211
Query: 374 EMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
P + N V +E+ L Q+ LC + P DRP + +LE
Sbjct: 212 -----PGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 30/219 (13%)
Query: 147 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
LG FGKVYKG L + VA+K LK++ +F+ E + + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK------------RI 248
++ L G +++ Y ++G + L R P + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 306
A G+ YL H ++H+D+ N+L+ ++ + D GL + + D +
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 307 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+R APE + GK S +D++ YG++L E+ +
Sbjct: 191 LLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 147 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
K LG G FGKV+ + S LVAVK LK+ T FQ E E+++ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRKR-----------I 248
+++ G C ++V+ YM +G + LR P + + +D R+ I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 306
A A G+ YL +HRD+ N L+ +GDFG+++ + D +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 307 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+R PE + K + ++DV+ +G++L E+ T
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 78/298 (26%), Positives = 124/298 (41%), Gaps = 63/298 (21%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSL-VAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+ K+ LG G +G+VY+G SL VAVK LKE+ E F E ++ H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
L++L G C ++ +M G++ LRE ++ +A + + YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLE 128
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIA 315
IHRD+ A N L+ E V DFGL++LM DT+ A ++ T A
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT----A 180
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374
PE L+ K S K+DV+ +G++L E+ T G +
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------------------- 213
Query: 375 MLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVRMLE 419
P + + V +E+ + ++ C Q +P DRP +E+ + E
Sbjct: 214 ----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 73/305 (23%), Positives = 119/305 (39%), Gaps = 62/305 (20%)
Query: 147 KNILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAV 197
LG G FG+V + VAVK LK + T +E+E M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR---------- 247
H+N++ L G C ++ Y + G++ L+ R P L +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 248 --IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D + T
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 306 A-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR-----LAND 355
V+ APE L + ++DV+ +G++L E+ T L + +
Sbjct: 251 TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 300
Query: 356 DDVMLLDWVK-GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ L +K G +K P E+ ++ C P RP ++
Sbjct: 301 E---LFKLLKEGHRMDK-------PS----NCTNELYMMM---RDCWHAVPSQRPTFKQL 343
Query: 415 VRMLE 419
V L+
Sbjct: 344 VEDLD 348
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 66/303 (21%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEMISMA 196
+ + ++G G FG+VYKG L S VA+K LK T + F E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
H N++RL G +++ YM NG++ LRE+ + G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGM 160
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTA-----VRGT 310
YL + +HRD+ A NIL++ V DFGL++++ D + TT+ +R T
Sbjct: 161 KYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 369
APE +S K + +DV+ +GI++ E++T G+R +
Sbjct: 218 ----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY---------------------- 251
Query: 370 EKKLEMLVDPDLQNNYVEAEVEQ-------------LIQVALLCTQGSPMDRPKMSEVVR 416
+L N+ V + + Q+ + C Q RPK +++V
Sbjct: 252 ---------WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302
Query: 417 MLE 419
+L+
Sbjct: 303 ILD 305
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
+LG+G +G VY GR L++ +A+K + E + + E+ + H+N+++ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ + GS+++ LR + L + T GL YLHD+ +I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 268 IHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-- 324
+HRD+K N+L++ + + DFG +K + + T GT+ ++APE + G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202
Query: 325 SEKTDVFGYGIMLLELITGQR 345
+ D++ G ++E+ TG+
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 147 KNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 199
LGRG FG+V + VAVK LKE T +E++ +I + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 200 NLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPPSQLPLDWPTRK------------ 246
N++ L G C P +++ + G++++ LR + +P
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 247 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 307 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
++ APE + + ++DV+ +G++L E+ +
Sbjct: 209 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 29/218 (13%)
Query: 147 KNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 199
LG G FGKV + VAVK LK + +E++ M + H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK----------RIA 249
N++ L G C L++ Y G + + LR + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--- 306
A+G+++L IHRDV A N+LL A +GDFGLA+ + ++
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 307 --VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
V+ APE + + ++DV+ YGI+L E+ +
Sbjct: 228 LPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 66/330 (20%), Positives = 106/330 (32%), Gaps = 43/330 (13%)
Query: 94 FAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRG 153
+ F + +P+ F A E + R Q SF + LG G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ----SFQRLSRLGHG 68
Query: 154 GFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCM 209
+G+V+K R DG L AVKR + + E+ S H +RL
Sbjct: 69 SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 210 TPTERLLVYPYM--ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+Y S+ L + L++LH +
Sbjct: 128 EGGI---LYLQTELCGPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GL 178
Query: 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 327
+H DVK ANI L +GDFGL + G ++APE L G
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAPELLQ-GSYGTA 235
Query: 328 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVE 387
DVF G+ +LE+ W + L++ L P+
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGE----------GWQQ--LRQGYL----PPEFTAGL-S 278
Query: 388 AEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
+E+ ++ + + P R ++ +
Sbjct: 279 SELRSVLV---MMLEPDPKLRATAEALLAL 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 58/274 (21%), Positives = 107/274 (39%), Gaps = 26/274 (9%)
Query: 78 ATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLREL 137
+G+++ G A A L + A +R P+ E++ V L + + E
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPE-------TEDNEGVLLTEKLKPVDYEY 53
Query: 138 QVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMA 196
+ +++ +GRG FG+V++ + G AVK+++ E E+ +
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGL 107
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
++ L G + + GS+ +++ L + GL
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGL 163
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTA----VRGTI 311
YLH +I+H DVKA N+LL + + DFG A + + + GT
Sbjct: 164 EYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 345
H+APE + K D++ M+L ++ G
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 51/297 (17%)
Query: 147 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
K LG G FGKV+ + LVAVK LKE + FQ E E+++M H++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQH 104
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRKR----------IA 249
++R G C L+V+ YM +G + LR P ++L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVT 304
A G+ YL +HRD+ N L+ + +GDFG+++ + DY
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 305 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDW 363
+R PE + K + ++DV+ +G++L E+ T G++ + +L+N + +D
Sbjct: 222 LPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSNTE---AIDC 272
Query: 364 VKGLLKEKKLEMLVD-PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ + ++LE P EV ++ C Q P R + +V L+
Sbjct: 273 IT---QGRELERPRACPP--------EVYAIM---RGCWQREPQQRHSIKDVHARLQ 315
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 63/299 (21%), Positives = 106/299 (35%), Gaps = 48/299 (16%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
F LGRGGFG V++ + D A+KR++ + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 201 LLRLRGFCMTPTERLLVYP------------YMANGSVASCLRERPPSQLPLDWPTRKRI 248
++R + + P ++ + R + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHI 123
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
L A + +LH ++HRD+K +NI + VGDFGL MD + T
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 309 -----------GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 357
GT +++PE + S K D+F G++L EL+ F
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------- 230
Query: 358 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
M ++ K P L E ++Q SPM+RP+ ++
Sbjct: 231 -MERVRTLTDVRNLKF-----PPLFTQKYPCEY-VMVQ---DMLSPSPMERPEAINIIE 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 7/213 (3%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QTEVEMISMAVHR 199
+ + +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 200 NLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
N++R + T L V Y G +AS + + + LD R+ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 258 YLHDHCDP--KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
H D ++HRD+K AN+ LD + +GDFGLA+++++ + T V GT +++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
PE ++ +EK+D++ G +L EL F
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 67/213 (31%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSL----VAVKRLKEERTPGGELQ--FQTEVEMISM 195
LG G FG V +G S VAVK LK + E F EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 255
HRNL+RL G +TP +V GS+ LR+ T R A+ A G
Sbjct: 78 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEG 133
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGH 313
+ YL + IHRD+ A N+LL +GDFGL + + D H
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQR 345
APE L T S +D + +G+ L E+ T GQ
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 55/302 (18%), Positives = 102/302 (33%), Gaps = 72/302 (23%)
Query: 147 KNILGRGGFGKVYKGRLADGSL--------VAVKRLKEERTPGGELQFQTEVEMISMAVH 198
LG+G F K++KG + V +K L + F M+S H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSH 71
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
++L+ G C+ E +LV ++ GS+ + L++ ++ + +A A + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHF 128
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGT 310
L ++ +IH +V A NILL E + + D G++ + + +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV 184
Query: 311 IGHIAPEYLSTGKS-SEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368
PE + K+ + TD + +G L E+ + G +
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--------------------- 219
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQ-----------LIQVALLCTQGSPMDRPKMSEVVRM 417
L + E L + C P RP ++R
Sbjct: 220 ----------SALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269
Query: 418 LE 419
L
Sbjct: 270 LN 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 147 KNILGRGGFGKVYKGRLADG------SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
LG G FGKV K + VAVK LKE +P +E ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS-------- 252
+++L G C LL+ Y GS+ LRE R +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 253 ------------ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
++G+ YL + K++HRD+ A NIL+ E + + DFGL++ + +D
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 301 THVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGIMLLELIT 342
++ V+ + G I A E L + ++DV+ +G++L E++T
Sbjct: 205 SY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 33/222 (14%)
Query: 147 KNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 199
LG G FGKV + VAVK LK +E++ + + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRKR----------- 247
N++ L G C L++ Y G + + LR R P
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 248 --IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
+ A+G+++L IHRD+ A NILL + DFGLA+ + +V
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 306 A-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
V+ APE + + ++DV+ YGI L EL +
Sbjct: 205 GNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 23/235 (9%)
Query: 125 HLGQLKRFSLRELQVATDSFSNKNILGRG--GFGKVYKGR-LADGSLVAVKRLKEERTPG 181
H+ L + + ++G+G V R G V V+R+ E
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 182 GELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPL 240
+ F Q E+ + + H N++ R + E +V +MA GS + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127
Query: 241 DWPTRKRIAL---GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297
IA G + L Y+H +HR VKA++IL+ + + + M
Sbjct: 128 LA-----IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 298 ---YKDTHVTTAVRGTIGHI---APEYLSTGKS--SEKTDVFGYGIMLLELITGQ 344
+ V + ++ + +PE L K+D++ GI EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 29/270 (10%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRL-KEE-RTPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG+G F VY+ + G VA+K + K+ G + Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+ LV NG + L+ R P + G+ YLH H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHSH---G 132
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
I+HRD+ +N+LL + DFGLA + T GT +I+PE +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGL 191
Query: 327 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386
++DV+ G M L+ G+ FD D V L K + + P ++
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFD------TDTVKNT-----LNKVVLADYEM-PS----FL 235
Query: 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
E + LI LL + +P DR +S V+
Sbjct: 236 SIEAKDLIH-QLL--RRNPADRLSLSSVLD 262
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 65/309 (21%)
Query: 147 KNILGRGGFGKVYKGRLADG------SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+G G FG+V++ R ++VAVK LKEE + + FQ E +++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPPSQLPLDWPTRK------------- 246
+++L G C L++ YMA G + LR P + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 247 ------RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
IA A G++YL + K +HRD+ N L+ E + DFGL++ + D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 301 THVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR---- 351
+ I PE + + + ++DV+ YG++L E+ +
Sbjct: 229 YY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------YGLQPYY 278
Query: 352 -LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK 410
+A+++ ++ +V+ L P+ E+ L+ LC P DRP
Sbjct: 279 GMAHEE---VIYYVR---DGNILAC---PE----NCPLELYNLM---RLCWSKLPADRPS 322
Query: 411 MSEVVRMLE 419
+ R+L+
Sbjct: 323 FCSIHRILQ 331
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 68/310 (21%), Positives = 111/310 (35%), Gaps = 66/310 (21%)
Query: 147 KNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 199
+LG G FGKV S VAVK LKE+ +E++ M + H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS------- 252
N++ L G C L++ Y G + + LR + + + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 253 ------------ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
A+G+ +L +HRD+ A N+L+ + DFGLA+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 301 THVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR---- 351
+V V+ APE L G + K+DV+ YGI+L E+ + L
Sbjct: 227 NYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS------LGVNPYP 276
Query: 352 -LANDDDVMLLDWVKGLLKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP 409
+ D + L++ K++ P Y E+ ++ C RP
Sbjct: 277 GIPVDANFY------KLIQNGFKMDQ---PF----YATEEIYIIM---QSCWAFDSRKRP 320
Query: 410 KMSEVVRMLE 419
+ L
Sbjct: 321 SFPNLTSFLG 330
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 13/213 (6%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
D + + ++G G V VA+KR+ E+ + E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWP-TRKRIAL---GSARGL 256
++ + E LV ++ GSV ++ IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH-- 313
YLH + IHRDVKA NILL E+ + DFG++ + VR T +G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 314 -IAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
+APE + + K D++ +GI +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 62/307 (20%), Positives = 122/307 (39%), Gaps = 54/307 (17%)
Query: 130 KRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRL-KEERTPGGELQFQT 188
+ + + V +S +G GG KV++ + A+K + EE ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 189 EVEMISMAVHRNL--LRLRGFCMTPTERLLVYPYM--ANGSVASCLRERPPSQLPLDWPT 244
E+ ++ + +RL + +T +Y M N + S L+++ +D
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKK----SIDPWE 128
Query: 245 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTH 302
RK + +H H I+H D+K AN L+ + ++ DFG+A M T
Sbjct: 129 RKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTS 182
Query: 303 VT-TAVRGTIGHIAPEYL-----------STGKSSEKTDVFGYGIMLLELITGQRAFDLA 350
V + GT+ ++ PE + S K S K+DV+ G +L + G+ F
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-- 240
Query: 351 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNY---VEAEVEQLIQVALLCTQGSPMD 407
+ + KL ++DP+ + + E +++ +++ C + P
Sbjct: 241 ---QIINQI-----------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQ 283
Query: 408 RPKMSEV 414
R + E+
Sbjct: 284 RISIPEL 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG+GGF K ++ + A K + + P + E+ + H++++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
F +V S+ + R L P + G YLH + +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN---R 135
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
+IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSF 194
Query: 327 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386
+ DV+ G ++ L+ G+ F+ + L+ KK E + P ++
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFE------TSCLKET-----YLRIKKNEYSI-PK----HI 238
Query: 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
LIQ +L Q P RP ++E++
Sbjct: 239 NPVAASLIQ-KML--QTDPTARPTINELLN 265
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+ F+ +G+G FG+V+KG +VA+K + E Q E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
+ + G + T+ ++ Y+ GS L P LD I +GL YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYL 135
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H K IHRD+KAAN+LL E E + DFG+A + T V GT +APE +
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191
Query: 320 STGKSSEKTDVFGYGIMLLELITGQ 344
K D++ GI +EL G+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 60/289 (20%), Positives = 116/289 (40%), Gaps = 54/289 (18%)
Query: 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL--LRL 204
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 205 RGFCMTPTERLLVYPYM--ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ +T +Y M N + S L+++ +D RK + +H H
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 263 CDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYL 319
I+H D+K AN L+ + ++ DFG+A M T V + GT+ ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 320 -----------STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368
S K S K+DV+ G +L + G+ F + +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI--------- 227
Query: 369 KEKKLEMLVDPDLQNNY---VEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
KL ++DP+ + + E +++ +++ C + P R + E+
Sbjct: 228 --SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 57/300 (19%), Positives = 96/300 (32%), Gaps = 54/300 (18%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-- 197
T F +G G FG V+K DG + A+KR K+ + Q E+ + AV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLG 68
Query: 198 -HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
H +++R L+ Y GS+A + E K + L RGL
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVV-------------------GDFGLAKLMD 297
Y+H ++H D+K +NI + GD G +
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 298 YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDD 356
G +A E L + K D+F + ++ + N D
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR-----NGD 235
Query: 357 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+ +G L P + ++ ++ + P RP +V+
Sbjct: 236 QWHEI--RQGRL----------PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 42/254 (16%), Positives = 84/254 (33%), Gaps = 24/254 (9%)
Query: 114 FDVPAEEDPEVHLGQLKRFSL-RELQVATDSFSNKNILGRGGFGKVYKGR------LADG 166
V + + +L E Q+ + ++LG G F +VY+ +
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 167 SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226
+K K P +E + ++ ++ + +LV + G++
Sbjct: 96 QKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 227 ASCLRE-RPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL------ 279
+ + + + + A+ + +HD +IIH D+K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 280 -----DEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 333
D + D G + M + + TA T G E LS + + D FG
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 334 GIMLLELITGQRAF 347
+ ++ G
Sbjct: 272 AATVYCMLFGTYMK 285
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG+GGF K ++ + A K + + P + E+ + H++++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
F +V S+ + R L P + G YLH + +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN---R 161
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
+IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSF 220
Query: 327 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386
+ DV+ G ++ L+ G+ F+ + L+ KK E + P ++
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFE------TSCLKET-----YLRIKKNEYSI-PK----HI 264
Query: 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
LIQ +L Q P RP ++E++
Sbjct: 265 NPVAASLIQ-KML--QTDPTARPTINELLN 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 54/289 (18%)
Query: 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNL--LRL 204
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 205 RGFCMTPTERLLVYPYM--ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
+ +T +Y M N + S L+++ +D RK + +H H
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 263 CDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYL 319
I+H D+K AN L+ + ++ DFG+A M T V + G + ++ PE +
Sbjct: 175 ---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 320 S-----------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368
K S K+DV+ G +L + G+ F + +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI--------- 274
Query: 369 KEKKLEMLVDPDLQNNY---VEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
KL ++DP+ + + E +++ +++ C + P R + E+
Sbjct: 275 --SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 318
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 27/234 (11%)
Query: 127 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ 185
L L L+ F ++G G +G+VYKGR + G L A+K + E++
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 186 FQTEVEMIS-MAVHRNLLR-----LRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQL 238
E+ M+ + HRN+ ++ ++L LV + GSV ++ + L
Sbjct: 69 --QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 239 PLDWPTRKRIAL---GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295
+W IA RGLS+LH H K+IHRD+K N+LL E E + DFG++
Sbjct: 127 KEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGIMLLELITGQ 344
+D T + GT +APE ++ ++ + K+D++ GI +E+ G
Sbjct: 179 LDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 70/303 (23%), Positives = 119/303 (39%), Gaps = 55/303 (18%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
F +LG+G FG+V K R D A+K+++ T +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 200 NLLRLRGFCMTPTERLLVYP-------------YMANGSVASCLRERPPSQLPLDWPTRK 246
++R + + Y NG++ + L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYW 119
Query: 247 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-------- 298
R+ LSY+H IIHRD+K NI +DE +GDFGLAK +
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 299 ------KDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGIMLLELITGQRAFDLAR 351
++T+A+ GT ++A E L TG +EK D++ GI+ E+I
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FST--- 230
Query: 352 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411
+ +L L+ +E PD +N ++ +++I+ L+ P RP
Sbjct: 231 -GMERVNILKK-----LRSVSIEF--PPDFDDNKMK-VEKKIIR-LLIDH--DPNKRPGA 278
Query: 412 SEV 414
+
Sbjct: 279 RTL 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 35/301 (11%), Positives = 74/301 (24%), Gaps = 50/301 (16%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVK--RLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
L G V+ R + A+K + E + + + + + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 206 GFC--------------------------MTPTERLLVYPYMA--NGSVASCLRERPPSQ 237
LL+ P + + S L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 238 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297
+ R + L ++H N+ + + ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 298 YKDTHVTTAVRGTIGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAFDLARLAND 355
K A + + E+L+ + + + + G+ + + F L
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 356 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415
W + L+ + L + V+ LI L R E +
Sbjct: 302 G-----SWKRPSLRVPGTDSLAFGSCTP--LPDFVKTLIG-RFLNFD--RRRRLLPLEAM 351
Query: 416 R 416
Sbjct: 352 E 352
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 70/270 (25%), Positives = 110/270 (40%), Gaps = 32/270 (11%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG+G FG VY R ++A+K L + + G E Q + EVE+ S H N+LRL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+ T L+ Y G+V L++ D A LSY H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---R 129
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
+IHRD+K N+LL E + DFG + GT+ ++ PE + E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC--GTLDYLPPEMIEGRMHDE 186
Query: 327 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386
K D++ G++ E + G+ F+ + + ++E +V
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFE------ANTYQET-----YKRISRVEFTFPD-----FV 230
Query: 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
LI LL + +P RP + EV+
Sbjct: 231 TEGARDLIS-RLL--KHNPSQRPMLREVLE 257
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 71/232 (30%), Positives = 100/232 (43%), Gaps = 21/232 (9%)
Query: 122 PEVHLGQLKRFSLRELQVATD---SFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEE 177
G LK + EL D FS+ +G G FG VY R + + +VA+K++
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90
Query: 178 RTPGGE--LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPP 235
E EV + H N ++ RG + LV Y GS + L
Sbjct: 91 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK 149
Query: 236 SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295
PL + G+ +GL+YLH H +IHRDVKA NILL E +GDFG A +
Sbjct: 150 ---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGIMLLELITGQ 344
M ++ V GT +APE + + K DV+ GI +EL +
Sbjct: 204 MAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 65/290 (22%), Positives = 110/290 (37%), Gaps = 41/290 (14%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE-MISMA 196
V SF K++LG G G + + D VAVKR+ E EV+ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESD 75
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
H N++R + + A ++ + ++ + L L+ + + GL
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGL 131
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLAKLMD---YKDTHVTTAVR 308
++LH I+HRD+K NIL+ A++ DFGL K + + + +
Sbjct: 132 AHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP- 187
Query: 309 GTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 364
GT G IAPE LS + D+F G + +I+ G F + +
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG------KSLQRQANIL 241
Query: 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
G L+ L + + +LI+ ++ P RP V
Sbjct: 242 LG---ACSLDCLHPEK----HEDVIARELIE-KMIAMD--PQKRPSAKHV 281
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 57/300 (19%), Positives = 101/300 (33%), Gaps = 53/300 (17%)
Query: 150 LGRGGFGKVYKGRLADGSLVAVKRLK----------------EERTPGGELQFQTEVEMI 193
L +G F K+ D A+K+ + + F+ E+++I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 194 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 253
+ + L G E ++Y YM N S+ LD I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV----LDKNYTCFIPIQVI 153
Query: 254 R--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
+ SY+H+ + I HRDVK +NIL+D+ + DFG ++ M D +
Sbjct: 154 KCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 306 AVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL-- 361
+ GT + PE+ S + K D++ GI L + F ++ L
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELFN 263
Query: 362 -------DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
++ NN++ E ++ L P +R +
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK-LFLRKN--PAERITSEDA 320
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+ + LG G FGKVYK + G+L A K ++ + E + E+E+++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
+++L G + ++ + G+V + + E L P + + L++L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFL 133
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIA 315
H +IIHRD+KA N+L+ E + + DFG K + +D+ + GT +A
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMA 185
Query: 316 PEYLSTGKSSE-----KTDVFGYGIMLLELITGQ 344
PE + + K D++ GI L+E+ +
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 31/288 (10%)
Query: 147 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
K LG GGFG V + G VA+K+ ++E +P ++ E++++ H N++ R
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 206 GFCMTPTE------RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
+ LL Y G + L + + L + + + L YL
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALRYL 137
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316
H++ +IIHRD+K NI+L + + + D G AK +D + T V GT+ ++AP
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLAP 192
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFD----------LARLANDDDVMLLDWVKG 366
E L K + D + +G + E ITG R F R +++ +++ D + G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+K +L P+ + + ++E+ +Q L R +
Sbjct: 253 AVKFSS--VLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
++ +G+G G VY +A G VA++++ ++ P EL E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N++ + E +V Y+A GS+ + E +D + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFL 132
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H + ++IHRD+K+ NILL + + DFG + + + +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 320 STGKSSEKTDVFGYGIMLLELITGQ 344
+ K D++ GIM +E+I G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 11/205 (5%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+ +G G G V R G VAVK + + EL EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N++ + + E ++ ++ G++ + + L+ + + L+YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYL 157
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H +IHRD+K+ +ILL + + DFG + + V GT +APE +
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVI 213
Query: 320 STGKSSEKTDVFGYGIMLLELITGQ 344
S + + D++ GIM++E++ G+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 19/215 (8%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG+G FG VY R + ++A+K L + + G E Q + E+E+ S H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK 266
+ L+ + G + L++ D A L Y H+ K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCHER---K 134
Query: 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
+IHRD+K N+L+ + E + DFG + T GT+ ++ PE + E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TMC--GTLDYLPPEMIEGKTHDE 191
Query: 327 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
K D++ G++ E + G FD
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD------SPSHTET 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 21/238 (8%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMA 196
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 197 VHRNLLRLRGFCMTPTERL--LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
H+N+++L T R L+ + GS+ + L E + L +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVG 123
Query: 255 GLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 310
G+++L ++ I+HR++K NI+ D + + DFG A+ ++ D + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GT 178
Query: 311 IGHIAPEYLSTGKS--------SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
++ P+ D++ G+ TG F + ++
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+ F LG G +G VYK G +VA+K++ E + E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSP 84
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
++++ G T+ +V Y GSV+ +R R L I + +GL YL
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYL 141
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H + IHRD+KA NILL+ E A + DFG+A + T + GT +APE +
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 320 STGKSSEKTDVFGYGIMLLELITGQ 344
+ D++ GI +E+ G+
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 26/237 (10%)
Query: 135 RELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE-M 192
+ +++ + +L GGF VY+ + + G A+KRL EV M
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFM 79
Query: 193 ISMAVHRNLLRLRGFCMTPTER-------LLVYPYMANGSVASCLRERPPSQLPLDWPTR 245
++ H N+++ E L+ + G + L++ S+ PL T
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTV 138
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
+I + R + ++H P IIHRD+K N+LL + + DFG A + + + +
Sbjct: 139 LKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 306 A-----------VRGTIGHIAPEYLSTGKS---SEKTDVFGYGIMLLELITGQRAFD 348
A T + PE + + EK D++ G +L L Q F+
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 55/229 (24%), Positives = 106/229 (46%), Gaps = 14/229 (6%)
Query: 119 EEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEE 177
+E L + ++ D F + LG G G V+K G ++A K + E
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 178 RTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQ 237
P Q E++++ ++ G + E + +M GS+ L++
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----A 125
Query: 238 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLM 296
+ ++++ +GL+YL + KI+HRDVK +NIL++ E + DFG++ +L+
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
Query: 297 DYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344
D ++ V GT +++PE L S ++D++ G+ L+E+ G+
Sbjct: 184 DSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 21/238 (8%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMA 196
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 197 VHRNLLRLRGFCMTPTERL--LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
H+N+++L T R L+ + GS+ + L E P + L +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVG 123
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDYKDTHVTTAVRGT 310
G+++L ++ I+HR++K NI+ + + DFG A+ ++ D + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GT 178
Query: 311 IGHIAPEYLSTGKS--------SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
++ P+ D++ G+ TG F + ++
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 39/311 (12%), Positives = 84/311 (27%), Gaps = 74/311 (23%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVK------------------------RLKEERTPG-- 181
+LG+ + G V L+ +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 182 -GELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMA--NGSVASCLRERPPS 236
L+F +++ + ++R+R R +YP M + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 237 QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296
L R ++ L R L+ LH + ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 297 DYKDTHVTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGIMLLELITGQR 345
+ + G PE + + D + G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 346 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSP 405
D + +W+ K + V L++ L
Sbjct: 312 PIT-----KDAALGGSEWIFRSCKN---------------IPQPVRALLE-GFLRYP--K 348
Query: 406 MDRPKMSEVVR 416
DR + +
Sbjct: 349 EDRLLPLQAME 359
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 18/228 (7%)
Query: 127 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ 185
G+LK + + + +GRG +G V K G ++AVKR++ + Q
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 186 FQTEVEMI-SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPT 244
+++++ + +++ G + + M+ +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 245 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHV 303
+I L + + L++L + + KIIHRD+K +NILLD + DFG+ +L+D
Sbjct: 127 LGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------ 178
Query: 304 TTAVRGTIG---HIAPEYLSTGKS----SEKTDVFGYGIMLLELITGQ 344
+ A G ++APE + S ++DV+ GI L EL TG+
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 38/305 (12%), Positives = 80/305 (26%), Gaps = 63/305 (20%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVK------------------------RLKEERTPGG- 182
+LG+ + G V L+ +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 183 --ELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYPYMA--NGSVASCLRERPPS 236
L+F +++ + ++R+R R +YP M + L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 237 QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296
L R ++ L R L+ LH + ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 297 DYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLAR 351
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-- 319
Query: 352 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411
D + +W+ K + V L++ L + DR
Sbjct: 320 ---DAALGGSEWIFRSCKN---------------IPQPVRALLEGFL---RYPKEDRLLP 358
Query: 412 SEVVR 416
+ +
Sbjct: 359 LQAME 363
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 65/302 (21%), Positives = 115/302 (38%), Gaps = 52/302 (17%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRN 200
+ ++ ILG G G V G VAVKR+ + E++ + H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPN 70
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTR---KRIALGSARGLS 257
++R T + N ++ + + S L + A G++
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 258 YLHDHCDPKIIHRDVKAANILLD-------------EEFEAVVGDFGLAKLMD----YKD 300
+LH KIIHRD+K NIL+ E ++ DFGL K +D
Sbjct: 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 301 THVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARL 352
T++ GT G APE L + + D+F G + +++ G+ F +
Sbjct: 187 TNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKY 244
Query: 353 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 412
+ + +++ +G+ +++ L D + AE LI ++ P+ RP
Sbjct: 245 SRESNII-----RGIFSLDEMKCLHDRS-----LIAEATDLIS-QMIDHD--PLKRPTAM 291
Query: 413 EV 414
+V
Sbjct: 292 KV 293
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 38/216 (17%)
Query: 150 LGRGGFGKVYKGRLADGSL---VAVKRLKEE--RTPGGELQFQTEVEMISMAVHRNLLRL 204
LG GG VY D L VA+K + +F+ EV S H+N++
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS- 75
Query: 205 RGFCMTPTERLLVY--------PYMA----NGSVASCLRERPPSQLPLDWPTRKRIALGS 252
+ Y+ G L E S PL T
Sbjct: 76 ------------MIDVDEEDDCYYLVMEYIEGPT---LSEYIESHGPLSVDTAINFTNQI 120
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 312
G+ + HD +I+HRD+K NIL+D + DFG+AK + T V GT+
Sbjct: 121 LDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
+ +PE + E TD++ GI+L E++ G+ F+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 50/232 (21%), Positives = 97/232 (41%), Gaps = 15/232 (6%)
Query: 137 LQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM 195
++V D LGRG +G V K R + G ++AVKR++ + + +++ ISM
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISM 60
Query: 196 AV--HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 253
+ G + + M + S+ ++ + +IA+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
+ L +LH +IHRDVK +N+L++ + + DFG++ + D G +
Sbjct: 120 KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPY 175
Query: 314 IAPEYLSTGKS----SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
+APE ++ + S K+D++ GI ++EL + F +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQ 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 43/205 (20%), Positives = 75/205 (36%), Gaps = 21/205 (10%)
Query: 150 LGRGGFGKVYKGR--LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
+ GG G +Y +G V +K L + E + ++ VH +++++ F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 208 CMTPTERLLVYPYMA----NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
Y+ G L+ +LP+ L LSYLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQS---LKRSKGQKLPVAEAIA--YLLEILPALSYLHSI- 201
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
+++ D+K NI+L EE + + D G ++ + GT G APE +
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE-IVRTG 252
Query: 324 SSEKTDVFGYGIMLLELITGQRAFD 348
+ TD++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 18/206 (8%)
Query: 150 LGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQ--FQTEVEMISMAVHRNLLRL 204
+GRGG G VY+ D VA+K + E + + Q E +++ +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
F + + + +A+ LR + P L P I L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLSTG 322
HRDVK NIL+ + A + DFG+A D +T GT+ ++APE S
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 323 KSSEKTDVFGYGIMLLELITGQRAFD 348
++ + D++ +L E +TG +
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 150 LGRGGFGKVYKGRLADGSL---VAVKRLKEE--RTPGGELQFQTEVEMISMAVHRNLLRL 204
LG GG +V+ R D VAVK L+ + R P L+F+ E + + H ++ +
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 205 --RGFCMTPTERLLVYPYMA----NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
G TP L PY+ +G LR+ ++ P+ + + + L++
Sbjct: 78 YDTGEAETPAGPL---PYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAP 316
H + IIHRDVK ANI++ V DFG+A+ + VT AV GT +++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
E ++DV+ G +L E++TG+ F
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 25/246 (10%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMIS 194
V ++F +LG+GGFG+V ++ G + A K+L+++R GE E +++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR-----IA 249
R ++ L T LV M G + + + P R I
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEIC 296
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 309
GL LH +I++RD+K NILLD+ + D GLA + T G
Sbjct: 297 C----GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVG 347
Query: 310 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 369
T+G++APE + + + D + G +L E+I GQ F + + V+ L+K
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ-----QRKKKIKREEVERLVK 402
Query: 370 EKKLEM 375
E E
Sbjct: 403 EVPEEY 408
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 73/258 (28%), Positives = 111/258 (43%), Gaps = 28/258 (10%)
Query: 114 FDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVK 172
F E D Q K L + + FS I+GRGGFG+VY R AD G + A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 173 RLKEER--TPGGELQFQTE---VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 227
L ++R GE E + ++S ++ + TP + + M G +
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 228 SCLRERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282
L + R I L GL ++H+ +++RD+K ANILLDE
Sbjct: 281 YHLSQHGVFSEA-----DMRFYAAEIIL----GLEHMHNR---FVVYRDLKPANILLDEH 328
Query: 283 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGIMLLELI 341
+ D GLA K H +V GT G++APE L G + + + D F G ML +L+
Sbjct: 329 GHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 342 TGQRAFDLARLANDDDVM 359
G F + + ++
Sbjct: 386 RGHSPFRQHKTKDKHEID 403
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 15/219 (6%)
Query: 133 SLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE 191
+ Q + N +G G G+V+K R G ++AVK+++ + +++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 192 -MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 250
++ +++ G +T T+ + M + R + P + ++ +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP----IPERILGKMTV 131
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 310
+ L YL + +IHRDVK +NILLDE + + DFG++ + D G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGC 187
Query: 311 IGHIAPEYLSTGKSSE-----KTDVFGYGIMLLELITGQ 344
++APE + ++ + DV+ GI L+EL TGQ
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 64/288 (22%), Positives = 107/288 (37%), Gaps = 64/288 (22%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMISM----AVHR 199
LG+GGFG V+ G L D VA+K R+ + EV ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-RIALGSAR---- 254
++RL + T +LV L D+ T K + G +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQ-----------DL-FDYITEKGPLGEGPSRCFFG 146
Query: 255 ----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRG 309
+ + H ++HRD+K NIL+D + DFG L+ D T G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-G 200
Query: 310 TIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368
T + PE++S + + V+ GI+L +++ G F+ D +++ + L
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEIL-----EAEL 250
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+V + LI+ L P RP + E++
Sbjct: 251 HFPA------------HVSPDCCALIR-RCLAP--KPSSRPSLEEILL 283
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMIS 194
+ D F + +LGRGGFG+V+ ++ G L A K+L ++R G E ++++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 195 MAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKR-----I 248
R ++ L + L LV M G + + P R I
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQI 298
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAV 307
GL +LH II+RD+K N+LLD++ + D GLA L + T
Sbjct: 299 VS----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGY 349
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
GT G +APE L + D F G+ L E+I + F
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 15/212 (7%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 198
++ + LG G +G+V R A+K +++ EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N+++L F LV G L + ++ + I G++Y
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 259 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
LH H I+HRD+K N+LL +++ + DFGL+ + +++ GT +IA
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTAYYIA 206
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
PE L K EK DV+ G++L L+ G F
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 37/229 (16%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVK---RLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
LG G +GKV + AVK + K R P GE + E++++ H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 206 G--FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------G 255
+ + +V Y G ++E LD KR + A G
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCG-----MQEM------LDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHI 314
L YLH I+H+D+K N+LL + G+A+ + + +G+
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 315 APEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
PE + S K D++ G+ L + TG F+ D++ L
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKL 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 62/286 (21%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMISMAVHR--NL 201
LG GGFG VY G ++D VA+K R+ + + EV ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-RIALGSAR------ 254
+RL + P +L+ P Q D+ T + + AR
Sbjct: 111 IRLLDWFERPDSFVLILERPE------------PVQDLFDFITERGALQEELARSFFWQV 158
Query: 255 --GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTI 311
+ + H+ ++HRD+K NIL+D + + DFG L+ KDT T GT
Sbjct: 159 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTR 212
Query: 312 GHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370
+ PE++ + V+ GI+L +++ G F+ +D++++ +G +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII-----RGQVFF 262
Query: 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
++ V +E + LI+ L P DRP E+
Sbjct: 263 RQ------------RVSSECQHLIR-WCLAL--RPSDRPTFEEIQN 293
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 65/303 (21%), Positives = 101/303 (33%), Gaps = 64/303 (21%)
Query: 50 RPCPGSPPFSPPPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKP 109
R P S N A A + +
Sbjct: 27 RHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA-----------------QPKGT 69
Query: 110 QEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSL 168
+ +F ED K F + K+++GRG V + A G
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 169 VAVK-------RLKEERTPGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPY 220
AVK RL E+ + E + +A H +++ L + + LV+
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 221 MANGSVASCLRERPPSQLPLDWPTRK-----RIALGSAR----GLSYLHDHCDPKIIHRD 271
M G +L D+ T K + R +S+LH + I+HRD
Sbjct: 182 MRKG------------EL-FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRD 225
Query: 272 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 331
+K NILLD+ + + DFG + + + + GT G++APE L K S
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEIL---KCSMDETHP 280
Query: 332 GYG 334
GYG
Sbjct: 281 GYG 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE--LQFQTEVEMISMAV 197
+D + + +LG+G FG+V + G AVK + + + EV+++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H N+++L F LV G L + S+ RI G++
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 258 YLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 314
Y+H + KI+HRD+K N+LL ++ + DFGL+ ++ + GT +I
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGTAYYI 195
Query: 315 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
APE L G EK DV+ G++L L++G F+
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 33/230 (14%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSYLH 260
+ L Y + G + + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEY 318
I HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 319 LSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366
L + +E DV+ GI+L ++ G+ +D +D DW +
Sbjct: 179 LK-RREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEK 224
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 69/314 (21%), Positives = 119/314 (37%), Gaps = 60/314 (19%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
+G+G F KV R + G VA+K + K + P + EV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSYL 259
T L+ Y + G V L R+ AR + Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH------------GRMKEKEARSKFRQIVSAVQYC 130
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H I+HRD+KA N+LLD + + DFG + + G + APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFC-GAPPYAAPELF 185
Query: 320 STGKSSE--KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
GK + + DV+ G++L L++G FD ++ L + + K +
Sbjct: 186 Q-GKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKEL---RERVLRGKYRI-- 233
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVEVLR 437
P Y+ + E L++ L +P+ R + ++++ D W
Sbjct: 234 -PF----YMSTDCENLLKRFL---VLNPIKRGTLEQIMK-----------DRWINAGHEE 274
Query: 438 QEVELAPHPNSDWI 451
E++ P D
Sbjct: 275 DELKPFVEPELDIS 288
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 40/213 (18%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK--------RLKEERTPGGELQFQTEVE 191
+++ K ILGRG V + AVK E EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 192 -MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK---- 246
+ ++ H N+++L+ T T LV+ M G +L D+ T K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG------------EL-FDYLTEKVTLS 122
Query: 247 -RIALGSAR----GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301
+ R + LH I+HRD+K NILLD++ + DFG + +
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPG 177
Query: 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 334
V GT ++APE + + GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 62/251 (24%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVK-------------------------RLKEERTPGGE 183
+G+G +G V D + A+K + G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 184 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLD 241
Q E+ ++ H N+++L P E L V+ + G V ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127
Query: 242 WPTRKRIALGSAR--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293
PT K ++ AR G+ YLH KIIHRD+K +N+L+ E+ + DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDLA 350
D ++ V GT +APE LS + S + DV+ G+ L + GQ F
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-- 241
Query: 351 RLANDDDVMLL 361
D+ +M L
Sbjct: 242 ----DERIMCL 248
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 36/175 (20%)
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR------ 308
+ +LH ++HRD+K +NI + VGDFGL MD + T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 309 -----GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLLD 362
GT +++PE + S K D+F G++L EL+ + R+ D
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITD------- 285
Query: 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417
++ K P L E ++Q SP +RP+ ++++
Sbjct: 286 -----VRNLKF-----PLLFTQKYPQEH-MMVQ---DMLSPSPTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 1/63 (1%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207
+GRGGFG V++ + D A+KR++ + EV+ ++ H ++R
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 208 CMT 210
+
Sbjct: 73 WLE 75
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 198
+ ++ +LG+G FG+V K + AVK + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N+++L + +V G L + + RI G++Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 259 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
+H H I+HRD+K NILL +++ + + DFGL+ ++ GT +IA
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIA 191
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
PE L G EK DV+ G++L L++G F
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 140 ATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QT---EV---E 191
AT + +G G +G VYK R G VA+K ++ GG + EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 192 MISMAVHRNLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPPSQLPLDWPTRK 246
+ H N++RL C T LV+ ++ + + L + PP LP T K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA--ETIK 123
Query: 247 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTH 302
+ RGL +LH + I+HRD+K NIL+ + DFGLA++ M T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TP 178
Query: 303 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344
VT R APE L + D++ G + E+ +
Sbjct: 179 VVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 33/230 (14%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSYLH 260
+ L Y + G + + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLH 122
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEY 318
I HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 319 LSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366
L + +E DV+ GI+L ++ G+ +D +D DW +
Sbjct: 179 LK-RREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEK 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 26/223 (11%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK------------EERTPGGELQFQ 187
+S+ LG G +G+V + S A+K +K + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 188 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
E+ ++ H N+++L LV + G L E+ ++ D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAAN 150
Query: 248 IALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVT 304
I G+ YLH H I+HRD+K NILL + + DFGL+ + +
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKL 205
Query: 305 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
GT +IAPE L K +EK DV+ G+++ L+ G F
Sbjct: 206 RDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 54/257 (21%), Positives = 84/257 (32%), Gaps = 53/257 (20%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK----RLKEERTPGGELQFQTEVEMISM 195
+ K +G+G +G V ++ A+K + P + +TEV ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANG-------------SVASCLRERPPSQLPLDW 242
H N+ RL LV G + + P
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 243 PTRKRIALGSAR-----------------------GLSYLHDHCDPKIIHRDVKAANILL 279
+ I L YLH+ I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 280 --DEEFEAVVGDFGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTG--KSSEKTDVF 331
++ FE + DFGL+K + +TT GT +APE L+T K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 332 GYGIMLLELITGQRAFD 348
G++L L+ G F
Sbjct: 261 SAGVLLHLLLMGAVPFP 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 58/265 (21%), Positives = 106/265 (40%), Gaps = 50/265 (18%)
Query: 99 IAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKV 158
IA + + + F F +D V+ L+ D + LG G G+V
Sbjct: 106 IALSL---SRNKVFVFFDLTVDDQSVYPKALR-----------DEYIMSKTLGSGACGEV 151
Query: 159 YKGR-LADGSLVAVK-------RLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 210
VA++ + R L +TE+E++ H +++++ F
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211
Query: 211 PTERLLVYPYMANGS-----VAS-CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCD 264
+ +V M G V + L+E T K + YLH++
Sbjct: 212 E-DYYIVLELMEGGELFDKVVGNKRLKEA----------TCKLYFYQMLLAVQYLHEN-- 258
Query: 265 PKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
IIHRD+K N+LL +E+ + DFG +K++ +T + + GT ++APE L +
Sbjct: 259 -GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVS 315
Query: 322 GKS---SEKTDVFGYGIMLLELITG 343
+ + D + G++L ++G
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 91.5 bits (226), Expect = 1e-19
Identities = 61/387 (15%), Positives = 119/387 (30%), Gaps = 93/387 (24%)
Query: 107 RKPQEFF-FDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNIL--GRGGFGKVYKGRL 163
Q F ++V + +L++ +L EL+ KN+L G G GK
Sbjct: 121 NDNQVFAKYNVSRLQ----PYLKLRQ-ALLELR------PAKNVLIDGVLGSGK------ 163
Query: 164 ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-----LVY 218
+ VA+ + + + ++ +++ C +P L L+Y
Sbjct: 164 ---TWVALDVCLSYKV---QCKMDFKIFWLNL----------KNCNSPETVLEMLQKLLY 207
Query: 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 278
N + S L + + + R L + + ++ +V+ A
Sbjct: 208 QIDPNWTSRSDHSSNIK--LRIHS-IQAEL-----RRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 279 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG-TIGHIAPEYLSTGKSSEKTDVFGYGIML 337
F + L+ + VT + T HI+ ++ S + ++ L
Sbjct: 260 --NAF-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK------SL 306
Query: 338 LELITGQRAFDLARLAND--------------DDVMLLDWVKGLLKEKK-------LEML 376
L R DL R D + D K + +K L +L
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL 366
Query: 377 VDPDLQNNYVEAEV---EQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKV 433
+ + + V I LL + + + VV L L E+ + +
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 434 EVLRQEVELAPHPNSDWIVDSTENLHA 460
+ +EL ++ LH
Sbjct: 427 SIPSIYLELKVKLENE------YALHR 447
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 9e-05
Identities = 47/355 (13%), Positives = 107/355 (30%), Gaps = 103/355 (29%)
Query: 115 DVPAEEDPEVHLGQLKRFSL--RELQVATDSFSNKNILGRGGFGKVYKGRLADG------ 166
+V ++ + F+L + L + T + L + +
Sbjct: 252 NV---QNAKA----WNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 167 -SLVA------VKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219
SL+ + L E + + +I+ ++ L + ++L
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRR----LSIIAESIRDGLATWDNWKHVNCDKL---- 355
Query: 220 YMANGSVASCL--------RER-------------PPSQLPLDWPTRKR----------- 247
+ S L R+ P L L W +
Sbjct: 356 ---TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
Query: 248 ----IALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVG----DFGLAKLMDY 298
+ + + + K+ + A + + + + D L Y
Sbjct: 413 KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL--ITGQ-RAFDLARLAND 355
+H IGH +L + E+ +F ++ L+ + + R A A+
Sbjct: 473 FYSH--------IGH----HLKNIEHPERMTLFR--MVFLDFRFLEQKIRHDSTAWNASG 518
Query: 356 ---DDVMLLDWVKGLL--KEKKLEMLVD------PDLQNNYVEAEVEQLIQVALL 399
+ + L + K + + K E LV+ P ++ N + ++ L+++AL+
Sbjct: 519 SILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 7e-04
Identities = 36/193 (18%), Positives = 65/193 (33%), Gaps = 49/193 (25%)
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H H D + + +IL E +A V +F D KD +
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFE-DAFVDNF------DCKDV--------------QDMP 42
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD-VMLLDWVKGLLKEKKLEMLVD 378
+ S E+ D + + + L W +E+ ++ V+
Sbjct: 43 KSILSKEEID------------------HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE 84
Query: 379 PDLQNNYVEAEVEQLI-QVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEW--QKVEV 435
L+ NY + L+ + Q S M R + + R+ + + +++ Q
Sbjct: 85 EVLRINY-----KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139
Query: 436 LRQEV-ELAPHPN 447
LRQ + EL P N
Sbjct: 140 LRQALLELRPAKN 152
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 27/225 (12%)
Query: 141 TDSFSNKNI---------LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEV 190
+ + I LG G FG V+ + G +K + ++R+ Q + E+
Sbjct: 12 ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI 71
Query: 191 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 250
E++ H N++++ +V G L ER S +
Sbjct: 72 EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVA 127
Query: 251 GSAR----GLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV 303
+ L+Y H ++H+D+K NIL + DFGLA+L D H
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHS 183
Query: 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
T A GT ++APE + K D++ G+++ L+TG F
Sbjct: 184 TNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 16/224 (7%)
Query: 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGELQ-FQTE 189
++++++ + F ++GRG FG+V +L + + A+K L K E E F+ E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 190 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 249
+++ + + L LV Y G + + L + +LP + R +A
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEM-ARFYLA 182
Query: 250 -LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
+ A + +H +HRD+K NIL+D + DFG + T ++
Sbjct: 183 EMVIA--IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 309 GTIGHIAPEYLSTGKSSEKT-----DVFGYGIMLLELITGQRAF 347
GT +I+PE L + + D + G+ + E++ G+ F
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 20/227 (8%)
Query: 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGEL-QFQTE 189
L+E+++ D F ++GRG F +V ++ G + A+K + K + GE+ F+ E
Sbjct: 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 190 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRI 248
+++ R + +L F L LV Y G + + L + ++P + R +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFYL 168
Query: 249 A-LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 307
A + A + +H +HRD+K NILLD + DFG + T +
Sbjct: 169 AEIVMA--IDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFG-------YGIMLLELITGQRAF 347
GT +++PE L T +G G+ E+ GQ F
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 58/250 (23%), Positives = 88/250 (35%), Gaps = 47/250 (18%)
Query: 117 PAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLK 175
AE P Q + + + + F ILG G F V R A A+K L+
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 176 ---------EERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 226
E +++S H ++L + Y NG +
Sbjct: 65 KRHIIKENKVPYV-------TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 227 ASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSYLHDHCDPKIIHRDVKAANIL 278
+R+ R L YLH IIHRD+K NIL
Sbjct: 118 LKYIRKI------------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENIL 162
Query: 279 LDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYG 334
L+E+ + DFG AK L + GT +++PE L+ KSS D++ G
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS---DLWALG 219
Query: 335 IMLLELITGQ 344
++ +L+ G
Sbjct: 220 CIIYQLVAGL 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 17/223 (7%)
Query: 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRL-KEERTPGGELQ-FQTE 189
+R+L++ + + ++GRG FG+V R + A+K L K E + F E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 190 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 249
++++ A +++L +V YM G + + + +P W R A
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKW-ARFYTA 175
Query: 250 -LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
+ A L +H IHRDVK N+LLD+ + DFG M+ +
Sbjct: 176 EVVLA--LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 309 GTIGHIAPEYLSTGKSSEK----TDVFGYGIMLLELITGQRAF 347
GT +I+PE L + D + G+ L E++ G F
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 19/209 (9%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEER-------TPGGELQFQTEVEMISMAVHRNL 201
LG G FG V+ V VK +K+E+ + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
+++ LV +G L LD P I + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
IIHRD+K NI++ E+F + DFG A ++ + T GTI + APE L
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTFC-GTIEYCAPEVLM- 202
Query: 322 GKSSE--KTDVFGYGIMLLELITGQRAFD 348
G + +++ G+ L L+ + F
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 53/244 (21%), Positives = 99/244 (40%), Gaps = 47/244 (19%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEER---------TPGGELQFQ 187
V D F +G+G FGKV + D + A+K + +++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-------F 63
Query: 188 TEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRK 246
E++++ H L+ L + E + +V + G + L++
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQN------------V 110
Query: 247 RIALGSAR--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298
+ + L YL + +IIHRD+K NILLDE + DF +A ++
Sbjct: 111 HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKT---DVFGYGIMLLELITGQRAFDLARLAND 355
+ T A GT ++APE S+ K + + D + G+ EL+ G+R + + +
Sbjct: 168 ETQITTMA--GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 356 DDVM 359
+++
Sbjct: 226 KEIV 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHR 199
+ + N ++G G +G V K R G +VA+K+ E + E++++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
NL+ L C LV+ ++ + ++ L P LD+ ++ G+ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFC 140
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGHI 314
H H IIHRD+K NIL+ + + DFG A+ + T R
Sbjct: 141 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR------ 191
Query: 315 APEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
APE L + DV+ G ++ E+ G+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 3e-18
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAV 197
+ + +G G +G VYK + + G +VA+KR++ +E P ++ E+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---EISLLKELH 77
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H N++ L + LV+ +M + L E L K RG++
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVA 133
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIG 312
+ H H +I+HRD+K N+L++ + + DFGLA+ TH VT R
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR---- 186
Query: 313 HIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
AP+ L K S D++ G + E+ITG+
Sbjct: 187 --APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 49/228 (21%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMIS 194
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANG---------------SVASCLRERPPSQLP 239
+H N++ L T+ +L+ ++ G S ++ Q+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI- 124
Query: 240 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKL 295
G++YLH KI H D+K NI+L + + + DFGLA
Sbjct: 125 -------------LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
+D + GT +APE ++ + D++ G++ L++G
Sbjct: 169 --IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 49/228 (21%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMIS 194
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANG---------------SVASCLRERPPSQLP 239
+H N++ L T+ +L+ ++ G S ++ Q+
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI- 124
Query: 240 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKL 295
G++YLH KI H D+K NI+L + + + DFGLA
Sbjct: 125 -------------LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
+D + GT +APE ++ + D++ G++ L++G
Sbjct: 169 --IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 198
+ ++ +LG+G FG+V K + AVK + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-----RIALGSA 253
N+++L + +V G +L D ++ A
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGG------------EL-FDEIIKRKRFSEHDAARII 127
Query: 254 R----GLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTA 306
+ G++Y+H H I+HRD+K NILL +++ + + DFGL+ ++T +
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
+ GT +IAPE L G EK DV+ G++L L++G F
Sbjct: 184 I-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 135 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKR-LKEERTPGGELQFQTEVEMI 193
+ + +++N ++G G FG V++ +L + VA+K+ L+++R ELQ V+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK-- 90
Query: 194 SMAVHRNLLRLRGFCMTPTERL------LVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
H N++ L+ F + ++ LV Y+ +V R + + K
Sbjct: 91 ----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKL 145
Query: 248 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTA 306
R L+Y+H I HRD+K N+LLD + + DFG AK + A
Sbjct: 146 YMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK--------ILIA 194
Query: 307 VRGTIGHI------APEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
+ +I APE + + + D++ G ++ EL+ GQ
Sbjct: 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 6e-18
Identities = 48/228 (21%), Positives = 82/228 (35%), Gaps = 49/228 (21%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMIS 194
D + LG G F V K R G A K RL R + + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANG---------------SVASCLRERPPSQLP 239
H N++ L T+ +L+ ++ G L+ Q+
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----QI- 117
Query: 240 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKL 295
G+ YLH +I H D+K NI+L + + + DFG+A
Sbjct: 118 -------------LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
++ GT +APE ++ + D++ G++ L++G
Sbjct: 162 IE-AGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 57/226 (25%), Positives = 87/226 (38%), Gaps = 41/226 (18%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G G FG R LVAVK + ER + Q E+ H N++R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-RIALGSAR--------GLSYL 259
+TPT ++ Y + G + + R + AR G+SY
Sbjct: 86 LTPTHLAIIMEYASGGEL-------------YERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
H +I HRD+K N LLD + DFG +K + + V GT +IAPE
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTV-GTPAYIAPE 187
Query: 318 YLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
L + + DV+ G+ L ++ G F+ D +
Sbjct: 188 VLL-RQEYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRD 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQTEVEMISMAV 197
+++ + LG G + VYKG+ +LVA+K ++ EE P ++ EV ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLK 58
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H N++ L T LV+ Y+ + + L + ++ K RGL+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG---NIINMHNVKLFLFQLLRGLA 114
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGT 310
Y H K++HRD+K N+L++E E + DFGLA+ Y + VT R
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYR-- 167
Query: 311 IGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
P+ L S + D++G G + E+ TG+
Sbjct: 168 ----PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 40/208 (19%), Positives = 78/208 (37%), Gaps = 25/208 (12%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 198
T+ + LG+G F V + + G A + ++ + Q + E + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRKRIALGS 252
N++RL L++ + G E S + L
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-------IQQILE- 121
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 309
+ + H ++HR++K N+LL + + DFGLA ++ + G
Sbjct: 122 --AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 310 TIGHIAPEYLSTGKSSEKTDVFGYGIML 337
T G+++PE L + D++ G++L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-18
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+F +LG G F +V+ + G L A+K +K+ + + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66
Query: 200 NLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRKRIALGSA 253
N++ L + T LV ++ G E+ S + +++
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV------IQQVL---- 116
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 310
+ YLH++ I+HRD+K N+L +E + ++ DFGL+K+ ++ ++TA GT
Sbjct: 117 SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GT 170
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIML 337
G++APE L+ S+ D + G++
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 50/228 (21%), Positives = 92/228 (40%), Gaps = 30/228 (13%)
Query: 130 KRFSLRELQVATDSFSNK----NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL 184
K++ + ++V S + LG G FG V++ A G + K + P +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLDKY 93
Query: 185 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG-------SVASCLRERPPSQ 237
+ E+ +++ H L+ L E +L+ +++ G + + E
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 238 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKL 295
R A GL ++H+H I+H D+K NI+ + + + V DFGLA
Sbjct: 154 Y-------MRQACE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
Query: 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
++ D V T APE + TD++ G++ L++G
Sbjct: 201 LN-PDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 50/243 (20%), Positives = 82/243 (33%), Gaps = 38/243 (15%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK----RLKEERTPGGELQFQTEVEMISM 195
D + ++G+G F V + G AVK + E + M
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYM----------ANGSVASCLRERPPSQLPLDWPTR 245
H +++ L + +V+ +M E S
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY------M 136
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 302
++I L Y HD+ IIHRDVK +LL + +G FG+A +
Sbjct: 137 RQIL----EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362
V GT +APE + + DV+G G++L L++G F L +
Sbjct: 190 AGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY------GTKERLFE 242
Query: 363 WVK 365
+
Sbjct: 243 GII 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 49/245 (20%), Positives = 91/245 (37%), Gaps = 30/245 (12%)
Query: 117 PAEEDPEVHLGQLKRFSLRELQVATDSFSNK----NILGRGGFGKVYKGR-LADGSLVAV 171
+ K++ + +++ D + LG G FG V++ A G+ A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 172 KRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG------- 224
K + E + E++ +S+ H L+ L E +++Y +M+ G
Sbjct: 188 KFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246
Query: 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284
+ + E + R GL ++H++ +H D+K NI+ +
Sbjct: 247 DEHNKMSEDEAVEY-------MRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTKRS 293
Query: 285 AVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342
+ DFGL +D V GT APE TD++ G++ L++
Sbjct: 294 NELKLIDFGLTAHLD-PKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 343 GQRAF 347
G F
Sbjct: 352 GLSPF 356
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 31/219 (14%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMA 196
+ +G G +G V+K + +VA+KR++ +E P L+ E+ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKEL 58
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
H+N++RL + + LV+ + + + LD K +GL
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGL 114
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRG 309
+ H ++HRD+K N+L++ E + +FGLA+ + Y + VT R
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYR- 168
Query: 310 TIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 347
P+ L K S D++ G + EL R
Sbjct: 169 -----PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG G FGKV G G VAVK L ++ + + + E++ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSY 258
TPT+ +V Y++ G + + + R+ AR + Y
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKH------------GRVEEMEARRLFQQILSAVDY 126
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
H H ++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEV 181
Query: 319 LSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
+S G+ + + D++ G++L L+ G FD D+ V L
Sbjct: 182 IS-GRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHVPTL 219
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 140 ATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQTEVEMISM 195
++ F LG G + VYKG G VA+K +K EE TP ++ E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKE 59
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLP--LDWPTRKRIALGSA 253
H N++RL T + LV+ +M + + + R P L+ K
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTH--VTTA 306
+GL++ H++ KI+HRD+K N+L+++ + +GDFGLA+ + + VT
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLW 173
Query: 307 VRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
R AP+ L ++ S D++ G +L E+ITG+
Sbjct: 174 YR------APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAV 197
+ + +G G +G VYK + G A+K+++ +E P ++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELK 58
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H N+++L T +LV+ ++ + + L L+ T K L G++
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIA 114
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGT 310
Y HD +++HRD+K N+L++ E E + DFGLA+ + Y TH VT R
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR-- 167
Query: 311 IGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
AP+ L K S D++ G + E++ G
Sbjct: 168 ----APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 31/231 (13%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-H 198
TD + K +G G + + A AVK + + + E+E++ H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-----RDPTEEIEILLRYGQH 75
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGS-----VA-SCLRERPPSQLPLDWPTRKRIALGS 252
N++ L+ +V M G + ER S + +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFT---ITK 127
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVTTAVR 308
+ YLH ++HRD+K +NIL E++ + DFG AK + ++ + T
Sbjct: 128 T--VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC- 181
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
T +APE L D++ G++L ++TG F ++++
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 26/208 (12%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVH 198
+D++ K LG+G F V + G A K + ++ + Q + E + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRKRIALGS 252
N++RL + LV+ + G E S ++I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC------IQQIL--- 115
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 309
++Y H + I+HR++K N+LL + + DFGLA + D+ G
Sbjct: 116 -ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAG 169
Query: 310 TIGHIAPEYLSTGKSSEKTDVFGYGIML 337
T G+++PE L S+ D++ G++L
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 43/226 (19%)
Query: 142 DSFSNKNILGRGGFGKVYKGR--LADGSLVAVKRLKEERTPGG-------E---LQFQTE 189
+ +G G +GKV+K R G VA+KR++ + G E L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR---- 66
Query: 190 VEMISMAVHRNLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPPSQLPLDWPT 244
+ H N++RL C LV+ ++ + + + L + P +P T
Sbjct: 67 --HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT--ET 121
Query: 245 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKD 300
K + RGL +LH H +++HRD+K NIL+ + + DFGLA++ M
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 301 TH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344
T VT R APE L + D++ G + E+ +
Sbjct: 177 TSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 26/223 (11%)
Query: 126 LGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL 184
+G+ F + +D++ K LG+G F V + G A K + ++ +
Sbjct: 13 MGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF 72
Query: 185 Q-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQ 237
Q + E + H N++RL + LV+ + G E S
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 238 LPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 294
+ L ++Y H + I+HR++K N+LL + + DFGLA
Sbjct: 133 C-------IQQILE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 337
+ D+ GT G+++PE L S+ D++ G++L
Sbjct: 180 EV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 141 TDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKR-LKEERTPGGELQFQTEVEMISMAVH 198
D F + + G+G FG V G+ G VA+K+ +++ R ELQ ++ +++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78
Query: 199 RNLLRLRGFCMTPTER-------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 251
N+++L+ + T ER +V Y+ ++ C R Q+ K
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAV--- 307
R + LH + HRD+K N+L++E + DFG AK + + +V
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 308 -RGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
R APE + + + D++ G + E++ G+
Sbjct: 197 YR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 58/294 (19%), Positives = 107/294 (36%), Gaps = 35/294 (11%)
Query: 61 PPPFIPPPPISSPGGNSATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQEFFFDVPAEE 120
+ + + G + + + ++ D+PA
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPV----KSKRTSALAVDIPAPP 70
Query: 121 DPEVH-LGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER 178
P H + K+ ++ + S ILG G FG+V+K A G +A K +K
Sbjct: 71 APFDHRIVTAKQGAVNSFY----TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 179 TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG-------SVASCLR 231
E + + E+ +++ H NL++L + + +LV Y+ G + L
Sbjct: 127 MKDKE-EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 232 ERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GD 289
E + G+ ++H I+H D+K NIL + D
Sbjct: 186 ELDTILF-------MKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIID 232
Query: 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
FGLA+ + GT +APE ++ S TD++ G++ L++G
Sbjct: 233 FGLARRYK-PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 27/212 (12%)
Query: 147 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205
+N +GRG +G+V A K++ + + +F+ E+E++ H N++RL
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLY 72
Query: 206 GFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
T+ LV G RE +++ + ++ ++Y
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS-----AVAYC 122
Query: 260 HDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316
H + HRD+K N L + + DFGLA + GT +++P
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPYYVSP 177
Query: 317 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
+ L G + D + G+M+ L+ G F
Sbjct: 178 QVLE-GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 31/216 (14%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHR 199
+ + +G G +G V+K R G +VA+K+ E P + E+ M+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
NL+ L LV+ Y + +V L + K I + + +++
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFC 118
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-----RGTIGHI 314
H H IHRDVK NIL+ + + DFG A+L+ + V R
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR------ 169
Query: 315 APEYL------STGKSSEKTDVFGYGIMLLELITGQ 344
+PE L DV+ G + EL++G
Sbjct: 170 SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 141 TDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKR-LKEERTPGGELQFQTEVEMISMAVH 198
S+++ ++G G FG VY+ +L D G LVA+K+ L+++R ELQ +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 199 RNLLRLRGFCMTPTERL------LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 252
N++RLR F + E+ LV Y+ +V R ++ L K
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV---- 307
R L+Y+H I HRD+K N+LLD + + + DFG AK + + + +
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRY 221
Query: 308 -RGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
R APE + + DV+ G +L EL+ GQ
Sbjct: 222 YR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 29/213 (13%)
Query: 147 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLLRL 204
LG G F K AVK + + E Q E+ + H N+++L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71
Query: 205 RGFCMTPTERLLVYPYMANGS-----VA-SCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
LV + G E S + RK L SA +S+
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRK---LVSA--VSH 121
Query: 259 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
+HD ++HRD+K N+L ++ E + DFG A+L + + T T+ + A
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
PE L+ E D++ G++L +++GQ F
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 51/228 (22%), Positives = 82/228 (35%), Gaps = 49/228 (21%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-----RLKEERTPGGELQFQTEVEMIS 194
D + LG G F V K R + G A K R K R + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANG---------------SVASCLRERPPSQLP 239
H N++ L T+ +L+ +A G L+ Q+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-----QI- 123
Query: 240 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKL 295
G+ YLH +I H D+K NI+L + + + DFGLA
Sbjct: 124 -------------LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
+D GT +APE ++ + D++ G++ L++G
Sbjct: 168 ID-FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 45/229 (19%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQF-QT---EVEMISMA 196
+ +G+G FG+V+K R G VA+K++ E G F T E++++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 197 VHRNLLRLRGFCMTPTERL--------LVYPYMAN---GSVASCLRERPPSQLPLDWPTR 245
H N++ L C T LV+ + + G L + L
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-----LLSNVLVKFTL--SEI 126
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD----- 300
KR+ GL Y+H + KI+HRD+KAAN+L+ + + DFGLA+
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 301 --TH--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
T+ VT R PE L + D++G G ++ E+ T
Sbjct: 184 RYTNRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 48/217 (22%), Positives = 88/217 (40%), Gaps = 36/217 (16%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVK-------RLKEERTPGGELQFQTEVEM 192
D + LG G G+V VA+K + R L +TE+E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 193 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANG------SVASCLRERPPSQLPLDWPTRK 246
+ H +++++ F + +V M G L+E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQ 122
Query: 247 RIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV 303
+ + YLH++ IIHRD+K N+LL +E+ + DFG +K++ +T +
Sbjct: 123 MLL-----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 304 TTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGIML 337
+ GT ++APE L + + + D + G++L
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 68/264 (25%)
Query: 147 KNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 199
LGRG FG+V + A VAVK LKE T +E++ +I + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 200 NLLRLRGFCMTPTERLLV-YPYMANGSVASCLRERPPSQLPLDWP--------------- 243
N++ L G C P L+V + G++++ LR + +P
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 244 --------------TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---------- 279
+ + LS + + P+ +++D L+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 280 --------------------DEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEY 318
E+ + DFGLA+ + +V R + +APE
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 319 LSTGKSSEKTDVFGYGIMLLELIT 342
+ + ++DV+ +G++L E+ +
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQT--EVEMISM 195
+ + LG G F VYK R +VA+K++K G + E++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG-INRTALREIKLLQE 68
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 255
H N++ L + LV+ +M + +++ L L K L + +G
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQG 124
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294
L YLH H I+HRD+K N+LLDE + DFGLAK
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT--EVEMISMAVHRNLLRLRG 206
LG G FGKV VA+K + + ++ + E+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSY 258
TPT+ ++V Y A G + + E+ KR+ R + Y
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEK------------KRMTEDEGRRFFQQIICAIEY 123
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
H H KI+HRD+K N+LLD+ + DFGL+ +M + T+ G+ + APE
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEV 178
Query: 319 LSTGKSSE--KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
++ GK + DV+ GI+L ++ G+ FD D+ + L
Sbjct: 179 IN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNL 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 37/224 (16%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMA 196
D + LG G +G+VYK VA+KR++ EE PG ++ EV ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---EVSLLKEL 90
Query: 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
HRN++ L+ L++ Y N + + + P + K G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD----VSMRVIKSFLYQLINGV 145
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----DFGLAKLM-----DYKDTH--VT 304
++ H + +HRD+K N+LL + DFGLA+ + TH +T
Sbjct: 146 NFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIIT 200
Query: 305 TAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 347
R PE L + S D++ + E++ F
Sbjct: 201 LWYR------PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRG 206
LG G FGKV G+ G VAVK L ++ + + + E++ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 207 FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR--------GLSY 258
TP++ +V Y++ G + + + R+ +R G+ Y
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKN------------GRLDEKESRRLFQQILSGVDY 131
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
H H ++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE
Sbjct: 132 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEV 186
Query: 319 LSTGKSSE--KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361
+S G+ + D++ G++L L+ G FD DD V L
Sbjct: 187 IS-GRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHVPTL 224
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 52/222 (23%), Positives = 80/222 (36%), Gaps = 46/222 (20%)
Query: 140 ATDSFS---------NKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTE 189
+TDSFS +++LG G +V L AVK ++++ + E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFRE 60
Query: 190 VE-MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS------CLRERPPSQLPLDW 242
VE + HRN+L L F LV+ M GS+ S E S +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---- 116
Query: 243 PTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYK 299
+ + SA L +LH+ I HRD+K NIL ++ + DF L +
Sbjct: 117 -VQD---VASA--LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 300 DTHV-------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 334
T G+ ++APE + Y
Sbjct: 168 GDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEAS----IYD 204
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 29/208 (13%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVE-MISMAVHRNLLRLRG 206
LGRG F V + + G A K L K R + E+ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 207 FCMTPTERLLVYPYMANG--------SVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
+E +L+ Y A G +A + E +L + L G+ Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-------IKQILE---GVYY 146
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
LH + I+H D+K NILL + + DFG+++ + + + GT ++A
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM-GTPEYLA 201
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITG 343
PE L+ + TD++ GI+ L+T
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 150 LGRGGFGKVYKGR---LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+GRG +G VYK + D A+K+++ + E+ ++ H N++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---EIALLRELKHPNVISLQK 85
Query: 207 FCMTPTERL--LVYPYMAN------GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
++ +R L++ Y + + + P QLP K + G+ Y
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR--GMVKSLLYQILDGIHY 143
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDY---KDTHVTTAVRGTI 311
LH + ++HRD+K ANIL+ E + D G A+L + + V T
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 312 GHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQ 344
+ APE L + ++ D++ G + EL+T +
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 41/226 (18%), Positives = 84/226 (37%), Gaps = 45/226 (19%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
+ + LGRG FG V++ + K +K ++ + E+ ++++A HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 200 NLLRLRGFCMTPTERLLVYPYMANG----------------SVASCLRERPPSQLPLDWP 243
N+L L + E ++++ +++ + S + Q+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QV----- 111
Query: 244 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDT 301
L +LH H I H D++ NI+ + + +FG A+ +
Sbjct: 112 ---------CEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGD 158
Query: 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
+ + APE S TD++ G ++ L++G F
Sbjct: 159 NFRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 56/241 (23%), Positives = 90/241 (37%), Gaps = 56/241 (23%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLK---------EERTPGGELQFQTEVE 191
D F LG G FG+V + + G+ A+K L E T E
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-------LNEKR 93
Query: 192 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 251
++ L++L + +V Y+A G + S LR R +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI------------GRFSEP 141
Query: 252 SAR--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303
AR YLH +I+RD+K N+L+D++ V DFG AK +
Sbjct: 142 HARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGR 194
Query: 304 TTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
T + GT +APE + + K+ D + G+++ E+ G F D +
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPFF------ADQPIQ 245
Query: 361 L 361
+
Sbjct: 246 I 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 44/240 (18%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMA 196
++ F+ +LG+G FGKV L AVK LK++ + +VE
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD-----VVIQDDDVE--CTM 389
Query: 197 VHRNLLRLRG---------FCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTR 245
V + +L L G C +RL V Y+ G + + + +
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEP---H 443
Query: 246 KR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 299
IA+G L +L II+RD+K N++LD E + DFG+ K +
Sbjct: 444 AVFYAAEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496
Query: 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
T T GT +IAPE ++ + D + +G++L E++ GQ F+ D+D +
Sbjct: 497 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 550
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 47/236 (19%), Positives = 86/236 (36%), Gaps = 46/236 (19%)
Query: 125 HLGQLKRFSLRELQVATDSFSN-----KNILGRGGFGKVYKGR-LADGSLVAVKRL-KEE 177
H + + + ++ K +LG G GKV + G A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP 66
Query: 178 RTPGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGS------- 225
+ + EV+ + +++ + L++ M G
Sbjct: 67 K-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE 119
Query: 226 -VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DE 281
ER +++ R +G+A + +LH H I HRDVK N+L ++
Sbjct: 120 RGDQAFTEREAAEI-----MRD---IGTA--IQFLHSH---NIAHRDVKPENLLYTSKEK 166
Query: 282 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 337
+ + DFG AK + T T ++APE L K + D++ G+++
Sbjct: 167 DAVLKLTDFGFAKETT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 36/256 (14%)
Query: 115 DVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKR 173
D E+ EV L + K +V + F +LG+G FGKV + G A+K
Sbjct: 127 DNSGAEEMEVSLAKPKH------RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180
Query: 174 LKEERTPGGELQFQTEVE--MISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL 230
LK+E + T E ++ + H L L+ + +RL V Y G + L
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL 239
Query: 231 -RERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284
RER D R R I L YLH + +++RD+K N++LD++
Sbjct: 240 SRER---VFSED---RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLENLMLDKDGH 287
Query: 285 AVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG 343
+ DFGL K + T GT ++APE L D +G G+++ E++ G
Sbjct: 288 IKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 344 QRAFDLARLANDDDVM 359
+ F D + +
Sbjct: 346 RLPFY----NQDHEKL 357
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 22/61 (36%), Positives = 31/61 (50%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPGSPPFSP 60
+++ ++ L +DLSNN LSG +P+ G F F P F NN LCG R P +
Sbjct: 698 QAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYA 757
Query: 61 P 61
Sbjct: 758 H 758
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 19/49 (38%), Positives = 28/49 (57%), Gaps = 5/49 (10%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPD---NGSFSLFTPISFANNLDLCGPV 47
+L + L+VLDLS N SG +P+ N S SL T + ++N GP+
Sbjct: 338 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT-LDLSSNN-FSGPI 384
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 8e-05
Identities = 16/40 (40%), Positives = 21/40 (52%), Gaps = 1/40 (2%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40
+L+N S L L LS N LSG +P + GS S + N
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 13/47 (27%), Positives = 19/47 (40%), Gaps = 2/47 (4%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCGPV 47
SL ++S L+ L L N L G +P + N L G +
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND-LTGEI 482
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 11/24 (45%), Positives = 17/24 (70%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPD 25
L+N ++L + LSNNRL+G +P
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPK 508
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 10/41 (24%), Positives = 17/41 (41%), Gaps = 2/41 (4%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDN--GSFSLFTPISFANN 40
+ S L+ L LS+N SG +P + + + N
Sbjct: 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 9e-04
Identities = 9/23 (39%), Positives = 13/23 (56%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVP 24
L + SL LDL+ N +G +P
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIP 555
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 42/214 (19%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAV----KRLKEERTPGGELQFQTEVEMISM 195
+D F ++ LGRG VY+ + A+ K + ++ +TE+ ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-------VRTEIGVLLR 104
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-----RIAL 250
H N+++L+ TPTE LV + G + D K R A
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAA 151
Query: 251 GSAR----GLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV 303
+ + ++YLH++ I+HRD+K N+L + + DFGL+K+++++
Sbjct: 152 DAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIML 337
T GT G+ APE L + D++ GI+
Sbjct: 209 TVC--GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 69/265 (26%), Positives = 104/265 (39%), Gaps = 32/265 (12%)
Query: 107 RKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRL-AD 165
+PQE P Q+ F ++G+G FGKV R A+
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 166 GSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERL-LVYPYM 221
AVK L+++ + + E ++ H L+ L F ++L V Y+
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYI 121
Query: 222 ANGSVASCL-RERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAA 275
G + L RER R R IA L YLH I++RD+K
Sbjct: 122 NGGELFYHLQRER---CFLEP---RARFYAAEIASA----LGYLHSL---NIVYRDLKPE 168
Query: 276 NILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 334
NILLD + V+ DFGL K +++ T T+ GT ++APE L D + G
Sbjct: 169 NILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 335 IMLLELITGQRAFDLARLANDDDVM 359
+L E++ G F + + M
Sbjct: 227 AVLYEMLYGLPPFY----SRNTAEM 247
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 40/275 (14%)
Query: 107 RKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKN------------ILGRGG 154
+D+P E+ + + T + ++GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 155 FGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVE---MISMAVHRNLLRLRGFCMT 210
+ KV RL + A++ +K+E E + E + H L+ L C
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQ 123
Query: 211 PTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHC 263
RL V Y+ G + + R+R +LP + R I+L L+YLH+
Sbjct: 124 TESRLFFVIEYVNGGDLMFHMQRQR---KLPEE---HARFYSAEISLA----LNYLHER- 172
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 322
II+RD+K N+LLD E + D+G+ K + DT T+ GT +IAPE L
Sbjct: 173 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGE 228
Query: 323 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 357
D + G+++ E++ G+ FD+ +++ D
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 67/245 (27%), Positives = 99/245 (40%), Gaps = 56/245 (22%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLK---------EERTPGGELQFQ 187
+ + F LG G FG+V+ R G A+K LK E T
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-------N 54
Query: 188 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKR 247
E M+S+ H ++R+ G + ++ Y+ G + S LR+ +R
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS------------QR 102
Query: 248 IALGSAR--------GLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299
A+ L YLH II+RD+K NILLD+ + DFG AK
Sbjct: 103 FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----Y 155
Query: 300 DTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 356
VT + GT +IAPE +ST KS D + +GI++ E++ G F D
Sbjct: 156 VPDVTYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFY------DS 206
Query: 357 DVMLL 361
+ M
Sbjct: 207 NTMKT 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 45/240 (18%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKE---------ERTPGGELQFQ 187
+V + F +LG+G FGKV R A G A+K L++ T
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-------V 53
Query: 188 TEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTR 245
TE ++ H L L+ + +RL V Y G + L RER + R
Sbjct: 54 TESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEE---R 106
Query: 246 KR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 299
R I L YLH +++RD+K N++LD++ + DFGL K +
Sbjct: 107 ARFYGAEIVSA----LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
T GT ++APE L D +G G+++ E++ G+ F D + +
Sbjct: 160 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDHERL 213
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 32/234 (13%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVE-MISM 195
++ + F +LG+G FGKV+ A+K LK++ + T VE +
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 196 AVHRN--LLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKR---- 247
+ L + E L V Y+ G + + + L R
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLS---RATFYAA 125
Query: 248 -IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTT 305
I LG L +LH I++RD+K NILLD++ + DFG+ K M T
Sbjct: 126 EIILG----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TN 176
Query: 306 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
GT +IAPE L K + D + +G++L E++ GQ F D++ +
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEEL 226
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 44/240 (18%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMA 196
++ F+ +LG+G FGKV L AVK LK++ + +VE
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD-----VVIQDDDVE--CTM 68
Query: 197 VHRNLLRLRG---------FCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTR 245
V + +L L G C +RL V Y+ G + + + +
Sbjct: 69 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEP---H 122
Query: 246 KR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 299
IA+G L +L II+RD+K N++LD E + DFG+ K +
Sbjct: 123 AVFYAAEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175
Query: 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
T T GT +IAPE ++ + D + +G++L E++ GQ F+ D+D +
Sbjct: 176 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 28/232 (12%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVE---MI 193
+ F ++GRG + KV RL + A+K +K+E E + E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 194 SMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTRKR---- 247
+ H L+ L C RL V Y+ G + + R+R +LP + R
Sbjct: 65 QASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEE---HARFYSA 117
Query: 248 -IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTT 305
I+L L+YLH+ II+RD+K N+LLD E + D+G+ K + DT T+
Sbjct: 118 EISLA----LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TS 168
Query: 306 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 357
GT +IAPE L D + G+++ E++ G+ FD+ +++ D
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 64/262 (24%), Positives = 107/262 (40%), Gaps = 31/262 (11%)
Query: 115 DVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVY---KGRLAD-GSLVA 170
D + H + + +V ++F +LG G +GKV+ K D G L A
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 171 VKRLKEER-TPGGELQFQTEVE-MISMAVHRN--LLRLRGFCMTPTERL-LVYPYMANGS 225
+K LK+ + T E + + ++ L+ L + +L L+ Y+ G
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGE 145
Query: 226 VASCL-RERPPSQLPLDWPTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILL 279
+ + L + + + I L L +LH II+RD+K NILL
Sbjct: 146 LFTHLSQRE---RFTEH---EVQIYVGEIVLA----LEHLHKL---GIIYRDIKLENILL 192
Query: 280 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV--FGYGIML 337
D V+ DFGL+K +T GTI ++AP+ + G S V + G+++
Sbjct: 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252
Query: 338 LELITGQRAFDLARLANDDDVM 359
EL+TG F + N +
Sbjct: 253 YELLTGASPFTVDGEKNSQAEI 274
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 58/242 (23%), Positives = 104/242 (42%), Gaps = 47/242 (19%)
Query: 138 QVATDSFSNKNILGRGGFGKVY----KGRLADGSLVAVKRLK--------EERTPGGELQ 185
+ F +LG+G FGKV+ L A+K LK RT
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT------ 73
Query: 186 FQTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWP 243
+ E +++ H +++L + +L L+ ++ G + + L +E +
Sbjct: 74 -KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEE-- 126
Query: 244 TRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MD 297
+ +AL L +LH II+RD+K NILLDEE + DFGL+K +D
Sbjct: 127 -DVKFYLAELALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178
Query: 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 357
++ + GT+ ++APE ++ ++ D + +G+++ E++TG F D
Sbjct: 179 HEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ----GKDRK 232
Query: 358 VM 359
Sbjct: 233 ET 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMA 196
++ D+F +LG+G FGKV R+ + G L AVK LK++ + +VE
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD-----VILQDDDVE--CTM 71
Query: 197 VHRNLLRLRG---------FCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDWPTR 245
+ +L L C +RL V ++ G + + + R + R
Sbjct: 72 TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEA---R 125
Query: 246 KR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 299
R I L +LHD II+RD+K N+LLD E + DFG+ K +
Sbjct: 126 ARFYAAEIISA----LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178
Query: 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGIMLLELITGQRAFDLARLANDDDV 358
T T GT +IAPE L D + G++L E++ G F+ A ++D
Sbjct: 179 VT--TATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFE----AENEDD 231
Query: 359 M 359
+
Sbjct: 232 L 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 7e-14
Identities = 33/223 (14%), Positives = 58/223 (26%), Gaps = 45/223 (20%)
Query: 127 GQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVK--RLKEERTPGGEL 184
Q + T+ +G G FG+V++ AD + VA+K ++ G
Sbjct: 6 SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63
Query: 185 Q-----FQTEVEM---------ISMAVHRNLLRLRGFCM----TPTERLLVYPYMA--NG 224
Q E+ + + L P L + + G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 225 SVASCLRERPPSQLPL-------------------DWPTRKRIALGSARGLSYLHDHCDP 265
S QL + T K I L+
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 266 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
+ HRD+ N+LL + + K + ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 54/255 (21%), Positives = 91/255 (35%), Gaps = 45/255 (17%)
Query: 106 RRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSN-----KNILGRGGFGKVYK 160
+ P PA+ P + LQ+ ++ + +LG G GKV +
Sbjct: 21 PQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQ 80
Query: 161 GR-LADGSLVAVKRL-KEERTPGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER--- 214
A+K L + + EVE + +++R+
Sbjct: 81 IFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 215 -LLVYPYMANGS--------VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDP 265
L+V + G ER S++ + +G A + YLH
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKS---IGEA--IQYLHSI--- 180
Query: 266 KIIHRDVKAANILL-DEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
I HRDVK N+L + A++ DFG AK +TT T ++APE L
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC-YTPYYVAPEVLGPE 238
Query: 323 KSSEKTDVFGYGIML 337
K + D++ G+++
Sbjct: 239 KYDKSCDMWSLGVIM 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 56/243 (23%), Positives = 97/243 (39%), Gaps = 47/243 (19%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMI 193
++ + F +LG+GG+GKV++ R G + A+K LK+ ++ +
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI----VRNAKDTA-- 66
Query: 194 SMAVHRNLL---------RLRGFCMTPTERL-LVYPYMANGSVASCL-RERPPSQLPLDW 242
RN+L L + +L L+ Y++ G + L RE D
Sbjct: 67 HTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREG---IFMED- 121
Query: 243 PTRKR-----IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-M 296
I++ L +LH II+RD+K NI+L+ + + DFGL K +
Sbjct: 122 --TACFYLAEISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172
Query: 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 356
T GTI ++APE L + D + G ++ +++TG F +
Sbjct: 173 HDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT----GENR 226
Query: 357 DVM 359
Sbjct: 227 KKT 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 8e-13
Identities = 17/44 (38%), Positives = 24/44 (54%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 45
LT + L L++S N L G +P G+ F ++ANN LCG
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 15/41 (36%), Positives = 27/41 (65%), Gaps = 2/41 (4%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSF-SLFTPISFANN 40
S++++ +L + NR+SG +PD+ GSF LFT ++ + N
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 2e-04
Identities = 8/40 (20%), Positives = 19/40 (47%), Gaps = 1/40 (2%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40
++ ++ L L +++ +SG +PD + F+ N
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 15/40 (37%), Positives = 20/40 (50%), Gaps = 1/40 (2%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40
L+ I +L LD S N LSG +P + S I+F N
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 43/256 (16%), Positives = 90/256 (35%), Gaps = 60/256 (23%)
Query: 137 LQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQT-EVEMIS 194
L+ ++ +S LG G FG V + + G A+K++ ++ +++ E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTR--------- 245
+ H N+++L + T + P + + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 246 ---------KRIALGSA-------------------RGLSYLHDHCDPKIIHRDVKAANI 277
++ R + ++H I HRD+K N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 278 LLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV----RGTIGHIAPEYLSTGKS-SEKTDVF 331
L++ + + + DFG AK + + V R APE + + D++
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLW 226
Query: 332 GYGIMLLELITGQRAF 347
G + ELI G+ F
Sbjct: 227 SIGCVFGELILGKPLF 242
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 29/276 (10%), Positives = 74/276 (26%), Gaps = 59/276 (21%)
Query: 150 LGRGGFGKVYKGRLADGSL---VAVKRLKEE--RTPGGELQFQTEVEMISMAVHRNLLRL 204
G + ++ D +L VA+ + + + + +S + R+
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 205 RGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK-RIALGSARGLSYLHDHC 263
T L+V ++ GS+ P P R A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPS-------PVGAIRAMQSLAAAADAAHRA- 148
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 323
+ + + + + + V+ +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD-- 178
Query: 324 SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383
++ + D+ G G L L+ + L + ++P +
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLP----EAGVRSGLAPAERDT-----AGQPIEPADID 229
Query: 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ ++ + ++ QG R S ++ +++
Sbjct: 230 RDIPFQISAVAARSV---QGDGGIRSA-STLLNLMQ 261
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 46/224 (20%), Positives = 89/224 (39%), Gaps = 27/224 (12%)
Query: 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQT---------EV 190
++ + + G +G V G ++G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 191 EMISMAVHRNLLRLRGFCMTPTERL------LVYPYMANGSVASCLRERPPSQLPLDWPT 244
+++ H N+L LR E LV M +A + ++ ++ +
Sbjct: 81 RLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ---RIVISPQH 135
Query: 245 RKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 304
+ GL LH+ ++HRD+ NILL + + + DF LA+ D + T
Sbjct: 136 IQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKT 191
Query: 305 TAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 347
V + APE + ++ D++ G ++ E+ + F
Sbjct: 192 HYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 190
+ N +G G G V VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 191 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 243
++ H+N++ L TP + L +V M + ++ ++ LD
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELM-DANLCQVIQM------ELDHE 127
Query: 244 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 182
Query: 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
T T + APE + E D++ G ++ E+I G F
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 47/234 (20%), Positives = 90/234 (38%), Gaps = 57/234 (24%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM-----------A 196
LG G F V+ + + + + VA+K ++ ++ + E++++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 197 VHRNLLRLRGF-----------CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTR 245
++L+L M E L ++ + +++ +PL
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMV-FEVL-------GENLLALIKKYEHRGIPL--IYV 133
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLAKLMDYK 299
K+I+ GL Y+H C IIH D+K N+L++ + + D G A +
Sbjct: 134 KQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWY 188
Query: 300 DTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
D H T ++ R +PE L D++ ++ ELITG F+
Sbjct: 189 DEHYTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 45/227 (19%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 190
++ + +G G +G V G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 191 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 243
++ H N++ L TP L LV P+M + +
Sbjct: 75 LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL------KFSEE 126
Query: 244 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 302
+ + +GL Y+H ++HRD+K N+ ++E+ E + DFGLA+ D + T
Sbjct: 127 KIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183
Query: 303 -VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
VT R APE LS ++ D++ G ++ E++TG+ F
Sbjct: 184 VVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 37/165 (22%), Positives = 58/165 (35%), Gaps = 36/165 (21%)
Query: 147 KNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLLRL 204
+LG G GKV + A+K L++ + + EVE + +++R+
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRI 76
Query: 205 RGFCMTPTER----LLVYPYMANG--------SVASCLRERPPSQLPLDWPTRKRIALGS 252
L+V + G ER S++ + +G
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKS---IGE 128
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 294
A + YLH I HRDVK N+L + DFG AK
Sbjct: 129 A--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 40/225 (17%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 190
+ N +G G G V VA+K+L FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 191 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 243
++ H+N++ L TP + L LV M + L + +L
Sbjct: 113 VLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQMEL---DH 163
Query: 244 TRKRIALGSA-RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302
R L G+ +LH IIHRD+K +NI++ + + DFGLA+ +
Sbjct: 164 ERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSF 218
Query: 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
+ T T + APE + E D++ G ++ E++ + F
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 45/223 (20%), Positives = 85/223 (38%), Gaps = 42/223 (18%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK---EERTPGGELQFQTEVE-MISM 195
D + LGRG + +V++ + + V VK LK +++ + E++ + ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-------KREIKILENL 87
Query: 196 AVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCLRERPPS-------QLPLDWPTRK 246
N++ L P R LV+ ++ N + ++
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI-------- 139
Query: 247 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTT 305
+ L Y H I+HRDVK N+++D E + + D+GLA+ +
Sbjct: 140 ------LKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NV 189
Query: 306 AVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAF 347
V + PE L + D++ G ML +I + F
Sbjct: 190 RV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 44/227 (19%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 190
+ + +G G +G V G+ VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 191 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 243
++ H N++ L TP E L LV P+M + L + + L
Sbjct: 76 RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHE-KLGED 128
Query: 244 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 302
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 303 -VTTAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 347
VT R APE L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 186 VVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 38/195 (19%), Positives = 64/195 (32%), Gaps = 35/195 (17%)
Query: 150 LGRGGFGKVYKG-RLADGSLVAVKRLKEERTPGGELQFQTEVEMI-------------SM 195
+G GGFG +Y A +K E G L + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 196 AVHRNLLRLRGFCMTPTE----RLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIAL 250
+ + G +T + R +V + G + + T ++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG--TFKKS--TVLQLGI 158
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--THVTTA 306
L Y+H++ +H D+KAAN+LL + V D+GL+ Y H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR--YCPNGNHKQYQ 213
Query: 307 VRGTIGHI-APEYLS 320
GH E+ S
Sbjct: 214 ENPRKGHNGTIEFTS 228
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 190
+ + N + +G G +G V G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 191 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPYMANGSVASCLRERPPSQLPLDWP 243
++ H N++ L TP L LV M + + ++ Q L
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-GADLNNIVK----CQ-KLTDD 132
Query: 244 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-- 301
+ + RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ + T
Sbjct: 133 HVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 302 HVTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
T R APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 190 VATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 18/103 (17%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTT 305
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D H T
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 306 AVRGTIGHIAPEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 347
R APE L++ ++ D++ G +L E+++ + F
Sbjct: 196 WYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 34/212 (16%), Positives = 72/212 (33%), Gaps = 51/212 (24%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQT---------EV 190
D + ++++G G +G V + + +VA+K++ F+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103
Query: 191 EMISMAVHRNLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPPSQLPLDWPTR 245
+++ H +++++ + +V R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFR 148
Query: 246 KRIALGSA----------RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295
+ L G+ Y+H I+HRD+K AN L++++ V DFGLA+
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 327
+DY + + + K
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 19/104 (18%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTH--------VT 304
RGL Y+H ++HRD+K AN+ ++ E +GDFGLA++MD +H VT
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 305 TAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
R +P LS ++ D++ G + E++TG+ F
Sbjct: 188 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
R + LH +IHRD+K +N+L++ + V DFGLA+++D + + G
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-ESAADNSEPTGQQSG 178
Query: 314 I----------APEY-LSTGKSSEKTDVFGYGIMLLELITGQRAF 347
+ APE L++ K S DV+ G +L EL + F
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 39/197 (19%), Positives = 67/197 (34%), Gaps = 37/197 (18%)
Query: 134 LRELQVATDSFSNK----NILGRGGFGKVYKGR---------LADGSLVAVKRLKEERTP 180
L V TD + + R G +Y+ ++K ++
Sbjct: 30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL 89
Query: 181 GGELQF-QTEVEMISMAVHRNLLRLRGFCMTPT----------ERLLVYPYMANG-SVAS 228
E F Q + + + + L + PT R LV P + G S+ S
Sbjct: 90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAI-PTCMGFGVHQDKYRFLVLPSL--GRSLQS 146
Query: 229 CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV- 287
L P L + ++A L +LH++ +H +V A NI +D E ++ V
Sbjct: 147 ALDVSPKHVLSE--RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT 201
Query: 288 -GDFGLAKLMDYKDTHV 303
+G A Y +
Sbjct: 202 LAGYGFAFR--YCPSGK 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 45/220 (20%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR------NL 201
++G+G FG+V K VA+K ++ E Q E+ ++ + N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 202 LRL------RG-FCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
+ + R CMT E L + ++ +++ L P ++ A +
Sbjct: 162 IHMLENFTFRNHICMT-FELL-------SMNLYELIKKNKFQGFSL--PLVRKFAHSILQ 211
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAV----- 307
L LH + +IIH D+K NILL ++ + V DFG + Y+ V T +
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQSRFY 265
Query: 308 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
R APE + + D++ G +L EL+TG
Sbjct: 266 R------APEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 25/115 (21%), Positives = 48/115 (41%), Gaps = 25/115 (21%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
G +++H+ IIHRD+K AN LL+++ V DFGLA+ ++ +
Sbjct: 140 LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 314 I---------------------APEYLSTGKS-SEKTDVFGYGIMLLELITGQRA 346
APE + ++ ++ D++ G + EL+ ++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 41/194 (21%), Positives = 71/194 (36%), Gaps = 37/194 (19%)
Query: 138 QVATDSFSNK----NILGRGGFGKVYKGRLADGSLVAVKR---LKEERTPGGELQFQTEV 190
++ TD + +G+GGFG +Y + V +K E + G L + +
Sbjct: 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKF 86
Query: 191 -------EMISMAVHRNLLRLRGFC----------MTPTERLLVYPYMANGSVASCLRER 233
E I + L+ G + R ++ GS + E
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEA 144
Query: 234 PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFG 291
+ T +++L L Y+H+H +H D+KA+N+LL+ + V D+G
Sbjct: 145 NAKRFSR--KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 292 LAKLMDYKD--THV 303
LA Y H
Sbjct: 200 LAY--RYCPEGVHK 211
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
+ + YLH ++HRD+K +NILL+ E V DFGL++ +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 314 I--------------------APEY-LSTGKSSEKTDVFGYGIMLLELITGQ 344
APE L + K ++ D++ G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 38/184 (20%), Positives = 58/184 (31%), Gaps = 62/184 (33%)
Query: 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAA 275
+V+ + + + + + LPL P K+I +GL YLH C +IIH D+K
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPL--PCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPE 176
Query: 276 NILL-------------------------------------------------DEEFEAV 286
NILL E+ +
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 287 VGDFGLAKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ 344
+ D G A + T T R + E L + D++ M EL TG
Sbjct: 237 IADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATGD 290
Query: 345 RAFD 348
F+
Sbjct: 291 YLFE 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 47/223 (21%)
Query: 148 NILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM------AVHRN 200
+++G+G FG+V K + VA+K +K Q Q EV ++ + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 201 LLRLRGF-------CMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALG 251
++ L+ C+ E L + L + R + + ++ A
Sbjct: 118 IVHLKRHFMFRNHLCLV-FEML-----------SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAV-- 307
L +L + IIH D+K NILL + + DFG + + +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQYIQS 221
Query: 308 ---RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
R +PE L D++ G +L+E+ TG+ F
Sbjct: 222 RFYR------SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 32/158 (20%), Positives = 57/158 (36%), Gaps = 19/158 (12%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRGF 207
+G G FG +++G L + VA+K E Q + E + + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+LV + G L + + + T A + +H+ +
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIHEKS---L 127
Query: 268 IHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKD 300
++RD+K N L+ V DFG+ K Y+D
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRD 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 40/175 (22%), Positives = 60/175 (34%), Gaps = 20/175 (11%)
Query: 133 SLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE 191
S+ L V +F +G G FG++ G+ L VA+K E Q E
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYR 56
Query: 192 MISMAVH-RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 250
+ ++ F +V + G L + L T IA+
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL--KTVLMIAI 112
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----DFGLAKLMDYKD 300
+ Y+H +I+RDVK N L+ DF LAK +Y D
Sbjct: 113 QLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--EYID 162
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 40/156 (25%), Positives = 59/156 (37%), Gaps = 17/156 (10%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRGF 207
+G G FG +Y G +A G VA+K E Q E ++ M + +R
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
++V + G L + L T +A + Y+H
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---F 126
Query: 268 IHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 300
IHRDVK N L+ + + DFGLAK Y+D
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRD 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 38/158 (24%), Positives = 62/158 (39%), Gaps = 17/158 (10%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS-MAVHRNLLRLRGF 207
+G G FG++Y G + VA+K E Q E ++ + + +R F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267
+ +LV + G L +L L T +A + ++H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKS---F 124
Query: 268 IHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 302
+HRD+K N L+ + + DFGLAK Y+DT
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTS 160
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 43/244 (17%), Positives = 78/244 (31%), Gaps = 77/244 (31%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM-----AVHRNLL 202
+G G FG+V + + + AVK ++ + E +++ + N++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR--NIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 203 RLRGF-------CMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALGSA 253
+ G C+ E L L E + K +
Sbjct: 100 KYHGKFMYYDHMCLI-FEPL-----------GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-----------------KLM 296
+ L+YL + H D+K NILLD+ + KL+
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 297 D-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSEKTDVFGYGIMLLEL 340
D +K + + + R APE + +D++ +G +L EL
Sbjct: 205 DFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DVSSDMWSFGCVLAEL 252
Query: 341 ITGQ 344
TG
Sbjct: 253 YTGS 256
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 4/40 (10%), Positives = 13/40 (32%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 41
L + +Q+++++ NR + +
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 10/43 (23%), Positives = 13/43 (30%)
Query: 1 MSLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDL 43
T + L +DLS N S + S N D
Sbjct: 507 FRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDA 549
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 43/237 (18%), Positives = 76/237 (32%), Gaps = 61/237 (25%)
Query: 149 ILGRGGFGKVYKG--RLADGSLVAVKRLKEERTPGGELQFQTEVEMISM------AVHRN 200
LG G FGKV + S VA+K ++ + E+ ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR--NVGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 201 LLRLRGF-------CMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALG 251
+ + + C+ E L E + + P P + +A
Sbjct: 84 CVLMSDWFNFHGHMCIA-FELL-----------GKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-----------KLMD--- 297
L +LH++ ++ H D+K NIL + + + ++ D
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 298 --YKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
+ H TT V R PE + ++ DV+ G +L E G F
Sbjct: 189 ATFDHEHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 467 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.3 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.16 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.11 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.0 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.51 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 95.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.66 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.24 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 93.73 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.73 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.6 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 93.27 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 93.0 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 92.99 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 92.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.69 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 91.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 91.52 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 91.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 90.88 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 89.99 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 89.89 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 89.88 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 89.53 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 89.52 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 88.9 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 88.65 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 88.52 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 88.01 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 87.91 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 87.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 87.55 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 87.11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 87.0 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 86.4 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 85.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 85.28 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 85.06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 84.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 84.67 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 84.67 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 84.07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 84.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 83.82 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 83.78 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 83.61 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 83.52 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 83.17 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 83.07 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 82.83 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 82.75 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 82.63 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 82.57 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 82.48 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 82.47 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.76 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 81.56 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 81.42 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 81.29 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 81.04 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 80.68 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 80.26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 80.19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 80.09 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-58 Score=434.92 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=210.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
+++++.+.||+|+||+||+|++. +++.||||+++........++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556678999999999999863 467899999986655556678999999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC
Q 012267 216 LVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 283 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~ 283 (467)
+|||||++|+|.++|...... ...++|..++.|+.|||+||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 999999999999999764321 23589999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCC-CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHH
Q 012267 284 EAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 284 ~~kl~Dfgl~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 361 (467)
.+||+|||+++.+...+ ........||+.|||||++.+..++.++|||||||+||||+| |+.||.... ..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--------~~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQ 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------HH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------HH
Confidence 99999999998764332 223345679999999999999999999999999999999999 899995321 12
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 362 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+.+.......... .+..+...+.+++.+||+.||++||||.||++.|+.
T Consensus 255 ~~~~~i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 255 DVVEMIRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 2222222211110 112234668899999999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=431.53 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=209.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|.+.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 56777889999999999999864 4778999999754 3445568999999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 216 LVYPYMANGSVASCLRERP---------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
+|||||++|+|.++|+... .....++|..++.|+.|||+||+|||++ +|+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999998642 2234599999999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHH
Q 012267 287 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 364 (467)
|+|||+++......... .....||+.|||||++.+..++.++|||||||+||||+| |+.||.... ..+.+
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~ 240 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVI 240 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999998765433322 233458999999999999999999999999999999999 999996421 12222
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.......... . +..+...+.+++.+||+.||++||||+||++.|++
T Consensus 241 ~~i~~~~~~~------~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 241 ECITQGRVLQ------R----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHHHTCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCCCC------C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222211111 1 11233678899999999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-57 Score=432.38 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=203.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|.+.++||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45666789999999999999864 4789999999753 3445568999999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 216 LVYPYMANGSVASCLRERPPS-----------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
||||||++|+|.++++..... ..+++|.+++.|+.|||+||+|||++ +|+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 999999999999999865321 23599999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHH
Q 012267 285 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 362 (467)
+||+|||+++.+..... .......||+.|||||++.+..++.++|||||||+||||+| |+.||.... ..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTE 268 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 99999999987643332 23344679999999999999999999999999999999999 999996321 122
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 363 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.+......... .. +..+...+.+++.+||+.||++||||.||++.|+.
T Consensus 269 ~~~~i~~g~~~------~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 269 AIDCITQGREL------ER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHHHHHTCCC------CC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHcCCCC------CC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 22222221111 11 11223668899999999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-57 Score=426.81 Aligned_cols=261 Identities=27% Similarity=0.439 Sum_probs=203.5
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++..+++.+.+.||+|+||+||+|++.+ .||||+++.... ....+.|.+|++++++++|||||+++|+|.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3445678888999999999999999753 599999975433 3345679999999999999999999999865 56899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|||||++|+|.++|+.... +++|..++.|+.|||+||+|||++ +||||||||+||||++++.+||+|||+++..
T Consensus 109 VmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999986432 499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CeeeecccccccccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 297 DYKD-THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 297 ~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
.... ........||+.|||||++.+ ..++.++|||||||+||||+||+.||.... . ...+.......
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~---~~~~~~~~~~~- 253 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----N---RDQIIFMVGRG- 253 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----C---HHHHHHHHHTT-
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----h---HHHHHHHHhcC-
Confidence 5322 233455679999999999863 468999999999999999999999995321 1 11111122111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...|.+. .....+...+.+++.+||+.||++||||.||++.|+.
T Consensus 254 ---~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 254 ---YASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp ---CCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred ---CCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112111 1122334678899999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=424.49 Aligned_cols=322 Identities=93% Similarity=1.410 Sum_probs=274.3
Q ss_pred CCCCCCCcccccCcccccCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHH
Q 012267 115 DVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMIS 194 (467)
Q Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~ 194 (467)
+.+.++++....+..+.+++.+++...++|+..+.||+|+||+||+|+..+|+.||||++...........+.+|++++.
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~ 82 (326)
T 3uim_A 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82 (326)
T ss_dssp ------------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGG
T ss_pred CCCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHH
Confidence 44556677777888899999999999999999999999999999999988899999999976554444446899999999
Q ss_pred hcCCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCC
Q 012267 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKA 274 (467)
Q Consensus 195 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~ 274 (467)
.++||||+++++++...+..++||||+++|+|.+++........++++..+..++.|++.||+|||+.+.++|+||||||
T Consensus 83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 99999999999999999999999999999999999998766666799999999999999999999998778899999999
Q ss_pred CcEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccC
Q 012267 275 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 354 (467)
Q Consensus 275 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~ 354 (467)
+|||++.++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|+|+||+.||+......
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999999876555555666679999999999988889999999999999999999999998766666
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCccchhhhHhH
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERWDEWQKVE 434 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~~~ 434 (467)
.......+|+.............+..+...........+.+++.+||+.||.+|||+.||++.|++..+.++|.+|+.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 322 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 322 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC------
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHH
Confidence 77788889998888888888888888888888889999999999999999999999999999999999999999988776
Q ss_pred Hh
Q 012267 435 VL 436 (467)
Q Consensus 435 ~~ 436 (467)
..
T Consensus 323 ~~ 324 (326)
T 3uim_A 323 MF 324 (326)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=419.92 Aligned_cols=267 Identities=22% Similarity=0.315 Sum_probs=202.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC----ceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 217 (467)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+.+ ..+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3567778999999999999998 58999999996432 12223345566667889999999999998654 57999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH-----CDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
||||++|+|.++++... ++|..+.+++.|+++||+|||++ +.++|+||||||+||||+.++++||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999998652 89999999999999999999986 246899999999999999999999999999
Q ss_pred ccccCCCCCee---eecccccccccccccccCC------CCCcchhHHHHHHHHHHHHcCCCCcccccccC-------CC
Q 012267 293 AKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGIMLLELITGQRAFDLARLAN-------DD 356 (467)
Q Consensus 293 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~-------~~ 356 (467)
++......... .....||+.|||||++.+. .++.++|||||||+||||+||+.||....... ..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98765443322 2345699999999998754 46789999999999999999998875322110 01
Q ss_pred CccHHHHHHHHhhhcccccccCccccCc-ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 357 DVMLLDWVKGLLKEKKLEMLVDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
......+. ..... ...+|.+... ...+....+.+++.+||+.||++||||.||++.|+++
T Consensus 235 ~~~~~~~~-~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 235 DPSVEEMR-KVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHH-HHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHH-HHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11122222 22111 1223333222 1335667889999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=417.50 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=205.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+.|+..+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++++.++|||||++++++.+.+..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45788889999999999999976 7999999999754332 234688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
|++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+...
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 223 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 223 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC-
Confidence 9999999999764 289999999999999999999999 9999999999999999999999999999876533
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+........ ..+.
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~------~~~~ 289 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDN------LPPR 289 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS------SCCC
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcC------CCCC
Confidence 233455789999999999999999999999999999999999999995321 11222222111 1111
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+. ........+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11122356889999999999999999998843
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=423.18 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=202.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|++++++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999975 799999999976543 3334578999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
||++|+|.++|..... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+...
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999976432 2478999999999999999999999 9999999999999999999999999999875421
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
.......+||+.|||||++.+..|+.++|||||||+||||+||+.||... ...+.+........ +
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~~------~ 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------SMKNLVLKIISGSF------P 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTCC------C
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCCC------C
Confidence 12234467999999999999999999999999999999999999999632 12233333322211 1
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVS----LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 112356889999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=424.99 Aligned_cols=269 Identities=26% Similarity=0.383 Sum_probs=219.1
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEECC------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC-Ceeeee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRL 204 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~ 204 (467)
+...+|++..++|++.+.||+|+||+||+|++.. ++.||||+++..........|.+|++++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4567788889999999999999999999998642 358999999876665566689999999999965 899999
Q ss_pred eeeeeCC-CceEEEeeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCC
Q 012267 205 RGFCMTP-TERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 271 (467)
Q Consensus 205 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~d 271 (467)
+|+|.+. +..++|||||++|+|.++|+.... ....++|..++.++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999976421 123489999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCccc
Q 012267 272 VKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDL 349 (467)
Q Consensus 272 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~ 349 (467)
|||+|||+++++.+||+|||+++.+..... .......||+.|||||++.+..++.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654433 33445678999999999999999999999999999999998 9999964
Q ss_pred ccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 350 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. ... .+...+..+.. +.. +.....++.+++.+||+.||++|||+.||++.|+.
T Consensus 291 ~~----~~~----~~~~~i~~g~~-----~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VK----IDE----EFCRRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CC----CSH----HHHHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----HHH----HHHHHHHcCCC-----CCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 21 111 12222222111 111 11223568899999999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=404.55 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=195.4
Q ss_pred CCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC----CCceEEEe
Q 012267 145 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 218 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 218 (467)
...++||+|+||+||+|.+. ++..||||++..... ......|.+|++++++++|||||+++++|.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999975 689999999975433 3344579999999999999999999999865 34579999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecCCccccC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD 297 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~ 297 (467)
|||++|+|.+++.... .+++..+..++.||+.||+|||++ .++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998643 389999999999999999999998 113999999999999984 7899999999998643
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
. ......+||+.|||||++.+ .++.++|||||||+||||+||+.||.... ............ ...
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~~~~~i~~~-~~~--- 248 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSG-VKP--- 248 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTT-CCC---
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------cHHHHHHHHHcC-CCC---
Confidence 2 23445679999999999865 69999999999999999999999995311 112222222111 111
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 249 -~~~~~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 -ASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -GGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 1245788999999999999999999854
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=413.36 Aligned_cols=250 Identities=22% Similarity=0.251 Sum_probs=202.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+.|...++||+|+||+||+|++. +|+.||||+++.... ..+|+.+++.++|||||++++++.+.+..||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45677788999999999999975 799999999976432 24699999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeecCCccccCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 299 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 299 (467)
|++|+|.++|+... ++++..+..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998653 389999999999999999999999 999999999999999987 6999999999876533
Q ss_pred CCe----eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 300 DTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 300 ~~~----~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
... .....+||+.|||||++.+..++.++|||||||++|||+||+.||.... ........ ........
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i----~~~~~~~~ 276 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF----RGPLCLKI----ASEPPPIR 276 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC----CSCCHHHH----HHSCCGGG
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHH----HcCCCCch
Confidence 211 1233579999999999999999999999999999999999999996422 11112121 11111000
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.+ .......+.+++.+||+.||.+|||+.|+++.|..
T Consensus 277 ----~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 ----EI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ----GS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----hc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11 11223568889999999999999999999988764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=418.57 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=205.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+.|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+..||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56889999999999999999975 799999999975533 2334688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
|++|+|.+++.... +++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+...
T Consensus 230 ~~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~- 300 (423)
T 4fie_A 230 LEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 300 (423)
T ss_dssp CTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred CCCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence 99999999997642 89999999999999999999999 9999999999999999999999999999876533
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+........ ..+.
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~------~~~~ 366 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDN------LPPR 366 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS------CCCC
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcC------CCCC
Confidence 233455679999999999999999999999999999999999999995321 11222222111 1111
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 367 ~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 LKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CSC--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Ccc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 110 1112356888999999999999999999854
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=408.47 Aligned_cols=248 Identities=22% Similarity=0.302 Sum_probs=207.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.++||+|+||+||+|+.. +|+.||||++.... .......+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46888999999999999999975 79999999996532 1223457899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998653 389999999999999999999999 999999999999999999999999999997753
Q ss_pred CC-CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. .......+||+.|||||++.+..++.++||||+||++|||+||+.||.... ..+......... .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~---- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLE-Y---- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-C----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-C----
Confidence 32 334556789999999999999999999999999999999999999996321 122222222211 1
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
.+... ...++.+++.+||+.||++|||++|++
T Consensus 252 --~~p~~----~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFPEK----FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCTT----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCcc----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11111 225678899999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=393.97 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=190.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|++++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999965 799999999975432 233457899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+ +|+|.+++.... ++++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999998754 389999999999999999999999 999999999999999999999999999986542
Q ss_pred CCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||... ............. .
T Consensus 165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~~i~~~~-~---- 229 (275)
T 3hyh_A 165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFKNISNGV-Y---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC-C----
T ss_pred --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCC-C----
Confidence 223345679999999999988776 58999999999999999999999632 1222222222211 1
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+... ....+.+++.+||+.||++|||++|+++
T Consensus 230 --~~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --TLPKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCC----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 2256788999999999999999999865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=400.43 Aligned_cols=243 Identities=24% Similarity=0.326 Sum_probs=193.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++|++.+.||+|+||+||+|+.. +++.||||+++..... .....+.+|++++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999863 4789999999754321 223367889999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|||||++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998753 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... .......+||+.|||||++.+..++.++|||||||++|||+||+.||.... ..+......... .
T Consensus 177 ~~~-~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~-~--- 243 (304)
T 3ubd_A 177 IDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILKAK-L--- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C---
T ss_pred cCC-CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHcCC-C---
Confidence 422 223345679999999999999999999999999999999999999996321 122222222211 1
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
.+.. .....+.+++.+||+.||++|||+
T Consensus 244 ---~~p~----~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ---GMPQ----FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCCT----TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCC----cCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111 123568889999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=396.02 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=190.0
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC---------
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--------- 212 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------- 212 (467)
+|+..+.||+|+||+||+|+.. +|+.||||+++........+.+.+|++++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888899999999999999975 799999999986655555667999999999999999999999987543
Q ss_pred ---ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 213 ---ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 213 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
..|+|||||++|+|.+++...... ...++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 368999999999999999875432 2356778899999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCe-----------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCc
Q 012267 290 FGLAKLMDYKDTH-----------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 358 (467)
Q Consensus 290 fgl~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~ 358 (467)
||+++.+...... .....+||+.|||||++.+..++.++|||||||++|||++ ||....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------- 231 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------- 231 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-------
Confidence 9999876533211 1234569999999999999999999999999999999996 774211
Q ss_pred cHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 359 MLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.....+... .... .|. ........+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~-~~~~-----~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ERVRTLTDV-RNLK-----FPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHH-HTTC-----CCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHH-hcCC-----CCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111111 1100 011 11223345678999999999999999999865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=384.58 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=198.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeC------CCc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 213 (467)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57888999999999999999975 7999999999755432 334568899999999999999999998764 357
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.|||||||+ |+|.+++.... ++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 68999997643 399999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC---CCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh
Q 012267 294 KLMDYK---DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 294 ~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
+.+... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-----~~~~l~~I~~~~g 280 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-----YVHQLQLIMMVLG 280 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-----HHHHHHHHHHHHC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHhcC
Confidence 876432 12234456899999999998775 56999999999999999999999996421 1111111111110
Q ss_pred hcccc---cc--------c--CccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 EKKLE---ML--------V--DPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ~~~~~---~~--------~--d~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... .+ + .+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 00 0 00000000 0011256789999999999999999998843
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=378.13 Aligned_cols=280 Identities=40% Similarity=0.676 Sum_probs=239.7
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 135 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 135 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
.++...+++|+..+.||+|+||+||+|+..+|+.||||++.... ......+.+|+++++.++||||+++++++...+..
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33444678999999999999999999998889999999986543 33456789999999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.+++.........++|..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999987654445699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 295 LMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 295 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
...... ........||+.|+|||++.+..++.++||||||+++|||+||+.||..... ........|.........+
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS--SSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc--HHHHHHHHHhhhccccccH
Confidence 654222 2223344589999999999888999999999999999999999999965322 2334556676666666677
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...+++.+...........+.+++.+||+.||++|||+.||++.|+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 77788877777778888999999999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=378.06 Aligned_cols=196 Identities=23% Similarity=0.412 Sum_probs=168.9
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCce
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 214 (467)
..++|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+|++++..+ +||||+++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999753 46789999986543 234678999999988 699999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEeecCCc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 293 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~ 293 (467)
++||||+++|+|.+++.. +++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999842 88999999999999999999999 99999999999999877 79999999999
Q ss_pred cccCCCCC---------------------------eeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCC
Q 012267 294 KLMDYKDT---------------------------HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQR 345 (467)
Q Consensus 294 ~~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~ 345 (467)
+....... ......+||+.|+|||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86532211 122345799999999999775 58999999999999999999999
Q ss_pred Ccc
Q 012267 346 AFD 348 (467)
Q Consensus 346 p~~ 348 (467)
||.
T Consensus 246 Pf~ 248 (361)
T 4f9c_A 246 PFY 248 (361)
T ss_dssp SSS
T ss_pred CCC
Confidence 995
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=390.44 Aligned_cols=251 Identities=20% Similarity=0.272 Sum_probs=205.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57899999999999999999975 79999999997543 33345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC--CcEEEeecCCccccCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMDY 298 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~ 298 (467)
|++|+|.++|..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 236 ~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999975432 389999999999999999999999 99999999999999854 8999999999997653
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. ......+||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+.......... .++
T Consensus 310 ~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~~---~~~ 376 (573)
T 3uto_A 310 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDW---NMD 376 (573)
T ss_dssp T--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCC---CCC
T ss_pred C--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCCC---CCC
Confidence 3 33445679999999999999999999999999999999999999996321 1122222211110 011
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 377 ~~~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 DSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1122356788999999999999999999865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=388.38 Aligned_cols=247 Identities=28% Similarity=0.332 Sum_probs=196.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHH---HHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|++.++||+|+||+||+|+.. +|+.||||++++... ........ .++.+++.++|||||+++++|.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57899999999999999999976 799999999964321 11122233 3456677789999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||++||+|.++|.... .+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999998753 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
+... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||...... ............ .
T Consensus 342 ~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~-~-- 410 (689)
T 3v5w_A 342 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTM-A-- 410 (689)
T ss_dssp CSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHC-C--
T ss_pred cCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCC-C--
Confidence 6432 2345689999999999964 57899999999999999999999999643211 111222211111 1
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEV 414 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev 414 (467)
..+.. .....+.+++.+||+.||.+|++ ++||
T Consensus 411 ----~~~p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei 447 (689)
T 3v5w_A 411 ----VELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447 (689)
T ss_dssp ----CCCCT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH
T ss_pred ----CCCCc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH
Confidence 11111 12356889999999999999998 5665
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=349.06 Aligned_cols=283 Identities=37% Similarity=0.610 Sum_probs=229.3
Q ss_pred cccccCHHHHHHHhcCCCCC------CeeeecCceEEEEEEECCCCEEEEEEeccCC---CcchHHHHHHHHHHHHhcCC
Q 012267 128 QLKRFSLRELQVATDSFSNK------NILGRGGFGKVYKGRLADGSLVAVKRLKEER---TPGGELQFQTEVEMISMAVH 198 (467)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h 198 (467)
....|++.++..++++|... +.||+|+||+||+|.. +++.||||++.... .......+.+|+.++..++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 8999999999999987 58899999986532 22335578999999999999
Q ss_pred CeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEE
Q 012267 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 278 (467)
Q Consensus 199 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nil 278 (467)
|||+++++++.+.+..++||||+++|+|.+++..... ..++++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999975432 23589999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCC
Q 012267 279 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 357 (467)
Q Consensus 279 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~ 357 (467)
++.++.+||+|||++........ .......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~ 240 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE----P 240 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS----S
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc----h
Confidence 99999999999999987643322 22334568999999998865 578999999999999999999999965321 1
Q ss_pred ccHHHHHHHHhhh-cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 358 VMLLDWVKGLLKE-KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 358 ~~~~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.....+....... ..+...+++.+ ..........+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2222333322221 22233344433 233566778899999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=348.27 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=205.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||+||+|.. .+|+.||||++...... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 46799999999999999999986 47899999999754433 34568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999998642 89999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... .............. ....
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~~-~~~~- 238 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTP-ELQN- 238 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSC-CCSC-
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC-CCCC-
Confidence 22 2344569999999999999999999999999999999999999995321 11111111111110 1111
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 239 ------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 ------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122356889999999999999999999965
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=365.43 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC--------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCC
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 211 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 211 (467)
.++|...+.||+|+||+||+|+.. ++..||||+++..........+.+|++++.++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888899999999999999852 35679999997665444556799999999999 899999999999999
Q ss_pred CceEEEeeccCCCChhhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE
Q 012267 212 TERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 279 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill 279 (467)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999999999999875321 23489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCC
Q 012267 280 DEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDD 357 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 357 (467)
+.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||+| |+.||.... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-----~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----H
Confidence 9999999999999986543322 12233456789999999999999999999999999999999 999996421 1
Q ss_pred ccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 358 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..+...+ ..... +.. .......+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 312 ~~~~~~~---~~~~~------~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 312 EELFKLL---KEGHR------MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp GGHHHHH---HTTCC------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHH---hcCCC------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111111 11110 011 11223568899999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=359.84 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=207.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.++|.+.+.||+|+||+||+|.+. .+..||||+++..........+.+|+.++..++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356788899999999999999974 3456999999876555566689999999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999976432 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCe--eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 297 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 297 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... ..+...........
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~~~~~~ 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEEGYRL 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHcCCCC
Confidence 533222 2223346778999999998899999999999999999999 999995321 11222222111110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. ........+.+++..||+.||.+|||+.+|++.|+.
T Consensus 274 ------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 274 ------P----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp ------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------C----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0 111223668899999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=350.98 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=207.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...++||+|+||+||+|... ++..||+|++... .......+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 56788899999999999999975 6899999998543 344456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999987432 389999999999999999999999 99999999999999999999999999998764322
Q ss_pred Cee-------------eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC-CccHHHHHHH
Q 012267 301 THV-------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD-DVMLLDWVKG 366 (467)
Q Consensus 301 ~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~ 366 (467)
... .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 211 11456899999999999999999999999999999999999998643221111 1111111111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
. ..+ .....+.+++.+||+.||++|||+.++++.|+..
T Consensus 243 ~---------~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 243 Y---------CPP--------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp T---------CCT--------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c---------CCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 011 1124588899999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=356.39 Aligned_cols=264 Identities=28% Similarity=0.422 Sum_probs=202.4
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
..++....++|++.+.||+|+||+||+|+. +|+.||||++...... .....+.+|++++.+++||||+++++++.+..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344445567888999999999999999987 5889999999765432 33457889999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cccCCCCCCcEEECCCCcEEEeec
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999986432 12388999999999999999999998 7 999999999999999999999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
|+++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+........
T Consensus 184 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~ 254 (309)
T 3p86_A 184 GLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFK 254 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHHS
T ss_pred CCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 999764322 222334568999999999999999999999999999999999999996321 11111111101
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. ...+ .......+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 255 ~~-----~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 255 CK-----RLEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp CC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-----CCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 0011 11122568899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=365.95 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=199.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.++|+..+.||+|+||.||+|+.. ++..||||+++..........+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999864 5778999999766555556679999999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999998643 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCee--eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 297 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 297 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
....... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+...........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~~~i~~~~~~ 269 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDEGYRL 269 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHHHHHHTTEEC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 5332211 122235678999999999999999999999999999998 999995321 11222221111110
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.........+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 270 ----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 270 ----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 00112236688999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=351.08 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=204.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|+..+.||+|+||.||+|++ .+|+.||||++..... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999997 4899999999975433 334456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997653 289999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccccccccCCCCC-cchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
. .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... ..+........ ...
T Consensus 167 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~-~~~--- 232 (328)
T 3fe3_A 167 G--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRG-KYR--- 232 (328)
T ss_dssp S--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CCC---
T ss_pred C--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CCC---
Confidence 2 233456799999999999887764 89999999999999999999996421 22222222221 110
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.| ......+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~p-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 IP-------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CC-------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CC-------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01 112256788999999999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=349.63 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|+..+.||+|+||.||+|+.. ++..||+|++...... .....+.+|+.++..++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467888999999999999999965 7899999998654322 2345788999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++.... ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998653 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
...........||+.|+|||.+.+..++.++||||||+++|+|+||+.||.... .............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~----- 229 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQDSV----- 229 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSSCC-----
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhccC-----
Confidence 443333445568999999999999999999999999999999999999996421 1111111111110
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCCCc
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-KMSEVVRMLEGDGLAE 425 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~~ 425 (467)
+.............+.+++.+|++.||.+|| +++++.+.|+......
T Consensus 230 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 -PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0000001112236688999999999999998 9999999998754433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=346.56 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=210.2
Q ss_pred cccCHHHHHHHhcC----------CCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC
Q 012267 130 KRFSLRELQVATDS----------FSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH 198 (467)
Q Consensus 130 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h 198 (467)
..++.+++..+++. |...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 35677777776654 555678999999999999976 79999999997543 3345578899999999999
Q ss_pred CeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEE
Q 012267 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 278 (467)
Q Consensus 199 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nil 278 (467)
|||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999998753 389999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCc
Q 012267 279 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 358 (467)
Q Consensus 279 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~ 358 (467)
++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------- 245 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------- 245 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------
T ss_pred ECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------
Confidence 9999999999999998764322 22344569999999999999999999999999999999999999995321
Q ss_pred cHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 359 MLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+........ ..+.+.. .......+.+++.+||+.||.+|||+.++++
T Consensus 246 -~~~~~~~~~~~------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 246 -PVQAMKRLRDS------PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHHHHHHHHHS------SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHhcC------CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11112111111 1111110 1112256888999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=340.77 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=211.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
..++|+..+.||+|+||+||+|...++..||||+++.... ....+.+|++++.+++||||+++++++.+....++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3467888899999999999999998888999999975432 34578999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999976432 389999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.........++..|+|||.+.+..++.++||||||+++|+|+| |+.||.... ............ ....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~---~~~~ 226 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQGH---RLYR 226 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTC---CCCC
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHcCC---CCCC
Confidence 4334444556778999999998889999999999999999999 999995321 111121111111 1111
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
+.. ....+.+++..||+.+|.+|||+.++++.|+...
T Consensus 227 ~~~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTT-------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCc-------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 1256889999999999999999999999998843
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=368.50 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=208.7
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
....++|...+.||+|+||.||+|++. +++.||||+++..........+.+|+++++.++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344567888899999999999999986 7899999999765444444568899999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999986432 389999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCeee-ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
........ ....++..|+|||.+.+..++.++|||||||++|||+| |..||.... . .+ +........
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-----~---~~-~~~~~~~~~-- 332 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-----N---QQ-TREFVEKGG-- 332 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-----H---HH-HHHHHHTTC--
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----H---HH-HHHHHHcCC--
Confidence 32211111 11224678999999998889999999999999999998 999995321 1 11 111111111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
....| ......+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 333 ~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 RLPCP-------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 00011 11235688999999999999999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=342.10 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=209.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.++|+..+.||+|+||+||+|...++..||+|++.... .....+.+|++++.+++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 46788889999999999999999888999999997543 2345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999976432 489999999999999999999999 99999999999999999999999999998654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..+......... ....+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~~~---~~~~~ 229 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGF---RLYKP 229 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTC---CCCCC
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhcCc---cCCCC
Confidence 222333446778999999998899999999999999999999 999996321 112222221111 11111
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. .....+.+++..||+.+|.+|||+.++++.|++
T Consensus 230 ~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 230 R-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp T-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 1 112568899999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=346.61 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=202.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHh--cCCCeeeeeeeeeeC----CCce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM--AVHRNLLRLRGFCMT----PTER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~ 214 (467)
.++|+..+.||+|+||+||+|+. +|+.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999998 5889999998543 33456667777666 799999999998654 3457
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH--------DHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh--------~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 8999999999999999653 3899999999999999999999 77 999999999999999999999
Q ss_pred EeecCCccccCCCCCee---eecccccccccccccccCC------CCCcchhHHHHHHHHHHHHcC----------CCCc
Q 012267 287 VGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGIMLLELITG----------QRAF 347 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~sDv~s~Gvil~elltg----------~~p~ 347 (467)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998765433322 2234689999999999876 456799999999999999999 7777
Q ss_pred ccccccCCCCccHHHHHHHHhhhcccccccCccccC-cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 348 DLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN-NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..... ......... ....... ..+.+.. .........+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 234 ~~~~~---~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVP---NDPSFEDMR-KVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSC---SSCCHHHHH-HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCC---CCcchhhhh-HHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 53221 111122221 1111111 1111111 12345667899999999999999999999999999863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=363.56 Aligned_cols=270 Identities=27% Similarity=0.393 Sum_probs=216.3
Q ss_pred ccCHHHHHHHhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeee
Q 012267 131 RFSLRELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLR 203 (467)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 203 (467)
.+...+++...++|+..+.||+|+||.||+|++ .+++.||||+++..........+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 456677888889999999999999999999974 246799999998765555556799999999999 7999999
Q ss_pred eeeeeeCCCc-eEEEeeccCCCChhhhhhcCCCC----------------------------------------------
Q 012267 204 LRGFCMTPTE-RLLVYPYMANGSVASCLRERPPS---------------------------------------------- 236 (467)
Q Consensus 204 ~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 236 (467)
+++++.+.+. .++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 89999999999999999875421
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 237 ----------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 237 ----------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 11288999999999999999999999 99999999999999999999999999998654332
Q ss_pred -CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 301 -THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 301 -~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
........||+.|+|||++.+..++.++||||||+++|||+| |+.||.... ..... ..........
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~----~~~~~~~~~~---- 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----IDEEF----CRRLKEGTRM---- 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----CSHHH----HHHHHHTCCC----
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc----hhHHH----HHHHHcCCCC----
Confidence 223344568899999999999999999999999999999998 999995421 11111 1111111100
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. .......+.+++..||+.||.+|||+.||++.|++
T Consensus 316 -~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 -RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp -CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 01 11122568899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=353.86 Aligned_cols=267 Identities=27% Similarity=0.332 Sum_probs=206.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC----ceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l 216 (467)
.++|+..++||+|+||+||+|+.. ++.||||+++... .....+..|+.++.+++||||+++++++.... ..++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 467888999999999999999986 7899999996532 23345667888899999999999999998754 3699
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCCcccCCCCCCcEEECCCCcEEEee
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC-------DPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~-------~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
||||+++|+|.+++.... +++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999998642 899999999999999999999862 34899999999999999999999999
Q ss_pred cCCccccCCCCCe-eeecccccccccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC-------
Q 012267 290 FGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD------- 356 (467)
Q Consensus 290 fgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~------- 356 (467)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876533222 2333568999999999876 35567899999999999999999999643211110
Q ss_pred -CccHHHHHHHHhhhcccccccCccccCc-ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 357 -DVMLLDWVKGLLKEKKLEMLVDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 357 -~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
......+....... ...+.+... ........+.+++.+||+.||++|||+.||++.|++
T Consensus 255 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 255 QHPSLEDMQEVVVHK-----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp SSCCHHHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcc-----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11112222211111 111111111 123455679999999999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=345.86 Aligned_cols=271 Identities=18% Similarity=0.218 Sum_probs=214.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC--ceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 217 (467)
.++|...++||+|+||+||+|+.. +|+.||||+++..........+.+|++++.+++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356888899999999999999976 589999999976554455667889999999999999999999988655 67999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE----CCCCcEEEeecCCc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 293 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 293 (467)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999987532 22389999999999999999999999 99999999999999 88888999999999
Q ss_pred cccCCCCCeeeeccccccccccccccc--------CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLS--------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
+...... ......||..|+|||++. +..++.++|||||||++|||+||+.||...... ....+.+.
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~ 237 (319)
T 4euu_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMY 237 (319)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----GGCHHHHH
T ss_pred eecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----chhHHHHH
Confidence 8764332 223456899999999886 567899999999999999999999999642211 11222222
Q ss_pred HHhhhccc---ccc---------cCcc--ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 366 GLLKEKKL---EML---------VDPD--LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 366 ~~~~~~~~---~~~---------~d~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
........ ..+ ..+. ............+.+++.+||+.||++|||++|+++...+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 22222110 000 0001 11233466777889999999999999999999999988763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=355.36 Aligned_cols=265 Identities=26% Similarity=0.435 Sum_probs=213.5
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee
Q 012267 136 ELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM 209 (467)
Q Consensus 136 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 209 (467)
.+....++|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+.++.+++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455688999999999999999999874 347899999986655555667999999999999999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCccc
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPPS--------------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIH 269 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH 269 (467)
+.+..++||||+++|+|.+++...... ...+++..++.++.||++||.|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999874321 14589999999999999999999999 9999
Q ss_pred CCCCCCcEEECCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCc
Q 012267 270 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAF 347 (467)
Q Consensus 270 ~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~ 347 (467)
|||||+|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986543221 22233457889999999998899999999999999999999 99999
Q ss_pred ccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 348 DLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.... ..+........ ... .. .......+.+++.+||+.||.+||++.+|++.|++.
T Consensus 278 ~~~~--------~~~~~~~~~~~-~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 278 YGMA--------HEEVIYYVRDG-NIL-----AC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TTSC--------HHHHHHHHHTT-CCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCC--------hHHHHHHHhCC-CcC-----CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 5321 11222222111 110 01 112235688999999999999999999999999984
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=373.41 Aligned_cols=264 Identities=27% Similarity=0.395 Sum_probs=214.4
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++....+|...+.||+|+||.||+|.+. ++..||||+++.... ....|.+|+.++++++||||++++++|......+
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 3445567888899999999999999986 488999999975432 3567999999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 293 lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccccee
Confidence 99999999999999986432 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.............++..|+|||++.+..++.++|||||||++|||+| |+.||.... .....+.+.. ....
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~---~~~~- 438 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK---DYRM- 438 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHT---TCCC-
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHc---CCCC-
Confidence 65333222333446789999999998899999999999999999999 999996421 1112222111 1100
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 425 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 425 (467)
.........+.+++.+||+.||.+|||+.+|++.|+......
T Consensus 439 ---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 439 ---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred ---------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 111122366889999999999999999999999999865433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=372.02 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=211.9
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 135 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 135 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
.+++...++|...+.||+|+||+||+|.+.++..||||+++... .....|.+|+++++.++||||+++++++. .+..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 34556677888999999999999999999888999999997543 34568999999999999999999999986 5678
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 999999999999999985421 1378899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
..............++..|+|||++....++.++|||||||++|||+| |+.||.... ..+...........
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~ 404 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERGYRM 404 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHHTCCC
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 754321111223346788999999998899999999999999999999 999995321 11222222111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
. . .......+.+++.+||+.||.+|||+.+|++.|++..
T Consensus 405 ~---~-------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 P---R-------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp C---C-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred C---C-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 1 1122366889999999999999999999999999853
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=353.97 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=212.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC--------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
..++|.+.+.||+|+||+||+|+.. .+..||||+++..........+.+|++++.++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888899999999999999852 23579999998765555566799999999999 89999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEE
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 278 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nil 278 (467)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 99999999999999999999875421 23489999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCC
Q 012267 279 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDD 356 (467)
Q Consensus 279 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~ 356 (467)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~----- 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 99999999999999986643322 22333457889999999999999999999999999999999 999995321
Q ss_pred CccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 357 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..+........... .. .......+.+++.+||+.+|.+|||+.||++.|+.+
T Consensus 299 ---~~~~~~~~~~~~~~------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 299 ---VEELFKLLKEGHRM------DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ---HHHHHHHHHTTCCC------CC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHcCCCC------CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12222222211111 01 111235688999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=349.87 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999976 78999999997655444445688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999997643 389999999999999999999999 99999999999999999999999999998654322
Q ss_pred -CeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 301 -THVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 301 -~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... ........|... . ....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~----~---~~~~ 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSDWKEK----K---TYLN 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC---TTSHHHHHHHTT----C---TTST
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---hHHHHHHHHhcc----c---ccCC
Confidence 222334579999999999987765 789999999999999999999996422 111112222111 0 0000
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+ .......+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 P------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 1112356788999999999999999998854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=354.29 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=199.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++|+..++||+|+||+||+|++. +++ +||+|.++..........+.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888899999999999999864 444 468888876555556678999999999999999999999998754 789
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|+||+.+|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999987532 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||.... ...+...+.. ....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~~---~~~~- 238 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK---GERL- 238 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHHT---TCCC-
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC-----HHHHHHHHHc---CCCC-
Confidence 543322 2233456889999999999999999999999999999999 999996421 1112222111 1000
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.........+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 239 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111235688999999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=346.33 Aligned_cols=256 Identities=22% Similarity=0.378 Sum_probs=206.2
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
...++|+..+.||+|+||+||+|.+.++..||||+++.... ....+.+|++++..++|+||+++++++.+.+..++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34567888899999999999999998888999999975432 3457899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999976322 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
..........+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||.... ..+......... ...
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~~---~~~ 241 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGL---RLY 241 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTC---CCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHhccc---CCC
Confidence 22222233446788999999998899999999999999999998 999996321 111111111110 001
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.+. .....+.+++.+||+.+|.+|||+.++++.|++
T Consensus 242 ~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 242 RPH-------LASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 111 112568899999999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=355.31 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=206.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 216 (467)
.++|+..++||+|+||+||+|+.. +++.||||+++...... ....+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467888999999999999999976 68899999997643222 223577899998876 89999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999998643 389999999999999999999999 9999999999999999999999999999853
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
. .........+||+.|+|||++.+..++.++|||||||++|||++|+.||..............+++.........
T Consensus 204 ~-~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 204 L-RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp C-CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred c-cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 2 223334556799999999999999999999999999999999999999964322211111112222222211111
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHhcCCC
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS---EVVRMLEGDGL 423 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~---evl~~L~~~~~ 423 (467)
.+ .......+.+++.+||+.||.+||++. .+.+.++...+
T Consensus 280 ---~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 280 ---RI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp ---CC----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred ---CC----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 11 111235688999999999999999962 34555555554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=345.82 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=203.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|+||+||+|+.. +|+.||+|+++... .......+..|+.++..++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888899999999999999976 69999999996532 1223456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 158 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~-~~----- 222 (337)
T 1o6l_A 158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILME-EI----- 222 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC-----
T ss_pred -CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcC-CC-----
Confidence 2223445679999999999999999999999999999999999999995321 11222222211 10
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
.+.. .....+.+++.+||+.||.+|| ++.||++
T Consensus 223 -~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -RFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1111 1225688899999999999999 8888854
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=347.98 Aligned_cols=257 Identities=21% Similarity=0.271 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-----hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
.+.|...+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.++..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467888999999999999999976 68999999997644321 345789999999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC----cEEEeec
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 290 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 290 (467)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999997643 389999999999999999999999 999999999999998877 7999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+........
T Consensus 164 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAV 233 (361)
T ss_dssp SSCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred CCceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 999876432 22344569999999999999899999999999999999999999995321 11222221111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
. ..+++.. .......+.+++..||..||.+|||+.|++ +...+.
T Consensus 234 ~---~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l---~hp~~~ 277 (361)
T 2yab_A 234 S---YDFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEAL---RHPWIT 277 (361)
T ss_dssp C---CCCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHH---TSTTTS
T ss_pred C---CCCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHh---cCcCcC
Confidence 0 0011111 111235688999999999999999999885 444443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=347.34 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=196.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
..++|+..+.||+|+||+||+|.... +..||+|+++..........+.+|+.++..++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 44678888999999999999998742 45799999876555555667999999999999999999999984 56789
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999998653 2389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..||.... ....... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-----~~~~~~~---i~~~~~~- 236 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGR---IENGERL- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHH---HHTTCCC-
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-----HHHHHHH---HHcCCCC-
Confidence 65433323333446789999999998899999999999999999997 999996421 1112111 1111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.+ .......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 237 -----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 -----PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01 112235688999999999999999999999999873
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=349.46 Aligned_cols=261 Identities=27% Similarity=0.413 Sum_probs=211.2
Q ss_pred HhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
..++|...+.||+|+||.||+|.. .++..||||+++..........+.+|++++..++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 456788889999999999999986 24578999999866555555678999999999999999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCC
Q 012267 214 RLLVYPYMANGSVASCLRERPP--------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVK 273 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk 273 (467)
.++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999987543 123488999999999999999999999 99999999
Q ss_pred CCcEEECCCCcEEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCccccc
Q 012267 274 AANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLAR 351 (467)
Q Consensus 274 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~ 351 (467)
|+||+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765333222 223346788999999998889999999999999999999 999996421
Q ss_pred ccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 352 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
...+...+. .... +.. .......+.+++.+||+.||.+||++.+|++.|++.
T Consensus 258 -----~~~~~~~~~----~~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 -----PERLFNLLK----TGHR-----MER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp -----GGGHHHHHH----TTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHhh----cCCc-----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111212111 1110 011 112235688999999999999999999999999873
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=349.52 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC--------
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-------- 212 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 212 (467)
++|+..+.||+|+||.||+|+.. +|+.||||+++..........+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56888899999999999999986 799999999986655556678999999999999999999999986543
Q ss_pred -------------------------------------------------ceEEEeeccCCCChhhhhhcCCCCCCCCCHH
Q 012267 213 -------------------------------------------------ERLLVYPYMANGSVASCLRERPPSQLPLDWP 243 (467)
Q Consensus 213 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 243 (467)
..++||||+++|+|.+++...... ...++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-EDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-GGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-cchhhH
Confidence 278999999999999999876432 336777
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC-----------eeeeccccccc
Q 012267 244 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-----------HVTTAVRGTIG 312 (467)
Q Consensus 244 ~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~g~~~ 312 (467)
.++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 999999999999999999999999999987654321 12233468999
Q ss_pred ccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHH
Q 012267 313 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ 392 (467)
Q Consensus 313 y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 392 (467)
|+|||++.+..++.++|||||||++|||++|..|+... ....... .... .+ .........
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~-~~~~-----~~----~~~~~~~~~ 301 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDV-RNLK-----FP----LLFTQKYPQ 301 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHH-HTTC-----CC----HHHHHHCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHh-hccC-----CC----cccccCChh
Confidence 99999999999999999999999999999998776321 0111111 0000 01 112233456
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 012267 393 LIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 393 l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.+++.+||+.||.+|||+.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 788999999999999999999964
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=343.35 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||+||+|+..+|+.||||+++...... ....+.+|++++.+++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788899999999999999999889999999997543322 34568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++ +|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 88888876432 389999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc---
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM--- 375 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 375 (467)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..... .........
T Consensus 173 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~-~~~~~~~~~~~~ 246 (311)
T 3niz_A 173 V-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT----DDDQLPKIFS-ILGTPNPREWPQ 246 (311)
T ss_dssp C-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----TTTHHHHHHH-HHCCCCTTTSGG
T ss_pred c-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH-HHCCCChHHhhh
Confidence 2 22333468999999999876 568999999999999999999999996421 1111222211 111100000
Q ss_pred -------------ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 -------------LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 -------------~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+..............+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000001112356889999999999999999999865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=354.96 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=208.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
.++|+..+.||+|+||+||+|++. ++..||||+++..........+.+|+.++.+++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367888899999999999999853 46789999997665556666789999999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC---cEEEe
Q 012267 215 LLVYPYMANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVVG 288 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 288 (467)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 223489999999999999999999999 999999999999999555 59999
Q ss_pred ecCCccccCCCC-CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHH
Q 012267 289 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 289 Dfgl~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH
Confidence 999997543211 112233457889999999998899999999999999999998 999995321 1122222
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........ . .......+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 299 i~~~~~~~------~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 299 VTSGGRMD------P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHTTCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCCCC------C----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 22111110 0 11123568899999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=369.82 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=205.5
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 136 ELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 136 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
.++...++|+..+.||+|+||.||+|.+.++..||||+++.... ....|.+|++++++++||||+++++++.+ +..+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34456678888999999999999999998888899999976432 34579999999999999999999999876 6789
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 255 iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 99999999999999975321 2389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.............++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+...........
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~- 400 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRM- 400 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCC-
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC-
Confidence 64332222333446789999999998899999999999999999999 999995321 11222222111111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.........+.+++.+||+.||++|||+.+|++.|++.
T Consensus 401 ---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 401 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00112236688999999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=342.12 Aligned_cols=251 Identities=18% Similarity=0.243 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|...+.||+|+||+||+|... ++..||+|.++.. ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 367888899999999999999976 6889999998643 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC--CCcEEEeecCCccccC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 297 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~ 297 (467)
|+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++....
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999997643 2489999999999999999999999 9999999999999987 7899999999998764
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+........... .
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~---~ 222 (321)
T 1tki_A 156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYT---F 222 (321)
T ss_dssp TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---C
T ss_pred CC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCCC---C
Confidence 32 23344568999999999998889999999999999999999999995321 11222222211100 0
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
++.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 223 ~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 0112356889999999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=355.99 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=209.7
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
++...++|...+.||+|+||+||+|.. .++..||||+++..........+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445667899999999999999999986 245689999997654444456789999999999 8999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccC
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPPS-------------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHR 270 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~ 270 (467)
..+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999875321 12379999999999999999999999 99999
Q ss_pred CCCCCcEEECCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcc
Q 012267 271 DVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFD 348 (467)
Q Consensus 271 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~ 348 (467)
||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986643332 23334457889999999988899999999999999999998 999996
Q ss_pred cccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 349 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
... ........ ..... .+.. .......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 277 ~~~----~~~~~~~~----~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 277 GIP----VDANFYKL----IQNGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TCC----CSHHHHHH----HHTTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----cHHHHHHH----HhcCC-----CCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 421 11111111 11110 0111 111235688999999999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=341.94 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=203.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-----chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
+.|...+.||+|+||.||+|... +|..||||+++..... .....+.+|+.++..++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56888899999999999999976 6899999999754322 13567899999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC----cEEEeecC
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFG 291 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 291 (467)
+||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999997643 389999999999999999999999 999999999999999887 79999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+.........
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVN 233 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHTC
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHhcC
Confidence 998764322 2234568999999999998899999999999999999999999995321 111111111110
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 234 ---~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 ---YEFEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ---CCCCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCcCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 1112356789999999999999999999854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=340.91 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-----CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~ 213 (467)
.++|+..+.||+|+||+||+|++ .+++.||||++... .......+.+|++++.+++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 46788889999999999999984 26889999999754 33344578999999999999999999999864 356
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 8999999999999999987532 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccccc------C-CCCccHHHHH
Q 012267 294 KLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA------N-DDDVMLLDWV 364 (467)
Q Consensus 294 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~------~-~~~~~~~~~~ 364 (467)
........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+...... . .........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87643322 1223344677899999999999999999999999999999999998643210 0 0111111111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
......... ..........+.+++.+||+.||.+|||+.||++.|++
T Consensus 242 ~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 242 IELLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111111100 01112233678899999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=347.21 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=203.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC----CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+.|+..+.||+|+||+||+|... +|+.||||++.... .......+.+|+.++..++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56888899999999999999875 78999999986321 12235578999999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc---EEEeecCCc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLA 293 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~ 293 (467)
||||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988875433334589999999999999999999999 9999999999999987654 999999999
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........... .
T Consensus 181 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~-~ 249 (351)
T 3c0i_A 181 IQLGES-GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGK-Y 249 (351)
T ss_dssp EECCTT-SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTC-C
T ss_pred eEecCC-CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCC-C
Confidence 876532 222344569999999999999899999999999999999999999996421 11111111110 0
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..++.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 250 --~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 --KMNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011100 0112356889999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=347.03 Aligned_cols=262 Identities=28% Similarity=0.441 Sum_probs=212.1
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 211 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 211 (467)
...++|+..+.||+|+||+||+|+. .+++.||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456788899999999999999985 256799999998665555566799999999999 999999999999999
Q ss_pred CceEEEeeccCCCChhhhhhcCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcE
Q 012267 212 TERLLVYPYMANGSVASCLRERPPS--------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 277 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Ni 277 (467)
+..++||||+++|+|.+++...... ..++++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 9999999999999999999875421 22489999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCC
Q 012267 278 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAND 355 (467)
Q Consensus 278 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~ 355 (467)
+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---- 252 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 252 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc----
Confidence 9999999999999999876543322 2333457789999999988899999999999999999999 999996421
Q ss_pred CCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 356 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........ .... ..... .......+.+++.+||+.||.+|||+.++++.|++
T Consensus 253 ~~~~~~~~----~~~~-~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 253 VDSKFYKM----IKEG-FRMLS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp SSHHHHHH----HHHT-CCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhHHHHH----hccC-CCCCC--------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11111111 1111 00000 11123568899999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=346.33 Aligned_cols=258 Identities=28% Similarity=0.408 Sum_probs=212.9
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+...++|+..+.||+|+||+||+|... ++..||+|++.... .....+.+|++++..++||||+++++++.+....++
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 345577888899999999999999976 58899999997533 345578999999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999987532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .....+.+.. ..
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-----~~~~~~~~~~---~~---- 229 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK---DY---- 229 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHT---TC----
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhc---cC----
Confidence 6544444445557889999999998899999999999999999999 999996421 1112121111 10
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.... .......+.+++..||+.||.+|||+.++++.|+.
T Consensus 230 --~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 230 --RMER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCC----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 0001 11223568899999999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.76 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=195.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-------------------------hHHHHHHHHHHHH
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-------------------------GELQFQTEVEMIS 194 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-------------------------~~~~~~~e~~~l~ 194 (467)
.++|+..+.||+|+||.||+|+.. +|+.||||++....... ....+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367888999999999999999875 68899999996543211 1235889999999
Q ss_pred hcCCCeeeeeeeeeeC--CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCC
Q 012267 195 MAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 272 (467)
Q Consensus 195 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dl 272 (467)
+++||||+++++++.+ ....++||||+++++|.+++... ++++..++.++.|++.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 56789999999999998875432 489999999999999999999999 9999999
Q ss_pred CCCcEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 273 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 273 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998765332 2334456999999999997655 37889999999999999999999953
Q ss_pred ccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 350 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ...+..... ...... +. .......+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~--------~~~~~~~~~-~~~~~~---~~-----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER--------IMCLHSKIK-SQALEF---PD-----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS--------HHHHHHHHH-HCCCCC---CS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc--------HHHHHHHHh-cccCCC---CC-----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 112222111 111110 10 0112256889999999999999999999853
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=333.44 Aligned_cols=253 Identities=31% Similarity=0.555 Sum_probs=201.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchH------HHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGE------LQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
.++|+..+.||+|+||+||+|+.. +++.||||++......... ..+.+|++++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888899999999999999975 7899999998654433221 46889999999999999999999986654
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cccCCCCCCcEEECCCCc-----EE
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDEEFE-----AV 286 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~--ivH~dlk~~Nill~~~~~-----~k 286 (467)
++||||+++|+|.+++..... ++++..++.++.|++.||+|||++ + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 799999999999999876432 489999999999999999999999 7 999999999999988776 99
Q ss_pred EeecCCccccCCCCCeeeeccccccccccccccc--CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 287 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 287 l~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
|+|||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..... ....+.
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~ 239 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY------GKIKFI 239 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------CHHHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------cHHHHH
Confidence 999999974332 234456899999999984 45678999999999999999999999964211 111111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...... .. .+.+. ......+.+++..||+.||.+|||+.+|++.|++
T Consensus 240 ~~~~~~-~~----~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 NMIREE-GL----RPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHS-CC----CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHhcc-CC----CCCCC----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111111 11 11111 1223568899999999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=347.29 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=199.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 217 (467)
++|+..+.||+|+||.||+|+.. +|+.||+|+++..... .....+..|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888899999999999999976 6889999999765332 2334578899999887 899999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||................+.........
T Consensus 162 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 162 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 22 2234456799999999999999999999999999999999999999964222111111111122221111111
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
.+. ......+.+++.+||+.||.+||++
T Consensus 237 --~~p----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RIP----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCC----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCC----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 1123568889999999999999996
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=356.44 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=207.7
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMT 210 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 210 (467)
+.++....++|+..++||+|+||+||+|+.. +++.||+|+++.... ......+.+|+.++..++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566789999999999999999999976 689999999864211 1112247889999999999999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
....++||||+++|+|.+++.... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~-----~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999997642 88999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCC----CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHH
Confidence 999876544433445677999999999997655 7899999999999999999999996321 1122222
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~ 416 (467)
....... ...|.. ......+.+++.+||+.+|.+ ||+++||++
T Consensus 285 i~~~~~~--~~~p~~-----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 IMNHKNS--LTFPDD-----NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHTHHHH--CCCCTT-----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHhcccc--ccCCCc-----ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 2221100 001100 011256888999999999988 999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=348.77 Aligned_cols=245 Identities=28% Similarity=0.370 Sum_probs=195.6
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 215 (467)
..++|+..++||+|+||+||+|+.. +|+.||||+++... .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999976 68999999997532 122344678899999988 6999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999998653 289999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 174 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~---- 240 (353)
T 3txo_A 174 GIC-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE---- 240 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC----
T ss_pred ccc-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC----
Confidence 332 2233445679999999999998889999999999999999999999996421 112222222211
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
...|. .....+.+++.+||+.||.+||++
T Consensus 241 ~~~p~-------~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 VVYPT-------WLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCCCT-------TSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCC-------CCCHHHHHHHHHHhhhCHHHccCC
Confidence 11111 122568889999999999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=335.42 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=208.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
.++|+..+.||+|+||.||+|...++..||+|++..... ....+.+|++++..++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 467888899999999999999998888999999976432 345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999986532 389999999999999999999999 99999999999999999999999999998654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 379 (467)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..+.......... ...+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~~~---~~~~ 227 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR---LYKP 227 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC---CCCC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcCCc---CCCC
Confidence 222223446788999999988889999999999999999999 899995321 1122222211110 0111
Q ss_pred cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 380 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. .....+.+++.+||+.+|.+||++.++++.|++
T Consensus 228 ~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 228 R-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp T-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c-------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 122568899999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=338.00 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=193.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc---chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|+..+.||+|+||+||+|.+. |..||||+++..... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888899999999999999985 889999998754322 2235688999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC--------CCcEEEee
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE--------EFEAVVGD 289 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~--------~~~~kl~D 289 (467)
|||+++++|.+++... .+++..++.++.|++.||+|||++...+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998643 3899999999999999999999992222999999999999986 67899999
Q ss_pred cCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..........
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------GLAVAYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHT
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHhhhc
Confidence 99998654322 223468999999999998899999999999999999999999995321 1111111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. ... ... .......+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 229 ~-~~~----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 N-KLA----LPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp S-CCC----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C-CCC----CCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1 110 011 11223568899999999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=352.63 Aligned_cols=253 Identities=17% Similarity=0.264 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|+..+.||+|+||+||+|... +|+.||+|++....... ....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467888999999999999999865 78999999997654332 3446889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC---CCCcEEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~ 295 (467)
||+++|+|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999998753 389999999999999999999999 999999999999998 467899999999987
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........... ...
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~-~~~- 231 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQQIKAG-AYD- 231 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHT-CCC-
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhC-CCC-
Confidence 65332 22344679999999999999899999999999999999999999995321 11112221111 110
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+. .......+.+++..||+.||.+|||+.|+++
T Consensus 232 ~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00111 1112356889999999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=361.44 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=204.0
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC-ceEEE
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLV 217 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv 217 (467)
...++|+..+.||+|+||.||+|.+. |+.||||+++... ....|.+|+.++++++||||+++++++.... ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 44567888899999999999999985 7899999997643 3457899999999999999999999987665 78999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999987532 2378999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.. .....++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ...... ........
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~~~~~---~i~~~~~~--- 405 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVP---RVEKGYKM--- 405 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-----TTTHHH---HHHTTCCC---
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHH---HHHcCCCC---
Confidence 22 112246889999999999999999999999999999998 999996421 111111 11111111
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. ....+...+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 406 ---~----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 406 ---D----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp ---C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---C----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0 111223678899999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=343.01 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=208.6
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+++..++|+..+.||+|+||+||+|...++..||||.++.... ....+.+|++++..++||||+++++++. .+..++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3445577888999999999999999998888999999975432 3457899999999999999999999986 456899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 9999999999999975321 1389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~~~--- 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGYR--- 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCC---
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHhcccC---
Confidence 5433333334456789999999988889999999999999999999 999995321 1122222211110
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+.. .......+.+++..||+.+|.+|||+.++++.|++
T Consensus 229 ---~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 229 ---MVR----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ---CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 001 11123568899999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=349.48 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=205.9
Q ss_pred CCCCCeeeecCceEEEEEEEC-----CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEE
Q 012267 144 FSNKNILGRGGFGKVYKGRLA-----DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 216 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 216 (467)
|+..+.||+|+||+||++.+. +++.||||+++..........+.+|++++..++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998653 58899999998765555566799999999999999999999999874 56799
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++.... +++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999997653 89999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCe--eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccccc------CCCCccHHHHHHHHh
Q 012267 297 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA------NDDDVMLLDWVKGLL 368 (467)
Q Consensus 297 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~ 368 (467)
...... ......++..|+|||.+.+..++.++||||||+++|+|+||+.||...... ..........+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 543322 223345788899999999888999999999999999999999999642210 000000000011111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. .............+.+++.+||+.||.+|||+.++++.|+.
T Consensus 265 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 265 ER---------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hc---------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11 11111112233678999999999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=345.06 Aligned_cols=252 Identities=19% Similarity=0.278 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|...+.||+|+||.||+|... +|..||+|++...... .....+.+|+.++..++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467899999999999999999975 6899999999765432 33456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC---cEEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~ 295 (467)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999997643 389999999999999999999999 999999999999998654 599999999986
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........... ...
T Consensus 181 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~~i~~~-~~~- 248 (362)
T 2bdw_A 181 VNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAG-AYD- 248 (362)
T ss_dssp CTTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT-CCC-
T ss_pred ecCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhC-CCC-
Confidence 5432 22334579999999999999899999999999999999999999995321 11222221111 110
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+ ........+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 YPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCcc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 01122356889999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=340.43 Aligned_cols=265 Identities=25% Similarity=0.356 Sum_probs=189.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||+||+|... +|+.||||+++..........+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999865 6899999999765544444578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 220 YMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|++ |+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999987532 1223489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc---c
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---L 373 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 373 (467)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+........ .
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-----DEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCChhHh
Confidence 3222 2233468999999999876 468999999999999999999999996421 1111111111110000 0
Q ss_pred cc-----ccCccccC------------cccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 374 EM-----LVDPDLQN------------NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 374 ~~-----~~d~~~~~------------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
.. ...+.+.. .........+.+++.+||+.||.+|||+.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 00 00000000 00011235688999999999999999999884
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=341.22 Aligned_cols=263 Identities=24% Similarity=0.388 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCceEEEEEEE-----CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--Cce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 214 (467)
+.|+..+.||+|+||.||+|++ .+++.||||+++..........+.+|++++..++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577889999999999999984 368899999998665555566899999999999999999999999876 668
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999965432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCe--eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccc------cCCCC-ccHHHHHH
Q 012267 295 LMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL------ANDDD-VMLLDWVK 365 (467)
Q Consensus 295 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~------~~~~~-~~~~~~~~ 365 (467)
........ ......||..|+|||.+.+..++.++||||||+++|+|+||..|+..... ..... .....+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76544332 22344578889999999988899999999999999999999998753210 00011 11111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
....... ..........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 255 ~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 255 TLKEGKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhccCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111110 00111223678899999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.44 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=198.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...+.||+|+||+||+|... ++..||+|++...........+.+|++++..++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888899999999999999975 68999999998766555567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE---CCCCcEEEeecCCccccC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~ 297 (467)
+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999865432233489999999999999999999999 99999999999999 456789999999998654
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. .......|++.|+|||.+. ..++.++||||||+++|||++|+.||.... ..+.......... ....
T Consensus 179 ~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~-~~~~ 246 (285)
T 3is5_A 179 SD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEP-NYAV 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC-CCCC
T ss_pred Cc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCc-cccc
Confidence 32 2233456899999999885 468999999999999999999999996421 1111111111100 0000
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .. .....+.+++.+||+.||.+|||+.||++
T Consensus 247 ~---~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E---CR----PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c---cC----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 01256788999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=353.94 Aligned_cols=264 Identities=25% Similarity=0.408 Sum_probs=211.3
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECC-C-----CEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLAD-G-----SLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
++...++|...+.||+|+||+||+|.... + ..||+|.++..........+.+|+.++..+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 45566789999999999999999998642 2 489999997765555566799999999999 8999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPP----------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 279 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill 279 (467)
..+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999975321 123489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCC
Q 012267 280 DEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDD 357 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 357 (467)
+.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||+| |..||.... ..
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~ 273 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL----VN 273 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----SS
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc----hh
Confidence 9999999999999986543322 22333456789999999998899999999999999999999 999995321 11
Q ss_pred ccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 358 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
......+ .... . ...+. .....+.+++..||+.||.+|||+.+|++.|++
T Consensus 274 ~~~~~~~----~~~~-~-~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 274 SKFYKLV----KDGY-Q-MAQPA-------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHHHHH----HHTC-C-CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHH----hcCC-C-CCCCC-------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1111111 1110 0 00111 112568899999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=341.34 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=210.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC--------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
..++|...+.||+|+||+||+|+.. ++..||||+++..........+.+|++++.++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578888999999999999999863 46789999998665555556789999999999 89999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEE
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 278 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nil 278 (467)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 99999999999999999999875421 12489999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCC
Q 012267 279 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDD 356 (467)
Q Consensus 279 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~ 356 (467)
++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----- 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-----
Confidence 999999999999999876543322 2223346789999999988889999999999999999999 999995321
Q ss_pred CccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 357 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..+.......... +.. .......+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus 265 ---~~~~~~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 ---VEELFKLLKEGHR------MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ---HHHHHHHHHHTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHhcCCC------CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1122222211111 011 111235688999999999999999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=359.04 Aligned_cols=264 Identities=19% Similarity=0.273 Sum_probs=209.2
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeee
Q 012267 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCM 209 (467)
Q Consensus 133 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 209 (467)
.+.++....++|+..++||+|+||+||+|+.. +++.||||+++.... ......+..|..++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45556667889999999999999999999986 578999999964211 111223789999999999999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
+.+..++||||+++|+|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999987422 389999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~ 290 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETY 290 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHH
Confidence 9999876544444455567999999999986 5678999999999999999999999996321 11112
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMD--RPKMSEVVR 416 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~ 416 (467)
........ ....|..... ....+.+++.+|+..+|++ ||+++|+++
T Consensus 291 ~~i~~~~~--~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 GKIMNHKE--RFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHTHHH--HCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred Hhhhhccc--cccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 22221100 0111111111 2256788999999888888 999998854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=338.39 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=203.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
..++|...+.||+|+||+||+|...+ +..||||.++..........+.+|+.++..++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678888999999999999998642 336999999876555556689999999999999999999999765 4568
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997643 2389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
.............++..|+|||.+.+..++.++||||||+++|||+| |+.||.... .......+. .....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-----~~~~~~~~~---~~~~~- 233 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVIGVLE---KGDRL- 233 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----GGGHHHHHH---HTCCC-
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-----hHHHHHHHh---cCCCC-
Confidence 65433333344457889999999988899999999999999999998 999995321 111211111 11110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..+ ......+.+++.+||+.+|.+|||+.++++.|++
T Consensus 234 --~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 234 --PKP-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp --CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 001 1122568899999999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=335.89 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=198.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||+|+||+||+|+..+|+.||||++...... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 467888999999999999999988999999999754322 2235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 976 99999876432 389999999999999999999999 99999999999999999999999999998754322
Q ss_pred CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc------
Q 012267 301 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL------ 373 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 373 (467)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+...... ......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~-~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRI-LGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHH-HCCCCTTTSTTG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHH-HCCCChhhchhh
Confidence 22233458999999999876 4589999999999999999999999964211 0111111111 000000
Q ss_pred --ccccCcccc-------CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 --EMLVDPDLQ-------NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 --~~~~d~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000111110 0011122356789999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=346.65 Aligned_cols=263 Identities=24% Similarity=0.413 Sum_probs=193.7
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECC-C---CEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-G---SLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
....++|+..+.||+|+||+||+|.... + ..||||+++... .......+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3455789999999999999999998653 3 279999997653 2334557899999999999999999999998776
Q ss_pred ce------EEEeeccCCCChhhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 213 ER------LLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 213 ~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
.. ++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 55 99999999999999996532 2223589999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHH
Q 012267 285 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 362 (467)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... .....
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~- 249 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-----NAEIY- 249 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHH-
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-----hHHHH-
Confidence 99999999986543222 12223346788999999999999999999999999999999 999996421 11111
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 363 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.......... ........+.+++.+||+.||.+|||+.++++.|++.
T Consensus 250 --~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 --NYLIGGNRLK----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp --HHHHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHhcCCCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111100 0112235688999999999999999999999999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=345.48 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=201.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|++++..++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888899999999999999976 68899999986432 1223456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+.+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999998643 389999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCeeeecccccccccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||.... .............. ..
T Consensus 168 --~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~-~~-- 237 (384)
T 4fr4_A 168 --ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-----STSSKEIVHTFETT-VV-- 237 (384)
T ss_dssp --TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT-----TSCHHHHHHHHHHC-CC--
T ss_pred --CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhhc-cc--
Confidence 223445679999999999864 458999999999999999999999996421 11122222221111 00
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC-HHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVV 415 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl 415 (467)
. ........+.+++..||+.||.+||+ +.+|.
T Consensus 238 -~-------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 238 -T-------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -C-------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -C-------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 0 01112356889999999999999998 66654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.36 Aligned_cols=258 Identities=17% Similarity=0.189 Sum_probs=205.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|+..+.||+|+||+||+|+. .+|+.||||++...... ..+..|++++..+ +|+||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 36788899999999999999996 47899999998754322 2578999999999 9999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc-----EEEeecCCc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLA 293 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~ 293 (467)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 999999998642 2489999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCCe------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHH
Q 012267 294 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 367 (467)
Q Consensus 294 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 367 (467)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i 232 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKI 232 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHH
Confidence 876433221 1234579999999999999999999999999999999999999996421 11222222221
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 368 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 368 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...... ....... .... .+.+++..||+.+|.+||++.+|++.|++
T Consensus 233 ~~~~~~---~~~~~~~---~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 233 GDTKRA---TPIEVLC---ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHHHH---SCHHHHT---TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred Hhhhcc---CCHHHHh---ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 111000 0000000 0112 78899999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.96 Aligned_cols=271 Identities=26% Similarity=0.404 Sum_probs=216.4
Q ss_pred ccCHHHHHHHhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeee
Q 012267 131 RFSLRELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLR 203 (467)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 203 (467)
.+...++....++|...+.||+|+||+||+|+. .+++.||||+++..........+.+|+.++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345666777788999999999999999999974 256899999998765555556789999999999 7999999
Q ss_pred eeeeeeCCC-ceEEEeeccCCCChhhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccC
Q 012267 204 LRGFCMTPT-ERLLVYPYMANGSVASCLRERPPS------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHR 270 (467)
Q Consensus 204 ~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~ 270 (467)
+++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999988754 489999999999999999875432 12378999999999999999999999 99999
Q ss_pred CCCCCcEEECCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcc
Q 012267 271 DVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFD 348 (467)
Q Consensus 271 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~ 348 (467)
||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986643332 23334557889999999998899999999999999999998 999995
Q ss_pred cccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 349 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
... ... ........... ..... .....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 253 ~~~----~~~---~~~~~~~~~~~------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVK----IDE---EFCRRLKEGTR------MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCC----CSH---HHHHHHHHTCC------CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc----hhH---HHHHHhccCcc------CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 421 111 11111111111 00111 1225688999999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=341.04 Aligned_cols=246 Identities=24% Similarity=0.283 Sum_probs=193.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|+..++||+|+||+||+|+.. +|+.||||++...... .....+..|+..+.++ +|+||++++++|.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367889999999999999999986 7999999998654332 2333455666655555 899999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+ +++|.+++..... .++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 6799998876532 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .| .. +.... .
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~-~~-~~~~~----~ 269 (311)
T 3p1a_A 209 TA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GW-QQ-LRQGY----L 269 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HH-HH-HTTTC----C
T ss_pred cC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HH-HH-HhccC----C
Confidence 32 22334568999999999876 78999999999999999999977664211 11 11 11111 1
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+ .......+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 1112366889999999999999999999964
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=339.05 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECC-----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.+|+..+.||+|+||+||+|.... +..||||+++..........+.+|+.++..++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 466677899999999999998642 236999999866555556679999999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999986432 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCe--eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 297 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 297 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+...........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFRL 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCCcC
Confidence 432211 1222345788999999998899999999999999999999 999995321 11222222111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
. . .......+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 270 ~------~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 270 P------T----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp C------C----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C------C----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 112235688999999999999999999999999873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.24 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=198.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999975 68999999997654333 34578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++ +|.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 6666665432 2389999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCeeeecccccccccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc----
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---- 374 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 374 (467)
. .......||+.|+|||++.+.. ++.++|||||||++|||++|..||... .........+..........
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~----~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC----SSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC----CCHHHHHHHHHHHhCCCChhhhhh
Confidence 2 2233456899999999997765 799999999999999999998886321 11111111111111100000
Q ss_pred --cccC-------c--cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 --MLVD-------P--DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 --~~~d-------~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+ + .............+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0 0000111123356789999999999999999999854
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=334.22 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=202.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC--CceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 218 (467)
++|...+.||+|+||+||+|++. |+.||||+++.... ......+.+|+.++.+++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57888899999999999999985 88999999976543 33345789999999999999999999999887 7789999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. + ++||||||+||+++.++.++|+|||+....
T Consensus 89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999987532 3489999999999999999999998 7 999999999999999999999999887643
Q ss_pred CCCCCeeeecccccccccccccccCCCCCc---chhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
.. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.... ............
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~-- 227 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEG-- 227 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSC--
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcC--
Confidence 22 2235789999999998765544 8999999999999999999995321 111111111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..+.+.. .....+.+++..||+.||.+|||+.++++.|++.
T Consensus 228 ---~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 ---LRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ---CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1111111 1235688999999999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=335.54 Aligned_cols=262 Identities=28% Similarity=0.446 Sum_probs=196.4
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
+..++|+..+.||+|+||+||+|+.. ..||||+++..... .....+.+|+++++.++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34578899999999999999999864 35999999765433 3345789999999999999999999975 45668999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999997543 2389999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC-Ceeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 298 YKD-THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 298 ~~~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
... ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||.... . ... +.........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~---~~~-~~~~~~~~~~ 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----N---RDQ-IIEMVGRGSL 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----C---HHH-HHHHHHHTSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----h---HHH-HHHHhccccc
Confidence 221 22233456899999999986 5678899999999999999999999995321 1 111 1111111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
. +.+. .........+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 244 ~----~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 S----PDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C----CCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred C----cchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 1110 011123367899999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=333.55 Aligned_cols=259 Identities=15% Similarity=0.160 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|+..+.||+|+||.||+|.. .+|+.||||++...... ..+.+|+.++..+ +|+|++++++++......++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 46788899999999999999996 47899999998654322 2478899999999 7999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc-----EEEeecCCc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLA 293 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~ 293 (467)
||+ +++|.+++..... ++++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 9999999986532 389999999999999999999999 9999999999999987776 999999999
Q ss_pred cccCCCCCe------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHH
Q 012267 294 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 367 (467)
Q Consensus 294 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 367 (467)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~ 233 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-----ATNKQKYERI 233 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS-----CCHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc-----cccHHHHHHH
Confidence 876543221 23445689999999999999999999999999999999999999964221 1111111111
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 368 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 368 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
....... ..+.+. ......+.+++..||+.+|.+||++.+|++.|++
T Consensus 234 ~~~~~~~--~~~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 234 GEKKQST--PLRELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHHHHS--CHHHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HhhccCc--cHHHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 1110000 000000 1123678899999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=344.72 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
.++|+..++||+|+||+||+|.+. +++ +||+|.+...........+.+|+.++..++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367888899999999999999864 444 468888876555566778999999999999999999999998754 78
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+|++|+.+|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999987532 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 296 MDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 296 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
...... .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||.... ...+...+.. ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~~~~---~~~~ 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK---GERL 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHHT---TCCC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc---CCCC
Confidence 643222 12223446788999999999999999999999999999999 999996421 1112221111 1100
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
. . .......+.+++.+||+.||.+||++.|+++.|+...
T Consensus 239 ~------~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 P------Q----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp C------C----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C------C----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 0 1112256889999999999999999999999998743
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=348.71 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++|+..++||+|+||+||+|.+. ++. +||+|.+...........+.+|+.++..++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56788899999999999999865 444 388888865443333345778999999999999999999986 456899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+.+|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999986422 388889999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... ......++..|+|||++.+..++.++||||||+++|||+| |+.||.... .......+. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~---~~~~-- 235 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-----LAEVPDLLE---KGER-- 235 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----TTHHHHHHH---TTCB--
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-----HHHHHHHHH---cCCC--
Confidence 543322 2334557889999999998899999999999999999999 999996421 111212111 1111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
...+.. ....+.+++.+||+.||.+||++.++++.|+...
T Consensus 236 -~~~~~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 -LAQPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -CCCCTT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -CCCCCc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 1234778999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.18 Aligned_cols=244 Identities=28% Similarity=0.372 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|+||+||+|+.. +|+.||+|+++.... ......+.+|..++..++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999976 799999999965321 123446788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999998753 389999999999999999999999 999999999999999999999999999986542
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~----- 220 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE-L----- 220 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC-C-----
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C-----
Confidence 2234579999999999999999999999999999999999999995321 112222222211 0
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVV 415 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl 415 (467)
.+.. .....+.+++.+|++.||.+|| ++++|+
T Consensus 221 -~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 221 -RFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp -CCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred -CCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 0111 1225688999999999999999 788875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=341.41 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=187.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||+||+|+.. +++.||||+++... ....+.+|++++.+++||||+++++++...+..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 467888899999999999999986 58899999997543 23467899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEEeecCCcccc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKLM 296 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~ 296 (467)
|+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999997643 389999999999999999999999 9999999999999975 889999999999865
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ........... .. .
T Consensus 202 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~---~~~~~~i~~~~-~~-~ 270 (349)
T 2w4o_A 202 EHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER----GD---QFMFRRILNCE-YY-F 270 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT----CH---HHHHHHHHTTC-CC-C
T ss_pred Ccc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc----cc---HHHHHHHHhCC-Cc-c
Confidence 422 22334568999999999999899999999999999999999999995321 11 11111111111 00 0
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+ ........+.+++.+||+.||++|||+.|+++
T Consensus 271 ~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 11122356889999999999999999999865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=341.75 Aligned_cols=269 Identities=24% Similarity=0.394 Sum_probs=215.4
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 205 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 205 (467)
+..++++...++|+..+.||+|+||.||+|... ++..||||++...........+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444555667788999999999999999999754 36789999997665555556789999999999999999999
Q ss_pred eeeeCCCceEEEeeccCCCChhhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE
Q 012267 206 GFCMTPTERLLVYPYMANGSVASCLRERP------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 279 (467)
Q Consensus 206 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill 279 (467)
+++.+.+..++||||+++|+|.+++.... ....++++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999987532 1123478999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCC
Q 012267 280 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDD 357 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 357 (467)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence 99999999999999865432221 1122346789999999998899999999999999999999 899985321
Q ss_pred ccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 358 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..+......... ... . .......+.+++.+||+.||.+|||+.++++.|++.
T Consensus 246 --~~~~~~~~~~~~-~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 246 --NEQVLRFVMEGG-LLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp --HHHHHHHHHTTC-CCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HHHHHHHHHcCC-cCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 112222221111 100 0 112235688999999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.19 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=199.1
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788889999999999999997 4789999999864321 112346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+ +|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 689999887643 389999999999999999999999 999999999999999999999999999986542
Q ss_pred CCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+.
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~i~ 221 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKKVN 221 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCCCC
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHHHH
Confidence 222344569999999999988776 7899999999999999999999964221110 00000
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000 011112356789999999999999999999964
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.34 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=202.0
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCc
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 213 (467)
....++|...++||+|+||+||+|+.. +|+.||||+++.... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999976 689999999975321 22344677888888876 89999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999998643 289999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 166 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-- 234 (345)
T 1xjd_A 166 KENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDN-- 234 (345)
T ss_dssp BCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC--
T ss_pred hhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCC--
Confidence 854322 223445679999999999999999999999999999999999999996321 112222221111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS-EVV 415 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl 415 (467)
+.+.. .....+.+++.+||+.||.+||++. +|+
T Consensus 235 -----~~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----PFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111 1225688999999999999999997 553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=374.02 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=208.2
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+++..++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++|+||+++++++.+ +..++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3444566777889999999999999998888899999976432 34579999999999999999999999876 67899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 339 v~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 9999999999999975321 2388999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
............++..|+|||++.+..++.++|||||||+||||+| |+.||.... ..+............
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~~- 484 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRMP- 484 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHHHHHHHHTTCCCC-
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCCC-
Confidence 4221111223346788999999998899999999999999999999 999995321 112222221111110
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
....+...+.+++.+||+.||++|||+.+|+++|++.
T Consensus 485 ---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 485 ---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0112235688999999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=351.06 Aligned_cols=271 Identities=18% Similarity=0.219 Sum_probs=213.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC--ceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 217 (467)
.++|...++||+|+||+||+|+.. +|+.||||+++..........+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357888899999999999999976 589999999976554455567889999999999999999999998755 67999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE----CCCCcEEEeecCCc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 293 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 293 (467)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986532 22389999999999999999999999 99999999999999 78888999999999
Q ss_pred cccCCCCCeeeecccccccccccccccC--------CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
+..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.+.
T Consensus 164 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~----~~~~~~ 237 (396)
T 4eut_A 164 RELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR----NKEVMY 237 (396)
T ss_dssp EECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT----CHHHHH
T ss_pred eEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc----hHHHHH
Confidence 875432 22234568999999999864 5678899999999999999999999964221111 122222
Q ss_pred HHhhhcccc---cc---------cCcc--ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 366 GLLKEKKLE---ML---------VDPD--LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 366 ~~~~~~~~~---~~---------~d~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
......... .+ .... ............+.+++..||+.||++||++.++++.++++
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 222221110 00 0001 11223466777889999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=335.44 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=198.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||.||+|... +++.||||++...... .....+.+|+.++.+++||||+++++++...+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 67888999999999999999975 7889999999754322 22357889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... ++++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 114 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 114 RLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp ECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998643 389999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
..........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ .
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~----~ 253 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQAIP----R 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSCCC----C
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccCCC----C
Confidence 333333445689999999999998999999999999999999999999964211 111111111110 0
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-KMSEVVRMLEGDG 422 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~ 422 (467)
+. .........+.+++.+||+.||++|| +++++++.|+...
T Consensus 254 ~~---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 PS---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GG---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cc---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 10 00111225688899999999999999 9999999998743
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.68 Aligned_cols=251 Identities=19% Similarity=0.291 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...+.||+|+||+||+|... +|+.||+|++.... ......+.+|++++..++||||+++++++.+....++||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 57888999999999999999975 78999999996543 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC--CCcEEEeecCCccccCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~ 298 (467)
+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999997643 2389999999999999999999999 9999999999999974 46799999999987653
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ...+
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~~---~~~~ 270 (387)
T 1kob_A 204 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCD---WEFD 270 (387)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCC---CCCC
T ss_pred Cc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC---CCCC
Confidence 32 2233468999999999999999999999999999999999999996321 111222211111 0111
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+... ......+.+++.+||+.||.+|||+.|+++
T Consensus 271 ~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 271 EDAF----SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp SSTT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1111 122356889999999999999999999965
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=337.50 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=192.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEE----CCCCEEEEEEeccCCC---cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
.++|+..++||+|+||.||+++. .+|+.||+|+++.... ......+.+|+.++..++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788899999999999999987 4789999999976432 2223457889999999999999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997643 288999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ............ .
T Consensus 169 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~-~ 238 (327)
T 3a62_A 169 KESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKCK-L 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC-C
T ss_pred cccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC-C
Confidence 754322 223344579999999999999899999999999999999999999996321 112222222211 0
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
.+. ......+.+++.+||+.||.+|| ++.|+++
T Consensus 239 ------~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ------NLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011 11225688999999999999999 5666643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=370.88 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=197.9
Q ss_pred eeeecCceEEEEEEEC---CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 149 ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
.||+|+||.||+|.+. ++..||||+++..........+.+|+++++.++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4667999999876555566789999999999999999999999976 56899999999999
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeee-
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT- 304 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~- 304 (467)
|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 999997642 2489999999999999999999999 999999999999999999999999999987643322211
Q ss_pred -ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcccc
Q 012267 305 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 382 (467)
Q Consensus 305 -~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 382 (467)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||.... .... ..........
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~~~---~~~i~~~~~~--------- 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEV---MAFIEQGKRM--------- 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----SHHH---HHHHHTTCCC---------
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHH---HHHHHcCCCC---------
Confidence 22235689999999998999999999999999999998 999996421 1112 1111111111
Q ss_pred CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 383 NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 383 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.....+...+.+++..||+.+|.+||++.+|++.|+.
T Consensus 559 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0111233678899999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.51 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=204.9
Q ss_pred cCCCCCC-eeeecCceEEEEEEEC---CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKN-ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~-~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++|...+ .||+|+||.||+|.+. ++..||||+++..........+.+|++++..++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999854 57889999998765555566799999999999999999999999 45668999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999997542 2489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCeee--ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 298 YKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 298 ~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
....... ....+|+.|+|||++.+..++.++||||||+++|||+| |+.||.... .. +..........
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~---~~~~~i~~~~~-- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GP---EVMAFIEQGKR-- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----TH---HHHHHHHTTCC--
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HH---HHHHHHhcCCc--
Confidence 4333221 22346789999999988889999999999999999999 999995321 11 11111111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+.. .......+.+++..||+.+|.+||++.+|++.|++
T Consensus 232 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 232 ----MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp ----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 11223678899999999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=352.33 Aligned_cols=264 Identities=21% Similarity=0.265 Sum_probs=207.4
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFC 208 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 208 (467)
+.+++.....++|+..++||+|+||+||+|+.. +|+.||||+++.... ......+..|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667789999999999999999999975 799999999964221 11122478899999999999999999999
Q ss_pred eCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEe
Q 012267 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 288 (467)
Q Consensus 209 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 288 (467)
.+.+..++||||+++|+|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999999986422 389999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCeeeeccccccccccccccc-------CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHH
Q 012267 289 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 289 Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~ 361 (467)
|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~ 276 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TA 276 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HH
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HH
Confidence 99999876544443444567999999999987 3568999999999999999999999995321 11
Q ss_pred HHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 012267 362 DWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR---PKMSEVVR 416 (467)
Q Consensus 362 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~evl~ 416 (467)
+.......... ....|... ......+.+++.+||. +|.+| |+++||++
T Consensus 277 ~~~~~i~~~~~--~~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 277 ETYGKIVHYKE--HLSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHHhccc--CcCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11222221100 00011111 1123568899999999 99998 58888743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=336.14 Aligned_cols=260 Identities=21% Similarity=0.339 Sum_probs=197.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.+.||+|+||.||+|... +|..||||+++... .......+.+|+.++..++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888899999999999999974 78999999997533 2334457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999975332334589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+....... ...
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~~---- 256 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQC-DYP---- 256 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHHTT-CSC----
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHHhhcc-cCC----
Confidence 22 22233458999999999999999999999999999999999999995321 1122222222111 111
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
... .......+.+++.+||+.||.+|||+.+|++.|++
T Consensus 257 -~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 257 -PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp -CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111 01123568899999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.34 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=201.3
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHh--cCCCeeeeeeeeeeCC---
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP--- 211 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~--- 211 (467)
.....++|+..+.||+|+||.||+|+.. |+.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445578999999999999999999986 899999998542 23345556666554 4899999999999876
Q ss_pred -CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCcccCCCCCCcEEECCCCcE
Q 012267 212 -TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC-----DPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 212 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~ 285 (467)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 6789999999999999999764 2899999999999999999999862 3489999999999999999999
Q ss_pred EEeecCCccccCCCCCee---eecccccccccccccccCCCCCcc------hhHHHHHHHHHHHHcC----------CCC
Q 012267 286 VVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTGKSSEK------TDVFGYGIMLLELITG----------QRA 346 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------sDv~s~Gvil~elltg----------~~p 346 (467)
||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997654332221 124568999999999987766554 9999999999999999 555
Q ss_pred cccccccCCCCccHHHHHHHHhhhcccccccCccccCc-ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 347 FDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
|..... .......+ ......... .+..... ........+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 262 ~~~~~~---~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 262 YHDLVP---SDPSYEDM-REIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTTSC---SSCCHHHH-HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhhcC---CCCchhhh-HHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 532211 11111111 121111111 1111111 123567889999999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=334.10 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=195.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
++|+..+.||+|+||+||+|+.. ++.||||++... .....+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 56778899999999999999985 788999998642 345578999999999999999999999874 489999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc-EEEeecCCccccCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDYKD 300 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~ 300 (467)
++|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999986532 223788999999999999999999932228999999999999988876 799999999754322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||.... . ............. .+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~--~~~~~~~~~~~~~------~~~ 224 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG----G--PAFRIMWAVHNGT------RPP 224 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC----S--SHHHHHHHHHTTC------CCC
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC----c--cHHHHHHHHhcCC------CCC
Confidence 223458999999999999999999999999999999999999996321 1 1111111111111 111
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
... .....+.+++.+||+.||.+|||+.++++.|+..
T Consensus 225 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 225 LIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp CBT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111 1225688999999999999999999999999873
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.41 Aligned_cols=267 Identities=23% Similarity=0.326 Sum_probs=210.2
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHh--cCCCeeeeeeeeeeCC
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP 211 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~ 211 (467)
........++|...+.||+|+||+||+|+. +|+.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 333455667899999999999999999998 4899999998542 34567788888887 7899999999999877
Q ss_pred C----ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCcccCCCCCCcEEE
Q 012267 212 T----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH--------DHCDPKIIHRDVKAANILL 279 (467)
Q Consensus 212 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh--------~~~~~~ivH~dlk~~Nill 279 (467)
. ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 5 789999999999999999764 2899999999999999999999 66 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCe---eeecccccccccccccccCC------CCCcchhHHHHHHHHHHHHcC-------
Q 012267 280 DEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGIMLLELITG------- 343 (467)
Q Consensus 280 ~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~sDv~s~Gvil~elltg------- 343 (467)
+.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999876544332 22344689999999998765 234789999999999999999
Q ss_pred ---CCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCc-ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 344 ---QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 344 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
..||..... .......+....... ...+.+... ........+.+++.+||+.||.+|||+.+|++.|+
T Consensus 261 ~~~~~p~~~~~~---~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 261 EDYQLPYYDLVP---SDPSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCCTTTTTSC---SSCCHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccCccccCc---CcccHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 667753211 122233333222211 112222111 12356678999999999999999999999999998
Q ss_pred cC
Q 012267 420 GD 421 (467)
Q Consensus 420 ~~ 421 (467)
++
T Consensus 333 ~i 334 (342)
T 1b6c_B 333 QL 334 (342)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=337.78 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=179.9
Q ss_pred CCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEeeccCCC
Q 012267 147 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANG 224 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g 224 (467)
.+.||+|+||+||+|... +|+.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 6899999999643 3456789999999997 999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC---cEEEeecCCccccCCCCC
Q 012267 225 SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 225 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~~ 301 (467)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..... .
T Consensus 92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~ 163 (325)
T 3kn6_A 92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-N 163 (325)
T ss_dssp BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-C
Confidence 9999998753 389999999999999999999999 999999999999997665 8999999999865432 2
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 381 (467)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+........ .. ..
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~-~~------~~ 235 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKG-DF------SF 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTT-CC------CC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcC-CC------CC
Confidence 22334568999999999999999999999999999999999999996532111 111122222222111 10 01
Q ss_pred cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 382 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
...........+.+++..||+.||.+|||+.|++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 1111122346788999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.02 Aligned_cols=266 Identities=17% Similarity=0.200 Sum_probs=201.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEECC------CCEEEEEEeccCCCcchH----------HHHHHHHHHHHhcCCCeeee
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLAD------GSLVAVKRLKEERTPGGE----------LQFQTEVEMISMAVHRNLLR 203 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~~------g~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~l~h~niv~ 203 (467)
..++|.+.+.||+|+||+||+|.+.. ++.||||++......... ..+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34678889999999999999998764 478999998654321100 12334555667788999999
Q ss_pred eeeeeeCC----CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE
Q 012267 204 LRGFCMTP----TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 279 (467)
Q Consensus 204 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill 279 (467)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4579999999 999999998742 2489999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEeecCCccccCCCCCe------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccc
Q 012267 280 D--EEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR 351 (467)
Q Consensus 280 ~--~~~~~kl~Dfgl~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~ 351 (467)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999875432111 1133459999999999999999999999999999999999999996421
Q ss_pred ccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 352 LANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.......+...... ..+..++++.+... .....+.+++..||+.+|.+||++.+|++.|++
T Consensus 266 ----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 ----KDPKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp ----TCHHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ----cCHHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11222222222111 12222233222111 113568899999999999999999999999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=349.55 Aligned_cols=254 Identities=31% Similarity=0.490 Sum_probs=193.4
Q ss_pred CCCCCCeeeecCceEEEEEEEC--C--CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-CCceEEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA--D--GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLV 217 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 217 (467)
.|...++||+|+||+||+|... + +..||||.++..........+.+|+.++++++||||++++++|.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556688999999999999864 2 246899999765555556689999999999999999999998764 4578999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++..... .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999986432 378999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCe---eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 298 YKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 298 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
..... ......++..|+|||.+.+..++.++|||||||++|||+| |..||.... .......+. ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~~~~---~~~~- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLL---QGRR- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHHHHH---TTCC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHHHHH---cCCC-
Confidence 32211 1223446789999999999999999999999999999999 677775321 112222111 1111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...+. .....+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 315 --~~~p~-------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 315 --LLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp --CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111 122568899999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=345.91 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=195.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCC--CeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv 217 (467)
.++|++.+.||+|+||+||++...+++.||||++...... .....+.+|+.++..++| +||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999888999999999755433 234578899999999986 9999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|| +.+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 56889999998753 389999999999999999999999 999999999999997 5789999999998764
Q ss_pred CCCCe-eeecccccccccccccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 298 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 298 ~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... . ......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~-~~~~~~ 231 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------N-QISKLH 231 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------S-HHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------h-HHHHHH
Confidence 33222 2334569999999999864 678999999999999999999999995311 1 111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
.... +.............+.+++..||+.||.+|||+.|+++.
T Consensus 232 ~~~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 AIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 111111111112568899999999999999999999753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.79 Aligned_cols=255 Identities=28% Similarity=0.403 Sum_probs=201.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CC---CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce-EEE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-LLV 217 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv 217 (467)
.|...++||+|+||+||+|.+. ++ ..||+|.+...........+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3445588999999999999853 22 379999997655555556789999999999999999999999876655 999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999998743 2389999999999999999999999 99999999999999999999999999998653
Q ss_pred CCC---CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 298 YKD---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 298 ~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
... ........++..|+|||.+.+..++.++||||||+++|+|++|..|+.. ..........+.. ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~----~~~~~~~~~~~~~---~~~~- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR----HIDPFDLTHFLAQ---GRRL- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT----TSCGGGHHHHHHT---TCCC-
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc----cCCHHHHHHHhhc---CCCC-
Confidence 221 1222334578899999999999999999999999999999996665422 1111222222111 1100
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. .......+.+++.+||+.||.+|||+.++++.|++
T Consensus 248 -----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 248 -----PQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp -----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 11122568899999999999999999999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=339.93 Aligned_cols=244 Identities=23% Similarity=0.296 Sum_probs=201.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..+.||+|+||.||+|+.. +|+.||||+++.... ......+.+|++++..++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999976 789999999864321 123456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998643 289999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~-~~----- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSG-KV----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC-----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcC-CC-----
Confidence 2 234568999999999999999999999999999999999999995321 11222222221 11
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVV 415 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl 415 (467)
.+. ......+.+++.+||+.||.+||+ +++|+
T Consensus 256 -~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~ 292 (350)
T 1rdq_E 256 -RFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp -CCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred -CCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH
Confidence 011 112356889999999999999998 77764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=341.00 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=193.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|...+.||+|+||+||+++.. +++.||||++...... ...+.+|+.+++.++||||+++++++.+....++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467888999999999999999976 7899999999754332 3468899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc--EEEeecCCccccC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMD 297 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~~~ 297 (467)
|+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999997643 289999999999999999999999 9999999999999987765 9999999997432
Q ss_pred CCCCeeeecccccccccccccccCCCCCcc-hhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... ........+........ .
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~~~~~~~~-~-- 240 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----EPRDYRKTIQRILSVKY-S-- 240 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCC-C--
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhcCCC-C--
Confidence 21 22234468999999999988777655 899999999999999999996422 11222232222222110 0
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
... .......+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 241 IPD------DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCT------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCC------cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000 0011256889999999999999999999976
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=340.10 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=199.3
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 215 (467)
..++|+..++||+|+||+||+|+.. +|+.||||+++... .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4468899999999999999999986 58899999997532 122344678899999887 7999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999998643 289999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 171 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-~-- 238 (353)
T 2i0e_A 171 NIW-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN-V-- 238 (353)
T ss_dssp CCC-TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C--
T ss_pred ccc-CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC-C--
Confidence 432 2223445679999999999999999999999999999999999999996321 112222222211 0
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
.+ .......+.+++.+||+.||.+||++
T Consensus 239 ----~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 ----AY----PKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ----CC----CTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ----CC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01 11123568899999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.72 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=196.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcC--CCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv 217 (467)
.++|++.+.||+|+||+||+|...+++.||||++..... ......+.+|+.++.+++ |+||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 356888999999999999999988899999999976543 233457899999999996 59999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|| +.+++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 56889999998754 388999999999999999999999 999999999999996 5789999999998764
Q ss_pred CCCCe-eeecccccccccccccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 298 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 298 ~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHH
Confidence 33222 2344569999999999865 368899999999999999999999995311 1111122
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... .............+.+++.+||+.||.+|||+.||++
T Consensus 279 ~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 279 AIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCc---------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 22111 1100011111256889999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=333.29 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=204.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-----hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
.++|...+.||+|+||.||+|... +|+.||||.++...... ....+.+|+.++..++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888899999999999999976 68999999997543222 356789999999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC----cEEEeec
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 290 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 290 (467)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999998643 389999999999999999999999 999999999999999888 7999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITSV 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998754322 2234568999999999999999999999999999999999999995321 11222221111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ...++... ......+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~---~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 S---YDFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C---CCCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c---cccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00111111 112256889999999999999999999854
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=328.28 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=204.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888899999999999999976 7899999999765555556678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999997542 389999999999999999999999 9999999999999999999999999999865422
Q ss_pred CC-eeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 300 DT-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 300 ~~-~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. .......|+..|+|||.+.+..+ +.++||||||+++|+|++|+.||.... ........|... .. ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~----~~---~~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSDWKEK----KT---YL 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC---TTSHHHHHHHTT----CT---TS
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---hHHHHHHHhhhc----cc---cc
Confidence 21 22334568999999999987665 789999999999999999999996422 111112222110 00 00
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+ .......+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NP------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 1112356788999999999999999998854
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=335.44 Aligned_cols=255 Identities=33% Similarity=0.500 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee-CCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~l 216 (467)
.+|...++||+|+||+||+|...+ ...||+|.++..........+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998642 23689999976555555667999999999999999999999865 4567899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997643 2378999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC---eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 297 DYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 297 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||... ......... ....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~~~~---~~~~- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYL---LQGR- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-----CTTTHHHHH---HTTC-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-----CHHHHHHHH---hcCC-
Confidence 43221 12233457789999999999899999999999999999999 55555421 111111111 1111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
....+. .....+.+++.+||+.+|.+|||+.++++.|++
T Consensus 250 --~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 250 --RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp --CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCc-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011111 112568899999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=337.58 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=201.6
Q ss_pred HhcCCCCCC-eeeecCceEEEEEEEC---CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 140 ATDSFSNKN-ILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 140 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
..++|...+ .||+|+||+||+|.+. ++..||||+++..... .....+.+|++++..++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 8999999999999642 4688999999765332 2345789999999999999999999998 56678
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999998753 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeee--ecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 295 LMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 295 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
.......... ....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||.... . .+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~---~~~~~~~~~~~ 237 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----G---SEVTAMLEKGE 237 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----H---HHHHHHHHTTC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HHHHHHHHcCC
Confidence 7654433222 22335788999999988889999999999999999999 999996421 1 11111111111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. +.. .......+.+++..||+.||.+||++.+|++.|++
T Consensus 238 ~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 238 R------MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp C------CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 111 11223568899999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=338.89 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=193.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce---
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER--- 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--- 214 (467)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... .....+.+|++++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36788899999999999999997 47899999999765332 2334688999999999999999999998765443
Q ss_pred -EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 215 -LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 215 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
++||||+++++|.+++.... ++++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999998643 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 294 KLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 294 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
+....... .......||+.|+|||++.+..++.++||||||+++|||+||+.||.... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCC
Confidence 86643322 12233568999999999999999999999999999999999999995321 111111211111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. .+.. ........+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~----~~~~---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PI----PPSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CC----CHHH---HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CC----Cccc---ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 10 0000 00112356889999999999999997666543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=344.28 Aligned_cols=210 Identities=21% Similarity=0.295 Sum_probs=182.4
Q ss_pred cccccCHHHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-----CCee
Q 012267 128 QLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----HRNL 201 (467)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni 201 (467)
....+++.+.....++|...++||+|+||+||+|+.. +++.||||+++. .......+..|++++..+. ||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3455666666777889999999999999999999974 789999999964 2333446778999999886 9999
Q ss_pred eeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC
Q 012267 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE 281 (467)
Q Consensus 202 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~ 281 (467)
+++++++...+..++||||+ +++|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD 172 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence 99999999999999999999 89999999875432 389999999999999999999999 9999999999999986
Q ss_pred -------------------------CCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHH
Q 012267 282 -------------------------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIM 336 (467)
Q Consensus 282 -------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvi 336 (467)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 788999999999864432 234568999999999999999999999999999
Q ss_pred HHHHHcCCCCccc
Q 012267 337 LLELITGQRAFDL 349 (467)
Q Consensus 337 l~elltg~~p~~~ 349 (467)
+|+|+||+.||..
T Consensus 249 l~ell~g~~pf~~ 261 (360)
T 3llt_A 249 LAELYTGSLLFRT 261 (360)
T ss_dssp HHHHHHSSCSCCC
T ss_pred HHHHHHCCCCCCC
Confidence 9999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=340.16 Aligned_cols=261 Identities=22% Similarity=0.242 Sum_probs=200.0
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC----CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER----TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
....++|...+.||+|+||+||+|... ++..||+|++.... .......+.+|++++.+++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 445678999999999999999999975 78899999986432 2334557899999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 012267 213 ERLLVYPYMANGSVASCLRERPPS------------------------------------QLPLDWPTRKRIALGSARGL 256 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~gl 256 (467)
..++||||+++|+|.+++...... ...+++..++.++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998631100 11235677889999999999
Q ss_pred HHHHcCCCCCcccCCCCCCcEEECCCC--cEEEeecCCccccCCCC---CeeeecccccccccccccccC--CCCCcchh
Q 012267 257 SYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKD---THVTTAVRGTIGHIAPEYLST--GKSSEKTD 329 (467)
Q Consensus 257 ~~Lh~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~--~~~~~~sD 329 (467)
+|||+. +|+||||||+|||++.++ .+||+|||++..+.... ........||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 89999999998654322 112344568999999999865 67899999
Q ss_pred HHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCC
Q 012267 330 VFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP 409 (467)
Q Consensus 330 v~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 409 (467)
|||||+++|||++|+.||.... ..+........... ...+. .......+.+++.+||+.||.+||
T Consensus 259 iwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKLC--FENPN-----YNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC--TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhcccc--cCCcc-----cccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999995321 11222222221110 00111 111235688999999999999999
Q ss_pred CHHHHHH
Q 012267 410 KMSEVVR 416 (467)
Q Consensus 410 s~~evl~ 416 (467)
++.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=353.41 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=194.2
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
..++|+..++||+|+||.||+|... +|+.||||+++... .......+..|+.++..++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467888999999999999999975 78999999997532 22233467889999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999997643 38999999999999999999998 7 999999999999999999999999999986
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 299 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-~-- 366 (446)
T 4ejn_A 299 GIK-DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEE-I-- 366 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C--
T ss_pred ccC-CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCC-C--
Confidence 432 2223445679999999999999999999999999999999999999995321 112222221111 0
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
.+.. .....+.+++.+||+.||.+|| +++|+++
T Consensus 367 ----~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ----RFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0111 1225688999999999999999 9988853
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=325.83 Aligned_cols=252 Identities=19% Similarity=0.287 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|+..+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++.+++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999975 6899999999765432 33456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc---EEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~ 295 (467)
||+++++|.+.+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887653 389999999999999999999999 9999999999999987655 99999999976
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
.... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ........... ...
T Consensus 158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~-~~~- 225 (284)
T 3kk8_A 158 VNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAG-AYD- 225 (284)
T ss_dssp CCSS--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT-CCC-
T ss_pred cccC--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhHHHHHHHhc-ccc-
Confidence 5432 22334568999999999999999999999999999999999999995321 11111111111 110
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+. .......+.+++..||+.||.+|||+.|+++
T Consensus 226 ~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00010 0112256889999999999999999999965
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=344.86 Aligned_cols=204 Identities=22% Similarity=0.302 Sum_probs=175.7
Q ss_pred hcCCCCCCeeeec--CceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 141 TDSFSNKNILGRG--GFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 141 ~~~~~~~~~lg~G--~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.++|++.++||+| +||+||+|+.. +|+.||||+++...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3678889999999 99999999976 79999999997654332 34468889999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++...... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999875322 389999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCCC------eeeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 297 DYKDT------HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 297 ~~~~~------~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 22111 11122368899999999987 5789999999999999999999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.51 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=194.4
Q ss_pred CCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 147 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
.++||+|+||.||+|... +|+.||+|+++... ......+.+|++++.+++||||+++++++.+.+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 567999999999999875 78999999997643 2345578999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE--CCCCcEEEeecCCccccCCCCCee
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 999987643 2389999999999999999999999 99999999999999 677899999999998764322 2
Q ss_pred eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccC
Q 012267 304 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQN 383 (467)
Q Consensus 304 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 383 (467)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........... ..+..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~---~~~~~-- 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACRWD---LEDEE-- 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---SCSGG--
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCC---CChhh--
Confidence 233468999999999998899999999999999999999999995321 11222222221100 00100
Q ss_pred cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 384 NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 384 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 312 --~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 --FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1122356889999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=344.51 Aligned_cols=269 Identities=25% Similarity=0.363 Sum_probs=196.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHH--HHhcCCCeeeeeeeeee-----CCCc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEM--ISMAVHRNLLRLRGFCM-----TPTE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~~~~ 213 (467)
.++|+..+.||+|+||+||+|+. +++.||||+++... ...+..|.++ +..++|+||+++++.+. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788889999999999999987 58999999996432 2334444444 45589999999998543 2335
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCcccCCCCCCcEEECCCCcEEE
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC------DPKIIHRDVKAANILLDEEFEAVV 287 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~------~~~ivH~dlk~~Nill~~~~~~kl 287 (467)
.++||||+++|+|.+++.... .++..++.++.|+++||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 689999999999999997653 588999999999999999999873 348999999999999999999999
Q ss_pred eecCCccccCCCC-------CeeeecccccccccccccccC-------CCCCcchhHHHHHHHHHHHHcCCCCccccccc
Q 012267 288 GDFGLAKLMDYKD-------THVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGIMLLELITGQRAFDLARLA 353 (467)
Q Consensus 288 ~Dfgl~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~ 353 (467)
+|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764321 112234468999999999976 45678999999999999999998877432211
Q ss_pred CCCCccH---------HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 354 NDDDVML---------LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 354 ~~~~~~~---------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
....... ................+.... .........+.+++.+||+.||.+|||+.||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1111000 011111111111111111111 11234556799999999999999999999999999983
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=331.20 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=199.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CC-------CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DG-------SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
.++|...+.||+|+||+||+|... ++ ..||+|++.... ......+.+|+++++.++||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 357888899999999999999865 33 479999986543 344567999999999999999999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc--------
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE-------- 284 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------- 284 (467)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999987532 388999999999999999999999 9999999999999998887
Q ss_pred EEEeecCCccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHH
Q 012267 285 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 363 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 363 (467)
+||+|||++..... .....|+..|+|||.+.+ ..++.++||||||+++|||++|..|+... .. ....
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~----~~---~~~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA----LD---SQRK 227 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT----SC---HHHH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc----cc---hHHH
Confidence 99999999875432 122447889999999987 67899999999999999999965544211 11 1111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 364 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
........... +.. ...+.+++..||+.||.+|||+.++++.|++..
T Consensus 228 ~~~~~~~~~~~----~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 228 LQFYEDRHQLP----APK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHHHTTCCCC----CCS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred HHHhhccCCCC----CCC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111111111 111 134788999999999999999999999999843
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=341.66 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=202.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCE--EEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSL--VAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 217 (467)
++|...+.||+|+||.||+|+.. +|.. ||||.++..........+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999999999999865 5654 4999987654444455789999999999 899999999999999999999
Q ss_pred eeccCCCChhhhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcE
Q 012267 218 YPYMANGSVASCLRERP------------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 285 (467)
|||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999998753 2234589999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHH
Q 012267 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 364 (467)
||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY 251 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHHH
Confidence 99999998743211 11122346789999999988889999999999999999998 999995321 11222
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........ ... .......+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 252 ~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 252 EKLPQGYR------LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HHGGGTCC------CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhhcCCC------CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22111100 111 11122568899999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=341.44 Aligned_cols=267 Identities=17% Similarity=0.188 Sum_probs=198.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCcch----------HHHHHHHHHHHHhcCCCeeeeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTPGG----------ELQFQTEVEMISMAVHRNLLRLRG 206 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~ 206 (467)
.++|...+.||+|+||+||+|... ++..||||++........ ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888899999999999999975 578899999875432211 113567888899999999999999
Q ss_pred eeeC----CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC
Q 012267 207 FCMT----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 282 (467)
Q Consensus 207 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~ 282 (467)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 67889999999 999999998654 489999999999999999999999 99999999999999888
Q ss_pred C--cEEEeecCCccccCCCCC------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccC
Q 012267 283 F--EAVVGDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN 354 (467)
Q Consensus 283 ~--~~kl~Dfgl~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~ 354 (467)
+ .+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--- 264 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL--- 264 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT---
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc---
Confidence 7 999999999987642211 11134568999999999999899999999999999999999999995311
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 423 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 423 (467)
................. ...+..... .......+.+++..||+.||.+||++.+|++.|+...+
T Consensus 265 -~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 -KDPVAVQTAKTNLLDEL-PQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -TCHHHHHHHHHHHHHTT-THHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -cccHHHHHHHHhhcccc-cHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111111100 000000000 00123578899999999999999999999999998554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=334.88 Aligned_cols=265 Identities=26% Similarity=0.334 Sum_probs=196.4
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCc----chHHHHHHHHHHHHhc---CCCeeeeeeeeeeC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTP----GGELQFQTEVEMISMA---VHRNLLRLRGFCMT 210 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~ 210 (467)
...++|+..+.||+|+||+||+|+. .+|+.||||+++..... .....+.+|++++..+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999996 47899999998643211 1123566777776666 49999999999986
Q ss_pred CC-----ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcE
Q 012267 211 PT-----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 211 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 285 (467)
.. ..++||||+. |+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 54 4789999997 599999987543 2389999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+....
T Consensus 160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~- 232 (308)
T 3g33_A 160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIF- 232 (308)
T ss_dssp EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH----HHHHHHHH-
T ss_pred EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-
Confidence 99999999865432 223445689999999999999999999999999999999999999954211 11111111
Q ss_pred HHhhhcccc----c------ccCcccc---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 366 GLLKEKKLE----M------LVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 366 ~~~~~~~~~----~------~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
......... . .+.+... .....+....+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111000000 0 0000000 0001122366889999999999999999998853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.19 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=198.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|+..+.||+|+||+||+|... ++..||||++..... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888899999999999999876 678999999864321 12245688999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999997653 289999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+.........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~------ 223 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVE------ 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTC------
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhCC------
Confidence 22 2234568999999999999899999999999999999999999996321 111111111110
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
... .......+.+++.+||+.||.+|||+.|+++
T Consensus 224 -~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 -FTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -CCC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001 1112256788999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.03 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=189.0
Q ss_pred cCCCCC-CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHH-HhcCCCeeeeeeeeeeC----CCce
Q 012267 142 DSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 214 (467)
Q Consensus 142 ~~~~~~-~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~ 214 (467)
++|... ++||+|+||+||+|... +|+.||||+++.. ..+.+|++++ ...+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 345554 68999999999999975 6899999998632 2467888876 45589999999998865 5668
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEEeecC
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 291 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 291 (467)
++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999987532 3489999999999999999999999 9999999999999998 7899999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+. ..
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~----~~ 282 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIR----MG 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHH----HT
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHH----cC
Confidence 99865422 223345689999999999999999999999999999999999999964321111111 111111 11
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
... ...+. .......+.+++.+||+.||.+|||+.|+++
T Consensus 283 ~~~-~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 283 QYE-FPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCC-CCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccc-CCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 100 00000 1122356889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=333.73 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=197.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..+.||+|+||+||+|... +|+.||||++....... ....+.+|++++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888899999999999999976 58999999986554332 24468899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999887643 389999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh---------
Q 012267 300 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 369 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 369 (467)
. .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||..... ......+.....
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 S-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHH
T ss_pred c-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhcccccccccc
Confidence 2 22334468999999999876 6679999999999999999999999954211 111111111100
Q ss_pred ---hccccc--ccCccccCc---ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 ---EKKLEM--LVDPDLQNN---YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ---~~~~~~--~~d~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... ..++..... ........+.+++..||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 001100000 00123356889999999999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=349.90 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||.||+|+.. +|+.||||+++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888899999999999999976 799999999964321 122446889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... ........... .. .
T Consensus 169 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~-~~---~ 234 (476)
T 2y94_A 169 G--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFKKICDG-IF---Y 234 (476)
T ss_dssp T--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHHHHHTT-CC---C
T ss_pred c--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcC-Cc---C
Confidence 2 23344579999999999988765 789999999999999999999996321 11222222211 10 0
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.|. .....+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~p~-------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 TPQ-------YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCT-------TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCc-------cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111 11246888999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=338.86 Aligned_cols=263 Identities=26% Similarity=0.333 Sum_probs=203.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee----CCCce
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTER 214 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~ 214 (467)
..++|+..+.||+|+||.||+++. .+|+.||||++... .......+.+|++++..++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 446789999999999999999997 47899999998653 2344557899999999999999999999987 34577
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.+++.........+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999999986433344589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCe--------eeecccccccccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHH
Q 012267 295 LMDYKDTH--------VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 363 (467)
Q Consensus 295 ~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 363 (467)
........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....... ......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~ 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVALA 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhHH
Confidence 54311100 011234689999999987554 6889999999999999999999996422111 111111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 364 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
.. . ... .+. .......+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 260 ~~----~-~~~---~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQ----N-QLS---IPQ-----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HH----C-C-----CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hh----c-cCC---CCc-----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11 0 000 000 1112356889999999999999999999999998743
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=334.32 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+.|...+.||+|+||.||+|... +++.||||++...........+.+|+.++..++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56888899999999999999865 68999999998765555667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++++|.+++... ++++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998753 389999999999999999999999 99999999999999999999999999998654322
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .......... .. .+.
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~-----~~~ 238 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLIPK-NN-----PPT 238 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHH-SC-----CCC
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHhhc-CC-----CCC
Confidence 22334568999999999999999999999999999999999999995321 1111111111 11 111
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRM 417 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 417 (467)
+.... ...+.+++..||+.||.+|||+.++++.
T Consensus 239 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred Ccccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11112 2568899999999999999999999763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=345.21 Aligned_cols=263 Identities=28% Similarity=0.388 Sum_probs=207.4
Q ss_pred cCCCCCCeeeecCceEEEEEEE-----CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee--CCCce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 214 (467)
++|+..+.||+|+||.||+|++ .++..||||++... .......+.+|++++.+++|+||+++++++. +....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5788889999999999999984 36889999999754 3334456899999999999999999999887 45668
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 899999999999999976422 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCee--eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccccc------C-CCCccHHHHHH
Q 012267 295 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA------N-DDDVMLLDWVK 365 (467)
Q Consensus 295 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~------~-~~~~~~~~~~~ 365 (467)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... . ...........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 765433322 22345788899999999888999999999999999999999998642210 0 00011111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..... ............+.+++..||+.||.+|||+.+|++.|+..
T Consensus 256 -~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 256 -LLEEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp -HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred -Hhhcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 00111122336688999999999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=353.43 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=204.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...++||+|+||+||+|+.. +|+.||||++..... ......+..|++++.+++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888889999999999999985 699999999965321 123456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999987654445699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+........ .
T Consensus 342 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~----~~~~~~~~~~~i~~~~-~----- 410 (543)
T 3c4z_A 342 GQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQA-V----- 410 (543)
T ss_dssp TC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT----CCCCHHHHHHHHHHCC-C-----
T ss_pred CC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc----cchhHHHHHHHHhhcc-c-----
Confidence 22 22344579999999999999999999999999999999999999996421 1112222322222211 0
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS 412 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 412 (467)
.. .......+.+++.+||+.||.+||++.
T Consensus 411 -~~----p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 -TY----PDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp -CC----CTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred -CC----CcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 01 112235688899999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=339.74 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|+..+.||+|+||+||+|... +|+.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999976 688999999975432 234678888777 7999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC----CcEEEeecCCcc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAK 294 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~ 294 (467)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999998653 389999999999999999999999 99999999999998543 359999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+........ ...
T Consensus 169 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~~-~~~ 241 (342)
T 2qr7_A 169 QLRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEILARIGSG-KFS 241 (342)
T ss_dssp ECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHHHHHHHHC-CCC
T ss_pred cCcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHHHHHHccC-Ccc
Confidence 764332 23344568999999999988888999999999999999999999996321 11222222222211 111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+...........+.+++.+||+.||++|||+.++++
T Consensus 242 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111122356889999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=341.86 Aligned_cols=251 Identities=25% Similarity=0.308 Sum_probs=194.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHH-HHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++|+..++||+|+||+||+|+.. +++.||||+++..... .....+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888899999999999999976 6889999999754322 223346667666 4678999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998643 288999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .. .+
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~-~~--~~ 258 (373)
T 2r5t_A 191 EH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNK-PL--QL 258 (373)
T ss_dssp CC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHS-CC--CC
T ss_pred cC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc-cc--CC
Confidence 22 223445679999999999999999999999999999999999999995321 12222222221 10 01
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
.+ . ....+.+++.+||+.||.+||++.+.++.+.
T Consensus 259 ~~----~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 259 KP----N----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp CS----S----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CC----C----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 11 1 1256888999999999999999865444443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=336.67 Aligned_cols=246 Identities=30% Similarity=0.438 Sum_probs=197.7
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+.|+..+.||+|+||+||+|+. .+|+.||||++....... ....+.+|++++.+++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577788999999999999996 478999999997543322 2346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+. |+|.+++.... .++++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 68888886432 2489999999999999999999999 999999999999999999999999999986542
Q ss_pred CCCeeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ............
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~---- 269 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE---- 269 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC----
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcC----
Confidence 2 2356899999999984 5678999999999999999999999995321 111222222111
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.... ......+.+++.+||+.||.+|||+.++++
T Consensus 270 --~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 --SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp --CCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111111 112255788999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=336.34 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeee--CCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv 217 (467)
++|+..+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.++++++||||+++++++. .....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 57888899999999999999976 789999999976543 333456899999999999999999999875 35678999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----cccCCCCCCcEEECCCCcEEEeecCC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK-----IIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
|||+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999986543444589999999999999999999998 6 99999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
+....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+...... ...
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~-~~~ 232 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIR-EGK 232 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HTC
T ss_pred heeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHHHh-hcc
Confidence 98654322 12223458999999999998899999999999999999999999996421 111111111 111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. .+.. .....+.+++.+||+.||.+||++.||++.+..
T Consensus 233 ~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 FR-----RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC-----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cc-----cCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 1111 123568899999999999999999999876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.37 Aligned_cols=254 Identities=25% Similarity=0.329 Sum_probs=201.2
Q ss_pred cCCCCCCeeeecCceEEEEEEE----CCCCEEEEEEeccCCC---cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL----ADGSLVAVKRLKEERT---PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 213 (467)
++|+..++||+|+||+||+|+. .+|+.||||+++.... ......+..|++++..+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788889999999999999987 3689999999865321 12233567899999999 69999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998643 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
+..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSE 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC----ccchHHHHHHHHhccC
Confidence 8654333333445679999999999985 347899999999999999999999996421 1222233333222211
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVRM 417 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 417 (467)
+.. .......+.+++.+||+.||.+|| ++.|+++.
T Consensus 283 -------~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 -------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------CCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 111 111225678899999999999999 88888653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=337.69 Aligned_cols=263 Identities=26% Similarity=0.435 Sum_probs=197.8
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCC
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 211 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 211 (467)
+....++|...+.||+|+||.||+|... ++..||||+++..... .....+.+|+.++.+++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3445678888999999999999999864 3458999999755433 3345689999999999999999999999875
Q ss_pred C-----ceEEEeeccCCCChhhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 212 T-----ERLLVYPYMANGSVASCLRERP--PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 212 ~-----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
. ..++||||+++|+|.+++.... .....+++..++.++.|+++||.|||++ +|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 4 3499999999999999985432 2234589999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHH
Q 012267 285 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 362 (467)
+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ......
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~ 260 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-----NHEMYD 260 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHHHH
Confidence 99999999986543221 12223446889999999999999999999999999999999 889985421 111111
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 363 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
....... +.. .......+.+++.+||+.+|.+|||+.++++.|++
T Consensus 261 ---~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 261 ---YLLHGHR------LKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp ---HHHTTCC------CCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHcCCC------CCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111111 011 11223568899999999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=339.23 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=202.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-------hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
.++|+..+.||+|+||+||+|... +++.||||+++...... ....+.+|++++..++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467899999999999999999864 78999999997643211 2224678999999999999999999999999
Q ss_pred ceEEEeeccCCC-ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 213 ERLLVYPYMANG-SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 213 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
..++||||+.+| +|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999998654 389999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 998764332 2233568999999999988776 88999999999999999999999532110
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCc
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 425 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 425 (467)
......+. ......+.+++..||+.||.+|||+.++++ ...+..
T Consensus 237 --~~~~~~~~------~~~~~~l~~li~~~L~~dP~~Rps~~ell~---hp~~~~ 280 (335)
T 3dls_A 237 --VEAAIHPP------YLVSKELMSLVSGLLQPVPERRTTLEKLVT---DPWVTQ 280 (335)
T ss_dssp --TTTCCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH---CTTTTC
T ss_pred --HhhccCCC------cccCHHHHHHHHHHccCChhhCcCHHHHhc---CccccC
Confidence 00000000 011256889999999999999999999854 555543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=327.05 Aligned_cols=260 Identities=19% Similarity=0.224 Sum_probs=200.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeee-eCCCceEEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLV 217 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv 217 (467)
..++|+..+.||+|+||+||+|+. .+++.||||++...... ..+..|++++..++|++++..++++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 357899999999999999999996 47899999987654322 2478899999999988877777665 566778999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE---CCCCcEEEeecCCcc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 294 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~ 294 (467)
|||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 9999999985432 389999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCC------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh
Q 012267 295 LMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 295 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
....... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-hhhhhhhhcccc
Confidence 7654322 122345689999999999999999999999999999999999999965322111 111111111111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. ... .+. ......+.+++..||+.+|++|||+.+|++.|++
T Consensus 236 ~~-~~~-----~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 236 ST-PIE-----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HS-CHH-----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred cc-hhh-----hhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 10 000 000 0112568899999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.25 Aligned_cols=252 Identities=15% Similarity=0.173 Sum_probs=202.6
Q ss_pred HHhcCCCCCCeeeecCceEEEEEE------ECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC---CCeeeeeeeeee
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGR------LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCM 209 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~ 209 (467)
...++|...++||+|+||+||+|. ..+++.||||+++.. ...++..|++++..++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 345778889999999999999994 446889999999643 2446778888888876 999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-------
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPP-SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE------- 281 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~------- 281 (467)
..+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999975321 123499999999999999999999999 9999999999999998
Q ss_pred ----CCcEEEeecCCccccC-CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC
Q 012267 282 ----EFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 356 (467)
Q Consensus 282 ----~~~~kl~Dfgl~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~ 356 (467)
++.+||+|||+++.+. ...........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 8999999999997654 233444556679999999999999999999999999999999999999995421100
Q ss_pred CccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhc
Q 012267 357 DVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDR-PKMSEVVRMLEG 420 (467)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~evl~~L~~ 420 (467)
... ...+..... ...+.+++..|++.+|.+| |+++++.+.|++
T Consensus 293 --------------~~~----~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 --------------CKP----EGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp --------------EEE----CSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred --------------eee----chhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 000 111111111 2456678888999999998 688888888876
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.75 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=176.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||+||+|... +|..||+|++...........+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457888899999999999999976 7899999999876555556679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.... .+++..+..++.+++.||+|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998653 2899999999999999999999832 7999999999999999999999999999754321
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22334689999999999999999999999999999999999999964
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=326.57 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=181.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888899999999999999974 789999999864321 122356889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... .++++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998643 2489999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... .. +
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~----~~---~ 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--------TLNKVV----LA---D 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC----SS---C
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------HHHHHh----hc---c
Confidence 222 2233468999999999998889999999999999999999999996422110 000000 00 0
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.... ......+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 YEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111 112256889999999999999999998854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=325.32 Aligned_cols=259 Identities=20% Similarity=0.231 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeee-eCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 218 (467)
.++|+..+.||+|+||+||+|+. .+|+.||||++...... ..+..|+.++..++|++++..+.++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788899999999999999997 47899999998654332 2588999999999998877666665 4567789999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC---CCCcEEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~ 295 (467)
||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 8999999975432 389999999999999999999999 999999999999994 888999999999987
Q ss_pred cCCCCCe------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh
Q 012267 296 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 296 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-KRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-SSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh-hhhhhhhhcccccC
Confidence 6543221 1234568999999999999999999999999999999999999997532211 11112122111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. ... .+. ......+.+++.+||+.||.+|||+.+|++.|++
T Consensus 237 ~-~~~-----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 237 T-PIE-----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp S-CHH-----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred C-chH-----HHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 0 000 000 1112568899999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=334.53 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=194.3
Q ss_pred cCCCCC-CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~-~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+.|.+. ++||+|+||+||+|... +++.||||++.... ......+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 456663 78999999999999864 78999999997543 33455788999999884 7999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc---EEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~ 295 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999998643 389999999999999999999999 9999999999999998776 99999999876
Q ss_pred cCCCCC------eeeecccccccccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCC---cc--
Q 012267 296 MDYKDT------HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD---VM-- 359 (467)
Q Consensus 296 ~~~~~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~---~~-- 359 (467)
...... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223458999999999865 457899999999999999999999996532111000 00
Q ss_pred --HHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 360 --LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 360 --~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
........ ...... .+. .........+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~i-~~~~~~---~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESI-QEGKYE---FPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHH-HHCCCC---CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHH-hccCcc---cCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 01111111 111100 000 000112356889999999999999999999854
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=340.35 Aligned_cols=201 Identities=26% Similarity=0.396 Sum_probs=162.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCC--ce
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--ER 214 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~ 214 (467)
..++|+..+.||+|+||+||+|... +|+.||||++..... ......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999875 789999999865432 233446789999999997 999999999997544 68
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 5899999864 288999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC--------------------CCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 295 LMDYK--------------------DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 295 ~~~~~--------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
.+... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 65321 1112334579999999999876 6789999999999999999999999954
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=333.47 Aligned_cols=260 Identities=27% Similarity=0.405 Sum_probs=204.8
Q ss_pred HhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
..++|...+.||+|+||.||+|+. .++..||||++...........+.+|+.++.+++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346788899999999999999984 25779999999765555556679999999999999999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEE
Q 012267 214 RLLVYPYMANGSVASCLRERPPS---QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVV 287 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl 287 (467)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999875422 23489999999999999999999999 9999999999999984 446999
Q ss_pred eecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHH
Q 012267 288 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 288 ~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||.... ..+...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLE 256 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHHH
Confidence 99999976532221 22233457889999999988899999999999999999998 999995321 112222
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
........ .. .......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 257 ~~~~~~~~------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 257 FVTSGGRM------DP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHTTCCC------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCCCC------CC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11111110 01 11123568899999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=323.89 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=200.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-----chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|+..+.||+|+||+||+|... +|+.||+|.++..... .....+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888899999999999999976 6899999998754322 23567899999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC----cEEEeecC
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFG 291 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 291 (467)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999997643 389999999999999999999999 999999999999998877 89999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+.........
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTNISAVN 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHHhHhcc
Confidence 998654322 2234458999999999998899999999999999999999999995321 111111111110
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...++.. .......+.+++.+||+.||.+|||+.++++
T Consensus 228 ---~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 ---YDFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ---CCCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---cCCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0001110 0112356889999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=352.26 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|...++||+|+||.||+|+.. +|+.||||++..... ......+.+|++++..++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999975 799999999965321 22345688999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999986532 2389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ..
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~----~~~~~~i~~~i~~-~~----- 405 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KIKREEVERLVKE-VP----- 405 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS----CCCHHHHHHHHHH-CC-----
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc----chhHHHHHHHhhc-cc-----
Confidence 322 23445799999999999998999999999999999999999999964221 1111111111111 10
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVV 415 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl 415 (467)
..+ .......+.+++.+||+.||.+|| ++.||+
T Consensus 406 -~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil 443 (576)
T 2acx_A 406 -EEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443 (576)
T ss_dssp -CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred -ccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence 011 111235688999999999999999 667664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=364.75 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=196.1
Q ss_pred CeeeecCceEEEEEEEC---CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA---DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
+.||+|+||+||+|.+. ++..||||+++.... ......+.+|++++.+++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999976432 3345679999999999999999999999864 458899999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe-
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 302 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 302 (467)
|+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997643 389999999999999999999999 9999999999999999999999999999876533221
Q ss_pred -eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 303 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 303 -~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+........... .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--------~~~~~~~i~~~~~~------~ 592 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGERM------G 592 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCC------C
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC------C
Confidence 2223346788999999999999999999999999999998 999995421 11111111111110 0
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. .......+.+++..||+.||++||++.+|+++|++
T Consensus 593 ~----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 C----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 11223678899999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=343.29 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=191.4
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-------chHHHHHHHHHHHHhcCCCeeeeeeeeeeC
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-------GGELQFQTEVEMISMAVHRNLLRLRGFCMT 210 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 210 (467)
...++|...+.||+|+||+||+|... +++.||||++...... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999875 6899999998653211 112247899999999999999999999754
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC---cEEE
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 287 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl 287 (467)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 45799999999999999987643 389999999999999999999999 999999999999997544 5999
Q ss_pred eecCCccccCCCCCeeeecccccccccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 288 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 288 ~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.... ....+...+
T Consensus 284 ~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQI 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS----SSCCHHHHH
T ss_pred eecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc----chHHHHHHH
Confidence 99999987542 223344679999999999853 567899999999999999999999996421 111222211
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ..... ..+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 358 ~----~~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 T----SGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp H----TTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred h----cCCCC--CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 11100 00100 0112356889999999999999999998854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=322.27 Aligned_cols=250 Identities=20% Similarity=0.240 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||+||+|... ++..||+|++..... .....+.+|++++..++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 456888899999999999999976 578999999976433 335578999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE---CCCCcEEEeecCCcccc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~ 296 (467)
|+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999987643 289999999999999999999999 99999999999999 78899999999999865
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... .......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||.... ..+........ ...
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~-- 225 (277)
T 3f3z_A 160 KPG--KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLKIREG-TFT-- 225 (277)
T ss_dssp CTT--SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CCC--
T ss_pred cCc--cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhC-CCC--
Confidence 432 223345689999999998654 8999999999999999999999996421 11111111111 000
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+. .........+.+++.+||+.||.+|||+.++++
T Consensus 226 -~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 -FPE---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCc---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000012356889999999999999999999854
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=339.46 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=193.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|...+.||+|+||+||+|+.. +++.||||+++..........+.+|++++..++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999976 78999999997544332222456799999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
++ |+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 599999886532 389999999999999999999999 99999999999999999999999999998654222
Q ss_pred CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc---cccc
Q 012267 301 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---LEML 376 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 376 (467)
.......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+........ ....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHhchhh
Confidence 22233458999999999876 568999999999999999999999996421 1111111211111100 0000
Q ss_pred c---------CccccCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 V---------DPDLQNN----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~---------d~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .+..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 0000000 00112356789999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.23 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=196.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC----CCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 215 (467)
..|...+.||+|+||+||+|... ++..||+|.+..... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34666778999999999999875 688999999875443 3344568899999999999999999998864 35579
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cccCCCCCCcEEEC-CCCcEEEeecCC
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGL 292 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl 292 (467)
+||||+++|+|.+++.... .+++..++.++.|++.||.|||+. + |+||||||+||+++ +++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999998643 389999999999999999999998 7 99999999999998 789999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
+...... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .............
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~- 246 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGV- 246 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTC-
T ss_pred ccccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-------cHHHHHHHHhccC-
Confidence 9754322 2234568999999998864 58999999999999999999999995311 1122222221111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.....+ ......+.+++..||+.||.+|||+.++++
T Consensus 247 ~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111 111246889999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=346.31 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=193.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------C
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 212 (467)
.++|+..+.||+|+||+||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999865 68999999997543 223345688999999999999999999999654 3
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++||||+++ +|.+.+... +++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~~------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999976 576666532 88999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH-------
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK------- 365 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------- 365 (467)
++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+.
T Consensus 211 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~----~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 211 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKVIEQLGTPCP 284 (464)
T ss_dssp C-------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCSCCH
T ss_pred eeecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCH
Confidence 986543 22334467899999999999999999999999999999999999999642110 00001100
Q ss_pred -----------HHhhhc-ccc-----cccCcccc---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 366 -----------GLLKEK-KLE-----MLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 366 -----------~~~~~~-~~~-----~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... ... ..+...+. ..........+.+++.+||+.||++|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000 00000000 0011222567899999999999999999998854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=334.10 Aligned_cols=264 Identities=25% Similarity=0.411 Sum_probs=205.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-----CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC--c
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-----ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--E 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~ 213 (467)
.++|+..+.||+|+||.||+|++ .+|+.||||++... .......+.+|++++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 35678889999999999999984 36889999999754 3344557899999999999999999999987654 6
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 8999999999999999987532 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCee--eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccc------cCC-CCccHHHHH
Q 012267 294 KLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL------AND-DDVMLLDWV 364 (467)
Q Consensus 294 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~------~~~-~~~~~~~~~ 364 (467)
.......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+..... ... ........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8765433322 1223467789999999888899999999999999999999999863210 000 001111111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
......... . .........+.+++.+||+.||.+|||+.+|++.|++
T Consensus 273 ~~~~~~~~~-----~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 273 IELLKNNGR-----L----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHTTCC-----C----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhcCCC-----C----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111111100 0 0111223668899999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=326.35 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=203.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56888899999999999999976 688999999865432 233456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... .+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999987643 389999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+........ ..
T Consensus 168 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~----- 232 (294)
T 2rku_A 168 DG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKN-EY----- 232 (294)
T ss_dssp TT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-CC-----
T ss_pred Cc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhhc-cC-----
Confidence 22 22334568999999999998889999999999999999999999996421 11111111111 00
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.. .....+.+++.+||+.||.+|||+.++++
T Consensus 233 -~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 -SIPK----HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0111 11256788999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=333.48 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=203.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||.||++... +++.||+|++..... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56788899999999999999976 588999999875432 234457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999987643 389999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ..+........ ..
T Consensus 194 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~-~~----- 258 (335)
T 2owb_A 194 DG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKN-EY----- 258 (335)
T ss_dssp TT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT-CC-----
T ss_pred Cc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcC-CC-----
Confidence 22 22334568999999999998889999999999999999999999996321 11111111111 00
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.. .....+.+++.+||+.||.+|||+.|+++
T Consensus 259 -~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -SIPK----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 11245788999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=330.21 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=195.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-CceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 219 (467)
.++|+..+.||+|+||+||+|+.. |+.||||+++... ....+.+|++++.+++||||+++++++... +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467888899999999999999885 8899999997542 345788999999999999999999997654 47899999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 9999999999976421 1278899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.....++..|+|||.+.+..++.++||||||+++|+|+| |+.||..... . +......... .
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~---~~~~~~~~~~------~ 232 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----K---DVVPRVEKGY------K 232 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----G---GHHHHHTTTC------C
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHHhcCC------C
Confidence 122346889999999998899999999999999999998 9999964211 1 1111111110 1
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+.. .......+.+++..||+.||.+|||+.++++.|+++
T Consensus 233 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 MDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111 112235688999999999999999999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.52 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=197.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|+..+.||+|+||+||+|... +++.||||+++.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888899999999999999976 799999999976433 33455788999999998 999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC---------------
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE--------------- 282 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~--------------- 282 (467)
|||+++++|.+++.........+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999986432223489999999999999999999999 99999999999999844
Q ss_pred ----CcEEEeecCCccccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCC
Q 012267 283 ----FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD 357 (467)
Q Consensus 283 ----~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~ 357 (467)
..+||+|||++....... ...||..|+|||.+.+. .++.++||||||+++|+|++|..++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998754322 23489999999999765 56789999999999999999998763211
Q ss_pred ccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 358 VMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+ ... ..... +.+... ....+.+++.+||+.||.+|||+.++++
T Consensus 236 ----~~-~~~-~~~~~-----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ----QW-HEI-RQGRL-----PRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HH-HHH-HTTCC-----CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH-HHH-HcCCC-----CCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11 111 11111 111111 2256889999999999999999999843
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=335.27 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=198.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..++||+|+||.||+|+.. +|+.||||++....... ....+.+|++++..++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56788899999999999999976 58999999986554332 34467899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999998876543 289999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH-----------HH
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK-----------GL 367 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~ 367 (467)
. .......|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... ...+..... ..
T Consensus 178 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 178 G-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD----IDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHHHHHHH
T ss_pred c-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhhhHh
Confidence 2 223345689999999998775 789999999999999999999999964211 011111110 00
Q ss_pred hhhcccccccCccccCccc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 368 LKEKKLEMLVDPDLQNNYV-----EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 368 ~~~~~~~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...........+.+..... ......+.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111111111111111111 123467899999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=332.38 Aligned_cols=265 Identities=26% Similarity=0.379 Sum_probs=185.3
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
+....++|...+.||+|+||.||+|... +++.||||++...........+.+|+.++..++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455678999999999999999999864 789999999876544444557889999999999999999999999999999
Q ss_pred EEeeccCCCChhhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 216 LVYPYMANGSVASCLRER----PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
+||||+++++|.+++... ......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998741 11223489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC----CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 292 LAKLMDYKD----THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 292 l~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
++....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ... .. .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~--~~-~ 238 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-----MKV--LM-L 238 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGH--HH-H
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch-----hhH--HH-H
Confidence 987654321 112233468999999999875 5689999999999999999999999964211 111 11 1
Q ss_pred Hhhhcc--c-ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LLKEKK--L-EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~--~-~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... . ....++..... ....+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQNDPPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHTSSCCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCCCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111100 0 01111111111 2256889999999999999999999854
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=338.14 Aligned_cols=259 Identities=18% Similarity=0.228 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCceEEEEEEECC---------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeee---------
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLAD---------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR--------- 203 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 203 (467)
++|...+.||+|+||+||+|+... ++.||||++... ..+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 578888999999999999998763 789999998654 25789999999999999988
Q ss_pred ------eeeeeeC-CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 204 ------LRGFCMT-PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 204 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5666665 67889999999 999999998652 12489999999999999999999999 99999999999
Q ss_pred EEECCCC--cEEEeecCCccccCCCCCe------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 012267 277 ILLDEEF--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 277 ill~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~ 348 (467)
||++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999865432111 1233468999999999999899999999999999999999999996
Q ss_pred cccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 349 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
... .....+......... ......++... .......+.+++..||+.||.+||++.+|++.|++
T Consensus 270 ~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 270 NCL---PNTEDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GGT---TCHHHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cCC---cCHHHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 422 111112222221111 11111111100 00112668899999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=332.58 Aligned_cols=264 Identities=25% Similarity=0.312 Sum_probs=195.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch----HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
..++|...+.||+|+||.||+|... +|+.||||+++....... ...+.+|++++..++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3468999999999999999999975 689999999975432211 23578999999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 8988887643 2378889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.... ....+......... ...
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~----~~~~~~~i~~~~~~-~~~ 234 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLGT-PTE 234 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCC-CCT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHcCC-CCh
Confidence 764322 223345689999999998764 57999999999999999999999985321 11111111111100 000
Q ss_pred ccccC----ccc-----cCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 EMLVD----PDL-----QNNY-----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ~~~~d----~~~-----~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+ +.. .... .......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 000 0000 0122367899999999999999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=335.13 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=192.4
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
..++|+..+.||+|+||+||+|... +|+.||||+++...... ....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467889999999999999999865 78999999997554322 234578999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE-----CCCCcEEEeecCC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGL 292 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfgl 292 (467)
|||+++ +|.+++..... +++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~~~----~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999975 99999987542 89999999999999999999999 99999999999999 4556699999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...........
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCC
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHHHHHhCCCc
Confidence 987643222 22334579999999999774 489999999999999999999999953211 111111111100000
Q ss_pred --ccccc--------cCccccCcccH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 --KLEML--------VDPDLQNNYVE-----AEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 --~~~~~--------~d~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... ..+........ .....+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00011111011 12356789999999999999999999965
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=325.06 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=201.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC---------
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------- 210 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------- 210 (467)
..+|+..+.||+|+||.||+|... +|+.||+|+++... ..+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 456888899999999999999986 79999999997543 246789999999999999999998854
Q ss_pred -------CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC
Q 012267 211 -------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF 283 (467)
Q Consensus 211 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~ 283 (467)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+|+||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 345789999999999999997642 22489999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHH
Q 012267 284 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 363 (467)
Q Consensus 284 ~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 363 (467)
.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..|+... ..+
T Consensus 160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~ 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKF 227 (284)
T ss_dssp EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHH
T ss_pred CEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHH
Confidence 99999999998764322 223345899999999999989999999999999999999999988421 111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 364 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.... ..... ... ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 228 ~~~~-~~~~~--------~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 FTDL-RDGII--------SDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHH-HTTCC--------CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHh-hcccc--------ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 11111 111 124578899999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=323.01 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=201.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|...+.||+|+||.||+|... ++..||||++..... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999976 678999999864321 122456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998653 389999999999999999999999 999999999999999999999999999876542
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ........... +
T Consensus 167 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~-------~ 228 (284)
T 2vgo_A 167 L---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIVNV-------D 228 (284)
T ss_dssp S---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-------C
T ss_pred c---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHhcc-------c
Confidence 2 2234568999999999999899999999999999999999999996321 11111111111 1
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+.. .....+.+++..||+.||.+||++.++++
T Consensus 229 ~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 LKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11111 12256889999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=346.32 Aligned_cols=194 Identities=23% Similarity=0.352 Sum_probs=154.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-----CCce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~ 214 (467)
++|++.++||+|+||+||+|... +|+.||||++..... ......+.+|++++..++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67899999999999999999865 789999999965432 2234578899999999999999999999853 3568
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+ +|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 569999997643 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--------------------------eeeecccccccccccccc-cCCCCCcchhHHHHHHHHHHHHcC
Q 012267 295 LMDYKDT--------------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGIMLLELITG 343 (467)
Q Consensus 295 ~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~sDv~s~Gvil~elltg 343 (467)
....... .......||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7642211 123345689999999976 566799999999999999999994
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=330.76 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=202.5
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-------hHHHHHHHHHHHHhc-CCCeeeeeeeee
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-------GELQFQTEVEMISMA-VHRNLLRLRGFC 208 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l-~h~niv~~~~~~ 208 (467)
....++|...+.||+|+||.||+|+.. +|+.||||+++...... ....+..|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 444577999999999999999999986 79999999987543211 133578899999998 799999999999
Q ss_pred eCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEe
Q 012267 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 288 (467)
Q Consensus 209 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 288 (467)
......++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999998643 389999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCeeeecccccccccccccccC------CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHH
Q 012267 289 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 289 Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 362 (467)
|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~ 312 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------QIL 312 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------HHH
Confidence 999998764322 2344568999999998853 357889999999999999999999995321 111
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 363 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
........ ... ...+.. ......+.+++.+||+.||.+|||+.++++
T Consensus 313 ~~~~i~~~-~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLRMIMEG-QYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHT-CCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhC-CCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 100 000000 011256889999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=334.91 Aligned_cols=271 Identities=20% Similarity=0.261 Sum_probs=198.7
Q ss_pred cCHHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcc----------hHHHHHHHHHHHHhcCCCee
Q 012267 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG----------GELQFQTEVEMISMAVHRNL 201 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~ni 201 (467)
....++....++|...+.||+|+||.||+|...+|..||||++....... ....+.+|++++..++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 44677888899999999999999999999998889999999986533221 12578999999999999999
Q ss_pred eeeeeeeeC-----CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 202 LRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 202 v~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
+++++++.. ....++||||++ |+|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 999999853 345799999997 58888887543 2489999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCC
Q 012267 277 ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND 355 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~ 355 (467)
||++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-- 240 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-- 240 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred EEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence 99999999999999999754322 22334568999999999876 67899999999999999999999999642110
Q ss_pred CCccHHHHHHHHhhhcccc-----------cccCccc---cC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 356 DDVMLLDWVKGLLKEKKLE-----------MLVDPDL---QN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~-----------~~~d~~~---~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+...+ ......... ....... .. .........+.+++.+||+.||.+|||+.|+++
T Consensus 241 --~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 --NQLNKIV-EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp --HHHHHHH-HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHH-HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0011111 000000000 0000000 00 001112356889999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.88 Aligned_cols=257 Identities=21% Similarity=0.244 Sum_probs=200.4
Q ss_pred HHHhcCCCCC-CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCc
Q 012267 138 QVATDSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 213 (467)
Q Consensus 138 ~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 213 (467)
+...++|... +.||+|+||+||+|... +|+.||||+++.... ......+.+|+.++..+. ||||+++++++.+...
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4445566666 78999999999999976 689999999975433 334567899999999985 6999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEEeec
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 290 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 290 (467)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999865422 2489999999999999999999999 9999999999999998 789999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 179 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~ 248 (327)
T 3lm5_A 179 GMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------NQETYLNISQV 248 (327)
T ss_dssp GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT
T ss_pred ccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------chHHHHHHHhc
Confidence 9998754322 2234568999999999999999999999999999999999999995321 11111111110
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ...+ .........+.+++.+||+.||.+|||+.++++
T Consensus 249 -~~--~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 -NV--DYSE----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -CC--CCCT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -cc--ccCc----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00 0001 111122356889999999999999999999854
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.88 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=192.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC------
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 212 (467)
.++|+..+.||+|+||.||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357888899999999999999975 7999999999654322 23456889999999999999999999987653
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 78999999863 289999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh-
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE- 370 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 370 (467)
++..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.+......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~ 242 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--------LDQLKEIMKVT 242 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhc
Confidence 9875422 234568999999999877 6789999999999999999999999964211 1111111100
Q ss_pred cc--------------------cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 KK--------------------LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ~~--------------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+. +.......+ ..........+.+++.+||+.||.+|||+.|+++
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00 000000000 0001122356889999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=319.51 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=194.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367888899999999999999976 79999999986432 122345688999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++.... .+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
.. .......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... .......... ...
T Consensus 163 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~--- 228 (276)
T 2h6d_A 163 DG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIRG-GVF--- 228 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCC---
T ss_pred CC--cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhc-Ccc---
Confidence 32 22233458999999999987765 689999999999999999999995321 1111111111 110
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+ . .....+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~~---~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 YIP---E----YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCC---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCc---h----hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011 1 11256888999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.43 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=185.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeee--------
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCM-------- 209 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-------- 209 (467)
...+|+..++||+|+||.||+|+.. +|+.||||++... .......+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3457888899999999999999975 7899999998554 2334457889999999996 999999999984
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cccCCCCCCcEEECCCCcEEE
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLDEEFEAVV 287 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl 287 (467)
.....++||||+. |+|.+++..... ..++++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3345789999996 699998875322 22489999999999999999999998 7 999999999999999999999
Q ss_pred eecCCccccCCCCCe-----------eeecccccccccccccc---cCCCCCcchhHHHHHHHHHHHHcCCCCccccccc
Q 012267 288 GDFGLAKLMDYKDTH-----------VTTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGIMLLELITGQRAFDLARLA 353 (467)
Q Consensus 288 ~Dfgl~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~---~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~ 353 (467)
+|||+++........ ......||+.|+|||++ .+..++.++||||||+++|+|+||+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876533221 11134589999999998 5667899999999999999999999999642110
Q ss_pred CCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 354 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
...... ... .+ .......+.+++..||+.||.+|||+.|+++.|+..
T Consensus 260 --------~~~~~~-----~~~--~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 260 --------RIVNGK-----YSI--PP------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -------------------CCC--CT------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --------HhhcCc-----ccC--Cc------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011100 000 00 001113477899999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=320.62 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=196.6
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.|....+||+|+||.||+|... ++..||||.+.... ......+.+|+.++..++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4555669999999999999974 68899999997543 333457899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecCCccccCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~ 300 (467)
++++|.+++..... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999987532 33477899999999999999999999 9999999999999987 8999999999998654322
Q ss_pred CeeeecccccccccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ........... ...
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~------~~~ 244 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMF------KVH 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHH------CCC
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccc------ccc
Confidence 2233456899999999987643 78999999999999999999999953210 00111110000 011
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.+.. .....+.+++.+||+.||++||++.++++
T Consensus 245 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 PEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 22356889999999999999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=324.47 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=187.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHH-HHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
..++|+..+.||+|+||+||+|... +|+.||||+++.......... +.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3467888999999999999999974 789999999976544433333 44444557888999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||++ |+|.+++.........+++..++.++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 4888887653223345999999999999999999999853 79999999999999999999999999998654
Q ss_pred CCCCeeeecccccccccccccc----cCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
... ......||+.|+|||.+ .+..++.++||||||+++|+|+||+.||... .... ...........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~-~~~~~~~~~~~- 231 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW------GTPF-QQLKQVVEEPS- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC------SCHH-HHHHHHHHSCC-
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc------CchH-HHHHHHhccCC-
Confidence 322 22334589999999996 5667899999999999999999999999531 1111 11111111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+... .......+.+++.+||+.||.+|||+.|+++
T Consensus 232 -----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1110 1112356889999999999999999999965
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.93 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=196.7
Q ss_pred cCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeC--CCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 217 (467)
++|+..+.||+|+||+||+|.. .+++.||||+++.. ....+.+|++++..++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5788889999999999999986 47899999999642 3457889999999997 9999999999987 5678999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeecCCcccc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 296 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~ 296 (467)
|||+++++|.+++.. +++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999864 78899999999999999999999 999999999999999776 8999999999865
Q ss_pred CCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc-
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE- 374 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 374 (467)
.... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... .....+..... ........
T Consensus 182 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~---~~~~~l~~~~~-~~~~~~~~~ 255 (330)
T 3nsz_A 182 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH---DNYDQLVRIAK-VLGTEDLYD 255 (330)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS---SHHHHHHHHHH-HHCHHHHHH
T ss_pred CCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC---chHHHHHHHHH-hcCCchhhh
Confidence 4322 2334468999999999877 678999999999999999999999994311 00001111110 00000000
Q ss_pred ------cccCc----------------cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 ------MLVDP----------------DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ------~~~d~----------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...++ .............+.+++.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000111113467889999999999999999999965
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.96 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=202.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|...+.||+|+||+||+|+.. +|+.||+|+++.... .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 357888899999999999999975 789999999975432 233468899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE---CCCCcEEEeecCCcccc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~ 296 (467)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999987643 389999999999999999999999 99999999999999 78889999999998754
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+........ ...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~-~~~-- 225 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEKIKEG-YYE-- 225 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHC-CCC--
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcC-CCC--
Confidence 321 1223458999999999999999999999999999999999999995321 11122221111 100
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR--MLEGD 421 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~ 421 (467)
..... .......+.+++.+||+.||.+|||+.|+++ .+++.
T Consensus 226 ~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 FESPF----WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CCTTT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 01111 1122356889999999999999999999986 45443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=330.97 Aligned_cols=258 Identities=30% Similarity=0.400 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC--CCC--EEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA--DGS--LVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~--~g~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
.++|+..+.||+|+||+||+|++. ++. .||||+++... .......+.+|++++..++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888899999999999999853 333 68999987543 2234557899999999999999999999988765 8
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999997642 2388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCee--eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 295 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 295 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..+.........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccC
Confidence 765433222 223457788999999988889999999999999999999 999995321 112222222211
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
.. ... .......+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 242 ~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ER-----LPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC-----CCC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 10 000 1122366889999999999999999999999998744
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=345.41 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=199.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc------------chHHHHHHHHHHHHhcCCCeeeeeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP------------GGELQFQTEVEMISMAVHRNLLRLRGF 207 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 207 (467)
.++|...++||+|+||+||+|+.. ++..||||+++..... .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999976 6889999999754322 234578899999999999999999999
Q ss_pred eeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC---c
Q 012267 208 CMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---E 284 (467)
Q Consensus 208 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~---~ 284 (467)
+.+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999987643 389999999999999999999999 999999999999998776 6
Q ss_pred EEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 285 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... ..+..
T Consensus 188 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~ 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDII 256 (504)
T ss_dssp EEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred EEEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 999999999876432 2234456999999999987 468999999999999999999999996421 11222
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... ... .+... .......+.+++..||+.||.+|||+.|+++
T Consensus 257 ~~i~~~-~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKG-KYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHC-CCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcC-CCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222111 100 00000 0112356889999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=344.24 Aligned_cols=244 Identities=13% Similarity=0.131 Sum_probs=188.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCC--CcchHHHHHHHH---HHHHhcCCCeeeeee-------ee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--TPGGELQFQTEV---EMISMAVHRNLLRLR-------GF 207 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 207 (467)
.++|...+.||+|+||+||+|+. .+|+.||||++.... .......+.+|+ +.++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45678889999999999999996 479999999997532 233445788999 455666899999998 55
Q ss_pred eeCCC-----------------ceEEEeeccCCCChhhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc
Q 012267 208 CMTPT-----------------ERLLVYPYMANGSVASCLRERPP---SQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267 (467)
Q Consensus 208 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~i 267 (467)
+.+.+ ..++||||+ +|+|.+++..... ....+++..++.|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 6799999986321 112345688899999999999999999 99
Q ss_pred ccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCC-----------CCCcchhHHHHHHH
Q 012267 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGIM 336 (467)
Q Consensus 268 vH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~sDv~s~Gvi 336 (467)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999998532 23445567 999999999887 89999999999999
Q ss_pred HHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 337 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 337 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+|||++|+.||....... ....+... . . .....+.+++.+||+.||.+|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~-----------------~~~~~~~~-~-~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG-----------------GSEWIFRS-C-K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C-----------------CSGGGGSS-C-C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc-----------------chhhhhhh-c-c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999996422110 00111110 0 1 11256889999999999999999999965
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=326.17 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.++|+..+.||+|+||.||+|... ++..||+|++.... ......+..|++++..++||||+++++++...+..++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 467888999999999999999986 68999999986543 3345578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++++|.+++..... .+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999876322 389999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCeeeecccccccccccccc-----cCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYL-----STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
........|+..|+|||++ ....++.++||||||+++|+|++|+.||.... ..............
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~- 240 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDPP- 240 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCC-
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCCc-
Confidence 1112234589999999998 46678999999999999999999999996421 11112222111111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.... .......+.+++.+||+.||.+|||+.++++
T Consensus 241 ~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 TLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111 1112356889999999999999999998854
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.05 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
.++|+..++||+|+||+||+|+.. +|+.||||++..... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888899999999999999976 789999999965432 23456789999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE---CCCCcEEEeecCCcc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 294 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~ 294 (467)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999997653 389999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+........ ...
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~-~~~ 245 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVEKG-KYT 245 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CCC
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcC-CCC
Confidence 764332 2334568999999999876 68999999999999999999999996421 11222222111 110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ..+ ........+.+++.+||+.+|.+|||+.|+++
T Consensus 246 ~-~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 F-ELP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-CSG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 001 01122356889999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=323.69 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=197.7
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
..++|+..+.||+|+||.||+|... +|+.||||.+.... ....+.+|+.++..++||||+++++++...+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567888999999999999999976 68999999997543 2346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++.... ..+++..++.++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999997432 2389999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ........... .......
T Consensus 178 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~~~ 247 (314)
T 3com_A 178 TM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAIFMIPTN-PPPTFRK 247 (314)
T ss_dssp TB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS-CCCCCSS
T ss_pred hc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcC-CCcccCC
Confidence 22 22334568999999999999899999999999999999999999995321 11111111111 1000001
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......+.+++.+||+.||.+|||+.++++
T Consensus 248 -------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 -------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112356889999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=339.72 Aligned_cols=200 Identities=23% Similarity=0.320 Sum_probs=167.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----Cc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 213 (467)
.++|...++||+|+||+||+|... +|+.||||+++..... .....+.+|++++..++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468899999999999999999975 6889999999754322 3345788999999999999999999998765 56
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||++ |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 59999998643 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---------------------eeeecccccccccccccc-cCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 012267 294 KLMDYKDT---------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 294 ~~~~~~~~---------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~sDv~s~Gvil~elltg~~p~~ 348 (467)
+....... .......||..|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87643221 123456789999999986 56679999999999999999999766654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=358.40 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=205.4
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
.+...++|...+.||+|+||+||+|.+.. +..||||+++..........+.+|+.++++++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34445678888999999999999998742 45799999876555555567999999999999999999999985 45
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 6899999999999999998643 2389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++..............+++.|+|||++.+..++.++|||||||++|||++ |..||.... ..+.........
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~~~ 609 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENGE 609 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHHTC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcCC
Confidence 98765433333333456789999999998899999999999999999997 999995321 112222221111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.. .. .......+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 610 ~~------~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 RL------PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CC------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC------CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 01 112235688999999999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=338.44 Aligned_cols=265 Identities=20% Similarity=0.231 Sum_probs=194.0
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-----
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT----- 210 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 210 (467)
++...++|+..+.||+|+||+||+|... +|+.||||++...... ..+|+++++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456678999999999999999999874 7999999998654322 2479999999999999999999843
Q ss_pred ---------------------------------CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 012267 211 ---------------------------------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257 (467)
Q Consensus 211 ---------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~ 257 (467)
....++||||++ |+|.+.+.........+++..+..++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 234789999998 5888877643223335899999999999999999
Q ss_pred HHHcCCCCCcccCCCCCCcEEEC-CCCcEEEeecCCccccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHH
Q 012267 258 YLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGI 335 (467)
Q Consensus 258 ~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gv 335 (467)
|||+. +|+||||||+|||++ .++.+||+|||+++.+.... ......+|..|+|||.+.+. .++.++|||||||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 999999999999997 68899999999998654322 22344689999999998764 4899999999999
Q ss_pred HHHHHHcCCCCcccccccCCCCccHHHHHHHHhh---------hcccccccCccccCc-----ccHHHHHHHHHHHHHcc
Q 012267 336 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------EKKLEMLVDPDLQNN-----YVEAEVEQLIQVALLCT 401 (467)
Q Consensus 336 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl 401 (467)
++|||++|+.||..... ...+...+...-. ........-+.+... ........+.+++.+||
T Consensus 231 il~ell~g~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 231 VFGELILGKPLFSGETS----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999964211 1111111111000 000011111111111 11122356889999999
Q ss_pred CCCCCCCCCHHHHHH
Q 012267 402 QGSPMDRPKMSEVVR 416 (467)
Q Consensus 402 ~~~p~~RPs~~evl~ 416 (467)
+.||.+|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999853
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=331.25 Aligned_cols=268 Identities=20% Similarity=0.301 Sum_probs=202.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----Cce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 214 (467)
.++|+..+.||+|+||.||+|... ++..||||++...........+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999875 78899999997655444456789999999999999999999998754 367
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+. |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 5999999764 289999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCe--eeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 295 LMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 295 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCC
Confidence 75432211 1234568999999998654 4589999999999999999999999964221 11111111111000
Q ss_pred c---ccc------------ccCcccc--CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCc
Q 012267 372 K---LEM------------LVDPDLQ--NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAE 425 (467)
Q Consensus 372 ~---~~~------------~~d~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 425 (467)
. ... ...+... ..........+.+++.+||+.||.+|||+.|++ +...+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l---~hp~~~~ 319 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL---AHPYLEQ 319 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH---TSGGGTT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh---cCcchhh
Confidence 0 000 0000000 000011235688999999999999999999985 4444443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=339.72 Aligned_cols=260 Identities=19% Similarity=0.241 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC-CeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|.+.++||+|+||.||+|+. .+++.||||++...... ..+..|++++..++| +++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 46799999999999999999996 47899999998654332 247889999999987 55666666667788889999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE---CCCCcEEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~ 295 (467)
||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 9999999985432 389999999999999999999999 99999999999999 5889999999999987
Q ss_pred cCCCCCe------eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh
Q 012267 296 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 296 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
....... ......||..|+|||++.+..++.++|||||||+||||++|+.||..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~i~~ 230 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----GTKKQKYEKISE 230 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----SSHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc-----hhHHHHHHHHhh
Confidence 6543321 12245699999999999999999999999999999999999999964221 111111111111
Q ss_pred hcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 370 EKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 370 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.. ....+. .+ .......+.+++..||+.+|++||++.+|+++|++.
T Consensus 231 ~~-~~~~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 231 KK-VATSIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH-HHSCHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cc-ccccHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10 000000 00 011235789999999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.88 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|.+.++||+|+||+||+|+.. +|+.||||++.... .......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357888999999999999999976 78999999986432 1223557899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC---CCCcEEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~ 295 (467)
||+.+|+|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999987643 389999999999999999999999 999999999999995 456799999999986
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+......... ...
T Consensus 174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~-~~~ 241 (486)
T 3mwu_A 174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGK-YAF 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-CCS
T ss_pred CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-CCC
Confidence 5432 22344569999999999876 58999999999999999999999995321 112222221111 100
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+ ........+.+++.+||+.+|.+|||+.++++
T Consensus 242 -~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 -DLP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -CSG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -CCc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001 01122356889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=343.73 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=196.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|...+.||+|+||+||+|+.. ++..||||+++.... ......+.+|+.+++.++||||++++++|.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 56888899999999999999976 789999999975432 2234578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC---CcEEEeecCCcccc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLM 296 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~ 296 (467)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.. +.+||+|||++...
T Consensus 117 ~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999887643 389999999999999999999999 99999999999999764 45999999999876
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... ..+......... .. .
T Consensus 190 ~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~-~~-~ 256 (494)
T 3lij_A 190 ENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVEKGK-YT-F 256 (494)
T ss_dssp BTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-CC-C
T ss_pred CCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-CC-C
Confidence 432 2234456999999999986 468999999999999999999999996421 112222221111 00 0
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+. .......+.+++.+||+.+|.+|||+.|+++
T Consensus 257 ~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0111 1112356889999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=330.83 Aligned_cols=263 Identities=21% Similarity=0.240 Sum_probs=190.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC------c
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------E 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 213 (467)
++|...+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 67888999999999999999875 688999999975432 233456889999999999999999999987654 6
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++ +|.+++... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~l~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCSE-EHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCCC-CHHHHHhhc------cCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7999999975 788888632 88999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccC-------CCCccHHHH---
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLAN-------DDDVMLLDW--- 363 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~-------~~~~~~~~~--- 363 (467)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.....+
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 865422 22334568999999999999899999999999999999999999996421100 000000000
Q ss_pred ----HHHHhhhc-c-----cccccCcccc---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 364 ----VKGLLKEK-K-----LEMLVDPDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 364 ----~~~~~~~~-~-----~~~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+....... . .......... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000 0 0000000000 0011233567899999999999999999999965
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=329.19 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=197.4
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC----
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT---- 210 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---- 210 (467)
+....++|+..+.||+|+||.||+|+.. +|+.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3445678999999999999999999974 78999999986543 2345788999999998 79999999999976
Q ss_pred --CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEe
Q 012267 211 --PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 288 (467)
Q Consensus 211 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 288 (467)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 467899999999999999998653 22488999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHH
Q 012267 289 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 363 (467)
Q Consensus 289 Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 363 (467)
|||++....... .......|++.|+|||++. +..++.++||||||+++|+|++|+.||.... ....
T Consensus 172 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~ 242 (326)
T 2x7f_A 172 DFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------PMRA 242 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHH
T ss_pred eCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHH
Confidence 999998654222 1223346899999999986 5678999999999999999999999995321 1111
Q ss_pred HHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 012267 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR--MLEG 420 (467)
Q Consensus 364 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~ 420 (467)
....... .. +.... ......+.+++.+||+.||.+||++.++++ .+++
T Consensus 243 ~~~~~~~-~~-----~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 243 LFLIPRN-PA-----PRLKS---KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHHHHS-CC-----CCCSC---SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred HHHhhcC-cc-----ccCCc---cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 1111111 11 11111 111256889999999999999999999987 4444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.01 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=197.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC---CcchHHHHHHHHHHHHhcCCCeeeeeeeeee--CCCce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER---TPGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 214 (467)
.++|...+.||+|+||.||+|... +++.||||+++... .......+.+|++++..++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999975 68999999996532 1234557899999999999999999999984 45678
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||++++ |.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777766432 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC-CCeeeecccccccccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 295 LMDYK-DTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 295 ~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
..... .........|+..|+|||++.+.. ++.++||||||+++|||++|+.||.... ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGKG- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhcC-
Confidence 76432 222334456899999999987644 3789999999999999999999996321 12222222111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. .+.. .....+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 229 SY------AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CC------CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC------CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10 1111 12256788999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=323.68 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=194.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-------cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-------PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++..++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467888999999999999999975 688999999865421 112234789999999999999999999987655
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc---EEEee
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGD 289 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~D 289 (467)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 899999999999999987543 389999999999999999999999 9999999999999987664 99999
Q ss_pred cCCccccCCCCCeeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||.... ....+...+..
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~ 234 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQITS 234 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT----CSSCHHHHHHH
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hHHHHHHHHHh
Confidence 9999865422 2223345899999999873 5678999999999999999999999996421 11122222111
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.... ..+.. .......+.+++.+||+.||.+||++.++++
T Consensus 235 ----~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 ----GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 00111 0112356889999999999999999999854
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=329.34 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=197.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeC--------C
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMT--------P 211 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 211 (467)
++|+..+.||+|+||+||+|+.. +|+.||||++....... ....+.+|++++..++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888899999999999999974 78999999986544322 24467899999999999999999999876 3
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
+..++||||+++ +|.+.+..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 467999999975 78887766432 389999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC---CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHH
Q 012267 292 LAKLMDYKD---THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 367 (467)
Q Consensus 292 l~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 367 (467)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... .......+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHH
Confidence 998764221 222334568999999998876 457999999999999999999999996421 11111111111
Q ss_pred hhhccc---ccccCc---------cccCcccHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 368 LKEKKL---EMLVDP---------DLQNNYVEAE------VEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 368 ~~~~~~---~~~~d~---------~~~~~~~~~~------~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... ...... .......... ...+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111000 000000 0000001111 245789999999999999999999854
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=328.49 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=197.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----Cce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 214 (467)
.++|...+.||+|+||+||+|... +|+.||||++...........+.+|++++..++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888899999999999999976 68999999997654444556788999999999999999999988654 678
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+. |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 5999998763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCe---------eeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 295 LMDYKDTH---------VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 295 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~ 235 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQLLLI 235 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHH
Confidence 76432211 1223468999999998754 6789999999999999999999999964221 0001111
Q ss_pred HHHhhhcc----cccccC----------ccccC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 365 KGLLKEKK----LEMLVD----------PDLQN----NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 365 ~~~~~~~~----~~~~~d----------~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
........ ...... +.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11100000 000000 00000 000122356789999999999999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=338.75 Aligned_cols=254 Identities=11% Similarity=0.022 Sum_probs=178.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhc--CCCeeeeee-------eeee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMA--VHRNLLRLR-------GFCM 209 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~~ 209 (467)
..|...+.||+|+||+||+|++. +|+.||||+++..... .....+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45778899999999999999975 7899999999875432 2234577775444444 699988755 3333
Q ss_pred CC-----------------CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCC
Q 012267 210 TP-----------------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTR------KRIALGSARGLSYLHDHCDPK 266 (467)
Q Consensus 210 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gl~~Lh~~~~~~ 266 (467)
.. ...++||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 22 33799999998 899999986422 1344455 77889999999999999 9
Q ss_pred cccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCC
Q 012267 267 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQ 344 (467)
Q Consensus 267 ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~ 344 (467)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 2223456799999999987 67899999999999999999999
Q ss_pred CCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 345 RAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 345 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.||.......... .........................+.+++.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc----------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997532111000 0000000000011110111122367889999999999999999999853
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=355.95 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=200.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 215 (467)
..++|+..++||+|+||+||+|+.. +++.||||+++... .......+..|..++..+ +|+||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467888899999999999999976 68899999997532 122234677889999887 7999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999998753 289999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 492 ~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~---- 558 (674)
T 3pfq_A 492 NIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN---- 558 (674)
T ss_dssp CCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSSC----
T ss_pred cccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC----
Confidence 4322 233455679999999999999999999999999999999999999996421 122222222211
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
. .+ .......+.+++..||+.||.+||++
T Consensus 559 ~---~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 V---AY----PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp C---CC----CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred C---CC----CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 0 01 11223568899999999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.17 Aligned_cols=197 Identities=21% Similarity=0.261 Sum_probs=170.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc------CCCeeeeeeeeeeCCCc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMA------VHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~ 213 (467)
..+|+..++||+|+||+||+|... +++.||||+++.. ......+..|++++..+ +|+||+++++++...+.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457888999999999999999875 6899999999653 23344677888888776 57799999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc--EEEeecC
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFG 291 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg 291 (467)
.++||||+. ++|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 6999999875432 389999999999999999999999 9999999999999999987 9999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 99764322 2345689999999999999999999999999999999999999964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.33 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=180.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------C
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 212 (467)
.++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367888999999999999999864 789999999965432 23345688999999999999999999998654 5
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
..++|+||+ +++|.+++... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 67999988753 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCC
Confidence 9864321 234568999999999876 6789999999999999999999999964211 11111111111000
Q ss_pred ---ccccccC----------ccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 ---KLEMLVD----------PDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ---~~~~~~d----------~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+.. +...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000 0000000 0011256789999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=330.56 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=201.9
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcc----------------hHHHHHHHHHHHHhcCCCeeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG----------------GELQFQTEVEMISMAVHRNLLRL 204 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~niv~~ 204 (467)
.++|...+.||+|+||.||+|.. +|+.||||++....... ....+.+|+.++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36788899999999999999999 89999999986432111 11678999999999999999999
Q ss_pred eeeeeCCCceEEEeeccCCCChhhh------hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcE
Q 012267 205 RGFCMTPTERLLVYPYMANGSVASC------LRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANI 277 (467)
Q Consensus 205 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Ni 277 (467)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||.|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999999 54421 3358999999999999999999999 8 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCC-CCCc-chhHHHHHHHHHHHHcCCCCcccccccCC
Q 012267 278 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSE-KTDVFGYGIMLLELITGQRAFDLARLAND 355 (467)
Q Consensus 278 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~sDv~s~Gvil~elltg~~p~~~~~~~~~ 355 (467)
+++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 256 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---- 256 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999999875432 33445689999999999877 5666 9999999999999999999996421
Q ss_pred CCccHHHHHHHHhhhcccccccC------cccc---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 356 DDVMLLDWVKGLLKEKKLEMLVD------PDLQ---NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~d------~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. .+........ ......+ +... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~---~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SL---VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CS---HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cH---HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10 1122222111 1100000 0000 0000223366889999999999999999999965
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=329.67 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=201.1
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 135 RELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 135 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
.++....++|+..+.||+|+||.||+|...+ .||+|+++..... .....+.+|+.++..++|+||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444556789999999999999999999854 4999998754322 223357789999999999999999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 999999999999999997643 2488999999999999999999999 999999999999998 679999999998
Q ss_pred cccCCCC----CeeeecccccccccccccccC---------CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccH
Q 012267 294 KLMDYKD----THVTTAVRGTIGHIAPEYLST---------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360 (467)
Q Consensus 294 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~ 360 (467)
....... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~ 248 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------A 248 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------H
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------H
Confidence 7643211 112233458999999999864 357889999999999999999999996321 1
Q ss_pred HHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 012267 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGL 423 (467)
Q Consensus 361 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 423 (467)
.......... . .+..... .....+.+++..||+.||.+|||+.+|+++|+...-
T Consensus 249 ~~~~~~~~~~-~-----~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 249 EAIIWQMGTG-M-----KPNLSQI---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHHHHHHTT-C-----CCCCCCS---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHHHHHhccC-C-----CCCCCcC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 1 1111100 112458899999999999999999999999998543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=334.66 Aligned_cols=265 Identities=21% Similarity=0.242 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC--------CCeeeeeeeeee--
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV--------HRNLLRLRGFCM-- 209 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~-- 209 (467)
.++|...++||+|+||+||+|+.. +++.||||+++.. ......+.+|++++..++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 467999999999999999999865 6889999999643 333456889999998885 788999999987
Q ss_pred --CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC----
Q 012267 210 --TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF---- 283 (467)
Q Consensus 210 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~---- 283 (467)
.....++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 566789999999 5677776665422 24899999999999999999999964 799999999999999775
Q ss_pred ---------------------------------------------cEEEeecCCccccCCCCCeeeeccccccccccccc
Q 012267 284 ---------------------------------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318 (467)
Q Consensus 284 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~ 318 (467)
.+||+|||++...... .....||..|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999865432 233468999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC-CccHHHHHHHHhhhc---------ccccccCcc-----c--
Q 012267 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD-DVMLLDWVKGLLKEK---------KLEMLVDPD-----L-- 381 (467)
Q Consensus 319 ~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~d~~-----~-- 381 (467)
+.+..++.++|||||||++|||+||+.||......... .......+....... .....+... +
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999643211100 000111111111000 000000000 0
Q ss_pred ------------cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 382 ------------QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 382 ------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...........+.+++.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00123556678999999999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.54 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=193.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce----
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER---- 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---- 214 (467)
.++|...+.||+|+||+||+|... +|+.||||++....... ....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888899999999999999875 68999999997643332 345788999999999999999999999877654
Q ss_pred --EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 215 --LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 215 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
++||||+. ++|.+++... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGME------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 5888887432 89999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+.+.......
T Consensus 191 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~ 258 (371)
T 4exu_A 191 ARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVT 258 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHH
T ss_pred cccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHh
Confidence 986432 2334568999999999877 6789999999999999999999999964211 11111111100
Q ss_pred c------cccc-----------cCccccCc---ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 K------LEML-----------VDPDLQNN---YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~------~~~~-----------~d~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ...+ +....... ........+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0000 00000000 00112367889999999999999999998853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.98 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=201.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--------chHHHHHHHHHHHHhcC-CCeeeeeeeeeeC
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--------GGELQFQTEVEMISMAV-HRNLLRLRGFCMT 210 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 210 (467)
.++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|++++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 6899999999754311 12345789999999996 9999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeec
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 290 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 290 (467)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999998643 389999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCeeeeccccccccccccccc------CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
|++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||.... .....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~ 238 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLML 238 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHH
Confidence 9998754322 233456899999999885 4567899999999999999999999995321 11111
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...... ... ...+ ........+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~-~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSG-NYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHT-CCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcC-Ccc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 211111 110 0001 11123366889999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=325.35 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=195.6
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcC--CCeeeeeeeeeeCCCce
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-PGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTER 214 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~ 214 (467)
....++|+..+.||+|+||.||++...+++.||||++..... ......+.+|++++.+++ |+||+++++++...+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 344577889999999999999999988899999999976443 233457899999999997 59999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||| +.+++|.+++.... .+++..++.++.|+++||.|||+. +|+||||||+|||+++ +.+||+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 56889999998753 389999999999999999999999 9999999999999964 899999999998
Q ss_pred ccCCCCCe-eeecccccccccccccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHH
Q 012267 295 LMDYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 295 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 362 (467)
........ ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.... . ...
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~-~~~ 247 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------N-QIS 247 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC------S-HHH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH------H-HHH
Confidence 65433221 2234468999999999865 467889999999999999999999995311 1 111
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 363 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
......... ............+.+++.+||+.||.+||++.|+++
T Consensus 248 ~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 KLHAIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111111111 100011111256889999999999999999999965
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=334.68 Aligned_cols=260 Identities=25% Similarity=0.325 Sum_probs=191.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------Cce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 214 (467)
.+|+..++||+|+||+||+|++. +|+.||||++..... ...+|+++++.++|+||++++++|... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35777899999999999999985 689999999865432 234799999999999999999998532 235
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-CcEEEeecCCc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 293 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~ 293 (467)
++||||+++ +|.+.+.........+++..++.++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 67666653222233489999999999999999999999 99999999999999955 67899999999
Q ss_pred cccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh---
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 369 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 369 (467)
+.+.... ......||..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+.++..-.
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCH
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 8754322 22345689999999998764 789999999999999999999999964211 1112222211100
Q ss_pred ------hcccccccCccccCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 ------EKKLEMLVDPDLQNNY-----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ------~~~~~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.........+.+.... .......+.+++.+||+.||.+|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0001111111111110 1112367889999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=323.25 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=197.5
Q ss_pred HhcCCCCCCeeeecCceEEEEEEE--CCCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhc---CCCeeeeeeeeee----
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRL--ADGSLVAVKRLKEERTPG-GELQFQTEVEMISMA---VHRNLLRLRGFCM---- 209 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~--~~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~~~~~~~---- 209 (467)
..++|+..+.||+|+||+||+|+. .+|+.||||+++...... ....+.+|+.++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999997 368899999986543221 122456677766655 8999999999987
Q ss_pred -CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEe
Q 012267 210 -TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 288 (467)
Q Consensus 210 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 288 (467)
.....++||||+. |+|.+++...... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 6999999875432 389999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh
Q 012267 289 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 289 Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
|||++...... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... ...+...+....
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHC
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHcC
Confidence 99999865422 122345689999999999998999999999999999999999999964211 011111111100
Q ss_pred h---hcccccccCcc---------ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 369 K---EKKLEMLVDPD---------LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 369 ~---~~~~~~~~d~~---------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .........+. ............+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000000000 000111123356889999999999999999999973
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=320.04 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=194.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC---------
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------- 210 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------- 210 (467)
.++|+..+.||+|+||.||+|+.. +|+.||||+++.. ......+.+|+.++..++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356888899999999999999975 7899999999642 2334578899999999999999999998754
Q ss_pred ----CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEE
Q 012267 211 ----PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286 (467)
Q Consensus 211 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 286 (467)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 346789999999999999998643 2378889999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCC-------------CeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccc
Q 012267 287 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARL 352 (467)
Q Consensus 287 l~Dfgl~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~ 352 (467)
|+|||++....... ........|+..|+|||++.+. .++.++||||||+++|||++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999998654221 1122334589999999999764 68999999999999999998 443210
Q ss_pred cCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCccc
Q 012267 353 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 427 (467)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 427 (467)
............ .....+ .........+.+++.+||+.||.+|||+.+++ +...+....
T Consensus 233 ------~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll---~h~~~~~~~ 291 (303)
T 1zy4_A 233 ------ERVNILKKLRSV---SIEFPP----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL---NSGWLPVKH 291 (303)
T ss_dssp ------HHHHHHHHHHST---TCCCCT----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH---HSSCSCCCC
T ss_pred ------hHHHHHHhcccc---ccccCc----cccccchHHHHHHHHHHHhcCcccCcCHHHHh---CCCCcCCCC
Confidence 111111111110 001111 11222335678999999999999999999985 455565443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=328.88 Aligned_cols=270 Identities=21% Similarity=0.254 Sum_probs=187.7
Q ss_pred HHHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc
Q 012267 135 RELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 213 (467)
Q Consensus 135 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 213 (467)
.......++|...+.||+|+||+||+|+.. +|+.||||++...... ...+..+++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 344566789999999999999999999975 6899999998654322 2246678888899999999999999865333
Q ss_pred -------eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCcccCCCCCCcEEECC-CC
Q 012267 214 -------RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH--DHCDPKIIHRDVKAANILLDE-EF 283 (467)
Q Consensus 214 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh--~~~~~~ivH~dlk~~Nill~~-~~ 283 (467)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999986 565555432223334889999999999999999999 77 9999999999999996 89
Q ss_pred cEEEeecCCccccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHH
Q 012267 284 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362 (467)
Q Consensus 284 ~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 362 (467)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN----SAGQLHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC----hHHHHHH
Confidence 99999999998764322 22345689999999998664 48999999999999999999999996421 1111111
Q ss_pred HHHHHhhh-----------cccccccCcc------ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 363 WVKGLLKE-----------KKLEMLVDPD------LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 363 ~~~~~~~~-----------~~~~~~~d~~------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+...... .......+.. ............+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111000 0000000000 000111123467899999999999999999999853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=334.41 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=190.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC------ceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~ 215 (467)
.+|+..++||+|+||+||+|+...+..||+|++...... ..+|+++++.++||||+++++++.... ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468888999999999999999877777999988644322 236899999999999999999986433 278
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC-CCCcEEEeecCCcc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAK 294 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~ 294 (467)
+||||++++ +.+.+.........+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999875 4443332111223489999999999999999999999 999999999999998 79999999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh---
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE--- 370 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 370 (467)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...++..-..
T Consensus 191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG----IDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHH
Confidence 764322 22345689999999998764 589999999999999999999999964211 11111111110000
Q ss_pred ------cccccccCccccCc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 ------KKLEMLVDPDLQNN-----YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ------~~~~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......-+..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000111100 01112357899999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=324.71 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=179.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHH-HHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|...+.||+|+||.||+|... +|+.||||+++..........+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999975 789999999976654444455666666 677789999999999999999999999
Q ss_pred eccCCCChhhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 219 PYMANGSVASCLRERP-PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 8888776311 11234899999999999999999999853 79999999999999999999999999998654
Q ss_pred CCCCeeeecccccccccccccc----cCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
... ......||..|+|||++ .+..++.++||||||+++|+|++|+.||...... .+......
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~----- 243 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVV----- 243 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCC-----
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHh-----
Confidence 322 22233589999999998 4567899999999999999999999999642110 00000000
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+.+...........+.+++..||+.||.+|||+.+|++
T Consensus 244 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 -KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000111111111122356889999999999999999999965
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=322.54 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=199.5
Q ss_pred hcCCCCCCeeeecCceEEEEEEE-C-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCC------eeeeeeeeeeCCC
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRL-A-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR------NLLRLRGFCMTPT 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~ 212 (467)
.++|++.+.||+|+||+||+|.. . +|+.||||+++.. ......+.+|++++..++|+ +++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 46788999999999999999986 3 6889999999643 23345688899998888765 4999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-----------
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE----------- 281 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~----------- 281 (467)
..++||||+ +++|.+++..... .++++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 8899999987542 3488999999999999999999999 9999999999999987
Q ss_pred --------CCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccccc
Q 012267 282 --------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA 353 (467)
Q Consensus 282 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~ 353 (467)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-- 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC--
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--
Confidence 668999999999864322 234568999999999999899999999999999999999999996421
Q ss_pred CCCCccHHHHHHHHhhhcc--------cccc---------------------cCccc-cCcccHHHHHHHHHHHHHccCC
Q 012267 354 NDDDVMLLDWVKGLLKEKK--------LEML---------------------VDPDL-QNNYVEAEVEQLIQVALLCTQG 403 (467)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~--------~~~~---------------------~d~~~-~~~~~~~~~~~l~~l~~~cl~~ 403 (467)
.......+........ .... ..+.. ...........+.+++.+||+.
T Consensus 239 ---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 239 ---SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp ---HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ---hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 1111111111110000 0000 00000 0011224457789999999999
Q ss_pred CCCCCCCHHHHHH
Q 012267 404 SPMDRPKMSEVVR 416 (467)
Q Consensus 404 ~p~~RPs~~evl~ 416 (467)
||.+|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=329.22 Aligned_cols=200 Identities=24% Similarity=0.375 Sum_probs=153.9
Q ss_pred CCCC-CCeeeecCceEEEEEEEC---CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee--CCCceEE
Q 012267 143 SFSN-KNILGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTERLL 216 (467)
Q Consensus 143 ~~~~-~~~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l 216 (467)
.|.. .++||+|+||+||+|+.. ++..||||++..... ...+.+|+.+++.++||||+++++++. .....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 3554 458999999999999965 578999999975432 236789999999999999999999995 4678899
Q ss_pred EeeccCCCChhhhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE----CCCCcEEE
Q 012267 217 VYPYMANGSVASCLRERP-----PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL----DEEFEAVV 287 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl 287 (467)
||||+.+ +|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999965 8888875321 1223489999999999999999999999 99999999999999 77789999
Q ss_pred eecCCccccCCCCC--eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 288 GDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 288 ~Dfgl~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999987643211 22344568999999999887 4589999999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=312.69 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=201.0
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
..++|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999976 789999999865432 33456789999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC---CcEEEeecCCcc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAK 294 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~ 294 (467)
|||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999887643 389999999999999999999999 99999999999999764 469999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..+........ ...
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~ 240 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETG-KYA 240 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CCC
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-CCC
Confidence 654322 1223347899999999875 48999999999999999999999995321 11222222111 110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ..+. .......+.+++.+||+.||.+|||+.++++
T Consensus 241 ~-~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F-DLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C-CSGG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-Cchh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0000 0112356889999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=320.70 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=193.0
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc------
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------ 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 213 (467)
++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888899999999999999975 68999999997643322 34568899999999999999999999987654
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.++||||+. ++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588888753 289999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc-
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK- 371 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 371 (467)
+..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+.+.......
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~ 241 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTG 241 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--------HHHHHHHHHHHC
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhC
Confidence 864322 233468999999999876 6789999999999999999999999964221 11111111000
Q ss_pred --------------------ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 --------------------KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 --------------------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.....+.+ ..........+.+++.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0011123467889999999999999999998853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=335.29 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=185.7
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEeecc
Q 012267 143 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.|...++||+|+||+||.+...+|+.||||++... ....+.+|++++..+ +||||+++++++.+.+..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34456789999999998776678999999998643 234578899999876 8999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCC---CHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC-------------CcE
Q 012267 222 ANGSVASCLRERPPSQLPL---DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE-------------FEA 285 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l---~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~-------------~~~ 285 (467)
. |+|.+++.......... ++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999998754322111 3334678999999999999999 99999999999999654 489
Q ss_pred EEeecCCccccCCCCCe---eeecccccccccccccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCcccccccC
Q 012267 286 VVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 354 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~ 354 (467)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--- 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--- 244 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT---
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch---
Confidence 99999999876543222 1234569999999999865 568999999999999999999 999995321
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.....+...... .+.............+.+++.+||+.||.+|||+.+|++
T Consensus 245 ---~~~~~i~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 ---SRESNIIRGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---THHHHHHHTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhHHHHhcCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111111110 011111123455678899999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.12 Aligned_cols=252 Identities=21% Similarity=0.240 Sum_probs=171.9
Q ss_pred hcCCCCC-CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC----CCce
Q 012267 141 TDSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTER 214 (467)
Q Consensus 141 ~~~~~~~-~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 214 (467)
.++|... ++||+|+||+||+|... +|+.||||++... ..........+..+.||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 3577774 46999999999999976 7999999998642 1122223344667799999999999875 4457
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEEeecC
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 291 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 291 (467)
++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 999999999999999987532 3489999999999999999999999 9999999999999976 4559999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .... .......
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~-~~~~~~~ 248 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI----SPGM-KRRIRLG 248 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh----hhhH-HHhhhcc
Confidence 99865422 22334579999999999888899999999999999999999999964221100 0000 0000000
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. . .............+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~---~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 Q---Y---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c---c---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0 0000001122356889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=324.63 Aligned_cols=200 Identities=24% Similarity=0.298 Sum_probs=169.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CC-----eeeeeeeeeeCCC
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HR-----NLLRLRGFCMTPT 212 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~ 212 (467)
..++|+..+.||+|+||+||+|... +++.||||+++.. ......+..|+.++..++ |+ +++++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4578999999999999999999976 6889999999643 223446778888888775 44 4999999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC--CCCcEEEeec
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDF 290 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Df 290 (467)
..++||||+. |+|.+++...... .+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999996 5999999875422 389999999999999999999952 22899999999999994 5778999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999875422 2345689999999999999999999999999999999999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=316.19 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=189.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeee----------
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCM---------- 209 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---------- 209 (467)
.++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 367888899999999999999976 5899999998654 2344557889999999999999999999874
Q ss_pred ----CCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC-CCCc
Q 012267 210 ----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFE 284 (467)
Q Consensus 210 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~-~~~~ 284 (467)
.....++||||++ |+|.+++... ++++..++.++.|++.||+|||++ +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3467799999997 5999998653 388999999999999999999999 999999999999997 5679
Q ss_pred EEEeecCCccccCCCCC--eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHH
Q 012267 285 AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLL 361 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~ 361 (467)
+||+|||+++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... .
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~ 231 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--------L 231 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--------H
Confidence 99999999986542211 12233457889999998765 6789999999999999999999999964211 1
Q ss_pred HHHHHHhhhccc------cc------------ccCcccc-CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 362 DWVKGLLKEKKL------EM------------LVDPDLQ-NNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 362 ~~~~~~~~~~~~------~~------------~~d~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+........... .. ...+... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111111110000 00 0000000 0000112366889999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=315.13 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=179.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHH-HHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|+..+.||+|+||.||+|... +|+.||||++........... +..+..++..++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356788899999999999999985 789999999976654443333 344445678889999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
||+ ++.+..+..... ..+++..++.++.|+++||.|||+ . +|+|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 555655554321 238999999999999999999998 5 89999999999999999999999999997654
Q ss_pred CCCCeeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
... ......|++.|+|||++. ...++.++||||||+++|||++|+.||.... ...+..........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------TDFEVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------ccHHHHHHHhccCC
Confidence 322 223345899999999984 4567899999999999999999999995311 11122222222111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .+.. .......+.+++.+||+.||.+||++.++++
T Consensus 248 ~------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 P------LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C------CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C------CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 0100 0011256889999999999999999999865
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=322.42 Aligned_cols=244 Identities=23% Similarity=0.389 Sum_probs=197.3
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-----hHHHHHHHHHHHHhcC--CCeeeeeeeeee
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMAV--HRNLLRLRGFCM 209 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~niv~~~~~~~ 209 (467)
+...++|+..+.||+|+||.||+|... +++.||||++....... ....+..|+.++.+++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344578899999999999999999864 78999999997543221 1224668899999986 599999999999
Q ss_pred CCCceEEEeeccCC-CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC-CCCcEEE
Q 012267 210 TPTERLLVYPYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFEAVV 287 (467)
Q Consensus 210 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl 287 (467)
..+..++|||++.+ ++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+|||++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 89999998643 389999999999999999999999 999999999999999 7899999
Q ss_pred eecCCccccCCCCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHH
Q 012267 288 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366 (467)
Q Consensus 288 ~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 366 (467)
+|||++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 192 ~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~--- 255 (320)
T 3a99_A 192 IDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EI--- 255 (320)
T ss_dssp CCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HH---
T ss_pred eeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hh---
Confidence 999999875432 2234568999999999877665 788999999999999999999996421 11
Q ss_pred HhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 367 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.... ....+ . ....+.+++.+||+.||.+|||+.+|++
T Consensus 256 -~~~~---~~~~~----~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 -IRGQ---VFFRQ----R----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -HHCC---CCCSS----C----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hccc---ccccc----c----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 00111 1 1256889999999999999999999965
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=318.25 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=192.1
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-----hHHHHHHHHHHHHhc----CCCeeeeeeee
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMA----VHRNLLRLRGF 207 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l----~h~niv~~~~~ 207 (467)
+...++|+..+.||+|+||.||+|+.. +++.||||++....... ....+..|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445578999999999999999999864 78999999996543221 122356789998888 89999999999
Q ss_pred eeCCCceEEEeec-cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC-CCCcE
Q 012267 208 CMTPTERLLVYPY-MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD-EEFEA 285 (467)
Q Consensus 208 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~ 285 (467)
+...+..++|||| +.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 78999999998643 389999999999999999999999 999999999999999 88999
Q ss_pred EEeecCCccccCCCCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHH
Q 012267 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 364 (467)
||+|||++....... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... ...
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~~ 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EIL 246 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHH
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------HHh
Confidence 999999998764322 234568999999999877665 458999999999999999999996321 110
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCcc
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAER 426 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 426 (467)
.. .. .+. ......+.+++.+||+.||++|||+.|+++ ...+...
T Consensus 247 ----~~-~~------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~---~~~~~~~ 290 (312)
T 2iwi_A 247 ----EA-EL------HFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILL---DPWMQTP 290 (312)
T ss_dssp ----HT-CC------CCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH---STTTCC-
T ss_pred ----hh-cc------CCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc---ChhhcCc
Confidence 00 00 011 112256889999999999999999999964 4444433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=324.15 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=196.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-----------CCeeeeeeeeee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----------HRNLLRLRGFCM 209 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 209 (467)
++|...+.||+|+||+||+|+.. +++.||||++... ......+.+|++++.+++ |+||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 57888999999999999999974 7899999999642 233456788999988876 899999999987
Q ss_pred CCC----ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC-----
Q 012267 210 TPT----ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD----- 280 (467)
Q Consensus 210 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~----- 280 (467)
..+ ..++||||+ +++|.+++...... .+++..++.++.||+.||+|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 543 689999999 88999999875322 3899999999999999999999953 799999999999994
Q ss_pred -CCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCC--C
Q 012267 281 -EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD--D 357 (467)
Q Consensus 281 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~--~ 357 (467)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......... .
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4558999999999865432 23346899999999999999999999999999999999999999643211100 0
Q ss_pred ccHHHHHHHHh-----------------hhc-ccccccCcc---------ccCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 012267 358 VMLLDWVKGLL-----------------KEK-KLEMLVDPD---------LQNNYVEAEVEQLIQVALLCTQGSPMDRPK 410 (467)
Q Consensus 358 ~~~~~~~~~~~-----------------~~~-~~~~~~d~~---------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 410 (467)
..+.......- ... ....+.... -...........+.+++.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 01111111000 000 000000000 001223566788999999999999999999
Q ss_pred HHHHHH
Q 012267 411 MSEVVR 416 (467)
Q Consensus 411 ~~evl~ 416 (467)
+.|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999854
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.82 Aligned_cols=259 Identities=24% Similarity=0.328 Sum_probs=198.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC------CCce
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTER 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~ 214 (467)
++|+..+.||+|+||+||+|... +|+.||||+++..........+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999874 6899999999776555556679999999999999999999998765 6678
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc---EEEeecC
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFG 291 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 291 (467)
++||||+++|+|.+++..... ...+++..++.++.+++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999987543 23488889999999999999999999 9999999999999987664 9999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++....... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....|........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------~~~~~~~~i~~~~ 240 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-------QPVQWHGKVREKS 240 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-------HHHHSSTTCC---
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-------chhhhhhhhhccc
Confidence 998764322 2334568999999999999999999999999999999999999995321 1111111110000
Q ss_pred ccccccC----------cc--ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012267 372 KLEMLVD----------PD--LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 413 (467)
Q Consensus 372 ~~~~~~d----------~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 413 (467)
....... .. ............+.+++..||+.||.+|||+.+
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000 00 011223345678899999999999999999966
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=317.68 Aligned_cols=258 Identities=20% Similarity=0.257 Sum_probs=196.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CC-CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe------eeeeeeeeeCCC
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DG-SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN------LLRLRGFCMTPT 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~ 212 (467)
.++|...+.||+|+||+||+|... ++ ..||||+++.. ......+..|+.++..++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 468899999999999999999875 34 68999999642 233456888999999887665 899999999999
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEE-------------
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL------------- 279 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill------------- 279 (467)
..++||||+ +++|.+++..... .++++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 6677777766432 2489999999999999999999999 99999999999999
Q ss_pred ------CCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccccccc
Q 012267 280 ------DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA 353 (467)
Q Consensus 280 ------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~ 353 (467)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE-- 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC--
Confidence 56789999999999864322 234568999999999999999999999999999999999999996421
Q ss_pred CCCCccHHHHHHHHhhhc--------cccc-ccCcc-------------------c--cCcccHHHHHHHHHHHHHccCC
Q 012267 354 NDDDVMLLDWVKGLLKEK--------KLEM-LVDPD-------------------L--QNNYVEAEVEQLIQVALLCTQG 403 (467)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~--------~~~~-~~d~~-------------------~--~~~~~~~~~~~l~~l~~~cl~~ 403 (467)
.......+....... .... ..... + ...........+.+++.+||+.
T Consensus 244 ---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 ---NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ---HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 111111111111000 0000 00000 0 0001123346788999999999
Q ss_pred CCCCCCCHHHHH
Q 012267 404 SPMDRPKMSEVV 415 (467)
Q Consensus 404 ~p~~RPs~~evl 415 (467)
||.+|||+.|++
T Consensus 321 dP~~Rpt~~e~l 332 (355)
T 2eu9_A 321 DPAQRITLAEAL 332 (355)
T ss_dssp STTTSCCHHHHT
T ss_pred ChhhCcCHHHHh
Confidence 999999999884
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=326.96 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=184.4
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 219 (467)
..+|...++||+|+||+||.....+|+.||||++...... .+.+|++++..+ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 4568888999999999976655667999999999654322 246899999998 79999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-----CCcEEEeecCCcc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLAK 294 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~ 294 (467)
|+. |+|.+++...... ..+..++.++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 996 5999999875432 34445678999999999999999 9999999999999953 3368899999998
Q ss_pred ccCCCCC--eeeeccccccccccccccc---CCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHh
Q 012267 295 LMDYKDT--HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368 (467)
Q Consensus 295 ~~~~~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 368 (467)
....... .......||+.|+|||++. ...++.++|||||||++|||+| |..||.... ... .....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~------~~~---~~~~~ 242 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------QRQ---ANILL 242 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT------THH---HHHHT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh------HHH---HHHHh
Confidence 7643221 2234456999999999997 4567889999999999999999 999985311 001 11111
Q ss_pred hhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 369 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
..... ....+ .......+.+++.+||+.||.+|||+.+|+
T Consensus 243 ~~~~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 243 GACSL-DCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp TCCCC-TTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccCCc-cccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 11000 00111 112335577899999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.61 Aligned_cols=238 Identities=21% Similarity=0.283 Sum_probs=193.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC--CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCc-----e
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA--DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-----R 214 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~ 214 (467)
++|++.++||+|+||+||+|.+. +|+.||||++...........+..|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67899999999999999999975 6899999998765554555678999999999999999999999987655 6
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999987754 389999999999999999999999 99999999999999986 89999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------- 284 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------- 284 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------
Confidence 75432 3456899999999987654 8999999999999999999998853211100
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~~L~~ 420 (467)
. ...........+.+++.+||+.||.+||+ ++++.+.|.+
T Consensus 285 --~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 --P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00011122356889999999999999995 6666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=306.09 Aligned_cols=230 Identities=13% Similarity=0.062 Sum_probs=181.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.+.||+|+||.||+|+.. +|+.||||++...... .....+.+|+..+..++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888899999999999999976 5899999999765432 23357899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++++|.+++... .....+..++.|++.||+|||++ +|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999642 34457889999999999999999 99999999999999999999997443
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc-cc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM-LV 377 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 377 (467)
|++ .++.++|||||||++|||+||+.||............ ...... ..
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------~~~~~~~~~ 223 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------ERDTAGQPI 223 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------CBCTTSCBC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------HHHhccCCC
Confidence 333 3688999999999999999999999653221100000 000000 00
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDG 422 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 422 (467)
.+. .........+.+++.+||+.||.+| |+.|+++.|++..
T Consensus 224 ~~~---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 224 EPA---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CHH---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred Chh---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000 0011223568899999999999999 9999999998743
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.34 Aligned_cols=243 Identities=14% Similarity=0.155 Sum_probs=183.6
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCC-------cchHHHHHHHHHHHHhcC---------CCeeeee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERT-------PGGELQFQTEVEMISMAV---------HRNLLRL 204 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------h~niv~~ 204 (467)
.++|+..+.||+|+||+||+|+. +|+.||||+++.... ......+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688889999999999999998 689999999976532 223457889999988886 6666555
Q ss_pred eee-----------------eeC-------------CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 012267 205 RGF-----------------CMT-------------PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254 (467)
Q Consensus 205 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 254 (467)
.+. +.+ .+..++||||+++|++.+.+... .+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHHH
Confidence 554 333 67899999999999877776442 3899999999999999
Q ss_pred HHHHHH-cCCCCCcccCCCCCCcEEECCCC--------------------cEEEeecCCccccCCCCCeeeecccccccc
Q 012267 255 GLSYLH-DHCDPKIIHRDVKAANILLDEEF--------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313 (467)
Q Consensus 255 gl~~Lh-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y 313 (467)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876432 23689999
Q ss_pred cccccccCCCCCcchhHHHHHHH-HHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHH
Q 012267 314 IAPEYLSTGKSSEKTDVFGYGIM-LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQ 392 (467)
Q Consensus 314 ~aPE~~~~~~~~~~sDv~s~Gvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 392 (467)
+|||++.+.. +.++||||++++ .+++++|..||.. ..|.......-.....................
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCcccchhhhhhcCHH
Confidence 9999998766 899999998777 7788999999842 12222111110000001111111223456678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHH
Q 012267 393 LIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 393 l~~l~~~cl~~~p~~RPs~~evl 415 (467)
+.+++.+||+.| |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 888886
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=298.00 Aligned_cols=228 Identities=21% Similarity=0.245 Sum_probs=176.4
Q ss_pred cCCCCC-CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHH-HhcCCCeeeeeeeeeeC----CCce
Q 012267 142 DSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 214 (467)
Q Consensus 142 ~~~~~~-~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~ 214 (467)
++|... ++||+|+||.||+|... +++.||||+++.. ..+.+|++++ ...+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 455555 77999999999999974 7899999998532 2567888887 66689999999999876 6678
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEEeecC
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 291 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 291 (467)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999987532 2489999999999999999999999 9999999999999998 7889999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
++.... +..++.++|||||||++|||+||+.||........ ...
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------------~~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------------SPG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------------hHH
Confidence 986432 23467899999999999999999999954221100 000
Q ss_pred ccccccCccc--cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDL--QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+..... ...........+.+++.+||+.||.+|||+.|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000000 00000122467889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=319.89 Aligned_cols=243 Identities=14% Similarity=0.110 Sum_probs=178.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCC-Cee---------------e
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVH-RNL---------------L 202 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h-~ni---------------v 202 (467)
..|...++||+|+||+||+|++. +|+.||||+++...... ..+.+.+|+.++..++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 44666789999999999999964 79999999987433322 24568899999999987 221 1
Q ss_pred eee------eeeeC-----CCceEEEeeccCCCChhhhhhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcc
Q 012267 203 RLR------GFCMT-----PTERLLVYPYMANGSVASCLRER---PPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268 (467)
Q Consensus 203 ~~~------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~iv 268 (467)
.+. .++.. ....+++|+++ +++|.+++... .....++++..++.++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 11111 12356777765 67999988521 11223478889999999999999999999 999
Q ss_pred cCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccc----------cCCCCCcchhHHHHHHHHH
Q 012267 269 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL----------STGKSSEKTDVFGYGIMLL 338 (467)
Q Consensus 269 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~sDv~s~Gvil~ 338 (467)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999999886432 2444567 999999999 5566889999999999999
Q ss_pred HHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 339 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 339 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
||+||+.||....... ....++... . .....+.+++.+||+.||.+||++.++++
T Consensus 309 elltg~~Pf~~~~~~~-----------------~~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALG-----------------GSEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGS-----------------CSGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhh-----------------hHHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999996432111 011111100 0 11256889999999999999999888754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=276.91 Aligned_cols=186 Identities=14% Similarity=0.073 Sum_probs=130.7
Q ss_pred eeecCceEEEEEE-ECCCCEEEEEEeccCCC---------cchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEEe
Q 012267 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERT---------PGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 150 lg~G~~g~V~~~~-~~~g~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 218 (467)
.+.|+.|.+..++ .-.|+.||||++..... ....++|.+|+++|+++ .|+||+++++++.+.+..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4456666555544 23578899999965421 12234689999999999 6999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||++|++|.++|..... ++.. +|+.||+.||+|+|++ +||||||||+||||++++.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~~~~----l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE----IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTCC----CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCCC----CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999987542 5543 5889999999999999 999999999999999999999999999987643
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~ 347 (467)
.. .......||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 392 ~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22 23344679999999999876 4567899999999988887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=250.65 Aligned_cols=185 Identities=15% Similarity=0.216 Sum_probs=146.1
Q ss_pred CCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcc-------hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 145 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
...++||+|+||+||+|.. .+..+++|+........ ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999955 47889999875432211 123478999999999999999777777777888999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999876 347899999999999999 9999999999999999 99999999999764
Q ss_pred CCCCe------eeecccccccccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCc
Q 012267 298 YKDTH------VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGIMLLELITGQRAF 347 (467)
Q Consensus 298 ~~~~~------~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~elltg~~p~ 347 (467)
..... ......||+.|+|||++.. ..|+..+|+||..+-.++.+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1234679999999999976 56788899999999999988877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-25 Score=206.00 Aligned_cols=154 Identities=14% Similarity=0.056 Sum_probs=122.5
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-----------------chHHHHHHHHHHHHhc
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-----------------GGELQFQTEVEMISMA 196 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l 196 (467)
+..+......|...+.||+|+||.||+|...+|+.||||.++..... .....+.+|++++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 33444455667777999999999999999977999999999643221 1244688999999999
Q ss_pred CCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 197 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
+ | +++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 8 5 66667554 356799999999999998 422 12446999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCeeeeccccccccccccccc
Q 012267 277 ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 320 (467)
||++ ++.+||+|||+++. +..|.|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9999 99999999999873 34578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=173.41 Aligned_cols=137 Identities=17% Similarity=0.195 Sum_probs=105.3
Q ss_pred CCCCCeeeecCceEEEEEEE-CCCCE--EEEEEeccCCCc-----------------------chHHHHHHHHHHHHhcC
Q 012267 144 FSNKNILGRGGFGKVYKGRL-ADGSL--VAVKRLKEERTP-----------------------GGELQFQTEVEMISMAV 197 (467)
Q Consensus 144 ~~~~~~lg~G~~g~V~~~~~-~~g~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 197 (467)
|+..+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+..+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678899999999999997 67888 999997543211 01125788999999998
Q ss_pred CCee--eeeeeeeeCCCceEEEeeccCC-C----ChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCccc
Q 012267 198 HRNL--LRLRGFCMTPTERLLVYPYMAN-G----SVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH-DHCDPKIIH 269 (467)
Q Consensus 198 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh-~~~~~~ivH 269 (467)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 7754 333332 357899999943 4 66666433 123456789999999999999 88 9999
Q ss_pred CCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 270 RDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 270 ~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
|||||+|||+++ .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.2e-18 Score=163.58 Aligned_cols=139 Identities=15% Similarity=0.140 Sum_probs=98.4
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-------------chHHHH--------HHHHHHHHhcCCCe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-------------GGELQF--------QTEVEMISMAVHRN 200 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-------------~~~~~~--------~~e~~~l~~l~h~n 200 (467)
.-|++.+.||+|++|.||+|...+|+.||||+++..... ...... .+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348888999999999999999989999999997642110 011112 23455555554333
Q ss_pred eeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC
Q 012267 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 280 (467)
Q Consensus 201 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~ 280 (467)
+.-..-+. ....+|||||+++++|..+... .....++.|++.+|.|||+. +||||||||.|||++
T Consensus 175 v~vp~p~~--~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIA--QSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEE--EETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeee--ccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 21111111 1234799999999888765432 12356788999999999998 999999999999998
Q ss_pred CCC----------cEEEeecCCccc
Q 012267 281 EEF----------EAVVGDFGLAKL 295 (467)
Q Consensus 281 ~~~----------~~kl~Dfgl~~~ 295 (467)
+++ .+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 876 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6e-12 Score=116.59 Aligned_cols=143 Identities=13% Similarity=0.064 Sum_probs=109.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 219 (467)
-..|+....++.|+.+.||++... +..+++|+...... .....+..|++++..+. +..+.++++++...+..++|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 356777777888888999999864 68899999864321 11225788999998884 6677788998888888999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC------------------------------------ 263 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~------------------------------------ 263 (467)
|++|.+|.+.+... .....++.+++++|+.||+..
T Consensus 91 ~i~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999998764211 123467889999999999810
Q ss_pred --------------------CCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 264 --------------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 264 --------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799998765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.6e-11 Score=113.46 Aligned_cols=129 Identities=14% Similarity=0.041 Sum_probs=96.0
Q ss_pred eecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe--eeeeeeeeeCCCceEEEeeccCCCChhh
Q 012267 151 GRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPYMANGSVAS 228 (467)
Q Consensus 151 g~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~ 228 (467)
+.|..+.||++...+|..+++|+..... ...+..|+.++..+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 3556699999987778889999976431 124678888888886544 455888887777889999999998884
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 012267 229 CLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--------------------------------------------- 263 (467)
Q Consensus 229 ~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~--------------------------------------------- 263 (467)
... .+ ...++.++++.|+.||+..
T Consensus 104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2356778888888888742
Q ss_pred ----------CCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 264 ----------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 264 ----------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=9.1e-11 Score=113.87 Aligned_cols=142 Identities=11% Similarity=0.131 Sum_probs=105.0
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEec--cCCCcchHHHHHHHHHHHHhcC--CCeeeeeeeeeeCC---CceEEEee
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLK--EERTPGGELQFQTEVEMISMAV--HRNLLRLRGFCMTP---TERLLVYP 219 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e 219 (467)
.+.|+.|.++.||+....+ ..+++|+.. ..........+..|..++..+. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 3568899999999998754 678889875 3322222346788999998886 45577888888766 44799999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC------------------------------------ 263 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~------------------------------------ 263 (467)
|++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999987754211 12677888899999999999999731
Q ss_pred -------------------CCCcccCCCCCCcEEECCCCc--EEEeecCCccc
Q 012267 264 -------------------DPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 295 (467)
Q Consensus 264 -------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~ 295 (467)
.+.++|+|+++.||+++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.3e-10 Score=110.09 Aligned_cols=187 Identities=19% Similarity=0.191 Sum_probs=120.2
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCe--eeeeeeeeeCCC---ceEEEeec
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRN--LLRLRGFCMTPT---ERLLVYPY 220 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~ 220 (467)
.+.++.|....||+.. ..+++|+.... .....+..|.+++..+. +.. +.+++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999863 45888886432 23456889999998773 322 333444433332 34889999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH-------------------------------------- 262 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~-------------------------------------- 262 (467)
++|.+|.+.... .++..++..++.++++.|+.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888754332 156677788888888888888861
Q ss_pred -----------------CCCCcccCCCCCCcEEECC--CCcEEEeecCCccccCCCCCeee--ec-----------cccc
Q 012267 263 -----------------CDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDYKDTHVT--TA-----------VRGT 310 (467)
Q Consensus 263 -----------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~--~~-----------~~g~ 310 (467)
..+.++|+|+++.||++++ ...+.|+||+.+...+....-.. .. ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1135799999999999988 45678999998875432100000 00 0000
Q ss_pred ccccc-cccccCCCCCcchhHHHHHHHHHHHHcCCCCcc
Q 012267 311 IGHIA-PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348 (467)
Q Consensus 311 ~~y~a-PE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~ 348 (467)
.+... |+.... .....+.|++|.++|.+.+|..+|-
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01111 221110 1123689999999999999988773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.3e-06 Score=82.37 Aligned_cols=135 Identities=18% Similarity=0.179 Sum_probs=91.7
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCC---eeeeeeeeee-CCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR---NLLRLRGFCM-TPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 223 (467)
+.++.|....||+. |..+++|+.. .......+..|.+++..+.+. .+-+++.++. ..+..++||||++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 56888988999988 4568888753 223345788999999988653 2445555553 34567899999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH----------------------------------------- 262 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~----------------------------------------- 262 (467)
.++.+..... ++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~~------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMAV------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHTT------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhhh------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 8887632211 33344445555555555555532
Q ss_pred ----------------CCCCcccCCCCCCcEEECC---CCc-EEEeecCCccc
Q 012267 263 ----------------CDPKIIHRDVKAANILLDE---EFE-AVVGDFGLAKL 295 (467)
Q Consensus 263 ----------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgl~~~ 295 (467)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235699999999999987 455 48999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=9.3e-07 Score=81.73 Aligned_cols=135 Identities=20% Similarity=0.182 Sum_probs=95.4
Q ss_pred eeeecCce-EEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceEEEeeccCCCC
Q 012267 149 ILGRGGFG-KVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 149 ~lg~G~~g-~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
.+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +--+-++++++.+.+..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34556555 68988765 4667899986432 2346788998888774 3335667888888888999999999988
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------------
Q 012267 226 VASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC------------------------------------------ 263 (467)
Q Consensus 226 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~------------------------------------------ 263 (467)
+.+...... .....+..++++.|+-||...
T Consensus 107 ~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 877654321 123345666777777777421
Q ss_pred -------------CCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 264 -------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 264 -------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999877777999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=2e-06 Score=82.88 Aligned_cols=81 Identities=9% Similarity=0.008 Sum_probs=52.7
Q ss_pred Cee-eecCceEEEEEEEC-------CCCEEEEEEeccCCC--cchHHHHHHHHHHHHhcCC---CeeeeeeeeeeCC---
Q 012267 148 NIL-GRGGFGKVYKGRLA-------DGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVH---RNLLRLRGFCMTP--- 211 (467)
Q Consensus 148 ~~l-g~G~~g~V~~~~~~-------~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~--- 211 (467)
+.| +.|....+|+.... ++..+++|+...... ......+..|..++..+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998764 266788998654220 0011246677777776642 3456677776554
Q ss_pred CceEEEeeccCCCChhh
Q 012267 212 TERLLVYPYMANGSVAS 228 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~ 228 (467)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=1.7e-05 Score=75.81 Aligned_cols=140 Identities=18% Similarity=0.246 Sum_probs=77.9
Q ss_pred eeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-----CCeeeeee-e--eeeCCCceEEEeec
Q 012267 149 ILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----HRNLLRLR-G--FCMTPTERLLVYPY 220 (467)
Q Consensus 149 ~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~ 220 (467)
.|+.|..+.||+....+| .+++|+.... ...+..|..++..+. .|.++... | +....+..+++|+|
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 455577889999987655 5899988642 123334444444332 34444311 1 11235567899999
Q ss_pred cCCCChh--------------hhhhcCC-----CCC-----CCCCHHHHH------------------------------
Q 012267 221 MANGSVA--------------SCLRERP-----PSQ-----LPLDWPTRK------------------------------ 246 (467)
Q Consensus 221 ~~~gsL~--------------~~l~~~~-----~~~-----~~l~~~~~~------------------------------ 246 (467)
++|.++. ..+|... ... ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0112110 000 012343211
Q ss_pred -HHHHHHHHHHHHHHc----------CCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 247 -RIALGSARGLSYLHD----------HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 247 -~i~~~ia~gl~~Lh~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
.+...+..++.+|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666653 123489999999999999888889999999765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=2.1e-06 Score=91.64 Aligned_cols=52 Identities=40% Similarity=0.733 Sum_probs=46.8
Q ss_pred cccCCCCCCeEEcccCcccccCCCCCCCCccCcccccccccCCCCCCCCCCCC
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGPVTGRPCPG 54 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N~~Lcg~~~~~~c~~ 54 (467)
++++|++|++||||+|+|+|.||+.++|..+...+|.||+.|||.+.. +|..
T Consensus 699 ~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp GGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred HHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 578899999999999999999999999999999999999999998876 7754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.2e-05 Score=76.87 Aligned_cols=75 Identities=12% Similarity=0.025 Sum_probs=47.3
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEeccCCC------cchHHHHHHHHHHHHhcCC--Cee-eeeeeeeeCCCceEEE
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT------PGGELQFQTEVEMISMAVH--RNL-LRLRGFCMTPTERLLV 217 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~ni-v~~~~~~~~~~~~~lv 217 (467)
+.||.|..+.||++... ++..++||....... ......+..|.+++..+.. +.. .+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999754 468899998653211 1112245678888876632 333 344443 34557899
Q ss_pred eeccCCC
Q 012267 218 YPYMANG 224 (467)
Q Consensus 218 ~e~~~~g 224 (467)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.92 E-value=4.1e-05 Score=71.29 Aligned_cols=79 Identities=18% Similarity=0.239 Sum_probs=54.4
Q ss_pred CCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCC---eeeeeeeeeeCCCceEEEee
Q 012267 143 SFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR---NLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e 219 (467)
.....+.+|.|..+.||+.+..+|+.|.+|+-..... .....|..|...|+.+.-. -+.+++++ +..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3444567899999999999999999999998754322 2223577898888877421 23334443 23478999
Q ss_pred ccCCCCh
Q 012267 220 YMANGSV 226 (467)
Q Consensus 220 ~~~~gsL 226 (467)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=9.1e-05 Score=69.63 Aligned_cols=139 Identities=15% Similarity=0.150 Sum_probs=90.7
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC---CCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|..+. ...+.+++.++...+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 35688999999999986 4678899987532 2446788888887763 35677788888777889999999998
Q ss_pred CChhh-----------hhhcCCC-CC-----------------CCCCHHHHH---HHH----------------HHHHHH
Q 012267 224 GSVAS-----------CLRERPP-SQ-----------------LPLDWPTRK---RIA----------------LGSARG 255 (467)
Q Consensus 224 gsL~~-----------~l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~~ia~g 255 (467)
..+.. .|+.... .. -.-+|.... ++. ..+.+.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 2233211 00 012465322 111 111111
Q ss_pred H-HHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 256 L-SYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 256 l-~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23422 2356899999999999999887 8898874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00018 Score=70.87 Aligned_cols=78 Identities=12% Similarity=0.079 Sum_probs=47.9
Q ss_pred CCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCeeeecc-cccccccccccccCC---CCCcchhHHHHHHHHHHH
Q 012267 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTG---KSSEKTDVFGYGIMLLEL 340 (467)
Q Consensus 265 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~---~~~~~sDv~s~Gvil~el 340 (467)
+.++|+|+++.|||++.++ ++|+||+.+...+.... ..... .-...|.+|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 99999998875321100 00000 001345666554321 112345566788888887
Q ss_pred HcCC
Q 012267 341 ITGQ 344 (467)
Q Consensus 341 ltg~ 344 (467)
+++.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00068 Score=63.36 Aligned_cols=71 Identities=10% Similarity=0.067 Sum_probs=42.1
Q ss_pred CCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCee-eeeeeeeeCCCceEEEeecc-CCC
Q 012267 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPYM-ANG 224 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g 224 (467)
.+.|+.|....+|+. ..+++|+........ .....|...+..+....+ -+++++ +.+.-++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY--INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C--CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce--eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 577889999999998 458888875431110 123456666665532222 234443 344457899999 554
Q ss_pred Ch
Q 012267 225 SV 226 (467)
Q Consensus 225 sL 226 (467)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0011 Score=62.95 Aligned_cols=32 Identities=44% Similarity=0.440 Sum_probs=27.6
Q ss_pred CCCcccCCCCCCcEEECCC----CcEEEeecCCccc
Q 012267 264 DPKIIHRDVKAANILLDEE----FEAVVGDFGLAKL 295 (467)
Q Consensus 264 ~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~ 295 (467)
.+.++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999875 6799999998865
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0026 Score=55.40 Aligned_cols=100 Identities=15% Similarity=0.100 Sum_probs=65.2
Q ss_pred CCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCe
Q 012267 223 NGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 302 (467)
Q Consensus 223 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 302 (467)
.-||.++|.... .|+++.++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence 347899998753 369999999999999999877632110 1 1222456899999999888764 1110
Q ss_pred eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc
Q 012267 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 342 (467)
Q Consensus 303 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt 342 (467)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123567888763 345788899999999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.012 Score=55.30 Aligned_cols=159 Identities=9% Similarity=0.055 Sum_probs=85.2
Q ss_pred cCHHHHHHHhcCCCCC-----CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe--eeee
Q 012267 132 FSLRELQVATDSFSNK-----NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN--LLRL 204 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~ 204 (467)
++.+++......|... +.|+.|....+|+....+| .+++|+....... ..+..|..++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence 4455555555556542 3356688889999987665 5889988652111 23455666665553211 2222
Q ss_pred eee------eeCCCceEEEeeccCCCChhh--------------hhhcCCCC---C--CCC---CHHHHHH---------
Q 012267 205 RGF------CMTPTERLLVYPYMANGSVAS--------------CLRERPPS---Q--LPL---DWPTRKR--------- 247 (467)
Q Consensus 205 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~---~--~~l---~~~~~~~--------- 247 (467)
+.. ....+..+++|+|++|..+.. .++..... . ... .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 221 112345689999998865421 11211000 0 001 2332111
Q ss_pred ---HHHHHHHHHHHHHcC----CCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 248 ---IALGSARGLSYLHDH----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 248 ---i~~~ia~gl~~Lh~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
+...+.+.+.+++.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666532 13479999999999999887656899998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00077 Score=66.40 Aligned_cols=72 Identities=15% Similarity=0.206 Sum_probs=47.3
Q ss_pred CeeeecCceEEEEEEECC--------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCee-eeeeeeeeCCCceEEEe
Q 012267 148 NILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 218 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 218 (467)
+.|+.|....+|+....+ +..+++|+..... ....+..|..++..+...++ .++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 457788889999998753 4789999874321 11345578888877743333 455665432 3899
Q ss_pred eccCCCCh
Q 012267 219 PYMANGSV 226 (467)
Q Consensus 219 e~~~~gsL 226 (467)
||++|-+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0062 Score=57.39 Aligned_cols=143 Identities=16% Similarity=0.139 Sum_probs=79.8
Q ss_pred CeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCC--eeeeeeee-----eeCCCceEEEeec
Q 012267 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR--NLLRLRGF-----CMTPTERLLVYPY 220 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~ 220 (467)
..++ |....||+....+|+.+++|..+.... ....+..|..++..+... .+.+++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 778899998877777899999864322 233566677777666421 23334432 1123455789999
Q ss_pred cCCCChh-----hh---------hhc----CCC-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHcC
Q 012267 221 MANGSVA-----SC---------LRE----RPP-SQLPLDWPTR----KRI---------------ALGSARGLSYLHDH 262 (467)
Q Consensus 221 ~~~gsL~-----~~---------l~~----~~~-~~~~l~~~~~----~~i---------------~~~ia~gl~~Lh~~ 262 (467)
++|..+. .+ ++. ... ....+++... ..+ ...+...+..+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875432 10 111 000 0111232211 001 01111223333221
Q ss_pred ----CCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 263 ----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 263 ----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0015 Score=63.08 Aligned_cols=142 Identities=15% Similarity=0.124 Sum_probs=80.7
Q ss_pred CeeeecCceEEEEEEEC--------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe-eeeeeeeeeCCCceEEEe
Q 012267 148 NILGRGGFGKVYKGRLA--------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 218 (467)
+.|..|-...+|+.... ++..+++|+.... ......+.+|..+++.+.-.. ..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45667888889998864 2478999986331 123445678888887764222 2445666543 2899
Q ss_pred eccCCCChhhh-----------------hhcCCC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 012267 219 PYMANGSVASC-----------------LRERPP-SQLPLD--WPTRKRIALGSAR-------------------GLSYL 259 (467)
Q Consensus 219 e~~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~ia~-------------------gl~~L 259 (467)
||++|.+|..- ||.... ...+.. |.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655311 111111 111122 4455555443321 23333
Q ss_pred H----cC-CCCCcccCCCCCCcEEECCC----CcEEEeecCCccc
Q 012267 260 H----DH-CDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKL 295 (467)
Q Consensus 260 h----~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~ 295 (467)
. .. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 21 22368999999999999876 6899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0024 Score=63.27 Aligned_cols=73 Identities=10% Similarity=0.101 Sum_probs=46.0
Q ss_pred CeeeecCceEEEEEEECC-CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCee-eeeeeeeeCCCceEEEeeccCCCC
Q 012267 148 NILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPYMANGS 225 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs 225 (467)
+.|+.|-...+|+....+ +..+++|+..... . .......|..++..+...++ .++++.+. + .+||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 457888889999998864 4778888874321 1 11123578888888765444 45666653 2 35999998754
Q ss_pred h
Q 012267 226 V 226 (467)
Q Consensus 226 L 226 (467)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0017 Score=62.63 Aligned_cols=73 Identities=8% Similarity=0.042 Sum_probs=41.0
Q ss_pred CeeeecCceEEEEEEECC---------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCee-eeeeeeeeCCCceEEE
Q 012267 148 NILGRGGFGKVYKGRLAD---------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLV 217 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv 217 (467)
+.|+.|....+|+....+ +..+++|+..... ........|.+++..+...++ .++++.. . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 356778888999998754 2678888865321 111123567777766642232 3455443 1 3789
Q ss_pred eeccCCCCh
Q 012267 218 YPYMANGSV 226 (467)
Q Consensus 218 ~e~~~~gsL 226 (467)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.017 Score=54.80 Aligned_cols=31 Identities=26% Similarity=0.354 Sum_probs=27.5
Q ss_pred CCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 265 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 265 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.78 E-value=0.0073 Score=64.93 Aligned_cols=36 Identities=31% Similarity=0.555 Sum_probs=19.4
Q ss_pred CCCeEEcccCcccccCCCCCCCCccCcccccccccCCC
Q 012267 8 SLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 45 (467)
Q Consensus 8 ~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N~~Lcg 45 (467)
+|+.||||+|+|+|.+|.. +..+..+.+.+|+-.|.
T Consensus 527 ~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 527 NLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICE 562 (844)
T ss_dssp CCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCS
T ss_pred cccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccc
Confidence 3444444444444444432 44555667788877774
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.26 E-value=0.025 Score=35.22 Aligned_cols=33 Identities=24% Similarity=0.219 Sum_probs=19.5
Q ss_pred ccceeeeeehhhHHHHHHHHHhhhhhhccCCCC
Q 012267 78 ATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQ 110 (467)
Q Consensus 78 ~~~~i~~~v~~~~~~l~~~~~~~~~~~~~~~~~ 110 (467)
....++++++.++++++++.+..++++|||+.+
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 345566667766666655555555566665544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.24 E-value=0.14 Score=49.85 Aligned_cols=141 Identities=9% Similarity=0.089 Sum_probs=80.5
Q ss_pred CeeeecCceEEEEEEECC--------CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCe-eeeeeeeeeCCCceEEEe
Q 012267 148 NILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 218 (467)
+.+..|-...+|+....+ +..+++|+..... . ...+..+|..++..+...+ ..++++.+. -++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 456678888999998753 5789999864321 1 1112456777776664222 233444332 37899
Q ss_pred eccCCCChhh--h---------------hhcC-------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 012267 219 PYMANGSVAS--C---------------LRER-------PP--SQLPLDWPTRKRIALGS-------------------A 253 (467)
Q Consensus 219 e~~~~gsL~~--~---------------l~~~-------~~--~~~~l~~~~~~~i~~~i-------------------a 253 (467)
||++|.+|.. + +|.. .. ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0 1110 00 11222344444443222 2
Q ss_pred HHHHHHHcC---------------------CCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 254 RGLSYLHDH---------------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 254 ~gl~~Lh~~---------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
..+.+|... ....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 233333211 1235899999999999 7778899999988753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=93.73 E-value=0.018 Score=61.22 Aligned_cols=22 Identities=32% Similarity=0.677 Sum_probs=10.9
Q ss_pred ccCCCCCCeEEcccCcccccCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVP 24 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP 24 (467)
|++|++|+.||||+|+|+|.||
T Consensus 652 l~~l~~L~~L~Ls~N~l~g~ip 673 (768)
T 3rgz_A 652 IGSMPYLFILNLGHNDISGSIP 673 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCC
T ss_pred HhccccCCEEeCcCCccCCCCC
Confidence 4444455555555555555544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.73 E-value=0.031 Score=34.72 Aligned_cols=35 Identities=26% Similarity=0.306 Sum_probs=20.9
Q ss_pred CccceeeeeehhhHHHHHHHHHhhhhhhccCCCCc
Q 012267 77 SATGAIAGGVAAGAALLFAAPAIAFAWWRRRKPQE 111 (467)
Q Consensus 77 ~~~~~i~~~v~~~~~~l~~~~~~~~~~~~~~~~~~ 111 (467)
+....++++++.++++++++....++++|||+.++
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34556777777766666555555555666655443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.60 E-value=0.11 Score=45.03 Aligned_cols=117 Identities=10% Similarity=0.094 Sum_probs=79.8
Q ss_pred CCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 197 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
.||+++.. .+-.+.+...+.|+.-+.+.=...++. ++...+++++..|+....+++.. +|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 58888866 455556666666665443222222433 67789999999999877666554 788899999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 277 ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
++++.++.+++.-.|+... ++|. ..+...=.-.+=+++..+++++..|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999987665432 2332 112222344688899999999999963
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=93.27 E-value=0.055 Score=51.19 Aligned_cols=39 Identities=21% Similarity=0.291 Sum_probs=23.5
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+|++|++|+.|||++|+|+|..|.. ..+..+..+.+.+|
T Consensus 51 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 51 DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp GSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred HhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 3566777777777777777766643 23444444555555
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=93.00 E-value=0.072 Score=44.70 Aligned_cols=39 Identities=26% Similarity=0.425 Sum_probs=28.1
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+|+++++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 49 ~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 49 VFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 4678899999999999999765543 33455556666666
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=92.99 E-value=0.066 Score=45.91 Aligned_cols=39 Identities=15% Similarity=0.296 Sum_probs=27.0
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.|+++++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 73 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 112 (192)
T 1w8a_A 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS
T ss_pred HcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence 4677888888888888888877753 23444555566666
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=92.53 E-value=0.088 Score=44.39 Aligned_cols=39 Identities=18% Similarity=0.380 Sum_probs=29.2
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.|+++++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 52 ~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 52 VFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred HhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 4778999999999999999854432 34556666777777
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.69 E-value=0.072 Score=51.70 Aligned_cols=30 Identities=30% Similarity=0.453 Sum_probs=25.0
Q ss_pred CcccCCCCCCcEEE------CCCCcEEEeecCCccc
Q 012267 266 KIIHRDVKAANILL------DEEFEAVVGDFGLAKL 295 (467)
Q Consensus 266 ~ivH~dlk~~Nill------~~~~~~kl~Dfgl~~~ 295 (467)
.++|+|+.+.|||+ +++..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999988753
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=91.56 E-value=0.12 Score=43.49 Aligned_cols=38 Identities=24% Similarity=0.339 Sum_probs=28.2
Q ss_pred CCCCeEEcccCcccccCCCC-CCCCccCcccccccccCCC
Q 012267 7 SSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCG 45 (467)
Q Consensus 7 ~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N~~Lcg 45 (467)
++|+.|||++|+|++..|.. ..+..+..+.+.+| .+.+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~ 71 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSN-KLTA 71 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCCC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCC-CCCc
Confidence 68999999999999998854 33555666777777 3443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=91.52 E-value=0.13 Score=43.18 Aligned_cols=34 Identities=26% Similarity=0.444 Sum_probs=26.4
Q ss_pred CCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 7 SSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 7 ~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N 64 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNN 64 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCC
Confidence 68999999999999998864 33455666777777
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.23 E-value=0.13 Score=45.18 Aligned_cols=38 Identities=29% Similarity=0.360 Sum_probs=27.4
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+.++++|++|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 101 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 139 (220)
T 2v70_A 101 FKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139 (220)
T ss_dssp GTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTS
T ss_pred hcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCC
Confidence 678899999999999999988753 22344445566666
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=90.88 E-value=0.17 Score=47.81 Aligned_cols=44 Identities=18% Similarity=0.132 Sum_probs=31.5
Q ss_pred cccCCCCCCeEEcccCcccccCCCCCCCCccCcccccccccCCC
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 45 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N~~Lcg 45 (467)
.|++|++|+.|||++|+|++..|..-....+..+.+.+|.--|.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 57899999999999999997655432222256677777765553
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.08 E-value=0.56 Score=40.82 Aligned_cols=114 Identities=16% Similarity=0.180 Sum_probs=78.0
Q ss_pred CCCeeeeeeeeeeCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCcccCCCCCC
Q 012267 197 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS-YLHDHCDPKIIHRDVKAA 275 (467)
Q Consensus 197 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~-~Lh~~~~~~ivH~dlk~~ 275 (467)
.||++ -..+-.+.+...+.|+.-+++.=...++. ++...+++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57877 34444667777777776544433444433 677889999888877555 4444 478889999
Q ss_pred cEEECCCCcEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhH-HHHHHHHHHHHcCCCCcc
Q 012267 276 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV-FGYGIMLLELITGQRAFD 348 (467)
Q Consensus 276 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv-~s~Gvil~elltg~~p~~ 348 (467)
|+++|.++.+++.-.|+-. -++|.-+ + ..|. -++=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~------------------~lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE------------------SLPPDEW-----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETT------------------TBSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcc------------------cCCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998766533 3344321 2 2333 368888999999998885
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=89.99 E-value=0.19 Score=44.05 Aligned_cols=38 Identities=24% Similarity=0.330 Sum_probs=27.6
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+.++++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 100 f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 138 (220)
T 2v9t_B 100 FEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138 (220)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCC
Confidence 567899999999999999987753 22344555666666
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=89.89 E-value=0.26 Score=41.33 Aligned_cols=38 Identities=16% Similarity=0.369 Sum_probs=29.1
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++++++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 110 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCC
Confidence 678999999999999999876653 33455666677777
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=89.88 E-value=0.071 Score=43.39 Aligned_cols=37 Identities=14% Similarity=0.274 Sum_probs=22.0
Q ss_pred ccCCCCCCeEEcccCcccccCCCCCCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N 40 (467)
+.++++|+.|+|++|++++. +....+..+..+.+.+|
T Consensus 38 ~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n 74 (149)
T 2je0_A 38 TDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDN 74 (149)
T ss_dssp CTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSS
T ss_pred HhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCC
Confidence 45667777777777777765 33333444444555555
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.53 E-value=0.24 Score=42.44 Aligned_cols=39 Identities=31% Similarity=0.436 Sum_probs=28.7
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.|.+|++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 73 ~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N 112 (193)
T 2wfh_A 73 SFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN 112 (193)
T ss_dssp TTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS
T ss_pred HccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCC
Confidence 4788999999999999999987753 23344555666666
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=89.52 E-value=0.21 Score=42.62 Aligned_cols=38 Identities=24% Similarity=0.461 Sum_probs=29.6
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++++++|++|||++|+|++.+|.. ..+..+..+.+.+|
T Consensus 50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 788999999999999999998864 23444555666666
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=88.90 E-value=0.33 Score=43.95 Aligned_cols=38 Identities=21% Similarity=0.364 Sum_probs=26.7
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++++++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 153 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 153 FDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 567888899999999888766643 33455555666666
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=88.65 E-value=0.12 Score=42.98 Aligned_cols=19 Identities=32% Similarity=0.378 Sum_probs=10.1
Q ss_pred cCCCCCCeEEcccCccccc
Q 012267 4 TNISSLQVLDLSNNRLSGV 22 (467)
Q Consensus 4 ~~l~~L~~ldls~N~lsG~ 22 (467)
..+++|++|||++|++++.
T Consensus 46 ~~l~~L~~L~l~~n~l~~~ 64 (168)
T 2ell_A 46 AEFVNLEFLSLINVGLISV 64 (168)
T ss_dssp GGGGGCCEEEEESSCCCCC
T ss_pred HhCCCCCEEeCcCCCCCCh
Confidence 4455555555555555544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=88.52 E-value=0.33 Score=43.40 Aligned_cols=38 Identities=18% Similarity=0.404 Sum_probs=26.5
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+.++++|+.|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 127 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 165 (251)
T 3m19_A 127 FDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165 (251)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence 567888999999999988766632 23445555666666
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=88.01 E-value=0.32 Score=49.75 Aligned_cols=39 Identities=23% Similarity=0.358 Sum_probs=22.5
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.|++|++|+.||||+|+|++..|.. ..+..+..+.+++|
T Consensus 513 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N 552 (635)
T 4g8a_A 513 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 552 (635)
T ss_dssp TTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTS
T ss_pred HHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCC
Confidence 3566777777777777777766542 12333444455555
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=87.91 E-value=0.45 Score=41.00 Aligned_cols=38 Identities=16% Similarity=0.330 Sum_probs=26.3
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++++++|++|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 96 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 134 (208)
T 2o6s_A 96 FDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQN 134 (208)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCC
Confidence 577888999999999988766542 23445555666666
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.80 E-value=0.36 Score=41.24 Aligned_cols=40 Identities=28% Similarity=0.451 Sum_probs=29.9
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCcccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 41 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N~ 41 (467)
.+.++++|+.|||++|++++..|.. ..+..+..+.+.+|.
T Consensus 49 ~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 49 ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 5778999999999999999877643 334455556677763
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=87.55 E-value=0.43 Score=42.03 Aligned_cols=37 Identities=19% Similarity=0.378 Sum_probs=25.7
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+..+++|+.|+|++|+|+ .||.. ..+..+..+.+.+|
T Consensus 108 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N 145 (229)
T 3e6j_A 108 FDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145 (229)
T ss_dssp TTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSS
T ss_pred hCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCC
Confidence 567889999999999998 67753 22344455566666
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=87.11 E-value=0.42 Score=39.99 Aligned_cols=38 Identities=18% Similarity=0.328 Sum_probs=29.2
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++++++|++|||++|+|++..|.. ..+..+..+.+.+|
T Consensus 48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 48 FDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 678999999999999999766543 34555666777777
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=87.00 E-value=0.26 Score=50.14 Aligned_cols=38 Identities=26% Similarity=0.435 Sum_probs=24.0
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.|++|++|+.||||+|+|+ .||.. ..+..+..+.+++|
T Consensus 458 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N 496 (567)
T 1dce_A 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN 496 (567)
T ss_dssp CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred CccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCC
Confidence 3667778888888888888 67752 22334444555555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=86.40 E-value=0.26 Score=41.37 Aligned_cols=32 Identities=16% Similarity=0.284 Sum_probs=18.8
Q ss_pred CCCeEEcccCcccccCCCCCCCCccCccccccc
Q 012267 8 SLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 40 (467)
Q Consensus 8 ~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N 40 (467)
+|++|||++|+|++. +.-..+..+..+.+.+|
T Consensus 43 ~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N 74 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNN 74 (176)
T ss_dssp CCSEEECCSSCCCEE-CCCCCCSSCCEEECCSS
T ss_pred CCCEEECCCCCCCcc-cccccCCCCCEEECCCC
Confidence 777777777777764 43333444444555555
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=85.73 E-value=0.35 Score=49.12 Aligned_cols=42 Identities=26% Similarity=0.381 Sum_probs=30.7
Q ss_pred cccCCCCCCeEEcccCcccccCCCCCCCCccCcccccccccCCC
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCG 45 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N~~Lcg 45 (467)
+|++|++|+.||||+|+|+| ||....+..+..+.+.+| .+.+
T Consensus 481 ~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N-~l~~ 522 (567)
T 1dce_A 481 ALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNN-RLQQ 522 (567)
T ss_dssp GGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSS-CCCS
T ss_pred hhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCC-CCCC
Confidence 57788999999999999998 785444556666677776 3443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=85.28 E-value=0.56 Score=41.23 Aligned_cols=39 Identities=21% Similarity=0.319 Sum_probs=25.6
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.|.++++|+.|+|++|+|++..+.. ..+..+..+.+.+|
T Consensus 59 ~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 59 VFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred HhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 4677888888999998885543332 23445555666666
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=85.06 E-value=0.65 Score=43.41 Aligned_cols=40 Identities=15% Similarity=0.202 Sum_probs=29.3
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCcccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNL 41 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N~ 41 (467)
+++++++|+.|||++|++.|.+|.. ..+..+..+.+.+|.
T Consensus 224 ~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 264 (328)
T 4fcg_A 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264 (328)
T ss_dssp GGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCT
T ss_pred hhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCC
Confidence 4678899999999999999999964 234445556666653
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.93 E-value=0.46 Score=41.53 Aligned_cols=38 Identities=18% Similarity=0.343 Sum_probs=25.4
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+.++++|+.|||++|++++..|.. ..+..+..+.+.+|
T Consensus 53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 677888888888888888876632 23344444555555
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=84.67 E-value=0.35 Score=48.14 Aligned_cols=31 Identities=23% Similarity=0.105 Sum_probs=26.0
Q ss_pred hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC
Q 012267 182 GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 212 (467)
Q Consensus 182 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 212 (467)
...+|..|++.+++++|+|+|+++|||....
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 3557999999999999999999999997754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=84.67 E-value=0.39 Score=44.55 Aligned_cols=39 Identities=21% Similarity=0.520 Sum_probs=27.1
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+|+++++|++|||++|+++|.+|.. ..+..+..+.+.+|
T Consensus 96 ~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 135 (313)
T 1ogq_A 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135 (313)
T ss_dssp GGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred hHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCC
Confidence 4678888888888888888888863 22344444555555
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=84.07 E-value=0.58 Score=47.05 Aligned_cols=36 Identities=28% Similarity=0.459 Sum_probs=25.0
Q ss_pred cCCCCCCeEEcccCcccccCCCCCCCCccCccccccc
Q 012267 4 TNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 40 (467)
Q Consensus 4 ~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N 40 (467)
+++++|+.|||++|+|+ .||....+..+..+.+.+|
T Consensus 448 ~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N 483 (549)
T 2z81_A 448 LFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRN 483 (549)
T ss_dssp CCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSS
T ss_pred ccCChhcEEECCCCccC-cCCCcccCccCCEEecCCC
Confidence 36778888888888887 6776544555555666666
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=84.00 E-value=0.72 Score=37.15 Aligned_cols=36 Identities=25% Similarity=0.238 Sum_probs=27.9
Q ss_pred CCCCCCeEEcccCccc-ccCCCC-CCCCccCccccccc
Q 012267 5 NISSLQVLDLSNNRLS-GVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 5 ~l~~L~~ldls~N~ls-G~iP~~-~~~~~~~~~~~~~N 40 (467)
..++|+.|+|++|+++ |.+|.. ..+..+..+.+.+|
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n 52 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV 52 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTS
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCC
Confidence 4578999999999999 899975 34555666677766
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=83.82 E-value=0.54 Score=43.61 Aligned_cols=22 Identities=36% Similarity=0.525 Sum_probs=12.4
Q ss_pred ccCCCCCCeEEcccCcccccCCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPD 25 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~ 25 (467)
+++++ |+.|||++|+++|.+|.
T Consensus 194 ~~~l~-L~~L~Ls~N~l~~~~~~ 215 (313)
T 1ogq_A 194 FANLN-LAFVDLSRNMLEGDASV 215 (313)
T ss_dssp GGGCC-CSEEECCSSEEEECCGG
T ss_pred HhCCc-ccEEECcCCcccCcCCH
Confidence 33444 66666666666665553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.78 E-value=0.65 Score=45.33 Aligned_cols=42 Identities=24% Similarity=0.318 Sum_probs=18.6
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCcccccccccCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLC 44 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N~~Lc 44 (467)
|.++++|+.|||++|+|++..+.. ..+..+..+.+.+|+-.|
T Consensus 251 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp STTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred hcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 344455555555555555433321 122333344555554444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=83.61 E-value=0.71 Score=41.10 Aligned_cols=22 Identities=23% Similarity=0.407 Sum_probs=10.9
Q ss_pred ccCCCCCCeEEcccCcccccCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVP 24 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP 24 (467)
|+++++|++|||++|+|++..|
T Consensus 55 ~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 55 FRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp TTTCTTCCEEECTTSCCCCCCT
T ss_pred hcCcccCCEEECCCCcCCccCH
Confidence 3444555555555555555443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=83.52 E-value=0.73 Score=40.21 Aligned_cols=23 Identities=39% Similarity=0.678 Sum_probs=14.0
Q ss_pred ccCCCCCCeEEcccCcccccCCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPD 25 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~ 25 (467)
+.++++|+.|||++|++++..|.
T Consensus 52 ~~~l~~L~~L~Ls~N~i~~~~~~ 74 (220)
T 2v9t_B 52 FSPYKKLRRIDLSNNQISELAPD 74 (220)
T ss_dssp STTCTTCCEEECCSSCCCEECTT
T ss_pred hhCCCCCCEEECCCCcCCCcCHH
Confidence 45566666666666666665554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=83.17 E-value=0.9 Score=40.94 Aligned_cols=38 Identities=26% Similarity=0.414 Sum_probs=26.7
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++++++|+.|+|++|++++..|.. ..+..+..+.+.+|
T Consensus 153 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred ccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 677899999999999998865542 22445555666666
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=83.07 E-value=0.77 Score=42.87 Aligned_cols=40 Identities=20% Similarity=0.339 Sum_probs=29.4
Q ss_pred cccCCCCCCeEEcccCcccccCCCCCCCCccCcccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNL 41 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N~ 41 (467)
+++++++|+.|+|++|+|+|..+....+..+..+.+.+|.
T Consensus 201 ~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~ 240 (328)
T 4fcg_A 201 SIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCT 240 (328)
T ss_dssp GGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCT
T ss_pred hhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCc
Confidence 4788999999999999999854443344555666777764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.83 E-value=1.7 Score=46.40 Aligned_cols=37 Identities=19% Similarity=0.364 Sum_probs=22.1
Q ss_pred ccCCCCCCeEEcccCcccccCCCCCCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N 40 (467)
+.++++|+.||||+|+|++..|.... ..+..+.+++|
T Consensus 500 ~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N 536 (844)
T 3j0a_A 500 FSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRN 536 (844)
T ss_dssp SSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEE
T ss_pred ccchhhhheeECCCCCCCccChhhhh-ccccEEECCCC
Confidence 56677777777777777775554311 33444555555
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=82.75 E-value=0.36 Score=43.77 Aligned_cols=36 Identities=31% Similarity=0.345 Sum_probs=23.5
Q ss_pred CCCCCCeEEcccCcccc--cCCCC-CCCCccCccccccc
Q 012267 5 NISSLQVLDLSNNRLSG--VVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 5 ~l~~L~~ldls~N~lsG--~iP~~-~~~~~~~~~~~~~N 40 (467)
++++|+.||||+|+|+| .||.. ..+..+..+++++|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N 206 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGN 206 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCC
Confidence 57888888888888888 66532 12344445555555
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=82.63 E-value=0.86 Score=39.13 Aligned_cols=38 Identities=21% Similarity=0.356 Sum_probs=25.8
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++++++|++|||++|+|++..+.. ..+..+..+.+.+|
T Consensus 48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 48 FDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 567888999999999888654432 23445555666666
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=82.57 E-value=0.98 Score=44.09 Aligned_cols=39 Identities=23% Similarity=0.380 Sum_probs=27.5
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.++++++|++|||++|++++.+|.. ..+..+..+.+.+|
T Consensus 342 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 381 (455)
T 3v47_A 342 MFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN 381 (455)
T ss_dssp GGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred HhcCcccCCEEECCCCcccccChhhccccccccEEECCCC
Confidence 3677889999999999998887753 23444555566666
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.48 E-value=0.71 Score=43.50 Aligned_cols=42 Identities=33% Similarity=0.456 Sum_probs=31.6
Q ss_pred ccCCCCCCeEEcccCcccccCCCC--CCCCccCcccccccccCCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN--GSFSLFTPISFANNLDLCG 45 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~~~N~~Lcg 45 (467)
+.++++|+.|||++|+|+ .||.. ..+..+..+.+.+|+-.|.
T Consensus 273 l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 273 LNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp HHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred HhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 567899999999999999 67764 3455666677888865553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=82.47 E-value=0.34 Score=43.86 Aligned_cols=41 Identities=22% Similarity=0.404 Sum_probs=28.0
Q ss_pred ccCCCCCCeEEcccCcccccCCCCCCCC--ccCcccccccccCCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDNGSFS--LFTPISFANNLDLCG 45 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~~~~~--~~~~~~~~~N~~Lcg 45 (467)
+..+++|+.||||+|+|++. .+...+. .+..+.+.+|+ +|+
T Consensus 192 ~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Np-l~~ 234 (267)
T 3rw6_A 192 VQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNS-LCD 234 (267)
T ss_dssp HHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTST-TGG
T ss_pred HhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCc-Ccc
Confidence 34789999999999999985 2212233 45556777774 554
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.76 E-value=0.15 Score=50.44 Aligned_cols=61 Identities=5% Similarity=0.008 Sum_probs=17.6
Q ss_pred CCCeeeecCceEEEEEEECC-CCEEEE------EEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeee
Q 012267 146 NKNILGRGGFGKVYKGRLAD-GSLVAV------KRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCM 209 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~-g~~vav------K~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 209 (467)
..+.|| ||.||+|.+.. ..+||| |..+..... .....+.+|..++..++|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345676 99999998763 467888 766543222 22235778888888899999999988754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=81.56 E-value=0.91 Score=41.68 Aligned_cols=39 Identities=23% Similarity=0.358 Sum_probs=26.4
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.++++++|+.|||++|++++..+.. ..+..+..+.+.+|
T Consensus 194 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 233 (306)
T 2z66_A 194 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233 (306)
T ss_dssp TTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTS
T ss_pred HhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCC
Confidence 4677888999999999888865532 22344555666666
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=81.42 E-value=0.89 Score=44.55 Aligned_cols=42 Identities=24% Similarity=0.361 Sum_probs=18.4
Q ss_pred ccCCCCCCeEEcccCcccccCCCC-CCCCccCcccccccccCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLC 44 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N~~Lc 44 (467)
|.++++|+.|||++|+|++..+.. ..+..+..+.+.+|+--|
T Consensus 262 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred hcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 344455555555555555433321 112333444555554433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=81.29 E-value=0.6 Score=43.18 Aligned_cols=36 Identities=28% Similarity=0.344 Sum_probs=28.8
Q ss_pred CCCCCCeEEcccCcccccCCCC---CCCCccCccccccc
Q 012267 5 NISSLQVLDLSNNRLSGVVPDN---GSFSLFTPISFANN 40 (467)
Q Consensus 5 ~l~~L~~ldls~N~lsG~iP~~---~~~~~~~~~~~~~N 40 (467)
++++|+.|||++|+++|.+|.. ..+..+..+.+.+|
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N 131 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCC
Confidence 6899999999999999999975 34555666677766
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=81.04 E-value=0.52 Score=42.90 Aligned_cols=39 Identities=23% Similarity=0.342 Sum_probs=28.5
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.+.++++|+.|||++|++++.+|.. ..+..+..+.+.+|
T Consensus 172 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 3678899999999999999988854 22344555666666
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=80.68 E-value=0.77 Score=47.34 Aligned_cols=39 Identities=10% Similarity=0.181 Sum_probs=30.4
Q ss_pred cccCCCCCCeEEcccCccccc-----------------CCCCCC---CCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGV-----------------VPDNGS---FSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~-----------------iP~~~~---~~~~~~~~~~~N 40 (467)
+|++|++|++|||++|+|+|. ||..-. +..+..+.+.+|
T Consensus 201 ~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred HHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 588999999999999999997 887532 445555666666
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=80.26 E-value=0.96 Score=46.61 Aligned_cols=40 Identities=20% Similarity=0.203 Sum_probs=28.1
Q ss_pred cccCCCCCCeEEc------ccCcccccCCCC-CCCCccCcccccccc
Q 012267 2 SLTNISSLQVLDL------SNNRLSGVVPDN-GSFSLFTPISFANNL 41 (467)
Q Consensus 2 ~l~~l~~L~~ldl------s~N~lsG~iP~~-~~~~~~~~~~~~~N~ 41 (467)
+++++++|+.||| ++|+++|.+|.. ..+..+..+.+.+|.
T Consensus 531 ~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 577 (636)
T 4eco_A 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577 (636)
T ss_dssp GGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred hhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence 5678889999998 568888888864 224445556666663
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=80.19 E-value=0.74 Score=45.73 Aligned_cols=37 Identities=30% Similarity=0.425 Sum_probs=20.2
Q ss_pred ccCCCCCCeEEcccCcccccCCCCCCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N 40 (467)
|+++++|++|||++|+++|.+| ...+..+..+.+.+|
T Consensus 54 ~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N 90 (487)
T 3oja_A 54 LAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNN 90 (487)
T ss_dssp GTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSS
T ss_pred HhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCC
Confidence 4556666666666666666555 223344444445444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.09 E-value=1.3 Score=44.60 Aligned_cols=39 Identities=31% Similarity=0.472 Sum_probs=28.3
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.+.++++|+.|||++|++++.+|.. ..+..+..+.+.+|
T Consensus 465 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 504 (570)
T 2z63_A 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504 (570)
T ss_dssp CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred hhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence 4677889999999999999888854 23444555666666
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 467 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 6e-67
Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 27/283 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRN 200
+ +G G FG VYKG+ VAVK L +LQ F+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+L G+ T + +V + S+ L + IA +A+G+ YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYL 319
IIHRD+K+ NI L E+ +GDFGLA + + +H + G+I +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 320 STGKS---SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376
S ++DV+ +GI+L EL+TGQ + ++ D + ++ L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRGYL--- 227
Query: 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
PDL + + ++ C + +RP +++ +E
Sbjct: 228 -SPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 4e-66
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 25/278 (8%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
++ LG G FG+V+ G + VAVK LK+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
+RL T ++ YM NGS+ L+ + L +A A G++++ +
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
IHRD++AANIL+ + + DFGLA+L++ + + I APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381
G + K+DV+ +GI+L E++T R + ++ + E+ M+ +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQNL-----ERGYRMVRPDNC 235
Query: 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
E+L Q+ LC + P DRP + +LE
Sbjct: 236 --------PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 5e-65
Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLADGS-----LVAVKRLKEERTPGGELQFQTEVEM 192
++ + + ++G G FG+VYKG L S VA+K LK T + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 193 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGS 252
+ H N++RL G +++ YM NG++ LRE+ + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGI 119
Query: 253 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 310
A G+ YL + +HRD+ A NIL++ V DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370
I APE +S K + +DV+ +GI++ E++T L
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------------LSN 219
Query: 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420
++ ++ + + Q+ + C Q RPK +++V +L+
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 7e-65
Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 25/278 (8%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+ +G G FG V+ G + VA+K ++E E F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 62
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
++L G C+ LV+ +M +G ++ LR + T + L G++YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLEE 119
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
C +IHRD+ A N L+ E V DFG+ + + +T + + +PE S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381
+ S K+DV+ +G+++ E+ + + N + +++ + L P L
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDI------STGFRLYKPRL 226
Query: 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ Q+ C + P DRP S ++R L
Sbjct: 227 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 1e-64
Identities = 73/314 (23%), Positives = 128/314 (40%), Gaps = 47/314 (14%)
Query: 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQF 186
L L+ ++ +G G FG+V++ R ++VAVK LKEE + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 187 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL-------- 238
Q E +++ + N+++L G C L++ YMA G + LR P +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 239 ------------PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 286
PL + IA A G++YL + K +HRD+ N L+ E
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 287 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 345
+ DFGL++ + D I + PE + + + ++DV+ YG++L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 346 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSP 405
G+ E+ + + D ++ E +L + LC P
Sbjct: 241 ----------------QPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLP 283
Query: 406 MDRPKMSEVVRMLE 419
DRP + R+L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-64
Identities = 83/281 (29%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 147 KNILGRGGFGKVYKGRLADGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 202
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 203 RLRGFCM-TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
L G C+ + L+V PYM +G + + +R L A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGM---KF 145
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 318
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
L T K + K+DV+ +G++L EL+T DV D LL+ ++L
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTFDITVYLLQGRRLL---Q 255
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
P+ + L +V L C RP SE+V +
Sbjct: 256 PEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 2e-64
Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 42/306 (13%)
Query: 132 FSLRELQVATDSFSNK---------NILGRGGFGKVYKGRLA----DGSLVAVKRLKEER 178
F+ + A F+ + ++G G FG+V G L VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 179 TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL 238
T F +E ++ H N++ L G T +++ +M NGS+ S LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 239 PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298
+ G A G+ YL D +HRD+ A NIL++ V DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 299 KDTHVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 353
+ T + I APE + K + +DV+ YGI++ E+++ G+R +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235
Query: 354 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 413
+ + + ++ D + L Q+ L C Q RPK +
Sbjct: 236 -------------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 414 VVRMLE 419
+V L+
Sbjct: 283 IVNTLD 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 4e-63
Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 29/294 (9%)
Query: 147 KNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+ +G+G FG+V++G+ G VAVK + E+ M H N+L
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIA 64
Query: 207 FCM----TPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
T T+ LV Y +GS+ L + ++AL +A GL++LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHME 119
Query: 263 C-----DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHI 314
P I HRD+K+ NIL+ + + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 315 APEYLST------GKSSEKTDVFGYGIMLLELITGQRAFDLARLAND--DDVMLLDWVKG 366
APE L +S ++ D++ G++ E+ + D++ D
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 367 LLKEKKLEMLVDPDLQNNYVEAEV-EQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+++ E + P++ N + E + ++ C + R + + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-62
Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 32/292 (10%)
Query: 135 RELQVATDSFSNKNI-LGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEV 190
++L + D+ +I LG G FG V +G VA+K LK+ + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 191 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 250
+++ + ++RL G C +LV G + L + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVR 308
+ G+ YL + +HRD+ A N+LL A + DFGL+K + D++ T +A +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 367
+ APE ++ K S ++DV+ YG+ + E ++ GQ+ + ++ +++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----KMKGPEVMAFIE-- 226
Query: 368 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ M P+ +L + C DRP V + +
Sbjct: 227 ---QGKRMECPPEC--------PPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-62
Identities = 61/310 (19%), Positives = 123/310 (39%), Gaps = 43/310 (13%)
Query: 137 LQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISM 195
+++ D F + LG G G V+K G ++A K + E P Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 255
++ G + E + +M GS+ L++ + ++++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
L+YL + KI+HRDVK +NIL++ E + DFG++ + + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
PE L S ++D++ G+ L+E+ G+ A + ++M V+G E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRP 230
Query: 376 LVD-----------------------------PDLQNNYVEAEVEQLIQVALLCTQGSPM 406
P L + E + + C +P
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPA 287
Query: 407 DRPKMSEVVR 416
+R + +++
Sbjct: 288 ERADLKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 6e-62
Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 41/302 (13%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMIS- 194
+ S LG G FGKV + VAVK LK +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS--------------QLPL 240
+ H N++ L G C L++ Y G + + LR + S +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
D + A+G+++L IHRD+ A NILL + DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 301 TH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
+ V R + +APE + + ++DV+ YGI L EL + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 360 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
G+ + K ++ + E ++ + C P+ RP ++V+++E
Sbjct: 247 ---PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 420 GD 421
Sbjct: 304 KQ 305
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 3e-61
Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 25/291 (8%)
Query: 130 KRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQT 188
+ + ++ + K+ LG G +G+VY+G VAVK LKE+ E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 189 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI 248
E ++ H NL++L G C ++ +M G++ LRE + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYM 120
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
A + + YL IHRD+ A N L+ E V DFGL++LM +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 368
I APE L+ K S K+DV+ +G++L E+ T + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------------PGI 220
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
++ L++ D + E E++ ++ C Q +P DRP +E+ + E
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-61
Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 27/279 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+ LG G FG V G+ VA+K +KE E +F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 61
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
++L G C ++ YMANG + + LRE + + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES 118
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
+HRD+ A N L++++ V DFGL++ + + + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 322 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
K S K+D++ +G+++ E+ + G+ ++ + + + + L P
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE-----RFTNSETAEHI------AQGLRLYRPH 224
Query: 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
L + E++ + C +RP ++ +
Sbjct: 225 LAS-------EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-61
Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 25/278 (8%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+S + LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74
Query: 202 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD 261
++L + +V YM+ GS+ L+ L P +A A G++Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVER 131
Query: 262 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 321
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 322 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381
G+ + K+DV+ +GI+L EL T R + +LD V E+ M P+
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQV-----ERGYRMPCPPEC 239
Query: 382 QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
E L + C + P +RP + LE
Sbjct: 240 --------PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-60
Identities = 66/306 (21%), Positives = 112/306 (36%), Gaps = 48/306 (15%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGS------LVAVKRLKEERTPGGELQFQTEVEMISM 195
++ +LG G FGKV S VAVK LKE+ +E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 196 AV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-------------------PP 235
H N++ L G C L++ Y G + + LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 236 SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295
L + A A+G+ +L +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 296 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLA 353
+ +V R + +APE L G + K+DV+ YGI+L E+ + G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----- 268
Query: 354 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSE 413
G+ + L+ + + E++ + C RP
Sbjct: 269 ------------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 414 VVRMLE 419
+ L
Sbjct: 317 LTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-59
Identities = 67/294 (22%), Positives = 125/294 (42%), Gaps = 38/294 (12%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSL---VAVKRLKEERTPGGELQFQTEVEMIS-MAV 197
+ ++++G G FG+V K R+ L A+KR+KE + F E+E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL------------PLDWPTR 245
H N++ L G C L Y +G++ LR+ + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
A ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 306 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365
R + +A E L+ + +DV+ YG++L E+++ + + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------YCGMTCAELYE 237
Query: 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
L + +LE ++ D +++ + C + P +RP ++++ L
Sbjct: 238 KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-59
Identities = 74/279 (26%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 201
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNL 62
Query: 202 LRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
++L G + L +V YMA GS+ LR R S L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 120
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
+ +HRD+ A N+L+ E+ A V DFGL K + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 321 TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
K S K+DV+ +GI+L E+ + R + L D V + K K++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKMDA----- 221
Query: 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ + +V C RP ++ LE
Sbjct: 222 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-58
Identities = 64/281 (22%), Positives = 111/281 (39%), Gaps = 25/281 (8%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHR 199
+ + +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 200 NLLRLRGFCMTPTERLL--VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
N++R + T L V Y G +AS + + + LD R+ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 258 YLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
H ++HRD+K AN+ LD + +GDFGLA++++ DT A GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375
PE ++ +EK+D++ G +L EL F A + +G
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----AFSQKELAGKIREG--------- 229
Query: 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
E+ ++I RP + E++
Sbjct: 230 --KFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 7e-58
Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 32/277 (11%)
Query: 147 KNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQ-FQTEVEMISMAVHRNLLRL 204
+GRG F VYKG + VA L++ + E Q F+ E EM+ H N++R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 205 RGFCMTPTER----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+ + +LV M +G++ + L+ + + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 261 DHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
P IIHRD+K NI + +GD GLA L AV GT +APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY 185
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
K E DV+ +G+ +LE+ T + + + + V +K + + P
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+++ + C + + +R + +++
Sbjct: 241 EVKE------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-57
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 33/279 (11%)
Query: 148 NILGRGGFGKVYKGRLAD---GSLVAVKRLKEERTPGGEL-QFQTEVEMISMAVHRNLLR 203
LG G FG V KG VAVK LK E + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
+ G C + +LV G + L++ + + + G+ YL +
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES- 126
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 321
+HRD+ A N+LL + A + DFGL+K + D T + + APE ++
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 322 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
K S K+DV+ +G+++ E + GQ+ + +K ++ +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYR------------------GMKGSEVTAMLEKG 226
Query: 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ ++ + LC +RP + V L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-57
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 26/278 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
+ + LG G +G+V VAVK + +R + E+ + M H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+++ G + L Y + G + + + + P +R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYL 319
I HRD+K N+LLDE + DFGLA + Y + + + GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 320 STGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
+ +E DV+ GI+L ++ G+ +D +D DW + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWK---- 230
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+++ L+ +P R + ++ +
Sbjct: 231 ------KIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 3e-56
Identities = 73/282 (25%), Positives = 110/282 (39%), Gaps = 35/282 (12%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAV 197
FS+ +G G FG VY R + + +VA+K++ E EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H N ++ RG + LV Y + + P L + G+ +GL+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
YLH H +IHRDVKA NILL E +GDFG A +M ++ V GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 181
Query: 318 YLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374
+ G+ K DV+ GI +EL + + L +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQN-------- 229
Query: 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
P LQ+ + + C Q P DRP +++
Sbjct: 230 --ESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-55
Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 130 KRFSLRELQVATDSFSNKNILGRGGFGKVYKGRL-ADGSLVAVKRLKEER--TPGGELQF 186
++++L + ++ LG+G FG VY R ++A+K L + + G E Q
Sbjct: 1 RQWALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 187 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRK 246
+ EVE+ S H N+LRL G+ T L+ Y G+V L++ D
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTA 109
Query: 247 RIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 306
A LSY H ++IHRD+K N+LL E + DFG +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 163
Query: 307 VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG 366
+ GT+ ++ PE + EK D++ G++ E + G+ F+ + +
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------------ANTYQE 211
Query: 367 LLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
K PD +V LI + +P RP + EV+
Sbjct: 212 TYKRISRVEFTFPD----FVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-55
Identities = 68/299 (22%), Positives = 129/299 (43%), Gaps = 33/299 (11%)
Query: 136 ELQVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTE 189
E +VA + + LG+G FG VY+G + VA+K + E + ++F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 190 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPPSQLPLDWP 243
++ +++RL G L++ M G + S LR P P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 244 TRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-TH 302
++A A G++YL+ + K +HRD+ A N ++ E+F +GDFG+ + + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 303 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLD 362
+ ++PE L G + +DV+ +G++L E+ T
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-------------- 236
Query: 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421
+GL E+ L +++ L + + + L ++ +C Q +P RP E++ ++ +
Sbjct: 237 --QGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-54
Identities = 64/291 (21%), Positives = 124/291 (42%), Gaps = 33/291 (11%)
Query: 137 LQVATDS-FSNKNILGRGGFGKVYKGRLAD-----GSLVAVKRLKEERTPGGELQFQTEV 190
L++ ++ F +LG G FG VYKG VA+K L+E +P + E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 191 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIAL 250
+++ + ++ RL G C+T T +L+ M G + +RE + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNI---GSQYLLNWCV 118
Query: 251 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRG 309
A+G++YL D +++HRD+ A N+L+ + DFGLAKL+ ++ + +
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 310 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 368
I +A E + + ++DV+ YG+ + EL+T G + +D +
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------------GI 217
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
++ +++ + + + + C RPK E++
Sbjct: 218 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-53
Identities = 77/279 (27%), Positives = 108/279 (38%), Gaps = 33/279 (11%)
Query: 150 LGRGGFGKVYKGRL----ADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLR 203
LG G FG V +G VAVK LK + P F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 204 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC 263
L G +TP ++ V GS+ LR+ T R A+ A G+ YL
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 264 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST 321
IHRD+ A N+LL +GDFGL + + D H + + APE L T
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 322 GKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380
S +D + +G+ L E+ T GQ + GL + L +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWI-----------------GLNGSQILHKIDKEG 231
Query: 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ E + + V + C P DRP + L
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-53
Identities = 75/299 (25%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 142 DSFSNKNILGRGGFGKVYKGR------LADGSLVAVKRLKEERTPGGELQFQTEVEMISM 195
D LGRG FG+V + A VAVK LKE T +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 196 AVHR-NLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPPSQLP------------LD 241
H N++ L G C P L ++ + G++++ LR + +P L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 242 WPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 302 HV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML 360
+V R + +APE + + ++DV+ +G++L E+ + + V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKI 242
Query: 361 LDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ LKE D ++ Q L C G P RP SE+V L
Sbjct: 243 DEEFCRRLKEGTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-52
Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 28/282 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAV 197
+ +G G FG V++G VA+K K + +F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H ++++L G T ++ G + S L+ R LD + A + L+
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALA 122
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
YL + +HRD+ A N+L+ +GDFGL++ M+ + + + I +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
++ + + +DV+ +G+ + E++ V D + + ++L M
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNNDVIGRIENGERLPM-- 230
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
P+ L + C P RP+ +E+ L
Sbjct: 231 PPNCP--------PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 4e-52
Identities = 62/282 (21%), Positives = 114/282 (40%), Gaps = 30/282 (10%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
D + LG G FGKVYK + L A K + + E + E+++++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N+++L ++ + A G+V + + E + PL + + + L+YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYL 126
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
HD+ KIIHRD+KA NIL + + + DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182
Query: 320 STGKS-----SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374
S K DV+ GI L+E+ + + +LL K
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH----ELNPMRVLLKIAKSEPPTLAQP 238
Query: 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+ ++ ++ C + + R S++++
Sbjct: 239 SRWSSNFKD---------FLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-51
Identities = 76/300 (25%), Positives = 122/300 (40%), Gaps = 42/300 (14%)
Query: 142 DSFSNKNILGRGGFGKVYKGRL--------ADGSLVAVKRLKEERTPGGELQFQTEVEMI 193
D LG G FG+V + VAVK LK + T +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 194 SMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQL------------PL 240
M H+N++ L G C ++ Y + G++ L+ R P L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 241 DWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 301 THVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 359
+ T R + +APE L + ++DV+ +G++L E+ T + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGV 241
Query: 360 LLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
++ + LLKE D +N +L + C P RP ++V L+
Sbjct: 242 PVEELFKLLKEGHR-----MDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-51
Identities = 61/278 (21%), Positives = 116/278 (41%), Gaps = 29/278 (10%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
++ +G+G G VY +A G VA++++ ++ P E E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N++ + E +V Y+A GS+ + E D + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFL 132
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H + ++IHRD+K+ NILL + + DFG + + + +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
+ K D++ GIM +E+I G+ + N++ + L + P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL-----NENPLRAL---------YLIATNGTP 234
Query: 380 DLQN-NYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+LQN + A + C R E+++
Sbjct: 235 ELQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (412), Expect = 1e-46
Identities = 55/276 (19%), Positives = 101/276 (36%), Gaps = 27/276 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
D + LG G FG V++ A G+ A K + E + E++ +S+ H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
L+ L E +++Y +M+ G + + + + +GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141
Query: 261 DHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
++ +H D+K NI+ E + DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
TD++ G++ L++G F +DD L +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFG----GENDDETLRNVKSCDWNM-------- 244
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
D + + + + I+ P R + +
Sbjct: 245 DDSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-46
Identities = 57/282 (20%), Positives = 102/282 (36%), Gaps = 30/282 (10%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERT--PGGELQFQTEVEMISMAVH 198
+ F ILG G F V R LA A+K L++ E +++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
++L + Y NG L + D + A +S
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYT---AEIVSA 120
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPE 317
L IIHRD+K NILL+E+ + DFG AK++ + + GT +++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
L+ + + +D++ G ++ +L+ G F A ++ ++ +K
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKL----------- 225
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ D + + L++ R E+
Sbjct: 226 EYDFPEKFFP-KARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 5e-46
Identities = 58/286 (20%), Positives = 115/286 (40%), Gaps = 28/286 (9%)
Query: 135 RELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMI 193
++ + D + +++LG G F +V LVA+K + ++ G E + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 194 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 253
H N++ L + L+ ++ G + + E+ R+
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 310
+ YLHD I+HRD+K N+L DE+ + ++ DFGL+K+ D V + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGT 172
Query: 311 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370
G++APE L+ S+ D + G++ L+ G F +D + +K +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY----DENDAKLFEQILKAEYE- 227
Query: 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+ + + I+ + P R + ++
Sbjct: 228 -------FDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (407), Expect = 7e-46
Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 27/278 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
D + LG G FG V++ A G + K + P + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPK 87
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
L+ L E +L+ +++ G + + + + GL ++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMH 144
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
+H I+H D+K NI+ + + + V DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
+ TD++ G++ L++G F +DD+ L VK E
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEF------- 247
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+ + V E + I+ Q P R + + +
Sbjct: 248 DEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 2e-45
Identities = 59/289 (20%), Positives = 107/289 (37%), Gaps = 40/289 (13%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK--------EERTPGGELQFQTEVEM 192
+++ K ILGRG V + AVK + E EV++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 193 IS-MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 251
+ ++ H N+++L+ T T LV+ M G + L E+ L ++I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 311
+ LH I+HRD+K NILLD++ + DFG + +D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173
Query: 312 GHIAPEYLSTG------KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365
++APE + ++ D++ G+++ L+ G F + +++L +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMI- 227
Query: 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ + + V+ L+ P R E
Sbjct: 228 ---MSGNYQF---GSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 4e-45
Identities = 47/270 (17%), Positives = 98/270 (36%), Gaps = 28/270 (10%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LGRG FG V++ + K +K + T ++ + E+ ++++A HRN+L L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESF 70
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
+ E ++++ +++ + + L+ L +LH H I
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 269 HRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 326
H D++ NI+ + + +FG A+ + D + APE S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 327 KTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYV 386
TD++ G ++ L++G F A + ++ + + + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFL----AETNQQIIENIMNAEYT--------FDEEAFKEI 230
Query: 387 EAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
E + R SE ++
Sbjct: 231 SIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-44
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 21/291 (7%)
Query: 140 ATDSFSNKNILGRGGFGKVYKGR--LADGSLVAVKRLK-EERTPGGELQFQTEVEMISMA 196
A + +G G +GKV+K R G VA+KR++ + G L EV ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 197 V---HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPPSQLPLDWPTRKRIALG 251
H N++RL C + V L + + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 311
RGL +LH H +++HRD+K NIL+ + + DFGLA++ ++ + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF----DLARLANDDDVMLL----DW 363
+ APE L + D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ + ++ +V E + L C +P R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (391), Expect = 2e-44
Identities = 65/289 (22%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEE--RTPGGELQFQTEVEMISMAV 197
+D + ILG GG +V+ R L VAVK L+ + R P L+F+ E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 198 HRNLLRLRGFCMTPTERL----LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSA 253
H ++ + T +V Y+ ++ + P + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 254 RGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTI 311
+ L++ H + IIHRDVK ANI++ V DFG+A+ + V T AV GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371
+++PE ++DV+ G +L E++TG+ F D + + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPV------SVAYQH 226
Query: 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-MSEVVRMLE 419
E + P ++ + A+++ ++ +P +R + +E+ L
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLV 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (397), Expect = 2e-44
Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEER--TPGGELQFQTEVEMISMAV- 197
+ FS I+GRGGFG+VY R AD G + A+K L ++R GE E M+S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 198 --HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 255
++ + TP + + M G + L + + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILG 119
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
L ++H+ +++RD+K ANILLDE + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 316 PEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFD 348
PE L G + D F G ML +L+ G F
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 5e-43
Identities = 52/294 (17%), Positives = 96/294 (32%), Gaps = 31/294 (10%)
Query: 136 ELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMIS 194
EL+V + + +G G FG +Y G +A G VA+K + Q E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYK 57
Query: 195 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
M + +C + ++ + S+ T +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMIS 114
Query: 255 GLSYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDTHV------TT 305
+ Y+H IHRDVK N L + + DFGLAK TH
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 306 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365
+ GT + + + S + D+ G +L+ G + + +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW--------QGLKAATKRQ 223
Query: 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
+ + +M ++ +E + C D+P S + ++
Sbjct: 224 KYERISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (381), Expect = 7e-43
Identities = 56/286 (19%), Positives = 109/286 (38%), Gaps = 18/286 (6%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRN 200
+ + +G G +G VYK + G A+K+++ E+ G E+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+++L T +LV+ ++ L+ T K L G++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCH 117
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
D +++HRD+K N+L++ E E + DFGLA+ T + +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 321 TGKSSEKTDVFGYGIMLLELITGQRAFD----------LARLANDDDVMLLDWVKGLLKE 370
+ K S D++ G + E++ G F + R+ + V L K
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+ +P ++++ E I + + P R + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 9e-43
Identities = 59/277 (21%), Positives = 109/277 (39%), Gaps = 33/277 (11%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRG 206
+LG G GKV + A+K L++ + + EVE+ A +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72
Query: 207 FCMTPTER----LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
L+V + G + S +++R I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTEREASEIMKSIGEAIQYLHSI 130
Query: 263 CDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
I HRDVK N+L + + DFG AK ++ T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
K + D++ G+++ L+ G F ++ + + +K ++ + E P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYEF---P 237
Query: 380 DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
+ + + V EV+ LI+ + P R ++E +
Sbjct: 238 NPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-42
Identities = 66/279 (23%), Positives = 106/279 (37%), Gaps = 31/279 (11%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISMAV- 197
+ F +LG+G FGKV+ A+K LK++ E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 198 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
H L + T V Y+ G + ++ D A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 317
+LH I++RD+K NILLD++ + DFG+ K D T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
L K + D + +G++L E++ GQ F D+ L ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRM----------- 217
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
D ++E E + L+ P R + +R
Sbjct: 218 DNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 53/292 (18%), Positives = 112/292 (38%), Gaps = 20/292 (6%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 199
++N + +G G +G V + VA+K++ + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N++ + PT + Y+ + + L + +Q L RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPE 317
H ++HRD+K +N+LL+ + + DFGLA++ D H T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 318 YLSTG-KSSEKTDVFGYGIMLLELITGQRAFD-----------LARLANDDDVMLLDWVK 365
+ ++ D++ G +L E+++ + F L L + L +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 366 GLLKEKKLEMLVDPDLQNNYVEAEV-EQLIQVALLCTQGSPMDRPKMSEVVR 416
+ L + + N + + + + +P R ++ + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 7e-41
Identities = 35/282 (12%), Positives = 79/282 (28%), Gaps = 32/282 (11%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
+G G FG +++G L + VA+K Q + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKII 268
++ + S+ L T A + +H+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 269 HRDVKAANILLDEEFEAVVG-----DFGLAKLMDYKDTHV------TTAVRGTIGHIAPE 317
+RD+K N L+ DFG+ K T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 318 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377
+ S + D+ G + + + G + + A + + + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY--------ERIGEKKQST 235
Query: 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419
E + + + P + +
Sbjct: 236 PLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-40
Identities = 55/286 (19%), Positives = 98/286 (34%), Gaps = 20/286 (6%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHR 199
++F +G G +G VYK R G +VA+K+++ + T G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N+++L T + LV+ ++ + P K +GL++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFC 118
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H H ++HRD+K N+L++ E + DFGLA+ T V L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAFD-----------LARLANDDDVMLLDWVKGLL 368
S D++ G + E++T + F L D+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 369 KEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ D + E + P R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLD-EDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-40
Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 28/291 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGRLAD-GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRN 200
S+++ ++G G FG VY+ +L D G LVA+K++ +++ E++++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCN 74
Query: 201 LLRLRGFCMTPTER------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSAR 254
++RLR F + E+ LV Y+ R ++ L K R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 255 GLSYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 313
L+Y+H I HRD+K N+LLD + + DFG AK + + +V+ +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYR 189
Query: 314 IAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD----------LARLANDDDVMLLDW 363
+ DV+ G +L EL+ GQ F + ++ +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 364 VKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEV 414
+ E K + + + I + + +P R E
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (366), Expect = 2e-40
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 132 FSLRELQVATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERT--PGGELQFQT 188
+SL++ Q+ LG G FG+V+ R +G A+K LK+E
Sbjct: 1 YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 189 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRI 248
E M+S+ H ++R+ G + ++ Y+ L P K
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY 109
Query: 249 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 308
A L YLH II+RD+K NILLD+ + DFG AK + +
Sbjct: 110 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---- 162
Query: 309 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
GT +IAPE +ST ++ D + +GI++ E++ G F
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-39
Identities = 61/285 (21%), Positives = 103/285 (36%), Gaps = 34/285 (11%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL-----QFQTEVEMISM 195
D + LG G F V K R + G A K +K+ RT + EV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 255
H N++ L T+ +L+ +A G L + + L G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLMDYKDTHVTTAVRGTI 311
+ YLH I H D+K NI+L + + DFGLA +D+ + + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 312 GHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371
+APE ++ + D++ G++ L++G F D L V + E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYE- 234
Query: 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
D + A + I+ P R + + ++
Sbjct: 235 ------FEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-39
Identities = 74/320 (23%), Positives = 116/320 (36%), Gaps = 44/320 (13%)
Query: 148 NILGRGGFGKVYKGR-LADGSLVAVKRLK----EERTPGGELQFQTEVEMISMAVHRNLL 202
+ LG G F VYK R +VA+K++K E G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 203 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDH 262
L + LV+ +M + L L K L + +GL YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 263 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 322
I+HRD+K N+LLDE + DFGLAK + T V T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 323 KS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 381
+ D++ G +L EL+ D D+ L + L E D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLP-----GDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 382 QNNYVEAEV--------------EQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAERW 427
+YV + + L+ + +P R ++ ++M
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM---------- 280
Query: 428 DEWQKVEVLRQEVELAPHPN 447
++ P PN
Sbjct: 281 -KYFSNRPGPTPGCQLPRPN 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-38
Identities = 59/278 (21%), Positives = 101/278 (36%), Gaps = 44/278 (15%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGE-----LQFQTEVEMISM--AVHRN 200
+LG GGFG VY G ++D VA+K ++++R + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 201 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
++RL + P +L+ L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 261 DHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
+ ++HRD+K NIL+D E + DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 320 STGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378
+ V+ GI+L +++ G F E E++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF----------------------EHDEEIIRG 219
Query: 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416
V +E + LI+ C P DRP E+
Sbjct: 220 QVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-36
Identities = 60/267 (22%), Positives = 103/267 (38%), Gaps = 18/267 (6%)
Query: 139 VATDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEER--TPGGELQFQTEVEMISM 195
V + F +LG+G FGKV R A G A+K L++E TE ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 196 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARG 255
H L L+ T V Y G + L T +R A
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEI 114
Query: 256 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 315
+S L +++RD+K N++LD++ + DFGL K GT ++A
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 316 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAF------DLARLANDDDVMLLDWVKGLLK 369
PE L D +G G+++ E++ G+ F L L +++ + K
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 370 EKKLEMLV-DPDLQNNYVEAEVEQLIQ 395
+L DP + ++ +++++
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-35
Identities = 53/288 (18%), Positives = 103/288 (35%), Gaps = 20/288 (6%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLK-EERTPGGELQFQTEVEMISMAVHR 199
+ +G G +G V+K + +VA+KR++ ++ G E+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 200 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYL 259
N++RL + + LV+ + + LD K +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 260 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 319
H ++HRD+K N+L++ E + +FGLA+ + V
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 320 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 379
S D++ G + EL R +D + + +E+ M P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 380 DLQNNYVEAEVEQLIQVA---------LL--CTQGSPMDRPKMSEVVR 416
D + + L+ V LL + +P+ R E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 3e-35
Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 19/226 (8%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGEL--QFQTEVEMISMAVH 198
D F LG G FG+V + G+ A+K L +++ + E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
L++L + +V Y+A G + S LR P + A Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
LH +I+RD+K N+L+D++ V DFG AK + + + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEI 209
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 364
+ + ++ D + G+++ E+ G F D + + + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYEKI 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 7e-35
Identities = 59/295 (20%), Positives = 114/295 (38%), Gaps = 27/295 (9%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVHR 199
+ +G+G FG+V+K R G VA+K++ E G + E++++ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 200 NLLRLRGFCMTPTER--------LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALG 251
N++ L C T LV+ + + KR+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVM-- 123
Query: 252 SARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVR 308
L+ L+ KI+HRD+KAAN+L+ + + DFGLA+ + T
Sbjct: 124 -QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 309 GTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 367
T+ + PE L + D++G G ++ E+ T + + L + L
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ-----GNTEQHQLALISQL 237
Query: 368 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV-RMLEGD 421
E+ + D Y + E+ + + + + + P +++ ++L D
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-33
Identities = 45/222 (20%), Positives = 86/222 (38%), Gaps = 12/222 (5%)
Query: 132 FSLRELQVATDSFSNK----NILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQ 185
F +E+ +G G +G V G+ VA+K+L + ++ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 186 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTR 245
E+ ++ H N++ L + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 246 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 305
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D+ +T
Sbjct: 124 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 306 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
V L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-31
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 17/221 (7%)
Query: 138 QVATDSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEER---TPGGELQFQTEV 190
+V ++F +LG G +GKV+ R G L A+K LK+ +TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 191 EMISMAVHR-NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIA 249
+++ L+ L T T+ L+ Y+ G + + L +R I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138
Query: 250 LGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 309
+ L II+RD+K NILLD V+ DFGL+K +T G
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 310 TIGHIAPEYLSTGKS--SEKTDVFGYGIMLLELITGQRAFD 348
TI ++AP+ + G S + D + G+++ EL+TG F
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 1e-30
Identities = 44/212 (20%), Positives = 83/212 (39%), Gaps = 22/212 (10%)
Query: 142 DSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVE-MISMAVHR 199
D + LGRG + +V++ + + V VK LK + + + + E++ + ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGP 90
Query: 200 NLLRLRGFCMTPTERL--LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLS 257
N++ L P R LV+ ++ N + L + + L
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143
Query: 258 YLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 316
Y H I+HRDVK N+++D E + + D+GLA+ + + P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 317 E-YLSTGKSSEKTDVFGYGIMLLELITGQRAF 347
E + D++ G ML +I + F
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 7e-29
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 20/207 (9%)
Query: 149 ILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVHRNLLRLRG 206
+G G G V VA+K+L + + + E+ ++ H+N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 207 FCMTP------TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH 260
+ LV M E + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 261 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 320
IIHRD+K +NI++ + + DFGLA+ + + T T + APE +
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 191
Query: 321 TGKSSEKTDVFGYGIMLLELITGQRAF 347
E D++ G ++ E++ + F
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 2e-28
Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 8/210 (3%)
Query: 141 TDSFSNKNILGRGGFGKVYKGR-LADGSLVAVKRL-KEERTPGGELQFQTEVEMISMAVH 198
+ + N + +G G +G V G VAVK+L + ++ + E+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
N++ L + L + + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 318
+H IIHRD+K +N+ ++E+ E + DFGLA+ D +T V
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190
Query: 319 LSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
L+ ++ D++ G ++ EL+TG+ F
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 7e-26
Identities = 38/214 (17%), Positives = 76/214 (35%), Gaps = 19/214 (8%)
Query: 150 LGRGGFGKVYKGR-LADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFC 208
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 209 MTPTERLLVYPY------------MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGL 256
+LL + + + K+I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 257 SYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHI 314
Y+H C IIH D+K N+L++ + +A L + T +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 315 APEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 348
+PE L D++ ++ ELITG F+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.1 bits (233), Expect = 5e-23
Identities = 24/162 (14%), Positives = 46/162 (28%), Gaps = 20/162 (12%)
Query: 148 NILGRGGFGKVYKGRLADGSLVAVKRLKEERT---------PGGELQFQTEVEMISMAVH 198
++G G V+ VK K T G+L F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 199 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSY 258
R L +L+G + Y G+ + + ++
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 259 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300
+ I+H D+ N+L+ E + DF + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.6 bits (153), Expect = 1e-11
Identities = 17/45 (37%), Positives = 24/45 (53%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANNLDLCGP 46
LT + L L++S N L G +P G+ F ++ANN LCG
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.4 bits (88), Expect = 0.001
Identities = 7/23 (30%), Positives = 15/23 (65%)
Query: 2 SLTNISSLQVLDLSNNRLSGVVP 24
SL N++++ L +N++S + P
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP 368
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 467 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.12 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.68 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.39 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 93.01 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 92.1 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 91.29 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 89.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 89.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 89.11 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 85.82 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 83.76 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 82.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 82.68 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 82.23 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 80.98 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=407.59 Aligned_cols=254 Identities=25% Similarity=0.415 Sum_probs=199.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 5677889999999999999999888899999997543 33567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++|+|.+++.... ..++|..++.++.|||.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999987643 2489999999999999999999999 999999999999999999999999999987654444
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcC-CCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......||+.|+|||++.+..++.++|||||||++|||+|+ ++||.. ....+.......... ...|.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--------~~~~~~~~~i~~~~~---~~~p~ 225 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDISTGFR---LYKPR 225 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--------CCHHHHHHHHHHTCC---CCCCT
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--------CCHHHHHHHHHhcCC---CCCcc
Confidence 444445689999999999999999999999999999999995 444432 112222222222111 11121
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.+...+.+++.+||+.||++||||+||++.|+++
T Consensus 226 -------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 -------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1235688999999999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-56 Score=416.66 Aligned_cols=265 Identities=28% Similarity=0.365 Sum_probs=216.5
Q ss_pred HHHHHhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 136 ELQVATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 136 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
+|++..++|++.+.||+|+||+||+|++. +|+.||||+++... ...++|.+|++++++++|||||+++++|.+.+..
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34455677888899999999999999976 68899999997543 3455799999999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999976432 3489999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
..............|++.|+|||++.+..++.++|||||||++|||++|..|+... . ....... ......
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~----~---~~~~~~~-~i~~~~-- 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----I---DLSQVYE-LLEKDY-- 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT----C---CHHHHHH-HHHTTC--
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc----c---hHHHHHH-HHhcCC--
Confidence 87655555555556889999999999999999999999999999999987776321 1 1111111 111110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
.+.. .......+.+++.+||+.||++||||.||++.|+.....
T Consensus 234 ---~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 234 ---RMER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---CCCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1111 112235688999999999999999999999999875433
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=410.76 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=209.1
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++..++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 34456788889999999999999999888899999997543 334579999999999999999999998754 567999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++..... .+++|..++.|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++.+.
T Consensus 86 ~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 999999999998765422 2389999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
...........||+.|+|||++.+..++.++|||||||++|||+||..|+... . ...+.......... ..
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~----~---~~~~~~~~i~~~~~---~~ 230 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----M---TNPEVIQNLERGYR---MV 230 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT----C---CHHHHHHHHHTTCC---CC
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC----C---CHHHHHHHHHhcCC---CC
Confidence 54444445567899999999999889999999999999999999976655321 1 11122222211111 11
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.| ......+.+++.+||+.||++||||++|++.|++
T Consensus 231 ~p-------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 RP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cc-------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11 1223568899999999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-55 Score=406.51 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=203.1
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCC-CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEER-TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
++..++|++.+.||+|+||+||+|++. ..||||+++... .....+.|.+|++++.+++|||||++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678999999999999999999875 359999997544 33445679999999999999999999999764 56899
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+++|+|.+++..... .+++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 81 v~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 9999999999999976432 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CeeeecccccccccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 297 DYKD-THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 297 ~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... . . ..+........
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-----~--~-~~~~~~~~~~~ 226 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-----N--R-DQIIFMVGRGY 226 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----C--H-HHHHHHHHHTS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-----h--H-HHHHHHHhcCC
Confidence 5332 233445679999999999864 357999999999999999999999996321 1 1 11111111111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
..|.+. .........+.+++.+||+.||++||||+||++.|+.
T Consensus 227 ----~~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 227 ----LSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp ----CCCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111110 1112233678899999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-54 Score=406.45 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=198.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CC---CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DG---SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++|++.++||+|+||+||+|++. +| ..||||.+.........+.|.+|++++++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45666789999999999999875 33 369999987766666667899999999999999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++..... .++|..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.+.
T Consensus 106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998886432 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCe----eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 298 YKDTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 298 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
..... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.+........
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------NQDVINAIEQDYR 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 33221 1222457899999999999999999999999999999998 899995321 1122222222111
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. ........+.+++.+||+.||++||||.||++.|++
T Consensus 252 ~~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 252 LP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp CC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 111233668899999999999999999999999976
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-55 Score=405.21 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=204.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||+|+||+||+|+.. +|+.||||+++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888899999999999999975 79999999997655444455789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999997643 389999999999999999999999 99999999999999999999999999998765333
Q ss_pred C-eeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 301 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 301 ~-~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... ........ ....... .
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~~----~~~~~~~---~- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSD----WKEKKTY---L- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS---TTSHHHHH----HHTTCTT---S-
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC---hHHHHHHH----HhcCCCC---C-
Confidence 2 23345679999999999988776 678999999999999999999996422 11111111 1111000 0
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLA 424 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 424 (467)
.........+.+++.+||+.||++|||++|+ |+...+.
T Consensus 227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei---l~hpwf~ 264 (271)
T d1nvra_ 227 -----NPWKKIDSAPLALLHKILVENPSARITIPDI---KKDRWYN 264 (271)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH---TTCTTTT
T ss_pred -----CccccCCHHHHHHHHHHcCCChhHCcCHHHH---hcCHhhC
Confidence 0011122567789999999999999999998 4555544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=395.58 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=213.2
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
++|+..++||+|+||+||+|++++++.||||+++.... ...+|.+|++++++++||||++++|+|.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 67899999999999999999998888999999976433 3457999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++|+|.+++..... .+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999776432 388999999999999999999999 999999999999999999999999999987654444
Q ss_pred eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 302 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+......... ....|.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~~~~---~~~~p~ 224 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGL---RLYRPH 224 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTC---CCCCCT
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHHhCC---CCCCcc
Confidence 44445668999999999999999999999999999999998 899996421 122222222211 111222
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.....+.+++.+||+.||++|||+++|++.|.++
T Consensus 225 -------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 -------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1225688999999999999999999999999763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=396.73 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=205.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 47999999999999999999964 7999999999755433 345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988764 289999999999999999999999 99999999999999999999999999998765332
Q ss_pred CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 301 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+.......... ...
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~~-~~~-- 238 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPE-LQN-- 238 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSCC-CSS--
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCCC-CCC--
Confidence 23345579999999999999999999999999999999999999995321 111122222211111 111
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 239 -----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 -----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122356889999999999999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=403.09 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCceEEEEEEECCC-----CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADG-----SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
+.|+..++||+|+||+||+|.+.+. ..||||+++.........+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999987532 37999999876666666679999999999999999999999999999999
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
||||+.+|++.+++..... .++|..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+
T Consensus 87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998876532 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
..... .......||+.|+|||++.+..++.++|||||||++|||+||..|+... . ...+..........
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~----~---~~~~~~~~i~~~~~-- 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----L---SNHEVMKAINDGFR-- 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----C---CHHHHHHHHHTTCC--
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc----C---CHHHHHHHHhccCC--
Confidence 43322 2233346899999999999999999999999999999999976665321 1 11222222211111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
+. ........+.+++.+||+.||++||||.||+++|+.
T Consensus 232 ----~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 232 ----LP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp ----CC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CC----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 11 111233668899999999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=401.53 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=205.8
Q ss_pred cCCCCCCe-eeecCceEEEEEEEC---CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNI-LGRGGFGKVYKGRLA---DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~-lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++|...++ ||+|+||+||+|.+. ++..||||+++........+.|.+|++++++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 44555564 999999999999764 3557999999876666566789999999999999999999999875 468999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++..... .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 mE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999865432 489999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCCee--eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 298 YKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 298 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .. +...........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----~~---~~~~~i~~~~~~- 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GP---EVMAFIEQGKRM- 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----TH---HHHHHHHTTCCC-
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----HH---HHHHHHHcCCCC-
Confidence 443322 223458899999999999999999999999999999998 999996321 11 222222111111
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. +......+.+++.+||+.||++||||.+|++.|+.
T Consensus 232 -----~~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 -----EC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -----CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CC----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 11223568899999999999999999999999976
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=391.80 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999985 68999999986432 1223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998643 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+......+..
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~------- 220 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVE------- 220 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC-------
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-------
Confidence 2 2344679999999999999999999999999999999999999996321 112222222111
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.+.. .....+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11111 12356888999999999999999999965
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=400.49 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=194.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeC--CCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 217 (467)
++|++.+.||+|+||+||+|+.. +|+.||||.+...... .....+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999975 7899999999765433 334568899999999999999999999865 4567999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
|||+++|+|.+++.........+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754333345999999999999999999999862 12499999999999999999999999999987
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
+... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+....... ....
T Consensus 164 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~i~~-~~~~- 232 (269)
T d2java1 164 LNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIRE-GKFR- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH-TCCC-
T ss_pred cccC-CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHHHHc-CCCC-
Confidence 6532 233445679999999999999999999999999999999999999995321 1122222211 1111
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.. .....+.+++.+||+.||.+|||+.|+++
T Consensus 233 ----~~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ----RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCc----ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 12356889999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-54 Score=409.51 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=207.9
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEECC-C-----CEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRLAD-G-----SLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
++..++|++.++||+|+||+||+|++.. + ..||||++...........+.+|+.++.++ +|||||+++++|.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3455788899999999999999998642 2 369999997655555555789999999988 89999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCC
Q 012267 211 PTERLLVYPYMANGSVASCLRERPPS-------------------QLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 271 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~d 271 (467)
.+..++||||+++|+|.++|+..... ...+++..++.++.||++||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 99999999999999999999865321 23489999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCccc
Q 012267 272 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDL 349 (467)
Q Consensus 272 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~ 349 (467)
|||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 3344568999999999999999999999999999999998 8999953
Q ss_pred ccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 012267 350 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLE 419 (467)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 419 (467)
. .....+.+.+ .... .+.. +......+.+++.+||+.||++|||++||++.|.
T Consensus 270 ~----~~~~~~~~~~----~~~~-----~~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 I----PVDANFYKLI----QNGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp C----CCSHHHHHHH----HTTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C----CHHHHHHHHH----hcCC-----CCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 1122222222 1111 0111 1122357889999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=398.54 Aligned_cols=258 Identities=27% Similarity=0.382 Sum_probs=202.9
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+..++|++.+.||+|+||+||+|++.++..||||+++... ...+.|.+|+.++.+++|||||+++|+|.+ +..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 3446788999999999999999999888899999997543 334679999999999999999999999854 5689999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++..... ..++|..++.++.||+.||+|||++ +|+||||||+||||++++++||+|||+++....
T Consensus 91 Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999999876422 2389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
..........||+.|+|||++....++.++|||||||++|||+||..|+... . ...+.+........
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~----~---~~~~~~~~i~~~~~------ 232 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG----M---VNREVLDQVERGYR------ 232 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT----C---CHHHHHHHHHTTCC------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC----C---CHHHHHHHHHhcCC------
Confidence 4444444456899999999999999999999999999999999977766321 1 12222222221111
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+.. .......+.+++.+||+.||++||||++|+++|++.
T Consensus 233 ~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 233 MPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCC----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 111 112235688999999999999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=394.10 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=197.5
Q ss_pred CeeeecCceEEEEEEEC---CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeeccCC
Q 012267 148 NILGRGGFGKVYKGRLA---DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 223 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 223 (467)
++||+|+||+||+|.+. .++.||||+++.... +...+.|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 346899999975433 3334579999999999999999999999865 457899999999
Q ss_pred CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCCee
Q 012267 224 GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 303 (467)
Q Consensus 224 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 303 (467)
|+|.+++.... ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998754 389999999999999999999999 99999999999999999999999999998765443332
Q ss_pred --eecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccCcc
Q 012267 304 --TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPD 380 (467)
Q Consensus 304 --~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 380 (467)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+........... .
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~~~i~~~~~~------~ 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGERM------G 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCC------C
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHHHHHHcCCCC------C
Confidence 233568999999999999999999999999999999998 899996321 11222222111111 1
Q ss_pred ccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 381 LQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 381 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. +......+.+++.+||+.||++|||+.+|+++|+.
T Consensus 231 ~----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 C----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C----CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1 11223568899999999999999999999999876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=403.82 Aligned_cols=200 Identities=26% Similarity=0.391 Sum_probs=179.1
Q ss_pred HhcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 140 ATDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 140 ~~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
..++|+..+.||+|+||+||+|+.. +|+.||+|+++..........+.+|+.+++.++|||||+++++|.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999975 789999999987655555668999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||+ + +|+||||||+|||+++++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999998653 28999999999999999999996 5 79999999999999999999999999998654
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 349 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~ 349 (467)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22 22345799999999999999999999999999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-53 Score=394.70 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=201.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
+.|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46788899999999999999975 78999999997643 33345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+++|+|.+++.... .++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 91 CAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence 99999999987532 2389999999999999999999999 9999999999999999999999999999764321
Q ss_pred Ceeeeccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 301 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
........||+.|+|||++. ...++.++|||||||++|||+||+.||.... ... .......... ..
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-----~~~---~~~~i~~~~~-~~ 234 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-----PMR---VLLKIAKSEP-PT 234 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----GGG---HHHHHHHSCC-CC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-----HHH---HHHHHHcCCC-CC
Confidence 11223456999999999984 4567899999999999999999999996421 111 1111121111 01
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
... .......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 LAQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CSS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1122356889999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=385.65 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=194.8
Q ss_pred CCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-cchHHHHHHHHHHHHhcCCCeeeeeeeeeeC----CCceEEEe
Q 012267 145 SNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-PGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 218 (467)
Q Consensus 145 ~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 218 (467)
+..++||+|+||+||+|+.. +++.||+|.+..... ......+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999975 688999999876543 3344578999999999999999999999864 34578999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cccCCCCCCcEEEC-CCCcEEEeecCCccc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKL 295 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~ 295 (467)
||+++|+|.+++.... .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+++.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999998653 389999999999999999999998 6 99999999999996 578999999999986
Q ss_pred cCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
... .......||+.|+|||++.+ .++.++|||||||++|||+||+.||.... ............ ..
T Consensus 165 ~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i~~~-~~-- 230 (270)
T d1t4ha_ 165 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSG-VK-- 230 (270)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTT-CC--
T ss_pred ccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHHHHHHHHcC-CC--
Confidence 432 22345679999999999865 58999999999999999999999995311 111222222111 11
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+.. ....++.+++.+||+.||++|||+.|+++
T Consensus 231 --~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 --PASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CcccCc----cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111111 11245788999999999999999999964
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-52 Score=397.86 Aligned_cols=267 Identities=26% Similarity=0.422 Sum_probs=215.7
Q ss_pred HHHHHHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeee
Q 012267 134 LRELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 207 (467)
Q Consensus 134 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 207 (467)
+.+++...++|++.+.||+|+||+||+|+.. +++.||||+++..........|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4556677889999999999999999999864 3578999999876666566789999999999999999999999
Q ss_pred eeCCCceEEEeeccCCCChhhhhhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc
Q 012267 208 CMTPTERLLVYPYMANGSVASCLRERPP--------------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKI 267 (467)
Q Consensus 208 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~i 267 (467)
|...+..++||||+++|+|.+++..... ....+++..++.|+.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999975321 123489999999999999999999999 99
Q ss_pred ccCCCCCCcEEECCCCcEEEeecCCccccCCCC-CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCC-C
Q 012267 268 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ-R 345 (467)
Q Consensus 268 vH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~-~ 345 (467)
+||||||+|||+|.++.+||+|||+++.+.... ........|++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998664332 22334456889999999999999999999999999999999996 5
Q ss_pred CcccccccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 346 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 346 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
||... ...+........ ... .. ......++.+++.+||+.+|++||||.||+++|+++
T Consensus 242 p~~~~--------~~~e~~~~v~~~-~~~-----~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGM--------AHEEVIYYVRDG-NIL-----AC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTS--------CHHHHHHHHHTT-CCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCC--------CHHHHHHHHHcC-CCC-----CC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 66431 112222222221 111 11 112235688999999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-52 Score=393.46 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=190.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
.+.|++.+.||+|+||+||+|+.. +|+.||||++...........+.+|+++++.++|||||++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 367888999999999999999975 6899999999766554445578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC---CCCcEEEeecCCcccc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLM 296 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~ 296 (467)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997643 399999999999999999999999 999999999999994 5789999999999865
Q ss_pred CCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccc
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEML 376 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (467)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.......... .
T Consensus 161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~---~ 227 (307)
T d1a06a_ 161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAEY---E 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTCC---C
T ss_pred cCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhccCC---C
Confidence 422 23344679999999999999999999999999999999999999995321 1112222222110 0
Q ss_pred cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... .......+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCcc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111 1122356889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=392.31 Aligned_cols=257 Identities=21% Similarity=0.346 Sum_probs=198.2
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECC----CCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLAD----GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
+..++|++.+.||+|+||+||+|++.. +..||||.++..........+.+|++++++++||||++++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345678889999999999999998642 35799999876655555667999999999999999999999986 4678
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
++||||+++|+|.+++..... ++++..++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999998876432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhccc
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 373 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (467)
.+............||+.|+|||++.+..++.++|||||||++|||+| |..||.... ...+...+ ......
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-----~~~~~~~i---~~~~~~ 228 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRI---ENGERL 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHH---HTTCCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-----HHHHHHHH---HcCCCC
Confidence 766544444555668999999999999999999999999999999998 899986422 11222211 111111
Q ss_pred ccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 374 EMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 374 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.. .......+.+++.+||+.||.+|||+.||++.|+.
T Consensus 229 ------~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ------PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 11223668899999999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=388.41 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=202.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56888999999999999999975 79999999986432 1223456899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988654 389999999999999999999999 999999999999999999999999999987653
Q ss_pred CC-CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 299 KD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 299 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
.. ........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.........
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~------ 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKLE------ 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcCC------
Confidence 32 223445679999999999999999999999999999999999999996321 112222222111
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+.. .....+.+++.+||+.||.+|||++|+++
T Consensus 227 -~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 -YDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11111 12356789999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-52 Score=393.16 Aligned_cols=246 Identities=29% Similarity=0.422 Sum_probs=200.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--hHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
+.|+..+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888899999999999999975 78899999997654332 2346889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
|||.+|+|..++.... ++++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987766543 389999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCeeeecccccccccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccc
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEM 375 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (467)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~---- 230 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE---- 230 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC----
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC----
Confidence 233569999999999864 458999999999999999999999995311 111122222111
Q ss_pred ccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 376 LVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 376 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.+.+.. ......+.+++.+||+.||.+|||+.|+++
T Consensus 231 --~~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 --SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CCCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111 112356889999999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=382.24 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=204.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC-----cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCce
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT-----PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 214 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 214 (467)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367899999999999999999975 799999999965432 22356799999999999999999999999999999
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC----cEEEeec
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 290 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 290 (467)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999998653 389999999999999999999999 999999999999998776 4999999
Q ss_pred CCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 291 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 291 gl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
|++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+........
T Consensus 162 G~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 231 (293)
T ss_dssp TTCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTT
T ss_pred hhhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc
Confidence 999876432 23344568999999999999999999999999999999999999996321 11112221111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. .. ..+. ........+.+++.+||+.||++|||++|+++
T Consensus 232 ~-~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 N-YE--FEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-CC--CCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-CC--CCch----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 0000 01112356789999999999999999999854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=392.51 Aligned_cols=254 Identities=25% Similarity=0.434 Sum_probs=200.6
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC----EEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS----LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 216 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 216 (467)
.+|+..++||+|+||+||+|.+. +|+ +||||+++........+.|.+|++++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888899999999999999875 444 69999997666666677899999999999999999999999875 5678
Q ss_pred EeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCcccc
Q 012267 217 VYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 296 (467)
Q Consensus 217 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 296 (467)
++||+.+|+|.+++..... .+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876532 489999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 297 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 297 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||+... ...+...+.. .....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~~---~~~~~ 233 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK---GERLP 233 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHHH---TCCCC
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc---CCCCC
Confidence 543332 2334468999999999999999999999999999999999 788886421 1122222211 11110
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. .......+.+++.+||+.||.+|||+.||++.|+.
T Consensus 234 ---~-------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 234 ---Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---C-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---C-------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 0 11223568899999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-50 Score=387.62 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=205.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57899999999999999999975 78999999996543 33445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC--CCCcEEEeecCCccccCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~ 298 (467)
+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999965432 389999999999999999999999 999999999999995 467899999999987653
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.......... ..+
T Consensus 179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~---~~~ 245 (350)
T d1koaa2 179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDW---NMD 245 (350)
T ss_dssp TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCC---CSC
T ss_pred cc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC---CCC
Confidence 33 3344569999999999999999999999999999999999999995321 1222222222111 011
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 DSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CGG----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1122356889999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=384.64 Aligned_cols=250 Identities=28% Similarity=0.394 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-CCceEEEee
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYP 219 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 219 (467)
.++|++.+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++||||++++|+|.+ .+..++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 456777889999999999999985 7899999996543 34578999999999999999999999865 456899999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+++|+|.+++.... ...++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999997642 12389999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.....++..|+|||++.+..++.++|||||||++|||+| |+.||... ....+..++. .. ..
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~~~i~---~~------~~ 218 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVE---KG------YK 218 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHHHT---TT------CC
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHH---cC------CC
Confidence 223457889999999999999999999999999999998 68777532 1222222221 11 11
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+.+. ......+.+++.+||+.||.+||||.+|+++|+++
T Consensus 219 ~~~~----~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAP----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC----ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111 12225688999999999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.7e-50 Score=385.95 Aligned_cols=251 Identities=19% Similarity=0.296 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++++++|||||++++++.+.+..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57899999999999999999975 79999999997543 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEEC--CCCcEEEeecCCccccCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~ 298 (467)
+++|+|.+++.... .++++..++.|+.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+++.+..
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999887543 2489999999999999999999999 999999999999998 678999999999987654
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+......... . ...
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~-~--~~~ 248 (352)
T d1koba_ 182 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCD-W--EFD 248 (352)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCC-C--CCC
T ss_pred CC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C--CCC
Confidence 32 3344568999999999999999999999999999999999999995321 112222221111 0 011
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 EDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1122356889999999999999999999965
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=383.16 Aligned_cols=252 Identities=32% Similarity=0.484 Sum_probs=202.1
Q ss_pred CCeeeecCceEEEEEEECCC----CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC-CCceEEEeecc
Q 012267 147 KNILGRGGFGKVYKGRLADG----SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPYM 221 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~~g----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 221 (467)
.++||+|+||+||+|++.++ ..||||+++..........|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999987532 36999999765555566789999999999999999999999875 46789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
++|+|.+++..... .+++..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999886543 378899999999999999999999 999999999999999999999999999987653322
Q ss_pred e---eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 302 H---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 302 ~---~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. ......||+.|+|||.+.+..++.++||||||+++|||+||..||.... .......+ .....+ ...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~----~~~~~~~~---i~~g~~---~~~ 255 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY---LLQGRR---LLQ 255 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH---HHTTCC---CCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC----CHHHHHHH---HHcCCC---CCC
Confidence 2 2223468999999999999999999999999999999999888875321 11112222 222111 111
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
|. .....+.+++.+||+.||++||+|.||++.|+++
T Consensus 256 p~-------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 21 1225688999999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=383.16 Aligned_cols=268 Identities=26% Similarity=0.367 Sum_probs=202.6
Q ss_pred CHHHHHHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeee
Q 012267 133 SLRELQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLR 205 (467)
Q Consensus 133 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 205 (467)
...+|++..++|++.+.||+|+||+||+|++. +++.||||+++..........+..|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556666788999999999999999999853 34689999998666555566788888888776 689999999
Q ss_pred eeeeCC-CceEEEeeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCC
Q 012267 206 GFCMTP-TERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDV 272 (467)
Q Consensus 206 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dl 272 (467)
+++... ...++||||+++|+|.++++.... ....+++..++.++.||++||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998765 468999999999999999976432 123489999999999999999999999 9999999
Q ss_pred CCCcEEECCCCcEEEeecCCccccCCCCCe-eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCC-CCcccc
Q 012267 273 KAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ-RAFDLA 350 (467)
Q Consensus 273 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~-~p~~~~ 350 (467)
||+||||++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876533322 334456999999999999999999999999999999999975 567431
Q ss_pred cccCCCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 351 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. ... .+...+..... +... ......+.+++.+||+.||++|||+.||++.|++
T Consensus 241 ~----~~~----~~~~~~~~~~~-----~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 241 K----IDE----EFCRRLKEGTR-----MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp C----CSH----HHHHHHHHTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----HHH----HHHHHHhcCCC-----CCCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 111 11222222111 1111 1123568899999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=381.06 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=200.7
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC----ceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 217 (467)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+..++||||++++++|.+.+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4566778999999999999997 58899999996432 11122334455556789999999999997643 57899
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
|||+++|+|.++++.. +++|..++.++.|+|.||+|||+.. .++|+||||||+||||++++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999874 2899999999999999999999731 34899999999999999999999999999
Q ss_pred ccccCCCCCe---eeecccccccccccccccCCC------CCcchhHHHHHHHHHHHHcCCCCcccccccCC------CC
Q 012267 293 AKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGIMLLELITGQRAFDLARLAND------DD 357 (467)
Q Consensus 293 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~------~~ 357 (467)
++........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..||........ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9877543322 233467999999999987542 57799999999999999999988754221110 01
Q ss_pred ccHHHHHHHHhhhcccccccCccccCc-ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 358 VMLLDWVKGLLKEKKLEMLVDPDLQNN-YVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.............. ..+|.+... ...+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11112222222221 222332221 1334567799999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=388.50 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=212.5
Q ss_pred HHHhcCCCCCCeeeecCceEEEEEEE------CCCCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeC
Q 012267 138 QVATDSFSNKNILGRGGFGKVYKGRL------ADGSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 210 (467)
Q Consensus 138 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 210 (467)
+...++|++.++||+|+||.||+|++ .+++.||||+++..........+.+|+.+++++ +|||||+++++|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 34557888889999999999999985 246789999998766666666799999999998 69999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCc
Q 012267 211 PTERLLVYPYMANGSVASCLRERPP--------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAAN 276 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~N 276 (467)
.+..++||||+++|+|.++++.... ....+++..+..++.||++||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999976432 223589999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCC-eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccC
Q 012267 277 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAN 354 (467)
Q Consensus 277 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~ 354 (467)
|+++.++.+|++|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~---- 251 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM---- 251 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999999987654433 33344678999999999999999999999999999999999 45555321
Q ss_pred CCCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 355 DDDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
.....+.+.+.. .. . +.. .......+.+++.+||+.||++||||.||+++|++
T Consensus 252 ~~~~~~~~~i~~----~~-~----~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 252 PVDSKFYKMIKE----GF-R----MLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp CSSHHHHHHHHH----TC-C----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHhc----CC-C----CCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111112222221 11 0 101 11123668999999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=385.89 Aligned_cols=262 Identities=29% Similarity=0.426 Sum_probs=207.0
Q ss_pred HHhcCCCCCCeeeecCceEEEEEEECC--------CCEEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeee
Q 012267 139 VATDSFSNKNILGRGGFGKVYKGRLAD--------GSLVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCM 209 (467)
Q Consensus 139 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 209 (467)
+..++|++.+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345678888999999999999998532 2479999998776656667888999998888 7999999999999
Q ss_pred CCCceEEEeeccCCCChhhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcE
Q 012267 210 TPTERLLVYPYMANGSVASCLRERPP------------SQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANI 277 (467)
Q Consensus 210 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Ni 277 (467)
+++..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||++ +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999976532 123589999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCC-CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCC
Q 012267 278 LLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLAND 355 (467)
Q Consensus 278 ll~~~~~~kl~Dfgl~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~ 355 (467)
|++.++.+||+|||+++...... ........+++.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---- 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC----
Confidence 99999999999999998765332 223444568999999999999999999999999999999998 688885321
Q ss_pred CCccHHHHHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 356 DDVMLLDWVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
..+ +...+.... .+.... .....+.+++.+||+.||.+|||+.||++.|+++
T Consensus 243 ----~~~-~~~~i~~~~-----~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 243 ----VEE-LFKLLKEGH-----RMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ----HHH-HHHHHHTTC-----CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHH-HHHHHHcCC-----CCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 112222111 111111 1235688999999999999999999999999763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=381.48 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=204.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|+..++||+|+||+||+|+.. +|+.||||+++... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56888999999999999999975 79999999997532 1223456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999987543 88999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+........ ..
T Consensus 158 ~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~~-~~----- 222 (337)
T d1o6la_ 158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILME-EI----- 222 (337)
T ss_dssp T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC-----
T ss_pred C-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhcC-CC-----
Confidence 2 233445679999999999999999999999999999999999999996421 11222222111 11
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 416 (467)
.+... ....+.+++.+||+.||.+||+ ++|+++
T Consensus 223 -~~p~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -RFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCcc----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11111 2255788999999999999995 677654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=384.60 Aligned_cols=264 Identities=24% Similarity=0.396 Sum_probs=213.6
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEEC------CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeC
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLA------DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 210 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 210 (467)
|++..++|+..+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||++++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4445577888899999999999999863 3578999999866555555679999999999999999999999999
Q ss_pred CCceEEEeeccCCCChhhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCc
Q 012267 211 PTERLLVYPYMANGSVASCLRERP------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFE 284 (467)
Q Consensus 211 ~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 284 (467)
.+..++||||+++|+|.+++.... .....+++..+..++.|+|+||.|||++ +|+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 999999999999999999986421 1223479999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCee-eecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCC-CCcccccccCCCCccHHH
Q 012267 285 AVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQ-RAFDLARLANDDDVMLLD 362 (467)
Q Consensus 285 ~kl~Dfgl~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~-~p~~~~~~~~~~~~~~~~ 362 (467)
+||+|||+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||.. ....+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~~~ 243 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQ 243 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CCHHH
Confidence 9999999998765333222 23345899999999999999999999999999999999985 56632 12233
Q ss_pred HHHHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 363 WVKGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 363 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
+........... . .......+.+++.+||+.+|.+||||++|+++|++.
T Consensus 244 ~~~~i~~~~~~~------~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 244 VLRFVMEGGLLD------K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHTTCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHhCCCCC------C----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 333332221111 1 111235699999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=383.89 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=202.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCC--EEEEEEeccCCCcchHHHHHHHHHHHHhc-CCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGS--LVAVKRLKEERTPGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 217 (467)
++|++.++||+|+||+||+|++. +|. .||||+++........+.|.+|++++.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57788899999999999999875 444 57888886555555556799999999998 799999999999999999999
Q ss_pred eeccCCCChhhhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcE
Q 012267 218 YPYMANGSVASCLRERP------------PSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 285 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 285 (467)
|||+++|+|.++++... .....++|..++.++.|||+||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997642 2234599999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCC-CcccccccCCCCccHHHHH
Q 012267 286 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR-AFDLARLANDDDVMLLDWV 364 (467)
Q Consensus 286 kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~~ 364 (467)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||... ...+..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELY 236 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------CHHHHH
Confidence 999999998543221 1223458999999999999999999999999999999999765 56421 122222
Q ss_pred HHHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 365 KGLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 365 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.......+ +.. .......+.+++.+||+.||++||||+||++.|+++
T Consensus 237 ~~i~~~~~------~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQGYR------LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGTCC------CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCC------CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22222111 111 112235788999999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=380.84 Aligned_cols=255 Identities=30% Similarity=0.397 Sum_probs=195.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC--CC--CEEEEEEeccCCC--cchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA--DG--SLVAVKRLKEERT--PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~--~g--~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|++.+.||+|+||+||+|++. ++ ..||||+++.... ....+.|.+|++++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999863 23 3789999875432 2334579999999999999999999999976 4678
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++|++.+++..... ++++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998876432 389999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCe--eeecccccccccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 296 MDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 296 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
+...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||... ...+......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEGE 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhCCC
Confidence 7544332 2233457889999999999999999999999999999998 89999532 12222222222211
Q ss_pred cccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 373 LEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 373 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
. +.. .......+.+++.+||+.||++||||.||++.|++
T Consensus 233 ~-----~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 R-----LPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-----CCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 111 11223568899999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-49 Score=372.79 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=200.8
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc--chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC----c
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----E 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 213 (467)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367899999999999999999974 7999999999765432 33456899999999999999999999987643 3
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.|+||||+++|+|.+++.... ++++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999987654 389999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCC--CeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 294 KLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 294 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcC
Confidence 7654322 223344579999999999999999999999999999999999999996321 112222222221
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-KMSEVVRMLEG 420 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~ 420 (467)
... +.. ........+.+++.+||+.||.+|| |++++++.|..
T Consensus 231 ~~~----~~~---~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIP----PSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCC----GGG---TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC----Cch---hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 111 110 0111225688999999999999999 89999888865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-49 Score=376.85 Aligned_cols=245 Identities=28% Similarity=0.369 Sum_probs=202.9
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888899999999999999975 79999999996432 1223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+++|+|..++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999987543 78889999999999999999999 999999999999999999999999999987643
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+......... . ...
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~-~--~~p 221 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE-L--RFP 221 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC-C--CCC
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcCC-C--CCC
Confidence 2 234679999999999999999999999999999999999999996321 122222222211 0 011
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
+ .....+.+++.+||+.||.+|| |++++++
T Consensus 222 ~--------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 P--------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp T--------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1 1125688899999999999996 8888854
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.8e-49 Score=367.25 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=202.3
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc--------hHHHHHHHHHHHHhcC-CCeeeeeeeeeeCC
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG--------GELQFQTEVEMISMAV-HRNLLRLRGFCMTP 211 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 211 (467)
++|++.+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999974 78999999997543221 1235889999999997 99999999999999
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
+..++||||+++|+|.+++.... ++++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997643 389999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCeeeecccccccccccccccC------CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 365 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 365 (467)
+++..... .......||+.|+|||.+.+ ..++.++||||+||++|||+||+.||.... ......
T Consensus 156 ~a~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~ 225 (277)
T d1phka_ 156 FSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLR 225 (277)
T ss_dssp TCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred heeEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHHHH
Confidence 99876532 23344679999999998853 356889999999999999999999996421 111111
Q ss_pred HHhhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 366 GLLKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 366 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... ... ...........++.+++.+||+.||++|||+.||++
T Consensus 226 ~i~~~-~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSG-NYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHT-CCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhC-CCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22211 111 001111123356889999999999999999999843
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=372.81 Aligned_cols=250 Identities=18% Similarity=0.248 Sum_probs=203.8
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|++.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 57888999999999999999975 78899999997643 2344688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCC--CcEEEeecCCccccCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMDY 298 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~ 298 (467)
|++|+|.+++.... .++++.++..++.||++||+|||++ +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999997643 2389999999999999999999999 99999999999999854 5899999999987643
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+.......... ..+
T Consensus 157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~---~~~ 223 (321)
T d1tkia_ 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEY---TFD 223 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCC---CCC
T ss_pred C--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC---CCC
Confidence 2 23344568999999999999999999999999999999999999996421 1122222222110 001
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
... .......+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0112356789999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=375.60 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=196.1
Q ss_pred cCCCCC-CeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHh-cCCCeeeeeeeeeeC----CCce
Q 012267 142 DSFSNK-NILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISM-AVHRNLLRLRGFCMT----PTER 214 (467)
Q Consensus 142 ~~~~~~-~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~ 214 (467)
++|.+. ++||+|+||+||+|+.. +|+.||||+++.. ..+.+|++++.+ .+|||||++++++.+ ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 567765 46999999999999974 7899999998642 357789988665 489999999999865 4568
Q ss_pred EEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEEeecC
Q 012267 215 LLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 291 (467)
Q Consensus 215 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 291 (467)
|+|||||++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++ ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 999999999999999986532 3489999999999999999999999 9999999999999985 4579999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .....+.....
T Consensus 160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-----~~~~~~~~~i~-- 230 (335)
T d2ozaa1 160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKTRIR-- 230 (335)
T ss_dssp TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCC--
T ss_pred eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-----HHHHHHHHHHh--
Confidence 998764332 234457999999999999999999999999999999999999999642211 01010100000
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
... ..+...........+.+++.+||+.||++|||+.|+++
T Consensus 231 -~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 -MGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -SCS---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -cCC---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 00111112234467899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=373.91 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHH-hcCCCeeeeeeeeeeCCCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 217 (467)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... .......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56888999999999999999976 79999999996432 1223345666776665 68999999999999999999999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccC
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 297 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 297 (467)
|||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999986543 88999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhccccccc
Q 012267 298 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLV 377 (467)
Q Consensus 298 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (467)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+....... .
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~-~------ 218 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRM-D------ 218 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-C------
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHc-C------
Confidence 332 23344579999999999999999999999999999999999999996421 1111222111 1
Q ss_pred CccccCcccHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 012267 378 DPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMS-EVV 415 (467)
Q Consensus 378 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl 415 (467)
.+.+... ....+.+++.+||+.||.+|||+. +++
T Consensus 219 ~~~~p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 219 NPFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCcc----CCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1111111 225588999999999999999995 664
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=376.14 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=202.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCC--CcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEe
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEER--TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 218 (467)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46888999999999999999975 79999999986432 1223456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCC
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 298 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 298 (467)
||+.+|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997654 289999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC
Q 012267 299 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD 378 (467)
Q Consensus 299 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 378 (467)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ........... ..
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~-~~----- 255 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSG-KV----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC-----
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhcC-CC-----
Confidence 2 234569999999999999999999999999999999999999995321 11222222211 10
Q ss_pred ccccCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012267 379 PDLQNNYVEAEVEQLIQVALLCTQGSPMDRP-----KMSEVVR 416 (467)
Q Consensus 379 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 416 (467)
... ......+.+++.+||+.||.+|+ |++++++
T Consensus 256 -~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111 11225688999999999999994 8888854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-48 Score=376.53 Aligned_cols=249 Identities=27% Similarity=0.327 Sum_probs=196.4
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCC--cchHHHHHH---HHHHHHhcCCCeeeeeeeeeeCCCceE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERT--PGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~ 215 (467)
++|++.++||+|+||+||+|+.. +|+.||||++..... ......+.+ ++.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999975 799999999864321 112223334 466777788999999999999999999
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998653 278999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccc
Q 012267 296 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 374 (467)
Q Consensus 296 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (467)
+... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||..... .............
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~---- 224 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTM---- 224 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSSSC----
T ss_pred cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcccC----
Confidence 6533 2334579999999999865 5689999999999999999999999964221 1111111111100
Q ss_pred cccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012267 375 MLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVVR 416 (467)
Q Consensus 375 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 416 (467)
.+..... ....+.+++.+||+.||.+||| ++|+++
T Consensus 225 ---~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ---AVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CCCCCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCCCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111111 2256889999999999999999 577753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=369.95 Aligned_cols=257 Identities=25% Similarity=0.272 Sum_probs=191.8
Q ss_pred CCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcch----HHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeecc
Q 012267 147 KNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 221 (467)
Q Consensus 147 ~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 221 (467)
.++||+|+||+||+|+.. +|+.||||+++....... ...+.+|+.+++.++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 699999999975433221 235889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCCC
Q 012267 222 ANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 301 (467)
Q Consensus 222 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 301 (467)
.++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9987776665432 378889999999999999999999 999999999999999999999999999987653322
Q ss_pred eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcccccccC--
Q 012267 302 HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVD-- 378 (467)
Q Consensus 302 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 378 (467)
......||+.|+|||++.. ..++.++|||||||++|||+||+.||.... ......-+.............+
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-----~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-----HHHHHHHHHHhcCCCChhhccchh
Confidence 2334568999999999865 457999999999999999999999995321 1111111111110000000000
Q ss_pred --------ccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 379 --------PDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 379 --------~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....... .......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 0112356889999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=366.20 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=196.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57888999999999999999974 7999999999754322 234578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
|+.++ +.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99764 4444443322 2389999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCeeeecccccccccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc--ccccc
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--KLEML 376 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 376 (467)
........||+.|+|||.+.... ++.++|||||||++|+|++|+.||..... ...+........... .....
T Consensus 156 -~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp -SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred -cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCCchhhcccc
Confidence 22333456899999999876655 58899999999999999999999964210 001111111100000 00000
Q ss_pred -cCc-------cccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 377 -VDP-------DLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 377 -~d~-------~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..+ ...... .......+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 000000 1122356888999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=363.12 Aligned_cols=240 Identities=23% Similarity=0.398 Sum_probs=194.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcc-----hHHHHHHHHHHHHhcC--CCeeeeeeeeeeCCCc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPG-----GELQFQTEVEMISMAV--HRNLLRLRGFCMTPTE 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 213 (467)
++|++.++||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57888999999999999999975 79999999997543211 1123668999999986 8999999999999999
Q ss_pred eEEEeeccCC-CChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-CCcEEEeecC
Q 012267 214 RLLVYPYMAN-GSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 291 (467)
Q Consensus 214 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 291 (467)
.++||||+.+ +++.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999975 68888887643 389999999999999999999999 9999999999999985 4799999999
Q ss_pred CccccCCCCCeeeecccccccccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 292 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 292 l~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... + ....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~----i~~~ 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E----IIRG 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----HHHC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------H----Hhhc
Confidence 99865322 2345679999999999987665 677999999999999999999996421 0 1111
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
...+.+. ...++.+++.+||+.||++|||++|+++
T Consensus 220 ---~~~~~~~--------~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ---QVFFRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---CCCCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccCCCCC--------CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011111 1256888999999999999999999865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.4e-48 Score=362.17 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=197.9
Q ss_pred cCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEeec
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 220 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 220 (467)
++|+..++||+|+||+||+|+..+|+.||||+++..... .....+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578888999999999999999999999999999765322 2345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCCC
Q 012267 221 MANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 300 (467)
Q Consensus 221 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 300 (467)
+.++.+..+..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++.......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877776665442 389999999999999999999999 99999999999999999999999999998765332
Q ss_pred CeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh--c------
Q 012267 301 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE--K------ 371 (467)
Q Consensus 301 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~------ 371 (467)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+.......... .
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHHHhhCCCChhhccchh
Confidence 23334458999999999865 4569999999999999999999999963211 00111111110000 0
Q ss_pred ccccc------cCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 372 KLEML------VDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 372 ~~~~~------~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
..... ..+.............+.+++.+||+.||++|||++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00000 000000011112235688999999999999999999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=359.38 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=193.2
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-C-CCEEEEEEeccCCCcc-hHHHHHHHHHHHHhc---CCCeeeeeeeeeeC----
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-D-GSLVAVKRLKEERTPG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT---- 210 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~-g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 210 (467)
.++|++.+.||+|+||+||+|+.. + ++.||||+++...... ....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 6679999986543222 122455677766554 79999999999853
Q ss_pred -CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEee
Q 012267 211 -PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 289 (467)
Q Consensus 211 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 289 (467)
....+++|||+.++++........ ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346799999998877765554432 2389999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh
Q 012267 290 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 369 (467)
Q Consensus 290 fgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 369 (467)
||+++.... ........||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+.........
T Consensus 160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGL 233 (305)
T ss_dssp CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCC
T ss_pred hhhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhhCC
Confidence 999886432 2233456799999999999999999999999999999999999999964211 1111111111100
Q ss_pred hc--cc-ccccCc---------cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 EK--KL-EMLVDP---------DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 ~~--~~-~~~~d~---------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. .. .....+ .............+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00 000000 0000011122356788999999999999999999865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-46 Score=356.92 Aligned_cols=263 Identities=19% Similarity=0.292 Sum_probs=195.0
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC----ceE
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERL 215 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 215 (467)
+.+|+..++||+|+||+||+|+.. +|+.||||+++........+.+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356888899999999999999864 899999999976555555567899999999999999999999987543 235
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 555667799999999764 289999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--eeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 296 MDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 296 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||..... ...............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPS 233 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHHHHhhhccCCC
Confidence 543222 12334568999999999854 5678999999999999999999999964211 001000000000000
Q ss_pred cc-------------cccCccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 LE-------------MLVDPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~~-------------~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.. ....+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000000 0011245789999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=347.77 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=191.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeC--------C
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--------P 211 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 211 (467)
++|++.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|++++++++|+|++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999999999999975 7999999998654332 234568899999999999999999999865 3
Q ss_pred CceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecC
Q 012267 212 TERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 291 (467)
Q Consensus 212 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 291 (467)
+..++||||+.++.+........ .++...++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 45789999998877665544332 388899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC---eeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHH
Q 012267 292 LAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 367 (467)
Q Consensus 292 l~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 367 (467)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-----~~~~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-----HHHHHHHHHHh
Confidence 9976543221 122334689999999998765 68999999999999999999999996321 11111111111
Q ss_pred hhh---cccccccC---------ccccCcccHH------HHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012267 368 LKE---KKLEMLVD---------PDLQNNYVEA------EVEQLIQVALLCTQGSPMDRPKMSEVV 415 (467)
Q Consensus 368 ~~~---~~~~~~~d---------~~~~~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~evl 415 (467)
... ........ .........+ ....+.+++.+||+.||++|||++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 110 00000000 0000000111 123567899999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=356.58 Aligned_cols=259 Identities=24% Similarity=0.311 Sum_probs=189.3
Q ss_pred CCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeeeeeeeeCC------CceE
Q 012267 143 SFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERL 215 (467)
Q Consensus 143 ~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 215 (467)
+|+..++||+|+||+||+|+.. +|+.||||+++.... ...+|++++++++|+||++++++|... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777789999999999999975 799999999976432 234799999999999999999998532 3468
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeecCCcc
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 294 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~ 294 (467)
+||||++++.+..+... ......+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999987644443322 11223499999999999999999999999 999999999999999775 89999999998
Q ss_pred ccCCCCCeeeecccccccccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHH--------
Q 012267 295 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK-------- 365 (467)
Q Consensus 295 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 365 (467)
...... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+...++
T Consensus 172 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 172 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp ECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred hccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHHHHHHhCCChHH
Confidence 764332 2334568999999998765 5689999999999999999999999964211 011111111
Q ss_pred ---HHhhh---cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 366 ---GLLKE---KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 366 ---~~~~~---~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
..... ......................+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000000000011122356888999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=344.31 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=201.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 219 (467)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47888999999999999999975 7899999999765433 335578999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCccccCCC
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 299 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 299 (467)
++.+++|..++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988887643 388999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCeeeecccccccccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh---ccc--
Q 012267 300 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKL-- 373 (467)
Q Consensus 300 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 373 (467)
.. ......++..|+|||.+.... ++.++|||||||++|||++|+.||.... ...+........ ...
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-------SHHHHHHHHHHHHCCCCTTT
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-------CHHHHHHHHHhhcCCCChhh
Confidence 32 223345788999999987655 6899999999999999999999974211 111222221110 000
Q ss_pred ----ccccC----ccc-----cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 374 ----EMLVD----PDL-----QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 374 ----~~~~d----~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
....+ +.. ...........+.+++.+||+.||.+|||++||++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000 00111122356788999999999999999999854
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=351.19 Aligned_cols=258 Identities=22% Similarity=0.285 Sum_probs=190.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCCC------
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 212 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 212 (467)
.++|+..+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 367888999999999999999975 6999999999754332 33456889999999999999999999997654
Q ss_pred ceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCC
Q 012267 213 ERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 292 (467)
Q Consensus 213 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 292 (467)
+.++||||+ +.+|..+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 56788877653 289999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhh--
Q 012267 293 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-- 369 (467)
Q Consensus 293 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 369 (467)
++..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+.........
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTGTPP 239 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh----HHHHHHHHhccCCCc
Confidence 9865432 2345689999999998764 568999999999999999999999964211 0001111000000
Q ss_pred -----h----------cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 370 -----E----------KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 370 -----~----------~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. ..........+ ..........+.+++.+||..||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000000000 0001112245788999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-44 Score=342.91 Aligned_cols=259 Identities=19% Similarity=0.188 Sum_probs=195.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCeeeee-eeeeeCCCceEEEee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRL-RGFCMTPTERLLVYP 219 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e 219 (467)
++|++.+.||+|+||+||+|++. +|+.||||++...... .++..|+++++.++|+|++.. .+++.+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 56889999999999999999974 6899999998754322 247889999999987775554 555567788899999
Q ss_pred ccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC---CCcEEEeecCCcccc
Q 012267 220 YMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKLM 296 (467)
Q Consensus 220 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~ 296 (467)
|+ +++|.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+++.+
T Consensus 84 ~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 5577776655332 389999999999999999999999 9999999999999864 457999999999876
Q ss_pred CCCCC------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhh
Q 012267 297 DYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 370 (467)
Q Consensus 297 ~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 370 (467)
..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMST 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHS
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH-HHHHHHhhcccCCC
Confidence 53322 123445799999999999999999999999999999999999999964321111 11111111111000
Q ss_pred cccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 012267 371 KKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGD 421 (467)
Q Consensus 371 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 421 (467)
.. +.+.. ....++.+++..||+.+|++||++.++.+.|++.
T Consensus 236 -~~-----~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 236 -PI-----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -CH-----HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -Ch-----hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00 00111 1225688999999999999999999999988763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-44 Score=340.31 Aligned_cols=259 Identities=15% Similarity=0.163 Sum_probs=202.1
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC-CeeeeeeeeeeCCCceEEEe
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 218 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 218 (467)
.++|++.++||+|+||+||+|++. +|+.||||+++..... ..+..|++.+..+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 357889999999999999999975 7899999998654332 246788899988875 89999999999999999999
Q ss_pred eccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECC-----CCcEEEeecCCc
Q 012267 219 PYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLA 293 (467)
Q Consensus 219 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~ 293 (467)
||+ +++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 81 e~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 6899999876532 389999999999999999999999 9999999999999974 568999999999
Q ss_pred cccCCCCC------eeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHH
Q 012267 294 KLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 367 (467)
Q Consensus 294 ~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 367 (467)
+.+..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-----~~~~~~~~i 228 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERI 228 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-----hHHHHHHHH
Confidence 87643221 1233457999999999999999999999999999999999999999642211 111111111
Q ss_pred hhhcccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 012267 368 LKEKKLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEG 420 (467)
Q Consensus 368 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 420 (467)
...... ..-+.+... ...++.+++..|++.+|++||+++.+.+.|++
T Consensus 229 ~~~~~~--~~~~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 229 GEKKQS--TPLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHHHH--SCHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HhccCC--CChHHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 110000 000011111 12568889999999999999999999888876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=350.50 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=200.5
Q ss_pred cCCCCCCeeeecCceEEEEEEEC----CCCEEEEEEeccCCC---cchHHHHHHHHHHHHhcCC-CeeeeeeeeeeCCCc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA----DGSLVAVKRLKEERT---PGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTE 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~----~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 213 (467)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999852 488999999865322 1223457899999999977 899999999999999
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.+++|||+.+|+|.+++..... ++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999987543 67888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCeeeecccccccccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 371 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (467)
+.+............|++.|+|||.+.+. .++.++|||||||+||||+||+.||..... ...............
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~----~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcccCC
Confidence 87654444444556799999999998754 468899999999999999999999965322 122222222221111
Q ss_pred ccccccCccccCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 012267 372 KLEMLVDPDLQNNYVEAEVEQLIQVALLCTQGSPMDRPK-----MSEVV 415 (467)
Q Consensus 372 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl 415 (467)
+.+ .......+.+++.+||+.||.+||| ++|++
T Consensus 253 -------~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 253 -------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp -------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred -------CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 111 1122367888999999999999995 67774
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-44 Score=344.22 Aligned_cols=255 Identities=19% Similarity=0.232 Sum_probs=193.1
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeC--CCceEEE
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLLV 217 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 217 (467)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+|+++|..++ ||||+++++++.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57899999999999999999974 7999999999643 2457889999999995 9999999999874 3568999
Q ss_pred eeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCC-cEEEeecCCcccc
Q 012267 218 YPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 296 (467)
Q Consensus 218 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~ 296 (467)
|||+.+++|..+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999987643 289999999999999999999999 999999999999998654 6999999999876
Q ss_pred CCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHh-------
Q 012267 297 DYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL------- 368 (467)
Q Consensus 297 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 368 (467)
.... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.... ........+....
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~----~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH----DNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS----SHHHHHHHHHHHHCHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc----hhHHHHHHHHHHHCCchhhh
Confidence 4322 23445689999999998765 47999999999999999999999995321 1110000000000
Q ss_pred --hhcc------cccccCc--------cccCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 369 --KEKK------LEMLVDP--------DLQNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 369 --~~~~------~~~~~d~--------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
.... ....... ............++.+++.+||+.||.+|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000000 0000011122356789999999999999999999954
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=345.47 Aligned_cols=266 Identities=20% Similarity=0.214 Sum_probs=192.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeC------CCc
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 213 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 213 (467)
++|++.++||+|+||+||+|++. +|+.||||+++..... .....+.+|+.++++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999976 6999999999765433 233468899999999999999999999864 367
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.|+||||+.++ +.+.+.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999765 4444432 288999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHH----------
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW---------- 363 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~---------- 363 (467)
+.... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||..... .......
T Consensus 167 ~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred hcccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHHHHHHHHhccCCCHH
Confidence 86542 2233445689999999999999999999999999999999999999953210 0000000
Q ss_pred --------HHHHhhhcc-c-----ccccCccc---cCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCcc
Q 012267 364 --------VKGLLKEKK-L-----EMLVDPDL---QNNYVEAEVEQLIQVALLCTQGSPMDRPKMSEVVRMLEGDGLAER 426 (467)
Q Consensus 364 --------~~~~~~~~~-~-----~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 426 (467)
......... . ........ ...........+.+++.+||+.||++|||++|+ |+...+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el---L~Hpw~~~~ 317 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA---LQHPYINVW 317 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH---HTSTTTGGG
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH---hcCcccCCC
Confidence 001111100 0 00000001 011123455678999999999999999999998 666666553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=341.67 Aligned_cols=259 Identities=20% Similarity=0.251 Sum_probs=191.7
Q ss_pred hcCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCc-chHHHHHHHHHHHHhcCCCeeeeeeeeeeCC-----Cc
Q 012267 141 TDSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTP-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 213 (467)
Q Consensus 141 ~~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 213 (467)
.++|+..+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++++.++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999964 7999999999765432 2344688999999999999999999998643 33
Q ss_pred eEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEeecCCc
Q 012267 214 RLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 293 (467)
Q Consensus 214 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 293 (467)
.+++++|+.+|+|.+++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 46777888899999999653 289999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCeeeecccccccccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCcccccccCCCCccHHHHHHHHhhhcc
Q 012267 294 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 372 (467)
Q Consensus 294 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (467)
..... ......|+..|+|||.+.+. .++.++|||||||++|+|++|+.||.... .......+........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-----~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTPG 239 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCC
Confidence 75432 23345689999999987665 46899999999999999999999995321 1001111100000000
Q ss_pred c--c---------ccc--CccccCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012267 373 L--E---------MLV--DPDLQNNY----VEAEVEQLIQVALLCTQGSPMDRPKMSEVVR 416 (467)
Q Consensus 373 ~--~---------~~~--d~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 416 (467)
. . ... .+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 0 000 00000000 0112255788999999999999999999965
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-39 Score=312.88 Aligned_cols=264 Identities=19% Similarity=0.227 Sum_probs=185.7
Q ss_pred cCCCCCCeeeecCceEEEEEEEC-CCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-----------CCeeeeeeeeee
Q 012267 142 DSFSNKNILGRGGFGKVYKGRLA-DGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-----------HRNLLRLRGFCM 209 (467)
Q Consensus 142 ~~~~~~~~lg~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 209 (467)
++|++.++||+|+||+||+|+.. +|+.||||+++... .....+.+|+++++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 35888999999999999999975 79999999997532 23346778888887765 578999998876
Q ss_pred C--CCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCC---
Q 012267 210 T--PTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEF--- 283 (467)
Q Consensus 210 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~--- 283 (467)
. ....+++++++..+.......... ....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 4 345666776665544333322211 22348889999999999999999998 5 899999999999997654
Q ss_pred ---cEEEeecCCccccCCCCCeeeecccccccccccccccCCCCCcchhHHHHHHHHHHHHcCCCCcccccccCCCC--c
Q 012267 284 ---EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDD--V 358 (467)
Q Consensus 284 ---~~kl~Dfgl~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~Gvil~elltg~~p~~~~~~~~~~~--~ 358 (467)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.......... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 3999999999864322 234568999999999999999999999999999999999999996432111100 0
Q ss_pred cHHHHHHHHhh-------h-cccccccCc--------c-----------ccCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 012267 359 MLLDWVKGLLK-------E-KKLEMLVDP--------D-----------LQNNYVEAEVEQLIQVALLCTQGSPMDRPKM 411 (467)
Q Consensus 359 ~~~~~~~~~~~-------~-~~~~~~~d~--------~-----------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 411 (467)
.+...+...-. . .......+. . ............+.+++.+|++.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111111000 0 000000000 0 0112234566789999999999999999999
Q ss_pred HHHH
Q 012267 412 SEVV 415 (467)
Q Consensus 412 ~evl 415 (467)
+|++
T Consensus 323 ~e~L 326 (362)
T d1q8ya_ 323 GGLV 326 (362)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 9985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.4e-24 Score=190.02 Aligned_cols=163 Identities=12% Similarity=0.071 Sum_probs=118.8
Q ss_pred CCCeeeecCceEEEEEEECCCCEEEEEEeccCCCc-----------------chHHHHHHHHHHHHhcCCCeeeeeeeee
Q 012267 146 NKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTP-----------------GGELQFQTEVEMISMAVHRNLLRLRGFC 208 (467)
Q Consensus 146 ~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~niv~~~~~~ 208 (467)
..++||+|+||+||+|+..+|+.||||+++..... ........|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 45789999999999999888999999987532110 0112345688889999999998887653
Q ss_pred eCCCceEEEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcccCCCCCCcEEECCCCcEEEe
Q 012267 209 MTPTERLLVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 288 (467)
Q Consensus 209 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 288 (467)
..+++|||+++..+.++ +......++.|+++||+|||++ +|+||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 24799999988655432 2234567899999999999999 99999999999999865 58999
Q ss_pred ecCCccccCCCCCeeeeccccccccccc------ccccCCCCCcchhHHHHHHHH
Q 012267 289 DFGLAKLMDYKDTHVTTAVRGTIGHIAP------EYLSTGKSSEKTDVFGYGIML 337 (467)
Q Consensus 289 Dfgl~~~~~~~~~~~~~~~~g~~~y~aP------E~~~~~~~~~~sDv~s~Gvil 337 (467)
|||++......... .|... +.+ ...|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999765422211 11111 111 35678889999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=5.8e-07 Score=80.45 Aligned_cols=148 Identities=13% Similarity=0.045 Sum_probs=94.8
Q ss_pred HHHHhcCCCCCCeeeecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcC-CCeeeeeeeeeeCCCceE
Q 012267 137 LQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 215 (467)
Q Consensus 137 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 215 (467)
+...-+.|+..+..+-++.+.||+... ++..+.+|+....... ....+..|...+..+. +--+-+++.++..++..+
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 333344555444433344578998875 4566788887543221 1224567777776653 333456677777788889
Q ss_pred EEeeccCCCChhhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q 012267 216 LVYPYMANGSVASCLRERPPSQLPLDWPTRKRIALGSARGLSYLHDHC-------------------------------- 263 (467)
Q Consensus 216 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh~~~-------------------------------- 263 (467)
+||+++++.++.+..... .. ...++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998886654321 11 2334555666666666321
Q ss_pred ------------------------CCCcccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 264 ------------------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 264 ------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
.+.++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999876677999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.12 E-value=5.3e-06 Score=73.54 Aligned_cols=129 Identities=16% Similarity=0.073 Sum_probs=82.6
Q ss_pred eeecC-ceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC--CeeeeeeeeeeCCCceEEEeeccCCCCh
Q 012267 150 LGRGG-FGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPYMANGSV 226 (467)
Q Consensus 150 lg~G~-~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 226 (467)
+..|. .+.||+....++..+++|.-...... .+..|...+..+.. -.+-+++.++.+++..++||+|++|-++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 36799999888888899987544322 35667777765532 2355667777788888999999988665
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 012267 227 ASCLRERPPSQLPLDWPTRKRIALGSARGLSYLH---------------------------------------------- 260 (467)
Q Consensus 227 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~Lh---------------------------------------------- 260 (467)
.+.. .. ...++.++++.|+-||
T Consensus 94 ~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3311 00 0111223333333333
Q ss_pred -----cCC----CCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 261 -----DHC----DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 261 -----~~~----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
... .+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 211 1247999999999999987667899998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.66 E-value=5.6e-05 Score=71.38 Aligned_cols=76 Identities=13% Similarity=0.042 Sum_probs=46.2
Q ss_pred CeeeecCceEEEEEEEC-CCCEEEEEEecc------CCCcchHHHHHHHHHHHHhcC-C--CeeeeeeeeeeCCCceEEE
Q 012267 148 NILGRGGFGKVYKGRLA-DGSLVAVKRLKE------ERTPGGELQFQTEVEMISMAV-H--RNLLRLRGFCMTPTERLLV 217 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~-~g~~vavK~~~~------~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 217 (467)
+.||.|....||+.... +++.|+||.-.. ...+........|.+.+..+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999865 467899996432 111112223456777776552 2 234445544 45567899
Q ss_pred eeccCCCC
Q 012267 218 YPYMANGS 225 (467)
Q Consensus 218 ~e~~~~gs 225 (467)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.00084 Score=61.23 Aligned_cols=136 Identities=15% Similarity=0.132 Sum_probs=75.5
Q ss_pred eEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCee--eeeee-----eeeCCCceEEEeeccCCCChh-
Q 012267 156 GKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL--LRLRG-----FCMTPTERLLVYPYMANGSVA- 227 (467)
Q Consensus 156 g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~gsL~- 227 (467)
-.||+++..+|..|++|+.+.... ..+++..|...+..+....+ +..+. .+......+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 589999999999999999865433 24467788887776642221 11111 122345568899998764321
Q ss_pred ----hh---------hhc----CC-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHc----CCCCC
Q 012267 228 ----SC---------LRE----RP-PSQLPLDWPT-------------------RKRIALGSARGLSYLHD----HCDPK 266 (467)
Q Consensus 228 ----~~---------l~~----~~-~~~~~l~~~~-------------------~~~i~~~ia~gl~~Lh~----~~~~~ 266 (467)
.+ ++. .. .....+++.. ...+...+...++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 10 111 00 0111122211 11111112222333322 22347
Q ss_pred cccCCCCCCcEEECCCCcEEEeecCCccc
Q 012267 267 IIHRDVKAANILLDEEFEAVVGDFGLAKL 295 (467)
Q Consensus 267 ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 295 (467)
++|+|+.+.|||++++ ..+.||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.68 E-value=0.0095 Score=53.55 Aligned_cols=159 Identities=9% Similarity=0.020 Sum_probs=79.6
Q ss_pred cCHHHHHHHhcCCCCCCeee-----ecCceEEEEEEECCCCEEEEEEeccCCCcchHHHHHHHHHHHHhcCC-----Cee
Q 012267 132 FSLRELQVATDSFSNKNILG-----RGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVH-----RNL 201 (467)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-----~ni 201 (467)
.+.++++.....|.+.++.. .|---+.|+.+..+|+ +++|+........ ++..|++++..+.. |..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHH---HHHHHHHHHHhhhhcccccccc
Confidence 45677777778887765543 5556788999887664 8999886432222 34445555555532 222
Q ss_pred eeee-e--eeeCCCceEEEeeccCCCChhh--------------hhhcC---CC--CCCCCCHH----------------
Q 012267 202 LRLR-G--FCMTPTERLLVYPYMANGSVAS--------------CLRER---PP--SQLPLDWP---------------- 243 (467)
Q Consensus 202 v~~~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~---~~--~~~~l~~~---------------- 243 (467)
+... | +..-......++.++.+..... .++.. .. ........
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2111 0 0111234455666665432211 00100 00 00000000
Q ss_pred --HHHHHHHHHHHHHHHHHc-CCCCCcccCCCCCCcEEECCCCcEEEeecCCcc
Q 012267 244 --TRKRIALGSARGLSYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 294 (467)
Q Consensus 244 --~~~~i~~~ia~gl~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 294 (467)
.....+..+...+.-.+. ....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111122222222221 123379999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.39 E-value=0.0044 Score=57.90 Aligned_cols=72 Identities=15% Similarity=0.195 Sum_probs=47.3
Q ss_pred CeeeecCceEEEEEEECCC--------CEEEEEEeccCCCcchHHHHHHHHHHHHhcCCCee-eeeeeeeeCCCceEEEe
Q 012267 148 NILGRGGFGKVYKGRLADG--------SLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 218 (467)
Q Consensus 148 ~~lg~G~~g~V~~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 218 (467)
+.|+.|-.-.+|+....++ ..|.+++... . .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4688888899999987542 4566666542 2 223356678888887753344 366776643 6899
Q ss_pred eccCCCCh
Q 012267 219 PYMANGSV 226 (467)
Q Consensus 219 e~~~~gsL 226 (467)
||+++.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=93.01 E-value=0.013 Score=52.51 Aligned_cols=39 Identities=23% Similarity=0.415 Sum_probs=30.7
Q ss_pred cccCCCCCCeEEccc-CcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSN-NRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~-N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
+|++|++|++|||++ |+|+|.||.. ..+..+..+.+.+|
T Consensus 71 ~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N 111 (313)
T d1ogqa_ 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111 (313)
T ss_dssp GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEE
T ss_pred HHhcCccccccccccccccccccccccccccccchhhhccc
Confidence 688999999999996 8999999964 33455566667666
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=92.10 E-value=0.027 Score=50.23 Aligned_cols=43 Identities=30% Similarity=0.594 Sum_probs=29.7
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCcccccccccCCC
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANNLDLCG 45 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N~~Lcg 45 (467)
+++.+++|++||||+|+|+|.||+. ..+..+..+.+++| .++|
T Consensus 239 ~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N-~l~g 282 (313)
T d1ogqa_ 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN-NLCG 282 (313)
T ss_dssp GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS-EEEE
T ss_pred ccccccccccccCccCeecccCChHHhCCCCCCEEECcCC-cccc
Confidence 4567788888888888888888864 23444555666666 4554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.29 E-value=0.069 Score=46.27 Aligned_cols=22 Identities=32% Similarity=0.542 Sum_probs=10.9
Q ss_pred ccCCCCCCeEEcccCcccccCCC
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPD 25 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~ 25 (467)
+..+++|+.|||++|+|+ .||.
T Consensus 168 ~~~l~~L~~L~Ls~N~L~-~lp~ 189 (266)
T d1p9ag_ 168 LNGLENLDTLLLQENSLY-TIPK 189 (266)
T ss_dssp TTTCTTCCEEECCSSCCC-CCCT
T ss_pred cccccccceeecccCCCc-ccCh
Confidence 344455555555555555 4443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=89.57 E-value=0.11 Score=42.28 Aligned_cols=39 Identities=15% Similarity=0.296 Sum_probs=24.6
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.+..+++|+.|+||+|+|++..|.. ..+..+..+.+.+|
T Consensus 73 ~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N 112 (192)
T d1w8aa_ 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS
T ss_pred ccccccccceeeeccccccccCHHHHhCCCcccccccCCc
Confidence 3566788888888888888765543 22333444555555
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=89.44 E-value=0.077 Score=40.02 Aligned_cols=38 Identities=26% Similarity=0.435 Sum_probs=27.1
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.|.+|++|+.||||+|+|+ .||.. ..+..+..+...+|
T Consensus 15 ~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N 53 (124)
T d1dcea3 15 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN 53 (124)
T ss_dssp CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccc
Confidence 4678899999999999998 46642 33445555666666
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.11 E-value=0.16 Score=39.89 Aligned_cols=39 Identities=21% Similarity=0.291 Sum_probs=24.8
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
.|.+|++|+.|+|++|+|++.-|.. ..+..+..+.+.+|
T Consensus 51 ~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 51 DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp GSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred hhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 4677888888888888888765542 12333444555555
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=85.82 E-value=0.17 Score=38.05 Aligned_cols=19 Identities=37% Similarity=0.562 Sum_probs=10.2
Q ss_pred ccCCCCCCeEEcccCcccc
Q 012267 3 LTNISSLQVLDLSNNRLSG 21 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG 21 (467)
++.+++|+.|||++|++++
T Consensus 39 ~~~l~~L~~L~l~~N~i~~ 57 (124)
T d1dcea3 39 LAALRCLEVLQASDNALEN 57 (124)
T ss_dssp GGGCTTCCEEECCSSCCCC
T ss_pred hhhhhcccccccccccccc
Confidence 4455555555555555553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.76 E-value=0.29 Score=38.27 Aligned_cols=37 Identities=14% Similarity=0.222 Sum_probs=20.2
Q ss_pred ccCCCCCCeEEcccCc-ccccCCCC--CCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNR-LSGVVPDN--GSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~-lsG~iP~~--~~~~~~~~~~~~~N 40 (467)
|..+++|+.|+|++|+ |+. ||.. ..+..+..+.+.+|
T Consensus 27 l~~l~~l~~L~l~~n~~l~~-i~~~~f~~l~~L~~L~Ls~N 66 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQH-LELRDLRGLGELRNLTIVKS 66 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCE-ECGGGSCSCCCCSEEECCSS
T ss_pred ccCccccCeeecCCCccccc-cCchhhccccccCcceeecc
Confidence 4567788888887665 554 3321 22333444455555
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.70 E-value=0.28 Score=42.07 Aligned_cols=14 Identities=36% Similarity=0.392 Sum_probs=8.0
Q ss_pred CCCeEEcccCcccc
Q 012267 8 SLQVLDLSNNRLSG 21 (467)
Q Consensus 8 ~L~~ldls~N~lsG 21 (467)
+|++|||++|+|++
T Consensus 32 ~l~~L~Ls~N~i~~ 45 (266)
T d1p9ag_ 32 DTTILHLSENLLYT 45 (266)
T ss_dssp TCCEEECTTSCCSE
T ss_pred CCCEEECcCCcCCC
Confidence 45555666665554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.68 E-value=0.34 Score=38.13 Aligned_cols=38 Identities=24% Similarity=0.394 Sum_probs=21.2
Q ss_pred cccCCCCCCeEEcccCcccccCCCC-CCCCccCccccccc
Q 012267 2 SLTNISSLQVLDLSNNRLSGVVPDN-GSFSLFTPISFANN 40 (467)
Q Consensus 2 ~l~~l~~L~~ldls~N~lsG~iP~~-~~~~~~~~~~~~~N 40 (467)
++.++..|+.|||++|+++.. |.. ..+..+..+.+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N 51 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDN 51 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSS
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCC
Confidence 345666777777777777553 422 12344455556655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=82.23 E-value=0.27 Score=41.03 Aligned_cols=37 Identities=27% Similarity=0.451 Sum_probs=20.6
Q ss_pred ccCCCCCCeEEcccCcccccCCCCCCCCccCccccccc
Q 012267 3 LTNISSLQVLDLSNNRLSGVVPDNGSFSLFTPISFANN 40 (467)
Q Consensus 3 l~~l~~L~~ldls~N~lsG~iP~~~~~~~~~~~~~~~N 40 (467)
++++++|+.|||++|++++ ||....+..+..+.+.+|
T Consensus 169 l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N 205 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNN 205 (227)
T ss_dssp GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTS
T ss_pred hcccccceecccCCCccCC-ChhhcCCCCCCEEECcCC
Confidence 5667777777777777765 343223333444444444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=80.98 E-value=0.51 Score=38.11 Aligned_cols=33 Identities=21% Similarity=0.364 Sum_probs=17.9
Q ss_pred CCCeEEcccCcccccCCCC--CCCCccCccccccc
Q 012267 8 SLQVLDLSNNRLSGVVPDN--GSFSLFTPISFANN 40 (467)
Q Consensus 8 ~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~~~N 40 (467)
+|+.|||++|+|++.++.. ..+..+..+.+.+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N 64 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN 64 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSS
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeecccc
Confidence 5677777777777665543 12233344444444
|